data_1uem_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1uem _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 161.14 24.23 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 111.606 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.53 141.81 30.29 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 162.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -69.48 162.42 42.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.421 2.081 . . . . 0.0 113.031 -168.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.37 168.34 9.75 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.194 2.596 . . . . 0.0 112.825 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -74.83 169.97 16.84 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 110.199 168.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -56.22 134.23 75.27 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 167.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.37 164.9 16.41 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 CA-C-O 124.04 1.6 . . . . 0.0 112.697 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -105.25 172.12 6.96 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 128.909 2.884 . . . . 0.0 106.644 162.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -123.75 137.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.119 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.9 p -124.32 -90.66 0.56 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.699 0.625 . . . . 0.0 110.646 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.94 138.71 42.52 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 125.343 1.457 . . . . 0.0 107.914 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.47 155.05 22.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.48 1.037 . . . . 0.0 110.046 163.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -137.33 -159.88 1.0 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.208 1.403 . . . . 0.0 108.039 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -65.1 -31.61 72.9 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.545 167.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -152.54 1.66 0.32 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -113.66 152.55 30.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.178 0.899 . . . . 0.0 108.919 162.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -147.87 148.44 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.4 m -110.31 133.83 52.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.16 140.03 48.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.356 1.863 . . . . 0.0 107.004 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.76 135.17 49.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 174.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -138.72 171.57 14.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 120.582 1.537 . . . . 0.0 108.628 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.71 142.77 25.66 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.609 1.164 . . . . 0.0 108.7 168.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.4 170.49 20.11 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.769 2.313 . . . . 0.0 112.707 -161.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.47 -175.6 22.93 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 164.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.53 149.19 71.09 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.84 -179.81 5.54 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.652 2.901 . . . . 0.0 113.13 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.36 -99.02 0.15 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -57.83 -51.95 67.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.452 1.901 . . . . 0.0 110.565 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.61 166.26 25.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 124.271 1.028 . . . . 0.0 110.278 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.93 167.51 25.06 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.292 3.328 . . . . 0.0 109.382 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.51 25.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.962 1.705 . . . . 0.0 109.04 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -94.54 -57.23 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.326 1.051 . . . . 0.0 109.713 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.61 -171.24 2.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.269 0.94 . . . . 0.0 108.932 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.39 164.9 16.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -118.03 159.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.85 2.06 . . . . 0.0 106.484 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -124.2 134.31 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 158.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.32 160.98 15.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 166.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.84 162.38 34.13 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.328 1.851 . . . . 0.0 107.313 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -148.07 141.0 24.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -155.79 121.36 4.93 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.71 -34.84 74.99 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.24 0.543 . . . . 0.0 111.693 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.08 17.22 3.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.11 2.564 . . . . 0.0 114.033 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.2 -73.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 t -147.7 146.54 29.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.59 -0.31 2.75 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.173 1.389 . . . . 0.0 113.681 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -102.62 155.67 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.974 2.51 . . . . 0.0 111.882 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -74.74 136.05 41.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 153.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.19 155.16 49.82 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.112 0.869 . . . . 0.0 110.528 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.97 130.65 43.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.296 1.438 . . . . 0.0 107.801 170.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.6 -6.75 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.058 1.343 . . . . 0.0 112.149 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.52 152.73 36.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 149.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -135.81 140.88 44.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.127 1.371 . . . . 0.0 108.421 -172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.45 43.77 29.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.661 1.184 . . . . 0.0 111.863 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.77 126.17 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 126.136 1.774 . . . . 0.0 107.161 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -108.2 15.2 24.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.798 0.839 . . . . 0.0 112.17 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -129.45 175.31 8.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.773 1.629 . . . . 0.0 109.306 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.5 p -112.42 -5.73 14.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.538 2.335 . . . . 0.0 111.545 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -135.73 123.18 22.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -145.9 121.14 10.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.859 0.754 . . . . 0.0 112.31 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.4 m -69.84 103.66 2.26 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.682 1.993 . . . . 0.0 110.241 164.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 t -60.9 148.64 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 126.936 2.094 . . . . 0.0 107.932 158.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -140.2 175.32 9.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.055 1.342 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.47 7.68 87.08 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 123.803 0.716 . . . . 0.0 114.455 165.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.73 -171.66 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.62 1.168 . . . . 0.0 109.039 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -113.05 132.89 22.16 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -59.23 156.46 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.544 2.163 . . . . 0.0 112.28 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.1 t30 41.57 33.63 0.32 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.718 2.807 . . . . 0.0 113.78 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.8 m -120.66 135.73 55.03 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.386 1.874 . . . . 0.0 106.831 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.16 148.6 8.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.825 0.85 . . . . 0.0 109.081 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -141.36 149.49 41.21 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.733 1.213 . . . . 0.0 110.62 171.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -107.72 160.83 15.41 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.371 162.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.04 144.45 33.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 124.753 1.283 . . . . 0.0 108.521 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 62.0 mtm -130.45 153.49 48.72 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.08 148.27 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -131.9 136.14 47.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.755 1.222 . . . . 0.0 108.249 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 152.13 22.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.82 148.15 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.005 2.122 . . . . 0.0 109.141 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -148.5 178.04 1.59 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 109.239 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.48 -2.68 2.72 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.602 2.868 . . . . 0.0 117.117 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -129.54 -17.42 3.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.393 1.451 . . . . 0.0 113.582 -167.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.33 -176.79 45.96 Favored Glycine 0 C--O 1.238 0.357 0 CA-C-N 119.527 1.058 . . . . 0.0 111.209 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.97 151.69 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 157.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 83.1 p -71.47 168.79 16.76 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.867 1.267 . . . . 0.0 110.102 168.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -42.07 149.04 0.45 Allowed Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.849 153.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.15 164.27 36.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.809 1.672 . . . . 0.0 110.952 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.2 p -67.14 167.07 15.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 159.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.57 149.89 4.36 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.257 1.971 . . . . 0.0 112.363 151.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.0 mtm -65.36 143.15 57.93 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.43 0.692 . . . . 0.0 111.405 166.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.2 t -54.01 -23.12 12.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.175 2.19 . . . . 0.0 113.621 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.54 154.14 0.13 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 127.055 2.142 . . . . 0.0 110.193 -162.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -68.89 110.05 2.28 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.384 2.723 . . . . 0.0 111.554 -159.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -75.4 162.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.64 133.52 54.98 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 163.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.4 p -62.67 169.34 3.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 166.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -81.91 -116.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t0 . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.359 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -63.0 158.18 44.84 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.47 2.113 . . . . 0.0 110.85 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.92 143.08 48.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.2 152.93 79.96 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.877 1.718 . . . . 0.0 110.645 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -64.15 171.8 7.16 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.929 2.42 . . . . 0.0 111.646 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -74.12 174.56 8.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.623 0.769 . . . . 0.0 110.255 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -55.74 135.62 72.0 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.034 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.91 124.62 10.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.745 1.302 . . . . 0.0 109.95 160.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.64 171.46 12.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.636 161.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.31 136.54 60.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 p -126.33 -66.59 0.91 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.812 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -104.69 139.48 39.46 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.937 0.895 . . . . 0.0 109.097 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.14 142.75 24.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 119.677 1.126 . . . . 0.0 110.147 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 p -130.41 -176.31 3.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.263 1.825 . . . . 0.0 109.107 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -63.86 -17.77 63.49 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 120.868 -1.145 . . . . 0.0 113.307 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.34 13.13 1.08 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 120.357 -1.464 . . . . 0.0 113.113 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.76 160.39 40.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.231 0.923 . . . . 0.0 110.421 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.18 129.09 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.512 0.725 . . . . 0.0 109.284 170.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -81.05 120.39 24.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.196 0.998 . . . . 0.0 108.345 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -90.34 157.1 17.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.961 1.305 . . . . 0.0 109.116 166.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -149.01 99.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.13 0.972 . . . . 0.0 109.071 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -105.44 161.63 14.16 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.777 0.831 . . . . 0.0 109.083 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -95.45 147.55 33.2 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 165.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.19 171.77 16.18 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.79 2.993 . . . . 0.0 111.94 -167.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.42 177.48 33.48 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 168.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -107.57 157.69 35.14 Favored Pre-proline 0 N--CA 1.443 -0.793 0 C-N-CA 127.75 2.42 . . . . 0.0 109.874 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.42 -159.96 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 125.014 3.809 . . . . 0.0 113.073 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.38 -123.05 0.8 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 170.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 p -72.35 -27.62 62.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.981 1.712 . . . . 0.0 112.415 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 mt -136.33 149.23 67.17 Favored Pre-proline 0 C--O 1.24 0.56 0 C-N-CA 123.311 0.644 . . . . 0.0 112.244 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.54 163.94 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.541 3.494 . . . . 0.0 110.891 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.75 141.5 28.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -112.77 -32.53 6.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.007 1.723 . . . . 0.0 112.198 -168.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.87 -162.03 0.67 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 159.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.12 165.09 14.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.306 1.443 . . . . 0.0 108.384 157.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -116.71 152.56 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.736 2.414 . . . . 0.0 105.288 164.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.2 mt -127.59 135.18 63.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 166.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -121.16 159.4 25.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.87 161.52 36.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.131 1.372 . . . . 0.0 108.246 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -138.87 135.89 34.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 t -115.98 149.29 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.581 1.082 . . . . 0.0 108.123 155.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -80.53 16.26 1.41 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.966 0.506 . . . . 0.0 111.001 162.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -132.35 10.99 4.51 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.542 -1.349 . . . . 0.0 110.417 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.311 34.8 m -121.84 -91.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.9 m -119.32 5.32 11.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 121.436 1.925 . . . . 0.0 113.179 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.28 21.19 1.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.783 1.633 . . . . 0.0 112.925 -171.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.4 m -122.17 163.98 18.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.579 3.151 . . . . 0.0 108.896 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.77 144.88 25.6 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 165.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -138.24 143.14 39.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.33 96.0 1.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.423 1.089 . . . . 0.0 108.178 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -82.9 -16.95 11.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 121.86 -0.525 . . . . 0.0 110.969 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.95 134.53 22.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 162.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -121.01 136.67 54.93 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 52.6 69.93 0.63 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.746 2.019 . . . . 0.0 112.418 -171.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.0 129.87 39.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.579 1.552 . . . . 0.0 107.575 168.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -117.42 38.13 3.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.428 1.091 . . . . 0.0 110.573 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -151.75 -178.49 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.044 1.738 . . . . 0.0 107.515 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p -113.23 -2.52 14.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.095 2.558 . . . . 0.0 111.9 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.93 139.7 46.31 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -146.66 140.94 26.36 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.1 m -94.18 102.57 14.6 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 174.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.87 135.99 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -130.82 178.85 6.35 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.42 1.088 . . . . 0.0 110.778 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.01 6.68 74.32 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.93 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.4 mt -72.17 -176.72 1.87 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.625 1.212 . . . . 0.0 110.381 -172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.4 mtp85 -108.51 149.83 39.87 Favored Pre-proline 0 CA--C 1.513 -0.471 0 C-N-CA 125.25 1.42 . . . . 0.0 108.608 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.42 154.52 24.45 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.873 1.715 . . . . 0.0 111.638 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.62 16.99 0.34 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.894 2.078 . . . . 0.0 114.373 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.9 m -102.11 133.01 47.64 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.123 2.169 . . . . 0.0 108.354 -172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.7 mm -70.04 148.43 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.54 158.27 44.06 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.52 164.99 12.0 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.647 1.179 . . . . 0.0 108.437 160.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.56 145.67 33.83 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.722 1.889 . . . . 0.0 109.643 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.3 mtm -135.42 162.84 31.48 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.732 1.213 . . . . 0.0 107.916 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.64 143.27 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.787 2.035 . . . . 0.0 105.817 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -132.6 138.85 47.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 124.57 33.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -86.4 152.82 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.812 1.245 . . . . 0.0 108.518 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.88 168.02 11.84 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.513 1.925 . . . . 0.0 109.066 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.69 -9.87 8.19 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.391 3.394 . . . . 0.0 117.05 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -111.48 -43.26 3.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.462 1.505 . . . . 0.0 110.141 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.08 -149.65 6.21 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 119.063 0.847 . . . . 0.0 111.074 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 pp -129.85 158.98 37.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.662 1.585 . . . . 0.0 108.7 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.1 p -71.89 167.09 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 111.308 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -47.26 151.15 1.33 Allowed Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 154.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.7 148.19 52.39 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.431 1.421 . . . . 0.0 110.338 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.4 p -50.46 151.99 3.55 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.023 163.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -47.41 122.52 6.76 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.942 1.762 . . . . 0.0 107.88 153.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.8 ttm -58.11 148.67 25.79 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 124.212 1.005 . . . . 0.0 109.871 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.5 p -60.38 162.5 6.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 123.047 1.403 . . . . 0.0 109.471 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.63 154.53 68.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.658 164.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.68 92.6 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.198 2.599 . . . . 0.0 111.846 -175.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.2 m -84.17 163.44 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.525 1.53 . . . . 0.0 109.482 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.91 146.35 47.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 125.385 1.474 . . . . 0.0 109.006 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -61.58 161.7 9.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 159.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -75.75 178.32 6.21 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 168.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.833 0.825 . . . . 0.0 110.494 177.82 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -59.27 156.12 36.88 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.678 2.252 . . . . 0.0 112.12 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.37 120.84 21.76 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 153.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.08 161.51 44.51 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.235 2.623 . . . . 0.0 111.103 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.38 158.16 57.0 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.282 1.988 . . . . 0.0 110.712 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -71.21 175.16 5.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.918 0.487 . . . . 0.0 110.835 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 103' ' ' MET . 83.8 tttt -53.54 120.83 23.71 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -66.5 149.44 84.42 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 120.715 1.291 . . . . 0.0 109.374 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -79.21 170.94 15.89 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 161.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.0 t -122.68 121.61 63.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 129.151 2.981 . . . . 0.0 104.506 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.254 82.1 p -119.21 -84.81 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.859 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.71 150.07 37.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.106 1.321 . . . . 0.0 108.274 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.98 152.6 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.493 0.717 . . . . 0.0 109.769 163.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.4 p -141.21 -172.45 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 108.869 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -57.89 -37.08 73.33 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.141 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -136.19 17.21 3.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.866 1.666 . . . . 0.0 112.14 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -151.37 161.33 42.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.551 -1.343 . . . . 0.0 110.175 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.01 140.85 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.72 145.5 47.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.536 1.934 . . . . 0.0 107.522 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.68 114.47 9.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.446 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.468 ' CE2' ' HA ' ' A' ' 72' ' ' THR . 39.2 p90 -123.3 171.32 9.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.997 1.272 . . . . 0.0 110.208 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -97.87 144.98 28.98 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 165.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.24 133.3 24.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.192 3.261 . . . . 0.0 107.669 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.67 -178.54 43.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -62.1 152.95 76.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.069 1.348 . . . . 0.0 110.157 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.82 -148.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.911 3.741 . . . . 0.0 109.843 167.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -125.44 0.76 Allowed Glycine 0 C--N 1.333 0.4 0 O-C-N 118.941 -2.349 . . . . 0.0 109.478 163.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.3 p -49.78 -35.88 24.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.642 2.377 . . . . 0.0 110.112 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 mt -135.75 170.03 12.11 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 127.642 2.377 . . . . 0.0 109.495 -168.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.48 170.07 18.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.896 3.064 . . . . 0.0 110.003 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.23 22.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 m -53.49 -49.45 67.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.28 2.632 . . . . 0.0 111.919 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.15 -162.2 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.126 0.97 . . . . 0.0 108.594 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -131.92 168.81 17.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.056 1.742 . . . . 0.0 107.752 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.0 165.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 129.266 3.027 . . . . 0.0 106.622 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.11 136.08 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 162.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -114.31 161.72 17.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.327 1.051 . . . . 0.0 108.314 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.76 150.19 36.81 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.125 1.37 . . . . 0.0 109.086 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -127.3 141.13 51.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.347 1.459 . . . . 0.0 107.533 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -144.85 136.65 25.67 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 153.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.85 -37.36 81.81 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.932 165.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -76.31 16.33 0.48 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.066 2.146 . . . . 0.0 113.966 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.51 -77.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 125.324 1.45 . . . . 0.0 107.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.15 21.19 0.97 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.898 0.479 . . . . 0.0 110.287 -176.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 36.66 51.02 0.87 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.687 2.395 . . . . 0.0 111.885 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -143.37 143.48 31.67 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -66.51 136.83 56.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 153.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.97 145.25 39.51 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.896 1.278 . . . . 0.0 107.624 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.08 125.53 24.77 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.36 -6.37 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.278 1.031 . . . . 0.0 112.243 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.93 151.33 33.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 154.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -132.92 150.45 52.16 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 44.32 64.46 1.31 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.163 1.785 . . . . 0.0 110.683 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.77 -28.45 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.319 1.848 . . . . 0.0 112.067 -161.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mttt 60.62 15.18 5.51 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.581 2.352 . . . . 0.0 114.172 163.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -137.42 -177.66 4.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.229 1.412 . . . . 0.0 108.063 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.468 ' HA ' ' CE2' ' A' ' 36' ' ' TRP . 23.6 p -124.96 0.33 7.95 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.917 1.687 . . . . 0.0 111.351 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.71 112.2 10.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -145.58 151.5 38.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.059 0.845 . . . . 0.0 111.376 -175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -103.71 102.19 12.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.134 1.774 . . . . 0.0 109.06 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.41 139.73 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.559 1.544 . . . . 0.0 107.719 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -133.71 -170.25 2.46 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.814 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.6 73.49 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.668 -0.518 . . . . 0.0 112.688 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.41 -166.68 1.66 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.055 0.928 . . . . 0.0 109.346 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -116.44 155.13 48.92 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 126.706 2.002 . . . . 0.0 108.472 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.57 156.74 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.901 2.4 . . . . 0.0 111.835 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.8 t30 43.31 37.02 1.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.299 2.239 . . . . 0.0 112.712 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.3 m -121.89 131.25 53.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.992 1.717 . . . . 0.0 107.403 -174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.2 mm -69.06 149.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.903 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -140.3 149.02 42.27 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.028 0.918 . . . . 0.0 111.289 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.92 162.58 13.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.129 156.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.85 166.71 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.707 1.88 . . . . 0.0 110.465 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 17.5 mtt -134.14 168.68 18.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 157.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.11 109.32 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -90.76 140.69 29.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.7 148.17 26.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.98 147.6 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 165.34 17.65 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -174.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.3 -20.89 71.43 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.457 1.438 . . . . 0.0 115.199 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.7 -38.66 11.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.398 1.479 . . . . 0.0 111.503 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.44 -149.7 6.28 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 118.905 0.775 . . . . 0.0 111.537 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.71 156.63 35.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.351 1.861 . . . . 0.0 106.424 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.4 p -76.05 167.39 21.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.621 0.768 . . . . 0.0 112.741 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.22 164.77 0.57 Allowed Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 122.055 -0.403 . . . . 0.0 111.116 161.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.12 127.43 6.02 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.709 2.273 . . . . 0.0 110.452 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.8 p -49.07 155.45 1.12 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 111.678 163.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -59.18 123.88 14.4 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.901 2.401 . . . . 0.0 108.698 164.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' MET . . . . . 0.422 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 4.3 mpp? -55.59 124.62 17.94 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.448 1.022 . . . . 0.0 109.933 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 p -54.68 -16.03 2.23 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.889 2.475 . . . . 0.0 115.356 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 92.04 146.5 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.421 1 C-N-CA 132.607 4.363 . . . . 0.0 109.575 168.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.29 107.81 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.394 2.729 . . . . 0.0 111.211 -153.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.47 169.52 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -126.8 148.14 49.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.71 1.604 . . . . 0.0 108.086 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.7 p -76.64 167.81 21.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.805 0.812 . . . . 0.0 110.966 166.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -77.32 178.25 7.28 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.719 -0.613 . . . . 0.0 110.119 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 123.945 0.898 . . . . 0.0 110.423 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.76 141.02 77.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.446 1.431 . . . . 0.0 109.775 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.34 138.75 45.44 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 163.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.36 153.49 55.87 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.276 1.984 . . . . 0.0 111.918 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.71 161.74 40.43 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.488 1.459 . . . . 0.0 110.343 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -77.48 173.82 11.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.105 0.562 . . . . 0.0 109.744 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -51.99 125.31 31.33 Favored Pre-proline 0 C--O 1.239 0.518 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.487 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.54 135.82 47.44 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.699 1.6 . . . . 0.0 109.78 169.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -91.37 134.47 34.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.841 1.256 . . . . 0.0 108.197 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.49 143.61 15.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 167.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 p -127.51 -97.45 0.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.84 135.69 56.8 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 126.05 1.74 . . . . 0.0 109.152 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.71 148.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.5 1.045 . . . . 0.0 110.654 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -137.82 -169.72 2.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.622 1.569 . . . . 0.0 109.547 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -57.55 -41.17 80.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.377 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -136.58 12.63 3.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.298 0.954 . . . . 0.0 112.481 -169.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -141.82 158.43 43.81 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.472 1.033 . . . . 0.0 110.336 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.97 134.14 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.318 1.047 . . . . 0.0 108.782 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -85.6 130.32 34.6 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 108.984 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.9 mt -109.49 146.12 35.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.003 1.721 . . . . 0.0 107.835 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.538 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.82 102.34 3.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.778 1.299 . . . . 0.0 107.993 -163.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -119.87 158.76 25.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.062 0.846 . . . . 0.0 110.986 -175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -81.77 134.94 49.5 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 164.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.3 157.76 56.14 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.868 3.045 . . . . 0.0 109.008 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.58 -176.62 35.58 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.752 1.168 . . . . 0.0 111.653 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 150.57 68.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.073 1.349 . . . . 0.0 109.855 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.11 -167.66 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 125.237 3.958 . . . . 0.0 112.54 169.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.61 -109.39 0.25 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 169.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 p -66.63 -46.09 76.94 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.105 2.162 . . . . 0.0 111.17 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.1 mt -128.46 162.27 51.92 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 124.14 0.976 . . . . 0.0 109.793 -164.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.14 145.28 27.51 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 108.159 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.84 158.38 25.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 -47.99 1.98 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.101 -170.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.23 -166.26 0.88 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -128.78 162.04 28.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.155 1.782 . . . . 0.0 109.217 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.84 152.19 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 128.733 2.813 . . . . 0.0 106.718 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.2 mt -137.94 105.22 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -101.04 136.67 40.51 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.743 1.217 . . . . 0.0 108.755 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -110.72 165.21 12.01 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.015 1.326 . . . . 0.0 109.258 174.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -137.89 145.26 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.804 1.242 . . . . 0.0 107.85 170.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -154.46 119.79 5.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -66.22 -19.06 65.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.63 12.77 22.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.019 0.928 . . . . 0.0 111.37 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.22 -59.82 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -158.86 137.56 11.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.384 1.874 . . . . 0.0 108.079 171.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.03 -17.51 63.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.001 0.819 . . . . 0.0 111.617 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 m -68.3 143.28 55.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.611 -0.68 . . . . 0.0 109.548 169.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -67.15 144.83 55.82 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -125.67 118.18 25.09 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 m -74.93 93.43 2.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.25 -17.67 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 0.0 111.076 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.28 149.47 34.92 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.97 147.97 42.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.477 1.911 . . . . 0.0 106.216 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.423 ' O ' ' HE2' ' A' ' 70' ' ' LYS . 8.9 m170 57.99 51.2 9.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.04 0.936 . . . . 0.0 111.211 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.2 t -82.61 139.11 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.389 1.476 . . . . 0.0 107.335 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 68' ' ' HIS . 3.5 mtmt -119.15 25.36 10.21 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.62 1.168 . . . . 0.0 112.243 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.2 t -143.93 173.2 11.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.177 0.991 . . . . 0.0 108.828 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -103.56 2.51 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.127 2.171 . . . . 0.0 112.042 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.538 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 4.7 tp -140.04 114.83 9.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.972 1.709 . . . . 0.0 107.425 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -145.65 120.97 10.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 118.148 0.431 . . . . 0.0 111.9 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.7 m -66.8 101.4 0.81 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.485 1.914 . . . . 0.0 109.08 164.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.92 144.83 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 162.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 50.7 mtt-85 -136.91 178.58 6.97 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.23 1.412 . . . . 0.0 110.502 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.56 80.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 123.5 0.571 . . . . 0.0 112.557 170.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.08 -172.75 4.33 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.704 0.752 . . . . 0.0 110.291 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -114.25 146.62 36.17 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 125.563 1.545 . . . . 0.0 107.811 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.71 154.12 30.39 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.492 2.128 . . . . 0.0 110.374 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.62 44.95 17.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.664 1.186 . . . . 0.0 111.465 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.9 m -131.13 136.26 48.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 mm -74.15 146.65 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.189 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.87 148.65 48.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.052 0.845 . . . . 0.0 109.457 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 12.8 mt -109.25 161.02 15.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.617 -1.174 . . . . 0.0 107.899 158.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -143.85 143.12 31.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 126.001 2.063 . . . . 0.0 107.814 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 13.2 mtm -136.67 125.65 24.33 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 129.209 3.004 . . . . 0.0 107.479 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.1 t -94.59 145.78 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -131.63 128.6 39.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 167.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 125.12 33.97 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.27 148.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.549 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -135.77 179.81 1.27 Allowed Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.221 1.809 . . . . 0.0 107.403 166.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.67 -0.1 9.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 122.4 1.893 . . . . 0.0 113.812 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -116.72 -37.91 3.57 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.981 1.312 . . . . 0.0 110.301 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.26 -141.39 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.9 159.52 42.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.753 2.421 . . . . 0.0 106.729 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.0 p -72.05 166.61 21.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.333 0.653 . . . . 0.0 110.244 -169.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.31 148.42 3.28 Favored Pre-proline 0 C--O 1.244 0.771 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 160.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.33 130.17 20.63 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.923 1.749 . . . . 0.0 108.631 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -54.62 161.73 2.05 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.119 0.568 . . . . 0.0 111.817 165.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.93 138.14 69.36 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.342 2.028 . . . . 0.0 110.649 159.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -58.64 150.24 23.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.913 0.779 . . . . 0.0 109.999 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 88.2 p -63.14 -4.58 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.25 149.87 0.11 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.935 1.694 . . . . 0.0 110.808 -163.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.01 99.02 1.13 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.134 1.889 . . . . 0.0 112.636 -164.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.46 155.22 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.432 0.693 . . . . 0.0 109.167 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -108.1 150.95 26.53 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.108 1.363 . . . . 0.0 109.901 166.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.4 p -77.7 167.95 20.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.789 0.804 . . . . 0.0 111.407 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -77.45 178.82 6.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.275 0.63 . . . . 0.0 109.943 169.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 109.404 170.952 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.43 149.6 84.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.434 2.089 . . . . 0.0 111.26 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -51.79 134.25 35.36 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.88 154.71 72.79 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.996 1.898 . . . . 0.0 111.361 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -60.81 168.55 6.92 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.743 2.295 . . . . 0.0 111.772 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.86 171.67 12.27 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -61.22 144.47 91.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.58 129.1 19.3 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.496 1.464 . . . . 0.0 111.337 161.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -81.64 158.18 24.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.017 2.127 . . . . 0.0 109.218 158.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.99 121.19 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.337 -1.756 . . . . 0.0 107.141 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.1 p -116.2 -95.67 0.47 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.329 -167.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.27 143.28 41.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.6 1.56 . . . . 0.0 109.653 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.37 148.96 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.719 0.808 . . . . 0.0 110.685 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 p -135.8 -168.33 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.399 1.48 . . . . 0.0 108.021 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -71.11 -16.32 62.56 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.444 -1.41 . . . . 0.0 112.642 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -152.36 15.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.099 -1.626 . . . . 0.0 112.633 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -139.43 161.85 36.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.46 140.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.446 1.499 . . . . 0.0 108.111 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -92.74 126.47 37.84 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.33 1.052 . . . . 0.0 108.642 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -107.35 139.8 41.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.133 1.773 . . . . 0.0 107.363 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -134.64 138.69 44.7 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -139.32 171.19 14.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.199 0.523 . . . . 0.0 111.474 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -98.87 148.83 35.1 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.24 161.49 17.67 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.546 2.831 . . . . 0.0 111.44 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.1 -173.3 49.56 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 165.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.41 171.78 11.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.158 1.383 . . . . 0.0 108.588 169.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.31 -156.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.151 3.234 . . . . 0.0 109.565 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.9 -131.75 2.75 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 167.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -55.53 -27.58 49.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.942 2.097 . . . . 0.0 112.118 164.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.9 mt -144.58 162.39 39.28 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 127.612 2.365 . . . . 0.0 109.543 -156.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.37 158.34 36.84 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.091 3.194 . . . . 0.0 110.989 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.68 128.9 41.67 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.96 -27.53 10.12 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.129 0.572 . . . . 0.0 111.508 -165.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.75 -165.97 1.64 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 160.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -128.83 169.74 14.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.785 2.034 . . . . 0.0 109.354 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.75 157.1 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 127.608 2.363 . . . . 0.0 107.214 171.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -125.43 133.08 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 165.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -113.4 158.42 20.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.78 146.68 46.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.368 1.067 . . . . 0.0 108.223 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -109.34 146.88 33.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 166.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.53 124.94 5.21 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.677 0.671 . . . . 0.0 109.346 170.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.54 -34.97 72.86 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -169.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 7.41 11.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.85 0.75 . . . . 0.0 112.276 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.5 t -121.68 -55.34 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.717 1.207 . . . . 0.0 107.944 -171.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 t -141.31 -98.3 0.14 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 p30 140.49 -17.18 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.778 2.831 . . . . 0.0 111.119 -149.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -119.02 150.98 39.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.294 1.038 . . . . 0.0 110.187 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -70.6 121.86 18.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -118.84 143.52 46.9 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.323 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.92 93.95 3.3 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.66 -15.43 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.084 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.08 152.38 30.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.103 0.961 . . . . 0.0 108.944 161.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -142.93 170.24 16.07 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.762 0.825 . . . . 0.0 111.355 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 51.97 38.19 23.08 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.915 0.864 . . . . 0.0 112.422 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.65 127.84 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 125.845 1.658 . . . . 0.0 108.449 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -113.34 29.96 7.58 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.701 0.801 . . . . 0.0 112.253 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -150.47 173.6 13.88 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 108.305 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -98.48 2.9 48.12 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.658 2.383 . . . . 0.0 112.186 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.28 117.1 10.98 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.583 1.083 . . . . 0.0 110.325 -176.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -146.1 151.41 37.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.545 0.738 . . . . 0.0 111.591 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -101.19 103.4 14.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.142 1.377 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.1 139.21 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -139.93 176.07 9.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 111.386 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.77 79.59 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.63 0.633 . . . . 0.0 112.35 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.42 -175.79 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.489 0.715 . . . . 0.0 110.403 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -98.16 145.06 29.16 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.043 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -75.61 159.38 39.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.73 2.953 . . . . 0.0 111.686 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.6 t30 45.54 38.13 3.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.645 1.978 . . . . 0.0 111.842 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.2 m -132.18 134.13 45.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.538 1.135 . . . . 0.0 108.817 -170.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.34 141.52 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.09 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -139.17 154.48 48.08 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 125.056 1.473 . . . . 0.0 108.077 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.25 165.69 11.31 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.051 1.34 . . . . 0.0 108.302 164.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -137.28 140.07 41.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.952 0.782 . . . . 0.0 109.953 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 28.2 mtm -118.86 167.71 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 161.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.94 155.82 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -133.78 141.66 47.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 165.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.54 142.81 27.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 165.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.74 147.07 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 124.492 1.117 . . . . 0.0 109.243 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.81 171.2 6.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.95 22.64 0.47 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 123.683 2.922 . . . . 0.0 114.929 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -131.55 -34.3 1.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.905 1.682 . . . . 0.0 111.201 172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.14 -165.26 33.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.515 1.052 . . . . 0.0 111.035 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -98.5 148.55 23.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 p -73.07 166.42 23.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.1 143.76 15.8 Favored Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 126.823 2.049 . . . . 0.0 110.301 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.99 127.77 22.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.858 1.705 . . . . 0.0 113.07 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -54.37 160.68 2.4 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.669 1.988 . . . . 0.0 112.666 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.94 120.79 8.74 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.136 1.891 . . . . 0.0 109.354 156.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 ptp -77.58 151.76 34.29 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 120.194 1.361 . . . . 0.0 109.182 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.4 t -58.95 154.47 15.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.464 1.106 . . . . 0.0 109.402 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.48 150.02 57.7 Favored Pre-proline 0 N--CA 1.475 0.792 0 O-C-N 120.874 -1.141 . . . . 0.0 109.465 158.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.09 102.98 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.104 2.536 . . . . 0.0 110.905 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.03 163.29 3.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -122.07 141.66 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.986 1.314 . . . . 0.0 107.655 164.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 p -68.07 161.08 27.58 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -66.74 -175.27 0.38 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.995 1.379 . . . . 0.0 109.205 163.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.065 -174.819 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 119.421 -0.323 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.02 150.57 83.51 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.285 1.99 . . . . 0.0 108.872 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.37 147.97 41.61 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 163.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.52 147.1 63.67 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.143 1.896 . . . . 0.0 111.431 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -66.0 165.14 24.85 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.411 2.074 . . . . 0.0 110.528 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.2 p -67.71 169.39 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.787 -0.571 . . . . 0.0 110.763 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -48.62 127.65 13.54 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.538 155.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.48 142.82 45.67 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.787 1.317 . . . . 0.0 110.261 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.43 161.4 26.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.53 1.532 . . . . 0.0 109.351 163.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -124.35 105.21 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -110.65 -62.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.838 1.655 . . . . 0.0 111.124 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -111.02 136.0 50.69 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.216 1.807 . . . . 0.0 110.738 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.26 150.39 17.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 119.855 1.207 . . . . 0.0 110.588 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.5 p -139.88 -174.54 3.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.345 1.858 . . . . 0.0 107.818 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -24.77 61.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.385 -1.447 . . . . 0.0 112.461 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -131.81 4.65 4.2 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.167 1.349 . . . . 0.0 110.959 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 m -150.78 163.61 38.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.525 1.511 . . . . 0.0 110.356 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 p -156.74 136.76 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.145 1.378 . . . . 0.0 108.155 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -80.3 140.72 36.04 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -114.55 150.05 35.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 t -138.16 134.68 34.85 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.447 1.099 . . . . 0.0 108.515 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -138.98 170.23 16.35 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 110.387 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.32 138.08 25.8 Favored Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 164.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.66 140.45 47.08 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.99 3.127 . . . . 0.0 107.62 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 163.07 43.35 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 m -73.3 143.36 82.95 Favored Pre-proline 0 N--CA 1.433 -1.308 0 C-N-CA 126.009 1.723 . . . . 0.0 110.938 -164.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.53 -169.13 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.438 3.426 . . . . 0.0 111.758 166.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.82 -114.09 0.54 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 163.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -47.05 -40.68 15.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.763 2.825 . . . . 0.0 112.607 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 mt -134.7 163.24 52.58 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.273 1.029 . . . . 0.0 109.277 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.62 171.31 15.9 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.664 2.909 . . . . 0.0 110.809 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.03 107.14 16.91 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.253 1.021 . . . . 0.0 109.064 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.4 m -58.91 -51.4 70.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.144 2.578 . . . . 0.0 112.388 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.0 -164.88 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.973 -1.079 . . . . 0.0 108.191 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.72 164.23 24.44 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.9 2.08 . . . . 0.0 108.63 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mt -120.34 154.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 127.131 2.172 . . . . 0.0 106.563 161.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.62 124.97 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 156.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -100.78 151.92 21.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -131.61 151.38 51.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -123.47 151.0 43.18 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -140.53 136.17 32.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -56.85 -50.84 71.21 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.599 163.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -73.7 25.37 0.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.04 2.936 . . . . 0.0 113.469 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -135.7 -62.55 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.43 -5.38 0.66 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -165.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t30 46.63 36.52 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.372 1.469 . . . . 0.0 111.931 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.8 m -149.97 157.85 43.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 128.412 2.685 . . . . 0.0 105.187 -169.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.91 154.02 21.15 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -136.34 146.03 46.1 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.8 m -71.32 128.5 36.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.16 -12.36 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.18 74.94 0.93 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.347 1.859 . . . . 0.0 108.834 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.71 144.64 29.23 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.21 2.604 . . . . 0.0 109.185 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 38.32 60.81 1.23 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.911 2.085 . . . . 0.0 111.8 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.53 145.56 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 40.68 3.63 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.17 1.388 . . . . 0.0 110.355 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -148.0 -176.93 5.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -114.99 2.31 14.21 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.675 2.79 . . . . 0.0 110.991 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mp -135.43 143.85 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.531 0.733 . . . . 0.0 109.271 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -146.26 129.74 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 m -71.6 94.49 1.33 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.377 1.471 . . . . 0.0 107.515 161.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.97 138.02 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.99 179.82 6.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.917 1.287 . . . . 0.0 110.045 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.42 22.15 79.07 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.862 -0.41 . . . . 0.0 112.38 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt -87.0 172.36 10.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.576 1.179 . . . . 0.0 110.087 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 mtt85 -103.4 149.73 37.3 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 125.668 1.587 . . . . 0.0 107.345 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.11 160.02 40.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.779 1.653 . . . . 0.0 110.338 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 t30 46.5 33.15 1.85 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.018 1.327 . . . . 0.0 111.633 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.8 m -119.99 126.91 52.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.59 148.19 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.208 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -139.92 146.65 39.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.289 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 13.7 mt -107.92 156.69 18.92 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 160.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -137.33 146.7 44.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.683 1.865 . . . . 0.0 107.816 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 45.0 mtm -134.53 137.84 44.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 160.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.95 139.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -120.43 146.53 46.12 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 168.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 163.97 16.49 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.46 150.86 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 126.665 1.986 . . . . 0.0 108.806 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.85 169.91 9.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 0.0 110.165 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.98 19.24 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.06 2.506 . . . . 0.0 114.982 -174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -127.85 -58.71 1.22 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 126.288 1.835 . . . . 0.0 110.091 166.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.66 -173.36 17.82 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 121.836 0.686 . . . . 0.0 113.983 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mp -81.69 157.08 24.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.6 p -71.64 168.43 17.71 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.875 0.87 . . . . 0.0 109.757 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -41.6 142.19 1.07 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 151.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.59 156.15 64.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.676 1.584 . . . . 0.0 109.346 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 p -68.59 166.53 25.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.891 -0.505 . . . . 0.0 110.296 164.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -54.58 146.53 53.08 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 111.17 163.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.9 mtm -60.2 144.85 49.08 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.29 0.496 . . . . 0.0 110.14 171.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.0 p -62.93 -11.39 18.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.238 1.815 . . . . 0.0 115.175 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 t0 69.62 156.46 0.15 Allowed Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.411 -153.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -76.07 101.15 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.411 2.074 . . . . 0.0 111.375 -173.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.27 165.45 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -127.34 141.05 51.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.559 2.344 . . . . 0.0 107.612 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.6 p -74.39 161.14 30.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.044 0.838 . . . . 0.0 109.527 163.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -67.22 165.66 15.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.745 0.783 . . . . 0.0 109.896 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.5 t0 . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 123.608 1.67 . . . . 0.0 112.498 -172.16 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.93 164.91 30.89 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.22 2.613 . . . . 0.0 111.457 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.97 149.65 49.5 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.75 141.01 44.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.334 2.689 . . . . 0.0 110.857 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -65.74 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.689 1.593 . . . . 0.0 110.203 170.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m -79.96 171.19 15.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -57.25 122.1 51.93 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.099 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.97 156.41 62.67 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.5 1.466 . . . . 0.0 109.358 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.75 124.68 43.91 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.88 151.24 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.787 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 p -136.53 -75.65 0.43 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.541 0.736 . . . . 0.0 109.47 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.12 135.46 37.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.77 157.19 20.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 162.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -141.13 -64.97 0.44 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -168.24 -39.25 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.208 2.203 . . . . 0.0 107.414 171.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -129.22 5.04 5.26 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.916 0.886 . . . . 0.0 110.863 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -152.5 152.17 31.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.592 0.633 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -153.59 127.31 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.8 m -77.98 148.09 34.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -128.35 138.97 52.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 126.647 1.979 . . . . 0.0 108.256 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -134.3 94.91 3.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.789 1.306 . . . . 0.0 110.74 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -109.26 170.72 7.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.901 0.858 . . . . 0.0 111.225 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -101.53 140.09 20.95 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 166.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.01 171.19 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.521 2.814 . . . . 0.0 109.26 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.75 -130.44 2.48 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.619 -2.193 . . . . 0.0 107.619 160.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.08 165.77 20.72 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 125.177 1.391 . . . . 0.0 107.916 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.84 -147.68 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.991 1 C-N-CA 125.892 4.395 . . . . 0.0 110.201 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.16 -91.68 0.12 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -62.78 -52.97 61.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 126.136 1.774 . . . . 0.0 109.928 172.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.6 mt -133.69 163.9 47.86 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 110.818 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.52 174.27 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.968 3.112 . . . . 0.0 110.856 167.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.85 108.1 19.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -54.82 -53.06 60.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.489 2.315 . . . . 0.0 111.913 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.08 -166.36 1.69 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 0.0 107.255 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -131.03 160.27 35.08 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.622 1.969 . . . . 0.0 107.929 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mt -118.73 156.19 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.12 2.168 . . . . 0.0 107.564 167.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.8 128.51 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -148.23 139.15 23.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.648 1.179 . . . . 0.0 107.84 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.89 129.96 55.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.326 1.45 . . . . 0.0 108.149 170.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.5 112.93 8.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.14 -20.66 60.87 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 3.45 26.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.357 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.04 -80.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.252 1.821 . . . . 0.0 106.695 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -133.12 -5.41 3.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.932 0.787 . . . . 0.0 112.888 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 54.57 42.93 30.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.934 0.873 . . . . 0.0 111.497 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.8 m -140.64 152.39 45.36 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 127.161 2.184 . . . . 0.0 106.946 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.468 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 93.0 m95 -72.17 132.84 44.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 157.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -125.54 151.78 45.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.352 1.461 . . . . 0.0 107.294 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.64 127.68 33.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.1 -3.67 10.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.641 0.776 . . . . 0.0 111.23 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.1 126.82 8.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.766 1.627 . . . . 0.0 108.454 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -115.06 139.89 49.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.767 0.827 . . . . 0.0 110.02 165.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 50.32 69.9 0.57 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.148 2.579 . . . . 0.0 114.637 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.7 141.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -124.2 32.67 5.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.904 0.882 . . . . 0.0 112.029 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.32 165.18 27.88 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -90.34 0.48 57.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.81 1.644 . . . . 0.0 112.595 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -132.5 133.06 43.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 108.78 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -146.72 152.17 38.38 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 127.197 2.199 . . . . 0.0 109.17 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -111.25 112.95 25.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.084 1.354 . . . . 0.0 108.626 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.7 t -66.22 143.57 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.64 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -136.25 -175.09 3.87 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.671 0.788 . . . . 0.0 110.723 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.87 17.93 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.509 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.7 mt -85.79 -163.39 0.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.676 1.238 . . . . 0.0 109.112 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -135.84 139.42 30.57 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.59 158.49 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.431 2.754 . . . . 0.0 111.121 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 48.64 31.31 2.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.235 1.814 . . . . 0.0 113.251 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.5 m -124.44 136.38 53.99 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.518 1.527 . . . . 0.0 108.396 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.6 mm -76.58 148.04 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 124.637 1.175 . . . . 0.0 109.413 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -139.54 153.93 47.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.64 2.376 . . . . 0.0 106.335 171.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 11.2 mt -112.64 157.0 21.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.359 1.463 . . . . 0.0 107.918 154.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -127.03 157.99 38.14 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.692 1.997 . . . . 0.0 110.013 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.468 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 20.0 mtt -128.71 155.89 44.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.85 2.06 . . . . 0.0 106.634 164.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.9 t -122.3 141.81 41.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 162.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -132.34 146.29 51.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.07 156.96 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.46 152.74 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 127.217 2.207 . . . . 0.0 107.226 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.3 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.297 1.039 . . . . 0.0 110.263 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -59.67 2.87 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.996 3.131 . . . . 0.0 116.463 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -127.91 -37.8 1.89 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.952 1.701 . . . . 0.0 112.018 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.28 -150.49 8.45 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -170.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.71 157.33 35.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.48 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.1 p -72.5 166.48 22.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.164 0.986 . . . . 0.0 111.598 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -44.61 152.97 0.49 Allowed Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 156.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.14 142.07 49.61 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.239 1.959 . . . . 0.0 110.895 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 94.0 p -60.04 165.41 4.86 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.181 0.592 . . . . 0.0 111.131 156.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.2 141.65 94.06 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 158.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.66 147.68 45.08 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.678 -1.264 . . . . 0.0 111.777 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 p -57.31 -18.16 15.58 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.598 2.759 . . . . 0.0 116.381 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 88.06 150.74 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 128.613 2.765 . . . . 0.0 107.156 -153.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.2 109.14 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.98 2.454 . . . . 0.0 108.709 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.2 127.72 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.218 1.007 . . . . 0.0 109.539 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 140.59 30.04 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.8 p -64.19 164.84 10.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -78.75 -175.99 4.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 122.302 1.049 . . . . 0.0 108.426 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.697 164.652 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 119.376 -0.345 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.96 150.45 38.35 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.774 2.316 . . . . 0.0 109.799 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 159.57 53.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.148 1.356 . . . . 0.0 112.381 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.14 124.32 12.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.145 2.563 . . . . 0.0 109.784 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.56 165.77 14.9 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.73 2.287 . . . . 0.0 112.456 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -70.42 162.13 29.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.567 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -56.38 121.91 46.01 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.687 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.88 142.76 94.38 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.59 1.527 . . . . 0.0 111.119 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -122.42 131.91 54.11 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.179 1.392 . . . . 0.0 110.102 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -80.27 142.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.104 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 p -135.64 -42.18 0.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.814 -166.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.28 145.33 48.33 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.794 1.238 . . . . 0.0 108.42 166.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.37 151.38 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.449 1.099 . . . . 0.0 108.099 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -125.24 -43.03 1.96 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -168.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 pttt 143.34 -27.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 1 C-N-CA 133.719 4.808 . . . . 0.0 110.071 -174.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -138.94 -4.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.101 1.76 . . . . 0.0 109.995 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.01 156.47 47.79 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.823 2.049 . . . . 0.0 106.937 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -154.37 128.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.6 m -80.42 137.05 36.46 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.1 mt -125.82 146.39 49.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 126.576 1.95 . . . . 0.0 106.925 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.6 116.96 11.28 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 125.15 1.531 . . . . 0.0 108.263 -166.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -139.03 156.91 46.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.453 1.024 . . . . 0.0 109.55 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.47 144.87 29.42 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.097 0.559 . . . . 0.0 109.96 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.65 117.68 3.72 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.594 2.862 . . . . 0.0 110.841 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 174.99 30.72 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 124.734 1.159 . . . . 0.0 110.391 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.3 m -61.65 153.69 69.63 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 129.091 2.956 . . . . 0.0 110.781 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.96 -173.23 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.239 2.626 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.11 -160.87 9.41 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 104.578 -3.409 . . . . 0.0 104.578 160.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.38 -50.03 63.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.141 -1.529 . . . . 0.0 109.69 166.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.32 161.58 32.35 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.689 1.131 . . . . 0.0 112.203 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.96 153.11 9.82 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 124.384 3.389 . . . . 0.0 110.23 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.91 37.8 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.896 0.855 . . . . 0.0 111.138 170.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.11 -59.93 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.406 1.482 . . . . 0.0 107.798 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.67 -170.47 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.382 1.073 . . . . 0.0 109.045 -165.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -111.9 163.17 14.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.391 1.876 . . . . 0.0 108.269 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.22 152.12 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.573 2.349 . . . . 0.0 107.099 157.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.29 108.38 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -99.89 158.95 15.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.53 150.88 44.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.758 2.023 . . . . 0.0 107.742 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -128.01 150.25 50.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.69 117.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.995 0.902 . . . . 0.0 110.54 171.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -67.1 -36.45 81.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.432 -0.793 . . . . 0.0 111.465 -173.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -71.9 5.98 2.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.114 2.166 . . . . 0.0 113.685 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.56 -69.36 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.4 m -158.83 121.05 3.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.221 2.208 . . . . 0.0 105.471 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -72.18 82.42 1.0 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.593 0.633 . . . . 0.0 109.72 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -170.47 159.26 6.84 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.535 2.734 . . . . 0.0 107.524 168.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -76.69 142.35 40.57 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 161.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -130.71 139.64 50.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.278 1.431 . . . . 0.0 107.943 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -88.46 94.07 9.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.5 -15.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.691 1.196 . . . . 0.0 113.044 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.48 149.73 39.58 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 156.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.88 154.07 51.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 62.32 29.11 17.25 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.8 134.43 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 120.698 -1.252 . . . . 0.0 108.193 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -106.16 -8.49 17.37 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.81 -174.44 3.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.009 1.723 . . . . 0.0 109.297 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.8 p -120.57 0.97 10.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.364 1.866 . . . . 0.0 111.929 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -130.64 137.91 49.83 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.261 -0.899 . . . . 0.0 108.72 161.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.16 145.47 30.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.765 0.711 . . . . 0.0 109.084 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.0 m -89.21 106.67 18.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.072 1.749 . . . . 0.0 108.578 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.33 151.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.334 1.054 . . . . 0.0 108.223 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -135.6 -176.16 4.19 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.494 1.518 . . . . 0.0 110.777 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.41 7.64 85.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.968 1.27 . . . . 0.0 114.004 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.56 -177.49 6.55 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 123.148 1.451 . . . . 0.0 110.238 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -118.54 151.04 49.19 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 126.49 1.916 . . . . 0.0 108.422 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.74 156.64 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.385 2.723 . . . . 0.0 109.929 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 53.58 26.14 5.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.788 1.235 . . . . 0.0 111.854 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.1 m -119.68 129.19 54.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.115 1.766 . . . . 0.0 107.758 -170.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.84 144.98 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.69 153.7 47.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 109.178 168.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.08 162.3 14.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.074 1.35 . . . . 0.0 107.506 160.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -139.69 135.18 32.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 125.099 1.499 . . . . 0.0 107.889 172.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.4 mtm -124.45 135.16 53.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.97 144.37 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -120.9 150.99 40.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 160.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 165.15 15.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.47 152.41 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 127.232 2.213 . . . . 0.0 108.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.92 178.17 1.78 Allowed Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.888 0.875 . . . . 0.0 111.329 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.67 -4.06 1.72 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.586 3.524 . . . . 0.0 117.905 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -130.45 -37.18 1.41 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.402 1.455 . . . . 0.0 111.394 -170.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.83 -170.84 34.75 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -168.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 mp -97.89 166.16 11.59 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.469 1.108 . . . . 0.0 109.046 166.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 91.4 p -72.08 167.73 19.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.665 0.786 . . . . 0.0 110.07 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -48.81 150.56 2.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.051 -0.405 . . . . 0.0 110.153 153.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.7 132.98 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.745 2.297 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.8 p -59.03 168.83 1.33 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.8 0.84 . . . . 0.0 112.66 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.13 136.35 37.8 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.374 2.716 . . . . 0.0 112.237 161.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 149.73 33.49 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.974 0.806 . . . . 0.0 109.583 165.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 76.5 p -60.31 -9.43 3.46 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.593 1.957 . . . . 0.0 115.89 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.6 147.0 0.11 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.073 2.149 . . . . 0.0 109.604 -155.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.21 118.83 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.677 2.251 . . . . 0.0 110.066 -168.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 m -114.45 131.58 66.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.882 1.273 . . . . 0.0 110.457 -174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 145.21 31.7 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 p -71.37 168.41 17.47 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.53 0.732 . . . . 0.0 110.829 162.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -65.39 -167.86 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.018 1.39 . . . . 0.0 110.1 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 113.516 -163.328 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -67.18 169.65 14.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.373 2.049 . . . . 0.0 110.922 167.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.38 168.06 49.69 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.38 1.467 . . . . 0.0 112.124 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.61 132.69 31.73 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.109 2.54 . . . . 0.0 108.844 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.09 165.37 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.7 1.6 . . . . 0.0 111.817 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.02 163.54 27.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.303 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 11.0 tmtt? -50.29 119.04 10.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.135 171.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -67.21 160.14 48.91 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 CA-C-N 120.082 1.065 . . . . 0.0 110.47 172.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -135.93 125.89 25.94 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.963 2.105 . . . . 0.0 107.975 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.13 149.27 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.6 p -134.06 -41.45 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.427 0.691 . . . . 0.0 110.169 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -123.44 145.09 49.08 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 109.146 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.82 145.82 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 119.758 1.163 . . . . 0.0 108.552 164.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.2 p -134.11 -169.12 2.25 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.533 1.133 . . . . 0.0 108.913 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -66.51 -16.49 64.17 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 120.857 -1.152 . . . . 0.0 113.35 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -156.35 6.2 0.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -123.64 160.07 27.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.201 1.364 . . . . 0.0 111.297 165.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.59 136.85 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -96.61 142.13 29.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.1 mt -134.74 133.79 40.3 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.073 1.749 . . . . 0.0 108.255 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 6.9 t -118.96 130.23 55.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 129.371 3.068 . . . . 0.0 108.311 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -139.12 170.94 15.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -104.87 148.59 36.35 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 162.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.58 160.66 44.96 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.202 2.601 . . . . 0.0 109.703 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.02 174.15 43.75 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -57.64 155.02 22.74 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 126.466 1.906 . . . . 0.0 110.074 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.86 -175.86 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.525 2.817 . . . . 0.0 111.892 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.02 -147.45 7.94 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 105.575 -3.01 . . . . 0.0 105.575 168.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -33.84 64.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 165.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.38 157.42 33.75 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 123.181 0.593 . . . . 0.0 112.052 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.88 150.28 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.794 3.662 . . . . 0.0 110.034 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 125.58 28.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.383 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -49.21 28.06 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.436 172.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.18 -165.18 1.28 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.434 1.015 . . . . 0.0 110.184 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.89 161.55 32.76 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.831 0.852 . . . . 0.0 109.943 167.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -118.84 158.26 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 128.203 2.601 . . . . 0.0 106.806 167.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mt -126.02 129.24 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 163.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -105.89 153.86 21.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.231 1.412 . . . . 0.0 108.112 171.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.1 127.68 20.12 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.493 1.517 . . . . 0.0 110.209 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -91.74 149.35 21.65 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.233 1.413 . . . . 0.0 107.772 169.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.22 113.56 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.338 1.066 . . . . 0.0 112.477 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.35 -38.56 81.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 112.844 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 m -73.87 8.43 2.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.943 1.297 . . . . 0.0 113.382 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.49 -72.54 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 124.268 1.027 . . . . 0.0 108.895 -168.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.1 t -150.38 12.88 0.74 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.631 0.772 . . . . 0.0 110.058 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 61.02 -79.73 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.593 2.357 . . . . 0.0 111.753 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.57 162.11 0.04 OUTLIER 'General case' 0 C--O 1.234 0.26 0 C-N-CA 129.664 3.186 . . . . 0.0 114.895 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 94.9 m95 -67.79 138.28 56.05 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -124.54 142.56 51.25 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -72.73 107.21 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -95.68 -28.28 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 0.0 111.655 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 138.07 31.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 135.47 41.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 50.04 68.83 0.69 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.798 2.039 . . . . 0.0 110.923 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.4 t -84.97 -53.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.93 1.292 . . . . 0.0 113.623 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 mttt 66.21 -23.66 0.1 Allowed 'General case' 0 C--N 1.316 -0.884 1 C-N-CA 131.79 4.036 . . . . 0.0 115.578 170.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.42 173.09 8.35 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.388 1.449 . . . . 0.0 108.607 168.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.04 -4.71 20.17 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.958 168.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.489 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 5.4 tp -121.17 131.71 54.4 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 121.596 1.998 . . . . 0.0 110.211 160.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -134.61 152.8 52.04 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.283 1.033 . . . . 0.0 109.432 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -112.77 101.07 9.18 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.355 1.862 . . . . 0.0 107.203 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.98 143.56 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 162.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -139.01 178.93 6.8 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.36 1.864 . . . . 0.0 108.2 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 24.29 67.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.414 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.1 mt -82.1 -173.54 4.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.624 1.17 . . . . 0.0 109.772 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -112.22 141.9 25.9 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 117.694 -1.146 . . . . 0.0 109.228 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.79 157.47 61.62 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.21 1.94 . . . . 0.0 112.156 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 41.62 42.64 2.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.477 1.911 . . . . 0.0 112.339 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.4 m -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.252 1.421 . . . . 0.0 107.817 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.57 147.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.73 155.63 46.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.038 167.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.77 163.12 13.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.87 132.38 26.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.414 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 41.0 mtm -131.4 165.6 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 123.895 0.747 . . . . 0.0 109.338 161.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.5 t -132.21 140.36 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.976 1.71 . . . . 0.0 107.284 -166.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -132.1 132.03 42.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.5 118.67 26.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.34 145.7 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -141.52 173.84 4.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.712 1.205 . . . . 0.0 108.096 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -73.26 31.63 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.34 2.693 . . . . 0.0 114.075 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -134.04 -67.83 0.58 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.325 1.85 . . . . 0.0 106.657 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.55 -148.26 4.73 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.914 1.245 . . . . 0.0 112.159 -167.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 mt -122.7 142.21 50.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.539 3.136 . . . . 0.0 106.398 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.9 p -72.33 166.96 21.45 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.359 0.6 . . . . 0.0 112.116 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -60.35 158.0 31.39 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 124.568 1.147 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.22 122.59 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.944 1.762 . . . . 0.0 111.983 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 p -60.5 157.79 34.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.454 1.501 . . . . 0.0 111.784 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 128.66 24.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.812 3.008 . . . . 0.0 110.506 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.8 mtt -56.27 150.66 14.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.082 1.764 . . . . 0.0 111.451 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.443 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 1.5 p -69.9 -1.61 10.03 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 81.82 155.54 0.12 Allowed Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 131.119 3.768 . . . . 0.0 108.874 -167.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.61 117.6 5.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.279 2.653 . . . . 0.0 109.171 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.97 144.68 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 123.599 0.76 . . . . 0.0 109.385 -171.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -104.32 138.51 40.66 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 123.38 0.672 . . . . 0.0 109.925 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -67.29 169.06 9.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.969 168.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -82.73 175.7 9.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.733 0.778 . . . . 0.0 110.007 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.749 164.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -60.0 142.63 98.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.381 2.721 . . . . 0.0 110.473 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.02 142.64 38.31 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 161.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.18 145.95 96.13 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.179 1.919 . . . . 0.0 110.187 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -64.68 157.96 52.93 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.72 1.613 . . . . 0.0 109.987 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -68.47 166.48 16.76 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.222 0.609 . . . . 0.0 110.37 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -46.03 121.83 5.98 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.21 1.004 . . . . 0.0 109.242 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -60.26 146.29 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -113.28 125.14 53.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.219 1.408 . . . . 0.0 109.007 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.58 112.54 18.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -102.31 -82.7 0.48 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.6 139.37 40.61 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -137.33 145.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 p -125.88 -173.58 2.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.183 0.993 . . . . 0.0 108.613 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -14.87 53.74 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -163.57 26.47 0.08 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.092 1.315 . . . . 0.0 112.939 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -146.93 161.87 39.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 107.982 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -158.26 136.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.126 0.97 . . . . 0.0 108.482 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -91.13 110.94 22.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.033 1.333 . . . . 0.0 107.942 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -93.11 140.84 29.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.805 1.242 . . . . 0.0 109.224 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.61 99.21 3.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.612 1.195 . . . . 0.0 108.887 -163.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -119.05 172.81 7.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.532 1.133 . . . . 0.0 109.674 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -118.79 145.57 38.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.99 143.9 29.63 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.671 2.914 . . . . 0.0 110.779 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.47 175.68 52.84 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 170.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -62.18 146.15 92.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.884 1.274 . . . . 0.0 109.167 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.13 -168.7 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.953 3.769 . . . . 0.0 112.42 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.31 -149.51 5.54 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -37.81 68.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.562 1.145 . . . . 0.0 110.673 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mt -111.95 167.31 9.32 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.714 0.806 . . . . 0.0 111.913 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.88 -130.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 124.628 3.552 . . . . 0.0 108.299 164.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.6 161.8 24.01 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 127.669 2.388 . . . . 0.0 106.622 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -105.84 -35.38 7.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.132 2.173 . . . . 0.0 110.502 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.74 -159.42 0.08 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.744 1.217 . . . . 0.0 109.626 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -128.82 169.24 14.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.445 2.298 . . . . 0.0 108.161 162.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.76 155.15 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.051 2.94 . . . . 0.0 106.031 167.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.5 mt -122.54 132.8 70.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -118.17 158.31 25.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.32 46.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 109.979 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -131.28 168.17 17.98 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.093 2.557 . . . . 0.0 105.833 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.6 t -144.12 -42.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.898 1.226 . . . . 0.0 113.676 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 115.95 -48.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.437 1 C-N-CA 133.234 4.614 . . . . 0.0 108.652 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -87.41 -36.68 17.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.533 0.733 . . . . 0.0 111.786 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.71 -62.17 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 123.591 0.757 . . . . 0.0 109.066 -159.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -160.26 98.81 1.3 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.5 -9.63 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.5 m -39.73 -39.6 0.8 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 129.122 2.969 . . . . 0.0 116.366 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.8 m95 61.34 140.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.16 1.384 . . . . 0.0 111.299 -138.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -134.11 152.9 52.04 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 134.21 50.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 165.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.0 -8.76 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.33 0.652 . . . . 0.0 111.616 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.94 138.46 17.71 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.158 1.783 . . . . 0.0 107.258 158.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -116.18 158.31 23.48 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m170 51.47 51.67 16.3 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.844 1.307 . . . . 0.0 112.218 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.87 110.69 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 127.112 2.165 . . . . 0.0 106.629 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -106.58 52.04 0.73 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.243 1.417 . . . . 0.0 108.203 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -158.39 -171.98 3.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.926 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.4 p -127.78 -3.75 5.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.967 1.307 . . . . 0.0 112.25 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -125.75 121.12 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.863 1.665 . . . . 0.0 107.476 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -145.35 117.51 8.37 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.445 0.64 . . . . 0.0 111.365 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -71.89 98.53 2.03 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.408 2.283 . . . . 0.0 108.802 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.6 143.69 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -136.77 172.69 12.64 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.538 1.535 . . . . 0.0 109.208 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.94 2.96 58.18 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.045 1.307 . . . . 0.0 113.055 170.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.8 mt -78.14 178.2 7.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 117.691 0.745 . . . . 0.0 109.607 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -96.67 146.74 31.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.203 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.64 158.79 46.88 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.376 2.717 . . . . 0.0 111.146 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.39 21.75 1.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.166 2.587 . . . . 0.0 112.876 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -119.28 121.37 39.48 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mm -59.27 147.44 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -138.51 152.83 48.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.582 162.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.4 mt -107.08 156.04 19.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.106 163.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -141.78 133.45 27.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.451 1.719 . . . . 0.0 107.843 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 15.5 mtt -112.34 156.09 23.04 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.526 2.331 . . . . 0.0 106.903 170.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.76 113.09 31.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 167.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -97.47 147.72 23.95 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.29 -1.506 . . . . 0.0 107.203 167.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.7 158.33 19.46 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.69 152.49 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 126.118 1.767 . . . . 0.0 107.323 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -139.97 172.71 5.94 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 127.186 2.195 . . . . 0.0 108.576 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 -19.15 27.72 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.807 2.338 . . . . 0.0 113.352 166.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -115.58 -11.13 11.77 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.63 -160.88 29.54 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -113.09 162.7 15.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.892 1.277 . . . . 0.0 110.802 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.4 p -77.82 168.55 19.75 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.053 2.141 . . . . 0.0 112.953 -171.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.45 149.73 0.97 Allowed Pre-proline 0 C--O 1.242 0.699 0 O-C-N 121.18 -0.95 . . . . 0.0 110.029 155.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.36 129.46 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.842 2.361 . . . . 0.0 109.717 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 p -52.61 162.08 1.01 Allowed Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.53 1.532 . . . . 0.0 113.458 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -63.8 125.96 16.45 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 109.818 158.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 57.6 mtm -55.53 148.2 16.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.798 -0.564 . . . . 0.0 111.418 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 -8.14 47.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.7 t0 85.04 153.35 0.11 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 130.605 3.562 . . . . 0.0 110.107 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -70.01 105.46 1.53 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.228 1.952 . . . . 0.0 111.516 -165.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.9 m -103.06 142.74 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.366 1.067 . . . . 0.0 109.361 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.0 141.39 32.89 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 109.295 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.1 p -72.89 151.04 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.174 0.59 . . . . 0.0 110.623 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.12 -178.76 2.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 112.07 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 N--CA 1.461 0.108 0 O-C-N 121.449 -0.782 . . . . 0.0 112.868 -178.152 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.08 156.71 53.29 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.195 2.597 . . . . 0.0 111.665 -168.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.61 152.09 48.24 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.64 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -67.64 141.16 54.02 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.264 1.976 . . . . 0.0 109.164 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.03 153.37 78.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.213 1.275 . . . . 0.0 109.189 162.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -74.03 177.87 5.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.678 0.791 . . . . 0.0 110.8 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -47.33 120.34 6.89 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 117.379 -1.296 . . . . 0.0 108.631 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.76 137.49 58.88 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -119.93 121.06 38.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.476 1.511 . . . . 0.0 108.822 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 149.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.202 173.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 p -129.35 -93.75 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.77 143.51 56.87 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.101 0.96 . . . . 0.0 109.615 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.91 141.8 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 p -128.21 -169.18 2.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.55 1.14 . . . . 0.0 108.541 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -61.61 -23.85 66.3 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 121.219 -0.926 . . . . 0.0 112.568 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -154.93 10.85 0.35 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.754 -1.216 . . . . 0.0 113.538 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -120.42 164.54 16.22 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.624 0.647 . . . . 0.0 110.833 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 p -153.48 134.26 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 165.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.1 m -88.53 114.45 25.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -93.72 138.49 31.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.844 1.658 . . . . 0.0 108.559 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -117.9 138.38 52.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.624 2.37 . . . . 0.0 107.189 170.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -139.8 170.92 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.734 0.414 . . . . 0.0 110.079 166.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 142.4 24.51 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.27 128.42 11.26 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.801 3.667 . . . . 0.0 109.546 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.52 167.96 54.63 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -85.49 154.95 59.67 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.769 1.228 . . . . 0.0 110.158 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.85 -158.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 125.193 3.928 . . . . 0.0 110.279 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.26 -112.7 0.46 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -58.74 -48.93 79.49 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.6 mt -140.82 148.09 51.12 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 125.068 1.347 . . . . 0.0 110.669 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 141.09 18.79 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.879 3.052 . . . . 0.0 110.14 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 109.34 1.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.604 1.561 . . . . 0.0 108.647 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.1 m -61.01 -62.46 1.84 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.377 2.271 . . . . 0.0 110.802 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.14 -166.72 2.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -121.73 163.77 18.52 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.201 1.4 . . . . 0.0 108.62 165.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mt -115.9 162.73 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.391 2.276 . . . . 0.0 107.315 162.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.04 129.76 72.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 161.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.58 150.86 30.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 160.37 32.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 107.467 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -133.6 147.86 51.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.58 117.48 4.42 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -75.09 -26.63 59.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.483 -0.761 . . . . 0.0 111.983 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -81.06 17.07 1.31 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.29 1.036 . . . . 0.0 111.398 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -128.29 -71.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 m -151.53 1.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.5 50.78 16.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.378 1.444 . . . . 0.0 110.68 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -135.31 146.52 48.56 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.767 1.227 . . . . 0.0 108.38 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -72.88 108.86 6.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 161.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -100.0 134.65 42.61 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.652 1.981 . . . . 0.0 108.053 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -78.74 94.76 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.4 -15.81 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.609 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.7 150.11 30.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.017 1.28 . . . . 0.0 108.576 164.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -142.82 161.81 37.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.951 0.341 . . . . 0.0 111.208 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 47.35 55.11 8.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.754 1.222 . . . . 0.0 111.332 -171.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -91.92 129.63 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 29.83 7.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.723 0.809 . . . . 0.0 111.848 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -136.76 174.27 10.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.022 1.329 . . . . 0.0 107.505 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.5 p -120.28 0.0 10.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.871 1.668 . . . . 0.0 111.687 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.18 104.35 5.87 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.27 150.93 50.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.952 1.301 . . . . 0.0 109.718 -169.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.5 m -103.51 106.02 16.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -62.54 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -139.72 176.04 9.07 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.27 1.028 . . . . 0.0 112.269 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.95 84.43 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 124.81 1.195 . . . . 0.0 112.616 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -74.67 179.43 4.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.296 1.046 . . . . 0.0 109.768 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -104.12 138.05 19.41 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.039 -1.458 . . . . 0.0 108.241 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.19 147.17 59.49 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.523 2.149 . . . . 0.0 112.112 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.9 t30 44.94 42.02 5.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.53 2.332 . . . . 0.0 112.526 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.1 m -129.38 136.61 50.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 127.091 2.156 . . . . 0.0 106.524 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.0 mm -72.44 145.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.966 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -140.62 155.27 46.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.343 1.457 . . . . 0.0 109.388 168.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.3 mt -108.24 166.18 10.94 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 126.229 1.811 . . . . 0.0 108.912 162.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.36 136.91 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 125.092 1.495 . . . . 0.0 111.257 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.9 mtt -105.38 151.37 24.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 160.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.21 149.58 6.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 154.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -125.11 139.58 53.64 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.29 151.03 23.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 165.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.07 152.12 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.87 1.668 . . . . 0.0 108.628 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -151.69 -176.84 0.62 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.608 1.563 . . . . 0.0 109.186 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.29 -14.08 27.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.227 . . . . 0.0 115.577 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -116.41 -14.04 10.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.031 1.332 . . . . 0.0 112.402 -164.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.04 -143.8 10.17 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 pp -140.02 160.98 38.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.33 1.852 . . . . 0.0 110.061 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 97.3 p -72.21 168.06 19.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 126.908 2.083 . . . . 0.0 114.463 -166.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -32.25 145.45 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 123.56 0.744 . . . . 0.0 109.914 145.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.35 132.48 31.56 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.175 1.917 . . . . 0.0 109.095 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 p -61.4 154.58 62.97 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.554 163.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.04 142.22 91.76 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.899 2.399 . . . . 0.0 110.303 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.6 mmt -53.12 131.92 37.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -17.01 16.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.961 1.704 . . . . 0.0 112.187 170.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t0 70.44 161.68 0.15 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.733 2.013 . . . . 0.0 109.265 -158.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -74.75 121.68 6.83 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.974 2.449 . . . . 0.0 111.072 -175.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.57 158.43 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.011 0.925 . . . . 0.0 108.997 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.48 137.22 43.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.102 1.361 . . . . 0.0 108.369 163.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.9 p -66.04 164.79 14.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.781 0.8 . . . . 0.0 109.53 158.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -80.79 173.5 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.403 1.097 . . . . 0.0 109.749 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.5 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.3 mt . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -63.07 166.46 14.39 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.378 3.385 . . . . 0.0 113.144 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 147.08 50.41 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.793 -1.004 . . . . 0.0 110.607 165.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.3 157.63 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.918 2.412 . . . . 0.0 112.047 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.78 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.346 2.031 . . . . 0.0 110.877 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.3 m -74.58 166.75 23.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.634 0.774 . . . . 0.0 110.933 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.39 127.04 16.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 116.78 -1.581 . . . . 0.0 109.576 168.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.62 159.25 22.06 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.75 2.3 . . . . 0.0 114.306 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -107.5 129.41 54.96 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 128.778 2.831 . . . . 0.0 107.849 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.59 153.78 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 p -132.04 -90.27 0.42 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.74 120.29 25.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.318 -172.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -120.32 147.95 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 119.738 1.154 . . . . 0.0 110.789 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.4 p -141.3 -167.2 2.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.684 1.594 . . . . 0.0 107.731 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -65.04 -33.59 76.41 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -149.2 17.32 0.95 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.667 -1.27 . . . . 0.0 112.763 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -136.64 150.43 48.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.98 132.68 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.804 1.241 . . . . 0.0 109.413 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.2 m -79.4 139.61 37.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.045 0.938 . . . . 0.0 109.412 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.38 144.19 45.2 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.46 2.304 . . . . 0.0 107.227 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.64 131.94 40.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.133 2.573 . . . . 0.0 106.506 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -139.26 172.07 13.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.274 1.03 . . . . 0.0 109.315 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.18 141.94 24.52 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.74 162.66 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.334 2.689 . . . . 0.0 111.094 -168.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 169.06 36.1 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 122.468 1.038 . . . . 0.0 110.952 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -65.3 147.16 98.78 Favored Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 126.99 2.116 . . . . 0.0 111.135 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.37 174.69 9.65 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 125.206 3.937 . . . . 0.0 113.911 166.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.93 -118.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.706 1.146 . . . . 0.0 110.314 -174.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.6 p -69.15 -37.51 78.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.151 1.78 . . . . 0.0 112.752 -162.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 mt -138.38 158.27 70.96 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 123.04 0.536 . . . . 0.0 111.216 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.13 165.46 32.35 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.298 2.665 . . . . 0.0 109.915 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.18 121.1 44.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.74 -33.04 25.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.331 0.652 . . . . 0.0 111.995 -162.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.47 -167.77 1.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.867 1.667 . . . . 0.0 106.561 167.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -118.08 166.19 12.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.42 154.56 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.013 2.525 . . . . 0.0 106.305 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 135.82 61.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -117.99 154.84 31.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.91 163.17 33.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.91 1.284 . . . . 0.0 109.034 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -140.16 145.54 37.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.05 1.74 . . . . 0.0 107.139 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 t -134.3 166.23 23.3 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 155.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -99.64 14.41 30.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.679 1.192 . . . . 0.0 111.957 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 t -139.26 21.52 2.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.302 1.841 . . . . 0.0 110.982 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.579 HG22 ' H ' ' A' ' 59' ' ' SER . 15.5 m -121.89 -85.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.764 1.226 . . . . 0.0 108.044 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.579 ' H ' HG22 ' A' ' 58' ' ' VAL . 28.7 m -139.19 8.66 2.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.795 2.038 . . . . 0.0 110.39 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 54.33 22.97 4.04 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.27 2.228 . . . . 0.0 113.683 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.7 m -116.35 159.32 22.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.943 0.897 . . . . 0.0 110.943 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -73.63 138.88 45.09 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 157.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.62 139.39 36.71 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 m -63.21 95.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.588 1.155 . . . . 0.0 108.277 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.6 m -87.22 -17.54 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.124 -0.985 . . . . 0.0 112.016 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.81 131.79 22.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 165.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -117.67 152.83 34.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 43.8 67.83 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.608 1.563 . . . . 0.0 112.491 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -98.64 118.54 45.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.596 1.158 . . . . 0.0 108.455 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.65 50.79 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.89 175.47 13.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.458 1.903 . . . . 0.0 107.388 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -125.39 12.42 8.14 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.003 1.721 . . . . 0.0 113.12 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mp -129.43 140.95 51.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 109.564 147.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -145.2 151.65 38.76 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.58 1.152 . . . . 0.0 108.419 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -109.94 108.79 19.18 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.868 1.667 . . . . 0.0 108.767 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -60.11 140.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 165.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -130.44 -177.63 4.42 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.428 1.091 . . . . 0.0 108.874 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.15 37.76 41.82 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 mt -108.0 -178.68 3.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 110.393 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -103.58 139.32 19.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 125.491 1.516 . . . . 0.0 109.391 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.75 159.33 42.34 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.049 2.499 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 55.28 15.51 1.36 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.481 1.912 . . . . 0.0 112.903 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -119.76 139.41 52.34 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.813 1.645 . . . . 0.0 110.149 -164.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.41 148.67 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.694 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -142.09 162.24 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.921 0.888 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.2 mt -124.86 162.81 23.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 125.841 1.656 . . . . 0.0 108.929 165.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -138.57 155.74 48.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 125.476 1.735 . . . . 0.0 110.968 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 6.8 mtt -129.22 167.07 18.19 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 126.525 1.93 . . . . 0.0 106.972 160.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.0 t -132.06 146.34 33.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 168.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -136.38 134.02 37.38 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.219 1.407 . . . . 0.0 107.244 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 126.21 34.72 Favored 'General case' 0 C--O 1.228 -0.076 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.59 152.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.773 0.829 . . . . 0.0 108.971 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.62 168.9 10.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.506 0.722 . . . . 0.0 109.83 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -72.38 19.61 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.153 2.569 . . . . 0.0 113.845 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -121.13 -65.35 1.15 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.513 1.525 . . . . 0.0 107.531 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.81 -127.44 1.89 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.397 1.475 . . . . 0.0 110.969 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 pp -139.23 145.74 39.61 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.525 2.33 . . . . 0.0 107.443 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.0 p -72.58 165.99 23.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.277 1.031 . . . . 0.0 109.869 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -54.85 142.95 53.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.565 -0.71 . . . . 0.0 109.188 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.99 133.15 42.8 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.435 1.423 . . . . 0.0 108.992 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.4 p -54.69 156.02 6.98 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.373 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -47.63 143.79 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.1 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 35.2 mtm -57.9 146.93 30.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.724 0.773 . . . . 0.0 110.299 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -65.26 0.2 1.5 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.062 -1.923 . . . . 0.0 115.81 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.2 t70 68.74 153.69 0.14 Allowed Pre-proline 0 N--CA 1.476 0.834 0 CA-C-N 121.147 1.794 . . . . 0.0 108.398 -154.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -67.47 113.26 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.006 2.471 . . . . 0.0 109.648 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.36 165.09 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -124.06 142.59 51.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 166.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 p -72.98 160.69 31.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.081 0.552 . . . . 0.0 110.745 165.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -79.14 -178.44 6.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.934 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.1 t70 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 125.285 1.434 . . . . 0.0 111.394 175.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.34 147.87 60.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.653 2.235 . . . . 0.0 109.169 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 155.41 50.23 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.13 140.97 81.08 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.43 2.086 . . . . 0.0 108.179 171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.09 172.06 7.96 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.287 1.991 . . . . 0.0 111.037 170.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -66.29 170.57 5.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.95 0.9 . . . . 0.0 110.1 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -49.76 124.81 16.45 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-O 117.593 -1.194 . . . . 0.0 107.796 160.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.06 136.0 46.25 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 CA-C-N 120.205 1.109 . . . . 0.0 109.352 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -78.77 164.55 24.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.176 1.465 . . . . 0.0 107.095 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 t -124.4 112.45 32.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.14 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -109.45 -82.5 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -167.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.07 134.47 47.08 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.245 1.418 . . . . 0.0 108.267 171.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -140.03 135.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.812 1.187 . . . . 0.0 108.545 163.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.0 p -110.68 -74.1 0.66 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -168.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -163.93 -26.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 129.641 3.177 . . . . 0.0 110.036 163.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -140.41 9.33 2.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.839 1.256 . . . . 0.0 112.287 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -126.99 160.66 30.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.851 0.75 . . . . 0.0 110.452 162.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -151.65 133.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.624 1.57 . . . . 0.0 106.946 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -79.98 132.64 36.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.7 142.08 35.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.291 1.437 . . . . 0.0 108.16 167.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.48 ' CB ' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -140.19 111.46 7.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.802 1.314 . . . . 0.0 108.466 -173.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -129.22 171.35 12.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.901 0.773 . . . . 0.0 109.56 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -124.84 145.48 50.02 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -74.72 144.07 30.86 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.461 2.774 . . . . 0.0 109.573 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.31 -175.78 49.73 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m -57.67 133.39 82.57 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 123.503 0.721 . . . . 0.0 111.506 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.02 -171.67 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.627 2.885 . . . . 0.0 113.417 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.68 -125.14 0.8 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 156.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -66.8 -23.03 66.01 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 128.992 2.917 . . . . 0.0 113.242 -160.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.3 mt -131.75 172.08 7.98 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.971 2.108 . . . . 0.0 109.356 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.38 -136.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.582 3.521 . . . . 0.0 107.774 163.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.61 120.15 5.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -35.71 78.59 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.345 1.058 . . . . 0.0 112.483 -170.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.3 -167.86 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.227 1.011 . . . . 0.0 108.707 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -123.36 169.22 11.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.404 2.282 . . . . 0.0 108.273 164.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -127.27 156.02 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 130.734 3.613 . . . . 0.0 105.721 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.3 mt -128.63 136.71 59.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 164.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.69 153.36 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 108.175 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.14 128.76 22.98 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.767 1.227 . . . . 0.0 109.461 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.64 151.3 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.787 1.635 . . . . 0.0 107.197 171.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.28 105.87 1.0 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.106 -0.372 . . . . 0.0 110.359 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.94 -31.36 72.43 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -171.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 m -105.36 49.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.081 1.352 . . . . 0.0 110.218 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -134.85 -88.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 160.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.67 3.85 7.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.387 1.875 . . . . 0.0 110.401 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.49 -71.64 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.796 2.038 . . . . 0.0 109.758 -170.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -36.74 148.89 0.02 OUTLIER 'General case' 0 C--O 1.238 0.474 0 C-N-CA 130.437 3.495 . . . . 0.0 115.418 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -65.44 134.76 54.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.329 1.452 . . . . 0.0 108.079 171.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -129.9 130.2 44.86 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.25 94.86 0.17 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.07 -13.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.358 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.86 26.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.296 0.953 . . . . 0.0 109.475 162.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.46 26.11 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.4 m170 40.98 63.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.683 1.993 . . . . 0.0 111.915 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.25 138.26 24.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 C-N-CA 128.073 2.549 . . . . 0.0 108.115 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 29.15 5.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.869 0.867 . . . . 0.0 111.695 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.74 152.95 44.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.8 p -88.28 2.97 51.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.291 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.48 ' CD1' ' CB ' ' A' ' 35' ' ' SER . 8.4 tp -136.32 121.62 19.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.635 2.374 . . . . 0.0 107.693 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -146.39 139.23 25.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.427 1.012 . . . . 0.0 112.271 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -81.0 99.68 8.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.827 2.051 . . . . 0.0 108.492 170.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.0 143.58 15.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -131.69 178.14 6.98 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.247 1.419 . . . . 0.0 110.374 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 23.48 68.93 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.27 -159.32 0.73 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -134.98 140.85 36.23 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-O 117.753 -1.118 . . . . 0.0 109.437 -172.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.17 158.91 51.08 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.935 2.423 . . . . 0.0 110.588 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.04 45.44 3.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.967 2.107 . . . . 0.0 112.294 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -136.22 128.14 29.39 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 125.845 1.658 . . . . 0.0 107.889 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mm -65.17 145.61 13.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -134.57 158.29 44.37 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.626 1.571 . . . . 0.0 108.085 159.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mt -107.26 162.22 14.08 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 154.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.47 148.54 49.27 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.9 mtm -130.86 167.97 18.05 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 158.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.34 154.4 16.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -132.26 141.47 49.02 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 160.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.03 153.78 22.51 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.19 150.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.612 1.565 . . . . 0.0 107.44 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -163.36 160.2 18.13 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.52 10.67 2.42 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.177 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -120.56 15.21 11.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.563 2.345 . . . . 0.0 110.23 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.99 176.47 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 124.896 1.236 . . . . 0.0 110.778 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mp -81.91 165.6 20.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.1 p -72.47 167.13 21.23 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.155 0.979 . . . . 0.0 110.144 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.52 150.11 0.55 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 152.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.36 149.65 80.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.198 1.932 . . . . 0.0 109.147 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -63.16 164.19 14.78 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 163.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.34 151.13 18.47 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.169 1.246 . . . . 0.0 109.519 154.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 40.9 mtm -68.31 151.28 47.14 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.988 -0.445 . . . . 0.0 110.528 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.5 p -60.5 -7.64 2.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.427 2.291 . . . . 0.0 115.24 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.23 157.24 0.15 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.228 2.211 . . . . 0.0 111.068 -158.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.01 100.88 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.159 2.573 . . . . 0.0 110.112 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.82 129.66 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.601 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -79.45 158.16 27.36 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 p -91.13 168.85 11.32 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.452 1.12 . . . . 0.0 109.903 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -71.64 177.05 4.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.903 1.811 . . . . 0.0 111.116 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 110.53 -3.032 . . . . 0.0 108.878 166.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.87 158.19 34.74 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.167 2.578 . . . . 0.0 112.041 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.33 151.46 50.22 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 167.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.446 2.097 . . . . 0.0 111.528 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -63.21 168.25 11.28 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.147 1.231 . . . . 0.0 110.491 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -88.19 163.39 16.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 10.9 tmtt? -57.39 125.49 71.71 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 117.092 -1.432 . . . . 0.0 109.467 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.88 157.9 56.71 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.293 1.328 . . . . 0.0 111.842 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -135.06 118.39 16.71 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 127.396 2.279 . . . . 0.0 105.988 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -63.16 161.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 114.394 -1.276 . . . . 0.0 109.429 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -140.75 -79.91 0.27 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.442 1.097 . . . . 0.0 109.082 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -79.69 143.01 34.98 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 108.335 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.01 146.51 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 160.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.3 p -118.04 -62.47 1.54 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 pttt 172.4 -34.98 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 130.647 3.579 . . . . 0.0 108.196 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.49 5.82 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.731 1.212 . . . . 0.0 111.018 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -132.75 155.34 49.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.44 134.64 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.261 1.424 . . . . 0.0 107.859 175.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.0 m -95.89 128.52 42.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.114 0.966 . . . . 0.0 109.22 178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.32 122.59 47.86 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.002 2.121 . . . . 0.0 107.381 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -92.42 147.83 22.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 159.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -139.85 172.15 13.19 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 124.821 1.248 . . . . 0.0 107.92 156.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -109.06 144.11 29.01 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.21 158.36 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.839 3.026 . . . . 0.0 112.141 -168.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.97 -176.21 39.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.915 0.769 . . . . 0.0 112.008 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.47 154.85 87.79 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.298 1.439 . . . . 0.0 111.326 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.41 -101.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 125.667 4.245 . . . . 0.0 109.631 161.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.34 -92.67 0.69 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 128.194 2.807 . . . . 0.0 108.769 161.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -55.66 28.91 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.292 2.237 . . . . 0.0 109.963 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -134.29 160.4 68.63 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.068 1.347 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -75.28 154.17 40.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.237 3.291 . . . . 0.0 108.981 172.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.2 161.82 21.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.489 1.137 . . . . 0.0 110.359 170.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.2 m -119.58 -43.87 2.57 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.76 2.424 . . . . 0.0 109.237 -175.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.07 -164.83 0.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.33 1.452 . . . . 0.0 107.725 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.92 161.03 30.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.372 2.269 . . . . 0.0 108.362 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.0 mt -126.98 156.2 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.872 2.469 . . . . 0.0 106.471 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.7 mt -122.66 136.27 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 160.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -109.73 153.05 24.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 166.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.09 155.84 48.37 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.977 1.311 . . . . 0.0 107.686 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -133.05 153.69 51.26 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.485 1.514 . . . . 0.0 107.258 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.6 t -153.37 133.47 13.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.36 -18.37 63.06 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -103.1 1.79 33.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.162 1.385 . . . . 0.0 113.127 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -94.21 -79.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.1 m -128.78 -6.14 5.1 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.133 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t30 55.46 47.55 20.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.582 1.083 . . . . 0.0 109.0 -169.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.1 m -142.61 139.37 31.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.53 2.332 . . . . 0.0 107.932 -172.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -77.47 129.61 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 162.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -126.55 152.54 46.42 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.538 1.135 . . . . 0.0 108.215 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 135.23 47.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.73 0.08 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.326 1.451 . . . . 0.0 112.317 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.68 139.53 19.92 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 164.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -142.93 143.69 32.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.102 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 37.37 63.15 0.77 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.508 1.523 . . . . 0.0 111.36 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -86.38 133.84 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -118.5 45.95 1.92 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.061 0.945 . . . . 0.0 109.754 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 t -157.88 -174.58 4.91 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.65 1.58 . . . . 0.0 107.543 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 p -124.95 3.26 8.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.051 2.141 . . . . 0.0 111.454 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.8 131.46 53.77 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 165.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -145.96 151.06 37.2 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.563 1.145 . . . . 0.0 109.267 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.3 m -109.84 102.31 11.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.058 1.743 . . . . 0.0 107.357 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.83 141.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -133.85 -177.59 4.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.032 1.733 . . . . 0.0 108.24 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.09 78.95 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 123.157 0.408 . . . . 0.0 112.876 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.83 -171.8 3.15 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.008 0.923 . . . . 0.0 108.837 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -116.39 143.19 30.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 125.107 1.363 . . . . 0.0 109.092 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -74.56 157.75 44.36 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.248 2.632 . . . . 0.0 111.885 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.1 t30 46.64 34.27 2.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.348 1.859 . . . . 0.0 112.023 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 m -125.02 130.33 52.11 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mm -74.71 151.29 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -131.91 169.1 16.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.11 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.6 mt -119.74 156.25 30.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 152.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -131.01 146.44 52.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.119 1.768 . . . . 0.0 106.742 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.73 117.92 9.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.863 1.665 . . . . 0.0 107.012 -177.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.24 112.76 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -97.85 135.56 39.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 163.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.71 166.74 15.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 165.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.73 151.56 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.74 1.616 . . . . 0.0 108.168 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -145.04 178.43 1.44 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.067 1.747 . . . . 0.0 108.447 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.63 -10.04 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.865 2.377 . . . . 0.0 115.848 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -113.13 -32.79 6.21 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.411 1.46 . . . . 0.0 112.935 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.4 -156.58 17.89 Favored Glycine 0 C--O 1.238 0.397 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mp -103.93 149.51 25.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.776 1.23 . . . . 0.0 110.056 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.9 p -72.16 166.27 22.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.772 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.37 146.62 0.34 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 126.446 1.899 . . . . 0.0 112.157 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.43 104.96 0.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.63 2.22 . . . . 0.0 109.051 166.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -48.82 166.89 0.22 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.002 2.521 . . . . 0.0 113.907 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.59 135.67 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.252 1.968 . . . . 0.0 110.044 155.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.5 mtt -63.69 163.4 11.52 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.9 0.773 . . . . 0.0 110.234 171.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.485 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 85.6 p -65.7 -1.75 3.03 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.57 155.08 0.11 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.726 1.611 . . . . 0.0 110.925 -159.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -69.98 98.74 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.48 2.12 . . . . 0.0 111.65 -168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 m -99.26 142.55 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.89 0.876 . . . . 0.0 110.597 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -93.11 147.99 22.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 122.96 0.504 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.7 p -79.32 152.03 30.71 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 158.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.87 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.611 1.964 . . . . 0.0 111.654 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.3 t0 . . . . . 0 C--N 1.331 -0.231 0 C-N-CA 127.335 2.254 . . . . 0.0 106.396 -177.249 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 119.423 -0.322 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.68 165.0 19.38 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.685 3.59 . . . . 0.0 110.829 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.92 159.38 41.75 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 170.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.2 152.86 78.94 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.061 2.508 . . . . 0.0 111.324 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.16 156.4 55.54 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.33 2.02 . . . . 0.0 110.493 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 m -79.02 176.99 9.15 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.845 -0.534 . . . . 0.0 109.724 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 28.5 tttt -55.51 120.3 30.57 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-O 117.945 -1.026 . . . . 0.0 108.679 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.48 141.42 95.41 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 CA-C-N 120.257 1.128 . . . . 0.0 109.391 167.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -79.74 171.61 14.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 161.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -117.84 137.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 162.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.257 68.7 p -117.18 -98.42 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -72.42 142.81 48.67 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 109.08 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.79 -177.67 3.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 pttt -74.71 -16.67 60.74 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.259 -0.901 . . . . 0.0 112.12 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -136.39 2.72 2.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.686 1.13 . . . . 0.0 111.718 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.4 p -153.33 166.83 31.39 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.43 -1.418 . . . . 0.0 110.19 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.63 145.83 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.427 1.091 . . . . 0.0 108.57 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -105.64 124.36 49.43 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.539 1.535 . . . . 0.0 107.315 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.82 132.01 53.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.725 2.01 . . . . 0.0 110.828 -171.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.8 108.68 11.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.321 1.848 . . . . 0.0 106.621 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -109.86 173.11 6.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.13 148.87 42.41 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.51 134.74 12.65 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.533 3.488 . . . . 0.0 110.915 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.47 30.87 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-O 122.756 1.198 . . . . 0.0 111.165 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -61.18 154.06 63.94 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.66 1.984 . . . . 0.0 111.148 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.73 -174.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 125.042 3.828 . . . . 0.0 114.702 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.03 -154.89 7.83 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -47.72 23.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 160.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mt -103.62 144.01 27.8 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.56 0.618 . . . . 0.0 110.487 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -81.36 151.75 17.78 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.371 2.714 . . . . 0.0 110.652 -165.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.71 122.42 5.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.762 1.225 . . . . 0.0 111.526 168.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.8 m -76.94 -61.82 1.85 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.578 1.951 . . . . 0.0 108.434 162.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -158.99 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 110.115 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -132.61 168.65 17.88 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.637 1.975 . . . . 0.0 109.219 165.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.76 159.67 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 128.745 2.818 . . . . 0.0 106.907 168.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.1 mt -130.22 129.79 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.91 166.03 11.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.934 0.894 . . . . 0.0 109.181 163.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.45 147.28 34.32 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.079 1.752 . . . . 0.0 108.205 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -127.89 119.78 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 44.6 t -73.59 -72.01 0.29 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.141 1.337 . . . . 0.0 110.082 166.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 142.73 -58.88 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 131.699 4.0 . . . . 0.0 106.096 -156.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 t -121.18 39.75 3.74 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.485 1.493 . . . . 0.0 109.363 -155.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.477 HG21 ' H ' ' A' ' 59' ' ' SER 0.272 25.1 m -120.41 -84.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -167.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.477 ' H ' HG21 ' A' ' 58' ' ' VAL . 8.3 m -129.96 16.83 5.69 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.441 1.096 . . . . 0.0 112.51 168.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 47.1 51.73 12.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.952 1.701 . . . . 0.0 111.161 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -153.26 153.33 32.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.06 1.744 . . . . 0.0 108.155 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.91 137.19 58.22 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 155.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -134.42 146.62 50.01 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.72 123.42 26.66 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.32 -3.02 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.537 1.135 . . . . 0.0 111.611 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.45 140.05 19.77 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 158.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.38 129.04 30.67 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -172.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 63.41 56.33 1.67 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.033 1.733 . . . . 0.0 112.094 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 134.31 27.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.474 1.51 . . . . 0.0 107.977 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -122.89 51.84 1.39 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.974 2.109 . . . . 0.0 109.108 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 t -150.45 -178.69 6.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.643 1.577 . . . . 0.0 107.22 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.6 p -118.52 2.12 11.76 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.171 1.789 . . . . 0.0 111.213 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -137.55 103.66 5.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -128.52 137.29 51.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -86.13 105.2 16.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.98 140.47 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -129.13 178.5 6.37 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.259 1.424 . . . . 0.0 110.89 -173.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.24 13.62 67.64 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 124.748 1.166 . . . . 0.0 114.304 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.02 164.81 25.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.68 1.229 . . . . 0.0 110.31 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -93.29 146.03 31.14 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.219 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.66 157.48 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.95 2.433 . . . . 0.0 110.581 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 53.23 14.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.782 1.633 . . . . 0.0 113.542 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -109.29 132.12 54.42 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 120.208 1.367 . . . . 0.0 108.744 -170.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -61.96 145.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 85.3 m-85 -140.42 150.77 44.28 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.927 1.346 . . . . 0.0 108.369 163.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.8 mt -110.36 162.28 14.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 111.675 -2.511 . . . . 0.0 107.926 159.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -142.21 126.31 17.39 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.48 1.912 . . . . 0.0 108.769 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.1 mtm -104.99 154.82 19.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 163.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.97 134.72 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -118.72 147.55 43.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 167.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.9 158.84 20.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.52 143.98 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.02 172.82 6.12 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 126.0 1.72 . . . . 0.0 107.288 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.97 28.12 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.553 2.168 . . . . 0.0 112.382 -172.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -132.78 -42.45 0.91 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 127.134 2.174 . . . . 0.0 110.46 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.27 -177.36 44.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 122.336 0.965 . . . . 0.0 112.959 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 pp -92.42 165.47 13.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.433 1.493 . . . . 0.0 111.052 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.9 p -87.18 167.16 14.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -174.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.1 150.72 1.02 Allowed Pre-proline 0 C--O 1.237 0.424 0 O-C-N 121.524 -0.735 . . . . 0.0 109.205 152.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.55 154.89 72.3 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 120.863 1.042 . . . . 0.0 110.444 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 p -53.25 151.36 9.77 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 123.463 0.705 . . . . 0.0 111.043 160.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -53.54 140.94 64.21 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.77 1.647 . . . . 0.0 109.841 154.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 mmt -57.66 129.44 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.027 0.531 . . . . 0.0 111.715 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.548 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.87 -16.41 50.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.534 1.534 . . . . 0.0 112.255 169.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t0 85.87 153.38 0.1 Allowed Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 129.457 3.103 . . . . 0.0 110.824 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.09 97.08 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.901 2.401 . . . . 0.0 112.185 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.73 156.3 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 124.66 1.184 . . . . 0.0 109.481 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -106.08 165.33 11.3 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.969 1.308 . . . . 0.0 109.038 172.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -102.03 163.76 12.07 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.283 1.433 . . . . 0.0 109.248 169.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -74.05 174.56 8.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.947 0.88 . . . . 0.0 111.669 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 C-N-CA 127.102 2.161 . . . . 0.0 109.73 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -66.93 147.11 79.82 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.345 2.03 . . . . 0.0 111.519 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.08 142.01 28.55 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.422 1.487 . . . . 0.0 110.363 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.3 148.85 85.11 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.706 2.27 . . . . 0.0 110.231 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -64.61 160.7 38.74 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.819 1.679 . . . . 0.0 110.867 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -67.16 168.32 10.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.86 0.864 . . . . 0.0 109.788 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -57.02 124.64 66.56 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.013 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.18 135.81 32.84 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.535 1.584 . . . . 0.0 110.535 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -80.36 168.61 18.81 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 125.103 1.361 . . . . 0.0 109.778 166.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.5 95.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 112.056 -2.338 . . . . 0.0 106.169 171.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.3 p -93.58 -89.33 0.21 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 126.29 28.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.566 1.146 . . . . 0.0 110.542 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.49 159.1 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.714 1.206 . . . . 0.0 108.079 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 p -137.95 -56.52 0.67 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt 170.85 -31.44 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 1 C-N-CA 132.082 4.153 . . . . 0.0 108.969 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.25 2.26 2.06 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.528 1.531 . . . . 0.0 112.12 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 p -132.4 154.56 49.69 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.093 0.86 . . . . 0.0 109.919 165.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 p -147.63 141.92 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.49 143.41 26.84 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.5 mt -112.66 138.35 49.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.352 1.461 . . . . 0.0 107.81 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.89 120.51 30.63 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -136.63 170.55 15.88 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.272 1.397 . . . . 0.0 107.63 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -115.64 149.61 43.33 Favored Pre-proline 0 C--O 1.237 0.443 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.51 153.29 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.358 2.039 . . . . 0.0 110.126 -165.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.87 176.44 54.02 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-O 122.642 1.135 . . . . 0.0 111.633 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.9 m -62.01 149.5 85.94 Favored Pre-proline 0 N--CA 1.435 -1.217 0 C-N-CA 126.355 1.862 . . . . 0.0 108.667 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -69.55 178.68 4.2 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 CA-C-O 123.77 1.488 . . . . 0.0 113.049 170.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.57 -160.79 9.24 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 130.686 3.993 . . . . 0.0 103.401 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -43.66 72.97 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.805 0.842 . . . . 0.0 111.52 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.46 154.52 37.52 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 118.793 0.724 . . . . 0.0 111.478 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.84 151.54 31.56 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.943 3.095 . . . . 0.0 110.316 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.27 104.27 9.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 m -52.43 -52.8 52.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.251 2.221 . . . . 0.0 112.929 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.81 -163.81 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.509 1.924 . . . . 0.0 107.201 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -127.23 157.96 38.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.82 1.248 . . . . 0.0 110.08 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -107.1 154.12 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.661 1.984 . . . . 0.0 107.217 164.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.45 119.73 46.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -100.91 155.85 17.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.66 156.37 48.95 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 126.192 1.797 . . . . 0.0 106.306 169.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -132.83 156.14 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.03 124.41 5.29 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -21.67 65.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.776 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 t -94.65 -3.49 49.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.18 0.992 . . . . 0.0 111.697 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 t -111.28 -68.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 125.235 1.414 . . . . 0.0 108.367 -161.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 m -142.95 -5.25 0.89 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 111.611 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 t30 54.36 32.03 15.63 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -133.95 153.16 51.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.568 1.547 . . . . 0.0 108.27 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -71.29 141.74 50.5 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 159.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -135.11 132.76 38.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 175.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -71.87 94.18 1.4 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.97 -25.63 14.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.781 0.832 . . . . 0.0 110.902 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.75 46.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 163.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -133.96 143.96 48.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.452 1.501 . . . . 0.0 107.597 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 47.26 64.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.068 1.347 . . . . 0.0 111.595 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.3 133.5 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -117.89 56.65 0.85 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.853 1.261 . . . . 0.0 108.271 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 t -161.35 176.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.4 p -110.46 0.0 17.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 111.465 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -142.99 101.57 3.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.581 1.152 . . . . 0.0 108.944 -169.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -134.18 124.29 25.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.612 0.765 . . . . 0.0 112.838 -164.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.0 m -70.82 98.37 1.55 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.764 2.426 . . . . 0.0 110.805 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.83 146.99 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 120.646 -1.284 . . . . 0.0 108.167 163.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -140.81 -178.19 5.43 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.861 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.25 49.66 60.45 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt -115.26 -160.5 0.74 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.822 1.249 . . . . 0.0 108.905 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -131.08 139.57 35.95 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.541 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.79 160.21 50.14 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.312 2.674 . . . . 0.0 111.601 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.1 m120 47.95 21.93 0.34 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.207 1.803 . . . . 0.0 113.844 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -121.03 121.44 37.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.83 1.652 . . . . 0.0 106.789 -170.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 mm -58.78 146.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -136.07 159.91 40.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 162.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.0 mt -112.2 162.57 15.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 125.758 1.623 . . . . 0.0 107.782 158.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -142.57 143.42 32.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.439 1.712 . . . . 0.0 107.727 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 mtm -138.46 149.04 45.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.13 150.31 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -129.02 148.46 50.97 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 167.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.25 152.42 22.32 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 163.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.34 151.03 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.61 174.99 2.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.034 0.934 . . . . 0.0 109.529 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.54 29.5 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.913 3.075 . . . . 0.0 114.114 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.56 -52.19 0.48 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.49 1.916 . . . . 0.0 109.756 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.96 -144.06 4.03 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 127.263 2.363 . . . . 0.0 108.971 -170.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 pp -142.73 167.43 22.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.865 1.266 . . . . 0.0 111.609 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.7 p -75.35 165.52 25.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.269 0.628 . . . . 0.0 110.645 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -51.83 152.19 5.5 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 157.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.9 142.28 51.35 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.665 1.577 . . . . 0.0 109.136 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 p -59.09 162.27 7.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 O-C-N 121.812 -0.555 . . . . 0.0 111.062 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -54.55 129.83 36.94 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.6 2.867 . . . . 0.0 109.835 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.4 mtm -49.75 151.68 1.7 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.322 1.419 . . . . 0.0 113.199 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.3 p -60.5 -12.22 9.12 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.79 155.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.344 1.857 . . . . 0.0 108.739 -157.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -70.74 137.42 32.56 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.229 1.953 . . . . 0.0 109.883 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.62 125.78 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.35 127.65 35.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.9 p -66.07 157.96 29.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -66.91 172.99 3.88 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.146 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 C-N-CA 124.579 1.151 . . . . 0.0 113.932 -169.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.21 149.66 84.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.889 2.392 . . . . 0.0 112.422 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 148.48 44.78 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 169.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 156.45 53.63 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.813 2.342 . . . . 0.0 113.053 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.68 175.07 5.66 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.493 2.795 . . . . 0.0 112.837 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -61.09 171.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.922 0.868 . . . . 0.0 111.769 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HZ2' ' HB2' ' A' ' 105' ' ' ASP . 78.2 tttt -52.96 133.57 48.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.299 -0.858 . . . . 0.0 108.856 157.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.54 148.27 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.433 1.422 . . . . 0.0 110.927 167.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -119.3 117.14 27.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.612 1.565 . . . . 0.0 108.658 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.89 144.6 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 113.357 -1.747 . . . . 0.0 107.698 169.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 p -128.75 -85.72 0.56 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -73.84 149.12 41.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.704 1.602 . . . . 0.0 109.475 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.97 141.95 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 122.004 0.907 . . . . 0.0 108.687 161.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.9 p -128.54 -172.21 2.65 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 107.996 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -62.05 -36.99 83.27 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.176 -0.953 . . . . 0.0 112.706 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -139.67 23.86 2.45 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.902 1.228 . . . . 0.0 111.398 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -146.14 164.13 33.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.518 0.599 . . . . 0.0 109.501 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.05 138.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -94.44 135.18 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.36 130.63 52.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 125.886 1.674 . . . . 0.0 108.318 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -103.32 151.92 22.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.69 1.196 . . . . 0.0 108.127 161.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -140.04 171.12 14.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 156.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.32 144.82 32.46 Favored Pre-proline 0 C--O 1.239 0.516 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.94 140.73 18.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.835 2.357 . . . . 0.0 110.751 -167.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.21 -168.19 26.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 166.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.3 m -86.85 159.98 50.76 Favored Pre-proline 0 N--CA 1.441 -0.878 0 C-N-CA 128.775 2.83 . . . . 0.0 109.458 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.84 -169.06 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.813 3.676 . . . . 0.0 111.085 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.35 -148.41 6.21 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 105.872 -2.891 . . . . 0.0 105.872 164.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -33.4 54.95 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.549 0.739 . . . . 0.0 110.144 171.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.6 mt -104.36 157.72 33.47 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 118.379 0.536 . . . . 0.0 111.124 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.36 170.58 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.045 2.497 . . . . 0.0 109.303 164.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.61 162.6 13.56 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.473 1.109 . . . . 0.0 109.033 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -116.54 -47.28 2.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.86 2.064 . . . . 0.0 109.481 -171.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.51 -160.99 0.55 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -134.83 148.86 50.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.444 2.298 . . . . 0.0 108.555 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 mt -124.99 113.86 37.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 129.15 2.98 . . . . 0.0 105.754 172.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 69.7 mt -94.54 120.39 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 171.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.78 154.29 20.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.26 148.21 51.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.015 1.726 . . . . 0.0 108.08 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.23 157.46 19.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 166.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.3 144.57 21.01 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -95.53 -4.99 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.545 1.538 . . . . 0.0 112.622 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.0 m -119.56 9.98 11.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.362 1.465 . . . . 0.0 113.281 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -115.17 -77.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.14 1.776 . . . . 0.0 109.023 -168.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -141.67 5.85 1.81 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.289 0.95 . . . . 0.0 112.786 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 m120 59.58 2.93 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.431 2.692 . . . . 0.0 114.964 -175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -106.23 161.16 14.78 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 126.632 1.973 . . . . 0.0 110.518 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.413 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 81.6 m95 -77.78 144.62 36.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 153.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -138.32 148.68 44.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.4 m -77.19 108.57 10.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -95.11 -15.47 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.215 1.006 . . . . 0.0 111.93 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.92 102.45 2.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.307 0.958 . . . . 0.0 108.835 167.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.81 157.89 15.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.196 0.998 . . . . 0.0 110.394 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.8 m170 44.89 46.23 8.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.473 2.709 . . . . 0.0 112.449 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t -79.99 136.75 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 126.75 2.02 . . . . 0.0 108.056 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -123.27 61.41 1.04 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 122.093 0.949 . . . . 0.0 108.799 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 t -158.31 179.27 9.3 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 p -122.85 5.86 9.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.697 1.199 . . . . 0.0 111.441 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -135.89 128.36 30.46 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 163.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -145.95 151.24 37.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -101.42 103.77 14.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.227 1.411 . . . . 0.0 107.827 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.52 137.49 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -122.48 -167.38 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.546 1.938 . . . . 0.0 107.543 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.68 21.11 64.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.112 171.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -99.95 -166.46 1.34 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.822 1.311 . . . . 0.0 110.616 -167.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -122.73 153.15 63.15 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 107.248 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.69 156.17 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.519 2.146 . . . . 0.0 110.382 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 35.58 57.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.222 1.809 . . . . 0.0 110.598 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.9 m -139.0 138.33 37.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.66 1.984 . . . . 0.0 106.19 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 mm -79.44 146.1 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.127 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -142.13 150.87 41.68 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.179 1.391 . . . . 0.0 109.411 173.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.03 166.27 10.85 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 162.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -138.34 149.22 45.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.647 1.217 . . . . 0.0 108.731 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.413 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 73.3 mtm -136.81 152.53 50.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 163.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.3 109.66 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -169.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -94.84 132.28 39.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 170.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 129.25 35.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 165.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.05 149.52 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.7 176.79 2.27 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.101 1.361 . . . . 0.0 108.926 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.99 4.09 0.77 Allowed 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.581 2.854 . . . . 0.0 115.935 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -140.48 -17.4 0.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.926 1.29 . . . . 0.0 112.617 -161.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.19 -156.84 29.05 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.858 1.694 . . . . 0.0 109.402 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 pp -129.76 146.97 51.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.849 1.66 . . . . 0.0 107.765 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.3 p -72.41 167.11 21.23 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.04 153.75 0.49 Allowed Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.234 1.413 . . . . 0.0 110.919 173.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.1 136.3 68.18 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -61.3 172.02 1.08 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 165.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.98 144.77 35.33 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.012 1.142 . . . . 0.0 109.733 156.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.51 143.6 57.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.6 p -64.48 -2.48 2.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.902 1.681 . . . . 0.0 115.043 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.439 ' HB2' ' HZ2' ' A' ' 21' ' ' LYS . 1.2 t0 68.71 151.5 0.13 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.945 2.498 . . . . 0.0 109.751 -158.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.65 105.58 1.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.081 2.521 . . . . 0.0 110.206 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.83 167.72 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 129.04 47.38 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.201 1.4 . . . . 0.0 108.233 172.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.2 p -65.4 160.64 21.52 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.208 0.317 . . . . 0.0 110.81 171.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -83.88 -176.75 6.43 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.202 1.001 . . . . 0.0 110.458 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 111.991 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 111.077 0.028 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.38 159.93 47.91 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.879 3.053 . . . . 0.0 111.35 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.07 152.38 48.99 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.91 138.91 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.708 1.605 . . . . 0.0 108.606 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -64.91 163.7 27.29 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 121.894 1.729 . . . . 0.0 111.168 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.3 m -74.25 160.46 31.09 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.54 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.89 121.12 21.53 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.042 1.337 . . . . 0.0 112.027 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.45 146.59 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.755 1.636 . . . . 0.0 113.577 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.11 125.25 53.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 125.602 1.561 . . . . 0.0 111.373 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 m -86.08 133.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 113.615 -1.63 . . . . 0.0 108.885 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -121.88 -90.97 0.57 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -167.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -72.23 141.16 48.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.34 136.02 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.9 p -105.76 -52.88 2.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.362 -170.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 pttp 160.61 -26.13 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.331 1 C-N-CA 133.795 4.838 . . . . 0.0 108.373 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.18 -0.29 1.13 Allowed 'General case' 0 CA--C 1.523 -0.083 0 O-C-N 121.173 -0.954 . . . . 0.0 112.745 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -125.15 160.33 29.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.945 1.248 . . . . 0.0 110.156 160.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.51 130.96 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.127 1.371 . . . . 0.0 108.475 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.3 m -90.21 122.57 33.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.825 2.05 . . . . 0.0 108.249 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.75 126.64 54.79 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.874 2.07 . . . . 0.0 107.844 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.06 152.65 18.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 160.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.7 p90 -139.76 172.42 12.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 152.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -102.09 146.03 31.56 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.3 156.12 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.558 2.839 . . . . 0.0 109.964 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.13 177.86 50.76 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-O 123.878 1.821 . . . . 0.0 110.815 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 m -64.73 154.82 84.29 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 127.546 2.338 . . . . 0.0 109.357 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.62 -171.69 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.995 2.463 . . . . 0.0 112.828 166.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.75 6.14 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -45.01 54.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 161.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 mt -97.59 150.19 36.52 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 123.365 0.666 . . . . 0.0 109.978 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.23 151.61 54.91 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.889 3.059 . . . . 0.0 109.537 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.58 159.97 26.3 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.649 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 m -135.71 -42.0 0.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.447 1.499 . . . . 0.0 110.514 -166.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.58 -171.07 2.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.373 1.069 . . . . 0.0 108.427 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.56 167.57 10.35 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.851 0.834 . . . . 0.0 109.686 156.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.05 158.16 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.677 2.791 . . . . 0.0 106.471 164.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -127.05 139.16 52.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 166.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.83 161.98 19.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.776 1.231 . . . . 0.0 108.275 172.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.87 162.15 36.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.195 1.398 . . . . 0.0 108.559 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -136.2 149.49 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.652 1.981 . . . . 0.0 106.057 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.419 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 8.1 t -141.42 165.07 28.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 161.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.71 33.84 2.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.378 1.071 . . . . 0.0 111.761 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.92 34.01 0.21 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.268 -0.895 . . . . 0.0 112.42 165.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 59' ' ' SER . 14.8 m -120.14 -72.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.959 1.304 . . . . 0.0 109.628 -175.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.422 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -154.01 0.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.887 1.275 . . . . 0.0 112.005 -178.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.14 -21.11 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.266 2.626 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 m -63.66 159.27 19.39 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.476 1.91 . . . . 0.0 110.714 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -76.37 154.49 34.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 151.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -141.92 152.97 44.02 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 134.46 49.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -122.98 -19.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.308 -0.854 . . . . 0.0 111.473 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.63 157.06 47.82 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.904 1.229 . . . . 0.0 108.338 160.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -143.02 147.75 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 52.52 49.37 20.56 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.014 0.912 . . . . 0.0 111.806 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.5 t -79.13 102.27 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -94.47 50.67 1.37 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.876 1.27 . . . . 0.0 109.076 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -157.44 -170.06 3.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.057 1.743 . . . . 0.0 107.508 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.4 p -131.98 2.91 4.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.116 2.166 . . . . 0.0 111.624 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.0 tp -129.38 120.64 25.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -145.21 151.45 38.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.051 0.94 . . . . 0.0 109.502 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.8 m -110.2 114.29 27.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.396 1.078 . . . . 0.0 108.733 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.88 145.96 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -133.43 176.98 8.05 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 112.111 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.42 27.09 57.78 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.788 1.185 . . . . 0.0 113.935 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.9 mt -79.32 -179.13 6.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.153 0.977 . . . . 0.0 110.075 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -96.8 139.23 21.47 Favored Pre-proline 0 CA--C 1.516 -0.365 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.63 159.97 47.56 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.513 2.142 . . . . 0.0 110.32 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 t30 48.53 34.79 5.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.94 1.696 . . . . 0.0 111.8 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.1 m -133.19 132.89 42.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.111 1.764 . . . . 0.0 107.581 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.31 147.87 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -131.58 159.16 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 156.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mt -107.52 157.71 17.8 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 152.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -132.72 152.12 51.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 125.828 1.955 . . . . 0.0 107.369 172.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.61 165.84 23.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 162.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.67 145.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -120.95 147.62 45.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 162.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.99 159.05 19.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.28 150.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 126.316 1.846 . . . . 0.0 107.535 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.62 172.2 5.49 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 127.138 2.175 . . . . 0.0 107.322 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.9 -23.93 74.37 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.65 2.233 . . . . 0.0 114.985 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -105.64 -45.99 4.28 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.576 1.55 . . . . 0.0 110.407 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.84 35.29 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 122.739 1.188 . . . . 0.0 112.214 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.86 166.75 16.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -72.36 166.24 22.91 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 122.171 0.986 . . . . 0.0 109.619 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.81 159.88 1.64 Allowed Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.148 152.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.24 148.3 61.66 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.091 1.194 . . . . 0.0 111.182 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.1 p -62.38 167.51 5.25 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 159.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.97 150.34 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.427 1.418 . . . . 0.0 109.724 152.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -69.04 154.85 41.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.648 166.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.1 p -60.54 -7.53 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.578 2.351 . . . . 0.0 115.143 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.7 153.63 0.14 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 127.333 2.253 . . . . 0.0 109.169 -155.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -77.55 108.5 2.59 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.976 2.451 . . . . 0.0 108.603 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.49 133.23 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 124.544 1.138 . . . . 0.0 109.156 -171.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -92.66 135.27 34.24 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.7 p -63.68 154.32 33.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.971 0.891 . . . . 0.0 109.185 164.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.44 171.66 0.57 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 123.614 1.673 . . . . 0.0 110.02 163.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.5 t0 . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.925 169.034 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 118.434 -0.794 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.52 159.45 36.29 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.078 3.852 . . . . 0.0 113.425 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.66 141.94 46.1 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.825 1.202 . . . . 0.0 111.227 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.84 147.49 80.88 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.255 1.97 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.9 164.76 15.68 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.583 2.189 . . . . 0.0 112.413 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -74.91 167.87 21.04 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.707 0.803 . . . . 0.0 110.037 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -59.4 117.83 25.55 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.854 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.03 157.33 60.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 120.619 1.257 . . . . 0.0 111.182 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -124.24 146.86 48.47 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 126.789 2.036 . . . . 0.0 109.367 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 m -96.75 139.03 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 C-N-CA 124.511 1.124 . . . . 0.0 108.309 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -128.74 -79.78 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.533 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.05 130.73 42.28 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.53 137.09 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.4 p -115.47 -74.33 0.62 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -162.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -171.34 -29.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 1 C-N-CA 133.272 4.629 . . . . 0.0 108.638 161.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.8 -15.47 14.1 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.821 1.648 . . . . 0.0 109.944 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 m -142.33 159.37 42.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.604 0.638 . . . . 0.0 110.094 -167.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.13 128.92 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.8 m -86.13 138.72 31.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.448 1.099 . . . . 0.0 110.066 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -113.04 141.38 46.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 107.931 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -130.77 129.45 42.47 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 126.99 2.116 . . . . 0.0 108.381 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -140.34 170.59 15.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.538 0.685 . . . . 0.0 112.19 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -98.77 145.63 30.27 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 124.324 1.05 . . . . 0.0 108.749 164.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.32 139.39 14.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 124.478 3.452 . . . . 0.0 109.483 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.75 -179.06 44.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 165.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.6 m -87.04 151.01 51.13 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 128.312 2.645 . . . . 0.0 110.163 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.81 -174.87 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.664 3.576 . . . . 0.0 111.757 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.98 -126.41 0.82 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 p -57.13 -31.02 64.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.266 2.626 . . . . 0.0 114.318 -173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 mt -130.95 164.91 38.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.35 1.46 . . . . 0.0 109.234 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.78 135.7 6.87 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.993 2.462 . . . . 0.0 109.843 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.9 149.97 43.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.328 164.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -125.06 -56.7 1.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.628 1.171 . . . . 0.0 109.014 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.55 -177.38 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -122.91 173.17 7.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.755 0.822 . . . . 0.0 109.204 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.3 mt -121.49 152.86 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 126.835 2.054 . . . . 0.0 106.448 166.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -123.29 137.44 56.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 160.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.52 164.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.514 1.125 . . . . 0.0 108.56 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.18 163.7 32.16 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.44 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -159.32 124.07 4.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 108.7 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.6 t -106.17 1.63 26.31 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.381 1.072 . . . . 0.0 112.457 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 53.46 3.09 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -167.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.53 1.24 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.651 -1.28 . . . . 0.0 111.907 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -74.69 -78.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 109.327 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 m -121.35 15.35 11.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.549 1.14 . . . . 0.0 110.848 164.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 53.86 27.16 6.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.298 1.439 . . . . 0.0 110.835 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.6 m -144.41 151.81 39.78 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.825 2.85 . . . . 0.0 108.503 -167.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -78.76 142.74 36.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 109.911 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -135.76 135.88 40.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.276 0.631 . . . . 0.0 109.71 -169.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.79 94.34 1.39 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -81.65 -21.75 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.053 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.39 107.34 3.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.84 168.09 16.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 169.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 36.5 58.61 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.84 2.456 . . . . 0.0 112.627 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.93 118.59 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -111.5 50.07 0.85 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.62 1.168 . . . . 0.0 108.645 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -156.14 -177.75 6.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.727 1.211 . . . . 0.0 108.064 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -118.58 0.98 11.65 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.909 2.883 . . . . 0.0 110.917 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 111.38 7.08 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.731 1.213 . . . . 0.0 109.182 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -141.19 127.77 20.13 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.737 0.815 . . . . 0.0 111.164 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.4 m -75.96 103.16 5.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.169 2.188 . . . . 0.0 109.229 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.7 t -70.15 147.34 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 166.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -135.96 174.49 10.55 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.046 1.339 . . . . 0.0 113.591 -168.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.09 6.07 82.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.117 1.817 . . . . 0.0 114.718 168.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 mt -74.48 171.96 12.83 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.17 1.788 . . . . 0.0 111.111 -168.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.0 142.77 29.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 126.011 1.724 . . . . 0.0 108.567 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.76 156.57 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 109.461 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 40.51 48.07 2.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.089 1.756 . . . . 0.0 111.958 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.5 m -133.64 132.73 41.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.918 1.687 . . . . 0.0 106.761 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.27 146.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.96 157.15 46.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 160.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.7 mt -107.35 157.13 18.19 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 127.504 2.322 . . . . 0.0 106.271 158.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -138.5 146.23 41.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 126.195 2.185 . . . . 0.0 107.862 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.1 mtm -142.53 152.51 42.7 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.13 144.04 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 125.366 1.466 . . . . 0.0 107.187 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -128.65 139.87 52.04 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.89 149.14 25.02 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.53 145.29 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.218 1.007 . . . . 0.0 109.889 -177.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -150.46 177.24 1.92 Allowed Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 109.109 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.69 67.24 8.48 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.072 2.514 . . . . 0.0 110.135 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -163.88 -73.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.835 2.854 . . . . 0.0 104.637 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.53 -164.34 12.09 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 126.136 1.827 . . . . 0.0 110.93 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 pp -101.14 151.59 21.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.13 1.372 . . . . 0.0 108.381 172.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.4 p -72.67 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.179 1.792 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -50.66 150.29 5.13 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.368 158.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.33 161.0 45.1 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.316 1.344 . . . . 0.0 111.106 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 91.8 p -55.57 167.61 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.258 163.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.52 144.25 10.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 121.66 1.573 . . . . 0.0 110.484 151.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.4 mtm -64.65 144.86 56.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.442 0.697 . . . . 0.0 109.789 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -63.99 -9.55 16.46 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 127.187 2.195 . . . . 0.0 113.736 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 77.56 155.28 0.14 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 128.808 2.843 . . . . 0.0 108.792 -160.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -73.14 117.94 5.33 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.591 2.194 . . . . 0.0 108.53 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.48 135.1 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.956 1.302 . . . . 0.0 110.083 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 142.37 27.77 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.5 p -73.46 159.33 33.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.428 1.585 . . . . 0.0 109.495 162.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -66.27 175.04 2.32 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.955 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.1 t0 . . . . . 0 N--CA 1.443 -0.805 0 CA-C-N 111.623 -2.535 . . . . 0.0 110.086 163.371 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -61.76 164.8 15.22 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.765 2.31 . . . . 0.0 111.806 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.17 126.61 28.79 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 164.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.95 154.49 61.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.215 1.943 . . . . 0.0 111.82 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -80.06 173.16 13.0 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.457 2.771 . . . . 0.0 111.236 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -66.61 170.13 6.74 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.702 -0.624 . . . . 0.0 111.373 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -49.9 124.41 16.54 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 150.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 150.1 74.77 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 121.203 1.269 . . . . 0.0 109.178 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -111.78 124.29 52.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.65 142.46 16.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.353 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.5 p -122.01 -87.63 0.63 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.92 134.59 38.9 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 109.049 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.77 138.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 119.099 0.863 . . . . 0.0 109.697 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -126.87 -162.21 1.13 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.998 1.719 . . . . 0.0 107.861 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -77.18 -29.06 54.21 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 121.192 -0.943 . . . . 0.0 111.075 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -150.87 14.57 0.73 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.199 0.909 . . . . 0.0 111.955 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -127.27 163.08 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.782 159.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.78 146.86 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.692 1.597 . . . . 0.0 107.38 169.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.9 m -102.07 149.43 24.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.469 1.508 . . . . 0.0 109.084 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.38 148.46 51.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.261 2.624 . . . . 0.0 107.535 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -139.94 114.71 9.47 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.515 1.134 . . . . 0.0 108.998 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -134.87 153.11 52.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.903 0.774 . . . . 0.0 111.217 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -93.48 140.9 23.3 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.49 148.29 18.27 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 124.096 3.197 . . . . 0.0 108.987 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.76 -178.05 52.21 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 122.27 0.928 . . . . 0.0 111.632 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -55.12 153.95 11.44 Favored Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.957 2.103 . . . . 0.0 108.444 158.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 -114.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.143 3.229 . . . . 0.0 108.51 162.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.4 -109.81 0.42 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 164.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.8 p -60.35 -35.3 75.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.729 2.012 . . . . 0.0 111.819 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 mt -132.63 169.24 14.46 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.849 1.66 . . . . 0.0 109.07 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.48 155.74 14.16 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.507 2.805 . . . . 0.0 109.271 168.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 160.46 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.551 0.691 . . . . 0.0 109.656 171.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -117.81 -43.37 2.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.074 1.75 . . . . 0.0 109.822 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.0 -172.27 1.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.468 1.107 . . . . 0.0 109.592 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.417 ' HB2' HG22 ' A' ' 69' ' ' VAL . 12.4 m-85 -116.78 165.6 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.729 1.612 . . . . 0.0 107.961 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.88 154.04 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 129.361 3.064 . . . . 0.0 104.833 168.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.2 mt -129.29 135.9 60.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.84 156.51 29.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.17 157.87 45.69 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.032 1.333 . . . . 0.0 108.193 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.96 163.11 35.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.915 1.686 . . . . 0.0 109.81 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -156.75 -38.69 0.08 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -161.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 64.09 -22.46 0.07 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.71 2.404 . . . . 0.0 116.585 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.25 -24.45 11.5 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 121.036 1.744 . . . . 0.0 112.109 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -69.9 -77.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 120.209 1.368 . . . . 0.0 109.418 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -135.49 22.91 3.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.511 1.125 . . . . 0.0 111.535 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 t30 23.22 60.23 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 C-N-CA 129.367 3.067 . . . . 0.0 112.815 176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.7 m -165.74 158.61 15.42 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.674 1.989 . . . . 0.0 108.952 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 67.3 m95 -72.46 123.85 23.96 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 162.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -113.24 139.17 49.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -83.41 94.36 7.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 m -82.33 -19.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.366 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.62 143.31 32.34 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.14 0.976 . . . . 0.0 108.488 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.91 157.2 47.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.338 0.655 . . . . 0.0 109.553 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m170 52.71 32.78 12.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.45 1.5 . . . . 0.0 111.922 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' A' ' 49' ' ' TYR . 3.2 m -74.39 154.28 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.326 1.06 . . . . 0.0 110.229 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -134.73 54.14 1.96 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -148.6 176.41 10.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.585 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 p -117.41 -3.04 11.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.441 1.497 . . . . 0.0 111.698 169.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.23 133.55 47.58 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.068 1.347 . . . . 0.0 108.949 166.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -146.48 146.31 30.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -108.09 97.85 7.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.919 1.688 . . . . 0.0 108.904 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.95 134.83 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -128.16 171.82 11.57 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.285 0.634 . . . . 0.0 112.028 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.13 50.95 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.99 1.281 . . . . 0.0 112.994 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.1 mt -83.32 -166.84 1.47 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.743 1.217 . . . . 0.0 109.51 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 -121.45 143.72 38.42 Favored Pre-proline 0 CA--C 1.517 -0.326 0 C-N-CA 124.422 1.089 . . . . 0.0 109.502 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.95 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.481 2.787 . . . . 0.0 111.822 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 55.02 3.83 0.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.016 2.526 . . . . 0.0 116.24 -176.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.2 m -101.3 130.66 47.5 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.34 1.856 . . . . 0.0 108.746 -166.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 mm -68.71 147.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.27 165.3 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.654 1.181 . . . . 0.0 108.928 168.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -117.39 157.95 25.29 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 125.53 1.532 . . . . 0.0 108.121 162.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -143.07 131.43 22.15 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 125.298 1.624 . . . . 0.0 109.283 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.463 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 5.4 mtt -115.67 173.31 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.89 151.8 35.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -138.65 121.9 17.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.15 118.95 25.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.14 148.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 108.996 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.76 173.6 4.21 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.773 1.629 . . . . 0.0 108.632 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.99 23.58 0.4 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.119 2.546 . . . . 0.0 113.658 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -130.38 -17.45 3.35 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.839 1.656 . . . . 0.0 113.919 173.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.47 9.4 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 123.909 0.766 . . . . 0.0 112.371 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.81 144.7 51.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.229 1.812 . . . . 0.0 107.768 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -72.33 159.37 34.14 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 109.737 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -48.86 132.31 14.65 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.084 0.954 . . . . 0.0 110.388 -172.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -51.04 113.96 1.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.112 3.208 . . . . 0.0 111.49 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 p -52.67 159.23 1.8 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.648 0.779 . . . . 0.0 112.832 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -52.26 144.14 40.17 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.863 3.042 . . . . 0.0 111.073 163.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.5 mtp -67.28 144.43 55.91 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.506 0.722 . . . . 0.0 112.619 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.3 p -65.7 -5.19 7.84 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.818 2.447 . . . . 0.0 116.1 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.46 144.64 0.1 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.139 1.776 . . . . 0.0 111.024 -165.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.58 106.84 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.166 2.578 . . . . 0.0 110.849 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.9 m -105.0 140.61 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.383 1.473 . . . . 0.0 109.965 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -87.15 -174.4 4.87 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.524 0.73 . . . . 0.0 109.98 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.0 p -130.99 158.23 40.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.364 1.866 . . . . 0.0 107.195 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -68.38 173.29 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.825 0.821 . . . . 0.0 110.039 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.94 172.829 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.788 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -71.43 -0.38 10.19 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.519 1.159 . . . . 0.0 113.669 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -133.31 160.01 38.59 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 150.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.18 14.88 1.3 Allowed Glycine 0 CA--C 1.522 0.492 0 C-N-CA 126.274 1.892 . . . . 0.0 111.748 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.7 155.49 44.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.742 1.271 . . . . 0.0 109.086 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -155.25 176.58 12.38 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.588 1.955 . . . . 0.0 107.266 171.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.0 -59.36 9.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -79.15 167.94 20.31 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 122.149 -0.618 . . . . 0.0 109.514 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -130.76 123.32 28.93 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.71 -179.98 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.66 1.984 . . . . 0.0 113.5 -174.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.52 164.46 38.19 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.983 1.713 . . . . 0.0 107.036 169.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.3 mt -86.74 65.89 9.21 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 165.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 t -142.05 145.38 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.329 0.652 . . . . 0.0 110.851 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -120.15 19.99 12.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.993 1.717 . . . . 0.0 110.437 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt -107.34 159.06 31.52 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 126.321 1.848 . . . . 0.0 110.439 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 161.14 24.23 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 111.606 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.53 141.81 30.29 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 162.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -69.48 162.42 42.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.421 2.081 . . . . 0.0 113.031 -168.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.37 168.34 9.75 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.194 2.596 . . . . 0.0 112.825 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -74.83 169.97 16.84 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 110.199 168.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -56.22 134.23 75.27 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 167.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.37 164.9 16.41 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 CA-C-O 124.04 1.6 . . . . 0.0 112.697 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -105.25 172.12 6.96 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 128.909 2.884 . . . . 0.0 106.644 162.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -123.75 137.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.119 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.9 p -124.32 -90.66 0.56 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.699 0.625 . . . . 0.0 110.646 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.94 138.71 42.52 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 125.343 1.457 . . . . 0.0 107.914 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.47 155.05 22.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.48 1.037 . . . . 0.0 110.046 163.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -137.33 -159.88 1.0 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.208 1.403 . . . . 0.0 108.039 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -65.1 -31.61 72.9 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.545 167.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -152.54 1.66 0.32 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -113.66 152.55 30.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.178 0.899 . . . . 0.0 108.919 162.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -147.87 148.44 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.4 m -110.31 133.83 52.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.16 140.03 48.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.356 1.863 . . . . 0.0 107.004 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.76 135.17 49.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 174.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -138.72 171.57 14.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 120.582 1.537 . . . . 0.0 108.628 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.71 142.77 25.66 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.609 1.164 . . . . 0.0 108.7 168.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.4 170.49 20.11 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.769 2.313 . . . . 0.0 112.707 -161.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.47 -175.6 22.93 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 164.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.53 149.19 71.09 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.84 -179.81 5.54 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.652 2.901 . . . . 0.0 113.13 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.36 -99.02 0.15 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -57.83 -51.95 67.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.452 1.901 . . . . 0.0 110.565 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.61 166.26 25.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 124.271 1.028 . . . . 0.0 110.278 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.93 167.51 25.06 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.292 3.328 . . . . 0.0 109.382 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.51 25.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.962 1.705 . . . . 0.0 109.04 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -94.54 -57.23 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.326 1.051 . . . . 0.0 109.713 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.61 -171.24 2.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.269 0.94 . . . . 0.0 108.932 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.39 164.9 16.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -118.03 159.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.85 2.06 . . . . 0.0 106.484 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -124.2 134.31 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 158.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.32 160.98 15.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 166.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.84 162.38 34.13 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.328 1.851 . . . . 0.0 107.313 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -148.07 141.0 24.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -155.79 121.36 4.93 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.71 -34.84 74.99 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.24 0.543 . . . . 0.0 111.693 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.08 17.22 3.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.11 2.564 . . . . 0.0 114.033 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.2 -73.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 t -147.7 146.54 29.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.59 -0.31 2.75 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.173 1.389 . . . . 0.0 113.681 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -102.62 155.67 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.974 2.51 . . . . 0.0 111.882 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -74.74 136.05 41.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 153.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.19 155.16 49.82 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.112 0.869 . . . . 0.0 110.528 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.97 130.65 43.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.296 1.438 . . . . 0.0 107.801 170.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.6 -6.75 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.058 1.343 . . . . 0.0 112.149 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.52 152.73 36.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 149.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -135.81 140.88 44.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.127 1.371 . . . . 0.0 108.421 -172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.45 43.77 29.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.661 1.184 . . . . 0.0 111.863 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.77 126.17 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 126.136 1.774 . . . . 0.0 107.161 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -108.2 15.2 24.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.798 0.839 . . . . 0.0 112.17 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -129.45 175.31 8.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.773 1.629 . . . . 0.0 109.306 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.5 p -112.42 -5.73 14.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.538 2.335 . . . . 0.0 111.545 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -135.73 123.18 22.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -145.9 121.14 10.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.859 0.754 . . . . 0.0 112.31 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.4 m -69.84 103.66 2.26 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.682 1.993 . . . . 0.0 110.241 164.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 t -60.9 148.64 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 126.936 2.094 . . . . 0.0 107.932 158.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -140.2 175.32 9.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.055 1.342 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.47 7.68 87.08 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 123.803 0.716 . . . . 0.0 114.455 165.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.73 -171.66 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.62 1.168 . . . . 0.0 109.039 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -113.05 132.89 22.16 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -59.23 156.46 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.544 2.163 . . . . 0.0 112.28 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.1 t30 41.57 33.63 0.32 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.718 2.807 . . . . 0.0 113.78 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.8 m -120.66 135.73 55.03 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.386 1.874 . . . . 0.0 106.831 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.16 148.6 8.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.825 0.85 . . . . 0.0 109.081 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -141.36 149.49 41.21 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.733 1.213 . . . . 0.0 110.62 171.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -107.72 160.83 15.41 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.371 162.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.04 144.45 33.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 124.753 1.283 . . . . 0.0 108.521 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 62.0 mtm -130.45 153.49 48.72 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.08 148.27 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -131.9 136.14 47.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.755 1.222 . . . . 0.0 108.249 176.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 152.13 22.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.82 148.15 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.005 2.122 . . . . 0.0 109.141 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -148.5 178.04 1.59 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 109.239 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.48 -2.68 2.72 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.602 2.868 . . . . 0.0 117.117 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -129.54 -17.42 3.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.393 1.451 . . . . 0.0 113.582 -167.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.33 -176.79 45.96 Favored Glycine 0 C--O 1.238 0.357 0 CA-C-N 119.527 1.058 . . . . 0.0 111.209 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -85.97 151.69 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 157.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 83.1 p -71.47 168.79 16.76 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.867 1.267 . . . . 0.0 110.102 168.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -42.07 149.04 0.45 Allowed Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.849 153.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.15 164.27 36.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.809 1.672 . . . . 0.0 110.952 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.2 p -67.14 167.07 15.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 159.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.57 149.89 4.36 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.257 1.971 . . . . 0.0 112.363 151.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.0 mtm -65.36 143.15 57.93 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.43 0.692 . . . . 0.0 111.405 166.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.2 t -54.01 -23.12 12.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.175 2.19 . . . . 0.0 113.621 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.54 154.14 0.13 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 127.055 2.142 . . . . 0.0 110.193 -162.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -68.89 110.05 2.28 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.384 2.723 . . . . 0.0 111.554 -159.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -75.4 162.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.64 133.52 54.98 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 163.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.4 p -62.67 169.34 3.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 166.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -81.91 -116.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -151.47 165.95 32.59 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 t -85.15 20.83 1.81 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.92 1.688 . . . . 0.0 111.232 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.83 174.79 52.57 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 163.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.0 -21.4 8.13 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.428 2.085 . . . . 0.0 112.599 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.1 m 54.17 48.07 21.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.156 1.383 . . . . 0.0 112.6 -166.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.27 106.73 6.05 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 159.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 N-CA-C 104.684 -3.366 . . . . 0.0 104.684 174.095 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.2 m -68.51 -29.9 68.59 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -169.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -87.23 132.01 34.03 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.38 -153.7 16.74 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 124.15 0.881 . . . . 0.0 112.056 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.3 p -76.74 86.92 3.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.32 1.048 . . . . 0.0 110.343 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -71.09 -60.32 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.669 0.788 . . . . 0.0 111.457 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.47 -166.08 27.36 Favored Glycine 0 C--O 1.239 0.414 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -163.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -137.9 93.08 2.73 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 169.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 60.33 73.14 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.462 1.905 . . . . 0.0 110.477 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -119.6 166.86 12.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.719 1.207 . . . . 0.0 108.794 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.64 168.28 4.96 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.951 1.3 . . . . 0.0 111.416 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.15 -121.82 0.29 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.438 1.495 . . . . 0.0 107.727 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.1 m -132.54 144.17 50.23 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.099 1.36 . . . . 0.0 109.249 -171.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -17.83 61.27 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.389 0.995 . . . . 0.0 110.891 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.8 mt -75.45 153.87 85.8 Favored Pre-proline 0 N--CA 1.444 -0.76 0 C-N-CA 123.455 0.702 . . . . 0.0 109.352 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -63.0 158.18 44.84 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.47 2.113 . . . . 0.0 110.85 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.92 143.08 48.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.2 152.93 79.96 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.877 1.718 . . . . 0.0 110.645 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -64.15 171.8 7.16 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.929 2.42 . . . . 0.0 111.646 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -74.12 174.56 8.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.623 0.769 . . . . 0.0 110.255 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -55.74 135.62 72.0 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.034 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.91 124.62 10.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.745 1.302 . . . . 0.0 109.95 160.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.64 171.46 12.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.636 161.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -125.31 136.54 60.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 p -126.33 -66.59 0.91 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.812 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -104.69 139.48 39.46 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.937 0.895 . . . . 0.0 109.097 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.14 142.75 24.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 119.677 1.126 . . . . 0.0 110.147 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 p -130.41 -176.31 3.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.263 1.825 . . . . 0.0 109.107 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -63.86 -17.77 63.49 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 120.868 -1.145 . . . . 0.0 113.307 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.34 13.13 1.08 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 120.357 -1.464 . . . . 0.0 113.113 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.76 160.39 40.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.231 0.923 . . . . 0.0 110.421 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.18 129.09 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.512 0.725 . . . . 0.0 109.284 170.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -81.05 120.39 24.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.196 0.998 . . . . 0.0 108.345 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -90.34 157.1 17.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.961 1.305 . . . . 0.0 109.116 166.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -149.01 99.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.13 0.972 . . . . 0.0 109.071 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.4 p90 -105.44 161.63 14.16 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.777 0.831 . . . . 0.0 109.083 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -95.45 147.55 33.2 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 165.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.19 171.77 16.18 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.79 2.993 . . . . 0.0 111.94 -167.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.42 177.48 33.48 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 168.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.8 m -107.57 157.69 35.14 Favored Pre-proline 0 N--CA 1.443 -0.793 0 C-N-CA 127.75 2.42 . . . . 0.0 109.874 -174.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -71.42 -159.96 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 125.014 3.809 . . . . 0.0 113.073 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.38 -123.05 0.8 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 170.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 p -72.35 -27.62 62.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.981 1.712 . . . . 0.0 112.415 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 mt -136.33 149.23 67.17 Favored Pre-proline 0 C--O 1.24 0.56 0 C-N-CA 123.311 0.644 . . . . 0.0 112.244 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.54 163.94 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.541 3.494 . . . . 0.0 110.891 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.75 141.5 28.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -112.77 -32.53 6.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.007 1.723 . . . . 0.0 112.198 -168.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.87 -162.03 0.67 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 159.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.12 165.09 14.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.306 1.443 . . . . 0.0 108.384 157.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -116.71 152.56 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.736 2.414 . . . . 0.0 105.288 164.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 83.2 mt -127.59 135.18 63.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 166.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -121.16 159.4 25.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.87 161.52 36.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.131 1.372 . . . . 0.0 108.246 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -138.87 135.89 34.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.1 t -115.98 149.29 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.581 1.082 . . . . 0.0 108.123 155.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -80.53 16.26 1.41 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.966 0.506 . . . . 0.0 111.001 162.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -132.35 10.99 4.51 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.542 -1.349 . . . . 0.0 110.417 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.311 34.8 m -121.84 -91.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 10.9 m -119.32 5.32 11.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 121.436 1.925 . . . . 0.0 113.179 -175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.28 21.19 1.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.783 1.633 . . . . 0.0 112.925 -171.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.4 m -122.17 163.98 18.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.579 3.151 . . . . 0.0 108.896 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.77 144.88 25.6 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 165.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -138.24 143.14 39.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.33 96.0 1.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.423 1.089 . . . . 0.0 108.178 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.0 m -82.9 -16.95 11.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 121.86 -0.525 . . . . 0.0 110.969 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.95 134.53 22.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 162.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -121.01 136.67 54.93 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 52.6 69.93 0.63 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.746 2.019 . . . . 0.0 112.418 -171.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.0 129.87 39.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.579 1.552 . . . . 0.0 107.575 168.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -117.42 38.13 3.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.428 1.091 . . . . 0.0 110.573 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -151.75 -178.49 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.044 1.738 . . . . 0.0 107.515 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p -113.23 -2.52 14.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.095 2.558 . . . . 0.0 111.9 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.93 139.7 46.31 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -146.66 140.94 26.36 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.1 m -94.18 102.57 14.6 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 174.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.87 135.99 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -130.82 178.85 6.35 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.42 1.088 . . . . 0.0 110.778 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.01 6.68 74.32 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.93 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.4 mt -72.17 -176.72 1.87 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.625 1.212 . . . . 0.0 110.381 -172.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.4 mtp85 -108.51 149.83 39.87 Favored Pre-proline 0 CA--C 1.513 -0.471 0 C-N-CA 125.25 1.42 . . . . 0.0 108.608 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.42 154.52 24.45 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.873 1.715 . . . . 0.0 111.638 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.62 16.99 0.34 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.894 2.078 . . . . 0.0 114.373 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.9 m -102.11 133.01 47.64 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.123 2.169 . . . . 0.0 108.354 -172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.7 mm -70.04 148.43 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.54 158.27 44.06 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.52 164.99 12.0 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.647 1.179 . . . . 0.0 108.437 160.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.56 145.67 33.83 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.722 1.889 . . . . 0.0 109.643 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.3 mtm -135.42 162.84 31.48 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.732 1.213 . . . . 0.0 107.916 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.64 143.27 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.787 2.035 . . . . 0.0 105.817 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -132.6 138.85 47.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 124.57 33.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -86.4 152.82 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.812 1.245 . . . . 0.0 108.518 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.88 168.02 11.84 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.513 1.925 . . . . 0.0 109.066 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.69 -9.87 8.19 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.391 3.394 . . . . 0.0 117.05 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -111.48 -43.26 3.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.462 1.505 . . . . 0.0 110.141 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.08 -149.65 6.21 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 119.063 0.847 . . . . 0.0 111.074 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 pp -129.85 158.98 37.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.662 1.585 . . . . 0.0 108.7 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.1 p -71.89 167.09 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 111.308 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -47.26 151.15 1.33 Allowed Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 154.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.7 148.19 52.39 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.431 1.421 . . . . 0.0 110.338 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.4 p -50.46 151.99 3.55 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.023 163.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -47.41 122.52 6.76 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.942 1.762 . . . . 0.0 107.88 153.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.8 ttm -58.11 148.67 25.79 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 124.212 1.005 . . . . 0.0 109.871 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.5 p -60.38 162.5 6.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 123.047 1.403 . . . . 0.0 109.471 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.63 154.53 68.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.658 164.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.68 92.6 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.198 2.599 . . . . 0.0 111.846 -175.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.2 m -84.17 163.44 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.525 1.53 . . . . 0.0 109.482 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.91 146.35 47.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 125.385 1.474 . . . . 0.0 109.006 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -61.58 161.7 9.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 159.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -75.75 178.32 6.21 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 168.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.54 153.85 29.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.833 0.825 . . . . 0.0 110.494 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -30.86 63.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.176 1.39 . . . . 0.0 113.437 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.94 163.09 30.43 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 119.524 1.056 . . . . 0.0 114.053 -162.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.28 82.24 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.268 3.312 . . . . 0.0 109.342 171.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.75 119.78 4.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.324 1.05 . . . . 0.0 109.203 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.0 m -73.46 99.48 3.0 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.474 0.71 . . . . 0.0 110.438 -167.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.639 -2.984 . . . . 0.0 105.639 -173.163 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.761 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 m 15.11 83.33 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 130.3 3.44 . . . . 0.0 114.916 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.5 m -69.59 106.47 3.04 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.342 1.457 . . . . 0.0 109.078 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.62 -17.79 0.07 OUTLIER Glycine 0 CA--C 1.519 0.292 0 CA-C-O 118.906 -0.941 . . . . 0.0 112.7 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m -72.04 123.9 23.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -156.82 166.73 32.54 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.036 0.935 . . . . 0.0 109.464 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.95 165.52 26.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 152.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -151.93 162.91 40.31 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 158.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -144.88 160.59 41.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 162.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.85 137.68 15.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 129.212 3.005 . . . . 0.0 106.72 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 t70 67.08 173.61 0.26 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.699 1.6 . . . . 0.0 110.463 -164.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 64.8 mt 5.46 85.63 0.01 OUTLIER 'General case' 0 C--N 1.348 0.517 0 C-N-CA 130.491 3.516 . . . . 0.0 113.483 -171.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.57 106.46 4.7 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -86.56 -20.83 27.38 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 165.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.61 160.04 74.97 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.76 2.024 . . . . 0.0 112.111 -160.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -59.27 156.12 36.88 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.678 2.252 . . . . 0.0 112.12 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.37 120.84 21.76 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 153.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.08 161.51 44.51 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.235 2.623 . . . . 0.0 111.103 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.38 158.16 57.0 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.282 1.988 . . . . 0.0 110.712 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -71.21 175.16 5.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.918 0.487 . . . . 0.0 110.835 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 103' ' ' MET . 83.8 tttt -53.54 120.83 23.71 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -66.5 149.44 84.42 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 120.715 1.291 . . . . 0.0 109.374 171.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -79.21 170.94 15.89 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 161.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.0 t -122.68 121.61 63.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 129.151 2.981 . . . . 0.0 104.506 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.254 82.1 p -119.21 -84.81 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.859 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.71 150.07 37.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.106 1.321 . . . . 0.0 108.274 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.98 152.6 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.493 0.717 . . . . 0.0 109.769 163.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.4 p -141.21 -172.45 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 108.869 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -57.89 -37.08 73.33 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.141 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -136.19 17.21 3.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.866 1.666 . . . . 0.0 112.14 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -151.37 161.33 42.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.551 -1.343 . . . . 0.0 110.175 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.01 140.85 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.72 145.5 47.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.536 1.934 . . . . 0.0 107.522 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.68 114.47 9.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.446 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.468 ' CE2' ' HA ' ' A' ' 72' ' ' THR . 39.2 p90 -123.3 171.32 9.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.997 1.272 . . . . 0.0 110.208 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -97.87 144.98 28.98 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 165.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.24 133.3 24.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.192 3.261 . . . . 0.0 107.669 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.67 -178.54 43.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -62.1 152.95 76.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.069 1.348 . . . . 0.0 110.157 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.82 -148.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.911 3.741 . . . . 0.0 109.843 167.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -125.44 0.76 Allowed Glycine 0 C--N 1.333 0.4 0 O-C-N 118.941 -2.349 . . . . 0.0 109.478 163.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.3 p -49.78 -35.88 24.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.642 2.377 . . . . 0.0 110.112 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.9 mt -135.75 170.03 12.11 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 127.642 2.377 . . . . 0.0 109.495 -168.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.48 170.07 18.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.896 3.064 . . . . 0.0 110.003 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.23 22.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 m -53.49 -49.45 67.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.28 2.632 . . . . 0.0 111.919 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.15 -162.2 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.126 0.97 . . . . 0.0 108.594 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -131.92 168.81 17.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.056 1.742 . . . . 0.0 107.752 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.0 165.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 129.266 3.027 . . . . 0.0 106.622 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.11 136.08 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 162.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -114.31 161.72 17.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.327 1.051 . . . . 0.0 108.314 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.76 150.19 36.81 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.125 1.37 . . . . 0.0 109.086 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -127.3 141.13 51.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.347 1.459 . . . . 0.0 107.533 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -144.85 136.65 25.67 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 153.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.85 -37.36 81.81 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.932 165.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -76.31 16.33 0.48 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.066 2.146 . . . . 0.0 113.966 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.51 -77.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 125.324 1.45 . . . . 0.0 107.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.15 21.19 0.97 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.898 0.479 . . . . 0.0 110.287 -176.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 36.66 51.02 0.87 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.687 2.395 . . . . 0.0 111.885 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -143.37 143.48 31.67 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -66.51 136.83 56.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 153.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.97 145.25 39.51 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.896 1.278 . . . . 0.0 107.624 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.08 125.53 24.77 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.36 -6.37 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.278 1.031 . . . . 0.0 112.243 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.93 151.33 33.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 154.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -132.92 150.45 52.16 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 44.32 64.46 1.31 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.163 1.785 . . . . 0.0 110.683 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.77 -28.45 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.319 1.848 . . . . 0.0 112.067 -161.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mttt 60.62 15.18 5.51 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.581 2.352 . . . . 0.0 114.172 163.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -137.42 -177.66 4.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.229 1.412 . . . . 0.0 108.063 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.468 ' HA ' ' CE2' ' A' ' 36' ' ' TRP . 23.6 p -124.96 0.33 7.95 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.917 1.687 . . . . 0.0 111.351 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.71 112.2 10.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -145.58 151.5 38.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.059 0.845 . . . . 0.0 111.376 -175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -103.71 102.19 12.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.134 1.774 . . . . 0.0 109.06 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.41 139.73 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.559 1.544 . . . . 0.0 107.719 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -133.71 -170.25 2.46 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.814 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.6 73.49 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.668 -0.518 . . . . 0.0 112.688 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.41 -166.68 1.66 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.055 0.928 . . . . 0.0 109.346 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -116.44 155.13 48.92 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 126.706 2.002 . . . . 0.0 108.472 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.57 156.74 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.901 2.4 . . . . 0.0 111.835 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.8 t30 43.31 37.02 1.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.299 2.239 . . . . 0.0 112.712 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.3 m -121.89 131.25 53.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.992 1.717 . . . . 0.0 107.403 -174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.2 mm -69.06 149.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.903 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -140.3 149.02 42.27 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.028 0.918 . . . . 0.0 111.289 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.92 162.58 13.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.129 156.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.85 166.71 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.707 1.88 . . . . 0.0 110.465 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 17.5 mtt -134.14 168.68 18.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 157.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.11 109.32 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -90.76 140.69 29.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.7 148.17 26.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.98 147.6 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 165.34 17.65 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -174.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.3 -20.89 71.43 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.457 1.438 . . . . 0.0 115.199 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.7 -38.66 11.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.398 1.479 . . . . 0.0 111.503 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.44 -149.7 6.28 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 118.905 0.775 . . . . 0.0 111.537 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.71 156.63 35.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.351 1.861 . . . . 0.0 106.424 172.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.4 p -76.05 167.39 21.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.621 0.768 . . . . 0.0 112.741 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.22 164.77 0.57 Allowed Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 122.055 -0.403 . . . . 0.0 111.116 161.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.12 127.43 6.02 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.709 2.273 . . . . 0.0 110.452 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.8 p -49.07 155.45 1.12 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 111.678 163.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -59.18 123.88 14.4 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.901 2.401 . . . . 0.0 108.698 164.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.422 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 4.3 mpp? -55.59 124.62 17.94 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.448 1.022 . . . . 0.0 109.933 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 73.0 p -54.68 -16.03 2.23 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.889 2.475 . . . . 0.0 115.356 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 92.04 146.5 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.421 1 C-N-CA 132.607 4.363 . . . . 0.0 109.575 168.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.29 107.81 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.394 2.729 . . . . 0.0 111.211 -153.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.47 169.52 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -126.8 148.14 49.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.71 1.604 . . . . 0.0 108.086 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.7 p -76.64 167.81 21.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.805 0.812 . . . . 0.0 110.966 166.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -77.32 178.25 7.28 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.719 -0.613 . . . . 0.0 110.119 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.49 164.72 22.78 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.945 0.898 . . . . 0.0 110.423 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.0 p -110.31 -5.3 15.28 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -109.69 -177.13 21.2 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.664 1.126 . . . . 0.0 111.569 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.66 116.08 4.38 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.362 2.708 . . . . 0.0 109.299 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.1 m -161.61 38.99 0.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.768 2.427 . . . . 0.0 108.116 169.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.4 t -89.5 -77.95 0.37 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 162.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.532 0 N-CA-C 104.763 -3.335 . . . . 0.0 104.763 126.726 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.949 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.7 m -132.47 122.02 24.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.869 1.668 . . . . 0.0 108.671 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 p -87.08 65.34 8.87 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.2 1.4 . . . . 0.0 112.911 -165.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.41 -167.72 3.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.939 0.78 . . . . 0.0 111.983 170.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 p -54.39 123.34 12.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.022 0.929 . . . . 0.0 110.64 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 m -76.65 -176.88 3.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.088 0.555 . . . . 0.0 110.471 164.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.96 41.85 1.37 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.336 1.445 . . . . 0.0 109.996 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -149.03 28.78 0.82 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.84 2.056 . . . . 0.0 110.044 -171.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -144.19 103.54 4.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -158.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -112.4 11.57 19.97 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.389 1.475 . . . . 0.0 110.993 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -57.69 146.14 31.94 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.171 0.989 . . . . 0.0 110.382 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -91.59 52.0 1.97 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.664 1.585 . . . . 0.0 108.735 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.4 t 46.48 79.79 0.05 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.616 2.366 . . . . 0.0 113.892 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.468 ' HB3' ' HG1' ' A' ' 43' ' ' THR . 10.1 m-20 -84.81 7.97 18.93 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.22 -0.925 . . . . 0.0 111.792 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.04 167.35 13.77 Favored Pre-proline 0 CA--C 1.537 0.478 0 O-C-N 119.563 -1.96 . . . . 0.0 109.068 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.76 141.02 77.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.446 1.431 . . . . 0.0 109.775 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.34 138.75 45.44 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 163.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.36 153.49 55.87 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.276 1.984 . . . . 0.0 111.918 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.71 161.74 40.43 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.488 1.459 . . . . 0.0 110.343 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -77.48 173.82 11.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.105 0.562 . . . . 0.0 109.744 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -51.99 125.31 31.33 Favored Pre-proline 0 C--O 1.239 0.518 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.487 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.54 135.82 47.44 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.699 1.6 . . . . 0.0 109.78 169.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -91.37 134.47 34.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.841 1.256 . . . . 0.0 108.197 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.49 143.61 15.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 167.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 p -127.51 -97.45 0.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.84 135.69 56.8 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 126.05 1.74 . . . . 0.0 109.152 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.71 148.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.5 1.045 . . . . 0.0 110.654 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -137.82 -169.72 2.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.622 1.569 . . . . 0.0 109.547 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -57.55 -41.17 80.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.377 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -136.58 12.63 3.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.298 0.954 . . . . 0.0 112.481 -169.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -141.82 158.43 43.81 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.472 1.033 . . . . 0.0 110.336 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.97 134.14 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.318 1.047 . . . . 0.0 108.782 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -85.6 130.32 34.6 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 108.984 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.9 mt -109.49 146.12 35.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.003 1.721 . . . . 0.0 107.835 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.538 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.82 102.34 3.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.778 1.299 . . . . 0.0 107.993 -163.625 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 36.3 p90 -119.87 158.76 25.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.062 0.846 . . . . 0.0 110.986 -175.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -81.77 134.94 49.5 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 164.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.3 157.76 56.14 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.868 3.045 . . . . 0.0 109.008 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.58 -176.62 35.58 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.752 1.168 . . . . 0.0 111.653 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 150.57 68.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.073 1.349 . . . . 0.0 109.855 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.11 -167.66 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 125.237 3.958 . . . . 0.0 112.54 169.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.61 -109.39 0.25 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 169.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.468 ' HG1' ' HB3' ' A' ' 14' ' ' ASP . 5.0 p -66.63 -46.09 76.94 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.105 2.162 . . . . 0.0 111.17 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.1 mt -128.46 162.27 51.92 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 124.14 0.976 . . . . 0.0 109.793 -164.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.14 145.28 27.51 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 108.159 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.84 158.38 25.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 -47.99 1.98 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.101 -170.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.23 -166.26 0.88 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -128.78 162.04 28.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.155 1.782 . . . . 0.0 109.217 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.84 152.19 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 128.733 2.813 . . . . 0.0 106.718 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 95.2 mt -137.94 105.22 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -101.04 136.67 40.51 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.743 1.217 . . . . 0.0 108.755 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -110.72 165.21 12.01 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.015 1.326 . . . . 0.0 109.258 174.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -137.89 145.26 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.804 1.242 . . . . 0.0 107.85 170.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -154.46 119.79 5.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -66.22 -19.06 65.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.63 12.77 22.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.019 0.928 . . . . 0.0 111.37 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.22 -59.82 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -158.86 137.56 11.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.384 1.874 . . . . 0.0 108.079 171.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.03 -17.51 63.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.001 0.819 . . . . 0.0 111.617 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 m -68.3 143.28 55.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.611 -0.68 . . . . 0.0 109.548 169.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -67.15 144.83 55.82 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -125.67 118.18 25.09 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 m -74.93 93.43 2.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.25 -17.67 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 0.0 111.076 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.28 149.47 34.92 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.97 147.97 42.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.477 1.911 . . . . 0.0 106.216 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.423 ' O ' ' HE2' ' A' ' 70' ' ' LYS . 8.9 m170 57.99 51.2 9.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.04 0.936 . . . . 0.0 111.211 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.2 t -82.61 139.11 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.389 1.476 . . . . 0.0 107.335 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 68' ' ' HIS . 3.5 mtmt -119.15 25.36 10.21 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.62 1.168 . . . . 0.0 112.243 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.2 t -143.93 173.2 11.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.177 0.991 . . . . 0.0 108.828 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -103.56 2.51 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.127 2.171 . . . . 0.0 112.042 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.538 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 4.7 tp -140.04 114.83 9.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.972 1.709 . . . . 0.0 107.425 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -145.65 120.97 10.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 118.148 0.431 . . . . 0.0 111.9 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.7 m -66.8 101.4 0.81 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.485 1.914 . . . . 0.0 109.08 164.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.92 144.83 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 162.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 50.7 mtt-85 -136.91 178.58 6.97 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.23 1.412 . . . . 0.0 110.502 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.56 80.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 123.5 0.571 . . . . 0.0 112.557 170.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.08 -172.75 4.33 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.704 0.752 . . . . 0.0 110.291 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -114.25 146.62 36.17 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 125.563 1.545 . . . . 0.0 107.811 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.71 154.12 30.39 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.492 2.128 . . . . 0.0 110.374 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.62 44.95 17.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.664 1.186 . . . . 0.0 111.465 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.9 m -131.13 136.26 48.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 mm -74.15 146.65 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.189 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.87 148.65 48.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.052 0.845 . . . . 0.0 109.457 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 12.8 mt -109.25 161.02 15.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.617 -1.174 . . . . 0.0 107.899 158.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -143.85 143.12 31.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 126.001 2.063 . . . . 0.0 107.814 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 13.2 mtm -136.67 125.65 24.33 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 129.209 3.004 . . . . 0.0 107.479 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.1 t -94.59 145.78 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -131.63 128.6 39.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 167.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 125.12 33.97 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.27 148.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.549 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -135.77 179.81 1.27 Allowed Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.221 1.809 . . . . 0.0 107.403 166.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.67 -0.1 9.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 122.4 1.893 . . . . 0.0 113.812 -172.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -116.72 -37.91 3.57 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.981 1.312 . . . . 0.0 110.301 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.26 -141.39 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 pp -142.9 159.52 42.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.753 2.421 . . . . 0.0 106.729 -176.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.0 p -72.05 166.61 21.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.333 0.653 . . . . 0.0 110.244 -169.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.31 148.42 3.28 Favored Pre-proline 0 C--O 1.244 0.771 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 160.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.33 130.17 20.63 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.923 1.749 . . . . 0.0 108.631 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -54.62 161.73 2.05 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.119 0.568 . . . . 0.0 111.817 165.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.93 138.14 69.36 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.342 2.028 . . . . 0.0 110.649 159.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -58.64 150.24 23.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.913 0.779 . . . . 0.0 109.999 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 88.2 p -63.14 -4.58 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.25 149.87 0.11 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.935 1.694 . . . . 0.0 110.808 -163.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.01 99.02 1.13 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.134 1.889 . . . . 0.0 112.636 -164.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.46 155.22 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.432 0.693 . . . . 0.0 109.167 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -108.1 150.95 26.53 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.108 1.363 . . . . 0.0 109.901 166.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.4 p -77.7 167.95 20.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.789 0.804 . . . . 0.0 111.407 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -77.45 178.82 6.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.275 0.63 . . . . 0.0 109.943 169.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.86 167.13 19.31 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 109.404 170.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.6 t -103.81 -0.22 29.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.268 2.227 . . . . 0.0 111.884 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -60.26 112.29 4.37 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 117.931 -1.483 . . . . 0.0 110.103 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.11 79.85 3.22 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.295 2.664 . . . . 0.0 110.895 -170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -134.4 138.03 44.51 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.8 m -166.6 164.23 16.93 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 129.027 2.931 . . . . 0.0 107.689 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 N-CA-C 106.433 -2.667 . . . . 0.0 106.433 179.063 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.748 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -52.5 158.1 1.34 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.372 1.086 . . . . 0.0 112.502 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.3 p -138.59 -39.19 0.52 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -166.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.7 -142.52 16.09 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -160.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -110.17 -29.78 8.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.704 1.202 . . . . 0.0 112.797 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 t -172.98 151.11 2.11 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.75 1.62 . . . . 0.0 107.505 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.16 -126.93 2.72 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -68.5 137.11 54.14 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 170.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -140.2 152.26 45.86 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 159.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -95.25 141.54 28.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 166.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.26 0.18 5.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.562 1.145 . . . . 0.0 113.153 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.22 65.06 5.25 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 127.354 2.262 . . . . 0.0 110.543 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.95 156.57 30.55 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.566 2.346 . . . . 0.0 108.08 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.15 -28.24 67.13 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.871 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.89 154.93 56.48 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.893 2.077 . . . . 0.0 111.667 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.43 149.6 84.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.434 2.089 . . . . 0.0 111.26 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -51.79 134.25 35.36 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.88 154.71 72.79 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.996 1.898 . . . . 0.0 111.361 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -60.81 168.55 6.92 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.743 2.295 . . . . 0.0 111.772 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.86 171.67 12.27 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -61.22 144.47 91.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.58 129.1 19.3 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.496 1.464 . . . . 0.0 111.337 161.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -81.64 158.18 24.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.017 2.127 . . . . 0.0 109.218 158.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.99 121.19 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.337 -1.756 . . . . 0.0 107.141 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.1 p -116.2 -95.67 0.47 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.329 -167.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.27 143.28 41.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.6 1.56 . . . . 0.0 109.653 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.37 148.96 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.719 0.808 . . . . 0.0 110.685 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 p -135.8 -168.33 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.399 1.48 . . . . 0.0 108.021 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -71.11 -16.32 62.56 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.444 -1.41 . . . . 0.0 112.642 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -152.36 15.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.099 -1.626 . . . . 0.0 112.633 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -139.43 161.85 36.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.46 140.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.446 1.499 . . . . 0.0 108.111 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -92.74 126.47 37.84 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.33 1.052 . . . . 0.0 108.642 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -107.35 139.8 41.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.133 1.773 . . . . 0.0 107.363 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -134.64 138.69 44.7 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.1 p90 -139.32 171.19 14.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.199 0.523 . . . . 0.0 111.474 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -98.87 148.83 35.1 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.24 161.49 17.67 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.546 2.831 . . . . 0.0 111.44 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.1 -173.3 49.56 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 165.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.41 171.78 11.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.158 1.383 . . . . 0.0 108.588 169.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.31 -156.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.151 3.234 . . . . 0.0 109.565 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.9 -131.75 2.75 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 167.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -55.53 -27.58 49.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.942 2.097 . . . . 0.0 112.118 164.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.9 mt -144.58 162.39 39.28 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 127.612 2.365 . . . . 0.0 109.543 -156.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.37 158.34 36.84 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.091 3.194 . . . . 0.0 110.989 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.68 128.9 41.67 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.96 -27.53 10.12 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.129 0.572 . . . . 0.0 111.508 -165.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.75 -165.97 1.64 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 160.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -128.83 169.74 14.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.785 2.034 . . . . 0.0 109.354 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.75 157.1 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 127.608 2.363 . . . . 0.0 107.214 171.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 55.9 mt -125.43 133.08 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 165.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -113.4 158.42 20.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.78 146.68 46.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.368 1.067 . . . . 0.0 108.223 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -109.34 146.88 33.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 166.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.53 124.94 5.21 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.677 0.671 . . . . 0.0 109.346 170.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.54 -34.97 72.86 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -169.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 7.41 11.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.85 0.75 . . . . 0.0 112.276 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.5 t -121.68 -55.34 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.717 1.207 . . . . 0.0 107.944 -171.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 t -141.31 -98.3 0.14 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 p30 140.49 -17.18 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.778 2.831 . . . . 0.0 111.119 -149.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -119.02 150.98 39.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.294 1.038 . . . . 0.0 110.187 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -70.6 121.86 18.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -118.84 143.52 46.9 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.323 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.92 93.95 3.3 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.66 -15.43 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.084 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.08 152.38 30.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.103 0.961 . . . . 0.0 108.944 161.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -142.93 170.24 16.07 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.762 0.825 . . . . 0.0 111.355 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 51.97 38.19 23.08 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.915 0.864 . . . . 0.0 112.422 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.65 127.84 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 125.845 1.658 . . . . 0.0 108.449 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -113.34 29.96 7.58 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.701 0.801 . . . . 0.0 112.253 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -150.47 173.6 13.88 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 108.305 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -98.48 2.9 48.12 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.658 2.383 . . . . 0.0 112.186 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.28 117.1 10.98 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.583 1.083 . . . . 0.0 110.325 -176.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -146.1 151.41 37.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.545 0.738 . . . . 0.0 111.591 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -101.19 103.4 14.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.142 1.377 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.1 139.21 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -139.93 176.07 9.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 111.386 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.77 79.59 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.63 0.633 . . . . 0.0 112.35 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.42 -175.79 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.489 0.715 . . . . 0.0 110.403 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -98.16 145.06 29.16 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.043 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -75.61 159.38 39.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.73 2.953 . . . . 0.0 111.686 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.6 t30 45.54 38.13 3.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.645 1.978 . . . . 0.0 111.842 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.2 m -132.18 134.13 45.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.538 1.135 . . . . 0.0 108.817 -170.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.34 141.52 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.09 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -139.17 154.48 48.08 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 125.056 1.473 . . . . 0.0 108.077 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.25 165.69 11.31 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.051 1.34 . . . . 0.0 108.302 164.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -137.28 140.07 41.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.952 0.782 . . . . 0.0 109.953 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 28.2 mtm -118.86 167.71 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 161.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.94 155.82 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -133.78 141.66 47.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 165.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.54 142.81 27.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 165.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.74 147.07 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 124.492 1.117 . . . . 0.0 109.243 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.81 171.2 6.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.95 22.64 0.47 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 123.683 2.922 . . . . 0.0 114.929 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -131.55 -34.3 1.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.905 1.682 . . . . 0.0 111.201 172.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.14 -165.26 33.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.515 1.052 . . . . 0.0 111.035 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -98.5 148.55 23.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 p -73.07 166.42 23.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.1 143.76 15.8 Favored Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 126.823 2.049 . . . . 0.0 110.301 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.99 127.77 22.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.858 1.705 . . . . 0.0 113.07 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -54.37 160.68 2.4 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.669 1.988 . . . . 0.0 112.666 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.94 120.79 8.74 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.136 1.891 . . . . 0.0 109.354 156.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 ptp -77.58 151.76 34.29 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 120.194 1.361 . . . . 0.0 109.182 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.4 t -58.95 154.47 15.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.464 1.106 . . . . 0.0 109.402 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.48 150.02 57.7 Favored Pre-proline 0 N--CA 1.475 0.792 0 O-C-N 120.874 -1.141 . . . . 0.0 109.465 158.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.09 102.98 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.104 2.536 . . . . 0.0 110.905 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.03 163.29 3.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -122.07 141.66 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.986 1.314 . . . . 0.0 107.655 164.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 p -68.07 161.08 27.58 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -66.74 -175.27 0.38 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.995 1.379 . . . . 0.0 109.205 163.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -104.34 153.84 20.55 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.065 -174.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.9 p -87.88 46.1 1.35 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.049 1.74 . . . . 0.0 111.939 -169.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -151.03 -140.46 3.18 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.258 1.408 . . . . 0.0 110.227 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.27 126.17 17.98 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.437 2.091 . . . . 0.0 109.309 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.9 t -141.62 124.77 16.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.77 2.028 . . . . 0.0 106.669 -167.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.1 m 52.75 178.46 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.208 1.403 . . . . 0.0 111.85 -158.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 N-CA-C 103.645 -3.782 . . . . 0.0 103.645 178.043 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.091 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t 57.75 177.85 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.098 0.949 . . . . 0.0 110.354 -149.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -164.55 178.73 7.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.512 2.725 . . . . 0.0 107.672 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.62 -172.73 52.31 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -175.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.4 m -153.71 142.59 21.11 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.449 -1.03 . . . . 0.0 108.39 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 m -176.18 176.59 1.69 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 129.087 2.955 . . . . 0.0 106.48 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.49 -68.82 0.47 Allowed Glycine 0 C--N 1.336 0.569 0 O-C-N 121.412 -0.805 . . . . 0.0 111.271 166.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.79 167.61 11.53 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 159.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -129.86 100.68 5.56 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.69 26.12 2.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.996 1.318 . . . . 0.0 113.379 -163.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -57.38 166.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.766 1.626 . . . . 0.0 112.694 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp -79.69 -106.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.888 0.875 . . . . 0.0 109.431 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.1 149.15 52.14 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.441 1.897 . . . . 0.0 107.686 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -19.38 65.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.68 1.592 . . . . 0.0 111.043 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.5 162.61 65.3 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 127.632 2.373 . . . . 0.0 110.353 -173.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.02 150.57 83.51 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.285 1.99 . . . . 0.0 108.872 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.37 147.97 41.61 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 163.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.52 147.1 63.67 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.143 1.896 . . . . 0.0 111.431 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -66.0 165.14 24.85 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.411 2.074 . . . . 0.0 110.528 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.2 p -67.71 169.39 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.787 -0.571 . . . . 0.0 110.763 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -48.62 127.65 13.54 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.538 155.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.48 142.82 45.67 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.787 1.317 . . . . 0.0 110.261 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.43 161.4 26.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.53 1.532 . . . . 0.0 109.351 163.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -124.35 105.21 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -110.65 -62.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.838 1.655 . . . . 0.0 111.124 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -111.02 136.0 50.69 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.216 1.807 . . . . 0.0 110.738 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.26 150.39 17.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 119.855 1.207 . . . . 0.0 110.588 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.5 p -139.88 -174.54 3.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.345 1.858 . . . . 0.0 107.818 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -24.77 61.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.385 -1.447 . . . . 0.0 112.461 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -131.81 4.65 4.2 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.167 1.349 . . . . 0.0 110.959 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 m -150.78 163.61 38.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.525 1.511 . . . . 0.0 110.356 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 p -156.74 136.76 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.145 1.378 . . . . 0.0 108.155 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -80.3 140.72 36.04 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -114.55 150.05 35.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 t -138.16 134.68 34.85 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.447 1.099 . . . . 0.0 108.515 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -138.98 170.23 16.35 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 110.387 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.32 138.08 25.8 Favored Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 164.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.66 140.45 47.08 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.99 3.127 . . . . 0.0 107.62 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 163.07 43.35 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.0 m -73.3 143.36 82.95 Favored Pre-proline 0 N--CA 1.433 -1.308 0 C-N-CA 126.009 1.723 . . . . 0.0 110.938 -164.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -71.53 -169.13 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.438 3.426 . . . . 0.0 111.758 166.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.82 -114.09 0.54 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 163.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -47.05 -40.68 15.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.763 2.825 . . . . 0.0 112.607 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 mt -134.7 163.24 52.58 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.273 1.029 . . . . 0.0 109.277 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.62 171.31 15.9 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.664 2.909 . . . . 0.0 110.809 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.03 107.14 16.91 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.253 1.021 . . . . 0.0 109.064 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 14.4 m -58.91 -51.4 70.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.144 2.578 . . . . 0.0 112.388 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.0 -164.88 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.973 -1.079 . . . . 0.0 108.191 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.72 164.23 24.44 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.9 2.08 . . . . 0.0 108.63 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mt -120.34 154.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 127.131 2.172 . . . . 0.0 106.563 161.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.62 124.97 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 156.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -100.78 151.92 21.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -131.61 151.38 51.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 173.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -123.47 151.0 43.18 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -140.53 136.17 32.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -56.85 -50.84 71.21 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.599 163.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -73.7 25.37 0.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.04 2.936 . . . . 0.0 113.469 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -135.7 -62.55 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.43 -5.38 0.66 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -165.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t30 46.63 36.52 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.372 1.469 . . . . 0.0 111.931 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.8 m -149.97 157.85 43.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 128.412 2.685 . . . . 0.0 105.187 -169.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.91 154.02 21.15 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -136.34 146.03 46.1 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.8 m -71.32 128.5 36.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.16 -12.36 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.18 74.94 0.93 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.347 1.859 . . . . 0.0 108.834 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.71 144.64 29.23 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.21 2.604 . . . . 0.0 109.185 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 38.32 60.81 1.23 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.911 2.085 . . . . 0.0 111.8 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.53 145.56 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.17 40.68 3.63 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.17 1.388 . . . . 0.0 110.355 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -148.0 -176.93 5.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -114.99 2.31 14.21 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.675 2.79 . . . . 0.0 110.991 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mp -135.43 143.85 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.531 0.733 . . . . 0.0 109.271 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -146.26 129.74 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 m -71.6 94.49 1.33 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.377 1.471 . . . . 0.0 107.515 161.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.97 138.02 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.99 179.82 6.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.917 1.287 . . . . 0.0 110.045 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.42 22.15 79.07 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.862 -0.41 . . . . 0.0 112.38 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt -87.0 172.36 10.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.576 1.179 . . . . 0.0 110.087 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 mtt85 -103.4 149.73 37.3 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 125.668 1.587 . . . . 0.0 107.345 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.11 160.02 40.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.779 1.653 . . . . 0.0 110.338 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 t30 46.5 33.15 1.85 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.018 1.327 . . . . 0.0 111.633 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.8 m -119.99 126.91 52.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.59 148.19 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.208 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -139.92 146.65 39.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.289 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 13.7 mt -107.92 156.69 18.92 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 160.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -137.33 146.7 44.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.683 1.865 . . . . 0.0 107.816 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 45.0 mtm -134.53 137.84 44.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 160.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.95 139.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -120.43 146.53 46.12 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 168.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 163.97 16.49 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.46 150.86 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 126.665 1.986 . . . . 0.0 108.806 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.85 169.91 9.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 0.0 110.165 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.98 19.24 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.06 2.506 . . . . 0.0 114.982 -174.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -127.85 -58.71 1.22 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 126.288 1.835 . . . . 0.0 110.091 166.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.66 -173.36 17.82 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 121.836 0.686 . . . . 0.0 113.983 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 mp -81.69 157.08 24.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.6 p -71.64 168.43 17.71 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.875 0.87 . . . . 0.0 109.757 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -41.6 142.19 1.07 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 151.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.59 156.15 64.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.676 1.584 . . . . 0.0 109.346 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 p -68.59 166.53 25.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.891 -0.505 . . . . 0.0 110.296 164.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -54.58 146.53 53.08 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 111.17 163.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.9 mtm -60.2 144.85 49.08 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.29 0.496 . . . . 0.0 110.14 171.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.0 p -62.93 -11.39 18.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.238 1.815 . . . . 0.0 115.175 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 t0 69.62 156.46 0.15 Allowed Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.411 -153.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -76.07 101.15 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.411 2.074 . . . . 0.0 111.375 -173.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.27 165.45 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -127.34 141.05 51.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.559 2.344 . . . . 0.0 107.612 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.6 p -74.39 161.14 30.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.044 0.838 . . . . 0.0 109.527 163.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -67.22 165.66 15.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.745 0.783 . . . . 0.0 109.896 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -89.04 39.65 0.94 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 123.608 1.67 . . . . 0.0 112.498 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.8 t 65.57 -71.43 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.964 2.106 . . . . 0.0 111.001 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -154.28 76.27 0.22 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.408 1.48 . . . . 0.0 109.68 -173.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.34 86.64 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.883 2.389 . . . . 0.0 107.956 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 m 56.47 -177.48 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.397 1.479 . . . . 0.0 112.25 -162.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -117.83 62.09 0.76 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 N-CA-C 105.344 -3.102 . . . . 0.0 105.344 -167.731 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 t -85.24 161.31 19.62 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 118.43 1.115 . . . . 0.0 109.244 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 p -155.31 164.8 38.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.717 1.207 . . . . 0.0 108.903 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.12 -162.78 54.54 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 t 58.08 -167.2 0.14 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.007 0.923 . . . . 0.0 110.238 -166.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.6 m -76.2 38.39 0.17 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.599 1.959 . . . . 0.0 112.46 -175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.68 119.75 13.08 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 120.805 -1.184 . . . . 0.0 110.89 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -67.61 167.0 13.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.301 1.05 . . . . 0.0 108.627 159.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -137.82 110.45 7.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.2 t80 78.1 -58.89 0.45 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 127.828 2.451 . . . . 0.0 112.185 167.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -146.26 168.91 19.9 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.355 1.462 . . . . 0.0 108.23 172.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.78 40.76 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.787 0.835 . . . . 0.0 110.945 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 m 60.49 67.09 0.86 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.277 2.231 . . . . 0.0 111.232 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.62 56.96 4.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.836 1.303 . . . . 0.0 110.308 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt -130.99 156.75 79.69 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 126.278 1.831 . . . . 0.0 109.062 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.93 164.91 30.89 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.22 2.613 . . . . 0.0 111.457 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.97 149.65 49.5 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.75 141.01 44.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.334 2.689 . . . . 0.0 110.857 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -65.74 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.689 1.593 . . . . 0.0 110.203 170.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m -79.96 171.19 15.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -57.25 122.1 51.93 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.099 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.97 156.41 62.67 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.5 1.466 . . . . 0.0 109.358 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.75 124.68 43.91 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.88 151.24 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.787 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 p -136.53 -75.65 0.43 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.541 0.736 . . . . 0.0 109.47 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.12 135.46 37.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.77 157.19 20.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 162.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -141.13 -64.97 0.44 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -168.24 -39.25 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.208 2.203 . . . . 0.0 107.414 171.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -129.22 5.04 5.26 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.916 0.886 . . . . 0.0 110.863 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -152.5 152.17 31.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.592 0.633 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -153.59 127.31 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.8 m -77.98 148.09 34.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -128.35 138.97 52.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 126.647 1.979 . . . . 0.0 108.256 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -134.3 94.91 3.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.789 1.306 . . . . 0.0 110.74 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -109.26 170.72 7.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.901 0.858 . . . . 0.0 111.225 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -101.53 140.09 20.95 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 166.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.01 171.19 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.521 2.814 . . . . 0.0 109.26 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.75 -130.44 2.48 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.619 -2.193 . . . . 0.0 107.619 160.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.08 165.77 20.72 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 125.177 1.391 . . . . 0.0 107.916 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.84 -147.68 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.991 1 C-N-CA 125.892 4.395 . . . . 0.0 110.201 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.16 -91.68 0.12 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -62.78 -52.97 61.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 126.136 1.774 . . . . 0.0 109.928 172.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.6 mt -133.69 163.9 47.86 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 110.818 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.52 174.27 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.968 3.112 . . . . 0.0 110.856 167.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.85 108.1 19.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -54.82 -53.06 60.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.489 2.315 . . . . 0.0 111.913 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.08 -166.36 1.69 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 0.0 107.255 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -131.03 160.27 35.08 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.622 1.969 . . . . 0.0 107.929 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mt -118.73 156.19 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.12 2.168 . . . . 0.0 107.564 167.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.8 128.51 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -148.23 139.15 23.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.648 1.179 . . . . 0.0 107.84 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.89 129.96 55.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.326 1.45 . . . . 0.0 108.149 170.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.5 112.93 8.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.14 -20.66 60.87 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 3.45 26.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.357 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.04 -80.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.252 1.821 . . . . 0.0 106.695 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -133.12 -5.41 3.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.932 0.787 . . . . 0.0 112.888 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 54.57 42.93 30.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.934 0.873 . . . . 0.0 111.497 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.8 m -140.64 152.39 45.36 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 127.161 2.184 . . . . 0.0 106.946 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.468 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 93.0 m95 -72.17 132.84 44.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 157.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -125.54 151.78 45.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.352 1.461 . . . . 0.0 107.294 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.64 127.68 33.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.1 -3.67 10.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.641 0.776 . . . . 0.0 111.23 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.1 126.82 8.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.766 1.627 . . . . 0.0 108.454 168.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -115.06 139.89 49.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.767 0.827 . . . . 0.0 110.02 165.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 50.32 69.9 0.57 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.148 2.579 . . . . 0.0 114.637 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.7 141.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -124.2 32.67 5.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.904 0.882 . . . . 0.0 112.029 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.32 165.18 27.88 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -90.34 0.48 57.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.81 1.644 . . . . 0.0 112.595 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -132.5 133.06 43.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 108.78 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -146.72 152.17 38.38 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 127.197 2.199 . . . . 0.0 109.17 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -111.25 112.95 25.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.084 1.354 . . . . 0.0 108.626 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.7 t -66.22 143.57 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.64 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -136.25 -175.09 3.87 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.671 0.788 . . . . 0.0 110.723 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.87 17.93 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.509 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.7 mt -85.79 -163.39 0.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.676 1.238 . . . . 0.0 109.112 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -135.84 139.42 30.57 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.59 158.49 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.431 2.754 . . . . 0.0 111.121 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 48.64 31.31 2.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.235 1.814 . . . . 0.0 113.251 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.5 m -124.44 136.38 53.99 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.518 1.527 . . . . 0.0 108.396 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.6 mm -76.58 148.04 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 124.637 1.175 . . . . 0.0 109.413 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -139.54 153.93 47.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.64 2.376 . . . . 0.0 106.335 171.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 11.2 mt -112.64 157.0 21.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.359 1.463 . . . . 0.0 107.918 154.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -127.03 157.99 38.14 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.692 1.997 . . . . 0.0 110.013 177.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.468 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 20.0 mtt -128.71 155.89 44.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.85 2.06 . . . . 0.0 106.634 164.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.9 t -122.3 141.81 41.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 162.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.2 mtt-85 -132.34 146.29 51.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.07 156.96 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.46 152.74 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 127.217 2.207 . . . . 0.0 107.226 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.3 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.297 1.039 . . . . 0.0 110.263 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -59.67 2.87 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.996 3.131 . . . . 0.0 116.463 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -127.91 -37.8 1.89 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.952 1.701 . . . . 0.0 112.018 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.28 -150.49 8.45 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -170.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 pp -124.71 157.33 35.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.48 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.1 p -72.5 166.48 22.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.164 0.986 . . . . 0.0 111.598 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -44.61 152.97 0.49 Allowed Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 156.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.14 142.07 49.61 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.239 1.959 . . . . 0.0 110.895 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 94.0 p -60.04 165.41 4.86 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.181 0.592 . . . . 0.0 111.131 156.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.2 141.65 94.06 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 158.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.66 147.68 45.08 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.678 -1.264 . . . . 0.0 111.777 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 p -57.31 -18.16 15.58 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.598 2.759 . . . . 0.0 116.381 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 88.06 150.74 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 128.613 2.765 . . . . 0.0 107.156 -153.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.2 109.14 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.98 2.454 . . . . 0.0 108.709 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.2 127.72 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.218 1.007 . . . . 0.0 109.539 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 140.59 30.04 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.8 p -64.19 164.84 10.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -78.75 -175.99 4.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 122.302 1.049 . . . . 0.0 108.426 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.24 154.42 39.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.697 164.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -79.93 46.18 0.77 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.269 1.828 . . . . 0.0 112.953 -168.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -150.81 -79.36 0.03 OUTLIER Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.048 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -81.39 59.79 7.46 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.963 3.109 . . . . 0.0 112.203 -167.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.1 m -67.42 168.96 9.81 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.523 0.729 . . . . 0.0 110.862 168.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.5 m -125.08 178.33 5.6 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 149.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 N-CA-C 105.259 -3.136 . . . . 0.0 105.259 -150.418 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.702 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.0 p -157.52 158.86 36.47 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.497 1.519 . . . . 0.0 109.08 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 p -162.53 -169.99 2.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.841 1.657 . . . . 0.0 107.676 168.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.52 15.58 70.82 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.877 -0.957 . . . . 0.0 115.048 163.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.1 t -137.46 169.12 18.33 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.146 1.473 . . . . 0.0 108.92 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -78.46 100.05 6.69 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.68 83.5 0.11 Allowed Glycine 0 C--N 1.335 0.484 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.46 155.77 44.27 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 163.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.32 98.4 6.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 -172.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 t80 57.21 -168.67 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.415 0.686 . . . . 0.0 109.886 -161.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.17 148.86 21.78 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 122.045 0.926 . . . . 0.0 109.351 167.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -81.8 26.12 0.52 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.625 1.57 . . . . 0.0 112.946 -167.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.9 t 122.39 147.65 0.0 OUTLIER 'General case' 0 C--O 1.24 0.555 1 C-N-CA 132.686 4.395 . . . . 0.0 110.188 174.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.407 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 67.1 m-20 -76.7 -42.9 39.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.005 0.922 . . . . 0.0 109.121 166.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 mt -79.44 159.24 72.66 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 126.808 2.043 . . . . 0.0 111.159 -170.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.96 150.45 38.35 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.774 2.316 . . . . 0.0 109.799 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 159.57 53.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.148 1.356 . . . . 0.0 112.381 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.14 124.32 12.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.145 2.563 . . . . 0.0 109.784 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.56 165.77 14.9 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.73 2.287 . . . . 0.0 112.456 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -70.42 162.13 29.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.567 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -56.38 121.91 46.01 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.687 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.88 142.76 94.38 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.59 1.527 . . . . 0.0 111.119 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -122.42 131.91 54.11 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.179 1.392 . . . . 0.0 110.102 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.2 m -80.27 142.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.104 -176.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 p -135.64 -42.18 0.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.814 -166.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.28 145.33 48.33 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.794 1.238 . . . . 0.0 108.42 166.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.37 151.38 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.449 1.099 . . . . 0.0 108.099 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -125.24 -43.03 1.96 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -168.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 pttt 143.34 -27.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 1 C-N-CA 133.719 4.808 . . . . 0.0 110.071 -174.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -138.94 -4.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.101 1.76 . . . . 0.0 109.995 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.01 156.47 47.79 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.823 2.049 . . . . 0.0 106.937 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -154.37 128.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.6 m -80.42 137.05 36.46 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.1 mt -125.82 146.39 49.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 126.576 1.95 . . . . 0.0 106.925 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.6 116.96 11.28 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 125.15 1.531 . . . . 0.0 108.263 -166.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 49.3 p90 -139.03 156.91 46.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.453 1.024 . . . . 0.0 109.55 179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.47 144.87 29.42 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.097 0.559 . . . . 0.0 109.96 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.65 117.68 3.72 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.594 2.862 . . . . 0.0 110.841 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 174.99 30.72 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 124.734 1.159 . . . . 0.0 110.391 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.3 m -61.65 153.69 69.63 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 129.091 2.956 . . . . 0.0 110.781 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.96 -173.23 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.239 2.626 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.11 -160.87 9.41 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 104.578 -3.409 . . . . 0.0 104.578 160.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.407 ' HB ' ' HA ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -52.38 -50.03 63.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.141 -1.529 . . . . 0.0 109.69 166.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.32 161.58 32.35 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.689 1.131 . . . . 0.0 112.203 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.96 153.11 9.82 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 124.384 3.389 . . . . 0.0 110.23 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.91 37.8 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.896 0.855 . . . . 0.0 111.138 170.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.11 -59.93 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.406 1.482 . . . . 0.0 107.798 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.67 -170.47 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.382 1.073 . . . . 0.0 109.045 -165.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -111.9 163.17 14.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.391 1.876 . . . . 0.0 108.269 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.22 152.12 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.573 2.349 . . . . 0.0 107.099 157.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.4 mt -132.29 108.38 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -99.89 158.95 15.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.53 150.88 44.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.758 2.023 . . . . 0.0 107.742 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -128.01 150.25 50.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.69 117.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.995 0.902 . . . . 0.0 110.54 171.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -67.1 -36.45 81.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.432 -0.793 . . . . 0.0 111.465 -173.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -71.9 5.98 2.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.114 2.166 . . . . 0.0 113.685 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.56 -69.36 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.4 m -158.83 121.05 3.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.221 2.208 . . . . 0.0 105.471 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -72.18 82.42 1.0 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.593 0.633 . . . . 0.0 109.72 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -170.47 159.26 6.84 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.535 2.734 . . . . 0.0 107.524 168.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -76.69 142.35 40.57 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 161.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -130.71 139.64 50.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.278 1.431 . . . . 0.0 107.943 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -88.46 94.07 9.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.5 -15.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.691 1.196 . . . . 0.0 113.044 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.48 149.73 39.58 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 156.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.88 154.07 51.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 62.32 29.11 17.25 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.8 134.43 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 120.698 -1.252 . . . . 0.0 108.193 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -106.16 -8.49 17.37 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.81 -174.44 3.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.009 1.723 . . . . 0.0 109.297 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.8 p -120.57 0.97 10.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.364 1.866 . . . . 0.0 111.929 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -130.64 137.91 49.83 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.261 -0.899 . . . . 0.0 108.72 161.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.16 145.47 30.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.765 0.711 . . . . 0.0 109.084 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.0 m -89.21 106.67 18.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.072 1.749 . . . . 0.0 108.578 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.33 151.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.334 1.054 . . . . 0.0 108.223 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -135.6 -176.16 4.19 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.494 1.518 . . . . 0.0 110.777 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.41 7.64 85.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.968 1.27 . . . . 0.0 114.004 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.56 -177.49 6.55 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 123.148 1.451 . . . . 0.0 110.238 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -118.54 151.04 49.19 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 126.49 1.916 . . . . 0.0 108.422 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.74 156.64 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.385 2.723 . . . . 0.0 109.929 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 53.58 26.14 5.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.788 1.235 . . . . 0.0 111.854 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.1 m -119.68 129.19 54.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.115 1.766 . . . . 0.0 107.758 -170.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.84 144.98 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.69 153.7 47.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 109.178 168.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.08 162.3 14.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.074 1.35 . . . . 0.0 107.506 160.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -139.69 135.18 32.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 125.099 1.499 . . . . 0.0 107.889 172.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.4 mtm -124.45 135.16 53.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.97 144.37 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.3 mtp180 -120.9 150.99 40.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 160.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 165.15 15.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.47 152.41 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 127.232 2.213 . . . . 0.0 108.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.92 178.17 1.78 Allowed Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.888 0.875 . . . . 0.0 111.329 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.67 -4.06 1.72 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.586 3.524 . . . . 0.0 117.905 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -130.45 -37.18 1.41 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.402 1.455 . . . . 0.0 111.394 -170.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.83 -170.84 34.75 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -168.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.2 mp -97.89 166.16 11.59 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.469 1.108 . . . . 0.0 109.046 166.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 91.4 p -72.08 167.73 19.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.665 0.786 . . . . 0.0 110.07 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -48.81 150.56 2.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.051 -0.405 . . . . 0.0 110.153 153.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.7 132.98 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.745 2.297 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.8 p -59.03 168.83 1.33 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.8 0.84 . . . . 0.0 112.66 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.13 136.35 37.8 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.374 2.716 . . . . 0.0 112.237 161.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 149.73 33.49 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.974 0.806 . . . . 0.0 109.583 165.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 76.5 p -60.31 -9.43 3.46 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.593 1.957 . . . . 0.0 115.89 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.6 147.0 0.11 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.073 2.149 . . . . 0.0 109.604 -155.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.21 118.83 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.677 2.251 . . . . 0.0 110.066 -168.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.5 m -114.45 131.58 66.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.882 1.273 . . . . 0.0 110.457 -174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 145.21 31.7 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 p -71.37 168.41 17.47 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.53 0.732 . . . . 0.0 110.829 162.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -65.39 -167.86 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.018 1.39 . . . . 0.0 110.1 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -114.52 8.51 16.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 113.516 -163.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.7 t 72.95 -2.88 2.57 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 129.055 2.942 . . . . 0.0 114.523 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -61.88 116.27 9.12 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 117.639 -1.645 . . . . 0.0 109.459 162.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.89 93.3 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.974 2.449 . . . . 0.0 108.418 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.3 t -149.44 100.12 2.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.99 170.01 23.14 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.221 1.008 . . . . 0.0 109.468 151.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.977 0 N-CA-C 104.995 -3.242 . . . . 0.0 104.995 -173.423 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.674 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -80.39 108.85 14.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.874 0.87 . . . . 0.0 109.022 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.1 p -156.64 167.34 30.76 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.057 0.943 . . . . 0.0 108.899 160.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.45 147.11 39.9 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.807 0.718 . . . . 0.0 112.144 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.0 t -160.19 -53.38 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.28 0.632 . . . . 0.0 109.783 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.2 m -60.16 151.83 26.03 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.594 0.357 . . . . 0.0 111.557 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.74 81.5 0.26 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 124.813 1.197 . . . . 0.0 110.156 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -62.47 106.9 0.83 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -157.95 144.0 17.33 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 129.888 3.275 . . . . 0.0 104.187 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.99 172.37 13.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.442 0.565 . . . . 0.0 110.204 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -147.8 162.9 38.3 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.94 -132.57 0.31 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.104 1.362 . . . . 0.0 107.336 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.9 m -149.09 61.15 1.05 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.051 1.74 . . . . 0.0 107.02 171.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.54 -37.92 68.16 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.645 1.178 . . . . 0.0 109.33 166.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.92 152.38 93.5 Favored Pre-proline 0 CA--C 1.53 0.181 0 C-N-CA 127.233 2.213 . . . . 0.0 110.483 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -67.18 169.65 14.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.373 2.049 . . . . 0.0 110.922 167.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.38 168.06 49.69 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.38 1.467 . . . . 0.0 112.124 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.61 132.69 31.73 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.109 2.54 . . . . 0.0 108.844 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.09 165.37 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.7 1.6 . . . . 0.0 111.817 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.02 163.54 27.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.303 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 11.0 tmtt? -50.29 119.04 10.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.135 171.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -67.21 160.14 48.91 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 CA-C-N 120.082 1.065 . . . . 0.0 110.47 172.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -135.93 125.89 25.94 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.963 2.105 . . . . 0.0 107.975 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.13 149.27 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.6 p -134.06 -41.45 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.427 0.691 . . . . 0.0 110.169 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -123.44 145.09 49.08 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 109.146 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.82 145.82 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 119.758 1.163 . . . . 0.0 108.552 164.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.2 p -134.11 -169.12 2.25 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.533 1.133 . . . . 0.0 108.913 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -66.51 -16.49 64.17 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 120.857 -1.152 . . . . 0.0 113.35 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -156.35 6.2 0.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -123.64 160.07 27.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.201 1.364 . . . . 0.0 111.297 165.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.59 136.85 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -96.61 142.13 29.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.1 mt -134.74 133.79 40.3 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.073 1.749 . . . . 0.0 108.255 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.489 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 6.9 t -118.96 130.23 55.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 129.371 3.068 . . . . 0.0 108.311 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -139.12 170.94 15.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -104.87 148.59 36.35 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 162.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.58 160.66 44.96 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.202 2.601 . . . . 0.0 109.703 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.02 174.15 43.75 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -57.64 155.02 22.74 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 126.466 1.906 . . . . 0.0 110.074 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.86 -175.86 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.525 2.817 . . . . 0.0 111.892 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.02 -147.45 7.94 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 105.575 -3.01 . . . . 0.0 105.575 168.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -33.84 64.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 165.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.38 157.42 33.75 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 123.181 0.593 . . . . 0.0 112.052 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.88 150.28 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.794 3.662 . . . . 0.0 110.034 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 125.58 28.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.383 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -49.21 28.06 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.436 172.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.18 -165.18 1.28 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.434 1.015 . . . . 0.0 110.184 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.89 161.55 32.76 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.831 0.852 . . . . 0.0 109.943 167.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -118.84 158.26 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 128.203 2.601 . . . . 0.0 106.806 167.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mt -126.02 129.24 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 163.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -105.89 153.86 21.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.231 1.412 . . . . 0.0 108.112 171.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.1 127.68 20.12 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.493 1.517 . . . . 0.0 110.209 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -91.74 149.35 21.65 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.233 1.413 . . . . 0.0 107.772 169.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.22 113.56 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.338 1.066 . . . . 0.0 112.477 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.35 -38.56 81.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 112.844 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 m -73.87 8.43 2.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.943 1.297 . . . . 0.0 113.382 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.49 -72.54 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 124.268 1.027 . . . . 0.0 108.895 -168.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.1 t -150.38 12.88 0.74 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.631 0.772 . . . . 0.0 110.058 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 61.02 -79.73 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.593 2.357 . . . . 0.0 111.753 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.57 162.11 0.04 OUTLIER 'General case' 0 C--O 1.234 0.26 0 C-N-CA 129.664 3.186 . . . . 0.0 114.895 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.414 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 94.9 m95 -67.79 138.28 56.05 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -124.54 142.56 51.25 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -72.73 107.21 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -95.68 -28.28 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 0.0 111.655 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 138.07 31.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 135.47 41.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 50.04 68.83 0.69 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.798 2.039 . . . . 0.0 110.923 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.4 t -84.97 -53.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.93 1.292 . . . . 0.0 113.623 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 mttt 66.21 -23.66 0.1 Allowed 'General case' 0 C--N 1.316 -0.884 1 C-N-CA 131.79 4.036 . . . . 0.0 115.578 170.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.42 173.09 8.35 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.388 1.449 . . . . 0.0 108.607 168.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.04 -4.71 20.17 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.958 168.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.489 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 5.4 tp -121.17 131.71 54.4 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 121.596 1.998 . . . . 0.0 110.211 160.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -134.61 152.8 52.04 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.283 1.033 . . . . 0.0 109.432 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -112.77 101.07 9.18 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.355 1.862 . . . . 0.0 107.203 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.98 143.56 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 162.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -139.01 178.93 6.8 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.36 1.864 . . . . 0.0 108.2 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 24.29 67.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.414 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.1 mt -82.1 -173.54 4.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.624 1.17 . . . . 0.0 109.772 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -112.22 141.9 25.9 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 117.694 -1.146 . . . . 0.0 109.228 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.79 157.47 61.62 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.21 1.94 . . . . 0.0 112.156 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 41.62 42.64 2.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.477 1.911 . . . . 0.0 112.339 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.4 m -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.252 1.421 . . . . 0.0 107.817 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.57 147.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.73 155.63 46.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.038 167.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.77 163.12 13.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.87 132.38 26.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.414 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 41.0 mtm -131.4 165.6 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 123.895 0.747 . . . . 0.0 109.338 161.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.5 t -132.21 140.36 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.976 1.71 . . . . 0.0 107.284 -166.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -132.1 132.03 42.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.5 118.67 26.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.34 145.7 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -141.52 173.84 4.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.712 1.205 . . . . 0.0 108.096 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -73.26 31.63 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.34 2.693 . . . . 0.0 114.075 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -134.04 -67.83 0.58 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.325 1.85 . . . . 0.0 106.657 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.55 -148.26 4.73 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.914 1.245 . . . . 0.0 112.159 -167.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 mt -122.7 142.21 50.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.539 3.136 . . . . 0.0 106.398 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.9 p -72.33 166.96 21.45 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.359 0.6 . . . . 0.0 112.116 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -60.35 158.0 31.39 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 124.568 1.147 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.22 122.59 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.944 1.762 . . . . 0.0 111.983 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 p -60.5 157.79 34.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.454 1.501 . . . . 0.0 111.784 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 128.66 24.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.812 3.008 . . . . 0.0 110.506 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.8 mtt -56.27 150.66 14.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.082 1.764 . . . . 0.0 111.451 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.443 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 1.5 p -69.9 -1.61 10.03 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 81.82 155.54 0.12 Allowed Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 131.119 3.768 . . . . 0.0 108.874 -167.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.61 117.6 5.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.279 2.653 . . . . 0.0 109.171 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.97 144.68 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 123.599 0.76 . . . . 0.0 109.385 -171.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -104.32 138.51 40.66 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 123.38 0.672 . . . . 0.0 109.925 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -67.29 169.06 9.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.969 168.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -82.73 175.7 9.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.733 0.778 . . . . 0.0 110.007 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.62 158.79 17.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.749 164.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.94 -6.9 20.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 46.12 -162.93 0.14 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.933 1.254 . . . . 0.0 114.028 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -81.95 13.71 2.42 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.882 3.055 . . . . 0.0 111.605 158.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 m -56.1 126.43 26.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.852 1.661 . . . . 0.0 112.346 -162.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.7 p -68.06 175.31 3.23 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.122 0.969 . . . . 0.0 111.515 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.45 0 N-CA-C 105.679 -2.969 . . . . 0.0 105.679 167.471 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.719 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t -60.69 126.7 28.39 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.102 0.961 . . . . 0.0 108.961 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -166.97 172.81 9.86 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.335 2.254 . . . . 0.0 107.795 171.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.73 98.75 0.43 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 166.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m -149.04 -60.07 0.22 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.396 1.098 . . . . 0.0 110.838 -172.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 m -85.36 130.72 34.53 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.734 0.813 . . . . 0.0 109.538 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.89 149.55 46.82 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 167.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -74.46 164.1 26.99 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -151.52 134.11 15.51 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 168.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 51.37 172.28 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.099 2.559 . . . . 0.0 113.432 -166.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -140.29 154.15 46.72 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.183 1.793 . . . . 0.0 106.827 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.37 -1.44 57.03 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.767 0.827 . . . . 0.0 111.356 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -151.22 173.86 13.93 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.657 -1.277 . . . . 0.0 108.997 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.61 -43.29 3.04 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.873 1.269 . . . . 0.0 111.362 -178.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.3 162.4 40.15 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.467 1.907 . . . . 0.0 109.025 -173.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -60.0 142.63 98.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.381 2.721 . . . . 0.0 110.473 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.02 142.64 38.31 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 161.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.18 145.95 96.13 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.179 1.919 . . . . 0.0 110.187 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -64.68 157.96 52.93 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.72 1.613 . . . . 0.0 109.987 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -68.47 166.48 16.76 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.222 0.609 . . . . 0.0 110.37 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -46.03 121.83 5.98 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.21 1.004 . . . . 0.0 109.242 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -60.26 146.29 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -113.28 125.14 53.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.219 1.408 . . . . 0.0 109.007 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.8 t -80.58 112.54 18.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 175.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -102.31 -82.7 0.48 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.6 139.37 40.61 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -137.33 145.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 p -125.88 -173.58 2.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.183 0.993 . . . . 0.0 108.613 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -14.87 53.74 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -163.57 26.47 0.08 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.092 1.315 . . . . 0.0 112.939 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -146.93 161.87 39.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 107.982 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -158.26 136.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.126 0.97 . . . . 0.0 108.482 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -91.13 110.94 22.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.033 1.333 . . . . 0.0 107.942 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -93.11 140.84 29.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.805 1.242 . . . . 0.0 109.224 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.61 99.21 3.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.612 1.195 . . . . 0.0 108.887 -163.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -119.05 172.81 7.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.532 1.133 . . . . 0.0 109.674 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -118.79 145.57 38.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.99 143.9 29.63 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.671 2.914 . . . . 0.0 110.779 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.47 175.68 52.84 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 170.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -62.18 146.15 92.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.884 1.274 . . . . 0.0 109.167 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.13 -168.7 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.953 3.769 . . . . 0.0 112.42 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.31 -149.51 5.54 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 174.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -37.81 68.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.562 1.145 . . . . 0.0 110.673 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.1 mt -111.95 167.31 9.32 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.714 0.806 . . . . 0.0 111.913 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.88 -130.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 124.628 3.552 . . . . 0.0 108.299 164.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.6 161.8 24.01 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 127.669 2.388 . . . . 0.0 106.622 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -105.84 -35.38 7.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.132 2.173 . . . . 0.0 110.502 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.74 -159.42 0.08 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.744 1.217 . . . . 0.0 109.626 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -128.82 169.24 14.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.445 2.298 . . . . 0.0 108.161 162.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.76 155.15 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.051 2.94 . . . . 0.0 106.031 167.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.5 mt -122.54 132.8 70.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -118.17 158.31 25.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.32 46.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 109.979 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -131.28 168.17 17.98 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.093 2.557 . . . . 0.0 105.833 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.6 t -144.12 -42.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.898 1.226 . . . . 0.0 113.676 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 115.95 -48.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.437 1 C-N-CA 133.234 4.614 . . . . 0.0 108.652 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -87.41 -36.68 17.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.533 0.733 . . . . 0.0 111.786 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.71 -62.17 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 123.591 0.757 . . . . 0.0 109.066 -159.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -160.26 98.81 1.3 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.5 -9.63 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.5 m -39.73 -39.6 0.8 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 129.122 2.969 . . . . 0.0 116.366 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.8 m95 61.34 140.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.16 1.384 . . . . 0.0 111.299 -138.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -134.11 152.9 52.04 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 134.21 50.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 165.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.0 -8.76 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.33 0.652 . . . . 0.0 111.616 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.94 138.46 17.71 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.158 1.783 . . . . 0.0 107.258 158.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -116.18 158.31 23.48 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m170 51.47 51.67 16.3 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.844 1.307 . . . . 0.0 112.218 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.87 110.69 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 127.112 2.165 . . . . 0.0 106.629 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -106.58 52.04 0.73 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.243 1.417 . . . . 0.0 108.203 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -158.39 -171.98 3.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.926 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.4 p -127.78 -3.75 5.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.967 1.307 . . . . 0.0 112.25 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.536 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -125.75 121.12 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.863 1.665 . . . . 0.0 107.476 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -145.35 117.51 8.37 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.445 0.64 . . . . 0.0 111.365 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -71.89 98.53 2.03 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.408 2.283 . . . . 0.0 108.802 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.6 143.69 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -136.77 172.69 12.64 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.538 1.535 . . . . 0.0 109.208 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.94 2.96 58.18 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.045 1.307 . . . . 0.0 113.055 170.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.8 mt -78.14 178.2 7.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 117.691 0.745 . . . . 0.0 109.607 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -96.67 146.74 31.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.203 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.64 158.79 46.88 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.376 2.717 . . . . 0.0 111.146 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.39 21.75 1.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.166 2.587 . . . . 0.0 112.876 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -119.28 121.37 39.48 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mm -59.27 147.44 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -138.51 152.83 48.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.582 162.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.4 mt -107.08 156.04 19.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.106 163.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -141.78 133.45 27.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.451 1.719 . . . . 0.0 107.843 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 15.5 mtt -112.34 156.09 23.04 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.526 2.331 . . . . 0.0 106.903 170.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.76 113.09 31.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 167.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 35.9 mtt180 -97.47 147.72 23.95 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.29 -1.506 . . . . 0.0 107.203 167.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.7 158.33 19.46 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.69 152.49 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 126.118 1.767 . . . . 0.0 107.323 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -139.97 172.71 5.94 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 127.186 2.195 . . . . 0.0 108.576 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 -19.15 27.72 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.807 2.338 . . . . 0.0 113.352 166.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -115.58 -11.13 11.77 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.63 -160.88 29.54 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 pp -113.09 162.7 15.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.892 1.277 . . . . 0.0 110.802 176.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.4 p -77.82 168.55 19.75 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.053 2.141 . . . . 0.0 112.953 -171.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.45 149.73 0.97 Allowed Pre-proline 0 C--O 1.242 0.699 0 O-C-N 121.18 -0.95 . . . . 0.0 110.029 155.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.36 129.46 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.842 2.361 . . . . 0.0 109.717 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 p -52.61 162.08 1.01 Allowed Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.53 1.532 . . . . 0.0 113.458 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -63.8 125.96 16.45 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 109.818 158.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 57.6 mtm -55.53 148.2 16.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.798 -0.564 . . . . 0.0 111.418 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 -8.14 47.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.7 t0 85.04 153.35 0.11 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 130.605 3.562 . . . . 0.0 110.107 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -70.01 105.46 1.53 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.228 1.952 . . . . 0.0 111.516 -165.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.9 m -103.06 142.74 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.366 1.067 . . . . 0.0 109.361 -175.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.0 141.39 32.89 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 109.295 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.1 p -72.89 151.04 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.174 0.59 . . . . 0.0 110.623 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.12 -178.76 2.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 112.07 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.51 147.12 37.99 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.449 -0.782 . . . . 0.0 112.868 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.2 p -84.99 -5.84 59.35 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.275 1.83 . . . . 0.0 114.924 -163.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -71.21 177.16 36.42 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 118.883 0.765 . . . . 0.0 113.387 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.75 129.84 15.01 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.738 2.292 . . . . 0.0 109.21 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.0 t -156.03 154.46 31.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 157.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 m 35.39 86.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.459 1.904 . . . . 0.0 112.936 -169.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.846 0 N-CA-C 108.536 -1.825 . . . . 0.0 108.536 148.174 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.677 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.1 m 62.35 120.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.821 2.449 . . . . 0.0 114.556 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.1 p -161.03 111.5 1.74 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 160.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.78 105.26 2.92 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 175.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.0 m -163.03 -52.88 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.892 1.677 . . . . 0.0 108.26 164.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 m -74.72 131.58 40.96 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 158.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.11 -70.56 0.93 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 124.463 1.03 . . . . 0.0 112.636 -164.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -133.73 78.18 1.76 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.638 0.719 . . . . 0.0 109.309 -169.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 41.67 82.12 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 128.257 2.623 . . . . 0.0 112.47 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -139.88 165.06 28.33 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.991 0.916 . . . . 0.0 109.386 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -158.78 -164.5 1.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.617 2.367 . . . . 0.0 108.814 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -128.16 0.42 5.81 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.522 1.529 . . . . 0.0 113.624 -164.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -87.3 165.85 15.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.319 0.509 . . . . 0.0 110.874 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -48.69 68.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -58.55 146.46 73.18 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 126.328 1.851 . . . . 0.0 111.711 -170.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.08 156.71 53.29 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.195 2.597 . . . . 0.0 111.665 -168.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.61 152.09 48.24 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.64 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -67.64 141.16 54.02 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.264 1.976 . . . . 0.0 109.164 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.03 153.37 78.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.213 1.275 . . . . 0.0 109.189 162.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -74.03 177.87 5.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.678 0.791 . . . . 0.0 110.8 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -47.33 120.34 6.89 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 117.379 -1.296 . . . . 0.0 108.631 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.76 137.49 58.88 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -119.93 121.06 38.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.476 1.511 . . . . 0.0 108.822 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 149.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.202 173.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 p -129.35 -93.75 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.77 143.51 56.87 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.101 0.96 . . . . 0.0 109.615 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.91 141.8 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 p -128.21 -169.18 2.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.55 1.14 . . . . 0.0 108.541 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -61.61 -23.85 66.3 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 121.219 -0.926 . . . . 0.0 112.568 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -154.93 10.85 0.35 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.754 -1.216 . . . . 0.0 113.538 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -120.42 164.54 16.22 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.624 0.647 . . . . 0.0 110.833 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 p -153.48 134.26 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 165.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.1 m -88.53 114.45 25.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -93.72 138.49 31.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.844 1.658 . . . . 0.0 108.559 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -117.9 138.38 52.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.624 2.37 . . . . 0.0 107.189 170.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -139.8 170.92 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.734 0.414 . . . . 0.0 110.079 166.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 142.4 24.51 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.27 128.42 11.26 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.801 3.667 . . . . 0.0 109.546 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.52 167.96 54.63 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -85.49 154.95 59.67 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.769 1.228 . . . . 0.0 110.158 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.85 -158.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 125.193 3.928 . . . . 0.0 110.279 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.26 -112.7 0.46 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -58.74 -48.93 79.49 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.6 mt -140.82 148.09 51.12 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 125.068 1.347 . . . . 0.0 110.669 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 141.09 18.79 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.879 3.052 . . . . 0.0 110.14 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 109.34 1.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.604 1.561 . . . . 0.0 108.647 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.1 m -61.01 -62.46 1.84 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.377 2.271 . . . . 0.0 110.802 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.14 -166.72 2.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -121.73 163.77 18.52 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.201 1.4 . . . . 0.0 108.62 165.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 mt -115.9 162.73 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.391 2.276 . . . . 0.0 107.315 162.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.04 129.76 72.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 161.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.58 150.86 30.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 160.37 32.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 107.467 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -133.6 147.86 51.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.58 117.48 4.42 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -75.09 -26.63 59.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.483 -0.761 . . . . 0.0 111.983 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -81.06 17.07 1.31 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.29 1.036 . . . . 0.0 111.398 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -128.29 -71.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 m -151.53 1.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.5 50.78 16.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.378 1.444 . . . . 0.0 110.68 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -135.31 146.52 48.56 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.767 1.227 . . . . 0.0 108.38 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -72.88 108.86 6.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 161.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -100.0 134.65 42.61 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.652 1.981 . . . . 0.0 108.053 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -78.74 94.76 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.4 -15.81 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.609 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.7 150.11 30.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.017 1.28 . . . . 0.0 108.576 164.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -142.82 161.81 37.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.951 0.341 . . . . 0.0 111.208 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 47.35 55.11 8.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.754 1.222 . . . . 0.0 111.332 -171.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -91.92 129.63 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 29.83 7.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.723 0.809 . . . . 0.0 111.848 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -136.76 174.27 10.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.022 1.329 . . . . 0.0 107.505 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.5 p -120.28 0.0 10.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.871 1.668 . . . . 0.0 111.687 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.18 104.35 5.87 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.27 150.93 50.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.952 1.301 . . . . 0.0 109.718 -169.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.5 m -103.51 106.02 16.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -62.54 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -139.72 176.04 9.07 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.27 1.028 . . . . 0.0 112.269 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.95 84.43 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 124.81 1.195 . . . . 0.0 112.616 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -74.67 179.43 4.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.296 1.046 . . . . 0.0 109.768 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -104.12 138.05 19.41 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.039 -1.458 . . . . 0.0 108.241 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.19 147.17 59.49 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.523 2.149 . . . . 0.0 112.112 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.9 t30 44.94 42.02 5.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.53 2.332 . . . . 0.0 112.526 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.1 m -129.38 136.61 50.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 127.091 2.156 . . . . 0.0 106.524 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.0 mm -72.44 145.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.966 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -140.62 155.27 46.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.343 1.457 . . . . 0.0 109.388 168.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.3 mt -108.24 166.18 10.94 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 126.229 1.811 . . . . 0.0 108.912 162.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.36 136.91 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 125.092 1.495 . . . . 0.0 111.257 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.9 mtt -105.38 151.37 24.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 160.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.21 149.58 6.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 154.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -125.11 139.58 53.64 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.29 151.03 23.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 165.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.07 152.12 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.87 1.668 . . . . 0.0 108.628 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -151.69 -176.84 0.62 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.608 1.563 . . . . 0.0 109.186 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.29 -14.08 27.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.227 . . . . 0.0 115.577 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -116.41 -14.04 10.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.031 1.332 . . . . 0.0 112.402 -164.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.04 -143.8 10.17 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 pp -140.02 160.98 38.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.33 1.852 . . . . 0.0 110.061 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 97.3 p -72.21 168.06 19.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 126.908 2.083 . . . . 0.0 114.463 -166.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -32.25 145.45 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 123.56 0.744 . . . . 0.0 109.914 145.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.35 132.48 31.56 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.175 1.917 . . . . 0.0 109.095 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 p -61.4 154.58 62.97 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.554 163.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.04 142.22 91.76 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.899 2.399 . . . . 0.0 110.303 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.6 mmt -53.12 131.92 37.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -17.01 16.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.961 1.704 . . . . 0.0 112.187 170.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t0 70.44 161.68 0.15 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.733 2.013 . . . . 0.0 109.265 -158.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -74.75 121.68 6.83 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.974 2.449 . . . . 0.0 111.072 -175.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.57 158.43 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.011 0.925 . . . . 0.0 108.997 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.48 137.22 43.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.102 1.361 . . . . 0.0 108.369 163.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.9 p -66.04 164.79 14.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.781 0.8 . . . . 0.0 109.53 158.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -80.79 173.5 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.403 1.097 . . . . 0.0 109.749 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.57 162.2 26.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.5 169.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.2 p -113.83 18.14 17.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.261 1.824 . . . . 0.0 112.765 -171.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -62.09 174.55 7.29 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.807 0.73 . . . . 0.0 111.807 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.38 66.58 7.17 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.734 2.956 . . . . 0.0 111.178 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -57.17 152.96 12.64 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.419 1.088 . . . . 0.0 110.556 173.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 61.3 p -95.29 86.32 4.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.79 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 -177.294 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 p -145.08 114.78 7.27 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 117.889 0.844 . . . . 0.0 109.439 -169.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -152.76 155.15 36.63 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.318 1.047 . . . . 0.0 109.555 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.19 -140.67 10.38 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 157.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.0 p -81.72 168.53 17.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.562 1.181 . . . . 0.0 108.963 164.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.99 85.74 0.16 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -172.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.67 -35.38 1.19 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 121.009 -1.057 . . . . 0.0 112.869 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -66.95 158.84 29.82 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.672 1.236 . . . . 0.0 109.111 155.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -151.12 164.84 35.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.868 2.067 . . . . 0.0 106.649 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -141.17 -89.92 0.15 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t0 74.49 158.62 0.21 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 128.107 2.563 . . . . 0.0 110.462 -166.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt 49.78 35.22 8.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.094 2.558 . . . . 0.0 112.695 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 t -83.68 88.82 7.06 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.648 1.579 . . . . 0.0 109.448 -169.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.2 11.96 0.14 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.244 1.818 . . . . 0.0 113.742 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.3 mt -91.91 152.54 43.06 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 120.48 -1.388 . . . . 0.0 109.395 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -63.07 166.46 14.39 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.378 3.385 . . . . 0.0 113.144 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 147.08 50.41 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.793 -1.004 . . . . 0.0 110.607 165.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.3 157.63 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.918 2.412 . . . . 0.0 112.047 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.78 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.346 2.031 . . . . 0.0 110.877 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.3 m -74.58 166.75 23.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.634 0.774 . . . . 0.0 110.933 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.39 127.04 16.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 116.78 -1.581 . . . . 0.0 109.576 168.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.62 159.25 22.06 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.75 2.3 . . . . 0.0 114.306 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -107.5 129.41 54.96 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 128.778 2.831 . . . . 0.0 107.849 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.59 153.78 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 p -132.04 -90.27 0.42 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.74 120.29 25.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.318 -172.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -120.32 147.95 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 119.738 1.154 . . . . 0.0 110.789 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.4 p -141.3 -167.2 2.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.684 1.594 . . . . 0.0 107.731 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -65.04 -33.59 76.41 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -149.2 17.32 0.95 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.667 -1.27 . . . . 0.0 112.763 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -136.64 150.43 48.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.98 132.68 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.804 1.241 . . . . 0.0 109.413 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.2 m -79.4 139.61 37.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.045 0.938 . . . . 0.0 109.412 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.38 144.19 45.2 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.46 2.304 . . . . 0.0 107.227 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.64 131.94 40.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.133 2.573 . . . . 0.0 106.506 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -139.26 172.07 13.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.274 1.03 . . . . 0.0 109.315 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.18 141.94 24.52 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.74 162.66 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.334 2.689 . . . . 0.0 111.094 -168.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 169.06 36.1 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 122.468 1.038 . . . . 0.0 110.952 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -65.3 147.16 98.78 Favored Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 126.99 2.116 . . . . 0.0 111.135 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.37 174.69 9.65 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 125.206 3.937 . . . . 0.0 113.911 166.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.93 -118.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.706 1.146 . . . . 0.0 110.314 -174.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.6 p -69.15 -37.51 78.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.151 1.78 . . . . 0.0 112.752 -162.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 mt -138.38 158.27 70.96 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 123.04 0.536 . . . . 0.0 111.216 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.13 165.46 32.35 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.298 2.665 . . . . 0.0 109.915 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.18 121.1 44.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.74 -33.04 25.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.331 0.652 . . . . 0.0 111.995 -162.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.47 -167.77 1.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.867 1.667 . . . . 0.0 106.561 167.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -118.08 166.19 12.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.42 154.56 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.013 2.525 . . . . 0.0 106.305 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 135.82 61.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -117.99 154.84 31.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.91 163.17 33.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.91 1.284 . . . . 0.0 109.034 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -140.16 145.54 37.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.05 1.74 . . . . 0.0 107.139 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 t -134.3 166.23 23.3 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 155.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -99.64 14.41 30.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.679 1.192 . . . . 0.0 111.957 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 t -139.26 21.52 2.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.302 1.841 . . . . 0.0 110.982 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.579 HG22 ' H ' ' A' ' 59' ' ' SER . 15.5 m -121.89 -85.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.764 1.226 . . . . 0.0 108.044 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.579 ' H ' HG22 ' A' ' 58' ' ' VAL . 28.7 m -139.19 8.66 2.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.795 2.038 . . . . 0.0 110.39 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 54.33 22.97 4.04 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.27 2.228 . . . . 0.0 113.683 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.7 m -116.35 159.32 22.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.943 0.897 . . . . 0.0 110.943 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -73.63 138.88 45.09 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 157.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.62 139.39 36.71 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 m -63.21 95.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.588 1.155 . . . . 0.0 108.277 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.6 m -87.22 -17.54 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.124 -0.985 . . . . 0.0 112.016 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.81 131.79 22.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 165.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -117.67 152.83 34.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 43.8 67.83 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.608 1.563 . . . . 0.0 112.491 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -98.64 118.54 45.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.596 1.158 . . . . 0.0 108.455 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.65 50.79 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.89 175.47 13.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.458 1.903 . . . . 0.0 107.388 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -125.39 12.42 8.14 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.003 1.721 . . . . 0.0 113.12 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mp -129.43 140.95 51.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 109.564 147.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -145.2 151.65 38.76 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.58 1.152 . . . . 0.0 108.419 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -109.94 108.79 19.18 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.868 1.667 . . . . 0.0 108.767 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -60.11 140.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 165.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -130.44 -177.63 4.42 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.428 1.091 . . . . 0.0 108.874 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.15 37.76 41.82 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 mt -108.0 -178.68 3.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 110.393 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -103.58 139.32 19.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 125.491 1.516 . . . . 0.0 109.391 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.75 159.33 42.34 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.049 2.499 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 55.28 15.51 1.36 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.481 1.912 . . . . 0.0 112.903 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -119.76 139.41 52.34 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.813 1.645 . . . . 0.0 110.149 -164.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.41 148.67 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.694 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -142.09 162.24 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.921 0.888 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 21.2 mt -124.86 162.81 23.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 125.841 1.656 . . . . 0.0 108.929 165.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -138.57 155.74 48.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 125.476 1.735 . . . . 0.0 110.968 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 6.8 mtt -129.22 167.07 18.19 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 126.525 1.93 . . . . 0.0 106.972 160.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.0 t -132.06 146.34 33.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 168.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -136.38 134.02 37.38 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.219 1.407 . . . . 0.0 107.244 175.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 126.21 34.72 Favored 'General case' 0 C--O 1.228 -0.076 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.59 152.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.773 0.829 . . . . 0.0 108.971 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.62 168.9 10.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.506 0.722 . . . . 0.0 109.83 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -72.38 19.61 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.153 2.569 . . . . 0.0 113.845 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -121.13 -65.35 1.15 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.513 1.525 . . . . 0.0 107.531 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.81 -127.44 1.89 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.397 1.475 . . . . 0.0 110.969 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 pp -139.23 145.74 39.61 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.525 2.33 . . . . 0.0 107.443 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.0 p -72.58 165.99 23.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.277 1.031 . . . . 0.0 109.869 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -54.85 142.95 53.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.565 -0.71 . . . . 0.0 109.188 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.99 133.15 42.8 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.435 1.423 . . . . 0.0 108.992 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.4 p -54.69 156.02 6.98 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.373 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -47.63 143.79 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.1 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 35.2 mtm -57.9 146.93 30.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.724 0.773 . . . . 0.0 110.299 175.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -65.26 0.2 1.5 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.062 -1.923 . . . . 0.0 115.81 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.2 t70 68.74 153.69 0.14 Allowed Pre-proline 0 N--CA 1.476 0.834 0 CA-C-N 121.147 1.794 . . . . 0.0 108.398 -154.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -67.47 113.26 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.006 2.471 . . . . 0.0 109.648 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.36 165.09 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -124.06 142.59 51.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 166.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 p -72.98 160.69 31.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.081 0.552 . . . . 0.0 110.745 165.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -79.14 -178.44 6.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.934 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -81.28 167.55 19.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.285 1.434 . . . . 0.0 111.394 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 t -103.6 37.7 1.97 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.044 2.138 . . . . 0.0 111.627 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.05 164.27 54.7 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 120.522 -1.361 . . . . 0.0 111.781 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.42 147.13 28.47 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.166 2.577 . . . . 0.0 110.549 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.2 m -156.21 111.88 2.98 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.729 1.612 . . . . 0.0 108.246 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.8 t -170.79 178.89 3.37 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.308 2.243 . . . . 0.0 106.172 172.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 1 N-CA-C 103.069 -4.012 . . . . 0.0 103.069 167.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -144.22 -70.76 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -64.96 165.55 10.72 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 149.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.0 -160.64 20.68 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.393 1.473 . . . . 0.0 110.08 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.5 m 74.42 178.1 0.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.031 2.132 . . . . 0.0 110.947 -169.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 m -59.74 156.01 14.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.726 1.21 . . . . 0.0 111.063 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.57 115.52 8.04 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 106.256 -2.738 . . . . 0.0 106.256 152.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.9 51.7 1.98 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.228 1.014 . . . . 0.0 109.094 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -77.74 78.17 4.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.616 1.566 . . . . 0.0 107.632 -171.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 55.37 -179.08 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.617 1.967 . . . . 0.0 111.175 -158.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -170.28 -177.24 2.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.002 1.721 . . . . 0.0 107.527 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.3 mp 16.24 79.23 0.01 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 129.157 2.983 . . . . 0.0 113.333 160.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -49.7 129.75 20.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.412 1.085 . . . . 0.0 111.522 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.1 -20.7 64.08 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.071 1.348 . . . . 0.0 110.912 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.55 160.35 36.85 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.504 1.922 . . . . 0.0 112.125 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.34 147.87 60.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.653 2.235 . . . . 0.0 109.169 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 155.41 50.23 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.13 140.97 81.08 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.43 2.086 . . . . 0.0 108.179 171.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.09 172.06 7.96 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.287 1.991 . . . . 0.0 111.037 170.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -66.29 170.57 5.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.95 0.9 . . . . 0.0 110.1 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -49.76 124.81 16.45 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-O 117.593 -1.194 . . . . 0.0 107.796 160.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.06 136.0 46.25 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 CA-C-N 120.205 1.109 . . . . 0.0 109.352 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -78.77 164.55 24.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.176 1.465 . . . . 0.0 107.095 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 t -124.4 112.45 32.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.14 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -109.45 -82.5 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -167.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.07 134.47 47.08 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.245 1.418 . . . . 0.0 108.267 171.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -140.03 135.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.812 1.187 . . . . 0.0 108.545 163.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.0 p -110.68 -74.1 0.66 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -168.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 2.1 pttp -163.93 -26.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 129.641 3.177 . . . . 0.0 110.036 163.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -140.41 9.33 2.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.839 1.256 . . . . 0.0 112.287 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -126.99 160.66 30.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.851 0.75 . . . . 0.0 110.452 162.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -151.65 133.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.624 1.57 . . . . 0.0 106.946 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -79.98 132.64 36.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.7 142.08 35.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.291 1.437 . . . . 0.0 108.16 167.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.48 ' CB ' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -140.19 111.46 7.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.802 1.314 . . . . 0.0 108.466 -173.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -129.22 171.35 12.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.901 0.773 . . . . 0.0 109.56 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -124.84 145.48 50.02 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -74.72 144.07 30.86 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.461 2.774 . . . . 0.0 109.573 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.31 -175.78 49.73 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m -57.67 133.39 82.57 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 123.503 0.721 . . . . 0.0 111.506 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.02 -171.67 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.627 2.885 . . . . 0.0 113.417 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.68 -125.14 0.8 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 156.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -66.8 -23.03 66.01 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 128.992 2.917 . . . . 0.0 113.242 -160.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 18.3 mt -131.75 172.08 7.98 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.971 2.108 . . . . 0.0 109.356 172.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.38 -136.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.582 3.521 . . . . 0.0 107.774 163.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.61 120.15 5.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -35.71 78.59 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.345 1.058 . . . . 0.0 112.483 -170.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.3 -167.86 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.227 1.011 . . . . 0.0 108.707 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -123.36 169.22 11.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.404 2.282 . . . . 0.0 108.273 164.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -127.27 156.02 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 130.734 3.613 . . . . 0.0 105.721 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.3 mt -128.63 136.71 59.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 164.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.69 153.36 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 108.175 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.14 128.76 22.98 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.767 1.227 . . . . 0.0 109.461 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.64 151.3 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.787 1.635 . . . . 0.0 107.197 171.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.28 105.87 1.0 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.106 -0.372 . . . . 0.0 110.359 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.94 -31.36 72.43 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -171.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 m -105.36 49.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.081 1.352 . . . . 0.0 110.218 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.2 t -134.85 -88.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 160.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.67 3.85 7.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.387 1.875 . . . . 0.0 110.401 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.49 -71.64 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.796 2.038 . . . . 0.0 109.758 -170.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -36.74 148.89 0.02 OUTLIER 'General case' 0 C--O 1.238 0.474 0 C-N-CA 130.437 3.495 . . . . 0.0 115.418 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -65.44 134.76 54.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.329 1.452 . . . . 0.0 108.079 171.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -129.9 130.2 44.86 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.25 94.86 0.17 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.07 -13.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.358 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.86 26.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.296 0.953 . . . . 0.0 109.475 162.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.46 26.11 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.4 m170 40.98 63.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.683 1.993 . . . . 0.0 111.915 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.25 138.26 24.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 C-N-CA 128.073 2.549 . . . . 0.0 108.115 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 29.15 5.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.869 0.867 . . . . 0.0 111.695 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.74 152.95 44.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.8 p -88.28 2.97 51.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.291 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.48 ' CD1' ' CB ' ' A' ' 35' ' ' SER . 8.4 tp -136.32 121.62 19.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.635 2.374 . . . . 0.0 107.693 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -146.39 139.23 25.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.427 1.012 . . . . 0.0 112.271 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -81.0 99.68 8.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.827 2.051 . . . . 0.0 108.492 170.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.0 143.58 15.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -131.69 178.14 6.98 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.247 1.419 . . . . 0.0 110.374 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 23.48 68.93 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.27 -159.32 0.73 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -134.98 140.85 36.23 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-O 117.753 -1.118 . . . . 0.0 109.437 -172.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.17 158.91 51.08 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.935 2.423 . . . . 0.0 110.588 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.04 45.44 3.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.967 2.107 . . . . 0.0 112.294 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -136.22 128.14 29.39 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 125.845 1.658 . . . . 0.0 107.889 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mm -65.17 145.61 13.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -134.57 158.29 44.37 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.626 1.571 . . . . 0.0 108.085 159.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mt -107.26 162.22 14.08 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 154.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.47 148.54 49.27 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.9 mtm -130.86 167.97 18.05 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 158.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.34 154.4 16.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -132.26 141.47 49.02 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 160.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.03 153.78 22.51 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.19 150.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.612 1.565 . . . . 0.0 107.44 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.4 t30 -163.36 160.2 18.13 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.52 10.67 2.42 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.177 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -120.56 15.21 11.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.563 2.345 . . . . 0.0 110.23 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.99 176.47 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 124.896 1.236 . . . . 0.0 110.778 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.0 mp -81.91 165.6 20.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 173.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.1 p -72.47 167.13 21.23 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.155 0.979 . . . . 0.0 110.144 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.52 150.11 0.55 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 152.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.36 149.65 80.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.198 1.932 . . . . 0.0 109.147 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -63.16 164.19 14.78 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 163.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.34 151.13 18.47 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.169 1.246 . . . . 0.0 109.519 154.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 40.9 mtm -68.31 151.28 47.14 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.988 -0.445 . . . . 0.0 110.528 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.5 p -60.5 -7.64 2.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.427 2.291 . . . . 0.0 115.24 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.23 157.24 0.15 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.228 2.211 . . . . 0.0 111.068 -158.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.01 100.88 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.159 2.573 . . . . 0.0 110.112 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.82 129.66 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.601 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -79.45 158.16 27.36 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 p -91.13 168.85 11.32 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.452 1.12 . . . . 0.0 109.903 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -71.64 177.05 4.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.903 1.811 . . . . 0.0 111.116 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -77.27 151.75 34.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 110.53 -3.032 . . . . 0.0 108.878 166.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.419 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -94.0 11.07 31.01 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -168.159 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.24 116.99 5.43 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 118.539 -1.145 . . . . 0.0 112.645 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.16 166.74 29.16 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 CA-C-N 120.409 2.104 . . . . 0.0 110.186 159.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.1 t -150.27 -160.22 1.14 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.787 1.635 . . . . 0.0 107.822 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 p -146.32 115.96 7.2 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.682 1.193 . . . . 0.0 109.138 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -172.037 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.413 0 CA-C-O 121.631 0.573 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.62 120.62 18.48 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 160.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 m 33.83 67.44 0.2 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.925 2.49 . . . . 0.0 113.847 168.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.34 -111.81 1.92 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 124.16 0.886 . . . . 0.0 111.421 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 m -59.31 98.71 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.86 1.264 . . . . 0.0 111.69 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 m -71.02 175.98 4.74 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 152.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -136.07 16.61 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -74.19 68.33 1.44 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.662 1.185 . . . . 0.0 110.205 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -67.69 119.23 12.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 164.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 t80 67.88 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.608 2.363 . . . . 0.0 109.553 -176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.37 171.19 15.86 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.077 1.351 . . . . 0.0 109.653 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' H ' HD11 ' A' ' 12' ' ' LEU . 6.0 mp -63.45 -0.44 0.89 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.794 2.438 . . . . 0.0 114.912 -166.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.2 p -33.75 118.65 0.36 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.585 2.354 . . . . 0.0 113.861 175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -74.0 62.54 0.88 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.543 1.937 . . . . 0.0 108.169 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt -127.47 159.04 67.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.158 2.183 . . . . 0.0 107.441 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.87 158.19 34.74 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.167 2.578 . . . . 0.0 112.041 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.33 151.46 50.22 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 167.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.446 2.097 . . . . 0.0 111.528 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -63.21 168.25 11.28 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.147 1.231 . . . . 0.0 110.491 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -88.19 163.39 16.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 10.9 tmtt? -57.39 125.49 71.71 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 117.092 -1.432 . . . . 0.0 109.467 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.88 157.9 56.71 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.293 1.328 . . . . 0.0 111.842 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -135.06 118.39 16.71 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 127.396 2.279 . . . . 0.0 105.988 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -63.16 161.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 114.394 -1.276 . . . . 0.0 109.429 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -140.75 -79.91 0.27 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.442 1.097 . . . . 0.0 109.082 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -79.69 143.01 34.98 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 108.335 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.01 146.51 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 160.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.3 p -118.04 -62.47 1.54 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 pttt 172.4 -34.98 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 130.647 3.579 . . . . 0.0 108.196 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.49 5.82 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.731 1.212 . . . . 0.0 111.018 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -132.75 155.34 49.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.44 134.64 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.261 1.424 . . . . 0.0 107.859 175.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.0 m -95.89 128.52 42.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.114 0.966 . . . . 0.0 109.22 178.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.32 122.59 47.86 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.002 2.121 . . . . 0.0 107.381 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -92.42 147.83 22.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 159.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 44.1 p90 -139.85 172.15 13.19 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 124.821 1.248 . . . . 0.0 107.92 156.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -109.06 144.11 29.01 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.21 158.36 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.839 3.026 . . . . 0.0 112.141 -168.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.97 -176.21 39.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.915 0.769 . . . . 0.0 112.008 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.47 154.85 87.79 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.298 1.439 . . . . 0.0 111.326 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.41 -101.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 125.667 4.245 . . . . 0.0 109.631 161.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.34 -92.67 0.69 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 128.194 2.807 . . . . 0.0 108.769 161.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -55.66 28.91 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.292 2.237 . . . . 0.0 109.963 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -134.29 160.4 68.63 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.068 1.347 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -75.28 154.17 40.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.237 3.291 . . . . 0.0 108.981 172.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.2 161.82 21.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.489 1.137 . . . . 0.0 110.359 170.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.2 m -119.58 -43.87 2.57 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.76 2.424 . . . . 0.0 109.237 -175.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.07 -164.83 0.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.33 1.452 . . . . 0.0 107.725 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.92 161.03 30.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.372 2.269 . . . . 0.0 108.362 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.0 mt -126.98 156.2 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.872 2.469 . . . . 0.0 106.471 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 70.7 mt -122.66 136.27 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 160.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -109.73 153.05 24.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 166.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.09 155.84 48.37 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.977 1.311 . . . . 0.0 107.686 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -133.05 153.69 51.26 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.485 1.514 . . . . 0.0 107.258 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.6 t -153.37 133.47 13.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.36 -18.37 63.06 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -103.1 1.79 33.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.162 1.385 . . . . 0.0 113.127 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -94.21 -79.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.1 m -128.78 -6.14 5.1 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.133 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t30 55.46 47.55 20.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.582 1.083 . . . . 0.0 109.0 -169.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.1 m -142.61 139.37 31.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.53 2.332 . . . . 0.0 107.932 -172.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -77.47 129.61 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 162.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -126.55 152.54 46.42 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.538 1.135 . . . . 0.0 108.215 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 135.23 47.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.73 0.08 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.326 1.451 . . . . 0.0 112.317 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.68 139.53 19.92 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 164.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -142.93 143.69 32.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.102 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 37.37 63.15 0.77 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.508 1.523 . . . . 0.0 111.36 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -86.38 133.84 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -118.5 45.95 1.92 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.061 0.945 . . . . 0.0 109.754 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 t -157.88 -174.58 4.91 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.65 1.58 . . . . 0.0 107.543 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 p -124.95 3.26 8.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.051 2.141 . . . . 0.0 111.454 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.8 131.46 53.77 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 165.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -145.96 151.06 37.2 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.563 1.145 . . . . 0.0 109.267 178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.3 m -109.84 102.31 11.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.058 1.743 . . . . 0.0 107.357 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.83 141.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -133.85 -177.59 4.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.032 1.733 . . . . 0.0 108.24 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.09 78.95 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 123.157 0.408 . . . . 0.0 112.876 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.83 -171.8 3.15 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.008 0.923 . . . . 0.0 108.837 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -116.39 143.19 30.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 125.107 1.363 . . . . 0.0 109.092 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -74.56 157.75 44.36 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.248 2.632 . . . . 0.0 111.885 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.1 t30 46.64 34.27 2.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.348 1.859 . . . . 0.0 112.023 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 m -125.02 130.33 52.11 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mm -74.71 151.29 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -131.91 169.1 16.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.11 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.6 mt -119.74 156.25 30.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 152.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -131.01 146.44 52.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.119 1.768 . . . . 0.0 106.742 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.73 117.92 9.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.863 1.665 . . . . 0.0 107.012 -177.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.24 112.76 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -97.85 135.56 39.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 163.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.71 166.74 15.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 165.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -127.73 151.56 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.74 1.616 . . . . 0.0 108.168 178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -145.04 178.43 1.44 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.067 1.747 . . . . 0.0 108.447 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.63 -10.04 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.865 2.377 . . . . 0.0 115.848 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -113.13 -32.79 6.21 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.411 1.46 . . . . 0.0 112.935 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.4 -156.58 17.89 Favored Glycine 0 C--O 1.238 0.397 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mp -103.93 149.51 25.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.776 1.23 . . . . 0.0 110.056 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.9 p -72.16 166.27 22.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.772 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.37 146.62 0.34 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 126.446 1.899 . . . . 0.0 112.157 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.43 104.96 0.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.63 2.22 . . . . 0.0 109.051 166.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -48.82 166.89 0.22 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.002 2.521 . . . . 0.0 113.907 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.59 135.67 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.252 1.968 . . . . 0.0 110.044 155.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 45.5 mtt -63.69 163.4 11.52 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.9 0.773 . . . . 0.0 110.234 171.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.485 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 85.6 p -65.7 -1.75 3.03 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.57 155.08 0.11 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.726 1.611 . . . . 0.0 110.925 -159.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -69.98 98.74 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.48 2.12 . . . . 0.0 111.65 -168.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 m -99.26 142.55 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.89 0.876 . . . . 0.0 110.597 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -93.11 147.99 22.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 122.96 0.504 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.7 p -79.32 152.03 30.71 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 158.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.87 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.611 1.964 . . . . 0.0 111.654 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -175.56 154.31 1.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.335 2.254 . . . . 0.0 106.396 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 t -111.64 17.37 20.0 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.507 1.123 . . . . 0.0 111.999 -172.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -63.98 -74.71 0.42 Allowed Glycine 0 CA--C 1.534 1.257 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 168.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.47 147.93 90.58 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.765 1.643 . . . . 0.0 110.328 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 m -142.48 140.56 31.93 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -174.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 t -151.87 90.55 1.55 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.419 1.009 . . . . 0.0 111.246 -168.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 N-CA-C 105.264 -3.135 . . . . 0.0 105.264 167.087 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.696 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -157.21 111.03 2.61 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.48 1.512 . . . . 0.0 107.697 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.0 p -157.5 169.98 23.47 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.976 0.91 . . . . 0.0 108.777 157.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.41 -162.87 11.02 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 125.357 1.456 . . . . 0.0 109.781 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.6 m -62.63 168.92 3.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.796 0.808 . . . . 0.0 110.049 162.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 m -57.17 166.96 0.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.042 0.937 . . . . 0.0 108.915 152.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.57 37.21 0.02 OUTLIER Glycine 0 C--N 1.33 0.231 0 CA-C-O 118.585 -1.119 . . . . 0.0 112.974 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -107.43 135.09 49.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.801 1.301 . . . . 0.0 108.353 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -141.39 -167.18 2.35 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 149.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -84.73 172.22 11.69 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.696 1.134 . . . . 0.0 108.055 154.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.12 -174.55 4.04 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 125.183 1.393 . . . . 0.0 107.533 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.49 -23.13 9.47 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.743 1.156 . . . . 0.0 113.531 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.88 145.39 29.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.588 1.155 . . . . 0.0 110.207 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -70.1 -27.13 64.34 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.757 -0.589 . . . . 0.0 111.044 172.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.01 157.02 87.52 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 129.048 2.939 . . . . 0.0 110.731 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.68 165.0 19.38 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.685 3.59 . . . . 0.0 110.829 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.92 159.38 41.75 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 170.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.2 152.86 78.94 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.061 2.508 . . . . 0.0 111.324 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.16 156.4 55.54 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.33 2.02 . . . . 0.0 110.493 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 m -79.02 176.99 9.15 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.845 -0.534 . . . . 0.0 109.724 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 28.5 tttt -55.51 120.3 30.57 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-O 117.945 -1.026 . . . . 0.0 108.679 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.48 141.42 95.41 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 CA-C-N 120.257 1.128 . . . . 0.0 109.391 167.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -79.74 171.61 14.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 161.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 46.2 t -117.84 137.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 162.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.257 68.7 p -117.18 -98.42 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -72.42 142.81 48.67 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 109.08 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.79 -177.67 3.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 pttt -74.71 -16.67 60.74 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.259 -0.901 . . . . 0.0 112.12 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -136.39 2.72 2.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.686 1.13 . . . . 0.0 111.718 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.4 p -153.33 166.83 31.39 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.43 -1.418 . . . . 0.0 110.19 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.63 145.83 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.427 1.091 . . . . 0.0 108.57 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -105.64 124.36 49.43 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.539 1.535 . . . . 0.0 107.315 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.82 132.01 53.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.725 2.01 . . . . 0.0 110.828 -171.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.8 108.68 11.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.321 1.848 . . . . 0.0 106.621 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -109.86 173.11 6.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.13 148.87 42.41 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.51 134.74 12.65 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.533 3.488 . . . . 0.0 110.915 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.47 30.87 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-O 122.756 1.198 . . . . 0.0 111.165 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -61.18 154.06 63.94 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.66 1.984 . . . . 0.0 111.148 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.73 -174.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 125.042 3.828 . . . . 0.0 114.702 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.03 -154.89 7.83 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -47.72 23.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 160.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 11.3 mt -103.62 144.01 27.8 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.56 0.618 . . . . 0.0 110.487 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -81.36 151.75 17.78 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.371 2.714 . . . . 0.0 110.652 -165.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.71 122.42 5.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.762 1.225 . . . . 0.0 111.526 168.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.8 m -76.94 -61.82 1.85 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.578 1.951 . . . . 0.0 108.434 162.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -158.99 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 110.115 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -132.61 168.65 17.88 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.637 1.975 . . . . 0.0 109.219 165.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.76 159.67 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 128.745 2.818 . . . . 0.0 106.907 168.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.1 mt -130.22 129.79 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.91 166.03 11.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.934 0.894 . . . . 0.0 109.181 163.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.45 147.28 34.32 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.079 1.752 . . . . 0.0 108.205 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -127.89 119.78 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 44.6 t -73.59 -72.01 0.29 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.141 1.337 . . . . 0.0 110.082 166.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 142.73 -58.88 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 131.699 4.0 . . . . 0.0 106.096 -156.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 t -121.18 39.75 3.74 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.485 1.493 . . . . 0.0 109.363 -155.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.477 HG21 ' H ' ' A' ' 59' ' ' SER 0.272 25.1 m -120.41 -84.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -167.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.477 ' H ' HG21 ' A' ' 58' ' ' VAL . 8.3 m -129.96 16.83 5.69 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.441 1.096 . . . . 0.0 112.51 168.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 47.1 51.73 12.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.952 1.701 . . . . 0.0 111.161 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -153.26 153.33 32.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.06 1.744 . . . . 0.0 108.155 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.91 137.19 58.22 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 155.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -134.42 146.62 50.01 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.72 123.42 26.66 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.32 -3.02 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.537 1.135 . . . . 0.0 111.611 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.45 140.05 19.77 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 158.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.38 129.04 30.67 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -172.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 63.41 56.33 1.67 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.033 1.733 . . . . 0.0 112.094 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 134.31 27.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.474 1.51 . . . . 0.0 107.977 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.9 mtpt -122.89 51.84 1.39 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.974 2.109 . . . . 0.0 109.108 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 t -150.45 -178.69 6.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.643 1.577 . . . . 0.0 107.22 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.6 p -118.52 2.12 11.76 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.171 1.789 . . . . 0.0 111.213 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -137.55 103.66 5.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -128.52 137.29 51.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -86.13 105.2 16.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.98 140.47 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -129.13 178.5 6.37 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.259 1.424 . . . . 0.0 110.89 -173.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.24 13.62 67.64 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 124.748 1.166 . . . . 0.0 114.304 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.02 164.81 25.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.68 1.229 . . . . 0.0 110.31 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -93.29 146.03 31.14 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.219 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.66 157.48 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.95 2.433 . . . . 0.0 110.581 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 53.23 14.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.782 1.633 . . . . 0.0 113.542 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -109.29 132.12 54.42 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 120.208 1.367 . . . . 0.0 108.744 -170.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -61.96 145.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 85.3 m-85 -140.42 150.77 44.28 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.927 1.346 . . . . 0.0 108.369 163.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.8 mt -110.36 162.28 14.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 111.675 -2.511 . . . . 0.0 107.926 159.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -142.21 126.31 17.39 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.48 1.912 . . . . 0.0 108.769 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.1 mtm -104.99 154.82 19.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 163.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.97 134.72 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 49.0 mtt180 -118.72 147.55 43.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 167.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.9 158.84 20.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.52 143.98 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.02 172.82 6.12 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 126.0 1.72 . . . . 0.0 107.288 173.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.97 28.12 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.553 2.168 . . . . 0.0 112.382 -172.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -132.78 -42.45 0.91 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 127.134 2.174 . . . . 0.0 110.46 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.27 -177.36 44.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 122.336 0.965 . . . . 0.0 112.959 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.5 pp -92.42 165.47 13.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.433 1.493 . . . . 0.0 111.052 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 18.9 p -87.18 167.16 14.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -174.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.1 150.72 1.02 Allowed Pre-proline 0 C--O 1.237 0.424 0 O-C-N 121.524 -0.735 . . . . 0.0 109.205 152.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.55 154.89 72.3 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 120.863 1.042 . . . . 0.0 110.444 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 p -53.25 151.36 9.77 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 123.463 0.705 . . . . 0.0 111.043 160.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -53.54 140.94 64.21 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.77 1.647 . . . . 0.0 109.841 154.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 mmt -57.66 129.44 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.027 0.531 . . . . 0.0 111.715 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.548 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.87 -16.41 50.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.534 1.534 . . . . 0.0 112.255 169.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t0 85.87 153.38 0.1 Allowed Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 129.457 3.103 . . . . 0.0 110.824 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.09 97.08 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.901 2.401 . . . . 0.0 112.185 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.73 156.3 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 124.66 1.184 . . . . 0.0 109.481 176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -106.08 165.33 11.3 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.969 1.308 . . . . 0.0 109.038 172.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -102.03 163.76 12.07 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.283 1.433 . . . . 0.0 109.248 169.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -74.05 174.56 8.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.947 0.88 . . . . 0.0 111.669 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.37 151.64 36.3 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.102 2.161 . . . . 0.0 109.73 170.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.8 t -130.56 74.48 1.6 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.418 1.087 . . . . 0.0 108.288 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -138.33 -115.85 1.38 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.12 158.22 45.69 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.283 2.655 . . . . 0.0 111.168 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.6 p -162.13 162.64 28.6 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.653 -0.654 . . . . 0.0 110.8 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.2 m 47.72 36.12 5.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.253 1.421 . . . . 0.0 112.768 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.817 0 N-CA-C 105.478 -3.049 . . . . 0.0 105.478 176.228 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.91 0 CA-C-O 121.143 0.302 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.6 m -141.96 3.79 1.63 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.156 1.782 . . . . 0.0 111.852 162.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 t -147.07 88.47 1.73 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.48 118.49 2.52 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.6 m -157.26 43.92 0.35 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.981 1.312 . . . . 0.0 109.865 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 p -145.71 167.35 23.36 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.688 0.795 . . . . 0.0 109.669 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.67 -134.77 41.33 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -140.89 167.17 22.83 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -154.97 139.4 16.8 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.508 1.049 . . . . 0.0 109.838 165.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -68.69 -30.04 68.62 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.801 0.841 . . . . 0.0 110.984 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 47.47 -162.6 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 127.349 2.26 . . . . 0.0 110.693 -162.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.41 31.09 5.67 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.4 1.08 . . . . 0.0 108.671 166.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 t -58.21 132.68 54.29 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.942 0.897 . . . . 0.0 110.379 -170.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.63 -42.58 24.56 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt -76.68 141.64 69.14 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 124.805 1.242 . . . . 0.0 110.227 -174.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -66.93 147.11 79.82 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.345 2.03 . . . . 0.0 111.519 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.08 142.01 28.55 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.422 1.487 . . . . 0.0 110.363 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.3 148.85 85.11 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.706 2.27 . . . . 0.0 110.231 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -64.61 160.7 38.74 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.819 1.679 . . . . 0.0 110.867 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -67.16 168.32 10.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.86 0.864 . . . . 0.0 109.788 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -57.02 124.64 66.56 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.013 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.18 135.81 32.84 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.535 1.584 . . . . 0.0 110.535 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -80.36 168.61 18.81 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 125.103 1.361 . . . . 0.0 109.778 166.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.5 95.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 112.056 -2.338 . . . . 0.0 106.169 171.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.3 p -93.58 -89.33 0.21 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 126.29 28.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.566 1.146 . . . . 0.0 110.542 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.49 159.1 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.714 1.206 . . . . 0.0 108.079 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 p -137.95 -56.52 0.67 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt 170.85 -31.44 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 1 C-N-CA 132.082 4.153 . . . . 0.0 108.969 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.25 2.26 2.06 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.528 1.531 . . . . 0.0 112.12 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 p -132.4 154.56 49.69 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.093 0.86 . . . . 0.0 109.919 165.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 p -147.63 141.92 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.49 143.41 26.84 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.5 mt -112.66 138.35 49.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.352 1.461 . . . . 0.0 107.81 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.89 120.51 30.63 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -136.63 170.55 15.88 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.272 1.397 . . . . 0.0 107.63 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -115.64 149.61 43.33 Favored Pre-proline 0 C--O 1.237 0.443 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.51 153.29 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.358 2.039 . . . . 0.0 110.126 -165.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.87 176.44 54.02 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-O 122.642 1.135 . . . . 0.0 111.633 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.9 m -62.01 149.5 85.94 Favored Pre-proline 0 N--CA 1.435 -1.217 0 C-N-CA 126.355 1.862 . . . . 0.0 108.667 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -69.55 178.68 4.2 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 CA-C-O 123.77 1.488 . . . . 0.0 113.049 170.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.57 -160.79 9.24 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 130.686 3.993 . . . . 0.0 103.401 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -43.66 72.97 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.805 0.842 . . . . 0.0 111.52 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.46 154.52 37.52 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 118.793 0.724 . . . . 0.0 111.478 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.84 151.54 31.56 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.943 3.095 . . . . 0.0 110.316 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.27 104.27 9.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.0 m -52.43 -52.8 52.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.251 2.221 . . . . 0.0 112.929 176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.81 -163.81 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.509 1.924 . . . . 0.0 107.201 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -127.23 157.96 38.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.82 1.248 . . . . 0.0 110.08 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -107.1 154.12 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.661 1.984 . . . . 0.0 107.217 164.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.45 119.73 46.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -100.91 155.85 17.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.66 156.37 48.95 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 126.192 1.797 . . . . 0.0 106.306 169.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -132.83 156.14 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.03 124.41 5.29 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -21.67 65.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.776 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 t -94.65 -3.49 49.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.18 0.992 . . . . 0.0 111.697 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 t -111.28 -68.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 125.235 1.414 . . . . 0.0 108.367 -161.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 m -142.95 -5.25 0.89 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 111.611 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 t30 54.36 32.03 15.63 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -133.95 153.16 51.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.568 1.547 . . . . 0.0 108.27 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -71.29 141.74 50.5 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 159.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -135.11 132.76 38.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 175.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -71.87 94.18 1.4 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.97 -25.63 14.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.781 0.832 . . . . 0.0 110.902 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.75 46.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 163.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -133.96 143.96 48.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.452 1.501 . . . . 0.0 107.597 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 47.26 64.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.068 1.347 . . . . 0.0 111.595 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.3 133.5 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -117.89 56.65 0.85 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.853 1.261 . . . . 0.0 108.271 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 t -161.35 176.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.4 p -110.46 0.0 17.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 111.465 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -142.99 101.57 3.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.581 1.152 . . . . 0.0 108.944 -169.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -134.18 124.29 25.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.612 0.765 . . . . 0.0 112.838 -164.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.0 m -70.82 98.37 1.55 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.764 2.426 . . . . 0.0 110.805 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.83 146.99 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 120.646 -1.284 . . . . 0.0 108.167 163.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -140.81 -178.19 5.43 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.861 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.25 49.66 60.45 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt -115.26 -160.5 0.74 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.822 1.249 . . . . 0.0 108.905 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -131.08 139.57 35.95 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.541 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.79 160.21 50.14 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.312 2.674 . . . . 0.0 111.601 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.1 m120 47.95 21.93 0.34 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.207 1.803 . . . . 0.0 113.844 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -121.03 121.44 37.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.83 1.652 . . . . 0.0 106.789 -170.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 mm -58.78 146.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -136.07 159.91 40.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 162.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.0 mt -112.2 162.57 15.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 125.758 1.623 . . . . 0.0 107.782 158.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -142.57 143.42 32.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.439 1.712 . . . . 0.0 107.727 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 mtm -138.46 149.04 45.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.13 150.31 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -129.02 148.46 50.97 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 167.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.25 152.42 22.32 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 163.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.34 151.03 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -146.61 174.99 2.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.034 0.934 . . . . 0.0 109.529 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.54 29.5 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.913 3.075 . . . . 0.0 114.114 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.56 -52.19 0.48 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.49 1.916 . . . . 0.0 109.756 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.96 -144.06 4.03 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 127.263 2.363 . . . . 0.0 108.971 -170.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 pp -142.73 167.43 22.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.865 1.266 . . . . 0.0 111.609 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.7 p -75.35 165.52 25.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.269 0.628 . . . . 0.0 110.645 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -51.83 152.19 5.5 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 157.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.9 142.28 51.35 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.665 1.577 . . . . 0.0 109.136 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 p -59.09 162.27 7.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 O-C-N 121.812 -0.555 . . . . 0.0 111.062 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -54.55 129.83 36.94 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.6 2.867 . . . . 0.0 109.835 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 5.4 mtm -49.75 151.68 1.7 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.322 1.419 . . . . 0.0 113.199 -176.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.3 p -60.5 -12.22 9.12 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.79 155.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.344 1.857 . . . . 0.0 108.739 -157.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -70.74 137.42 32.56 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.229 1.953 . . . . 0.0 109.883 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.62 125.78 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.35 127.65 35.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.9 p -66.07 157.96 29.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -66.91 172.99 3.88 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.146 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.74 8.0 9.04 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.579 1.151 . . . . 0.0 113.932 -169.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 t 59.53 31.27 20.88 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.032 2.533 . . . . 0.0 113.714 -177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -136.04 73.32 0.44 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.26 177.05 6.33 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.866 2.377 . . . . 0.0 112.59 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.1 t -136.41 -177.48 4.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.719 2.008 . . . . 0.0 106.856 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.7 p -130.62 114.51 15.52 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.279 1.832 . . . . 0.0 107.128 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.786 0 CA-C-O 117.462 -1.744 . . . . 0.0 109.042 178.915 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -110.08 11.28 23.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.336 0.655 . . . . 0.0 112.605 -153.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.3 p -66.69 -179.94 0.95 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.199 0.999 . . . . 0.0 110.95 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.87 -126.66 0.73 Allowed Glycine 0 CA--C 1.528 0.845 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 149.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.9 m 75.38 126.49 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.868 2.467 . . . . 0.0 109.607 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -42.26 127.2 3.57 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.238 1.415 . . . . 0.0 110.315 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.29 -179.45 29.65 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.042 1.306 . . . . 0.0 110.459 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 mttp 60.39 168.27 0.08 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.048 2.539 . . . . 0.0 113.167 -164.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -154.0 100.7 2.36 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.601 1.96 . . . . 0.0 107.04 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -67.64 -28.91 68.12 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.503 0.721 . . . . 0.0 112.766 -174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 53.35 -159.57 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 111.932 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.6 mt -119.46 78.53 1.32 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 166.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 m -69.67 161.8 28.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.944 0.878 . . . . 0.0 110.138 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -74.05 -36.25 64.35 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.909 -0.494 . . . . 0.0 110.666 173.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.99 155.24 64.36 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.405 1.082 . . . . 0.0 109.99 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.21 149.66 84.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.889 2.392 . . . . 0.0 112.422 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 148.48 44.78 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 169.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 156.45 53.63 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.813 2.342 . . . . 0.0 113.053 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.68 175.07 5.66 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.493 2.795 . . . . 0.0 112.837 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -61.09 171.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.922 0.868 . . . . 0.0 111.769 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.439 ' HZ2' ' HB2' ' A' ' 105' ' ' ASP . 78.2 tttt -52.96 133.57 48.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.299 -0.858 . . . . 0.0 108.856 157.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.54 148.27 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.433 1.422 . . . . 0.0 110.927 167.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -119.3 117.14 27.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.612 1.565 . . . . 0.0 108.658 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.89 144.6 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 113.357 -1.747 . . . . 0.0 107.698 169.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 p -128.75 -85.72 0.56 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -73.84 149.12 41.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.704 1.602 . . . . 0.0 109.475 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.97 141.95 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 122.004 0.907 . . . . 0.0 108.687 161.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.9 p -128.54 -172.21 2.65 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 107.996 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.516 ' HB2' ' HG ' ' A' ' 112' ' ' SER . 8.5 pttt -62.05 -36.99 83.27 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.176 -0.953 . . . . 0.0 112.706 -177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -139.67 23.86 2.45 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.902 1.228 . . . . 0.0 111.398 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -146.14 164.13 33.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.518 0.599 . . . . 0.0 109.501 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.05 138.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -94.44 135.18 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.36 130.63 52.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 125.886 1.674 . . . . 0.0 108.318 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -103.32 151.92 22.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.69 1.196 . . . . 0.0 108.127 161.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 24.2 p90 -140.04 171.12 14.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 156.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.32 144.82 32.46 Favored Pre-proline 0 C--O 1.239 0.516 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.94 140.73 18.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.835 2.357 . . . . 0.0 110.751 -167.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.21 -168.19 26.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 166.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.3 m -86.85 159.98 50.76 Favored Pre-proline 0 N--CA 1.441 -0.878 0 C-N-CA 128.775 2.83 . . . . 0.0 109.458 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.84 -169.06 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.813 3.676 . . . . 0.0 111.085 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.35 -148.41 6.21 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 105.872 -2.891 . . . . 0.0 105.872 164.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -33.4 54.95 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.549 0.739 . . . . 0.0 110.144 171.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 12.6 mt -104.36 157.72 33.47 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 118.379 0.536 . . . . 0.0 111.124 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.36 170.58 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.045 2.497 . . . . 0.0 109.303 164.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.61 162.6 13.56 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.473 1.109 . . . . 0.0 109.033 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -116.54 -47.28 2.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.86 2.064 . . . . 0.0 109.481 -171.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.51 -160.99 0.55 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -134.83 148.86 50.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.444 2.298 . . . . 0.0 108.555 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 mt -124.99 113.86 37.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 129.15 2.98 . . . . 0.0 105.754 172.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 69.7 mt -94.54 120.39 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 171.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.78 154.29 20.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.26 148.21 51.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.015 1.726 . . . . 0.0 108.08 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.23 157.46 19.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 166.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.3 144.57 21.01 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -95.53 -4.99 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.545 1.538 . . . . 0.0 112.622 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.0 m -119.56 9.98 11.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.362 1.465 . . . . 0.0 113.281 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -115.17 -77.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.14 1.776 . . . . 0.0 109.023 -168.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -141.67 5.85 1.81 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.289 0.95 . . . . 0.0 112.786 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 m120 59.58 2.93 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.431 2.692 . . . . 0.0 114.964 -175.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -106.23 161.16 14.78 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 126.632 1.973 . . . . 0.0 110.518 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.413 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 81.6 m95 -77.78 144.62 36.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 153.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -138.32 148.68 44.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.4 m -77.19 108.57 10.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -95.11 -15.47 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.215 1.006 . . . . 0.0 111.93 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.92 102.45 2.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.307 0.958 . . . . 0.0 108.835 167.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.81 157.89 15.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.196 0.998 . . . . 0.0 110.394 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.8 m170 44.89 46.23 8.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.473 2.709 . . . . 0.0 112.449 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t -79.99 136.75 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 126.75 2.02 . . . . 0.0 108.056 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -123.27 61.41 1.04 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 122.093 0.949 . . . . 0.0 108.799 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 t -158.31 179.27 9.3 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 p -122.85 5.86 9.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.697 1.199 . . . . 0.0 111.441 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.8 tp -135.89 128.36 30.46 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 163.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -145.95 151.24 37.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -101.42 103.77 14.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.227 1.411 . . . . 0.0 107.827 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.52 137.49 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -122.48 -167.38 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.546 1.938 . . . . 0.0 107.543 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.68 21.11 64.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.112 171.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -99.95 -166.46 1.34 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.822 1.311 . . . . 0.0 110.616 -167.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -122.73 153.15 63.15 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 107.248 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.69 156.17 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.519 2.146 . . . . 0.0 110.382 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 35.58 57.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.222 1.809 . . . . 0.0 110.598 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.9 m -139.0 138.33 37.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.66 1.984 . . . . 0.0 106.19 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 mm -79.44 146.1 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.127 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -142.13 150.87 41.68 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.179 1.391 . . . . 0.0 109.411 173.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.03 166.27 10.85 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 162.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -138.34 149.22 45.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.647 1.217 . . . . 0.0 108.731 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.413 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 73.3 mtm -136.81 152.53 50.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 163.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 71.0 t -119.3 109.66 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -169.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -94.84 132.28 39.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 170.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 129.25 35.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 165.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.05 149.52 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.7 176.79 2.27 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.101 1.361 . . . . 0.0 108.926 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.99 4.09 0.77 Allowed 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.581 2.854 . . . . 0.0 115.935 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.8 tp60 -140.48 -17.4 0.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.926 1.29 . . . . 0.0 112.617 -161.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.19 -156.84 29.05 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.858 1.694 . . . . 0.0 109.402 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.4 pp -129.76 146.97 51.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.849 1.66 . . . . 0.0 107.765 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.3 p -72.41 167.11 21.23 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.04 153.75 0.49 Allowed Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.234 1.413 . . . . 0.0 110.919 173.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.1 136.3 68.18 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -61.3 172.02 1.08 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 165.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.98 144.77 35.33 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.012 1.142 . . . . 0.0 109.733 156.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.51 143.6 57.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.6 p -64.48 -2.48 2.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.902 1.681 . . . . 0.0 115.043 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.439 ' HB2' ' HZ2' ' A' ' 21' ' ' LYS . 1.2 t0 68.71 151.5 0.13 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.945 2.498 . . . . 0.0 109.751 -158.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.65 105.58 1.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.081 2.521 . . . . 0.0 110.206 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.83 167.72 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 129.04 47.38 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.201 1.4 . . . . 0.0 108.233 172.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.2 p -65.4 160.64 21.52 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.208 0.317 . . . . 0.0 110.81 171.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -83.88 -176.75 6.43 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.202 1.001 . . . . 0.0 110.458 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.95 157.52 31.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 111.991 -177.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.516 ' HG ' ' HB2' ' A' ' 29' ' ' LYS . 1.3 m -115.83 32.67 5.95 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.562 1.945 . . . . 0.0 113.345 -177.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.86 -138.31 1.17 Allowed Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 168.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.8 163.54 18.63 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 CA-C-N 119.688 1.744 . . . . 0.0 110.441 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.36 133.1 46.49 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.722 0.809 . . . . 0.0 109.353 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.12 165.23 7.39 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 157.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.908 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 -176.013 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -125.33 67.43 1.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -145.64 80.1 1.58 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -162.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.7 -44.95 95.62 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.565 -164.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -179.57 155.03 0.64 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.294 1.438 . . . . 0.0 109.999 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -73.41 -39.46 65.02 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.807 0.443 . . . . 0.0 110.865 163.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.53 -152.4 45.04 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -168.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -131.5 129.36 41.01 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -144.51 91.03 2.14 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 171.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -75.8 162.34 28.25 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 163.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 72.86 -178.0 0.19 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.441 1.896 . . . . 0.0 109.365 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.5 mt -101.17 34.39 2.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.961 1.304 . . . . 0.0 108.263 160.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.2 m 56.66 37.33 28.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.209 1.803 . . . . 0.0 112.59 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.97 -34.3 77.8 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.645 1.178 . . . . 0.0 111.861 176.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.26 151.22 96.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.159 1.784 . . . . 0.0 111.077 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.38 159.93 47.91 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.879 3.053 . . . . 0.0 111.35 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.07 152.38 48.99 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.91 138.91 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.708 1.605 . . . . 0.0 108.606 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -64.91 163.7 27.29 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 121.894 1.729 . . . . 0.0 111.168 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.3 m -74.25 160.46 31.09 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.54 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.89 121.12 21.53 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.042 1.337 . . . . 0.0 112.027 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.45 146.59 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.755 1.636 . . . . 0.0 113.577 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.11 125.25 53.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 125.602 1.561 . . . . 0.0 111.373 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.3 m -86.08 133.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 113.615 -1.63 . . . . 0.0 108.885 -176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -121.88 -90.97 0.57 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -167.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -72.23 141.16 48.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.34 136.02 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.9 p -105.76 -52.88 2.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.362 -170.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 pttp 160.61 -26.13 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.331 1 C-N-CA 133.795 4.838 . . . . 0.0 108.373 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.18 -0.29 1.13 Allowed 'General case' 0 CA--C 1.523 -0.083 0 O-C-N 121.173 -0.954 . . . . 0.0 112.745 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -125.15 160.33 29.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.945 1.248 . . . . 0.0 110.156 160.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.51 130.96 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.127 1.371 . . . . 0.0 108.475 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.3 m -90.21 122.57 33.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.825 2.05 . . . . 0.0 108.249 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.75 126.64 54.79 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.874 2.07 . . . . 0.0 107.844 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.06 152.65 18.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 160.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.7 p90 -139.76 172.42 12.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 152.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -102.09 146.03 31.56 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.3 156.12 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.558 2.839 . . . . 0.0 109.964 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.13 177.86 50.76 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-O 123.878 1.821 . . . . 0.0 110.815 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 m -64.73 154.82 84.29 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 127.546 2.338 . . . . 0.0 109.357 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.62 -171.69 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.995 2.463 . . . . 0.0 112.828 166.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.75 6.14 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -45.01 54.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 161.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 mt -97.59 150.19 36.52 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 123.365 0.666 . . . . 0.0 109.978 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.23 151.61 54.91 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.889 3.059 . . . . 0.0 109.537 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.58 159.97 26.3 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.649 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 m -135.71 -42.0 0.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.447 1.499 . . . . 0.0 110.514 -166.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.58 -171.07 2.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.373 1.069 . . . . 0.0 108.427 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.56 167.57 10.35 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.851 0.834 . . . . 0.0 109.686 156.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.05 158.16 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.677 2.791 . . . . 0.0 106.471 164.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 92.3 mt -127.05 139.16 52.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 166.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.83 161.98 19.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.776 1.231 . . . . 0.0 108.275 172.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.87 162.15 36.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.195 1.398 . . . . 0.0 108.559 172.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -136.2 149.49 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.652 1.981 . . . . 0.0 106.057 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.419 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 8.1 t -141.42 165.07 28.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 161.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.71 33.84 2.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.378 1.071 . . . . 0.0 111.761 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.92 34.01 0.21 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.268 -0.895 . . . . 0.0 112.42 165.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.422 HG22 ' H ' ' A' ' 59' ' ' SER . 14.8 m -120.14 -72.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.959 1.304 . . . . 0.0 109.628 -175.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.422 ' H ' HG22 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -154.01 0.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.887 1.275 . . . . 0.0 112.005 -178.48 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.14 -21.11 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.266 2.626 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 m -63.66 159.27 19.39 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.476 1.91 . . . . 0.0 110.714 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -76.37 154.49 34.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 151.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -141.92 152.97 44.02 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 134.46 49.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.9 m -122.98 -19.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.308 -0.854 . . . . 0.0 111.473 176.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.63 157.06 47.82 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.904 1.229 . . . . 0.0 108.338 160.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -143.02 147.75 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 52.52 49.37 20.56 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.014 0.912 . . . . 0.0 111.806 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.5 t -79.13 102.27 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -94.47 50.67 1.37 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.876 1.27 . . . . 0.0 109.076 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -157.44 -170.06 3.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.057 1.743 . . . . 0.0 107.508 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.4 p -131.98 2.91 4.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.116 2.166 . . . . 0.0 111.624 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.0 tp -129.38 120.64 25.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -145.21 151.45 38.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.051 0.94 . . . . 0.0 109.502 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.8 m -110.2 114.29 27.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.396 1.078 . . . . 0.0 108.733 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.88 145.96 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -133.43 176.98 8.05 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 112.111 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.42 27.09 57.78 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.788 1.185 . . . . 0.0 113.935 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.9 mt -79.32 -179.13 6.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.153 0.977 . . . . 0.0 110.075 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -96.8 139.23 21.47 Favored Pre-proline 0 CA--C 1.516 -0.365 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.63 159.97 47.56 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.513 2.142 . . . . 0.0 110.32 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 t30 48.53 34.79 5.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.94 1.696 . . . . 0.0 111.8 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.1 m -133.19 132.89 42.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.111 1.764 . . . . 0.0 107.581 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.31 147.87 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -131.58 159.16 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 156.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mt -107.52 157.71 17.8 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 152.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -132.72 152.12 51.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 125.828 1.955 . . . . 0.0 107.369 172.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.61 165.84 23.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 162.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.67 145.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -120.95 147.62 45.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 162.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.99 159.05 19.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.5 mt -121.28 150.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 126.316 1.846 . . . . 0.0 107.535 175.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.62 172.2 5.49 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 127.138 2.175 . . . . 0.0 107.322 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.9 -23.93 74.37 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.65 2.233 . . . . 0.0 114.985 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -105.64 -45.99 4.28 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.576 1.55 . . . . 0.0 110.407 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.84 35.29 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 122.739 1.188 . . . . 0.0 112.214 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 mp -84.86 166.75 16.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -72.36 166.24 22.91 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 122.171 0.986 . . . . 0.0 109.619 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.81 159.88 1.64 Allowed Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.148 152.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.24 148.3 61.66 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.091 1.194 . . . . 0.0 111.182 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.1 p -62.38 167.51 5.25 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 159.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.97 150.34 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.427 1.418 . . . . 0.0 109.724 152.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -69.04 154.85 41.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.648 166.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.1 p -60.54 -7.53 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.578 2.351 . . . . 0.0 115.143 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.7 153.63 0.14 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 127.333 2.253 . . . . 0.0 109.169 -155.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -77.55 108.5 2.59 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.976 2.451 . . . . 0.0 108.603 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.49 133.23 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 124.544 1.138 . . . . 0.0 109.156 -171.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -92.66 135.27 34.24 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.7 p -63.68 154.32 33.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.971 0.891 . . . . 0.0 109.185 164.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.44 171.66 0.57 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 123.614 1.673 . . . . 0.0 110.02 163.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -77.27 149.72 35.39 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.925 169.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 p -58.32 15.97 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 129.16 2.984 . . . . 0.0 115.41 167.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -67.62 147.13 48.08 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 119.667 1.121 . . . . 0.0 110.823 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.33 139.59 46.06 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 N-CA-C 107.423 -1.799 . . . . 0.0 107.423 159.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.7 p -148.66 175.91 10.8 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.497 1.519 . . . . 0.0 108.916 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.41 -168.4 3.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.688 1.195 . . . . 0.0 108.455 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 171.53 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.704 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m 66.4 81.52 0.2 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 126.12 1.768 . . . . 0.0 112.325 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -145.04 152.9 40.85 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.527 0.731 . . . . 0.0 109.616 164.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.16 166.46 54.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.5 t -136.38 99.86 4.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 -175.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -153.26 14.92 0.52 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.478 1.111 . . . . 0.0 112.596 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.87 83.23 0.92 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 125.531 1.539 . . . . 0.0 110.103 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -75.94 74.85 2.85 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.236 1.017 . . . . 0.0 110.819 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.99 157.78 39.69 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.899 2.479 . . . . 0.0 104.962 166.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -68.76 157.0 37.29 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 155.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.53 157.46 34.27 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.584 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.3 mt -117.51 -132.3 0.32 Allowed 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -168.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -67.41 157.91 33.0 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.15 0.98 . . . . 0.0 111.909 -170.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -73.64 18.2 0.13 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.771 1.628 . . . . 0.0 112.505 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt -105.87 148.34 36.33 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 110.193 -171.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.52 159.45 36.29 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.078 3.852 . . . . 0.0 113.425 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.66 141.94 46.1 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.825 1.202 . . . . 0.0 111.227 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.84 147.49 80.88 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.255 1.97 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.9 164.76 15.68 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.583 2.189 . . . . 0.0 112.413 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -74.91 167.87 21.04 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.707 0.803 . . . . 0.0 110.037 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -59.4 117.83 25.55 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.854 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.03 157.33 60.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 120.619 1.257 . . . . 0.0 111.182 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -124.24 146.86 48.47 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 126.789 2.036 . . . . 0.0 109.367 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.5 m -96.75 139.03 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 C-N-CA 124.511 1.124 . . . . 0.0 108.309 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -128.74 -79.78 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.533 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.05 130.73 42.28 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.53 137.09 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.4 p -115.47 -74.33 0.62 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -162.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.409 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 3.1 pttp -171.34 -29.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 1 C-N-CA 133.272 4.629 . . . . 0.0 108.638 161.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.8 -15.47 14.1 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.821 1.648 . . . . 0.0 109.944 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 m -142.33 159.37 42.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.604 0.638 . . . . 0.0 110.094 -167.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 p -153.13 128.92 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.8 m -86.13 138.72 31.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.448 1.099 . . . . 0.0 110.066 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -113.04 141.38 46.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 107.931 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -130.77 129.45 42.47 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 126.99 2.116 . . . . 0.0 108.381 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -140.34 170.59 15.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.538 0.685 . . . . 0.0 112.19 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -98.77 145.63 30.27 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 124.324 1.05 . . . . 0.0 108.749 164.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.32 139.39 14.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 124.478 3.452 . . . . 0.0 109.483 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.75 -179.06 44.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 165.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.6 m -87.04 151.01 51.13 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 128.312 2.645 . . . . 0.0 110.163 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.81 -174.87 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.664 3.576 . . . . 0.0 111.757 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.98 -126.41 0.82 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 p -57.13 -31.02 64.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.266 2.626 . . . . 0.0 114.318 -173.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 mt -130.95 164.91 38.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.35 1.46 . . . . 0.0 109.234 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.78 135.7 6.87 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.993 2.462 . . . . 0.0 109.843 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.9 149.97 43.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.328 164.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -125.06 -56.7 1.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.628 1.171 . . . . 0.0 109.014 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.55 -177.38 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -122.91 173.17 7.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.755 0.822 . . . . 0.0 109.204 174.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.3 mt -121.49 152.86 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 126.835 2.054 . . . . 0.0 106.448 166.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -123.29 137.44 56.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 160.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.52 164.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.514 1.125 . . . . 0.0 108.56 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.18 163.7 32.16 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.44 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -159.32 124.07 4.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 108.7 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.6 t -106.17 1.63 26.31 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.381 1.072 . . . . 0.0 112.457 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 53.46 3.09 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -167.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.53 1.24 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.651 -1.28 . . . . 0.0 111.907 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -74.69 -78.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 109.327 173.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 m -121.35 15.35 11.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.549 1.14 . . . . 0.0 110.848 164.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 53.86 27.16 6.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.298 1.439 . . . . 0.0 110.835 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.6 m -144.41 151.81 39.78 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.825 2.85 . . . . 0.0 108.503 -167.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -78.76 142.74 36.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 109.911 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -135.76 135.88 40.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.276 0.631 . . . . 0.0 109.71 -169.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.79 94.34 1.39 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -81.65 -21.75 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.053 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.39 107.34 3.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.84 168.09 16.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 169.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 36.5 58.61 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.84 2.456 . . . . 0.0 112.627 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.93 118.59 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -111.5 50.07 0.85 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.62 1.168 . . . . 0.0 108.645 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -156.14 -177.75 6.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.727 1.211 . . . . 0.0 108.064 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -118.58 0.98 11.65 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.909 2.883 . . . . 0.0 110.917 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 111.38 7.08 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.731 1.213 . . . . 0.0 109.182 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -141.19 127.77 20.13 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.737 0.815 . . . . 0.0 111.164 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.4 m -75.96 103.16 5.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.169 2.188 . . . . 0.0 109.229 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.7 t -70.15 147.34 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 166.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -135.96 174.49 10.55 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.046 1.339 . . . . 0.0 113.591 -168.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.09 6.07 82.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.117 1.817 . . . . 0.0 114.718 168.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 mt -74.48 171.96 12.83 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.17 1.788 . . . . 0.0 111.111 -168.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.0 142.77 29.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 126.011 1.724 . . . . 0.0 108.567 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.76 156.57 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 109.461 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 40.51 48.07 2.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.089 1.756 . . . . 0.0 111.958 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.5 m -133.64 132.73 41.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.918 1.687 . . . . 0.0 106.761 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.27 146.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.96 157.15 46.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 160.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 70.7 mt -107.35 157.13 18.19 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 127.504 2.322 . . . . 0.0 106.271 158.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -138.5 146.23 41.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 126.195 2.185 . . . . 0.0 107.862 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.1 mtm -142.53 152.51 42.7 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.13 144.04 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 125.366 1.466 . . . . 0.0 107.187 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -128.65 139.87 52.04 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.89 149.14 25.02 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.53 145.29 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.218 1.007 . . . . 0.0 109.889 -177.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -150.46 177.24 1.92 Allowed Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 109.109 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.69 67.24 8.48 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.072 2.514 . . . . 0.0 110.135 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -163.88 -73.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.835 2.854 . . . . 0.0 104.637 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.53 -164.34 12.09 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 126.136 1.827 . . . . 0.0 110.93 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.6 pp -101.14 151.59 21.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.13 1.372 . . . . 0.0 108.381 172.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.4 p -72.67 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.179 1.792 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -50.66 150.29 5.13 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.368 158.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.33 161.0 45.1 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.316 1.344 . . . . 0.0 111.106 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 91.8 p -55.57 167.61 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.258 163.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.52 144.25 10.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 121.66 1.573 . . . . 0.0 110.484 151.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 22.4 mtm -64.65 144.86 56.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.442 0.697 . . . . 0.0 109.789 171.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -63.99 -9.55 16.46 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 127.187 2.195 . . . . 0.0 113.736 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 77.56 155.28 0.14 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 128.808 2.843 . . . . 0.0 108.792 -160.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -73.14 117.94 5.33 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.591 2.194 . . . . 0.0 108.53 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 m -116.48 135.1 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.956 1.302 . . . . 0.0 110.083 -175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 142.37 27.77 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.5 p -73.46 159.33 33.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.428 1.585 . . . . 0.0 109.495 162.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -66.27 175.04 2.32 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.955 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -74.18 157.69 35.49 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 111.623 -2.535 . . . . 0.0 110.086 163.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.409 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 6.2 t -85.6 48.96 1.67 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.869 1.668 . . . . 0.0 109.101 169.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -115.8 159.54 13.78 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.963 2.221 . . . . 0.0 110.04 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.91 164.74 33.57 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.721 2.281 . . . . 0.0 111.377 -171.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.0 m -153.26 -54.86 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.491 1.117 . . . . 0.0 108.538 166.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.3 m 55.57 18.84 2.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.46 1.104 . . . . 0.0 113.615 -172.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.343 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 177.934 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.407 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 m -134.93 85.02 2.14 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.965 0.882 . . . . 0.0 109.26 -170.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -152.76 3.9 0.34 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.47 72.07 0.66 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.4 t -54.23 121.66 8.67 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.662 1.585 . . . . 0.0 111.439 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -61.26 -57.54 11.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.572 0.749 . . . . 0.0 111.075 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 -69.52 1.11 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.26 -1.3 . . . . 0.0 110.372 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 40.07 80.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.747 2.819 . . . . 0.0 111.646 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -141.32 179.97 6.47 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.925 1.69 . . . . 0.0 107.335 171.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -143.26 123.16 13.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.314 1.446 . . . . 0.0 109.214 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.01 155.19 34.88 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.572 1.549 . . . . 0.0 108.682 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.39 78.47 9.64 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 125.863 1.665 . . . . 0.0 107.385 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -139.83 153.08 46.97 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.797 0.839 . . . . 0.0 110.485 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -101.87 17.8 22.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.686 2.394 . . . . 0.0 109.762 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt -98.78 162.69 20.8 Favored Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 119.799 -1.813 . . . . 0.0 110.556 -174.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -61.76 164.8 15.22 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.765 2.31 . . . . 0.0 111.806 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.17 126.61 28.79 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 164.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.95 154.49 61.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.215 1.943 . . . . 0.0 111.82 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -80.06 173.16 13.0 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.457 2.771 . . . . 0.0 111.236 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -66.61 170.13 6.74 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.702 -0.624 . . . . 0.0 111.373 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -49.9 124.41 16.54 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 150.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 150.1 74.77 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 121.203 1.269 . . . . 0.0 109.178 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -111.78 124.29 52.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.65 142.46 16.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.353 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.5 p -122.01 -87.63 0.63 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.92 134.59 38.9 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 109.049 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.77 138.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 119.099 0.863 . . . . 0.0 109.697 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -126.87 -162.21 1.13 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.998 1.719 . . . . 0.0 107.861 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -77.18 -29.06 54.21 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 121.192 -0.943 . . . . 0.0 111.075 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -150.87 14.57 0.73 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.199 0.909 . . . . 0.0 111.955 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -127.27 163.08 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.782 159.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.78 146.86 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.692 1.597 . . . . 0.0 107.38 169.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.9 m -102.07 149.43 24.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.469 1.508 . . . . 0.0 109.084 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.38 148.46 51.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.261 2.624 . . . . 0.0 107.535 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -139.94 114.71 9.47 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.515 1.134 . . . . 0.0 108.998 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.6 p90 -134.87 153.11 52.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.903 0.774 . . . . 0.0 111.217 -176.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -93.48 140.9 23.3 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.49 148.29 18.27 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 124.096 3.197 . . . . 0.0 108.987 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.76 -178.05 52.21 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 122.27 0.928 . . . . 0.0 111.632 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -55.12 153.95 11.44 Favored Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.957 2.103 . . . . 0.0 108.444 158.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 -114.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.143 3.229 . . . . 0.0 108.51 162.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.4 -109.81 0.42 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 164.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.8 p -60.35 -35.3 75.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.729 2.012 . . . . 0.0 111.819 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 mt -132.63 169.24 14.46 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.849 1.66 . . . . 0.0 109.07 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.48 155.74 14.16 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.507 2.805 . . . . 0.0 109.271 168.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 160.46 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.551 0.691 . . . . 0.0 109.656 171.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -117.81 -43.37 2.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.074 1.75 . . . . 0.0 109.822 -175.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.0 -172.27 1.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.468 1.107 . . . . 0.0 109.592 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.417 ' HB2' HG22 ' A' ' 69' ' ' VAL . 12.4 m-85 -116.78 165.6 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.729 1.612 . . . . 0.0 107.961 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.88 154.04 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 129.361 3.064 . . . . 0.0 104.833 168.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 82.2 mt -129.29 135.9 60.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 166.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.84 156.51 29.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.17 157.87 45.69 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.032 1.333 . . . . 0.0 108.193 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.96 163.11 35.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.915 1.686 . . . . 0.0 109.81 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -156.75 -38.69 0.08 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -161.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 64.09 -22.46 0.07 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.71 2.404 . . . . 0.0 116.585 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.25 -24.45 11.5 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 121.036 1.744 . . . . 0.0 112.109 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -69.9 -77.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 120.209 1.368 . . . . 0.0 109.418 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -135.49 22.91 3.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.511 1.125 . . . . 0.0 111.535 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 t30 23.22 60.23 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 C-N-CA 129.367 3.067 . . . . 0.0 112.815 176.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.7 m -165.74 158.61 15.42 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.674 1.989 . . . . 0.0 108.952 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 67.3 m95 -72.46 123.85 23.96 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 162.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -113.24 139.17 49.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -83.41 94.36 7.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 m -82.33 -19.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.366 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.62 143.31 32.34 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.14 0.976 . . . . 0.0 108.488 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.91 157.2 47.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.338 0.655 . . . . 0.0 109.553 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m170 52.71 32.78 12.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.45 1.5 . . . . 0.0 111.922 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' A' ' 49' ' ' TYR . 3.2 m -74.39 154.28 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.326 1.06 . . . . 0.0 110.229 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -134.73 54.14 1.96 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -148.6 176.41 10.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.585 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 p -117.41 -3.04 11.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.441 1.497 . . . . 0.0 111.698 169.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.23 133.55 47.58 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.068 1.347 . . . . 0.0 108.949 166.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -146.48 146.31 30.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -108.09 97.85 7.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.919 1.688 . . . . 0.0 108.904 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.95 134.83 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -128.16 171.82 11.57 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.285 0.634 . . . . 0.0 112.028 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.13 50.95 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.99 1.281 . . . . 0.0 112.994 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.1 mt -83.32 -166.84 1.47 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.743 1.217 . . . . 0.0 109.51 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.9 mtt85 -121.45 143.72 38.42 Favored Pre-proline 0 CA--C 1.517 -0.326 0 C-N-CA 124.422 1.089 . . . . 0.0 109.502 176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.95 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.481 2.787 . . . . 0.0 111.822 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 55.02 3.83 0.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.016 2.526 . . . . 0.0 116.24 -176.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.2 m -101.3 130.66 47.5 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.34 1.856 . . . . 0.0 108.746 -166.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 mm -68.71 147.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.27 165.3 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.654 1.181 . . . . 0.0 108.928 168.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -117.39 157.95 25.29 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 125.53 1.532 . . . . 0.0 108.121 162.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -143.07 131.43 22.15 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 125.298 1.624 . . . . 0.0 109.283 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.463 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 5.4 mtt -115.67 173.31 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.89 151.8 35.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -138.65 121.9 17.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.15 118.95 25.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.14 148.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 108.996 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.76 173.6 4.21 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.773 1.629 . . . . 0.0 108.632 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.99 23.58 0.4 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.119 2.546 . . . . 0.0 113.658 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -130.38 -17.45 3.35 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.839 1.656 . . . . 0.0 113.919 173.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.47 9.4 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 123.909 0.766 . . . . 0.0 112.371 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 pp -129.81 144.7 51.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.229 1.812 . . . . 0.0 107.768 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -72.33 159.37 34.14 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 109.737 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -48.86 132.31 14.65 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.084 0.954 . . . . 0.0 110.388 -172.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -51.04 113.96 1.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.112 3.208 . . . . 0.0 111.49 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 p -52.67 159.23 1.8 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.648 0.779 . . . . 0.0 112.832 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -52.26 144.14 40.17 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.863 3.042 . . . . 0.0 111.073 163.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.5 mtp -67.28 144.43 55.91 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.506 0.722 . . . . 0.0 112.619 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.3 p -65.7 -5.19 7.84 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.818 2.447 . . . . 0.0 116.1 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.46 144.64 0.1 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.139 1.776 . . . . 0.0 111.024 -165.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.58 106.84 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.166 2.578 . . . . 0.0 110.849 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.9 m -105.0 140.61 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.383 1.473 . . . . 0.0 109.965 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -87.15 -174.4 4.87 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.524 0.73 . . . . 0.0 109.98 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.0 p -130.99 158.23 40.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.364 1.866 . . . . 0.0 107.195 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -68.38 173.29 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.825 0.821 . . . . 0.0 110.039 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -80.32 160.34 25.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.94 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 t -111.09 -8.87 14.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.31 2.644 . . . . 0.0 110.736 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -76.77 -177.7 45.26 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.715 1.15 . . . . 0.0 111.45 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.63 62.84 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.131 3.221 . . . . 0.0 108.915 165.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.2 m -50.73 113.04 0.8 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.893 2.077 . . . . 0.0 111.117 -166.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.1 p -154.3 176.06 12.76 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 125.162 1.385 . . . . 0.0 109.968 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.027 0 N-CA-C 104.723 -3.351 . . . . 0.0 104.723 -167.743 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 161.14 24.23 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 111.606 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.53 141.81 30.29 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 162.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -69.48 162.42 42.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.421 2.081 . . . . 0.0 113.031 -168.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.37 168.34 9.75 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.194 2.596 . . . . 0.0 112.825 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -74.83 169.97 16.84 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 110.199 168.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -56.22 134.23 75.27 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 167.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.37 164.9 16.41 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 CA-C-O 124.04 1.6 . . . . 0.0 112.697 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -105.25 172.12 6.96 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 128.909 2.884 . . . . 0.0 106.644 162.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -123.75 137.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.119 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.9 p -124.32 -90.66 0.56 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.699 0.625 . . . . 0.0 110.646 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.94 138.71 42.52 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 125.343 1.457 . . . . 0.0 107.914 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.47 155.05 22.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.48 1.037 . . . . 0.0 110.046 163.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -137.33 -159.88 1.0 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.208 1.403 . . . . 0.0 108.039 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -65.1 -31.61 72.9 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.545 167.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -152.54 1.66 0.32 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -113.66 152.55 30.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.178 0.899 . . . . 0.0 108.919 162.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -147.87 148.44 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.4 m -110.31 133.83 52.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.16 140.03 48.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.356 1.863 . . . . 0.0 107.004 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.76 135.17 49.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 174.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -138.72 171.57 14.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 120.582 1.537 . . . . 0.0 108.628 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.71 142.77 25.66 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.609 1.164 . . . . 0.0 108.7 168.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.4 170.49 20.11 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.769 2.313 . . . . 0.0 112.707 -161.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.47 -175.6 22.93 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 164.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.53 149.19 71.09 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.84 -179.81 5.54 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.652 2.901 . . . . 0.0 113.13 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.36 -99.02 0.15 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -57.83 -51.95 67.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.452 1.901 . . . . 0.0 110.565 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.61 166.26 25.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 124.271 1.028 . . . . 0.0 110.278 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.93 167.51 25.06 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.292 3.328 . . . . 0.0 109.382 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.51 25.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.962 1.705 . . . . 0.0 109.04 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -94.54 -57.23 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.326 1.051 . . . . 0.0 109.713 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.61 -171.24 2.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.269 0.94 . . . . 0.0 108.932 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.39 164.9 16.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -118.03 159.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.85 2.06 . . . . 0.0 106.484 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -124.2 134.31 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 158.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.32 160.98 15.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 166.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.84 162.38 34.13 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.328 1.851 . . . . 0.0 107.313 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -148.07 141.0 24.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -155.79 121.36 4.93 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.71 -34.84 74.99 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.24 0.543 . . . . 0.0 111.693 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.08 17.22 3.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.11 2.564 . . . . 0.0 114.033 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.2 -73.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 t -147.7 146.54 29.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.59 -0.31 2.75 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.173 1.389 . . . . 0.0 113.681 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -102.62 155.67 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.974 2.51 . . . . 0.0 111.882 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -74.74 136.05 41.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 153.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.19 155.16 49.82 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.112 0.869 . . . . 0.0 110.528 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.97 130.65 43.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.296 1.438 . . . . 0.0 107.801 170.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.6 -6.75 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.058 1.343 . . . . 0.0 112.149 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.52 152.73 36.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 149.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -135.81 140.88 44.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.127 1.371 . . . . 0.0 108.421 -172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.45 43.77 29.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.661 1.184 . . . . 0.0 111.863 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.77 126.17 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 126.136 1.774 . . . . 0.0 107.161 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -108.2 15.2 24.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.798 0.839 . . . . 0.0 112.17 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -129.45 175.31 8.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.773 1.629 . . . . 0.0 109.306 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.5 p -112.42 -5.73 14.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.538 2.335 . . . . 0.0 111.545 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -135.73 123.18 22.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -145.9 121.14 10.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.859 0.754 . . . . 0.0 112.31 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.4 m -69.84 103.66 2.26 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.682 1.993 . . . . 0.0 110.241 164.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 76' ' ' VAL . 9.9 t -60.9 148.64 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 126.936 2.094 . . . . 0.0 107.932 158.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -140.2 175.32 9.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.055 1.342 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.47 7.68 87.08 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 123.803 0.716 . . . . 0.0 114.455 165.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.73 -171.66 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.62 1.168 . . . . 0.0 109.039 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -113.05 132.89 22.16 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -59.23 156.46 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.544 2.163 . . . . 0.0 112.28 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.1 t30 41.57 33.63 0.32 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.718 2.807 . . . . 0.0 113.78 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.8 m -120.66 135.73 55.03 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.386 1.874 . . . . 0.0 106.831 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.16 148.6 8.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.825 0.85 . . . . 0.0 109.081 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -141.36 149.49 41.21 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.733 1.213 . . . . 0.0 110.62 171.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -107.72 160.83 15.41 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.371 162.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.04 144.45 33.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 124.753 1.283 . . . . 0.0 108.521 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 62.0 mtm -130.45 153.49 48.72 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.08 148.27 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HD3' HD22 ' A' ' 97' ' ' LEU . 3.0 mtt180 -131.9 136.14 47.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.755 1.222 . . . . 0.0 108.249 176.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 152.13 22.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.82 148.15 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.005 2.122 . . . . 0.0 109.141 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -148.5 178.04 1.59 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 109.239 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.48 -2.68 2.72 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.602 2.868 . . . . 0.0 117.117 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -129.54 -17.42 3.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.393 1.451 . . . . 0.0 113.582 -167.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.33 -176.79 45.96 Favored Glycine 0 C--O 1.238 0.357 0 CA-C-N 119.527 1.058 . . . . 0.0 111.209 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.424 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.97 151.69 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 157.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 83.1 p -71.47 168.79 16.76 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.867 1.267 . . . . 0.0 110.102 168.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -42.07 149.04 0.45 Allowed Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.849 153.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.15 164.27 36.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.809 1.672 . . . . 0.0 110.952 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.2 p -67.14 167.07 15.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 159.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.57 149.89 4.36 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.257 1.971 . . . . 0.0 112.363 151.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.0 mtm -65.36 143.15 57.93 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.43 0.692 . . . . 0.0 111.405 166.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.2 t -54.01 -23.12 12.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.175 2.19 . . . . 0.0 113.621 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.54 154.14 0.13 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 127.055 2.142 . . . . 0.0 110.193 -162.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -68.89 110.05 2.28 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.384 2.723 . . . . 0.0 111.554 -159.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -75.4 162.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.64 133.52 54.98 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 163.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.4 p -62.67 169.34 3.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 166.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -81.91 -116.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t0 . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.359 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -63.0 158.18 44.84 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.47 2.113 . . . . 0.0 110.85 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.92 143.08 48.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.2 152.93 79.96 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.877 1.718 . . . . 0.0 110.645 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -64.15 171.8 7.16 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.929 2.42 . . . . 0.0 111.646 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -74.12 174.56 8.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.623 0.769 . . . . 0.0 110.255 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -55.74 135.62 72.0 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.034 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.91 124.62 10.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.745 1.302 . . . . 0.0 109.95 160.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.64 171.46 12.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.636 161.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 107' ' ' VAL . 62.0 t -125.31 136.54 60.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 p -126.33 -66.59 0.91 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.812 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -104.69 139.48 39.46 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.937 0.895 . . . . 0.0 109.097 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.14 142.75 24.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 119.677 1.126 . . . . 0.0 110.147 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 p -130.41 -176.31 3.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.263 1.825 . . . . 0.0 109.107 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -63.86 -17.77 63.49 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 120.868 -1.145 . . . . 0.0 113.307 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.34 13.13 1.08 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 120.357 -1.464 . . . . 0.0 113.113 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.76 160.39 40.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.231 0.923 . . . . 0.0 110.421 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.18 129.09 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.512 0.725 . . . . 0.0 109.284 170.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -81.05 120.39 24.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.196 0.998 . . . . 0.0 108.345 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -90.34 157.1 17.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.961 1.305 . . . . 0.0 109.116 166.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -149.01 99.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.13 0.972 . . . . 0.0 109.071 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.564 ' CH2' HD11 ' A' ' 51' ' ' ILE . 29.4 p90 -105.44 161.63 14.16 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.777 0.831 . . . . 0.0 109.083 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -95.45 147.55 33.2 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 165.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.19 171.77 16.18 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.79 2.993 . . . . 0.0 111.94 -167.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.42 177.48 33.48 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 168.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.503 HG23 ' HD2' ' A' ' 41' ' ' PRO . 2.8 m -107.57 157.69 35.14 Favored Pre-proline 0 N--CA 1.443 -0.793 0 C-N-CA 127.75 2.42 . . . . 0.0 109.874 -174.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 40' ' ' THR . 40.1 Cg_endo -71.42 -159.96 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 125.014 3.809 . . . . 0.0 113.073 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.38 -123.05 0.8 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 170.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 p -72.35 -27.62 62.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.981 1.712 . . . . 0.0 112.415 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 mt -136.33 149.23 67.17 Favored Pre-proline 0 C--O 1.24 0.56 0 C-N-CA 123.311 0.644 . . . . 0.0 112.244 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.54 163.94 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.541 3.494 . . . . 0.0 110.891 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.75 141.5 28.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -112.77 -32.53 6.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.007 1.723 . . . . 0.0 112.198 -168.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.87 -162.03 0.67 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 159.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.12 165.09 14.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.306 1.443 . . . . 0.0 108.384 157.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -116.71 152.56 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.736 2.414 . . . . 0.0 105.288 164.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.564 HD11 ' CH2' ' A' ' 36' ' ' TRP . 83.2 mt -127.59 135.18 63.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 166.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -121.16 159.4 25.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -137.87 161.52 36.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.131 1.372 . . . . 0.0 108.246 174.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -138.87 135.89 34.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.762 ' HB3' HG22 ' A' ' 58' ' ' VAL . 5.1 t -115.98 149.29 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.581 1.082 . . . . 0.0 108.123 155.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -80.53 16.26 1.41 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.966 0.506 . . . . 0.0 111.001 162.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -132.35 10.99 4.51 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.542 -1.349 . . . . 0.0 110.417 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 55' ' ' SER 0.311 34.8 m -121.84 -91.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.381 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.596 ' H ' HG23 ' A' ' 58' ' ' VAL . 10.9 m -119.32 5.32 11.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 121.436 1.925 . . . . 0.0 113.179 -175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.28 21.19 1.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.783 1.633 . . . . 0.0 112.925 -171.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.4 m -122.17 163.98 18.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.579 3.151 . . . . 0.0 108.896 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.77 144.88 25.6 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 165.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -138.24 143.14 39.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.33 96.0 1.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.423 1.089 . . . . 0.0 108.178 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 53' ' ' ALA . 33.0 m -82.9 -16.95 11.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 121.86 -0.525 . . . . 0.0 110.969 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.95 134.53 22.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 162.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -121.01 136.67 54.93 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 52.6 69.93 0.63 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.746 2.019 . . . . 0.0 112.418 -171.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.0 129.87 39.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.579 1.552 . . . . 0.0 107.575 168.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -117.42 38.13 3.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.428 1.091 . . . . 0.0 110.573 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -151.75 -178.49 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.044 1.738 . . . . 0.0 107.515 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p -113.23 -2.52 14.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.095 2.558 . . . . 0.0 111.9 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.93 139.7 46.31 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -146.66 140.94 26.36 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.1 m -94.18 102.57 14.6 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 174.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.87 135.99 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -130.82 178.85 6.35 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.42 1.088 . . . . 0.0 110.778 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.01 6.68 74.32 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.93 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.4 mt -72.17 -176.72 1.87 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.625 1.212 . . . . 0.0 110.381 -172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.4 mtp85 -108.51 149.83 39.87 Favored Pre-proline 0 CA--C 1.513 -0.471 0 C-N-CA 125.25 1.42 . . . . 0.0 108.608 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.42 154.52 24.45 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.873 1.715 . . . . 0.0 111.638 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.62 16.99 0.34 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.894 2.078 . . . . 0.0 114.373 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.9 m -102.11 133.01 47.64 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.123 2.169 . . . . 0.0 108.354 -172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.7 mm -70.04 148.43 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.54 158.27 44.06 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.52 164.99 12.0 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.647 1.179 . . . . 0.0 108.437 160.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.56 145.67 33.83 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.722 1.889 . . . . 0.0 109.643 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.3 mtm -135.42 162.84 31.48 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.732 1.213 . . . . 0.0 107.916 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.64 143.27 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.787 2.035 . . . . 0.0 105.817 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.577 ' HD3' HD13 ' A' ' 97' ' ' LEU . 27.3 mtt85 -132.6 138.85 47.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 124.57 33.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -86.4 152.82 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.812 1.245 . . . . 0.0 108.518 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.88 168.02 11.84 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.513 1.925 . . . . 0.0 109.066 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.69 -9.87 8.19 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.391 3.394 . . . . 0.0 117.05 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -111.48 -43.26 3.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.462 1.505 . . . . 0.0 110.141 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.08 -149.65 6.21 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 119.063 0.847 . . . . 0.0 111.074 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.577 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -129.85 158.98 37.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.662 1.585 . . . . 0.0 108.7 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.1 p -71.89 167.09 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 111.308 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -47.26 151.15 1.33 Allowed Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 154.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.7 148.19 52.39 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.431 1.421 . . . . 0.0 110.338 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.4 p -50.46 151.99 3.55 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.023 163.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -47.41 122.52 6.76 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.942 1.762 . . . . 0.0 107.88 153.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.8 ttm -58.11 148.67 25.79 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 124.212 1.005 . . . . 0.0 109.871 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.5 p -60.38 162.5 6.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 123.047 1.403 . . . . 0.0 109.471 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.63 154.53 68.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.658 164.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.68 92.6 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.198 2.599 . . . . 0.0 111.846 -175.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 24' ' ' VAL . 2.2 m -84.17 163.44 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.525 1.53 . . . . 0.0 109.482 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.91 146.35 47.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 125.385 1.474 . . . . 0.0 109.006 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -61.58 161.7 9.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 159.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -75.75 178.32 6.21 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 168.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.833 0.825 . . . . 0.0 110.494 177.82 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -59.27 156.12 36.88 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.678 2.252 . . . . 0.0 112.12 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.37 120.84 21.76 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 153.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.08 161.51 44.51 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.235 2.623 . . . . 0.0 111.103 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.38 158.16 57.0 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.282 1.988 . . . . 0.0 110.712 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -71.21 175.16 5.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.918 0.487 . . . . 0.0 110.835 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 103' ' ' MET . 83.8 tttt -53.54 120.83 23.71 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 104' ' ' SER . 8.4 Cg_endo -66.5 149.44 84.42 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 120.715 1.291 . . . . 0.0 109.374 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -79.21 170.94 15.89 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 161.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.0 t -122.68 121.61 63.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 129.151 2.981 . . . . 0.0 104.506 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.254 82.1 p -119.21 -84.81 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.859 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.71 150.07 37.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.106 1.321 . . . . 0.0 108.274 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.98 152.6 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.493 0.717 . . . . 0.0 109.769 163.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.4 p -141.21 -172.45 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 108.869 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -57.89 -37.08 73.33 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.141 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -136.19 17.21 3.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.866 1.666 . . . . 0.0 112.14 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -151.37 161.33 42.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.551 -1.343 . . . . 0.0 110.175 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.01 140.85 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.72 145.5 47.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.536 1.934 . . . . 0.0 107.522 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.68 114.47 9.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.446 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.492 ' CE2' ' HA ' ' A' ' 72' ' ' THR . 39.2 p90 -123.3 171.32 9.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.997 1.272 . . . . 0.0 110.208 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -97.87 144.98 28.98 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 165.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.24 133.3 24.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.192 3.261 . . . . 0.0 107.669 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.67 -178.54 43.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -62.1 152.95 76.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.069 1.348 . . . . 0.0 110.157 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.82 -148.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.911 3.741 . . . . 0.0 109.843 167.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -125.44 0.76 Allowed Glycine 0 C--N 1.333 0.4 0 O-C-N 118.941 -2.349 . . . . 0.0 109.478 163.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.3 p -49.78 -35.88 24.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.642 2.377 . . . . 0.0 110.112 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 59.9 mt -135.75 170.03 12.11 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 127.642 2.377 . . . . 0.0 109.495 -168.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 62.3 Cg_endo -78.48 170.07 18.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.896 3.064 . . . . 0.0 110.003 169.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.23 22.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 m -53.49 -49.45 67.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.28 2.632 . . . . 0.0 111.919 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.15 -162.2 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.126 0.97 . . . . 0.0 108.594 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -131.92 168.81 17.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.056 1.742 . . . . 0.0 107.752 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.0 165.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 129.266 3.027 . . . . 0.0 106.622 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.11 136.08 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 162.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -114.31 161.72 17.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.327 1.051 . . . . 0.0 108.314 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.76 150.19 36.81 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.125 1.37 . . . . 0.0 109.086 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -127.3 141.13 51.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.347 1.459 . . . . 0.0 107.533 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -144.85 136.65 25.67 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 153.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.85 -37.36 81.81 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.932 165.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -76.31 16.33 0.48 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.066 2.146 . . . . 0.0 113.966 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.51 -77.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 125.324 1.45 . . . . 0.0 107.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.15 21.19 0.97 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.898 0.479 . . . . 0.0 110.287 -176.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 36.66 51.02 0.87 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.687 2.395 . . . . 0.0 111.885 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -143.37 143.48 31.67 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -66.51 136.83 56.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 153.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.97 145.25 39.51 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.896 1.278 . . . . 0.0 107.624 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.08 125.53 24.77 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.36 -6.37 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.278 1.031 . . . . 0.0 112.243 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.93 151.33 33.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 154.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -132.92 150.45 52.16 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 44.32 64.46 1.31 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.163 1.785 . . . . 0.0 110.683 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.77 -28.45 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.319 1.848 . . . . 0.0 112.067 -161.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mttt 60.62 15.18 5.51 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.581 2.352 . . . . 0.0 114.172 163.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -137.42 -177.66 4.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.229 1.412 . . . . 0.0 108.063 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 36' ' ' TRP . 23.6 p -124.96 0.33 7.95 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.917 1.687 . . . . 0.0 111.351 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.71 112.2 10.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -145.58 151.5 38.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.059 0.845 . . . . 0.0 111.376 -175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -103.71 102.19 12.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.134 1.774 . . . . 0.0 109.06 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.41 139.73 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.559 1.544 . . . . 0.0 107.719 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -133.71 -170.25 2.46 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.814 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.6 73.49 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.668 -0.518 . . . . 0.0 112.688 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.41 -166.68 1.66 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.055 0.928 . . . . 0.0 109.346 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -116.44 155.13 48.92 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 126.706 2.002 . . . . 0.0 108.472 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.57 156.74 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.901 2.4 . . . . 0.0 111.835 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.8 t30 43.31 37.02 1.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.299 2.239 . . . . 0.0 112.712 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.3 m -121.89 131.25 53.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.992 1.717 . . . . 0.0 107.403 -174.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.2 mm -69.06 149.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.903 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -140.3 149.02 42.27 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.028 0.918 . . . . 0.0 111.289 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.92 162.58 13.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.129 156.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.85 166.71 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.707 1.88 . . . . 0.0 110.465 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 17.5 mtt -134.14 168.68 18.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 157.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.11 109.32 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.744 ' HD3' HD13 ' A' ' 97' ' ' LEU . 50.6 mtt180 -90.76 140.69 29.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.7 148.17 26.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.98 147.6 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 165.34 17.65 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -174.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.3 -20.89 71.43 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.457 1.438 . . . . 0.0 115.199 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.7 -38.66 11.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.398 1.479 . . . . 0.0 111.503 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.44 -149.7 6.28 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 118.905 0.775 . . . . 0.0 111.537 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.744 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -123.71 156.63 35.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.351 1.861 . . . . 0.0 106.424 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.4 p -76.05 167.39 21.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.621 0.768 . . . . 0.0 112.741 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.22 164.77 0.57 Allowed Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 122.055 -0.403 . . . . 0.0 111.116 161.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.12 127.43 6.02 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.709 2.273 . . . . 0.0 110.452 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.8 p -49.07 155.45 1.12 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 111.678 163.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -59.18 123.88 14.4 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.901 2.401 . . . . 0.0 108.698 164.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.423 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 4.3 mpp? -55.59 124.62 17.94 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.448 1.022 . . . . 0.0 109.933 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.441 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 73.0 p -54.68 -16.03 2.23 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.889 2.475 . . . . 0.0 115.356 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 92.04 146.5 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.421 1 C-N-CA 132.607 4.363 . . . . 0.0 109.575 168.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.29 107.81 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.394 2.729 . . . . 0.0 111.211 -153.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.47 169.52 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -126.8 148.14 49.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.71 1.604 . . . . 0.0 108.086 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.7 p -76.64 167.81 21.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.805 0.812 . . . . 0.0 110.966 166.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -77.32 178.25 7.28 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.719 -0.613 . . . . 0.0 110.119 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 123.945 0.898 . . . . 0.0 110.423 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.76 141.02 77.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.446 1.431 . . . . 0.0 109.775 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.34 138.75 45.44 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 163.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.36 153.49 55.87 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.276 1.984 . . . . 0.0 111.918 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.71 161.74 40.43 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.488 1.459 . . . . 0.0 110.343 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -77.48 173.82 11.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.105 0.562 . . . . 0.0 109.744 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -51.99 125.31 31.33 Favored Pre-proline 0 C--O 1.239 0.518 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.487 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.54 135.82 47.44 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.699 1.6 . . . . 0.0 109.78 169.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -91.37 134.47 34.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.841 1.256 . . . . 0.0 108.197 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.49 143.61 15.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 167.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 p -127.51 -97.45 0.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.84 135.69 56.8 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 126.05 1.74 . . . . 0.0 109.152 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.71 148.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.5 1.045 . . . . 0.0 110.654 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -137.82 -169.72 2.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.622 1.569 . . . . 0.0 109.547 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -57.55 -41.17 80.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.377 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -136.58 12.63 3.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.298 0.954 . . . . 0.0 112.481 -169.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -141.82 158.43 43.81 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.472 1.033 . . . . 0.0 110.336 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.97 134.14 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.318 1.047 . . . . 0.0 108.782 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -85.6 130.32 34.6 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 108.984 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.9 mt -109.49 146.12 35.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.003 1.721 . . . . 0.0 107.835 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.657 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.82 102.34 3.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.778 1.299 . . . . 0.0 107.993 -163.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.552 ' CH2' HD11 ' A' ' 51' ' ' ILE . 36.3 p90 -119.87 158.76 25.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.062 0.846 . . . . 0.0 110.986 -175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -81.77 134.94 49.5 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 164.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.3 157.76 56.14 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.868 3.045 . . . . 0.0 109.008 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.58 -176.62 35.58 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.752 1.168 . . . . 0.0 111.653 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 150.57 68.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.073 1.349 . . . . 0.0 109.855 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.11 -167.66 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 125.237 3.958 . . . . 0.0 112.54 169.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.61 -109.39 0.25 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 169.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 p -66.63 -46.09 76.94 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.105 2.162 . . . . 0.0 111.17 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' A' ' 94' ' ' PRO . 49.1 mt -128.46 162.27 51.92 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 124.14 0.976 . . . . 0.0 109.793 -164.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.14 145.28 27.51 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 108.159 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.84 158.38 25.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 -47.99 1.98 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.101 -170.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.23 -166.26 0.88 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -128.78 162.04 28.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.155 1.782 . . . . 0.0 109.217 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.84 152.19 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 128.733 2.813 . . . . 0.0 106.718 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.552 HD11 ' CH2' ' A' ' 36' ' ' TRP . 95.2 mt -137.94 105.22 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -101.04 136.67 40.51 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.743 1.217 . . . . 0.0 108.755 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.72 165.21 12.01 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.015 1.326 . . . . 0.0 109.258 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -137.89 145.26 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.804 1.242 . . . . 0.0 107.85 170.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -154.46 119.79 5.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -66.22 -19.06 65.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.63 12.77 22.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.019 0.928 . . . . 0.0 111.37 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.22 -59.82 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -158.86 137.56 11.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.384 1.874 . . . . 0.0 108.079 171.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.03 -17.51 63.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.001 0.819 . . . . 0.0 111.617 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 m -68.3 143.28 55.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.611 -0.68 . . . . 0.0 109.548 169.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -67.15 144.83 55.82 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -125.67 118.18 25.09 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 m -74.93 93.43 2.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.25 -17.67 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 0.0 111.076 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.28 149.47 34.92 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.97 147.97 42.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.477 1.911 . . . . 0.0 106.216 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.43 ' O ' ' HE2' ' A' ' 70' ' ' LYS . 8.9 m170 57.99 51.2 9.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.04 0.936 . . . . 0.0 111.211 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.2 t -82.61 139.11 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.389 1.476 . . . . 0.0 107.335 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 68' ' ' HIS . 3.5 mtmt -119.15 25.36 10.21 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.62 1.168 . . . . 0.0 112.243 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.2 t -143.93 173.2 11.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.177 0.991 . . . . 0.0 108.828 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -103.56 2.51 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.127 2.171 . . . . 0.0 112.042 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.657 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 4.7 tp -140.04 114.83 9.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.972 1.709 . . . . 0.0 107.425 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -145.65 120.97 10.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 118.148 0.431 . . . . 0.0 111.9 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.7 m -66.8 101.4 0.81 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.485 1.914 . . . . 0.0 109.08 164.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.92 144.83 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 162.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 50.7 mtt-85 -136.91 178.58 6.97 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.23 1.412 . . . . 0.0 110.502 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.56 80.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 123.5 0.571 . . . . 0.0 112.557 170.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.08 -172.75 4.33 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.704 0.752 . . . . 0.0 110.291 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -114.25 146.62 36.17 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 125.563 1.545 . . . . 0.0 107.811 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.71 154.12 30.39 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.492 2.128 . . . . 0.0 110.374 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.62 44.95 17.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.664 1.186 . . . . 0.0 111.465 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.9 m -131.13 136.26 48.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 mm -74.15 146.65 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.189 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.87 148.65 48.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.052 0.845 . . . . 0.0 109.457 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.25 161.02 15.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.617 -1.174 . . . . 0.0 107.899 158.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -143.85 143.12 31.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 126.001 2.063 . . . . 0.0 107.814 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 13.2 mtm -136.67 125.65 24.33 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 129.209 3.004 . . . . 0.0 107.479 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.1 t -94.59 145.78 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.434 ' HD3' HD13 ' A' ' 97' ' ' LEU . 35.1 mtt180 -131.63 128.6 39.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 167.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 125.12 33.97 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.27 148.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.549 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -135.77 179.81 1.27 Allowed Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.221 1.809 . . . . 0.0 107.403 166.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HG2' HD13 ' A' ' 44' ' ' LEU . 88.2 Cg_endo -74.67 -0.1 9.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 122.4 1.893 . . . . 0.0 113.812 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -116.72 -37.91 3.57 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.981 1.312 . . . . 0.0 110.301 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.26 -141.39 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.434 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -142.9 159.52 42.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.753 2.421 . . . . 0.0 106.729 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.0 p -72.05 166.61 21.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.333 0.653 . . . . 0.0 110.244 -169.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.31 148.42 3.28 Favored Pre-proline 0 C--O 1.244 0.771 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 160.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.33 130.17 20.63 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.923 1.749 . . . . 0.0 108.631 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -54.62 161.73 2.05 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.119 0.568 . . . . 0.0 111.817 165.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.93 138.14 69.36 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.342 2.028 . . . . 0.0 110.649 159.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -58.64 150.24 23.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.913 0.779 . . . . 0.0 109.999 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 88.2 p -63.14 -4.58 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.25 149.87 0.11 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.935 1.694 . . . . 0.0 110.808 -163.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.01 99.02 1.13 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.134 1.889 . . . . 0.0 112.636 -164.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.46 155.22 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.432 0.693 . . . . 0.0 109.167 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -108.1 150.95 26.53 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.108 1.363 . . . . 0.0 109.901 166.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.4 p -77.7 167.95 20.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.789 0.804 . . . . 0.0 111.407 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -77.45 178.82 6.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.275 0.63 . . . . 0.0 109.943 169.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 109.404 170.952 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.43 149.6 84.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.434 2.089 . . . . 0.0 111.26 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -51.79 134.25 35.36 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.88 154.71 72.79 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.996 1.898 . . . . 0.0 111.361 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -60.81 168.55 6.92 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.743 2.295 . . . . 0.0 111.772 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.86 171.67 12.27 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -61.22 144.47 91.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.58 129.1 19.3 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.496 1.464 . . . . 0.0 111.337 161.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -81.64 158.18 24.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.017 2.127 . . . . 0.0 109.218 158.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.99 121.19 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.337 -1.756 . . . . 0.0 107.141 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.1 p -116.2 -95.67 0.47 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.329 -167.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.27 143.28 41.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.6 1.56 . . . . 0.0 109.653 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.37 148.96 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.719 0.808 . . . . 0.0 110.685 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 p -135.8 -168.33 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.399 1.48 . . . . 0.0 108.021 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -71.11 -16.32 62.56 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.444 -1.41 . . . . 0.0 112.642 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -152.36 15.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.099 -1.626 . . . . 0.0 112.633 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -139.43 161.85 36.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.46 140.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.446 1.499 . . . . 0.0 108.111 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -92.74 126.47 37.84 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.33 1.052 . . . . 0.0 108.642 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -107.35 139.8 41.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.133 1.773 . . . . 0.0 107.363 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -134.64 138.69 44.7 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 51' ' ' ILE . 14.1 p90 -139.32 171.19 14.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.199 0.523 . . . . 0.0 111.474 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -98.87 148.83 35.1 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.24 161.49 17.67 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.546 2.831 . . . . 0.0 111.44 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.1 -173.3 49.56 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 165.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.41 171.78 11.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.158 1.383 . . . . 0.0 108.588 169.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.31 -156.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.151 3.234 . . . . 0.0 109.565 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.9 -131.75 2.75 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 167.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -55.53 -27.58 49.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.942 2.097 . . . . 0.0 112.118 164.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 51.9 mt -144.58 162.39 39.28 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 127.612 2.365 . . . . 0.0 109.543 -156.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 92.6 Cg_endo -76.37 158.34 36.84 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.091 3.194 . . . . 0.0 110.989 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.68 128.9 41.67 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.96 -27.53 10.12 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.129 0.572 . . . . 0.0 111.508 -165.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.75 -165.97 1.64 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 160.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -128.83 169.74 14.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.785 2.034 . . . . 0.0 109.354 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.75 157.1 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 127.608 2.363 . . . . 0.0 107.214 171.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.492 HD11 ' CH2' ' A' ' 36' ' ' TRP . 55.9 mt -125.43 133.08 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 165.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -113.4 158.42 20.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.78 146.68 46.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.368 1.067 . . . . 0.0 108.223 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -109.34 146.88 33.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 166.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.53 124.94 5.21 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.677 0.671 . . . . 0.0 109.346 170.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.54 -34.97 72.86 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -169.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 7.41 11.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.85 0.75 . . . . 0.0 112.276 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.5 t -121.68 -55.34 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.717 1.207 . . . . 0.0 107.944 -171.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 t -141.31 -98.3 0.14 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 p30 140.49 -17.18 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.778 2.831 . . . . 0.0 111.119 -149.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -119.02 150.98 39.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.294 1.038 . . . . 0.0 110.187 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -70.6 121.86 18.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -118.84 143.52 46.9 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.323 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.92 93.95 3.3 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.66 -15.43 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.084 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.08 152.38 30.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.103 0.961 . . . . 0.0 108.944 161.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -142.93 170.24 16.07 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.762 0.825 . . . . 0.0 111.355 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 51.97 38.19 23.08 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.915 0.864 . . . . 0.0 112.422 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.65 127.84 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 125.845 1.658 . . . . 0.0 108.449 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -113.34 29.96 7.58 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.701 0.801 . . . . 0.0 112.253 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -150.47 173.6 13.88 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 108.305 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -98.48 2.9 48.12 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.658 2.383 . . . . 0.0 112.186 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.28 117.1 10.98 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.583 1.083 . . . . 0.0 110.325 -176.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -146.1 151.41 37.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.545 0.738 . . . . 0.0 111.591 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -101.19 103.4 14.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.142 1.377 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.1 139.21 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -139.93 176.07 9.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 111.386 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.77 79.59 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.63 0.633 . . . . 0.0 112.35 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.42 -175.79 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.489 0.715 . . . . 0.0 110.403 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -98.16 145.06 29.16 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.043 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -75.61 159.38 39.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.73 2.953 . . . . 0.0 111.686 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.6 t30 45.54 38.13 3.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.645 1.978 . . . . 0.0 111.842 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.2 m -132.18 134.13 45.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.538 1.135 . . . . 0.0 108.817 -170.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.34 141.52 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.09 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -139.17 154.48 48.08 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 125.056 1.473 . . . . 0.0 108.077 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.25 165.69 11.31 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.051 1.34 . . . . 0.0 108.302 164.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -137.28 140.07 41.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.952 0.782 . . . . 0.0 109.953 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 28.2 mtm -118.86 167.71 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 161.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.94 155.82 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -133.78 141.66 47.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 165.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.54 142.81 27.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 165.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.74 147.07 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 124.492 1.117 . . . . 0.0 109.243 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.81 171.2 6.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.95 22.64 0.47 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 123.683 2.922 . . . . 0.0 114.929 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -131.55 -34.3 1.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.905 1.682 . . . . 0.0 111.201 172.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.14 -165.26 33.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.515 1.052 . . . . 0.0 111.035 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -98.5 148.55 23.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 p -73.07 166.42 23.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.1 143.76 15.8 Favored Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 126.823 2.049 . . . . 0.0 110.301 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.99 127.77 22.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.858 1.705 . . . . 0.0 113.07 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -54.37 160.68 2.4 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.669 1.988 . . . . 0.0 112.666 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.94 120.79 8.74 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.136 1.891 . . . . 0.0 109.354 156.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 ptp -77.58 151.76 34.29 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 120.194 1.361 . . . . 0.0 109.182 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.4 t -58.95 154.47 15.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.464 1.106 . . . . 0.0 109.402 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.48 150.02 57.7 Favored Pre-proline 0 N--CA 1.475 0.792 0 O-C-N 120.874 -1.141 . . . . 0.0 109.465 158.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.09 102.98 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.104 2.536 . . . . 0.0 110.905 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.03 163.29 3.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -122.07 141.66 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.986 1.314 . . . . 0.0 107.655 164.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 p -68.07 161.08 27.58 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -66.74 -175.27 0.38 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.995 1.379 . . . . 0.0 109.205 163.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.065 -174.819 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 119.421 -0.323 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.02 150.57 83.51 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.285 1.99 . . . . 0.0 108.872 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.37 147.97 41.61 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 163.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.52 147.1 63.67 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.143 1.896 . . . . 0.0 111.431 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -66.0 165.14 24.85 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.411 2.074 . . . . 0.0 110.528 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.2 p -67.71 169.39 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.787 -0.571 . . . . 0.0 110.763 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -48.62 127.65 13.54 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.538 155.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.48 142.82 45.67 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.787 1.317 . . . . 0.0 110.261 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.43 161.4 26.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.53 1.532 . . . . 0.0 109.351 163.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -124.35 105.21 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -110.65 -62.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.838 1.655 . . . . 0.0 111.124 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -111.02 136.0 50.69 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.216 1.807 . . . . 0.0 110.738 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.26 150.39 17.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 119.855 1.207 . . . . 0.0 110.588 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.5 p -139.88 -174.54 3.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.345 1.858 . . . . 0.0 107.818 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -24.77 61.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.385 -1.447 . . . . 0.0 112.461 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -131.81 4.65 4.2 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.167 1.349 . . . . 0.0 110.959 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 m -150.78 163.61 38.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.525 1.511 . . . . 0.0 110.356 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 p -156.74 136.76 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.145 1.378 . . . . 0.0 108.155 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -80.3 140.72 36.04 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -114.55 150.05 35.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 t -138.16 134.68 34.85 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.447 1.099 . . . . 0.0 108.515 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -138.98 170.23 16.35 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 110.387 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.32 138.08 25.8 Favored Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 164.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.66 140.45 47.08 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.99 3.127 . . . . 0.0 107.62 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 163.07 43.35 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 41' ' ' PRO . 3.0 m -73.3 143.36 82.95 Favored Pre-proline 0 N--CA 1.433 -1.308 0 C-N-CA 126.009 1.723 . . . . 0.0 110.938 -164.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.488 ' O ' HG22 ' A' ' 40' ' ' THR . 61.2 Cg_endo -71.53 -169.13 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.438 3.426 . . . . 0.0 111.758 166.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.82 -114.09 0.54 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 163.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -47.05 -40.68 15.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.763 2.825 . . . . 0.0 112.607 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 mt -134.7 163.24 52.58 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.273 1.029 . . . . 0.0 109.277 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.62 171.31 15.9 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.664 2.909 . . . . 0.0 110.809 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.03 107.14 16.91 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.253 1.021 . . . . 0.0 109.064 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' HG22 ' A' ' 92' ' ' ILE . 14.4 m -58.91 -51.4 70.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.144 2.578 . . . . 0.0 112.388 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.0 -164.88 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.973 -1.079 . . . . 0.0 108.191 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.72 164.23 24.44 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.9 2.08 . . . . 0.0 108.63 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mt -120.34 154.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 127.131 2.172 . . . . 0.0 106.563 161.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.62 124.97 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 156.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -100.78 151.92 21.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.61 151.38 51.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -123.47 151.0 43.18 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -140.53 136.17 32.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -56.85 -50.84 71.21 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.599 163.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -73.7 25.37 0.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.04 2.936 . . . . 0.0 113.469 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -135.7 -62.55 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.43 -5.38 0.66 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -165.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t30 46.63 36.52 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.372 1.469 . . . . 0.0 111.931 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.8 m -149.97 157.85 43.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 128.412 2.685 . . . . 0.0 105.187 -169.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.91 154.02 21.15 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -136.34 146.03 46.1 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.8 m -71.32 128.5 36.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.16 -12.36 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.18 74.94 0.93 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.347 1.859 . . . . 0.0 108.834 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.71 144.64 29.23 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.21 2.604 . . . . 0.0 109.185 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.403 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 57.8 m-70 38.32 60.81 1.23 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.911 2.085 . . . . 0.0 111.8 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.53 145.56 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -128.17 40.68 3.63 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.17 1.388 . . . . 0.0 110.355 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -148.0 -176.93 5.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -114.99 2.31 14.21 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.675 2.79 . . . . 0.0 110.991 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mp -135.43 143.85 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.531 0.733 . . . . 0.0 109.271 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -146.26 129.74 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 m -71.6 94.49 1.33 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.377 1.471 . . . . 0.0 107.515 161.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.97 138.02 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.99 179.82 6.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.917 1.287 . . . . 0.0 110.045 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.42 22.15 79.07 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.862 -0.41 . . . . 0.0 112.38 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt -87.0 172.36 10.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.576 1.179 . . . . 0.0 110.087 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 mtt85 -103.4 149.73 37.3 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 125.668 1.587 . . . . 0.0 107.345 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.11 160.02 40.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.779 1.653 . . . . 0.0 110.338 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 t30 46.5 33.15 1.85 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.018 1.327 . . . . 0.0 111.633 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.8 m -119.99 126.91 52.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.59 148.19 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.208 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -139.92 146.65 39.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.289 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.92 156.69 18.92 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 160.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -137.33 146.7 44.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.683 1.865 . . . . 0.0 107.816 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 45.0 mtm -134.53 137.84 44.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 160.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.95 139.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.551 ' HD3' HD22 ' A' ' 97' ' ' LEU . 73.6 mtt180 -120.43 146.53 46.12 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 168.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 163.97 16.49 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.2 OUTLIER -126.46 150.86 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 126.665 1.986 . . . . 0.0 108.806 174.539 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.85 169.91 9.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 0.0 110.165 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.98 19.24 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.06 2.506 . . . . 0.0 114.982 -174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -127.85 -58.71 1.22 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 126.288 1.835 . . . . 0.0 110.091 166.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.66 -173.36 17.82 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 121.836 0.686 . . . . 0.0 113.983 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.1 mp -81.69 157.08 24.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.6 p -71.64 168.43 17.71 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.875 0.87 . . . . 0.0 109.757 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -41.6 142.19 1.07 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 151.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.59 156.15 64.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.676 1.584 . . . . 0.0 109.346 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 p -68.59 166.53 25.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.891 -0.505 . . . . 0.0 110.296 164.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -54.58 146.53 53.08 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 111.17 163.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.9 mtm -60.2 144.85 49.08 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.29 0.496 . . . . 0.0 110.14 171.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.0 p -62.93 -11.39 18.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.238 1.815 . . . . 0.0 115.175 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 t0 69.62 156.46 0.15 Allowed Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.411 -153.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -76.07 101.15 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.411 2.074 . . . . 0.0 111.375 -173.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.27 165.45 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -127.34 141.05 51.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.559 2.344 . . . . 0.0 107.612 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.6 p -74.39 161.14 30.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.044 0.838 . . . . 0.0 109.527 163.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -67.22 165.66 15.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.745 0.783 . . . . 0.0 109.896 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.5 t0 . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 123.608 1.67 . . . . 0.0 112.498 -172.16 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.93 164.91 30.89 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.22 2.613 . . . . 0.0 111.457 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.97 149.65 49.5 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.75 141.01 44.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.334 2.689 . . . . 0.0 110.857 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -65.74 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.689 1.593 . . . . 0.0 110.203 170.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m -79.96 171.19 15.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -57.25 122.1 51.93 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.099 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.97 156.41 62.67 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.5 1.466 . . . . 0.0 109.358 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.75 124.68 43.91 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.88 151.24 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.787 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 p -136.53 -75.65 0.43 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.541 0.736 . . . . 0.0 109.47 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.12 135.46 37.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.77 157.19 20.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 162.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -141.13 -64.97 0.44 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -168.24 -39.25 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.208 2.203 . . . . 0.0 107.414 171.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -129.22 5.04 5.26 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.916 0.886 . . . . 0.0 110.863 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -152.5 152.17 31.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.592 0.633 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -153.59 127.31 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.8 m -77.98 148.09 34.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 87' ' ' PHE . 70.2 mt -128.35 138.97 52.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 126.647 1.979 . . . . 0.0 108.256 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -134.3 94.91 3.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.789 1.306 . . . . 0.0 110.74 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -109.26 170.72 7.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.901 0.858 . . . . 0.0 111.225 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -101.53 140.09 20.95 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 166.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.01 171.19 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.521 2.814 . . . . 0.0 109.26 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.75 -130.44 2.48 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.619 -2.193 . . . . 0.0 107.619 160.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.08 165.77 20.72 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 125.177 1.391 . . . . 0.0 107.916 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.84 -147.68 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.991 1 C-N-CA 125.892 4.395 . . . . 0.0 110.201 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.16 -91.68 0.12 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -62.78 -52.97 61.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 126.136 1.774 . . . . 0.0 109.928 172.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.6 mt -133.69 163.9 47.86 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 110.818 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.52 174.27 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.968 3.112 . . . . 0.0 110.856 167.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.85 108.1 19.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -54.82 -53.06 60.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.489 2.315 . . . . 0.0 111.913 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.08 -166.36 1.69 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 0.0 107.255 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -131.03 160.27 35.08 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.622 1.969 . . . . 0.0 107.929 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mt -118.73 156.19 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.12 2.168 . . . . 0.0 107.564 167.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.8 128.51 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -148.23 139.15 23.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.648 1.179 . . . . 0.0 107.84 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.89 129.96 55.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.326 1.45 . . . . 0.0 108.149 170.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.5 112.93 8.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.14 -20.66 60.87 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 3.45 26.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.357 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.04 -80.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.252 1.821 . . . . 0.0 106.695 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -133.12 -5.41 3.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.932 0.787 . . . . 0.0 112.888 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 54.57 42.93 30.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.934 0.873 . . . . 0.0 111.497 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.8 m -140.64 152.39 45.36 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 127.161 2.184 . . . . 0.0 106.946 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.475 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 93.0 m95 -72.17 132.84 44.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 157.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -125.54 151.78 45.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.352 1.461 . . . . 0.0 107.294 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.64 127.68 33.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.1 -3.67 10.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.641 0.776 . . . . 0.0 111.23 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . . . -154.1 126.82 8.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.766 1.627 . . . . 0.0 108.454 168.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -115.06 139.89 49.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.767 0.827 . . . . 0.0 110.02 165.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.6 m80 50.32 69.9 0.57 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.148 2.579 . . . . 0.0 114.637 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.7 141.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -124.2 32.67 5.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.904 0.882 . . . . 0.0 112.029 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.32 165.18 27.88 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -90.34 0.48 57.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.81 1.644 . . . . 0.0 112.595 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -132.5 133.06 43.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 108.78 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 76.2 t80 -146.72 152.17 38.38 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 127.197 2.199 . . . . 0.0 109.17 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -111.25 112.95 25.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.084 1.354 . . . . 0.0 108.626 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.7 t -66.22 143.57 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.64 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -136.25 -175.09 3.87 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.671 0.788 . . . . 0.0 110.723 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.87 17.93 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.509 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.7 mt -85.79 -163.39 0.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.676 1.238 . . . . 0.0 109.112 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -135.84 139.42 30.57 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.59 158.49 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.431 2.754 . . . . 0.0 111.121 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 48.64 31.31 2.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.235 1.814 . . . . 0.0 113.251 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.5 m -124.44 136.38 53.99 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.518 1.527 . . . . 0.0 108.396 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.6 mm -76.58 148.04 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 124.637 1.175 . . . . 0.0 109.413 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -139.54 153.93 47.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.64 2.376 . . . . 0.0 106.335 171.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 11.2 mt -112.64 157.0 21.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.359 1.463 . . . . 0.0 107.918 154.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.459 ' CD2' HD21 ' A' ' 34' ' ' LEU . 31.1 m-85 -127.03 157.99 38.14 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.692 1.997 . . . . 0.0 110.013 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.475 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 20.0 mtt -128.71 155.89 44.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.85 2.06 . . . . 0.0 106.634 164.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.9 t -122.3 141.81 41.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 162.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.841 ' HD3' HD13 ' A' ' 97' ' ' LEU . 83.2 mtt-85 -132.34 146.29 51.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.07 156.96 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.46 152.74 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 127.217 2.207 . . . . 0.0 107.226 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.3 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.297 1.039 . . . . 0.0 110.263 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -59.67 2.87 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.996 3.131 . . . . 0.0 116.463 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -127.91 -37.8 1.89 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.952 1.701 . . . . 0.0 112.018 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.28 -150.49 8.45 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -170.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.841 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.5 pp -124.71 157.33 35.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 97' ' ' LEU . 89.1 p -72.5 166.48 22.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.164 0.986 . . . . 0.0 111.598 -174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -44.61 152.97 0.49 Allowed Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 156.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.14 142.07 49.61 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.239 1.959 . . . . 0.0 110.895 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 94.0 p -60.04 165.41 4.86 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.181 0.592 . . . . 0.0 111.131 156.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.2 141.65 94.06 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 158.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.66 147.68 45.08 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.678 -1.264 . . . . 0.0 111.777 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 p -57.31 -18.16 15.58 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.598 2.759 . . . . 0.0 116.381 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 88.06 150.74 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 128.613 2.765 . . . . 0.0 107.156 -153.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.2 109.14 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.98 2.454 . . . . 0.0 108.709 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.2 127.72 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.218 1.007 . . . . 0.0 109.539 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 140.59 30.04 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.8 p -64.19 164.84 10.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -78.75 -175.99 4.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 122.302 1.049 . . . . 0.0 108.426 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.697 164.652 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 119.376 -0.345 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.96 150.45 38.35 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.774 2.316 . . . . 0.0 109.799 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 159.57 53.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.148 1.356 . . . . 0.0 112.381 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.14 124.32 12.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.145 2.563 . . . . 0.0 109.784 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.56 165.77 14.9 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.73 2.287 . . . . 0.0 112.456 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -70.42 162.13 29.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.567 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -56.38 121.91 46.01 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.687 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.88 142.76 94.38 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.59 1.527 . . . . 0.0 111.119 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -122.42 131.91 54.11 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.179 1.392 . . . . 0.0 110.102 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.588 HG11 HG11 ' A' ' 107' ' ' VAL . 2.2 m -80.27 142.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.104 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 p -135.64 -42.18 0.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.814 -166.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.28 145.33 48.33 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.794 1.238 . . . . 0.0 108.42 166.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.37 151.38 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.449 1.099 . . . . 0.0 108.099 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -125.24 -43.03 1.96 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -168.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 pttt 143.34 -27.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 1 C-N-CA 133.719 4.808 . . . . 0.0 110.071 -174.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -138.94 -4.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.101 1.76 . . . . 0.0 109.995 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.01 156.47 47.79 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.823 2.049 . . . . 0.0 106.937 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -154.37 128.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.6 m -80.42 137.05 36.46 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.1 mt -125.82 146.39 49.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 126.576 1.95 . . . . 0.0 106.925 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.6 116.96 11.28 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 125.15 1.531 . . . . 0.0 108.263 -166.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.587 ' CH2' HD11 ' A' ' 51' ' ' ILE . 49.3 p90 -139.03 156.91 46.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.453 1.024 . . . . 0.0 109.55 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.47 144.87 29.42 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.097 0.559 . . . . 0.0 109.96 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.65 117.68 3.72 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.594 2.862 . . . . 0.0 110.841 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 174.99 30.72 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 124.734 1.159 . . . . 0.0 110.391 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.3 m -61.65 153.69 69.63 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 129.091 2.956 . . . . 0.0 110.781 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.96 -173.23 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.239 2.626 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.11 -160.87 9.41 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 104.578 -3.409 . . . . 0.0 104.578 160.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.38 -50.03 63.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.141 -1.529 . . . . 0.0 109.69 166.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.32 161.58 32.35 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.689 1.131 . . . . 0.0 112.203 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.96 153.11 9.82 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 124.384 3.389 . . . . 0.0 110.23 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.91 37.8 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.896 0.855 . . . . 0.0 111.138 170.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.11 -59.93 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.406 1.482 . . . . 0.0 107.798 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.67 -170.47 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.382 1.073 . . . . 0.0 109.045 -165.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -111.9 163.17 14.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.391 1.876 . . . . 0.0 108.269 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.22 152.12 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.573 2.349 . . . . 0.0 107.099 157.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.587 HD11 ' CH2' ' A' ' 36' ' ' TRP . 85.4 mt -132.29 108.38 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -99.89 158.95 15.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.53 150.88 44.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.758 2.023 . . . . 0.0 107.742 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -128.01 150.25 50.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.69 117.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.995 0.902 . . . . 0.0 110.54 171.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -67.1 -36.45 81.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.432 -0.793 . . . . 0.0 111.465 -173.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -71.9 5.98 2.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.114 2.166 . . . . 0.0 113.685 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.56 -69.36 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.4 m -158.83 121.05 3.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.221 2.208 . . . . 0.0 105.471 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -72.18 82.42 1.0 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.593 0.633 . . . . 0.0 109.72 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -170.47 159.26 6.84 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.535 2.734 . . . . 0.0 107.524 168.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -76.69 142.35 40.57 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 161.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -130.71 139.64 50.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.278 1.431 . . . . 0.0 107.943 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -88.46 94.07 9.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.5 -15.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.691 1.196 . . . . 0.0 113.044 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . -142.48 149.73 39.58 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 156.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.88 154.07 51.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 62.32 29.11 17.25 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.8 134.43 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 120.698 -1.252 . . . . 0.0 108.193 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -106.16 -8.49 17.37 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.81 -174.44 3.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.009 1.723 . . . . 0.0 109.297 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.8 p -120.57 0.97 10.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.364 1.866 . . . . 0.0 111.929 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -130.64 137.91 49.83 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.261 -0.899 . . . . 0.0 108.72 161.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.16 145.47 30.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.765 0.711 . . . . 0.0 109.084 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.0 m -89.21 106.67 18.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.072 1.749 . . . . 0.0 108.578 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.33 151.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.334 1.054 . . . . 0.0 108.223 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -135.6 -176.16 4.19 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.494 1.518 . . . . 0.0 110.777 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.41 7.64 85.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.968 1.27 . . . . 0.0 114.004 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.56 -177.49 6.55 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 123.148 1.451 . . . . 0.0 110.238 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -118.54 151.04 49.19 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 126.49 1.916 . . . . 0.0 108.422 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.74 156.64 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.385 2.723 . . . . 0.0 109.929 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 53.58 26.14 5.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.788 1.235 . . . . 0.0 111.854 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.1 m -119.68 129.19 54.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.115 1.766 . . . . 0.0 107.758 -170.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.84 144.98 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.69 153.7 47.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 109.178 168.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.08 162.3 14.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.074 1.35 . . . . 0.0 107.506 160.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -139.69 135.18 32.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 125.099 1.499 . . . . 0.0 107.889 172.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.4 mtm -124.45 135.16 53.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.97 144.37 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.606 ' HD3' HD22 ' A' ' 97' ' ' LEU . 6.3 mtp180 -120.9 150.99 40.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 160.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 165.15 15.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.47 152.41 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 127.232 2.213 . . . . 0.0 108.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.92 178.17 1.78 Allowed Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.888 0.875 . . . . 0.0 111.329 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.67 -4.06 1.72 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.586 3.524 . . . . 0.0 117.905 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -130.45 -37.18 1.41 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.402 1.455 . . . . 0.0 111.394 -170.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.83 -170.84 34.75 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -168.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.606 HD22 ' HD3' ' A' ' 90' ' ' ARG . 2.2 mp -97.89 166.16 11.59 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.469 1.108 . . . . 0.0 109.046 166.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 91.4 p -72.08 167.73 19.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.665 0.786 . . . . 0.0 110.07 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -48.81 150.56 2.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.051 -0.405 . . . . 0.0 110.153 153.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.7 132.98 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.745 2.297 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.8 p -59.03 168.83 1.33 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.8 0.84 . . . . 0.0 112.66 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.13 136.35 37.8 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.374 2.716 . . . . 0.0 112.237 161.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 149.73 33.49 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.974 0.806 . . . . 0.0 109.583 165.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 76.5 p -60.31 -9.43 3.46 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.593 1.957 . . . . 0.0 115.89 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.6 147.0 0.11 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.073 2.149 . . . . 0.0 109.604 -155.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.21 118.83 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.677 2.251 . . . . 0.0 110.066 -168.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.588 HG11 HG11 ' A' ' 24' ' ' VAL . 1.5 m -114.45 131.58 66.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.882 1.273 . . . . 0.0 110.457 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 145.21 31.7 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 p -71.37 168.41 17.47 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.53 0.732 . . . . 0.0 110.829 162.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -65.39 -167.86 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.018 1.39 . . . . 0.0 110.1 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 113.516 -163.328 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -67.18 169.65 14.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.373 2.049 . . . . 0.0 110.922 167.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.38 168.06 49.69 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.38 1.467 . . . . 0.0 112.124 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.61 132.69 31.73 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.109 2.54 . . . . 0.0 108.844 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.09 165.37 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.7 1.6 . . . . 0.0 111.817 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.02 163.54 27.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.303 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 11.0 tmtt? -50.29 119.04 10.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.135 171.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -67.21 160.14 48.91 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 CA-C-N 120.082 1.065 . . . . 0.0 110.47 172.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -135.93 125.89 25.94 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.963 2.105 . . . . 0.0 107.975 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 107' ' ' VAL . 9.2 m -69.13 149.27 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.6 p -134.06 -41.45 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.427 0.691 . . . . 0.0 110.169 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -123.44 145.09 49.08 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 109.146 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.82 145.82 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 119.758 1.163 . . . . 0.0 108.552 164.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.2 p -134.11 -169.12 2.25 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.533 1.133 . . . . 0.0 108.913 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -66.51 -16.49 64.17 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 120.857 -1.152 . . . . 0.0 113.35 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -156.35 6.2 0.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -123.64 160.07 27.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.201 1.364 . . . . 0.0 111.297 165.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.59 136.85 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -96.61 142.13 29.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.1 mt -134.74 133.79 40.3 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.073 1.749 . . . . 0.0 108.255 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 6.9 t -118.96 130.23 55.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 129.371 3.068 . . . . 0.0 108.311 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -139.12 170.94 15.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -104.87 148.59 36.35 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 162.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.58 160.66 44.96 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.202 2.601 . . . . 0.0 109.703 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.02 174.15 43.75 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -57.64 155.02 22.74 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 126.466 1.906 . . . . 0.0 110.074 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.86 -175.86 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.525 2.817 . . . . 0.0 111.892 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.02 -147.45 7.94 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 105.575 -3.01 . . . . 0.0 105.575 168.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -33.84 64.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 165.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.38 157.42 33.75 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 123.181 0.593 . . . . 0.0 112.052 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.88 150.28 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.794 3.662 . . . . 0.0 110.034 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 125.58 28.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.383 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -73.45 -49.21 28.06 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.436 172.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 68' ' ' HIS . . . -161.18 -165.18 1.28 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.434 1.015 . . . . 0.0 110.184 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.89 161.55 32.76 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.831 0.852 . . . . 0.0 109.943 167.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -118.84 158.26 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 128.203 2.601 . . . . 0.0 106.806 167.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mt -126.02 129.24 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 163.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -105.89 153.86 21.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.231 1.412 . . . . 0.0 108.112 171.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.1 127.68 20.12 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.493 1.517 . . . . 0.0 110.209 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -91.74 149.35 21.65 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.233 1.413 . . . . 0.0 107.772 169.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.22 113.56 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.338 1.066 . . . . 0.0 112.477 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.35 -38.56 81.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 112.844 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 m -73.87 8.43 2.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.943 1.297 . . . . 0.0 113.382 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.49 -72.54 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 124.268 1.027 . . . . 0.0 108.895 -168.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.1 t -150.38 12.88 0.74 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.631 0.772 . . . . 0.0 110.058 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 61.02 -79.73 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.593 2.357 . . . . 0.0 111.753 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.57 162.11 0.04 OUTLIER 'General case' 0 C--O 1.234 0.26 0 C-N-CA 129.664 3.186 . . . . 0.0 114.895 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 94.9 m95 -67.79 138.28 56.05 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -124.54 142.56 51.25 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -72.73 107.21 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -95.68 -28.28 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 0.0 111.655 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 138.07 31.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 135.47 41.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.44 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 10.9 m-70 50.04 68.83 0.69 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.798 2.039 . . . . 0.0 110.923 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.4 t -84.97 -53.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.93 1.292 . . . . 0.0 113.623 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 mttt 66.21 -23.66 0.1 Allowed 'General case' 0 C--N 1.316 -0.884 1 C-N-CA 131.79 4.036 . . . . 0.0 115.578 170.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -71.42 173.09 8.35 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.388 1.449 . . . . 0.0 108.607 168.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.04 -4.71 20.17 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.958 168.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 5.4 tp -121.17 131.71 54.4 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 121.596 1.998 . . . . 0.0 110.211 160.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -134.61 152.8 52.04 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.283 1.033 . . . . 0.0 109.432 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -112.77 101.07 9.18 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.355 1.862 . . . . 0.0 107.203 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.98 143.56 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 162.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -139.01 178.93 6.8 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.36 1.864 . . . . 0.0 108.2 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 24.29 67.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.414 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.1 mt -82.1 -173.54 4.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.624 1.17 . . . . 0.0 109.772 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -112.22 141.9 25.9 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 117.694 -1.146 . . . . 0.0 109.228 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.79 157.47 61.62 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.21 1.94 . . . . 0.0 112.156 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 41.62 42.64 2.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.477 1.911 . . . . 0.0 112.339 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.4 m -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.252 1.421 . . . . 0.0 107.817 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.57 147.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.73 155.63 46.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.038 167.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.77 163.12 13.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.87 132.38 26.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.43 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 41.0 mtm -131.4 165.6 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 123.895 0.747 . . . . 0.0 109.338 161.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.5 t -132.21 140.36 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.976 1.71 . . . . 0.0 107.284 -166.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.489 ' HD3' HD22 ' A' ' 97' ' ' LEU . 13.1 mtt180 -132.1 132.03 42.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.5 118.67 26.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.34 145.7 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' A' ' 47' ' ' SER . 1.9 p-10 -141.52 173.84 4.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.712 1.205 . . . . 0.0 108.096 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -73.26 31.63 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.34 2.693 . . . . 0.0 114.075 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -134.04 -67.83 0.58 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.325 1.85 . . . . 0.0 106.657 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.55 -148.26 4.73 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.914 1.245 . . . . 0.0 112.159 -167.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.489 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.4 mt -122.7 142.21 50.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.539 3.136 . . . . 0.0 106.398 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.9 p -72.33 166.96 21.45 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.359 0.6 . . . . 0.0 112.116 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -60.35 158.0 31.39 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 124.568 1.147 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.22 122.59 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.944 1.762 . . . . 0.0 111.983 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 p -60.5 157.79 34.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.454 1.501 . . . . 0.0 111.784 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 128.66 24.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.812 3.008 . . . . 0.0 110.506 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.8 mtt -56.27 150.66 14.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.082 1.764 . . . . 0.0 111.451 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.499 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 1.5 p -69.9 -1.61 10.03 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 81.82 155.54 0.12 Allowed Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 131.119 3.768 . . . . 0.0 108.874 -167.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.61 117.6 5.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.279 2.653 . . . . 0.0 109.171 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 24' ' ' VAL . 2.7 m -116.97 144.68 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 123.599 0.76 . . . . 0.0 109.385 -171.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -104.32 138.51 40.66 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 123.38 0.672 . . . . 0.0 109.925 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -67.29 169.06 9.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.969 168.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -82.73 175.7 9.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.733 0.778 . . . . 0.0 110.007 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.749 164.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -60.0 142.63 98.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.381 2.721 . . . . 0.0 110.473 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.02 142.64 38.31 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 161.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.18 145.95 96.13 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.179 1.919 . . . . 0.0 110.187 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -64.68 157.96 52.93 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.72 1.613 . . . . 0.0 109.987 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -68.47 166.48 16.76 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.222 0.609 . . . . 0.0 110.37 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -46.03 121.83 5.98 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.21 1.004 . . . . 0.0 109.242 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -60.26 146.29 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -113.28 125.14 53.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.219 1.408 . . . . 0.0 109.007 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 107' ' ' VAL . 19.8 t -80.58 112.54 18.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -102.31 -82.7 0.48 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.6 139.37 40.61 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -137.33 145.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 p -125.88 -173.58 2.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.183 0.993 . . . . 0.0 108.613 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -14.87 53.74 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -163.57 26.47 0.08 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.092 1.315 . . . . 0.0 112.939 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -146.93 161.87 39.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 107.982 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -158.26 136.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.126 0.97 . . . . 0.0 108.482 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -91.13 110.94 22.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.033 1.333 . . . . 0.0 107.942 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -93.11 140.84 29.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.805 1.242 . . . . 0.0 109.224 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.656 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.61 99.21 3.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.612 1.195 . . . . 0.0 108.887 -163.312 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -119.05 172.81 7.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.532 1.133 . . . . 0.0 109.674 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -118.79 145.57 38.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.99 143.9 29.63 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.671 2.914 . . . . 0.0 110.779 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.47 175.68 52.84 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 170.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -62.18 146.15 92.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.884 1.274 . . . . 0.0 109.167 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.13 -168.7 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.953 3.769 . . . . 0.0 112.42 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.31 -149.51 5.54 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -37.81 68.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.562 1.145 . . . . 0.0 110.673 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 7.1 mt -111.95 167.31 9.32 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.714 0.806 . . . . 0.0 111.913 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 61.0 Cg_endo -73.88 -130.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 124.628 3.552 . . . . 0.0 108.299 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.6 161.8 24.01 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 127.669 2.388 . . . . 0.0 106.622 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -105.84 -35.38 7.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.132 2.173 . . . . 0.0 110.502 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.74 -159.42 0.08 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.744 1.217 . . . . 0.0 109.626 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 91' ' ' ALA . 84.6 m-85 -128.82 169.24 14.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.445 2.298 . . . . 0.0 108.161 162.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.76 155.15 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.051 2.94 . . . . 0.0 106.031 167.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.5 mt -122.54 132.8 70.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -118.17 158.31 25.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.32 46.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 109.979 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -131.28 168.17 17.98 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.093 2.557 . . . . 0.0 105.833 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.6 t -144.12 -42.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.898 1.226 . . . . 0.0 113.676 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 115.95 -48.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.437 1 C-N-CA 133.234 4.614 . . . . 0.0 108.652 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -87.41 -36.68 17.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.533 0.733 . . . . 0.0 111.786 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.71 -62.17 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 123.591 0.757 . . . . 0.0 109.066 -159.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -160.26 98.81 1.3 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.5 -9.63 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.5 m -39.73 -39.6 0.8 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 129.122 2.969 . . . . 0.0 116.366 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.8 m95 61.34 140.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.16 1.384 . . . . 0.0 111.299 -138.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -134.11 152.9 52.04 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 134.21 50.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 165.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.0 -8.76 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.33 0.652 . . . . 0.0 111.616 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.94 138.46 17.71 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.158 1.783 . . . . 0.0 107.258 158.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -116.18 158.31 23.48 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m170 51.47 51.67 16.3 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.844 1.307 . . . . 0.0 112.218 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.87 110.69 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 127.112 2.165 . . . . 0.0 106.629 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -106.58 52.04 0.73 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.243 1.417 . . . . 0.0 108.203 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -158.39 -171.98 3.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.926 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.4 p -127.78 -3.75 5.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.967 1.307 . . . . 0.0 112.25 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -125.75 121.12 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.863 1.665 . . . . 0.0 107.476 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -145.35 117.51 8.37 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.445 0.64 . . . . 0.0 111.365 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -71.89 98.53 2.03 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.408 2.283 . . . . 0.0 108.802 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.6 143.69 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -136.77 172.69 12.64 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.538 1.535 . . . . 0.0 109.208 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.94 2.96 58.18 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.045 1.307 . . . . 0.0 113.055 170.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.8 mt -78.14 178.2 7.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 117.691 0.745 . . . . 0.0 109.607 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -96.67 146.74 31.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.203 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.64 158.79 46.88 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.376 2.717 . . . . 0.0 111.146 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.39 21.75 1.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.166 2.587 . . . . 0.0 112.876 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -119.28 121.37 39.48 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mm -59.27 147.44 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -138.51 152.83 48.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.582 162.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 103' ' ' MET . 36.4 mt -107.08 156.04 19.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.106 163.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -141.78 133.45 27.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.451 1.719 . . . . 0.0 107.843 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 15.5 mtt -112.34 156.09 23.04 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.526 2.331 . . . . 0.0 106.903 170.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.76 113.09 31.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 167.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.785 ' HD3' HD13 ' A' ' 97' ' ' LEU . 35.9 mtt180 -97.47 147.72 23.95 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.29 -1.506 . . . . 0.0 107.203 167.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 98' ' ' SER . . . -86.7 158.33 19.46 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.69 152.49 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 126.118 1.767 . . . . 0.0 107.323 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -139.97 172.71 5.94 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 127.186 2.195 . . . . 0.0 108.576 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 -19.15 27.72 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.807 2.338 . . . . 0.0 113.352 166.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -115.58 -11.13 11.77 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.63 -160.88 29.54 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.785 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.6 pp -113.09 162.7 15.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.892 1.277 . . . . 0.0 110.802 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 51.4 p -77.82 168.55 19.75 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.053 2.141 . . . . 0.0 112.953 -171.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.45 149.73 0.97 Allowed Pre-proline 0 C--O 1.242 0.699 0 O-C-N 121.18 -0.95 . . . . 0.0 110.029 155.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.36 129.46 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.842 2.361 . . . . 0.0 109.717 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 p -52.61 162.08 1.01 Allowed Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.53 1.532 . . . . 0.0 113.458 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -63.8 125.96 16.45 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 109.818 158.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.414 ' SD ' HD13 ' A' ' 86' ' ' LEU . 57.6 mtm -55.53 148.2 16.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.798 -0.564 . . . . 0.0 111.418 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 -8.14 47.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 3.7 t0 85.04 153.35 0.11 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 130.605 3.562 . . . . 0.0 110.107 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 105' ' ' ASP . 19.4 Cg_endo -70.01 105.46 1.53 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.228 1.952 . . . . 0.0 111.516 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 24' ' ' VAL . 1.9 m -103.06 142.74 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.366 1.067 . . . . 0.0 109.361 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.0 141.39 32.89 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 109.295 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.1 p -72.89 151.04 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.174 0.59 . . . . 0.0 110.623 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.12 -178.76 2.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 112.07 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 N--CA 1.461 0.108 0 O-C-N 121.449 -0.782 . . . . 0.0 112.868 -178.152 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.08 156.71 53.29 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.195 2.597 . . . . 0.0 111.665 -168.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.61 152.09 48.24 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.64 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -67.64 141.16 54.02 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.264 1.976 . . . . 0.0 109.164 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.03 153.37 78.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.213 1.275 . . . . 0.0 109.189 162.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -74.03 177.87 5.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.678 0.791 . . . . 0.0 110.8 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -47.33 120.34 6.89 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 117.379 -1.296 . . . . 0.0 108.631 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.76 137.49 58.88 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -119.93 121.06 38.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.476 1.511 . . . . 0.0 108.822 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 149.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.202 173.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 p -129.35 -93.75 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.77 143.51 56.87 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.101 0.96 . . . . 0.0 109.615 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.91 141.8 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 p -128.21 -169.18 2.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.55 1.14 . . . . 0.0 108.541 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -61.61 -23.85 66.3 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 121.219 -0.926 . . . . 0.0 112.568 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -154.93 10.85 0.35 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.754 -1.216 . . . . 0.0 113.538 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -120.42 164.54 16.22 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.624 0.647 . . . . 0.0 110.833 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 p -153.48 134.26 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 165.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.1 m -88.53 114.45 25.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -93.72 138.49 31.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.844 1.658 . . . . 0.0 108.559 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -117.9 138.38 52.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.624 2.37 . . . . 0.0 107.189 170.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -139.8 170.92 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.734 0.414 . . . . 0.0 110.079 166.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 142.4 24.51 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.27 128.42 11.26 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.801 3.667 . . . . 0.0 109.546 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.52 167.96 54.63 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -85.49 154.95 59.67 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.769 1.228 . . . . 0.0 110.158 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.85 -158.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 125.193 3.928 . . . . 0.0 110.279 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.26 -112.7 0.46 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -58.74 -48.93 79.49 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.6 mt -140.82 148.09 51.12 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 125.068 1.347 . . . . 0.0 110.669 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 141.09 18.79 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.879 3.052 . . . . 0.0 110.14 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 109.34 1.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.604 1.561 . . . . 0.0 108.647 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' HG22 ' A' ' 92' ' ' ILE . 24.1 m -61.01 -62.46 1.84 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.377 2.271 . . . . 0.0 110.802 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.14 -166.72 2.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -121.73 163.77 18.52 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.201 1.4 . . . . 0.0 108.62 165.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.403 HD12 HD11 ' A' ' 92' ' ' ILE . 1.2 mt -115.9 162.73 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.391 2.276 . . . . 0.0 107.315 162.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.04 129.76 72.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 161.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.58 150.86 30.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 160.37 32.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 107.467 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -133.6 147.86 51.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.58 117.48 4.42 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -75.09 -26.63 59.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.483 -0.761 . . . . 0.0 111.983 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -81.06 17.07 1.31 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.29 1.036 . . . . 0.0 111.398 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -128.29 -71.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 m -151.53 1.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.5 50.78 16.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.378 1.444 . . . . 0.0 110.68 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -135.31 146.52 48.56 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.767 1.227 . . . . 0.0 108.38 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -72.88 108.86 6.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 161.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -100.0 134.65 42.61 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.652 1.981 . . . . 0.0 108.053 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -78.74 94.76 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.4 -15.81 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.609 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.7 150.11 30.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.017 1.28 . . . . 0.0 108.576 164.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -142.82 161.81 37.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.951 0.341 . . . . 0.0 111.208 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 47.35 55.11 8.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.754 1.222 . . . . 0.0 111.332 -171.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -91.92 129.63 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 29.83 7.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.723 0.809 . . . . 0.0 111.848 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -136.76 174.27 10.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.022 1.329 . . . . 0.0 107.505 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.5 p -120.28 0.0 10.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.871 1.668 . . . . 0.0 111.687 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.18 104.35 5.87 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.27 150.93 50.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.952 1.301 . . . . 0.0 109.718 -169.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.5 m -103.51 106.02 16.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -62.54 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -139.72 176.04 9.07 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.27 1.028 . . . . 0.0 112.269 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.95 84.43 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 124.81 1.195 . . . . 0.0 112.616 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -74.67 179.43 4.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.296 1.046 . . . . 0.0 109.768 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -104.12 138.05 19.41 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.039 -1.458 . . . . 0.0 108.241 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.19 147.17 59.49 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.523 2.149 . . . . 0.0 112.112 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.9 t30 44.94 42.02 5.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.53 2.332 . . . . 0.0 112.526 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.1 m -129.38 136.61 50.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 127.091 2.156 . . . . 0.0 106.524 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.0 mm -72.44 145.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.966 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -140.62 155.27 46.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.343 1.457 . . . . 0.0 109.388 168.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.3 mt -108.24 166.18 10.94 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 126.229 1.811 . . . . 0.0 108.912 162.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.36 136.91 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 125.092 1.495 . . . . 0.0 111.257 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.9 mtt -105.38 151.37 24.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 160.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.21 149.58 6.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 154.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.498 ' HD3' HD13 ' A' ' 97' ' ' LEU . 73.3 mtt180 -125.11 139.58 53.64 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.29 151.03 23.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 165.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 47' ' ' SER . 2.0 mt -125.07 152.12 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.87 1.668 . . . . 0.0 108.628 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -151.69 -176.84 0.62 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.608 1.563 . . . . 0.0 109.186 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.29 -14.08 27.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.227 . . . . 0.0 115.577 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -116.41 -14.04 10.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.031 1.332 . . . . 0.0 112.402 -164.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.04 -143.8 10.17 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.498 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.0 pp -140.02 160.98 38.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.33 1.852 . . . . 0.0 110.061 -175.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 97.3 p -72.21 168.06 19.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 126.908 2.083 . . . . 0.0 114.463 -166.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -32.25 145.45 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 123.56 0.744 . . . . 0.0 109.914 145.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.35 132.48 31.56 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.175 1.917 . . . . 0.0 109.095 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 p -61.4 154.58 62.97 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.554 163.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.04 142.22 91.76 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.899 2.399 . . . . 0.0 110.303 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.6 mmt -53.12 131.92 37.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -17.01 16.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.961 1.704 . . . . 0.0 112.187 170.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t0 70.44 161.68 0.15 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.733 2.013 . . . . 0.0 109.265 -158.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -74.75 121.68 6.83 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.974 2.449 . . . . 0.0 111.072 -175.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.57 158.43 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.011 0.925 . . . . 0.0 108.997 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.48 137.22 43.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.102 1.361 . . . . 0.0 108.369 163.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.9 p -66.04 164.79 14.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.781 0.8 . . . . 0.0 109.53 158.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -80.79 173.5 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.403 1.097 . . . . 0.0 109.749 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.5 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.3 mt . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -63.07 166.46 14.39 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.378 3.385 . . . . 0.0 113.144 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 147.08 50.41 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.793 -1.004 . . . . 0.0 110.607 165.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.3 157.63 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.918 2.412 . . . . 0.0 112.047 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.78 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.346 2.031 . . . . 0.0 110.877 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.3 m -74.58 166.75 23.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.634 0.774 . . . . 0.0 110.933 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.39 127.04 16.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 116.78 -1.581 . . . . 0.0 109.576 168.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.62 159.25 22.06 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.75 2.3 . . . . 0.0 114.306 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -107.5 129.41 54.96 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 128.778 2.831 . . . . 0.0 107.849 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.59 153.78 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 p -132.04 -90.27 0.42 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.74 120.29 25.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.318 -172.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -120.32 147.95 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 119.738 1.154 . . . . 0.0 110.789 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.4 p -141.3 -167.2 2.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.684 1.594 . . . . 0.0 107.731 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -65.04 -33.59 76.41 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -149.2 17.32 0.95 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.667 -1.27 . . . . 0.0 112.763 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -136.64 150.43 48.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.98 132.68 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.804 1.241 . . . . 0.0 109.413 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.2 m -79.4 139.61 37.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.045 0.938 . . . . 0.0 109.412 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.38 144.19 45.2 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.46 2.304 . . . . 0.0 107.227 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.64 131.94 40.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.133 2.573 . . . . 0.0 106.506 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -139.26 172.07 13.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.274 1.03 . . . . 0.0 109.315 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.18 141.94 24.52 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.74 162.66 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.334 2.689 . . . . 0.0 111.094 -168.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 169.06 36.1 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 122.468 1.038 . . . . 0.0 110.952 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -65.3 147.16 98.78 Favored Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 126.99 2.116 . . . . 0.0 111.135 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.37 174.69 9.65 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 125.206 3.937 . . . . 0.0 113.911 166.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.93 -118.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.706 1.146 . . . . 0.0 110.314 -174.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.6 p -69.15 -37.51 78.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.151 1.78 . . . . 0.0 112.752 -162.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 mt -138.38 158.27 70.96 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 123.04 0.536 . . . . 0.0 111.216 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.13 165.46 32.35 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.298 2.665 . . . . 0.0 109.915 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.18 121.1 44.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.74 -33.04 25.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.331 0.652 . . . . 0.0 111.995 -162.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' H ' HG22 ' A' ' 92' ' ' ILE . . . -166.47 -167.77 1.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.867 1.667 . . . . 0.0 106.561 167.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -118.08 166.19 12.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.42 154.56 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.013 2.525 . . . . 0.0 106.305 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 135.82 61.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -117.99 154.84 31.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.445 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -141.91 163.17 33.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.91 1.284 . . . . 0.0 109.034 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -140.16 145.54 37.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.05 1.74 . . . . 0.0 107.139 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.628 ' HB3' HG22 ' A' ' 58' ' ' VAL . 4.9 t -134.3 166.23 23.3 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 155.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -99.64 14.41 30.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.679 1.192 . . . . 0.0 111.957 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 t -139.26 21.52 2.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.302 1.841 . . . . 0.0 110.982 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.808 HG23 ' H ' ' A' ' 59' ' ' SER . 15.5 m -121.89 -85.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.764 1.226 . . . . 0.0 108.044 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.808 ' H ' HG23 ' A' ' 58' ' ' VAL . 28.7 m -139.19 8.66 2.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.795 2.038 . . . . 0.0 110.39 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 54.33 22.97 4.04 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.27 2.228 . . . . 0.0 113.683 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.7 m -116.35 159.32 22.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.943 0.897 . . . . 0.0 110.943 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -73.63 138.88 45.09 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 157.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.62 139.39 36.71 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 m -63.21 95.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.588 1.155 . . . . 0.0 108.277 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 53' ' ' ALA . 18.6 m -87.22 -17.54 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.124 -0.985 . . . . 0.0 112.016 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.81 131.79 22.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 165.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -117.67 152.83 34.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.4 m80 43.8 67.83 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.608 1.563 . . . . 0.0 112.491 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -98.64 118.54 45.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.596 1.158 . . . . 0.0 108.455 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.65 50.79 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.89 175.47 13.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.458 1.903 . . . . 0.0 107.388 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -125.39 12.42 8.14 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.003 1.721 . . . . 0.0 113.12 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mp -129.43 140.95 51.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 109.564 147.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -145.2 151.65 38.76 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.58 1.152 . . . . 0.0 108.419 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -109.94 108.79 19.18 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.868 1.667 . . . . 0.0 108.767 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -60.11 140.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 165.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -130.44 -177.63 4.42 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.428 1.091 . . . . 0.0 108.874 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.15 37.76 41.82 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 mt -108.0 -178.68 3.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 110.393 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -103.58 139.32 19.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 125.491 1.516 . . . . 0.0 109.391 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.75 159.33 42.34 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.049 2.499 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 55.28 15.51 1.36 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.481 1.912 . . . . 0.0 112.903 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -119.76 139.41 52.34 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.813 1.645 . . . . 0.0 110.149 -164.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.41 148.67 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.694 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -142.09 162.24 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.921 0.888 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.548 HD13 ' SD ' ' A' ' 103' ' ' MET . 21.2 mt -124.86 162.81 23.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 125.841 1.656 . . . . 0.0 108.929 165.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -138.57 155.74 48.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 125.476 1.735 . . . . 0.0 110.968 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 6.8 mtt -129.22 167.07 18.19 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 126.525 1.93 . . . . 0.0 106.972 160.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.0 t -132.06 146.34 33.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 168.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.546 ' HD3' HD13 ' A' ' 97' ' ' LEU . 82.5 mtt180 -136.38 134.02 37.38 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.219 1.407 . . . . 0.0 107.244 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 126.21 34.72 Favored 'General case' 0 C--O 1.228 -0.076 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -86.59 152.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.773 0.829 . . . . 0.0 108.971 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.62 168.9 10.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.506 0.722 . . . . 0.0 109.83 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -72.38 19.61 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.153 2.569 . . . . 0.0 113.845 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -121.13 -65.35 1.15 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.513 1.525 . . . . 0.0 107.531 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.81 -127.44 1.89 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.397 1.475 . . . . 0.0 110.969 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.546 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -139.23 145.74 39.61 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.525 2.33 . . . . 0.0 107.443 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.0 p -72.58 165.99 23.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.277 1.031 . . . . 0.0 109.869 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -54.85 142.95 53.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.565 -0.71 . . . . 0.0 109.188 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.99 133.15 42.8 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.435 1.423 . . . . 0.0 108.992 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.4 p -54.69 156.02 6.98 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.373 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -47.63 143.79 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.1 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.548 ' SD ' HD13 ' A' ' 86' ' ' LEU . 35.2 mtm -57.9 146.93 30.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.724 0.773 . . . . 0.0 110.299 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -65.26 0.2 1.5 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.062 -1.923 . . . . 0.0 115.81 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.2 t70 68.74 153.69 0.14 Allowed Pre-proline 0 N--CA 1.476 0.834 0 CA-C-N 121.147 1.794 . . . . 0.0 108.398 -154.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -67.47 113.26 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.006 2.471 . . . . 0.0 109.648 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.36 165.09 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -124.06 142.59 51.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 166.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 p -72.98 160.69 31.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.081 0.552 . . . . 0.0 110.745 165.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -79.14 -178.44 6.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.934 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.1 t70 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 125.285 1.434 . . . . 0.0 111.394 175.965 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.34 147.87 60.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.653 2.235 . . . . 0.0 109.169 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 155.41 50.23 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.13 140.97 81.08 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.43 2.086 . . . . 0.0 108.179 171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.09 172.06 7.96 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.287 1.991 . . . . 0.0 111.037 170.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -66.29 170.57 5.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.95 0.9 . . . . 0.0 110.1 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -49.76 124.81 16.45 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-O 117.593 -1.194 . . . . 0.0 107.796 160.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.06 136.0 46.25 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 CA-C-N 120.205 1.109 . . . . 0.0 109.352 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -78.77 164.55 24.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.176 1.465 . . . . 0.0 107.095 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 t -124.4 112.45 32.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.14 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -109.45 -82.5 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -167.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.07 134.47 47.08 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.245 1.418 . . . . 0.0 108.267 171.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -140.03 135.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.812 1.187 . . . . 0.0 108.545 163.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.0 p -110.68 -74.1 0.66 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -168.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -163.93 -26.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 129.641 3.177 . . . . 0.0 110.036 163.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -140.41 9.33 2.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.839 1.256 . . . . 0.0 112.287 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -126.99 160.66 30.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.851 0.75 . . . . 0.0 110.452 162.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -151.65 133.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.624 1.57 . . . . 0.0 106.946 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -79.98 132.64 36.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.7 142.08 35.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.291 1.437 . . . . 0.0 108.16 167.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.524 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -140.19 111.46 7.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.802 1.314 . . . . 0.0 108.466 -173.235 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.483 ' CH2' HD11 ' A' ' 51' ' ' ILE . 42.8 p90 -129.22 171.35 12.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.901 0.773 . . . . 0.0 109.56 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -124.84 145.48 50.02 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -74.72 144.07 30.86 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.461 2.774 . . . . 0.0 109.573 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.31 -175.78 49.73 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m -57.67 133.39 82.57 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 123.503 0.721 . . . . 0.0 111.506 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.02 -171.67 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.627 2.885 . . . . 0.0 113.417 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.68 -125.14 0.8 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 156.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -66.8 -23.03 66.01 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 128.992 2.917 . . . . 0.0 113.242 -160.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 18.3 mt -131.75 172.08 7.98 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.971 2.108 . . . . 0.0 109.356 172.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 41.9 Cg_endo -76.38 -136.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.582 3.521 . . . . 0.0 107.774 163.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.61 120.15 5.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -35.71 78.59 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.345 1.058 . . . . 0.0 112.483 -170.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.3 -167.86 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.227 1.011 . . . . 0.0 108.707 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -123.36 169.22 11.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.404 2.282 . . . . 0.0 108.273 164.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -127.27 156.02 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 130.734 3.613 . . . . 0.0 105.721 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.483 HD11 ' CH2' ' A' ' 36' ' ' TRP . 24.3 mt -128.63 136.71 59.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 164.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.69 153.36 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 108.175 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.14 128.76 22.98 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.767 1.227 . . . . 0.0 109.461 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.64 151.3 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.787 1.635 . . . . 0.0 107.197 171.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.28 105.87 1.0 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.106 -0.372 . . . . 0.0 110.359 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.94 -31.36 72.43 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -171.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 m -105.36 49.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.081 1.352 . . . . 0.0 110.218 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG22 ' HD2' ' A' ' 80' ' ' ARG . 92.2 t -134.85 -88.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 160.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.67 3.85 7.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.387 1.875 . . . . 0.0 110.401 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.49 -71.64 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.796 2.038 . . . . 0.0 109.758 -170.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -36.74 148.89 0.02 OUTLIER 'General case' 0 C--O 1.238 0.474 0 C-N-CA 130.437 3.495 . . . . 0.0 115.418 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -65.44 134.76 54.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.329 1.452 . . . . 0.0 108.079 171.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -129.9 130.2 44.86 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.25 94.86 0.17 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.07 -13.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.358 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.86 26.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.296 0.953 . . . . 0.0 109.475 162.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.46 26.11 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.4 m170 40.98 63.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.683 1.993 . . . . 0.0 111.915 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.25 138.26 24.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 C-N-CA 128.073 2.549 . . . . 0.0 108.115 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 29.15 5.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.869 0.867 . . . . 0.0 111.695 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.74 152.95 44.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.8 p -88.28 2.97 51.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.291 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -136.32 121.62 19.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.635 2.374 . . . . 0.0 107.693 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -146.39 139.23 25.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.427 1.012 . . . . 0.0 112.271 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -81.0 99.68 8.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.827 2.051 . . . . 0.0 108.492 170.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.0 143.58 15.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -131.69 178.14 6.98 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.247 1.419 . . . . 0.0 110.374 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 23.48 68.93 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.27 -159.32 0.73 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.408 ' HD2' HG22 ' A' ' 58' ' ' VAL . 58.1 mtt-85 -134.98 140.85 36.23 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-O 117.753 -1.118 . . . . 0.0 109.437 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.17 158.91 51.08 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.935 2.423 . . . . 0.0 110.588 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.04 45.44 3.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.967 2.107 . . . . 0.0 112.294 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -136.22 128.14 29.39 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 125.845 1.658 . . . . 0.0 107.889 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mm -65.17 145.61 13.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -134.57 158.29 44.37 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.626 1.571 . . . . 0.0 108.085 159.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mt -107.26 162.22 14.08 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 154.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.47 148.54 49.27 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.9 mtm -130.86 167.97 18.05 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 158.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.34 154.4 16.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.562 ' HD3' HD22 ' A' ' 97' ' ' LEU . 9.8 mtt180 -132.26 141.47 49.02 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.03 153.78 22.51 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.19 150.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.612 1.565 . . . . 0.0 107.44 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.36 160.2 18.13 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.52 10.67 2.42 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.177 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -120.56 15.21 11.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.563 2.345 . . . . 0.0 110.23 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.99 176.47 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 124.896 1.236 . . . . 0.0 110.778 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.562 HD22 ' HD3' ' A' ' 90' ' ' ARG . 2.0 mp -81.91 165.6 20.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.1 p -72.47 167.13 21.23 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.155 0.979 . . . . 0.0 110.144 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.52 150.11 0.55 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 152.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.36 149.65 80.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.198 1.932 . . . . 0.0 109.147 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -63.16 164.19 14.78 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 163.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.34 151.13 18.47 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.169 1.246 . . . . 0.0 109.519 154.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 40.9 mtm -68.31 151.28 47.14 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.988 -0.445 . . . . 0.0 110.528 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.5 p -60.5 -7.64 2.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.427 2.291 . . . . 0.0 115.24 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.23 157.24 0.15 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.228 2.211 . . . . 0.0 111.068 -158.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.01 100.88 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.159 2.573 . . . . 0.0 110.112 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.82 129.66 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.601 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -79.45 158.16 27.36 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 p -91.13 168.85 11.32 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.452 1.12 . . . . 0.0 109.903 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -71.64 177.05 4.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.903 1.811 . . . . 0.0 111.116 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 110.53 -3.032 . . . . 0.0 108.878 166.915 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.87 158.19 34.74 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.167 2.578 . . . . 0.0 112.041 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.33 151.46 50.22 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 167.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.446 2.097 . . . . 0.0 111.528 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -63.21 168.25 11.28 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.147 1.231 . . . . 0.0 110.491 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -88.19 163.39 16.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 10.9 tmtt? -57.39 125.49 71.71 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 117.092 -1.432 . . . . 0.0 109.467 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.88 157.9 56.71 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.293 1.328 . . . . 0.0 111.842 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -135.06 118.39 16.71 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 127.396 2.279 . . . . 0.0 105.988 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -63.16 161.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 114.394 -1.276 . . . . 0.0 109.429 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -140.75 -79.91 0.27 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.442 1.097 . . . . 0.0 109.082 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -79.69 143.01 34.98 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 108.335 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.01 146.51 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 160.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.3 p -118.04 -62.47 1.54 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 pttt 172.4 -34.98 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 130.647 3.579 . . . . 0.0 108.196 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.49 5.82 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.731 1.212 . . . . 0.0 111.018 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -132.75 155.34 49.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.44 134.64 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.261 1.424 . . . . 0.0 107.859 175.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.0 m -95.89 128.52 42.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.114 0.966 . . . . 0.0 109.22 178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.32 122.59 47.86 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.002 2.121 . . . . 0.0 107.381 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -92.42 147.83 22.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 159.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.49 ' CH2' HD11 ' A' ' 51' ' ' ILE . 44.1 p90 -139.85 172.15 13.19 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 124.821 1.248 . . . . 0.0 107.92 156.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -109.06 144.11 29.01 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.21 158.36 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.839 3.026 . . . . 0.0 112.141 -168.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.97 -176.21 39.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.915 0.769 . . . . 0.0 112.008 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.47 154.85 87.79 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.298 1.439 . . . . 0.0 111.326 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.41 -101.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 125.667 4.245 . . . . 0.0 109.631 161.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.34 -92.67 0.69 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 128.194 2.807 . . . . 0.0 108.769 161.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -55.66 28.91 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.292 2.237 . . . . 0.0 109.963 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -134.29 160.4 68.63 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.068 1.347 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -75.28 154.17 40.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.237 3.291 . . . . 0.0 108.981 172.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.2 161.82 21.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.489 1.137 . . . . 0.0 110.359 170.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.439 ' HB2' HG22 ' A' ' 92' ' ' ILE . 3.2 m -119.58 -43.87 2.57 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.76 2.424 . . . . 0.0 109.237 -175.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.07 -164.83 0.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.33 1.452 . . . . 0.0 107.725 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.92 161.03 30.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.372 2.269 . . . . 0.0 108.362 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.0 mt -126.98 156.2 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.872 2.469 . . . . 0.0 106.471 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.49 HD11 ' CH2' ' A' ' 36' ' ' TRP . 70.7 mt -122.66 136.27 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 160.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -109.73 153.05 24.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 166.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.09 155.84 48.37 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.977 1.311 . . . . 0.0 107.686 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -133.05 153.69 51.26 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.485 1.514 . . . . 0.0 107.258 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.6 t -153.37 133.47 13.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.36 -18.37 63.06 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -103.1 1.79 33.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.162 1.385 . . . . 0.0 113.127 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -94.21 -79.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.1 m -128.78 -6.14 5.1 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.133 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t30 55.46 47.55 20.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.582 1.083 . . . . 0.0 109.0 -169.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.1 m -142.61 139.37 31.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.53 2.332 . . . . 0.0 107.932 -172.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -77.47 129.61 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 162.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -126.55 152.54 46.42 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.538 1.135 . . . . 0.0 108.215 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 135.23 47.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.73 0.08 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.326 1.451 . . . . 0.0 112.317 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.565 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . . . -151.68 139.53 19.92 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 164.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -142.93 143.69 32.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.102 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 37.37 63.15 0.77 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.508 1.523 . . . . 0.0 111.36 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -86.38 133.84 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -118.5 45.95 1.92 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.061 0.945 . . . . 0.0 109.754 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 t -157.88 -174.58 4.91 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.65 1.58 . . . . 0.0 107.543 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 p -124.95 3.26 8.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.051 2.141 . . . . 0.0 111.454 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.8 131.46 53.77 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 165.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 56.4 t80 -145.96 151.06 37.2 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.563 1.145 . . . . 0.0 109.267 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.3 m -109.84 102.31 11.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.058 1.743 . . . . 0.0 107.357 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.83 141.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -133.85 -177.59 4.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.032 1.733 . . . . 0.0 108.24 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.09 78.95 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 123.157 0.408 . . . . 0.0 112.876 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.83 -171.8 3.15 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.008 0.923 . . . . 0.0 108.837 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -116.39 143.19 30.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 125.107 1.363 . . . . 0.0 109.092 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -74.56 157.75 44.36 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.248 2.632 . . . . 0.0 111.885 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.1 t30 46.64 34.27 2.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.348 1.859 . . . . 0.0 112.023 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 m -125.02 130.33 52.11 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mm -74.71 151.29 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -131.91 169.1 16.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.11 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.425 HD13 ' SD ' ' A' ' 103' ' ' MET . 14.6 mt -119.74 156.25 30.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 152.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -131.01 146.44 52.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.119 1.768 . . . . 0.0 106.742 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.73 117.92 9.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.863 1.665 . . . . 0.0 107.012 -177.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.24 112.76 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -97.85 135.56 39.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 163.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.71 166.74 15.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 165.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.6 OUTLIER -127.73 151.56 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.74 1.616 . . . . 0.0 108.168 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -145.04 178.43 1.44 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.067 1.747 . . . . 0.0 108.447 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.63 -10.04 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.865 2.377 . . . . 0.0 115.848 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -113.13 -32.79 6.21 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.411 1.46 . . . . 0.0 112.935 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.4 -156.58 17.89 Favored Glycine 0 C--O 1.238 0.397 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mp -103.93 149.51 25.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.776 1.23 . . . . 0.0 110.056 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.9 p -72.16 166.27 22.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.772 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.37 146.62 0.34 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 126.446 1.899 . . . . 0.0 112.157 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.43 104.96 0.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.63 2.22 . . . . 0.0 109.051 166.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -48.82 166.89 0.22 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.002 2.521 . . . . 0.0 113.907 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.59 135.67 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.252 1.968 . . . . 0.0 110.044 155.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.425 ' SD ' HD13 ' A' ' 86' ' ' LEU . 45.5 mtt -63.69 163.4 11.52 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.9 0.773 . . . . 0.0 110.234 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.482 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 85.6 p -65.7 -1.75 3.03 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.57 155.08 0.11 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.726 1.611 . . . . 0.0 110.925 -159.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -69.98 98.74 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.48 2.12 . . . . 0.0 111.65 -168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 m -99.26 142.55 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.89 0.876 . . . . 0.0 110.597 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -93.11 147.99 22.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 122.96 0.504 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.7 p -79.32 152.03 30.71 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 158.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.87 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.611 1.964 . . . . 0.0 111.654 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.3 t0 . . . . . 0 C--N 1.331 -0.231 0 C-N-CA 127.335 2.254 . . . . 0.0 106.396 -177.249 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 119.423 -0.322 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.68 165.0 19.38 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.685 3.59 . . . . 0.0 110.829 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.92 159.38 41.75 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 170.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.2 152.86 78.94 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.061 2.508 . . . . 0.0 111.324 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.16 156.4 55.54 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.33 2.02 . . . . 0.0 110.493 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 m -79.02 176.99 9.15 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.845 -0.534 . . . . 0.0 109.724 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 28.5 tttt -55.51 120.3 30.57 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-O 117.945 -1.026 . . . . 0.0 108.679 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.48 141.42 95.41 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 CA-C-N 120.257 1.128 . . . . 0.0 109.391 167.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -79.74 171.61 14.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 161.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.656 HG21 HG11 ' A' ' 107' ' ' VAL . 46.2 t -117.84 137.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 162.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.257 68.7 p -117.18 -98.42 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -72.42 142.81 48.67 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 109.08 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.79 -177.67 3.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 pttt -74.71 -16.67 60.74 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.259 -0.901 . . . . 0.0 112.12 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -136.39 2.72 2.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.686 1.13 . . . . 0.0 111.718 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.4 p -153.33 166.83 31.39 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.43 -1.418 . . . . 0.0 110.19 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.63 145.83 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.427 1.091 . . . . 0.0 108.57 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -105.64 124.36 49.43 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.539 1.535 . . . . 0.0 107.315 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.82 132.01 53.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.725 2.01 . . . . 0.0 110.828 -171.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.8 108.68 11.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.321 1.848 . . . . 0.0 106.621 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -109.86 173.11 6.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.13 148.87 42.41 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.51 134.74 12.65 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.533 3.488 . . . . 0.0 110.915 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.47 30.87 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-O 122.756 1.198 . . . . 0.0 111.165 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -61.18 154.06 63.94 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.66 1.984 . . . . 0.0 111.148 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.73 -174.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 125.042 3.828 . . . . 0.0 114.702 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.03 -154.89 7.83 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -47.72 23.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 160.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.506 HD13 ' HG2' ' A' ' 94' ' ' PRO . 11.3 mt -103.62 144.01 27.8 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.56 0.618 . . . . 0.0 110.487 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -81.36 151.75 17.78 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.371 2.714 . . . . 0.0 110.652 -165.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.71 122.42 5.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.762 1.225 . . . . 0.0 111.526 168.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.592 ' HB2' HG22 ' A' ' 92' ' ' ILE . 33.8 m -76.94 -61.82 1.85 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.578 1.951 . . . . 0.0 108.434 162.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -158.99 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 110.115 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -132.61 168.65 17.88 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.637 1.975 . . . . 0.0 109.219 165.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.76 159.67 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 128.745 2.818 . . . . 0.0 106.907 168.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.1 mt -130.22 129.79 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.91 166.03 11.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.934 0.894 . . . . 0.0 109.181 163.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.45 147.28 34.32 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.079 1.752 . . . . 0.0 108.205 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -127.89 119.78 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 44.6 t -73.59 -72.01 0.29 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.141 1.337 . . . . 0.0 110.082 166.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 142.73 -58.88 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 131.699 4.0 . . . . 0.0 106.096 -156.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 t -121.18 39.75 3.74 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.485 1.493 . . . . 0.0 109.363 -155.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.718 HG23 ' H ' ' A' ' 59' ' ' SER 0.272 25.1 m -120.41 -84.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -167.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.718 ' H ' HG23 ' A' ' 58' ' ' VAL . 8.3 m -129.96 16.83 5.69 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.441 1.096 . . . . 0.0 112.51 168.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 47.1 51.73 12.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.952 1.701 . . . . 0.0 111.161 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -153.26 153.33 32.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.06 1.744 . . . . 0.0 108.155 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.91 137.19 58.22 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 155.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -134.42 146.62 50.01 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.72 123.42 26.66 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.32 -3.02 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.537 1.135 . . . . 0.0 111.611 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.45 140.05 19.77 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 158.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.38 129.04 30.67 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -172.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 63.41 56.33 1.67 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.033 1.733 . . . . 0.0 112.094 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 134.31 27.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.474 1.51 . . . . 0.0 107.977 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . 32.9 mtpt -122.89 51.84 1.39 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.974 2.109 . . . . 0.0 109.108 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 t -150.45 -178.69 6.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.643 1.577 . . . . 0.0 107.22 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.6 p -118.52 2.12 11.76 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.171 1.789 . . . . 0.0 111.213 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -137.55 103.66 5.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -128.52 137.29 51.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -86.13 105.2 16.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.98 140.47 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -129.13 178.5 6.37 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.259 1.424 . . . . 0.0 110.89 -173.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.24 13.62 67.64 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 124.748 1.166 . . . . 0.0 114.304 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.02 164.81 25.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.68 1.229 . . . . 0.0 110.31 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -93.29 146.03 31.14 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.219 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.66 157.48 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.95 2.433 . . . . 0.0 110.581 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 53.23 14.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.782 1.633 . . . . 0.0 113.542 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -109.29 132.12 54.42 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 120.208 1.367 . . . . 0.0 108.744 -170.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -61.96 145.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 85.3 m-85 -140.42 150.77 44.28 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.927 1.346 . . . . 0.0 108.369 163.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.8 mt -110.36 162.28 14.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 111.675 -2.511 . . . . 0.0 107.926 159.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -142.21 126.31 17.39 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.48 1.912 . . . . 0.0 108.769 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.1 mtm -104.99 154.82 19.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 163.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.97 134.72 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.871 ' HD3' HD13 ' A' ' 97' ' ' LEU . 49.0 mtt180 -118.72 147.55 43.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 167.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.9 158.84 20.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.592 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.5 OUTLIER -125.52 143.98 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.232 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.417 ' HA ' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -138.02 172.82 6.12 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 126.0 1.72 . . . . 0.0 107.288 173.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.506 ' HG2' HD13 ' A' ' 44' ' ' LEU . 44.8 Cg_endo -81.97 28.12 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.553 2.168 . . . . 0.0 112.382 -172.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -132.78 -42.45 0.91 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 127.134 2.174 . . . . 0.0 110.46 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.27 -177.36 44.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 122.336 0.965 . . . . 0.0 112.959 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.871 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.5 pp -92.42 165.47 13.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.433 1.493 . . . . 0.0 111.052 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.55 ' O ' HD12 ' A' ' 97' ' ' LEU . 18.9 p -87.18 167.16 14.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -174.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.1 150.72 1.02 Allowed Pre-proline 0 C--O 1.237 0.424 0 O-C-N 121.524 -0.735 . . . . 0.0 109.205 152.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.55 154.89 72.3 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 120.863 1.042 . . . . 0.0 110.444 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 p -53.25 151.36 9.77 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 123.463 0.705 . . . . 0.0 111.043 160.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -53.54 140.94 64.21 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.77 1.647 . . . . 0.0 109.841 154.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 mmt -57.66 129.44 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.027 0.531 . . . . 0.0 111.715 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.645 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.87 -16.41 50.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.534 1.534 . . . . 0.0 112.255 169.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t0 85.87 153.38 0.1 Allowed Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 129.457 3.103 . . . . 0.0 110.824 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.09 97.08 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.901 2.401 . . . . 0.0 112.185 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.656 HG11 HG21 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -85.73 156.3 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 124.66 1.184 . . . . 0.0 109.481 176.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -106.08 165.33 11.3 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.969 1.308 . . . . 0.0 109.038 172.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -102.03 163.76 12.07 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.283 1.433 . . . . 0.0 109.248 169.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -74.05 174.56 8.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.947 0.88 . . . . 0.0 111.669 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 C-N-CA 127.102 2.161 . . . . 0.0 109.73 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -66.93 147.11 79.82 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.345 2.03 . . . . 0.0 111.519 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.08 142.01 28.55 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.422 1.487 . . . . 0.0 110.363 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.3 148.85 85.11 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.706 2.27 . . . . 0.0 110.231 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -64.61 160.7 38.74 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.819 1.679 . . . . 0.0 110.867 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -67.16 168.32 10.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.86 0.864 . . . . 0.0 109.788 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -57.02 124.64 66.56 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.013 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.18 135.81 32.84 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.535 1.584 . . . . 0.0 110.535 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -80.36 168.61 18.81 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 125.103 1.361 . . . . 0.0 109.778 166.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.5 95.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 112.056 -2.338 . . . . 0.0 106.169 171.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.3 p -93.58 -89.33 0.21 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 126.29 28.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.566 1.146 . . . . 0.0 110.542 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.49 159.1 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.714 1.206 . . . . 0.0 108.079 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 p -137.95 -56.52 0.67 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt 170.85 -31.44 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 1 C-N-CA 132.082 4.153 . . . . 0.0 108.969 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.25 2.26 2.06 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.528 1.531 . . . . 0.0 112.12 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 p -132.4 154.56 49.69 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.093 0.86 . . . . 0.0 109.919 165.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 p -147.63 141.92 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.49 143.41 26.84 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.5 mt -112.66 138.35 49.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.352 1.461 . . . . 0.0 107.81 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.89 120.51 30.63 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -136.63 170.55 15.88 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.272 1.397 . . . . 0.0 107.63 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -115.64 149.61 43.33 Favored Pre-proline 0 C--O 1.237 0.443 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.51 153.29 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.358 2.039 . . . . 0.0 110.126 -165.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.87 176.44 54.02 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-O 122.642 1.135 . . . . 0.0 111.633 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.9 m -62.01 149.5 85.94 Favored Pre-proline 0 N--CA 1.435 -1.217 0 C-N-CA 126.355 1.862 . . . . 0.0 108.667 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -69.55 178.68 4.2 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 CA-C-O 123.77 1.488 . . . . 0.0 113.049 170.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.57 -160.79 9.24 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 130.686 3.993 . . . . 0.0 103.401 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -43.66 72.97 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.805 0.842 . . . . 0.0 111.52 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.46 154.52 37.52 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 118.793 0.724 . . . . 0.0 111.478 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.84 151.54 31.56 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.943 3.095 . . . . 0.0 110.316 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.27 104.27 9.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.426 ' H ' ' HA ' ' A' ' 93' ' ' ASN . 3.0 m -52.43 -52.8 52.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.251 2.221 . . . . 0.0 112.929 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.81 -163.81 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.509 1.924 . . . . 0.0 107.201 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -127.23 157.96 38.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.82 1.248 . . . . 0.0 110.08 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -107.1 154.12 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.661 1.984 . . . . 0.0 107.217 164.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.45 119.73 46.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -100.91 155.85 17.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.66 156.37 48.95 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 126.192 1.797 . . . . 0.0 106.306 169.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -132.83 156.14 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.03 124.41 5.29 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -21.67 65.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.776 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 t -94.65 -3.49 49.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.18 0.992 . . . . 0.0 111.697 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 t -111.28 -68.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 125.235 1.414 . . . . 0.0 108.367 -161.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 m -142.95 -5.25 0.89 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 111.611 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 t30 54.36 32.03 15.63 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -133.95 153.16 51.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.568 1.547 . . . . 0.0 108.27 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -71.29 141.74 50.5 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 159.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -135.11 132.76 38.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 175.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -71.87 94.18 1.4 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.97 -25.63 14.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.781 0.832 . . . . 0.0 110.902 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.75 46.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 163.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -133.96 143.96 48.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.452 1.501 . . . . 0.0 107.597 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 m80 47.26 64.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.068 1.347 . . . . 0.0 111.595 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.3 133.5 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -117.89 56.65 0.85 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.853 1.261 . . . . 0.0 108.271 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 t -161.35 176.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.4 p -110.46 0.0 17.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 111.465 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -142.99 101.57 3.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.581 1.152 . . . . 0.0 108.944 -169.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -134.18 124.29 25.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.612 0.765 . . . . 0.0 112.838 -164.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.0 m -70.82 98.37 1.55 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.764 2.426 . . . . 0.0 110.805 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.83 146.99 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 120.646 -1.284 . . . . 0.0 108.167 163.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -140.81 -178.19 5.43 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.861 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.25 49.66 60.45 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt -115.26 -160.5 0.74 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.822 1.249 . . . . 0.0 108.905 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -131.08 139.57 35.95 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.541 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.79 160.21 50.14 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.312 2.674 . . . . 0.0 111.601 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.1 m120 47.95 21.93 0.34 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.207 1.803 . . . . 0.0 113.844 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -121.03 121.44 37.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.83 1.652 . . . . 0.0 106.789 -170.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 mm -58.78 146.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -136.07 159.91 40.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 162.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.4 HD13 ' SD ' ' A' ' 103' ' ' MET . 15.0 mt -112.2 162.57 15.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 125.758 1.623 . . . . 0.0 107.782 158.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -142.57 143.42 32.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.439 1.712 . . . . 0.0 107.727 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 mtm -138.46 149.04 45.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.13 150.31 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -129.02 148.46 50.97 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 167.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.25 152.42 22.32 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 163.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.34 151.03 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.426 ' HA ' ' H ' ' A' ' 47' ' ' SER . 1.0 OUTLIER -146.61 174.99 2.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.034 0.934 . . . . 0.0 109.529 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.54 29.5 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.913 3.075 . . . . 0.0 114.114 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.56 -52.19 0.48 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.49 1.916 . . . . 0.0 109.756 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.96 -144.06 4.03 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 127.263 2.363 . . . . 0.0 108.971 -170.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 pp -142.73 167.43 22.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.865 1.266 . . . . 0.0 111.609 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.7 p -75.35 165.52 25.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.269 0.628 . . . . 0.0 110.645 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -51.83 152.19 5.5 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 157.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.9 142.28 51.35 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.665 1.577 . . . . 0.0 109.136 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 p -59.09 162.27 7.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 O-C-N 121.812 -0.555 . . . . 0.0 111.062 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -54.55 129.83 36.94 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.6 2.867 . . . . 0.0 109.835 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.4 ' SD ' HD13 ' A' ' 86' ' ' LEU . 5.4 mtm -49.75 151.68 1.7 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.322 1.419 . . . . 0.0 113.199 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.3 p -60.5 -12.22 9.12 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.79 155.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.344 1.857 . . . . 0.0 108.739 -157.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -70.74 137.42 32.56 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.229 1.953 . . . . 0.0 109.883 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.62 125.78 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.35 127.65 35.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.9 p -66.07 157.96 29.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -66.91 172.99 3.88 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.146 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 C-N-CA 124.579 1.151 . . . . 0.0 113.932 -169.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.21 149.66 84.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.889 2.392 . . . . 0.0 112.422 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 148.48 44.78 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 169.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 156.45 53.63 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.813 2.342 . . . . 0.0 113.053 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.68 175.07 5.66 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.493 2.795 . . . . 0.0 112.837 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -61.09 171.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.922 0.868 . . . . 0.0 111.769 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -52.96 133.57 48.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.299 -0.858 . . . . 0.0 108.856 157.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.54 148.27 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.433 1.422 . . . . 0.0 110.927 167.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -119.3 117.14 27.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.612 1.565 . . . . 0.0 108.658 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.89 144.6 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 113.357 -1.747 . . . . 0.0 107.698 169.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 p -128.75 -85.72 0.56 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -73.84 149.12 41.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.704 1.602 . . . . 0.0 109.475 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.97 141.95 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 122.004 0.907 . . . . 0.0 108.687 161.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.9 p -128.54 -172.21 2.65 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 107.996 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -62.05 -36.99 83.27 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.176 -0.953 . . . . 0.0 112.706 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -139.67 23.86 2.45 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.902 1.228 . . . . 0.0 111.398 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -146.14 164.13 33.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.518 0.599 . . . . 0.0 109.501 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.05 138.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -94.44 135.18 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.36 130.63 52.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 125.886 1.674 . . . . 0.0 108.318 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 1.4 t -103.32 151.92 22.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.69 1.196 . . . . 0.0 108.127 161.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.597 ' CH2' HD11 ' A' ' 51' ' ' ILE . 24.2 p90 -140.04 171.12 14.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 156.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.32 144.82 32.46 Favored Pre-proline 0 C--O 1.239 0.516 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.94 140.73 18.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.835 2.357 . . . . 0.0 110.751 -167.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.21 -168.19 26.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 166.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.3 m -86.85 159.98 50.76 Favored Pre-proline 0 N--CA 1.441 -0.878 0 C-N-CA 128.775 2.83 . . . . 0.0 109.458 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.84 -169.06 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.813 3.676 . . . . 0.0 111.085 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.35 -148.41 6.21 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 105.872 -2.891 . . . . 0.0 105.872 164.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -33.4 54.95 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.549 0.739 . . . . 0.0 110.144 171.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 95' ' ' GLN . 12.6 mt -104.36 157.72 33.47 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 118.379 0.536 . . . . 0.0 111.124 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.36 170.58 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.045 2.497 . . . . 0.0 109.303 164.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.61 162.6 13.56 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.473 1.109 . . . . 0.0 109.033 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -116.54 -47.28 2.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.86 2.064 . . . . 0.0 109.481 -171.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.51 -160.99 0.55 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -134.83 148.86 50.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.444 2.298 . . . . 0.0 108.555 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 64' ' ' THR . 2.2 mt -124.99 113.86 37.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 129.15 2.98 . . . . 0.0 105.754 172.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.597 HD11 ' CH2' ' A' ' 36' ' ' TRP . 69.7 mt -94.54 120.39 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 171.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.78 154.29 20.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.26 148.21 51.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.015 1.726 . . . . 0.0 108.08 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.23 157.46 19.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 166.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.3 144.57 21.01 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -95.53 -4.99 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.545 1.538 . . . . 0.0 112.622 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.0 m -119.56 9.98 11.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.362 1.465 . . . . 0.0 113.281 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -115.17 -77.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.14 1.776 . . . . 0.0 109.023 -168.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -141.67 5.85 1.81 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.289 0.95 . . . . 0.0 112.786 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 m120 59.58 2.93 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.431 2.692 . . . . 0.0 114.964 -175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -106.23 161.16 14.78 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 126.632 1.973 . . . . 0.0 110.518 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.424 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 81.6 m95 -77.78 144.62 36.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 153.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -138.32 148.68 44.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 HG23 ' A' ' 50' ' ' ILE . 32.4 m -77.19 108.57 10.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -95.11 -15.47 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.215 1.006 . . . . 0.0 111.93 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.92 102.45 2.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.307 0.958 . . . . 0.0 108.835 167.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.81 157.89 15.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.196 0.998 . . . . 0.0 110.394 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 44.89 46.23 8.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.473 2.709 . . . . 0.0 112.449 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t -79.99 136.75 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 126.75 2.02 . . . . 0.0 108.056 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -123.27 61.41 1.04 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 122.093 0.949 . . . . 0.0 108.799 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 t -158.31 179.27 9.3 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 p -122.85 5.86 9.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.697 1.199 . . . . 0.0 111.441 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 7.8 tp -135.89 128.36 30.46 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 163.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -145.95 151.24 37.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -101.42 103.77 14.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.227 1.411 . . . . 0.0 107.827 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.52 137.49 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -122.48 -167.38 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.546 1.938 . . . . 0.0 107.543 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.68 21.11 64.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.112 171.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -99.95 -166.46 1.34 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.822 1.311 . . . . 0.0 110.616 -167.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -122.73 153.15 63.15 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 107.248 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.69 156.17 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.519 2.146 . . . . 0.0 110.382 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 35.58 57.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.222 1.809 . . . . 0.0 110.598 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.9 m -139.0 138.33 37.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.66 1.984 . . . . 0.0 106.19 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 mm -79.44 146.1 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.127 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -142.13 150.87 41.68 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.179 1.391 . . . . 0.0 109.411 173.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.03 166.27 10.85 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 162.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -138.34 149.22 45.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.647 1.217 . . . . 0.0 108.731 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.424 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 73.3 mtm -136.81 152.53 50.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 163.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 36' ' ' TRP . 71.0 t -119.3 109.66 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -169.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.603 ' HD3' HD13 ' A' ' 97' ' ' LEU . 73.8 mtt180 -94.84 132.28 39.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 129.25 35.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 165.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.05 149.52 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.7 176.79 2.27 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.101 1.361 . . . . 0.0 108.926 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.99 4.09 0.77 Allowed 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.581 2.854 . . . . 0.0 115.935 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.537 ' HB2' HD12 ' A' ' 44' ' ' LEU . 15.8 tp60 -140.48 -17.4 0.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.926 1.29 . . . . 0.0 112.617 -161.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.19 -156.84 29.05 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.858 1.694 . . . . 0.0 109.402 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.603 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -129.76 146.97 51.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.849 1.66 . . . . 0.0 107.765 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.3 p -72.41 167.11 21.23 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.04 153.75 0.49 Allowed Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.234 1.413 . . . . 0.0 110.919 173.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.1 136.3 68.18 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -61.3 172.02 1.08 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 165.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.98 144.77 35.33 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.012 1.142 . . . . 0.0 109.733 156.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.51 143.6 57.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.6 p -64.48 -2.48 2.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.902 1.681 . . . . 0.0 115.043 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t0 68.71 151.5 0.13 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.945 2.498 . . . . 0.0 109.751 -158.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.65 105.58 1.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.081 2.521 . . . . 0.0 110.206 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.83 167.72 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 129.04 47.38 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.201 1.4 . . . . 0.0 108.233 172.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.2 p -65.4 160.64 21.52 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.208 0.317 . . . . 0.0 110.81 171.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -83.88 -176.75 6.43 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.202 1.001 . . . . 0.0 110.458 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 111.991 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 111.077 0.028 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.38 159.93 47.91 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.879 3.053 . . . . 0.0 111.35 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.07 152.38 48.99 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.91 138.91 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.708 1.605 . . . . 0.0 108.606 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -64.91 163.7 27.29 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 121.894 1.729 . . . . 0.0 111.168 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.3 m -74.25 160.46 31.09 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.54 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.89 121.12 21.53 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.042 1.337 . . . . 0.0 112.027 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.45 146.59 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.755 1.636 . . . . 0.0 113.577 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.11 125.25 53.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 125.602 1.561 . . . . 0.0 111.373 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 107' ' ' VAL . 1.3 m -86.08 133.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 113.615 -1.63 . . . . 0.0 108.885 -176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -121.88 -90.97 0.57 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -167.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -72.23 141.16 48.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.34 136.02 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.9 p -105.76 -52.88 2.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.362 -170.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 pttp 160.61 -26.13 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.331 1 C-N-CA 133.795 4.838 . . . . 0.0 108.373 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.18 -0.29 1.13 Allowed 'General case' 0 CA--C 1.523 -0.083 0 O-C-N 121.173 -0.954 . . . . 0.0 112.745 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -125.15 160.33 29.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.945 1.248 . . . . 0.0 110.156 160.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.51 130.96 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.127 1.371 . . . . 0.0 108.475 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.3 m -90.21 122.57 33.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.825 2.05 . . . . 0.0 108.249 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.75 126.64 54.79 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.874 2.07 . . . . 0.0 107.844 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.06 152.65 18.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 160.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.7 p90 -139.76 172.42 12.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 152.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -102.09 146.03 31.56 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.3 156.12 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.558 2.839 . . . . 0.0 109.964 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.13 177.86 50.76 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-O 123.878 1.821 . . . . 0.0 110.815 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 m -64.73 154.82 84.29 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 127.546 2.338 . . . . 0.0 109.357 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.62 -171.69 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.995 2.463 . . . . 0.0 112.828 166.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.75 6.14 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -45.01 54.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 161.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 mt -97.59 150.19 36.52 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 123.365 0.666 . . . . 0.0 109.978 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.23 151.61 54.91 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.889 3.059 . . . . 0.0 109.537 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.58 159.97 26.3 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.649 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.499 ' HB2' HG22 ' A' ' 92' ' ' ILE . 21.2 m -135.71 -42.0 0.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.447 1.499 . . . . 0.0 110.514 -166.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.58 -171.07 2.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.373 1.069 . . . . 0.0 108.427 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.56 167.57 10.35 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.851 0.834 . . . . 0.0 109.686 156.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.05 158.16 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.677 2.791 . . . . 0.0 106.471 164.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 92.3 mt -127.05 139.16 52.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 166.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.83 161.98 19.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.776 1.231 . . . . 0.0 108.275 172.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -143.87 162.15 36.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.195 1.398 . . . . 0.0 108.559 172.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -136.2 149.49 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.652 1.981 . . . . 0.0 106.057 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.665 ' HB3' HG22 ' A' ' 58' ' ' VAL . 8.1 t -141.42 165.07 28.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 161.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.71 33.84 2.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.378 1.071 . . . . 0.0 111.761 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.92 34.01 0.21 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.268 -0.895 . . . . 0.0 112.42 165.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.665 HG22 ' HB3' ' A' ' 55' ' ' SER . 14.8 m -120.14 -72.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.959 1.304 . . . . 0.0 109.628 -175.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.577 ' H ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -154.01 0.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.887 1.275 . . . . 0.0 112.005 -178.48 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.14 -21.11 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.266 2.626 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 m -63.66 159.27 19.39 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.476 1.91 . . . . 0.0 110.714 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -76.37 154.49 34.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 151.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -141.92 152.97 44.02 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 134.46 49.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 53' ' ' ALA . 22.9 m -122.98 -19.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.308 -0.854 . . . . 0.0 111.473 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . -135.63 157.06 47.82 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.904 1.229 . . . . 0.0 108.338 160.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -143.02 147.75 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 52.52 49.37 20.56 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.014 0.912 . . . . 0.0 111.806 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.5 t -79.13 102.27 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -94.47 50.67 1.37 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.876 1.27 . . . . 0.0 109.076 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -157.44 -170.06 3.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.057 1.743 . . . . 0.0 107.508 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.4 p -131.98 2.91 4.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.116 2.166 . . . . 0.0 111.624 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.0 tp -129.38 120.64 25.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -145.21 151.45 38.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.051 0.94 . . . . 0.0 109.502 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.8 m -110.2 114.29 27.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.396 1.078 . . . . 0.0 108.733 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.88 145.96 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -133.43 176.98 8.05 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 112.111 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.42 27.09 57.78 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.788 1.185 . . . . 0.0 113.935 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.9 mt -79.32 -179.13 6.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.153 0.977 . . . . 0.0 110.075 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -96.8 139.23 21.47 Favored Pre-proline 0 CA--C 1.516 -0.365 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.63 159.97 47.56 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.513 2.142 . . . . 0.0 110.32 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 t30 48.53 34.79 5.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.94 1.696 . . . . 0.0 111.8 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.1 m -133.19 132.89 42.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.111 1.764 . . . . 0.0 107.581 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.31 147.87 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -131.58 159.16 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 156.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mt -107.52 157.71 17.8 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 152.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -132.72 152.12 51.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 125.828 1.955 . . . . 0.0 107.369 172.511 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.61 165.84 23.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 162.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.67 145.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.653 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.8 mtp180 -120.95 147.62 45.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 162.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.99 159.05 19.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.499 HG22 ' HB2' ' A' ' 47' ' ' SER . 1.5 mt -121.28 150.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 126.316 1.846 . . . . 0.0 107.535 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.62 172.2 5.49 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 127.138 2.175 . . . . 0.0 107.322 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.9 -23.93 74.37 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.65 2.233 . . . . 0.0 114.985 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -105.64 -45.99 4.28 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.576 1.55 . . . . 0.0 110.407 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.84 35.29 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 122.739 1.188 . . . . 0.0 112.214 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.653 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.3 mp -84.86 166.75 16.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -72.36 166.24 22.91 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 122.171 0.986 . . . . 0.0 109.619 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.81 159.88 1.64 Allowed Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.148 152.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.24 148.3 61.66 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.091 1.194 . . . . 0.0 111.182 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.1 p -62.38 167.51 5.25 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 159.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.97 150.34 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.427 1.418 . . . . 0.0 109.724 152.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -69.04 154.85 41.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.648 166.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.1 p -60.54 -7.53 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.578 2.351 . . . . 0.0 115.143 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.7 153.63 0.14 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 127.333 2.253 . . . . 0.0 109.169 -155.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -77.55 108.5 2.59 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.976 2.451 . . . . 0.0 108.603 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 24' ' ' VAL . 3.6 m -108.49 133.23 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 124.544 1.138 . . . . 0.0 109.156 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -92.66 135.27 34.24 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.7 p -63.68 154.32 33.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.971 0.891 . . . . 0.0 109.185 164.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.44 171.66 0.57 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 123.614 1.673 . . . . 0.0 110.02 163.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.5 t0 . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.925 169.034 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 118.434 -0.794 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.52 159.45 36.29 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.078 3.852 . . . . 0.0 113.425 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.66 141.94 46.1 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.825 1.202 . . . . 0.0 111.227 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.84 147.49 80.88 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.255 1.97 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.9 164.76 15.68 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.583 2.189 . . . . 0.0 112.413 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -74.91 167.87 21.04 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.707 0.803 . . . . 0.0 110.037 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -59.4 117.83 25.55 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.854 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.03 157.33 60.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 120.619 1.257 . . . . 0.0 111.182 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -124.24 146.86 48.47 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 126.789 2.036 . . . . 0.0 109.367 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 107' ' ' VAL . 2.5 m -96.75 139.03 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 C-N-CA 124.511 1.124 . . . . 0.0 108.309 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -128.74 -79.78 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.533 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.05 130.73 42.28 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.53 137.09 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.4 p -115.47 -74.33 0.62 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -162.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -171.34 -29.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 1 C-N-CA 133.272 4.629 . . . . 0.0 108.638 161.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.8 -15.47 14.1 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.821 1.648 . . . . 0.0 109.944 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 m -142.33 159.37 42.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.604 0.638 . . . . 0.0 110.094 -167.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.428 HG12 ' CD1' ' A' ' 79' ' ' LEU . 1.8 p -153.13 128.92 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.8 m -86.13 138.72 31.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.448 1.099 . . . . 0.0 110.066 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -113.04 141.38 46.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 107.931 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -130.77 129.45 42.47 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 126.99 2.116 . . . . 0.0 108.381 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -140.34 170.59 15.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.538 0.685 . . . . 0.0 112.19 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -98.77 145.63 30.27 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 124.324 1.05 . . . . 0.0 108.749 164.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.32 139.39 14.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 124.478 3.452 . . . . 0.0 109.483 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.75 -179.06 44.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 165.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.6 m -87.04 151.01 51.13 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 128.312 2.645 . . . . 0.0 110.163 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.81 -174.87 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.664 3.576 . . . . 0.0 111.757 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.98 -126.41 0.82 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 p -57.13 -31.02 64.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.266 2.626 . . . . 0.0 114.318 -173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 mt -130.95 164.91 38.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.35 1.46 . . . . 0.0 109.234 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.78 135.7 6.87 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.993 2.462 . . . . 0.0 109.843 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.9 149.97 43.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.328 164.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -125.06 -56.7 1.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.628 1.171 . . . . 0.0 109.014 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 92' ' ' ILE . . . -152.55 -177.38 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 91' ' ' ALA . 89.1 m-85 -122.91 173.17 7.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.755 0.822 . . . . 0.0 109.204 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.3 mt -121.49 152.86 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 126.835 2.054 . . . . 0.0 106.448 166.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -123.29 137.44 56.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 160.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.52 164.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.514 1.125 . . . . 0.0 108.56 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.18 163.7 32.16 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.44 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -159.32 124.07 4.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 108.7 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.69 ' HB3' HG22 ' A' ' 58' ' ' VAL . 12.6 t -106.17 1.63 26.31 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.381 1.072 . . . . 0.0 112.457 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 53.46 3.09 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -167.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.53 1.24 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.651 -1.28 . . . . 0.0 111.907 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 55' ' ' SER . 1.6 m -74.69 -78.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 109.327 173.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.407 ' H ' HG23 ' A' ' 58' ' ' VAL . 37.2 m -121.35 15.35 11.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.549 1.14 . . . . 0.0 110.848 164.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 53.86 27.16 6.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.298 1.439 . . . . 0.0 110.835 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.6 m -144.41 151.81 39.78 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.825 2.85 . . . . 0.0 108.503 -167.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -78.76 142.74 36.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 109.911 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -135.76 135.88 40.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.276 0.631 . . . . 0.0 109.71 -169.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.79 94.34 1.39 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -81.65 -21.75 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.053 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.39 107.34 3.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.84 168.09 16.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 169.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 36.5 58.61 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.84 2.456 . . . . 0.0 112.627 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.93 118.59 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -111.5 50.07 0.85 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.62 1.168 . . . . 0.0 108.645 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -156.14 -177.75 6.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.727 1.211 . . . . 0.0 108.064 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -118.58 0.98 11.65 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.909 2.883 . . . . 0.0 110.917 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 111.38 7.08 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.731 1.213 . . . . 0.0 109.182 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -141.19 127.77 20.13 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.737 0.815 . . . . 0.0 111.164 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.4 m -75.96 103.16 5.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.169 2.188 . . . . 0.0 109.229 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.7 t -70.15 147.34 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 166.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -135.96 174.49 10.55 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.046 1.339 . . . . 0.0 113.591 -168.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.09 6.07 82.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.117 1.817 . . . . 0.0 114.718 168.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD1' HG12 ' A' ' 32' ' ' VAL . 24.9 mt -74.48 171.96 12.83 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.17 1.788 . . . . 0.0 111.111 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.0 142.77 29.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 126.011 1.724 . . . . 0.0 108.567 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.76 156.57 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 109.461 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 40.51 48.07 2.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.089 1.756 . . . . 0.0 111.958 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.5 m -133.64 132.73 41.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.918 1.687 . . . . 0.0 106.761 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.27 146.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.96 157.15 46.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 160.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' SD ' ' A' ' 103' ' ' MET . 70.7 mt -107.35 157.13 18.19 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 127.504 2.322 . . . . 0.0 106.271 158.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -138.5 146.23 41.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 126.195 2.185 . . . . 0.0 107.862 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.1 mtm -142.53 152.51 42.7 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.13 144.04 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 125.366 1.466 . . . . 0.0 107.187 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.477 ' HD3' HD13 ' A' ' 97' ' ' LEU . 43.7 mtt180 -128.65 139.87 52.04 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 169.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 49' ' ' TYR . . . -86.89 149.14 25.02 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -123.53 145.29 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.218 1.007 . . . . 0.0 109.889 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -150.46 177.24 1.92 Allowed Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 109.109 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.69 67.24 8.48 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.072 2.514 . . . . 0.0 110.135 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -163.88 -73.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.835 2.854 . . . . 0.0 104.637 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.53 -164.34 12.09 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 126.136 1.827 . . . . 0.0 110.93 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.477 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -101.14 151.59 21.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.13 1.372 . . . . 0.0 108.381 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.4 p -72.67 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.179 1.792 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -50.66 150.29 5.13 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.368 158.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.33 161.0 45.1 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.316 1.344 . . . . 0.0 111.106 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 91.8 p -55.57 167.61 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.258 163.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.52 144.25 10.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 121.66 1.573 . . . . 0.0 110.484 151.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' MET . . . . . 0.474 ' SD ' HD13 ' A' ' 86' ' ' LEU . 22.4 mtm -64.65 144.86 56.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.442 0.697 . . . . 0.0 109.789 171.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -63.99 -9.55 16.46 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 127.187 2.195 . . . . 0.0 113.736 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 77.56 155.28 0.14 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 128.808 2.843 . . . . 0.0 108.792 -160.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -73.14 117.94 5.33 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.591 2.194 . . . . 0.0 108.53 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 24' ' ' VAL . 2.7 m -116.48 135.1 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.956 1.302 . . . . 0.0 110.083 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 142.37 27.77 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.5 p -73.46 159.33 33.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.428 1.585 . . . . 0.0 109.495 162.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -66.27 175.04 2.32 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.955 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.1 t0 . . . . . 0 N--CA 1.443 -0.805 0 CA-C-N 111.623 -2.535 . . . . 0.0 110.086 163.371 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' LEU . 86.1 mt . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -61.76 164.8 15.22 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.765 2.31 . . . . 0.0 111.806 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.17 126.61 28.79 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 164.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.95 154.49 61.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.215 1.943 . . . . 0.0 111.82 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -80.06 173.16 13.0 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.457 2.771 . . . . 0.0 111.236 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -66.61 170.13 6.74 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.702 -0.624 . . . . 0.0 111.373 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -49.9 124.41 16.54 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 150.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 150.1 74.77 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 121.203 1.269 . . . . 0.0 109.178 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -111.78 124.29 52.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.65 142.46 16.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.353 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.5 p -122.01 -87.63 0.63 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.92 134.59 38.9 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 109.049 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.77 138.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 119.099 0.863 . . . . 0.0 109.697 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -126.87 -162.21 1.13 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.998 1.719 . . . . 0.0 107.861 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -77.18 -29.06 54.21 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 121.192 -0.943 . . . . 0.0 111.075 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -150.87 14.57 0.73 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.199 0.909 . . . . 0.0 111.955 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -127.27 163.08 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.782 159.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.78 146.86 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.692 1.597 . . . . 0.0 107.38 169.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.9 m -102.07 149.43 24.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.469 1.508 . . . . 0.0 109.084 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.38 148.46 51.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.261 2.624 . . . . 0.0 107.535 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -139.94 114.71 9.47 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.515 1.134 . . . . 0.0 108.998 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CH2' HD11 ' A' ' 51' ' ' ILE . 42.6 p90 -134.87 153.11 52.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.903 0.774 . . . . 0.0 111.217 -176.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -93.48 140.9 23.3 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.49 148.29 18.27 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 124.096 3.197 . . . . 0.0 108.987 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.76 -178.05 52.21 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 122.27 0.928 . . . . 0.0 111.632 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -55.12 153.95 11.44 Favored Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.957 2.103 . . . . 0.0 108.444 158.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 -114.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.143 3.229 . . . . 0.0 108.51 162.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.4 -109.81 0.42 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 164.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.8 p -60.35 -35.3 75.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.729 2.012 . . . . 0.0 111.819 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 mt -132.63 169.24 14.46 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.849 1.66 . . . . 0.0 109.07 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.48 155.74 14.16 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.507 2.805 . . . . 0.0 109.271 168.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 160.46 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.551 0.691 . . . . 0.0 109.656 171.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.429 ' HB2' HG22 ' A' ' 92' ' ' ILE . 3.5 m -117.81 -43.37 2.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.074 1.75 . . . . 0.0 109.822 -175.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.0 -172.27 1.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.468 1.107 . . . . 0.0 109.592 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.714 ' HB2' HG23 ' A' ' 69' ' ' VAL . 12.4 m-85 -116.78 165.6 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.729 1.612 . . . . 0.0 107.961 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.88 154.04 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 129.361 3.064 . . . . 0.0 104.833 168.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.455 HD11 ' CH2' ' A' ' 36' ' ' TRP . 82.2 mt -129.29 135.9 60.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 166.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.84 156.51 29.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.17 157.87 45.69 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.032 1.333 . . . . 0.0 108.193 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.96 163.11 35.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.915 1.686 . . . . 0.0 109.81 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -156.75 -38.69 0.08 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -161.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 64.09 -22.46 0.07 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.71 2.404 . . . . 0.0 116.585 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.25 -24.45 11.5 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 121.036 1.744 . . . . 0.0 112.109 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 80' ' ' ARG . 78.3 t -69.9 -77.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 120.209 1.368 . . . . 0.0 109.418 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -135.49 22.91 3.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.511 1.125 . . . . 0.0 111.535 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 t30 23.22 60.23 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 C-N-CA 129.367 3.067 . . . . 0.0 112.815 176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.7 m -165.74 158.61 15.42 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.674 1.989 . . . . 0.0 108.952 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.462 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 67.3 m95 -72.46 123.85 23.96 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 162.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -113.24 139.17 49.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -83.41 94.36 7.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 m -82.33 -19.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.366 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.62 143.31 32.34 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.14 0.976 . . . . 0.0 108.488 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.91 157.2 47.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.338 0.655 . . . . 0.0 109.553 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m170 52.71 32.78 12.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.45 1.5 . . . . 0.0 111.922 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 49' ' ' TYR . 3.2 m -74.39 154.28 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.326 1.06 . . . . 0.0 110.229 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -134.73 54.14 1.96 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -148.6 176.41 10.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.585 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 p -117.41 -3.04 11.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.441 1.497 . . . . 0.0 111.698 169.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.23 133.55 47.58 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.068 1.347 . . . . 0.0 108.949 166.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.538 ' CD2' HG11 ' A' ' 69' ' ' VAL . 27.3 t80 -146.48 146.31 30.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -108.09 97.85 7.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.919 1.688 . . . . 0.0 108.904 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.95 134.83 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -128.16 171.82 11.57 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.285 0.634 . . . . 0.0 112.028 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.13 50.95 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.99 1.281 . . . . 0.0 112.994 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.1 mt -83.32 -166.84 1.47 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.743 1.217 . . . . 0.0 109.51 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HD2' HG22 ' A' ' 58' ' ' VAL . 12.9 mtt85 -121.45 143.72 38.42 Favored Pre-proline 0 CA--C 1.517 -0.326 0 C-N-CA 124.422 1.089 . . . . 0.0 109.502 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.95 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.481 2.787 . . . . 0.0 111.822 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 55.02 3.83 0.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.016 2.526 . . . . 0.0 116.24 -176.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.2 m -101.3 130.66 47.5 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.34 1.856 . . . . 0.0 108.746 -166.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 mm -68.71 147.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.27 165.3 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.654 1.181 . . . . 0.0 108.928 168.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -117.39 157.95 25.29 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 125.53 1.532 . . . . 0.0 108.121 162.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -143.07 131.43 22.15 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 125.298 1.624 . . . . 0.0 109.283 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . 0.462 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 5.4 mtt -115.67 173.31 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.89 151.8 35.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.426 ' HD3' HD13 ' A' ' 97' ' ' LEU . 95.4 mtt180 -138.65 121.9 17.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . . . -86.15 118.95 25.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.8 OUTLIER -86.14 148.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 108.996 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.76 173.6 4.21 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.773 1.629 . . . . 0.0 108.632 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.99 23.58 0.4 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.119 2.546 . . . . 0.0 113.658 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -130.38 -17.45 3.35 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.839 1.656 . . . . 0.0 113.919 173.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.47 9.4 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 123.909 0.766 . . . . 0.0 112.371 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 15' ' ' LEU . 4.1 pp -129.81 144.7 51.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.229 1.812 . . . . 0.0 107.768 177.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -72.33 159.37 34.14 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 109.737 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -48.86 132.31 14.65 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.084 0.954 . . . . 0.0 110.388 -172.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -51.04 113.96 1.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.112 3.208 . . . . 0.0 111.49 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 p -52.67 159.23 1.8 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.648 0.779 . . . . 0.0 112.832 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -52.26 144.14 40.17 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.863 3.042 . . . . 0.0 111.073 163.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.5 mtp -67.28 144.43 55.91 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.506 0.722 . . . . 0.0 112.619 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.3 p -65.7 -5.19 7.84 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.818 2.447 . . . . 0.0 116.1 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.46 144.64 0.1 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.139 1.776 . . . . 0.0 111.024 -165.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.58 106.84 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.166 2.578 . . . . 0.0 110.849 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.9 m -105.0 140.61 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.383 1.473 . . . . 0.0 109.965 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -87.15 -174.4 4.87 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.524 0.73 . . . . 0.0 109.98 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.0 p -130.99 158.23 40.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.364 1.866 . . . . 0.0 107.195 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -68.38 173.29 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.825 0.821 . . . . 0.0 110.039 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.94 172.829 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.788 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -71.43 -0.38 10.19 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.519 1.159 . . . . 0.0 113.669 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -133.31 160.01 38.59 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 150.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.18 14.88 1.3 Allowed Glycine 0 CA--C 1.522 0.492 0 C-N-CA 126.274 1.892 . . . . 0.0 111.748 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.7 155.49 44.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.742 1.271 . . . . 0.0 109.086 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -155.25 176.58 12.38 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.588 1.955 . . . . 0.0 107.266 171.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.0 -59.36 9.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -79.15 167.94 20.31 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 122.149 -0.618 . . . . 0.0 109.514 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -130.76 123.32 28.93 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.71 -179.98 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.66 1.984 . . . . 0.0 113.5 -174.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.52 164.46 38.19 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.983 1.713 . . . . 0.0 107.036 169.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.3 mt -86.74 65.89 9.21 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 165.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 t -142.05 145.38 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.329 0.652 . . . . 0.0 110.851 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -120.15 19.99 12.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.993 1.717 . . . . 0.0 110.437 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt -107.34 159.06 31.52 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 126.321 1.848 . . . . 0.0 110.439 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 161.14 24.23 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 111.606 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.53 141.81 30.29 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 162.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -69.48 162.42 42.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.421 2.081 . . . . 0.0 113.031 -168.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.37 168.34 9.75 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.194 2.596 . . . . 0.0 112.825 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -74.83 169.97 16.84 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 110.199 168.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -56.22 134.23 75.27 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 167.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.37 164.9 16.41 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 CA-C-O 124.04 1.6 . . . . 0.0 112.697 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -105.25 172.12 6.96 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 128.909 2.884 . . . . 0.0 106.644 162.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -123.75 137.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.119 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.9 p -124.32 -90.66 0.56 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.699 0.625 . . . . 0.0 110.646 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.94 138.71 42.52 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 125.343 1.457 . . . . 0.0 107.914 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.47 155.05 22.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.48 1.037 . . . . 0.0 110.046 163.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -137.33 -159.88 1.0 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.208 1.403 . . . . 0.0 108.039 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -65.1 -31.61 72.9 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.545 167.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -152.54 1.66 0.32 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -113.66 152.55 30.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.178 0.899 . . . . 0.0 108.919 162.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -147.87 148.44 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.4 m -110.31 133.83 52.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.16 140.03 48.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.356 1.863 . . . . 0.0 107.004 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.76 135.17 49.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 174.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -138.72 171.57 14.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 120.582 1.537 . . . . 0.0 108.628 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.71 142.77 25.66 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.609 1.164 . . . . 0.0 108.7 168.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.4 170.49 20.11 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.769 2.313 . . . . 0.0 112.707 -161.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.47 -175.6 22.93 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 164.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.53 149.19 71.09 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.84 -179.81 5.54 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.652 2.901 . . . . 0.0 113.13 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.36 -99.02 0.15 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -57.83 -51.95 67.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.452 1.901 . . . . 0.0 110.565 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.61 166.26 25.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 124.271 1.028 . . . . 0.0 110.278 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.93 167.51 25.06 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.292 3.328 . . . . 0.0 109.382 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.51 25.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.962 1.705 . . . . 0.0 109.04 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -94.54 -57.23 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.326 1.051 . . . . 0.0 109.713 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.61 -171.24 2.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.269 0.94 . . . . 0.0 108.932 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.39 164.9 16.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -118.03 159.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.85 2.06 . . . . 0.0 106.484 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -124.2 134.31 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 158.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.32 160.98 15.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 166.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.84 162.38 34.13 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.328 1.851 . . . . 0.0 107.313 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -148.07 141.0 24.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -155.79 121.36 4.93 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.71 -34.84 74.99 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.24 0.543 . . . . 0.0 111.693 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.08 17.22 3.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.11 2.564 . . . . 0.0 114.033 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.2 -73.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 t -147.7 146.54 29.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.59 -0.31 2.75 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.173 1.389 . . . . 0.0 113.681 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -102.62 155.67 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.974 2.51 . . . . 0.0 111.882 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -74.74 136.05 41.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 153.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.19 155.16 49.82 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.112 0.869 . . . . 0.0 110.528 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.97 130.65 43.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.296 1.438 . . . . 0.0 107.801 170.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.6 -6.75 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.058 1.343 . . . . 0.0 112.149 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.52 152.73 36.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 149.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -135.81 140.88 44.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.127 1.371 . . . . 0.0 108.421 -172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.45 43.77 29.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.661 1.184 . . . . 0.0 111.863 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.77 126.17 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 126.136 1.774 . . . . 0.0 107.161 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -108.2 15.2 24.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.798 0.839 . . . . 0.0 112.17 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -129.45 175.31 8.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.773 1.629 . . . . 0.0 109.306 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.5 p -112.42 -5.73 14.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.538 2.335 . . . . 0.0 111.545 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -135.73 123.18 22.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -145.9 121.14 10.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.859 0.754 . . . . 0.0 112.31 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.4 m -69.84 103.66 2.26 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.682 1.993 . . . . 0.0 110.241 164.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 76' ' ' VAL . 9.9 t -60.9 148.64 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 126.936 2.094 . . . . 0.0 107.932 158.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -140.2 175.32 9.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.055 1.342 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.47 7.68 87.08 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 123.803 0.716 . . . . 0.0 114.455 165.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.73 -171.66 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.62 1.168 . . . . 0.0 109.039 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -113.05 132.89 22.16 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -59.23 156.46 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.544 2.163 . . . . 0.0 112.28 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.1 t30 41.57 33.63 0.32 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.718 2.807 . . . . 0.0 113.78 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.8 m -120.66 135.73 55.03 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.386 1.874 . . . . 0.0 106.831 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.16 148.6 8.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.825 0.85 . . . . 0.0 109.081 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -141.36 149.49 41.21 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.733 1.213 . . . . 0.0 110.62 171.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -107.72 160.83 15.41 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.371 162.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.04 144.45 33.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 124.753 1.283 . . . . 0.0 108.521 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 62.0 mtm -130.45 153.49 48.72 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.08 148.27 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HD3' HD22 ' A' ' 97' ' ' LEU . 3.0 mtt180 -131.9 136.14 47.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.755 1.222 . . . . 0.0 108.249 176.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 152.13 22.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.82 148.15 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.005 2.122 . . . . 0.0 109.141 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -148.5 178.04 1.59 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 109.239 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.48 -2.68 2.72 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.602 2.868 . . . . 0.0 117.117 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -129.54 -17.42 3.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.393 1.451 . . . . 0.0 113.582 -167.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.33 -176.79 45.96 Favored Glycine 0 C--O 1.238 0.357 0 CA-C-N 119.527 1.058 . . . . 0.0 111.209 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.424 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.97 151.69 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 157.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 83.1 p -71.47 168.79 16.76 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.867 1.267 . . . . 0.0 110.102 168.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -42.07 149.04 0.45 Allowed Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.849 153.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.15 164.27 36.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.809 1.672 . . . . 0.0 110.952 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.2 p -67.14 167.07 15.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 159.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.57 149.89 4.36 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.257 1.971 . . . . 0.0 112.363 151.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.0 mtm -65.36 143.15 57.93 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.43 0.692 . . . . 0.0 111.405 166.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.2 t -54.01 -23.12 12.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.175 2.19 . . . . 0.0 113.621 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.54 154.14 0.13 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 127.055 2.142 . . . . 0.0 110.193 -162.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -68.89 110.05 2.28 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.384 2.723 . . . . 0.0 111.554 -159.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -75.4 162.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.64 133.52 54.98 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 163.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.4 p -62.67 169.34 3.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 166.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -81.91 -116.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -151.47 165.95 32.59 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 t -85.15 20.83 1.81 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.92 1.688 . . . . 0.0 111.232 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.83 174.79 52.57 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 163.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.0 -21.4 8.13 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.428 2.085 . . . . 0.0 112.599 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.1 m 54.17 48.07 21.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.156 1.383 . . . . 0.0 112.6 -166.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.27 106.73 6.05 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 159.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 N-CA-C 104.684 -3.366 . . . . 0.0 104.684 174.095 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.2 m -68.51 -29.9 68.59 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -169.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -87.23 132.01 34.03 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.38 -153.7 16.74 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 124.15 0.881 . . . . 0.0 112.056 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.3 p -76.74 86.92 3.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.32 1.048 . . . . 0.0 110.343 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -71.09 -60.32 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.669 0.788 . . . . 0.0 111.457 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.47 -166.08 27.36 Favored Glycine 0 C--O 1.239 0.414 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -163.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -137.9 93.08 2.73 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 169.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 60.33 73.14 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.462 1.905 . . . . 0.0 110.477 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -119.6 166.86 12.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.719 1.207 . . . . 0.0 108.794 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.64 168.28 4.96 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.951 1.3 . . . . 0.0 111.416 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.15 -121.82 0.29 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.438 1.495 . . . . 0.0 107.727 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.1 m -132.54 144.17 50.23 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.099 1.36 . . . . 0.0 109.249 -171.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -17.83 61.27 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.389 0.995 . . . . 0.0 110.891 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.8 mt -75.45 153.87 85.8 Favored Pre-proline 0 N--CA 1.444 -0.76 0 C-N-CA 123.455 0.702 . . . . 0.0 109.352 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -63.0 158.18 44.84 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.47 2.113 . . . . 0.0 110.85 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.92 143.08 48.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.2 152.93 79.96 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.877 1.718 . . . . 0.0 110.645 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -64.15 171.8 7.16 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.929 2.42 . . . . 0.0 111.646 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -74.12 174.56 8.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.623 0.769 . . . . 0.0 110.255 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -55.74 135.62 72.0 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.034 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.91 124.62 10.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.745 1.302 . . . . 0.0 109.95 160.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.64 171.46 12.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.636 161.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 107' ' ' VAL . 62.0 t -125.31 136.54 60.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 p -126.33 -66.59 0.91 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.812 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -104.69 139.48 39.46 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.937 0.895 . . . . 0.0 109.097 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.14 142.75 24.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 119.677 1.126 . . . . 0.0 110.147 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 p -130.41 -176.31 3.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.263 1.825 . . . . 0.0 109.107 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -63.86 -17.77 63.49 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 120.868 -1.145 . . . . 0.0 113.307 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.34 13.13 1.08 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 120.357 -1.464 . . . . 0.0 113.113 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.76 160.39 40.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.231 0.923 . . . . 0.0 110.421 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.18 129.09 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.512 0.725 . . . . 0.0 109.284 170.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -81.05 120.39 24.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.196 0.998 . . . . 0.0 108.345 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -90.34 157.1 17.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.961 1.305 . . . . 0.0 109.116 166.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -149.01 99.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.13 0.972 . . . . 0.0 109.071 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.564 ' CH2' HD11 ' A' ' 51' ' ' ILE . 29.4 p90 -105.44 161.63 14.16 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.777 0.831 . . . . 0.0 109.083 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -95.45 147.55 33.2 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 165.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.19 171.77 16.18 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.79 2.993 . . . . 0.0 111.94 -167.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.42 177.48 33.48 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 168.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.503 HG23 ' HD2' ' A' ' 41' ' ' PRO . 2.8 m -107.57 157.69 35.14 Favored Pre-proline 0 N--CA 1.443 -0.793 0 C-N-CA 127.75 2.42 . . . . 0.0 109.874 -174.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 40' ' ' THR . 40.1 Cg_endo -71.42 -159.96 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 125.014 3.809 . . . . 0.0 113.073 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.38 -123.05 0.8 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 170.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 p -72.35 -27.62 62.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.981 1.712 . . . . 0.0 112.415 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 mt -136.33 149.23 67.17 Favored Pre-proline 0 C--O 1.24 0.56 0 C-N-CA 123.311 0.644 . . . . 0.0 112.244 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.54 163.94 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.541 3.494 . . . . 0.0 110.891 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.75 141.5 28.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -112.77 -32.53 6.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.007 1.723 . . . . 0.0 112.198 -168.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.87 -162.03 0.67 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 159.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.12 165.09 14.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.306 1.443 . . . . 0.0 108.384 157.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -116.71 152.56 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.736 2.414 . . . . 0.0 105.288 164.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.564 HD11 ' CH2' ' A' ' 36' ' ' TRP . 83.2 mt -127.59 135.18 63.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 166.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -121.16 159.4 25.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -137.87 161.52 36.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.131 1.372 . . . . 0.0 108.246 174.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -138.87 135.89 34.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.762 ' HB3' HG22 ' A' ' 58' ' ' VAL . 5.1 t -115.98 149.29 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.581 1.082 . . . . 0.0 108.123 155.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -80.53 16.26 1.41 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.966 0.506 . . . . 0.0 111.001 162.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -132.35 10.99 4.51 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.542 -1.349 . . . . 0.0 110.417 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 55' ' ' SER 0.311 34.8 m -121.84 -91.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.381 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.596 ' H ' HG23 ' A' ' 58' ' ' VAL . 10.9 m -119.32 5.32 11.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 121.436 1.925 . . . . 0.0 113.179 -175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.28 21.19 1.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.783 1.633 . . . . 0.0 112.925 -171.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.4 m -122.17 163.98 18.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.579 3.151 . . . . 0.0 108.896 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.77 144.88 25.6 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 165.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -138.24 143.14 39.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.33 96.0 1.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.423 1.089 . . . . 0.0 108.178 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 53' ' ' ALA . 33.0 m -82.9 -16.95 11.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 121.86 -0.525 . . . . 0.0 110.969 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.95 134.53 22.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 162.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -121.01 136.67 54.93 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 52.6 69.93 0.63 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.746 2.019 . . . . 0.0 112.418 -171.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.0 129.87 39.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.579 1.552 . . . . 0.0 107.575 168.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -117.42 38.13 3.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.428 1.091 . . . . 0.0 110.573 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -151.75 -178.49 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.044 1.738 . . . . 0.0 107.515 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p -113.23 -2.52 14.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.095 2.558 . . . . 0.0 111.9 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.93 139.7 46.31 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -146.66 140.94 26.36 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.1 m -94.18 102.57 14.6 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 174.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.87 135.99 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -130.82 178.85 6.35 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.42 1.088 . . . . 0.0 110.778 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.01 6.68 74.32 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.93 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.4 mt -72.17 -176.72 1.87 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.625 1.212 . . . . 0.0 110.381 -172.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.4 mtp85 -108.51 149.83 39.87 Favored Pre-proline 0 CA--C 1.513 -0.471 0 C-N-CA 125.25 1.42 . . . . 0.0 108.608 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.42 154.52 24.45 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.873 1.715 . . . . 0.0 111.638 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.62 16.99 0.34 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.894 2.078 . . . . 0.0 114.373 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.9 m -102.11 133.01 47.64 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.123 2.169 . . . . 0.0 108.354 -172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.7 mm -70.04 148.43 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.54 158.27 44.06 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.52 164.99 12.0 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.647 1.179 . . . . 0.0 108.437 160.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.56 145.67 33.83 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.722 1.889 . . . . 0.0 109.643 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.3 mtm -135.42 162.84 31.48 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.732 1.213 . . . . 0.0 107.916 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.64 143.27 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.787 2.035 . . . . 0.0 105.817 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.577 ' HD3' HD13 ' A' ' 97' ' ' LEU . 27.3 mtt85 -132.6 138.85 47.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 124.57 33.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -86.4 152.82 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.812 1.245 . . . . 0.0 108.518 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.88 168.02 11.84 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.513 1.925 . . . . 0.0 109.066 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.69 -9.87 8.19 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.391 3.394 . . . . 0.0 117.05 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -111.48 -43.26 3.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.462 1.505 . . . . 0.0 110.141 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.08 -149.65 6.21 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 119.063 0.847 . . . . 0.0 111.074 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.577 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -129.85 158.98 37.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.662 1.585 . . . . 0.0 108.7 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.1 p -71.89 167.09 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 111.308 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -47.26 151.15 1.33 Allowed Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 154.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.7 148.19 52.39 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.431 1.421 . . . . 0.0 110.338 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.4 p -50.46 151.99 3.55 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.023 163.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -47.41 122.52 6.76 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.942 1.762 . . . . 0.0 107.88 153.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.8 ttm -58.11 148.67 25.79 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 124.212 1.005 . . . . 0.0 109.871 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.5 p -60.38 162.5 6.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 123.047 1.403 . . . . 0.0 109.471 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.63 154.53 68.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.658 164.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.68 92.6 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.198 2.599 . . . . 0.0 111.846 -175.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 24' ' ' VAL . 2.2 m -84.17 163.44 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.525 1.53 . . . . 0.0 109.482 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.91 146.35 47.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 125.385 1.474 . . . . 0.0 109.006 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -61.58 161.7 9.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 159.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -75.75 178.32 6.21 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 168.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.54 153.85 29.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.833 0.825 . . . . 0.0 110.494 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -30.86 63.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.176 1.39 . . . . 0.0 113.437 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.94 163.09 30.43 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 119.524 1.056 . . . . 0.0 114.053 -162.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.28 82.24 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.268 3.312 . . . . 0.0 109.342 171.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.75 119.78 4.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.324 1.05 . . . . 0.0 109.203 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.0 m -73.46 99.48 3.0 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.474 0.71 . . . . 0.0 110.438 -167.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.639 -2.984 . . . . 0.0 105.639 -173.163 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.761 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 m 15.11 83.33 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 130.3 3.44 . . . . 0.0 114.916 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.5 m -69.59 106.47 3.04 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.342 1.457 . . . . 0.0 109.078 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.62 -17.79 0.07 OUTLIER Glycine 0 CA--C 1.519 0.292 0 CA-C-O 118.906 -0.941 . . . . 0.0 112.7 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m -72.04 123.9 23.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -156.82 166.73 32.54 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.036 0.935 . . . . 0.0 109.464 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.95 165.52 26.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 152.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -151.93 162.91 40.31 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 158.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -144.88 160.59 41.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 162.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.85 137.68 15.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 129.212 3.005 . . . . 0.0 106.72 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 t70 67.08 173.61 0.26 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.699 1.6 . . . . 0.0 110.463 -164.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 64.8 mt 5.46 85.63 0.01 OUTLIER 'General case' 0 C--N 1.348 0.517 0 C-N-CA 130.491 3.516 . . . . 0.0 113.483 -171.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.57 106.46 4.7 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -86.56 -20.83 27.38 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 165.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.61 160.04 74.97 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.76 2.024 . . . . 0.0 112.111 -160.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -59.27 156.12 36.88 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.678 2.252 . . . . 0.0 112.12 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.37 120.84 21.76 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 153.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.08 161.51 44.51 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.235 2.623 . . . . 0.0 111.103 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.38 158.16 57.0 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.282 1.988 . . . . 0.0 110.712 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -71.21 175.16 5.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.918 0.487 . . . . 0.0 110.835 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 103' ' ' MET . 83.8 tttt -53.54 120.83 23.71 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 104' ' ' SER . 8.4 Cg_endo -66.5 149.44 84.42 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 120.715 1.291 . . . . 0.0 109.374 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -79.21 170.94 15.89 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 161.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.0 t -122.68 121.61 63.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 129.151 2.981 . . . . 0.0 104.506 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.254 82.1 p -119.21 -84.81 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.859 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.71 150.07 37.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.106 1.321 . . . . 0.0 108.274 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.98 152.6 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.493 0.717 . . . . 0.0 109.769 163.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.4 p -141.21 -172.45 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 108.869 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -57.89 -37.08 73.33 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.141 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -136.19 17.21 3.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.866 1.666 . . . . 0.0 112.14 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -151.37 161.33 42.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.551 -1.343 . . . . 0.0 110.175 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.01 140.85 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.72 145.5 47.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.536 1.934 . . . . 0.0 107.522 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.68 114.47 9.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.446 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.492 ' CE2' ' HA ' ' A' ' 72' ' ' THR . 39.2 p90 -123.3 171.32 9.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.997 1.272 . . . . 0.0 110.208 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -97.87 144.98 28.98 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 165.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.24 133.3 24.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.192 3.261 . . . . 0.0 107.669 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.67 -178.54 43.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -62.1 152.95 76.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.069 1.348 . . . . 0.0 110.157 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.82 -148.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.911 3.741 . . . . 0.0 109.843 167.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -125.44 0.76 Allowed Glycine 0 C--N 1.333 0.4 0 O-C-N 118.941 -2.349 . . . . 0.0 109.478 163.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.3 p -49.78 -35.88 24.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.642 2.377 . . . . 0.0 110.112 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 59.9 mt -135.75 170.03 12.11 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 127.642 2.377 . . . . 0.0 109.495 -168.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 62.3 Cg_endo -78.48 170.07 18.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.896 3.064 . . . . 0.0 110.003 169.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.23 22.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 m -53.49 -49.45 67.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.28 2.632 . . . . 0.0 111.919 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.15 -162.2 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.126 0.97 . . . . 0.0 108.594 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -131.92 168.81 17.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.056 1.742 . . . . 0.0 107.752 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.0 165.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 129.266 3.027 . . . . 0.0 106.622 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.11 136.08 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 162.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -114.31 161.72 17.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.327 1.051 . . . . 0.0 108.314 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.76 150.19 36.81 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.125 1.37 . . . . 0.0 109.086 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -127.3 141.13 51.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.347 1.459 . . . . 0.0 107.533 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -144.85 136.65 25.67 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 153.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.85 -37.36 81.81 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.932 165.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -76.31 16.33 0.48 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.066 2.146 . . . . 0.0 113.966 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.51 -77.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 125.324 1.45 . . . . 0.0 107.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.15 21.19 0.97 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.898 0.479 . . . . 0.0 110.287 -176.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 36.66 51.02 0.87 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.687 2.395 . . . . 0.0 111.885 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -143.37 143.48 31.67 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -66.51 136.83 56.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 153.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.97 145.25 39.51 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.896 1.278 . . . . 0.0 107.624 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.08 125.53 24.77 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.36 -6.37 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.278 1.031 . . . . 0.0 112.243 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.93 151.33 33.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 154.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -132.92 150.45 52.16 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 44.32 64.46 1.31 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.163 1.785 . . . . 0.0 110.683 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.77 -28.45 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.319 1.848 . . . . 0.0 112.067 -161.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mttt 60.62 15.18 5.51 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.581 2.352 . . . . 0.0 114.172 163.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -137.42 -177.66 4.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.229 1.412 . . . . 0.0 108.063 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 36' ' ' TRP . 23.6 p -124.96 0.33 7.95 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.917 1.687 . . . . 0.0 111.351 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.71 112.2 10.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -145.58 151.5 38.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.059 0.845 . . . . 0.0 111.376 -175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -103.71 102.19 12.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.134 1.774 . . . . 0.0 109.06 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.41 139.73 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.559 1.544 . . . . 0.0 107.719 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -133.71 -170.25 2.46 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.814 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.6 73.49 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.668 -0.518 . . . . 0.0 112.688 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.41 -166.68 1.66 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.055 0.928 . . . . 0.0 109.346 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -116.44 155.13 48.92 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 126.706 2.002 . . . . 0.0 108.472 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.57 156.74 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.901 2.4 . . . . 0.0 111.835 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.8 t30 43.31 37.02 1.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.299 2.239 . . . . 0.0 112.712 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.3 m -121.89 131.25 53.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.992 1.717 . . . . 0.0 107.403 -174.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.2 mm -69.06 149.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.903 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -140.3 149.02 42.27 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.028 0.918 . . . . 0.0 111.289 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.92 162.58 13.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.129 156.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.85 166.71 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.707 1.88 . . . . 0.0 110.465 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 17.5 mtt -134.14 168.68 18.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 157.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.11 109.32 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.744 ' HD3' HD13 ' A' ' 97' ' ' LEU . 50.6 mtt180 -90.76 140.69 29.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.7 148.17 26.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.98 147.6 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 165.34 17.65 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -174.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.3 -20.89 71.43 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.457 1.438 . . . . 0.0 115.199 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.7 -38.66 11.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.398 1.479 . . . . 0.0 111.503 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.44 -149.7 6.28 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 118.905 0.775 . . . . 0.0 111.537 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.744 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -123.71 156.63 35.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.351 1.861 . . . . 0.0 106.424 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.4 p -76.05 167.39 21.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.621 0.768 . . . . 0.0 112.741 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.22 164.77 0.57 Allowed Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 122.055 -0.403 . . . . 0.0 111.116 161.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.12 127.43 6.02 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.709 2.273 . . . . 0.0 110.452 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.8 p -49.07 155.45 1.12 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 111.678 163.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -59.18 123.88 14.4 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.901 2.401 . . . . 0.0 108.698 164.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.423 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 4.3 mpp? -55.59 124.62 17.94 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.448 1.022 . . . . 0.0 109.933 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.441 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 73.0 p -54.68 -16.03 2.23 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.889 2.475 . . . . 0.0 115.356 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 92.04 146.5 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.421 1 C-N-CA 132.607 4.363 . . . . 0.0 109.575 168.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.29 107.81 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.394 2.729 . . . . 0.0 111.211 -153.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.47 169.52 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -126.8 148.14 49.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.71 1.604 . . . . 0.0 108.086 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.7 p -76.64 167.81 21.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.805 0.812 . . . . 0.0 110.966 166.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -77.32 178.25 7.28 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.719 -0.613 . . . . 0.0 110.119 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.49 164.72 22.78 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.945 0.898 . . . . 0.0 110.423 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.0 p -110.31 -5.3 15.28 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -109.69 -177.13 21.2 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.664 1.126 . . . . 0.0 111.569 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.66 116.08 4.38 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.362 2.708 . . . . 0.0 109.299 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.1 m -161.61 38.99 0.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.768 2.427 . . . . 0.0 108.116 169.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.4 t -89.5 -77.95 0.37 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 162.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.532 0 N-CA-C 104.763 -3.335 . . . . 0.0 104.763 126.726 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.949 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.7 m -132.47 122.02 24.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.869 1.668 . . . . 0.0 108.671 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 p -87.08 65.34 8.87 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.2 1.4 . . . . 0.0 112.911 -165.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.41 -167.72 3.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.939 0.78 . . . . 0.0 111.983 170.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 p -54.39 123.34 12.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.022 0.929 . . . . 0.0 110.64 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 m -76.65 -176.88 3.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.088 0.555 . . . . 0.0 110.471 164.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.96 41.85 1.37 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.336 1.445 . . . . 0.0 109.996 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -149.03 28.78 0.82 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.84 2.056 . . . . 0.0 110.044 -171.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -144.19 103.54 4.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -158.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -112.4 11.57 19.97 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.389 1.475 . . . . 0.0 110.993 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -57.69 146.14 31.94 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.171 0.989 . . . . 0.0 110.382 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -91.59 52.0 1.97 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.664 1.585 . . . . 0.0 108.735 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.4 t 46.48 79.79 0.05 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.616 2.366 . . . . 0.0 113.892 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.81 7.97 18.93 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.22 -0.925 . . . . 0.0 111.792 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.04 167.35 13.77 Favored Pre-proline 0 CA--C 1.537 0.478 0 O-C-N 119.563 -1.96 . . . . 0.0 109.068 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.76 141.02 77.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.446 1.431 . . . . 0.0 109.775 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.34 138.75 45.44 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 163.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.36 153.49 55.87 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.276 1.984 . . . . 0.0 111.918 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.71 161.74 40.43 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.488 1.459 . . . . 0.0 110.343 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -77.48 173.82 11.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.105 0.562 . . . . 0.0 109.744 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -51.99 125.31 31.33 Favored Pre-proline 0 C--O 1.239 0.518 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.487 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.54 135.82 47.44 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.699 1.6 . . . . 0.0 109.78 169.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -91.37 134.47 34.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.841 1.256 . . . . 0.0 108.197 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.49 143.61 15.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 167.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 p -127.51 -97.45 0.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.84 135.69 56.8 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 126.05 1.74 . . . . 0.0 109.152 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.71 148.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.5 1.045 . . . . 0.0 110.654 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -137.82 -169.72 2.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.622 1.569 . . . . 0.0 109.547 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -57.55 -41.17 80.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.377 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -136.58 12.63 3.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.298 0.954 . . . . 0.0 112.481 -169.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -141.82 158.43 43.81 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.472 1.033 . . . . 0.0 110.336 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.97 134.14 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.318 1.047 . . . . 0.0 108.782 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -85.6 130.32 34.6 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 108.984 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.9 mt -109.49 146.12 35.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.003 1.721 . . . . 0.0 107.835 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.657 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.82 102.34 3.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.778 1.299 . . . . 0.0 107.993 -163.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.552 ' CH2' HD11 ' A' ' 51' ' ' ILE . 36.3 p90 -119.87 158.76 25.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.062 0.846 . . . . 0.0 110.986 -175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -81.77 134.94 49.5 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 164.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.3 157.76 56.14 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.868 3.045 . . . . 0.0 109.008 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.58 -176.62 35.58 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.752 1.168 . . . . 0.0 111.653 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 150.57 68.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.073 1.349 . . . . 0.0 109.855 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.11 -167.66 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 125.237 3.958 . . . . 0.0 112.54 169.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.61 -109.39 0.25 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 169.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 p -66.63 -46.09 76.94 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.105 2.162 . . . . 0.0 111.17 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' A' ' 94' ' ' PRO . 49.1 mt -128.46 162.27 51.92 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 124.14 0.976 . . . . 0.0 109.793 -164.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.14 145.28 27.51 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 108.159 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.84 158.38 25.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 -47.99 1.98 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.101 -170.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.23 -166.26 0.88 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -128.78 162.04 28.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.155 1.782 . . . . 0.0 109.217 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.84 152.19 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 128.733 2.813 . . . . 0.0 106.718 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.552 HD11 ' CH2' ' A' ' 36' ' ' TRP . 95.2 mt -137.94 105.22 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -101.04 136.67 40.51 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.743 1.217 . . . . 0.0 108.755 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.72 165.21 12.01 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.015 1.326 . . . . 0.0 109.258 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -137.89 145.26 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.804 1.242 . . . . 0.0 107.85 170.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -154.46 119.79 5.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -66.22 -19.06 65.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.63 12.77 22.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.019 0.928 . . . . 0.0 111.37 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.22 -59.82 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -158.86 137.56 11.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.384 1.874 . . . . 0.0 108.079 171.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.03 -17.51 63.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.001 0.819 . . . . 0.0 111.617 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 m -68.3 143.28 55.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.611 -0.68 . . . . 0.0 109.548 169.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -67.15 144.83 55.82 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -125.67 118.18 25.09 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 m -74.93 93.43 2.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.25 -17.67 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 0.0 111.076 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.28 149.47 34.92 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.97 147.97 42.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.477 1.911 . . . . 0.0 106.216 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.43 ' O ' ' HE2' ' A' ' 70' ' ' LYS . 8.9 m170 57.99 51.2 9.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.04 0.936 . . . . 0.0 111.211 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.2 t -82.61 139.11 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.389 1.476 . . . . 0.0 107.335 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 68' ' ' HIS . 3.5 mtmt -119.15 25.36 10.21 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.62 1.168 . . . . 0.0 112.243 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.2 t -143.93 173.2 11.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.177 0.991 . . . . 0.0 108.828 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -103.56 2.51 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.127 2.171 . . . . 0.0 112.042 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.657 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 4.7 tp -140.04 114.83 9.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.972 1.709 . . . . 0.0 107.425 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -145.65 120.97 10.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 118.148 0.431 . . . . 0.0 111.9 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.7 m -66.8 101.4 0.81 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.485 1.914 . . . . 0.0 109.08 164.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.92 144.83 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 162.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 50.7 mtt-85 -136.91 178.58 6.97 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.23 1.412 . . . . 0.0 110.502 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.56 80.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 123.5 0.571 . . . . 0.0 112.557 170.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.08 -172.75 4.33 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.704 0.752 . . . . 0.0 110.291 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -114.25 146.62 36.17 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 125.563 1.545 . . . . 0.0 107.811 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.71 154.12 30.39 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.492 2.128 . . . . 0.0 110.374 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.62 44.95 17.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.664 1.186 . . . . 0.0 111.465 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.9 m -131.13 136.26 48.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 mm -74.15 146.65 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.189 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.87 148.65 48.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.052 0.845 . . . . 0.0 109.457 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.25 161.02 15.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.617 -1.174 . . . . 0.0 107.899 158.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -143.85 143.12 31.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 126.001 2.063 . . . . 0.0 107.814 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 13.2 mtm -136.67 125.65 24.33 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 129.209 3.004 . . . . 0.0 107.479 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.1 t -94.59 145.78 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.434 ' HD3' HD13 ' A' ' 97' ' ' LEU . 35.1 mtt180 -131.63 128.6 39.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 167.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 125.12 33.97 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.27 148.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.549 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -135.77 179.81 1.27 Allowed Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.221 1.809 . . . . 0.0 107.403 166.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HG2' HD13 ' A' ' 44' ' ' LEU . 88.2 Cg_endo -74.67 -0.1 9.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 122.4 1.893 . . . . 0.0 113.812 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -116.72 -37.91 3.57 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.981 1.312 . . . . 0.0 110.301 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.26 -141.39 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.434 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -142.9 159.52 42.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.753 2.421 . . . . 0.0 106.729 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.0 p -72.05 166.61 21.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.333 0.653 . . . . 0.0 110.244 -169.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.31 148.42 3.28 Favored Pre-proline 0 C--O 1.244 0.771 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 160.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.33 130.17 20.63 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.923 1.749 . . . . 0.0 108.631 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -54.62 161.73 2.05 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.119 0.568 . . . . 0.0 111.817 165.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.93 138.14 69.36 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.342 2.028 . . . . 0.0 110.649 159.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -58.64 150.24 23.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.913 0.779 . . . . 0.0 109.999 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 88.2 p -63.14 -4.58 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.25 149.87 0.11 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.935 1.694 . . . . 0.0 110.808 -163.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.01 99.02 1.13 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.134 1.889 . . . . 0.0 112.636 -164.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.46 155.22 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.432 0.693 . . . . 0.0 109.167 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -108.1 150.95 26.53 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.108 1.363 . . . . 0.0 109.901 166.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.4 p -77.7 167.95 20.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.789 0.804 . . . . 0.0 111.407 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -77.45 178.82 6.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.275 0.63 . . . . 0.0 109.943 169.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.86 167.13 19.31 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 109.404 170.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.6 t -103.81 -0.22 29.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.268 2.227 . . . . 0.0 111.884 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -60.26 112.29 4.37 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 117.931 -1.483 . . . . 0.0 110.103 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.11 79.85 3.22 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.295 2.664 . . . . 0.0 110.895 -170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -134.4 138.03 44.51 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.8 m -166.6 164.23 16.93 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 129.027 2.931 . . . . 0.0 107.689 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 N-CA-C 106.433 -2.667 . . . . 0.0 106.433 179.063 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.748 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -52.5 158.1 1.34 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.372 1.086 . . . . 0.0 112.502 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.3 p -138.59 -39.19 0.52 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -166.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.7 -142.52 16.09 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -160.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -110.17 -29.78 8.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.704 1.202 . . . . 0.0 112.797 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 t -172.98 151.11 2.11 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.75 1.62 . . . . 0.0 107.505 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.16 -126.93 2.72 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -68.5 137.11 54.14 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 170.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -140.2 152.26 45.86 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 159.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -95.25 141.54 28.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 166.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.26 0.18 5.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.562 1.145 . . . . 0.0 113.153 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.22 65.06 5.25 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 127.354 2.262 . . . . 0.0 110.543 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.95 156.57 30.55 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.566 2.346 . . . . 0.0 108.08 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.15 -28.24 67.13 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.871 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.89 154.93 56.48 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.893 2.077 . . . . 0.0 111.667 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.43 149.6 84.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.434 2.089 . . . . 0.0 111.26 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -51.79 134.25 35.36 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.88 154.71 72.79 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.996 1.898 . . . . 0.0 111.361 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -60.81 168.55 6.92 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.743 2.295 . . . . 0.0 111.772 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.86 171.67 12.27 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -61.22 144.47 91.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.58 129.1 19.3 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.496 1.464 . . . . 0.0 111.337 161.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -81.64 158.18 24.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.017 2.127 . . . . 0.0 109.218 158.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.99 121.19 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.337 -1.756 . . . . 0.0 107.141 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.1 p -116.2 -95.67 0.47 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.329 -167.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.27 143.28 41.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.6 1.56 . . . . 0.0 109.653 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.37 148.96 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.719 0.808 . . . . 0.0 110.685 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 p -135.8 -168.33 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.399 1.48 . . . . 0.0 108.021 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -71.11 -16.32 62.56 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.444 -1.41 . . . . 0.0 112.642 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -152.36 15.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.099 -1.626 . . . . 0.0 112.633 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -139.43 161.85 36.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.46 140.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.446 1.499 . . . . 0.0 108.111 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -92.74 126.47 37.84 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.33 1.052 . . . . 0.0 108.642 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -107.35 139.8 41.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.133 1.773 . . . . 0.0 107.363 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -134.64 138.69 44.7 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 51' ' ' ILE . 14.1 p90 -139.32 171.19 14.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.199 0.523 . . . . 0.0 111.474 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -98.87 148.83 35.1 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.24 161.49 17.67 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.546 2.831 . . . . 0.0 111.44 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.1 -173.3 49.56 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 165.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.41 171.78 11.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.158 1.383 . . . . 0.0 108.588 169.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.31 -156.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.151 3.234 . . . . 0.0 109.565 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.9 -131.75 2.75 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 167.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -55.53 -27.58 49.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.942 2.097 . . . . 0.0 112.118 164.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 51.9 mt -144.58 162.39 39.28 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 127.612 2.365 . . . . 0.0 109.543 -156.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 92.6 Cg_endo -76.37 158.34 36.84 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.091 3.194 . . . . 0.0 110.989 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.68 128.9 41.67 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.96 -27.53 10.12 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.129 0.572 . . . . 0.0 111.508 -165.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.75 -165.97 1.64 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 160.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -128.83 169.74 14.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.785 2.034 . . . . 0.0 109.354 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.75 157.1 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 127.608 2.363 . . . . 0.0 107.214 171.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.492 HD11 ' CH2' ' A' ' 36' ' ' TRP . 55.9 mt -125.43 133.08 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 165.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -113.4 158.42 20.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.78 146.68 46.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.368 1.067 . . . . 0.0 108.223 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -109.34 146.88 33.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 166.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.53 124.94 5.21 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.677 0.671 . . . . 0.0 109.346 170.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.54 -34.97 72.86 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -169.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 7.41 11.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.85 0.75 . . . . 0.0 112.276 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.5 t -121.68 -55.34 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.717 1.207 . . . . 0.0 107.944 -171.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 t -141.31 -98.3 0.14 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 p30 140.49 -17.18 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.778 2.831 . . . . 0.0 111.119 -149.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -119.02 150.98 39.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.294 1.038 . . . . 0.0 110.187 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -70.6 121.86 18.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -118.84 143.52 46.9 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.323 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.92 93.95 3.3 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.66 -15.43 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.084 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.08 152.38 30.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.103 0.961 . . . . 0.0 108.944 161.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -142.93 170.24 16.07 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.762 0.825 . . . . 0.0 111.355 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 51.97 38.19 23.08 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.915 0.864 . . . . 0.0 112.422 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.65 127.84 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 125.845 1.658 . . . . 0.0 108.449 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -113.34 29.96 7.58 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.701 0.801 . . . . 0.0 112.253 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -150.47 173.6 13.88 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 108.305 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -98.48 2.9 48.12 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.658 2.383 . . . . 0.0 112.186 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.28 117.1 10.98 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.583 1.083 . . . . 0.0 110.325 -176.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -146.1 151.41 37.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.545 0.738 . . . . 0.0 111.591 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -101.19 103.4 14.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.142 1.377 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.1 139.21 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -139.93 176.07 9.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 111.386 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.77 79.59 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.63 0.633 . . . . 0.0 112.35 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.42 -175.79 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.489 0.715 . . . . 0.0 110.403 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -98.16 145.06 29.16 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.043 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -75.61 159.38 39.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.73 2.953 . . . . 0.0 111.686 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.6 t30 45.54 38.13 3.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.645 1.978 . . . . 0.0 111.842 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.2 m -132.18 134.13 45.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.538 1.135 . . . . 0.0 108.817 -170.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.34 141.52 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.09 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -139.17 154.48 48.08 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 125.056 1.473 . . . . 0.0 108.077 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.25 165.69 11.31 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.051 1.34 . . . . 0.0 108.302 164.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -137.28 140.07 41.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.952 0.782 . . . . 0.0 109.953 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 28.2 mtm -118.86 167.71 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 161.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.94 155.82 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -133.78 141.66 47.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 165.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.54 142.81 27.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 165.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.74 147.07 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 124.492 1.117 . . . . 0.0 109.243 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.81 171.2 6.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.95 22.64 0.47 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 123.683 2.922 . . . . 0.0 114.929 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -131.55 -34.3 1.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.905 1.682 . . . . 0.0 111.201 172.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.14 -165.26 33.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.515 1.052 . . . . 0.0 111.035 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -98.5 148.55 23.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 p -73.07 166.42 23.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.1 143.76 15.8 Favored Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 126.823 2.049 . . . . 0.0 110.301 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.99 127.77 22.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.858 1.705 . . . . 0.0 113.07 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -54.37 160.68 2.4 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.669 1.988 . . . . 0.0 112.666 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.94 120.79 8.74 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.136 1.891 . . . . 0.0 109.354 156.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 ptp -77.58 151.76 34.29 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 120.194 1.361 . . . . 0.0 109.182 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.4 t -58.95 154.47 15.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.464 1.106 . . . . 0.0 109.402 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.48 150.02 57.7 Favored Pre-proline 0 N--CA 1.475 0.792 0 O-C-N 120.874 -1.141 . . . . 0.0 109.465 158.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.09 102.98 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.104 2.536 . . . . 0.0 110.905 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.03 163.29 3.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -122.07 141.66 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.986 1.314 . . . . 0.0 107.655 164.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 p -68.07 161.08 27.58 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -66.74 -175.27 0.38 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.995 1.379 . . . . 0.0 109.205 163.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -104.34 153.84 20.55 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.065 -174.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.9 p -87.88 46.1 1.35 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.049 1.74 . . . . 0.0 111.939 -169.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -151.03 -140.46 3.18 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.258 1.408 . . . . 0.0 110.227 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.27 126.17 17.98 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.437 2.091 . . . . 0.0 109.309 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.9 t -141.62 124.77 16.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.77 2.028 . . . . 0.0 106.669 -167.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.1 m 52.75 178.46 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.208 1.403 . . . . 0.0 111.85 -158.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 N-CA-C 103.645 -3.782 . . . . 0.0 103.645 178.043 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.091 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t 57.75 177.85 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.098 0.949 . . . . 0.0 110.354 -149.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -164.55 178.73 7.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.512 2.725 . . . . 0.0 107.672 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.62 -172.73 52.31 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -175.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.4 m -153.71 142.59 21.11 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.449 -1.03 . . . . 0.0 108.39 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 m -176.18 176.59 1.69 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 129.087 2.955 . . . . 0.0 106.48 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.49 -68.82 0.47 Allowed Glycine 0 C--N 1.336 0.569 0 O-C-N 121.412 -0.805 . . . . 0.0 111.271 166.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.79 167.61 11.53 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 159.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -129.86 100.68 5.56 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.69 26.12 2.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.996 1.318 . . . . 0.0 113.379 -163.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -57.38 166.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.766 1.626 . . . . 0.0 112.694 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp -79.69 -106.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.888 0.875 . . . . 0.0 109.431 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.1 149.15 52.14 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.441 1.897 . . . . 0.0 107.686 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -19.38 65.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.68 1.592 . . . . 0.0 111.043 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.5 162.61 65.3 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 127.632 2.373 . . . . 0.0 110.353 -173.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.02 150.57 83.51 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.285 1.99 . . . . 0.0 108.872 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.37 147.97 41.61 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 163.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.52 147.1 63.67 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.143 1.896 . . . . 0.0 111.431 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -66.0 165.14 24.85 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.411 2.074 . . . . 0.0 110.528 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.2 p -67.71 169.39 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.787 -0.571 . . . . 0.0 110.763 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -48.62 127.65 13.54 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.538 155.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.48 142.82 45.67 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.787 1.317 . . . . 0.0 110.261 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.43 161.4 26.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.53 1.532 . . . . 0.0 109.351 163.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -124.35 105.21 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -110.65 -62.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.838 1.655 . . . . 0.0 111.124 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -111.02 136.0 50.69 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.216 1.807 . . . . 0.0 110.738 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.26 150.39 17.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 119.855 1.207 . . . . 0.0 110.588 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.5 p -139.88 -174.54 3.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.345 1.858 . . . . 0.0 107.818 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -72.6 -24.77 61.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.385 -1.447 . . . . 0.0 112.461 -175.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -131.81 4.65 4.2 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.167 1.349 . . . . 0.0 110.959 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 m -150.78 163.61 38.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.525 1.511 . . . . 0.0 110.356 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 p -156.74 136.76 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.145 1.378 . . . . 0.0 108.155 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -80.3 140.72 36.04 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -114.55 150.05 35.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 t -138.16 134.68 34.85 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.447 1.099 . . . . 0.0 108.515 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -138.98 170.23 16.35 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 110.387 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.32 138.08 25.8 Favored Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 164.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.66 140.45 47.08 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.99 3.127 . . . . 0.0 107.62 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 163.07 43.35 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 41' ' ' PRO . 3.0 m -73.3 143.36 82.95 Favored Pre-proline 0 N--CA 1.433 -1.308 0 C-N-CA 126.009 1.723 . . . . 0.0 110.938 -164.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' O ' HG22 ' A' ' 40' ' ' THR . 61.2 Cg_endo -71.53 -169.13 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.438 3.426 . . . . 0.0 111.758 166.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.82 -114.09 0.54 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 163.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -47.05 -40.68 15.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.763 2.825 . . . . 0.0 112.607 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 mt -134.7 163.24 52.58 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.273 1.029 . . . . 0.0 109.277 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.62 171.31 15.9 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.664 2.909 . . . . 0.0 110.809 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.03 107.14 16.91 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.253 1.021 . . . . 0.0 109.064 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' HG22 ' A' ' 92' ' ' ILE . 14.4 m -58.91 -51.4 70.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.144 2.578 . . . . 0.0 112.388 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.0 -164.88 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.973 -1.079 . . . . 0.0 108.191 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.72 164.23 24.44 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.9 2.08 . . . . 0.0 108.63 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mt -120.34 154.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 127.131 2.172 . . . . 0.0 106.563 161.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.62 124.97 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 156.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -100.78 151.92 21.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.61 151.38 51.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -123.47 151.0 43.18 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -140.53 136.17 32.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -56.85 -50.84 71.21 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.599 163.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -73.7 25.37 0.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.04 2.936 . . . . 0.0 113.469 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -135.7 -62.55 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.43 -5.38 0.66 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -165.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t30 46.63 36.52 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.372 1.469 . . . . 0.0 111.931 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.8 m -149.97 157.85 43.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 128.412 2.685 . . . . 0.0 105.187 -169.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.91 154.02 21.15 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -136.34 146.03 46.1 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.8 m -71.32 128.5 36.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.16 -12.36 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.18 74.94 0.93 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.347 1.859 . . . . 0.0 108.834 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.71 144.64 29.23 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.21 2.604 . . . . 0.0 109.185 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.403 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 57.8 m-70 38.32 60.81 1.23 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.911 2.085 . . . . 0.0 111.8 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.53 145.56 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -128.17 40.68 3.63 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.17 1.388 . . . . 0.0 110.355 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -148.0 -176.93 5.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -114.99 2.31 14.21 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.675 2.79 . . . . 0.0 110.991 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mp -135.43 143.85 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.531 0.733 . . . . 0.0 109.271 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -146.26 129.74 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 m -71.6 94.49 1.33 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.377 1.471 . . . . 0.0 107.515 161.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.97 138.02 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.99 179.82 6.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.917 1.287 . . . . 0.0 110.045 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.42 22.15 79.07 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.862 -0.41 . . . . 0.0 112.38 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt -87.0 172.36 10.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.576 1.179 . . . . 0.0 110.087 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 mtt85 -103.4 149.73 37.3 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 125.668 1.587 . . . . 0.0 107.345 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.11 160.02 40.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.779 1.653 . . . . 0.0 110.338 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 t30 46.5 33.15 1.85 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.018 1.327 . . . . 0.0 111.633 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.8 m -119.99 126.91 52.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.59 148.19 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.208 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -139.92 146.65 39.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.289 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.92 156.69 18.92 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 160.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -137.33 146.7 44.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.683 1.865 . . . . 0.0 107.816 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 45.0 mtm -134.53 137.84 44.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 160.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.95 139.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.551 ' HD3' HD22 ' A' ' 97' ' ' LEU . 73.6 mtt180 -120.43 146.53 46.12 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 168.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 163.97 16.49 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.2 OUTLIER -126.46 150.86 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 126.665 1.986 . . . . 0.0 108.806 174.539 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.85 169.91 9.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 0.0 110.165 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.98 19.24 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.06 2.506 . . . . 0.0 114.982 -174.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -127.85 -58.71 1.22 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 126.288 1.835 . . . . 0.0 110.091 166.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.66 -173.36 17.82 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 121.836 0.686 . . . . 0.0 113.983 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.1 mp -81.69 157.08 24.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.6 p -71.64 168.43 17.71 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.875 0.87 . . . . 0.0 109.757 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -41.6 142.19 1.07 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 151.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.59 156.15 64.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.676 1.584 . . . . 0.0 109.346 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 p -68.59 166.53 25.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.891 -0.505 . . . . 0.0 110.296 164.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -54.58 146.53 53.08 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 111.17 163.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.9 mtm -60.2 144.85 49.08 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.29 0.496 . . . . 0.0 110.14 171.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.0 p -62.93 -11.39 18.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.238 1.815 . . . . 0.0 115.175 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 t0 69.62 156.46 0.15 Allowed Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.411 -153.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -76.07 101.15 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.411 2.074 . . . . 0.0 111.375 -173.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.27 165.45 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -127.34 141.05 51.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.559 2.344 . . . . 0.0 107.612 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.6 p -74.39 161.14 30.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.044 0.838 . . . . 0.0 109.527 163.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -67.22 165.66 15.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.745 0.783 . . . . 0.0 109.896 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -89.04 39.65 0.94 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 123.608 1.67 . . . . 0.0 112.498 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 22.8 t 65.57 -71.43 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.964 2.106 . . . . 0.0 111.001 -173.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -154.28 76.27 0.22 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.408 1.48 . . . . 0.0 109.68 -173.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.34 86.64 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.883 2.389 . . . . 0.0 107.956 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 m 56.47 -177.48 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.397 1.479 . . . . 0.0 112.25 -162.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -117.83 62.09 0.76 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 N-CA-C 105.344 -3.102 . . . . 0.0 105.344 -167.731 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 t -85.24 161.31 19.62 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 118.43 1.115 . . . . 0.0 109.244 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 p -155.31 164.8 38.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.717 1.207 . . . . 0.0 108.903 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.12 -162.78 54.54 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 t 58.08 -167.2 0.14 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.007 0.923 . . . . 0.0 110.238 -166.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.6 m -76.2 38.39 0.17 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.599 1.959 . . . . 0.0 112.46 -175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.68 119.75 13.08 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 120.805 -1.184 . . . . 0.0 110.89 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -67.61 167.0 13.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.301 1.05 . . . . 0.0 108.627 159.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -137.82 110.45 7.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.2 t80 78.1 -58.89 0.45 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 127.828 2.451 . . . . 0.0 112.185 167.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -146.26 168.91 19.9 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.355 1.462 . . . . 0.0 108.23 172.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.78 40.76 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.787 0.835 . . . . 0.0 110.945 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 m 60.49 67.09 0.86 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.277 2.231 . . . . 0.0 111.232 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.62 56.96 4.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.836 1.303 . . . . 0.0 110.308 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt -130.99 156.75 79.69 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 126.278 1.831 . . . . 0.0 109.062 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.93 164.91 30.89 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.22 2.613 . . . . 0.0 111.457 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.97 149.65 49.5 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.75 141.01 44.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.334 2.689 . . . . 0.0 110.857 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -65.74 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.689 1.593 . . . . 0.0 110.203 170.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m -79.96 171.19 15.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -57.25 122.1 51.93 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.099 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.97 156.41 62.67 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.5 1.466 . . . . 0.0 109.358 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.75 124.68 43.91 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.88 151.24 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.787 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 p -136.53 -75.65 0.43 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.541 0.736 . . . . 0.0 109.47 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.12 135.46 37.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.77 157.19 20.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 162.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -141.13 -64.97 0.44 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -168.24 -39.25 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.208 2.203 . . . . 0.0 107.414 171.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -129.22 5.04 5.26 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.916 0.886 . . . . 0.0 110.863 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -152.5 152.17 31.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.592 0.633 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -153.59 127.31 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.8 m -77.98 148.09 34.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 87' ' ' PHE . 70.2 mt -128.35 138.97 52.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 126.647 1.979 . . . . 0.0 108.256 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -134.3 94.91 3.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.789 1.306 . . . . 0.0 110.74 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -109.26 170.72 7.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.901 0.858 . . . . 0.0 111.225 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -101.53 140.09 20.95 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 166.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.01 171.19 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.521 2.814 . . . . 0.0 109.26 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.75 -130.44 2.48 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.619 -2.193 . . . . 0.0 107.619 160.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.08 165.77 20.72 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 125.177 1.391 . . . . 0.0 107.916 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.84 -147.68 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.991 1 C-N-CA 125.892 4.395 . . . . 0.0 110.201 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.16 -91.68 0.12 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -62.78 -52.97 61.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 126.136 1.774 . . . . 0.0 109.928 172.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.6 mt -133.69 163.9 47.86 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 110.818 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.52 174.27 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.968 3.112 . . . . 0.0 110.856 167.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.85 108.1 19.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -54.82 -53.06 60.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.489 2.315 . . . . 0.0 111.913 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.08 -166.36 1.69 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 0.0 107.255 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -131.03 160.27 35.08 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.622 1.969 . . . . 0.0 107.929 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mt -118.73 156.19 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.12 2.168 . . . . 0.0 107.564 167.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.8 128.51 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -148.23 139.15 23.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.648 1.179 . . . . 0.0 107.84 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.89 129.96 55.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.326 1.45 . . . . 0.0 108.149 170.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.5 112.93 8.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.14 -20.66 60.87 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 3.45 26.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.357 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.04 -80.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.252 1.821 . . . . 0.0 106.695 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -133.12 -5.41 3.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.932 0.787 . . . . 0.0 112.888 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 54.57 42.93 30.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.934 0.873 . . . . 0.0 111.497 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.8 m -140.64 152.39 45.36 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 127.161 2.184 . . . . 0.0 106.946 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.475 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 93.0 m95 -72.17 132.84 44.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 157.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -125.54 151.78 45.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.352 1.461 . . . . 0.0 107.294 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.64 127.68 33.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.1 -3.67 10.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.641 0.776 . . . . 0.0 111.23 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . . . -154.1 126.82 8.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.766 1.627 . . . . 0.0 108.454 168.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -115.06 139.89 49.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.767 0.827 . . . . 0.0 110.02 165.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.6 m80 50.32 69.9 0.57 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.148 2.579 . . . . 0.0 114.637 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.7 141.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -124.2 32.67 5.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.904 0.882 . . . . 0.0 112.029 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.32 165.18 27.88 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -90.34 0.48 57.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.81 1.644 . . . . 0.0 112.595 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -132.5 133.06 43.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 108.78 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 76.2 t80 -146.72 152.17 38.38 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 127.197 2.199 . . . . 0.0 109.17 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -111.25 112.95 25.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.084 1.354 . . . . 0.0 108.626 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.7 t -66.22 143.57 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.64 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -136.25 -175.09 3.87 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.671 0.788 . . . . 0.0 110.723 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.87 17.93 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.509 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.7 mt -85.79 -163.39 0.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.676 1.238 . . . . 0.0 109.112 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -135.84 139.42 30.57 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.59 158.49 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.431 2.754 . . . . 0.0 111.121 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 48.64 31.31 2.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.235 1.814 . . . . 0.0 113.251 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.5 m -124.44 136.38 53.99 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.518 1.527 . . . . 0.0 108.396 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.6 mm -76.58 148.04 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 124.637 1.175 . . . . 0.0 109.413 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -139.54 153.93 47.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.64 2.376 . . . . 0.0 106.335 171.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 11.2 mt -112.64 157.0 21.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.359 1.463 . . . . 0.0 107.918 154.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.459 ' CD2' HD21 ' A' ' 34' ' ' LEU . 31.1 m-85 -127.03 157.99 38.14 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.692 1.997 . . . . 0.0 110.013 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.475 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 20.0 mtt -128.71 155.89 44.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.85 2.06 . . . . 0.0 106.634 164.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.9 t -122.3 141.81 41.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 162.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.841 ' HD3' HD13 ' A' ' 97' ' ' LEU . 83.2 mtt-85 -132.34 146.29 51.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.07 156.96 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.46 152.74 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 127.217 2.207 . . . . 0.0 107.226 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.3 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.297 1.039 . . . . 0.0 110.263 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -59.67 2.87 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.996 3.131 . . . . 0.0 116.463 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -127.91 -37.8 1.89 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.952 1.701 . . . . 0.0 112.018 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.28 -150.49 8.45 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -170.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.841 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.5 pp -124.71 157.33 35.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 97' ' ' LEU . 89.1 p -72.5 166.48 22.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.164 0.986 . . . . 0.0 111.598 -174.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -44.61 152.97 0.49 Allowed Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 156.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.14 142.07 49.61 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.239 1.959 . . . . 0.0 110.895 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 94.0 p -60.04 165.41 4.86 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.181 0.592 . . . . 0.0 111.131 156.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.2 141.65 94.06 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 158.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.66 147.68 45.08 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.678 -1.264 . . . . 0.0 111.777 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 p -57.31 -18.16 15.58 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.598 2.759 . . . . 0.0 116.381 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 88.06 150.74 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 128.613 2.765 . . . . 0.0 107.156 -153.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.2 109.14 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.98 2.454 . . . . 0.0 108.709 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.2 127.72 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.218 1.007 . . . . 0.0 109.539 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 140.59 30.04 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.8 p -64.19 164.84 10.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -78.75 -175.99 4.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 122.302 1.049 . . . . 0.0 108.426 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.24 154.42 39.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.697 164.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -79.93 46.18 0.77 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.269 1.828 . . . . 0.0 112.953 -168.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -150.81 -79.36 0.03 OUTLIER Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.048 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -81.39 59.79 7.46 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.963 3.109 . . . . 0.0 112.203 -167.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.1 m -67.42 168.96 9.81 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.523 0.729 . . . . 0.0 110.862 168.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.5 m -125.08 178.33 5.6 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 149.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 N-CA-C 105.259 -3.136 . . . . 0.0 105.259 -150.418 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.702 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.0 p -157.52 158.86 36.47 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.497 1.519 . . . . 0.0 109.08 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 p -162.53 -169.99 2.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.841 1.657 . . . . 0.0 107.676 168.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.52 15.58 70.82 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.877 -0.957 . . . . 0.0 115.048 163.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.1 t -137.46 169.12 18.33 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.146 1.473 . . . . 0.0 108.92 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -78.46 100.05 6.69 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.68 83.5 0.11 Allowed Glycine 0 C--N 1.335 0.484 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.46 155.77 44.27 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 163.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.32 98.4 6.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 -172.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 t80 57.21 -168.67 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.415 0.686 . . . . 0.0 109.886 -161.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.17 148.86 21.78 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 122.045 0.926 . . . . 0.0 109.351 167.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -81.8 26.12 0.52 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.625 1.57 . . . . 0.0 112.946 -167.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.9 t 122.39 147.65 0.0 OUTLIER 'General case' 0 C--O 1.24 0.555 1 C-N-CA 132.686 4.395 . . . . 0.0 110.188 174.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 67.1 m-20 -76.7 -42.9 39.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.005 0.922 . . . . 0.0 109.121 166.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 mt -79.44 159.24 72.66 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 126.808 2.043 . . . . 0.0 111.159 -170.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.96 150.45 38.35 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.774 2.316 . . . . 0.0 109.799 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 159.57 53.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.148 1.356 . . . . 0.0 112.381 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.14 124.32 12.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.145 2.563 . . . . 0.0 109.784 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.56 165.77 14.9 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.73 2.287 . . . . 0.0 112.456 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -70.42 162.13 29.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.567 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -56.38 121.91 46.01 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.687 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.88 142.76 94.38 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.59 1.527 . . . . 0.0 111.119 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -122.42 131.91 54.11 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.179 1.392 . . . . 0.0 110.102 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.588 HG11 HG11 ' A' ' 107' ' ' VAL . 2.2 m -80.27 142.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.104 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 p -135.64 -42.18 0.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.814 -166.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.28 145.33 48.33 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.794 1.238 . . . . 0.0 108.42 166.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.37 151.38 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.449 1.099 . . . . 0.0 108.099 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -125.24 -43.03 1.96 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -168.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 2.1 pttt 143.34 -27.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 1 C-N-CA 133.719 4.808 . . . . 0.0 110.071 -174.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -138.94 -4.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.101 1.76 . . . . 0.0 109.995 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.01 156.47 47.79 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.823 2.049 . . . . 0.0 106.937 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -154.37 128.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.6 m -80.42 137.05 36.46 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.1 mt -125.82 146.39 49.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 126.576 1.95 . . . . 0.0 106.925 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.6 116.96 11.28 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 125.15 1.531 . . . . 0.0 108.263 -166.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.587 ' CH2' HD11 ' A' ' 51' ' ' ILE . 49.3 p90 -139.03 156.91 46.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.453 1.024 . . . . 0.0 109.55 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.47 144.87 29.42 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.097 0.559 . . . . 0.0 109.96 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.65 117.68 3.72 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.594 2.862 . . . . 0.0 110.841 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 174.99 30.72 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 124.734 1.159 . . . . 0.0 110.391 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.3 m -61.65 153.69 69.63 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 129.091 2.956 . . . . 0.0 110.781 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.96 -173.23 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.239 2.626 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.11 -160.87 9.41 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 104.578 -3.409 . . . . 0.0 104.578 160.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -52.38 -50.03 63.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.141 -1.529 . . . . 0.0 109.69 166.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.32 161.58 32.35 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.689 1.131 . . . . 0.0 112.203 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.96 153.11 9.82 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 124.384 3.389 . . . . 0.0 110.23 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.91 37.8 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.896 0.855 . . . . 0.0 111.138 170.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.11 -59.93 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.406 1.482 . . . . 0.0 107.798 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.67 -170.47 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.382 1.073 . . . . 0.0 109.045 -165.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -111.9 163.17 14.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.391 1.876 . . . . 0.0 108.269 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.22 152.12 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.573 2.349 . . . . 0.0 107.099 157.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.587 HD11 ' CH2' ' A' ' 36' ' ' TRP . 85.4 mt -132.29 108.38 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -99.89 158.95 15.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.53 150.88 44.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.758 2.023 . . . . 0.0 107.742 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -128.01 150.25 50.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.69 117.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.995 0.902 . . . . 0.0 110.54 171.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -67.1 -36.45 81.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.432 -0.793 . . . . 0.0 111.465 -173.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -71.9 5.98 2.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.114 2.166 . . . . 0.0 113.685 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.56 -69.36 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.4 m -158.83 121.05 3.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.221 2.208 . . . . 0.0 105.471 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -72.18 82.42 1.0 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.593 0.633 . . . . 0.0 109.72 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -170.47 159.26 6.84 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.535 2.734 . . . . 0.0 107.524 168.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -76.69 142.35 40.57 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 161.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -130.71 139.64 50.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.278 1.431 . . . . 0.0 107.943 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -88.46 94.07 9.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.5 -15.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.691 1.196 . . . . 0.0 113.044 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . -142.48 149.73 39.58 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 156.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.88 154.07 51.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 62.32 29.11 17.25 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.8 134.43 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 120.698 -1.252 . . . . 0.0 108.193 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -106.16 -8.49 17.37 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.81 -174.44 3.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.009 1.723 . . . . 0.0 109.297 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.8 p -120.57 0.97 10.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.364 1.866 . . . . 0.0 111.929 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -130.64 137.91 49.83 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.261 -0.899 . . . . 0.0 108.72 161.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.16 145.47 30.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.765 0.711 . . . . 0.0 109.084 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.0 m -89.21 106.67 18.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.072 1.749 . . . . 0.0 108.578 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.33 151.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.334 1.054 . . . . 0.0 108.223 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -135.6 -176.16 4.19 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.494 1.518 . . . . 0.0 110.777 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.41 7.64 85.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.968 1.27 . . . . 0.0 114.004 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.56 -177.49 6.55 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 123.148 1.451 . . . . 0.0 110.238 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -118.54 151.04 49.19 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 126.49 1.916 . . . . 0.0 108.422 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.74 156.64 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.385 2.723 . . . . 0.0 109.929 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 53.58 26.14 5.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.788 1.235 . . . . 0.0 111.854 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.1 m -119.68 129.19 54.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.115 1.766 . . . . 0.0 107.758 -170.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.84 144.98 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.69 153.7 47.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 109.178 168.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.08 162.3 14.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.074 1.35 . . . . 0.0 107.506 160.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -139.69 135.18 32.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 125.099 1.499 . . . . 0.0 107.889 172.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.4 mtm -124.45 135.16 53.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.97 144.37 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.606 ' HD3' HD22 ' A' ' 97' ' ' LEU . 6.3 mtp180 -120.9 150.99 40.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 160.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 165.15 15.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.47 152.41 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 127.232 2.213 . . . . 0.0 108.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.92 178.17 1.78 Allowed Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.888 0.875 . . . . 0.0 111.329 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.67 -4.06 1.72 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.586 3.524 . . . . 0.0 117.905 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -130.45 -37.18 1.41 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.402 1.455 . . . . 0.0 111.394 -170.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.83 -170.84 34.75 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -168.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.606 HD22 ' HD3' ' A' ' 90' ' ' ARG . 2.2 mp -97.89 166.16 11.59 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.469 1.108 . . . . 0.0 109.046 166.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 91.4 p -72.08 167.73 19.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.665 0.786 . . . . 0.0 110.07 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -48.81 150.56 2.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.051 -0.405 . . . . 0.0 110.153 153.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.7 132.98 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.745 2.297 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.8 p -59.03 168.83 1.33 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.8 0.84 . . . . 0.0 112.66 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.13 136.35 37.8 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.374 2.716 . . . . 0.0 112.237 161.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 149.73 33.49 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.974 0.806 . . . . 0.0 109.583 165.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 76.5 p -60.31 -9.43 3.46 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.593 1.957 . . . . 0.0 115.89 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.6 147.0 0.11 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.073 2.149 . . . . 0.0 109.604 -155.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.21 118.83 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.677 2.251 . . . . 0.0 110.066 -168.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.588 HG11 HG11 ' A' ' 24' ' ' VAL . 1.5 m -114.45 131.58 66.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.882 1.273 . . . . 0.0 110.457 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 145.21 31.7 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 p -71.37 168.41 17.47 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.53 0.732 . . . . 0.0 110.829 162.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -65.39 -167.86 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.018 1.39 . . . . 0.0 110.1 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -114.52 8.51 16.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 113.516 -163.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.461 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 1.7 t 72.95 -2.88 2.57 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 129.055 2.942 . . . . 0.0 114.523 175.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -61.88 116.27 9.12 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 117.639 -1.645 . . . . 0.0 109.459 162.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.89 93.3 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.974 2.449 . . . . 0.0 108.418 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.3 t -149.44 100.12 2.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.99 170.01 23.14 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.221 1.008 . . . . 0.0 109.468 151.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.977 0 N-CA-C 104.995 -3.242 . . . . 0.0 104.995 -173.423 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.674 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -80.39 108.85 14.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.874 0.87 . . . . 0.0 109.022 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.1 p -156.64 167.34 30.76 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.057 0.943 . . . . 0.0 108.899 160.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.45 147.11 39.9 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.807 0.718 . . . . 0.0 112.144 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.0 t -160.19 -53.38 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.28 0.632 . . . . 0.0 109.783 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.2 m -60.16 151.83 26.03 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.594 0.357 . . . . 0.0 111.557 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.74 81.5 0.26 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 124.813 1.197 . . . . 0.0 110.156 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -62.47 106.9 0.83 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -157.95 144.0 17.33 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 129.888 3.275 . . . . 0.0 104.187 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.99 172.37 13.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.442 0.565 . . . . 0.0 110.204 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -147.8 162.9 38.3 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.94 -132.57 0.31 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.104 1.362 . . . . 0.0 107.336 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.9 m -149.09 61.15 1.05 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.051 1.74 . . . . 0.0 107.02 171.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.54 -37.92 68.16 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.645 1.178 . . . . 0.0 109.33 166.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.92 152.38 93.5 Favored Pre-proline 0 CA--C 1.53 0.181 0 C-N-CA 127.233 2.213 . . . . 0.0 110.483 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -67.18 169.65 14.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.373 2.049 . . . . 0.0 110.922 167.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.38 168.06 49.69 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.38 1.467 . . . . 0.0 112.124 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.61 132.69 31.73 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.109 2.54 . . . . 0.0 108.844 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.09 165.37 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.7 1.6 . . . . 0.0 111.817 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.02 163.54 27.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.303 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 11.0 tmtt? -50.29 119.04 10.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.135 171.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -67.21 160.14 48.91 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 CA-C-N 120.082 1.065 . . . . 0.0 110.47 172.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -135.93 125.89 25.94 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.963 2.105 . . . . 0.0 107.975 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 107' ' ' VAL . 9.2 m -69.13 149.27 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.6 p -134.06 -41.45 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.427 0.691 . . . . 0.0 110.169 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -123.44 145.09 49.08 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 109.146 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.82 145.82 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 119.758 1.163 . . . . 0.0 108.552 164.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.2 p -134.11 -169.12 2.25 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.533 1.133 . . . . 0.0 108.913 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -66.51 -16.49 64.17 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 120.857 -1.152 . . . . 0.0 113.35 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -156.35 6.2 0.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -123.64 160.07 27.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.201 1.364 . . . . 0.0 111.297 165.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.59 136.85 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -96.61 142.13 29.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.1 mt -134.74 133.79 40.3 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.073 1.749 . . . . 0.0 108.255 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 6.9 t -118.96 130.23 55.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 129.371 3.068 . . . . 0.0 108.311 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -139.12 170.94 15.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -104.87 148.59 36.35 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 162.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.58 160.66 44.96 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.202 2.601 . . . . 0.0 109.703 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.02 174.15 43.75 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -57.64 155.02 22.74 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 126.466 1.906 . . . . 0.0 110.074 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.86 -175.86 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.525 2.817 . . . . 0.0 111.892 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.02 -147.45 7.94 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 105.575 -3.01 . . . . 0.0 105.575 168.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -33.84 64.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 165.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.38 157.42 33.75 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 123.181 0.593 . . . . 0.0 112.052 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.88 150.28 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.794 3.662 . . . . 0.0 110.034 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 125.58 28.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.383 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -73.45 -49.21 28.06 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.436 172.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 68' ' ' HIS . . . -161.18 -165.18 1.28 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.434 1.015 . . . . 0.0 110.184 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.89 161.55 32.76 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.831 0.852 . . . . 0.0 109.943 167.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -118.84 158.26 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 128.203 2.601 . . . . 0.0 106.806 167.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mt -126.02 129.24 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 163.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -105.89 153.86 21.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.231 1.412 . . . . 0.0 108.112 171.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.1 127.68 20.12 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.493 1.517 . . . . 0.0 110.209 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -91.74 149.35 21.65 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.233 1.413 . . . . 0.0 107.772 169.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.22 113.56 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.338 1.066 . . . . 0.0 112.477 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.35 -38.56 81.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 112.844 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 m -73.87 8.43 2.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.943 1.297 . . . . 0.0 113.382 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.49 -72.54 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 124.268 1.027 . . . . 0.0 108.895 -168.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.1 t -150.38 12.88 0.74 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.631 0.772 . . . . 0.0 110.058 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 61.02 -79.73 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.593 2.357 . . . . 0.0 111.753 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.57 162.11 0.04 OUTLIER 'General case' 0 C--O 1.234 0.26 0 C-N-CA 129.664 3.186 . . . . 0.0 114.895 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 94.9 m95 -67.79 138.28 56.05 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -124.54 142.56 51.25 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -72.73 107.21 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -95.68 -28.28 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 0.0 111.655 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 138.07 31.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 135.47 41.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 10.9 m-70 50.04 68.83 0.69 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.798 2.039 . . . . 0.0 110.923 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.4 t -84.97 -53.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.93 1.292 . . . . 0.0 113.623 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 mttt 66.21 -23.66 0.1 Allowed 'General case' 0 C--N 1.316 -0.884 1 C-N-CA 131.79 4.036 . . . . 0.0 115.578 170.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -71.42 173.09 8.35 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.388 1.449 . . . . 0.0 108.607 168.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.04 -4.71 20.17 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.958 168.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 5.4 tp -121.17 131.71 54.4 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 121.596 1.998 . . . . 0.0 110.211 160.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -134.61 152.8 52.04 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.283 1.033 . . . . 0.0 109.432 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -112.77 101.07 9.18 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.355 1.862 . . . . 0.0 107.203 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.98 143.56 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 162.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -139.01 178.93 6.8 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.36 1.864 . . . . 0.0 108.2 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 24.29 67.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.414 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.1 mt -82.1 -173.54 4.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.624 1.17 . . . . 0.0 109.772 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -112.22 141.9 25.9 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 117.694 -1.146 . . . . 0.0 109.228 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.79 157.47 61.62 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.21 1.94 . . . . 0.0 112.156 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 41.62 42.64 2.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.477 1.911 . . . . 0.0 112.339 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.4 m -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.252 1.421 . . . . 0.0 107.817 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.57 147.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.73 155.63 46.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.038 167.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.77 163.12 13.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.87 132.38 26.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.43 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 41.0 mtm -131.4 165.6 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 123.895 0.747 . . . . 0.0 109.338 161.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.5 t -132.21 140.36 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.976 1.71 . . . . 0.0 107.284 -166.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.489 ' HD3' HD22 ' A' ' 97' ' ' LEU . 13.1 mtt180 -132.1 132.03 42.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.5 118.67 26.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.34 145.7 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' A' ' 47' ' ' SER . 1.9 p-10 -141.52 173.84 4.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.712 1.205 . . . . 0.0 108.096 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -73.26 31.63 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.34 2.693 . . . . 0.0 114.075 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -134.04 -67.83 0.58 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.325 1.85 . . . . 0.0 106.657 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.55 -148.26 4.73 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.914 1.245 . . . . 0.0 112.159 -167.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.489 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.4 mt -122.7 142.21 50.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.539 3.136 . . . . 0.0 106.398 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.9 p -72.33 166.96 21.45 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.359 0.6 . . . . 0.0 112.116 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -60.35 158.0 31.39 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 124.568 1.147 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.22 122.59 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.944 1.762 . . . . 0.0 111.983 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 p -60.5 157.79 34.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.454 1.501 . . . . 0.0 111.784 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 128.66 24.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.812 3.008 . . . . 0.0 110.506 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.8 mtt -56.27 150.66 14.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.082 1.764 . . . . 0.0 111.451 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.499 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 1.5 p -69.9 -1.61 10.03 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 81.82 155.54 0.12 Allowed Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 131.119 3.768 . . . . 0.0 108.874 -167.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.61 117.6 5.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.279 2.653 . . . . 0.0 109.171 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 24' ' ' VAL . 2.7 m -116.97 144.68 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 123.599 0.76 . . . . 0.0 109.385 -171.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -104.32 138.51 40.66 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 123.38 0.672 . . . . 0.0 109.925 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -67.29 169.06 9.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.969 168.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -82.73 175.7 9.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.733 0.778 . . . . 0.0 110.007 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.62 158.79 17.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.749 164.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.94 -6.9 20.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 46.12 -162.93 0.14 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.933 1.254 . . . . 0.0 114.028 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -81.95 13.71 2.42 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.882 3.055 . . . . 0.0 111.605 158.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 m -56.1 126.43 26.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.852 1.661 . . . . 0.0 112.346 -162.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.7 p -68.06 175.31 3.23 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.122 0.969 . . . . 0.0 111.515 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.45 0 N-CA-C 105.679 -2.969 . . . . 0.0 105.679 167.471 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.719 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t -60.69 126.7 28.39 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.102 0.961 . . . . 0.0 108.961 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -166.97 172.81 9.86 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.335 2.254 . . . . 0.0 107.795 171.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.73 98.75 0.43 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 166.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m -149.04 -60.07 0.22 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.396 1.098 . . . . 0.0 110.838 -172.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 m -85.36 130.72 34.53 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.734 0.813 . . . . 0.0 109.538 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.89 149.55 46.82 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 167.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -74.46 164.1 26.99 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -151.52 134.11 15.51 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 168.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 51.37 172.28 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.099 2.559 . . . . 0.0 113.432 -166.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -140.29 154.15 46.72 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.183 1.793 . . . . 0.0 106.827 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.37 -1.44 57.03 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.767 0.827 . . . . 0.0 111.356 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -151.22 173.86 13.93 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.657 -1.277 . . . . 0.0 108.997 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.61 -43.29 3.04 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.873 1.269 . . . . 0.0 111.362 -178.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.3 162.4 40.15 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.467 1.907 . . . . 0.0 109.025 -173.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -60.0 142.63 98.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.381 2.721 . . . . 0.0 110.473 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.02 142.64 38.31 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 161.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.18 145.95 96.13 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.179 1.919 . . . . 0.0 110.187 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -64.68 157.96 52.93 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.72 1.613 . . . . 0.0 109.987 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -68.47 166.48 16.76 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.222 0.609 . . . . 0.0 110.37 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -46.03 121.83 5.98 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.21 1.004 . . . . 0.0 109.242 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -60.26 146.29 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -113.28 125.14 53.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.219 1.408 . . . . 0.0 109.007 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 107' ' ' VAL . 19.8 t -80.58 112.54 18.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -102.31 -82.7 0.48 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.6 139.37 40.61 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -137.33 145.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 p -125.88 -173.58 2.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.183 0.993 . . . . 0.0 108.613 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 1.0 OUTLIER -63.11 -14.87 53.74 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.154 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -163.57 26.47 0.08 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.092 1.315 . . . . 0.0 112.939 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -146.93 161.87 39.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 107.982 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -158.26 136.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.126 0.97 . . . . 0.0 108.482 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -91.13 110.94 22.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.033 1.333 . . . . 0.0 107.942 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -93.11 140.84 29.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.805 1.242 . . . . 0.0 109.224 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.656 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.61 99.21 3.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.612 1.195 . . . . 0.0 108.887 -163.312 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -119.05 172.81 7.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.532 1.133 . . . . 0.0 109.674 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -118.79 145.57 38.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.99 143.9 29.63 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.671 2.914 . . . . 0.0 110.779 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.47 175.68 52.84 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 170.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -62.18 146.15 92.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.884 1.274 . . . . 0.0 109.167 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.13 -168.7 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.953 3.769 . . . . 0.0 112.42 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.31 -149.51 5.54 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 174.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -37.81 68.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.562 1.145 . . . . 0.0 110.673 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 7.1 mt -111.95 167.31 9.32 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.714 0.806 . . . . 0.0 111.913 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 61.0 Cg_endo -73.88 -130.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 124.628 3.552 . . . . 0.0 108.299 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.6 161.8 24.01 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 127.669 2.388 . . . . 0.0 106.622 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -105.84 -35.38 7.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.132 2.173 . . . . 0.0 110.502 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.74 -159.42 0.08 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.744 1.217 . . . . 0.0 109.626 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 91' ' ' ALA . 84.6 m-85 -128.82 169.24 14.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.445 2.298 . . . . 0.0 108.161 162.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.76 155.15 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.051 2.94 . . . . 0.0 106.031 167.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.5 mt -122.54 132.8 70.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -118.17 158.31 25.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.32 46.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 109.979 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -131.28 168.17 17.98 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.093 2.557 . . . . 0.0 105.833 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.6 t -144.12 -42.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.898 1.226 . . . . 0.0 113.676 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 115.95 -48.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.437 1 C-N-CA 133.234 4.614 . . . . 0.0 108.652 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -87.41 -36.68 17.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.533 0.733 . . . . 0.0 111.786 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.71 -62.17 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 123.591 0.757 . . . . 0.0 109.066 -159.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -160.26 98.81 1.3 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.5 -9.63 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.5 m -39.73 -39.6 0.8 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 129.122 2.969 . . . . 0.0 116.366 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.8 m95 61.34 140.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.16 1.384 . . . . 0.0 111.299 -138.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -134.11 152.9 52.04 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 134.21 50.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 165.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.0 -8.76 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.33 0.652 . . . . 0.0 111.616 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.94 138.46 17.71 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.158 1.783 . . . . 0.0 107.258 158.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -116.18 158.31 23.48 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m170 51.47 51.67 16.3 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.844 1.307 . . . . 0.0 112.218 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.87 110.69 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 127.112 2.165 . . . . 0.0 106.629 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -106.58 52.04 0.73 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.243 1.417 . . . . 0.0 108.203 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -158.39 -171.98 3.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.926 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.4 p -127.78 -3.75 5.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.967 1.307 . . . . 0.0 112.25 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -125.75 121.12 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.863 1.665 . . . . 0.0 107.476 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -145.35 117.51 8.37 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.445 0.64 . . . . 0.0 111.365 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -71.89 98.53 2.03 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.408 2.283 . . . . 0.0 108.802 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.6 143.69 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -136.77 172.69 12.64 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.538 1.535 . . . . 0.0 109.208 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.94 2.96 58.18 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.045 1.307 . . . . 0.0 113.055 170.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.8 mt -78.14 178.2 7.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 117.691 0.745 . . . . 0.0 109.607 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -96.67 146.74 31.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.203 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.64 158.79 46.88 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.376 2.717 . . . . 0.0 111.146 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.39 21.75 1.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.166 2.587 . . . . 0.0 112.876 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -119.28 121.37 39.48 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mm -59.27 147.44 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -138.51 152.83 48.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.582 162.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 103' ' ' MET . 36.4 mt -107.08 156.04 19.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.106 163.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -141.78 133.45 27.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.451 1.719 . . . . 0.0 107.843 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 15.5 mtt -112.34 156.09 23.04 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.526 2.331 . . . . 0.0 106.903 170.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.76 113.09 31.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 167.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.785 ' HD3' HD13 ' A' ' 97' ' ' LEU . 35.9 mtt180 -97.47 147.72 23.95 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.29 -1.506 . . . . 0.0 107.203 167.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 98' ' ' SER . . . -86.7 158.33 19.46 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.69 152.49 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 126.118 1.767 . . . . 0.0 107.323 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -139.97 172.71 5.94 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 127.186 2.195 . . . . 0.0 108.576 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 -19.15 27.72 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.807 2.338 . . . . 0.0 113.352 166.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -115.58 -11.13 11.77 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.63 -160.88 29.54 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.785 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.6 pp -113.09 162.7 15.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.892 1.277 . . . . 0.0 110.802 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 51.4 p -77.82 168.55 19.75 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.053 2.141 . . . . 0.0 112.953 -171.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.45 149.73 0.97 Allowed Pre-proline 0 C--O 1.242 0.699 0 O-C-N 121.18 -0.95 . . . . 0.0 110.029 155.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.36 129.46 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.842 2.361 . . . . 0.0 109.717 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 p -52.61 162.08 1.01 Allowed Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.53 1.532 . . . . 0.0 113.458 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -63.8 125.96 16.45 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 109.818 158.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.414 ' SD ' HD13 ' A' ' 86' ' ' LEU . 57.6 mtm -55.53 148.2 16.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.798 -0.564 . . . . 0.0 111.418 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 -8.14 47.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 3.7 t0 85.04 153.35 0.11 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 130.605 3.562 . . . . 0.0 110.107 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 105' ' ' ASP . 19.4 Cg_endo -70.01 105.46 1.53 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.228 1.952 . . . . 0.0 111.516 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 24' ' ' VAL . 1.9 m -103.06 142.74 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.366 1.067 . . . . 0.0 109.361 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.0 141.39 32.89 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 109.295 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.1 p -72.89 151.04 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.174 0.59 . . . . 0.0 110.623 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.12 -178.76 2.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 112.07 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.51 147.12 37.99 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.449 -0.782 . . . . 0.0 112.868 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 2.2 p -84.99 -5.84 59.35 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.275 1.83 . . . . 0.0 114.924 -163.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -71.21 177.16 36.42 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 118.883 0.765 . . . . 0.0 113.387 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.75 129.84 15.01 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.738 2.292 . . . . 0.0 109.21 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.0 t -156.03 154.46 31.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 157.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 m 35.39 86.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.459 1.904 . . . . 0.0 112.936 -169.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.846 0 N-CA-C 108.536 -1.825 . . . . 0.0 108.536 148.174 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.677 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.1 m 62.35 120.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.821 2.449 . . . . 0.0 114.556 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.1 p -161.03 111.5 1.74 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 160.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.78 105.26 2.92 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 175.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.0 m -163.03 -52.88 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.892 1.677 . . . . 0.0 108.26 164.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 m -74.72 131.58 40.96 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 158.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.11 -70.56 0.93 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 124.463 1.03 . . . . 0.0 112.636 -164.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -133.73 78.18 1.76 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.638 0.719 . . . . 0.0 109.309 -169.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 41.67 82.12 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 128.257 2.623 . . . . 0.0 112.47 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -139.88 165.06 28.33 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.991 0.916 . . . . 0.0 109.386 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -158.78 -164.5 1.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.617 2.367 . . . . 0.0 108.814 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -128.16 0.42 5.81 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.522 1.529 . . . . 0.0 113.624 -164.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -87.3 165.85 15.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.319 0.509 . . . . 0.0 110.874 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.423 ' HA ' HG21 ' A' ' 43' ' ' THR . 0.9 OUTLIER -66.6 -48.69 68.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.314 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -58.55 146.46 73.18 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 126.328 1.851 . . . . 0.0 111.711 -170.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.08 156.71 53.29 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.195 2.597 . . . . 0.0 111.665 -168.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.61 152.09 48.24 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.64 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -67.64 141.16 54.02 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.264 1.976 . . . . 0.0 109.164 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.03 153.37 78.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.213 1.275 . . . . 0.0 109.189 162.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -74.03 177.87 5.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.678 0.791 . . . . 0.0 110.8 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -47.33 120.34 6.89 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 117.379 -1.296 . . . . 0.0 108.631 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.76 137.49 58.88 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -119.93 121.06 38.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.476 1.511 . . . . 0.0 108.822 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 149.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.202 173.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 p -129.35 -93.75 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.77 143.51 56.87 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.101 0.96 . . . . 0.0 109.615 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.91 141.8 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 p -128.21 -169.18 2.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.55 1.14 . . . . 0.0 108.541 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -61.61 -23.85 66.3 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 121.219 -0.926 . . . . 0.0 112.568 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -154.93 10.85 0.35 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.754 -1.216 . . . . 0.0 113.538 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -120.42 164.54 16.22 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.624 0.647 . . . . 0.0 110.833 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 p -153.48 134.26 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 165.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.1 m -88.53 114.45 25.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -93.72 138.49 31.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.844 1.658 . . . . 0.0 108.559 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -117.9 138.38 52.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.624 2.37 . . . . 0.0 107.189 170.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -139.8 170.92 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.734 0.414 . . . . 0.0 110.079 166.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 142.4 24.51 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.27 128.42 11.26 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.801 3.667 . . . . 0.0 109.546 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.52 167.96 54.63 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -85.49 154.95 59.67 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.769 1.228 . . . . 0.0 110.158 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.85 -158.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 125.193 3.928 . . . . 0.0 110.279 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.26 -112.7 0.46 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 14' ' ' ASP . 44.1 p -58.74 -48.93 79.49 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.6 mt -140.82 148.09 51.12 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 125.068 1.347 . . . . 0.0 110.669 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 141.09 18.79 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.879 3.052 . . . . 0.0 110.14 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 109.34 1.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.604 1.561 . . . . 0.0 108.647 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' HG22 ' A' ' 92' ' ' ILE . 24.1 m -61.01 -62.46 1.84 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.377 2.271 . . . . 0.0 110.802 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.14 -166.72 2.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -121.73 163.77 18.52 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.201 1.4 . . . . 0.0 108.62 165.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.403 HD12 HD11 ' A' ' 92' ' ' ILE . 1.2 mt -115.9 162.73 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.391 2.276 . . . . 0.0 107.315 162.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.04 129.76 72.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 161.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.58 150.86 30.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 160.37 32.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 107.467 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -133.6 147.86 51.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.58 117.48 4.42 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -75.09 -26.63 59.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.483 -0.761 . . . . 0.0 111.983 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -81.06 17.07 1.31 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.29 1.036 . . . . 0.0 111.398 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -128.29 -71.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 m -151.53 1.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.5 50.78 16.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.378 1.444 . . . . 0.0 110.68 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -135.31 146.52 48.56 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.767 1.227 . . . . 0.0 108.38 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -72.88 108.86 6.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 161.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -100.0 134.65 42.61 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.652 1.981 . . . . 0.0 108.053 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -78.74 94.76 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.4 -15.81 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.609 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.7 150.11 30.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.017 1.28 . . . . 0.0 108.576 164.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -142.82 161.81 37.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.951 0.341 . . . . 0.0 111.208 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 47.35 55.11 8.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.754 1.222 . . . . 0.0 111.332 -171.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -91.92 129.63 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 29.83 7.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.723 0.809 . . . . 0.0 111.848 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -136.76 174.27 10.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.022 1.329 . . . . 0.0 107.505 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.5 p -120.28 0.0 10.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.871 1.668 . . . . 0.0 111.687 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.18 104.35 5.87 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.27 150.93 50.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.952 1.301 . . . . 0.0 109.718 -169.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.5 m -103.51 106.02 16.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -62.54 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -139.72 176.04 9.07 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.27 1.028 . . . . 0.0 112.269 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.95 84.43 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 124.81 1.195 . . . . 0.0 112.616 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -74.67 179.43 4.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.296 1.046 . . . . 0.0 109.768 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -104.12 138.05 19.41 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.039 -1.458 . . . . 0.0 108.241 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.19 147.17 59.49 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.523 2.149 . . . . 0.0 112.112 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.9 t30 44.94 42.02 5.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.53 2.332 . . . . 0.0 112.526 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.1 m -129.38 136.61 50.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 127.091 2.156 . . . . 0.0 106.524 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.0 mm -72.44 145.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.966 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -140.62 155.27 46.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.343 1.457 . . . . 0.0 109.388 168.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.3 mt -108.24 166.18 10.94 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 126.229 1.811 . . . . 0.0 108.912 162.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.36 136.91 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 125.092 1.495 . . . . 0.0 111.257 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.9 mtt -105.38 151.37 24.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 160.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.21 149.58 6.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 154.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.498 ' HD3' HD13 ' A' ' 97' ' ' LEU . 73.3 mtt180 -125.11 139.58 53.64 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.29 151.03 23.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 165.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 47' ' ' SER . 2.0 mt -125.07 152.12 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.87 1.668 . . . . 0.0 108.628 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -151.69 -176.84 0.62 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.608 1.563 . . . . 0.0 109.186 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.29 -14.08 27.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.227 . . . . 0.0 115.577 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -116.41 -14.04 10.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.031 1.332 . . . . 0.0 112.402 -164.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.04 -143.8 10.17 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.498 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.0 pp -140.02 160.98 38.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.33 1.852 . . . . 0.0 110.061 -175.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 97.3 p -72.21 168.06 19.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 126.908 2.083 . . . . 0.0 114.463 -166.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -32.25 145.45 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 123.56 0.744 . . . . 0.0 109.914 145.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.35 132.48 31.56 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.175 1.917 . . . . 0.0 109.095 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 p -61.4 154.58 62.97 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.554 163.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.04 142.22 91.76 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.899 2.399 . . . . 0.0 110.303 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.6 mmt -53.12 131.92 37.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -17.01 16.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.961 1.704 . . . . 0.0 112.187 170.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t0 70.44 161.68 0.15 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.733 2.013 . . . . 0.0 109.265 -158.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -74.75 121.68 6.83 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.974 2.449 . . . . 0.0 111.072 -175.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.57 158.43 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.011 0.925 . . . . 0.0 108.997 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.48 137.22 43.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.102 1.361 . . . . 0.0 108.369 163.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.9 p -66.04 164.79 14.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.781 0.8 . . . . 0.0 109.53 158.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -80.79 173.5 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.403 1.097 . . . . 0.0 109.749 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.57 162.2 26.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.5 169.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.2 p -113.83 18.14 17.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.261 1.824 . . . . 0.0 112.765 -171.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -62.09 174.55 7.29 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.807 0.73 . . . . 0.0 111.807 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.38 66.58 7.17 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.734 2.956 . . . . 0.0 111.178 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -57.17 152.96 12.64 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.419 1.088 . . . . 0.0 110.556 173.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 61.3 p -95.29 86.32 4.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.79 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 -177.294 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 p -145.08 114.78 7.27 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 117.889 0.844 . . . . 0.0 109.439 -169.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -152.76 155.15 36.63 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.318 1.047 . . . . 0.0 109.555 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.19 -140.67 10.38 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 157.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.0 p -81.72 168.53 17.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.562 1.181 . . . . 0.0 108.963 164.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.99 85.74 0.16 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -172.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.67 -35.38 1.19 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 121.009 -1.057 . . . . 0.0 112.869 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -66.95 158.84 29.82 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.672 1.236 . . . . 0.0 109.111 155.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -151.12 164.84 35.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.868 2.067 . . . . 0.0 106.649 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -141.17 -89.92 0.15 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t0 74.49 158.62 0.21 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 128.107 2.563 . . . . 0.0 110.462 -166.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt 49.78 35.22 8.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.094 2.558 . . . . 0.0 112.695 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 t -83.68 88.82 7.06 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.648 1.579 . . . . 0.0 109.448 -169.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.2 11.96 0.14 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.244 1.818 . . . . 0.0 113.742 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.3 mt -91.91 152.54 43.06 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 120.48 -1.388 . . . . 0.0 109.395 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -63.07 166.46 14.39 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.378 3.385 . . . . 0.0 113.144 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 147.08 50.41 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.793 -1.004 . . . . 0.0 110.607 165.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.3 157.63 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.918 2.412 . . . . 0.0 112.047 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.78 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.346 2.031 . . . . 0.0 110.877 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.3 m -74.58 166.75 23.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.634 0.774 . . . . 0.0 110.933 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.39 127.04 16.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 116.78 -1.581 . . . . 0.0 109.576 168.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.62 159.25 22.06 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.75 2.3 . . . . 0.0 114.306 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -107.5 129.41 54.96 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 128.778 2.831 . . . . 0.0 107.849 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.59 153.78 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 p -132.04 -90.27 0.42 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.74 120.29 25.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.318 -172.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -120.32 147.95 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 119.738 1.154 . . . . 0.0 110.789 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.4 p -141.3 -167.2 2.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.684 1.594 . . . . 0.0 107.731 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -65.04 -33.59 76.41 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -149.2 17.32 0.95 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.667 -1.27 . . . . 0.0 112.763 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -136.64 150.43 48.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.98 132.68 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.804 1.241 . . . . 0.0 109.413 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.2 m -79.4 139.61 37.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.045 0.938 . . . . 0.0 109.412 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.38 144.19 45.2 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.46 2.304 . . . . 0.0 107.227 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.64 131.94 40.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.133 2.573 . . . . 0.0 106.506 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -139.26 172.07 13.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.274 1.03 . . . . 0.0 109.315 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.18 141.94 24.52 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.74 162.66 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.334 2.689 . . . . 0.0 111.094 -168.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 169.06 36.1 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 122.468 1.038 . . . . 0.0 110.952 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -65.3 147.16 98.78 Favored Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 126.99 2.116 . . . . 0.0 111.135 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.37 174.69 9.65 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 125.206 3.937 . . . . 0.0 113.911 166.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.93 -118.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.706 1.146 . . . . 0.0 110.314 -174.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.6 p -69.15 -37.51 78.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.151 1.78 . . . . 0.0 112.752 -162.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 mt -138.38 158.27 70.96 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 123.04 0.536 . . . . 0.0 111.216 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.13 165.46 32.35 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.298 2.665 . . . . 0.0 109.915 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.18 121.1 44.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.74 -33.04 25.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.331 0.652 . . . . 0.0 111.995 -162.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' H ' HG22 ' A' ' 92' ' ' ILE . . . -166.47 -167.77 1.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.867 1.667 . . . . 0.0 106.561 167.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -118.08 166.19 12.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.42 154.56 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.013 2.525 . . . . 0.0 106.305 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 135.82 61.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -117.99 154.84 31.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -141.91 163.17 33.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.91 1.284 . . . . 0.0 109.034 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -140.16 145.54 37.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.05 1.74 . . . . 0.0 107.139 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.628 ' HB3' HG22 ' A' ' 58' ' ' VAL . 4.9 t -134.3 166.23 23.3 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 155.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -99.64 14.41 30.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.679 1.192 . . . . 0.0 111.957 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 t -139.26 21.52 2.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.302 1.841 . . . . 0.0 110.982 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.808 HG23 ' H ' ' A' ' 59' ' ' SER . 15.5 m -121.89 -85.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.764 1.226 . . . . 0.0 108.044 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.808 ' H ' HG23 ' A' ' 58' ' ' VAL . 28.7 m -139.19 8.66 2.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.795 2.038 . . . . 0.0 110.39 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 54.33 22.97 4.04 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.27 2.228 . . . . 0.0 113.683 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.7 m -116.35 159.32 22.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.943 0.897 . . . . 0.0 110.943 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -73.63 138.88 45.09 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 157.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.62 139.39 36.71 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 m -63.21 95.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.588 1.155 . . . . 0.0 108.277 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 53' ' ' ALA . 18.6 m -87.22 -17.54 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.124 -0.985 . . . . 0.0 112.016 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.81 131.79 22.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 165.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -117.67 152.83 34.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.4 m80 43.8 67.83 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.608 1.563 . . . . 0.0 112.491 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -98.64 118.54 45.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.596 1.158 . . . . 0.0 108.455 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.65 50.79 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.89 175.47 13.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.458 1.903 . . . . 0.0 107.388 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -125.39 12.42 8.14 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.003 1.721 . . . . 0.0 113.12 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mp -129.43 140.95 51.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 109.564 147.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -145.2 151.65 38.76 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.58 1.152 . . . . 0.0 108.419 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -109.94 108.79 19.18 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.868 1.667 . . . . 0.0 108.767 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -60.11 140.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 165.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -130.44 -177.63 4.42 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.428 1.091 . . . . 0.0 108.874 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.15 37.76 41.82 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 mt -108.0 -178.68 3.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 110.393 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -103.58 139.32 19.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 125.491 1.516 . . . . 0.0 109.391 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.75 159.33 42.34 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.049 2.499 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 55.28 15.51 1.36 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.481 1.912 . . . . 0.0 112.903 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -119.76 139.41 52.34 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.813 1.645 . . . . 0.0 110.149 -164.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.41 148.67 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.694 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -142.09 162.24 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.921 0.888 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.548 HD13 ' SD ' ' A' ' 103' ' ' MET . 21.2 mt -124.86 162.81 23.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 125.841 1.656 . . . . 0.0 108.929 165.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -138.57 155.74 48.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 125.476 1.735 . . . . 0.0 110.968 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 6.8 mtt -129.22 167.07 18.19 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 126.525 1.93 . . . . 0.0 106.972 160.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.0 t -132.06 146.34 33.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 168.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.546 ' HD3' HD13 ' A' ' 97' ' ' LEU . 82.5 mtt180 -136.38 134.02 37.38 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.219 1.407 . . . . 0.0 107.244 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 126.21 34.72 Favored 'General case' 0 C--O 1.228 -0.076 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -86.59 152.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.773 0.829 . . . . 0.0 108.971 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.62 168.9 10.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.506 0.722 . . . . 0.0 109.83 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -72.38 19.61 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.153 2.569 . . . . 0.0 113.845 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -121.13 -65.35 1.15 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.513 1.525 . . . . 0.0 107.531 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.81 -127.44 1.89 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.397 1.475 . . . . 0.0 110.969 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.546 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -139.23 145.74 39.61 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.525 2.33 . . . . 0.0 107.443 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.0 p -72.58 165.99 23.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.277 1.031 . . . . 0.0 109.869 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -54.85 142.95 53.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.565 -0.71 . . . . 0.0 109.188 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.99 133.15 42.8 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.435 1.423 . . . . 0.0 108.992 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.4 p -54.69 156.02 6.98 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.373 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -47.63 143.79 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.1 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.548 ' SD ' HD13 ' A' ' 86' ' ' LEU . 35.2 mtm -57.9 146.93 30.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.724 0.773 . . . . 0.0 110.299 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -65.26 0.2 1.5 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.062 -1.923 . . . . 0.0 115.81 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.2 t70 68.74 153.69 0.14 Allowed Pre-proline 0 N--CA 1.476 0.834 0 CA-C-N 121.147 1.794 . . . . 0.0 108.398 -154.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -67.47 113.26 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.006 2.471 . . . . 0.0 109.648 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.36 165.09 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -124.06 142.59 51.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 166.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 p -72.98 160.69 31.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.081 0.552 . . . . 0.0 110.745 165.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -79.14 -178.44 6.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.934 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -81.28 167.55 19.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.285 1.434 . . . . 0.0 111.394 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 t -103.6 37.7 1.97 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.044 2.138 . . . . 0.0 111.627 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.05 164.27 54.7 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 120.522 -1.361 . . . . 0.0 111.781 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.42 147.13 28.47 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.166 2.577 . . . . 0.0 110.549 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.2 m -156.21 111.88 2.98 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.729 1.612 . . . . 0.0 108.246 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.8 t -170.79 178.89 3.37 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.308 2.243 . . . . 0.0 106.172 172.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 1 N-CA-C 103.069 -4.012 . . . . 0.0 103.069 167.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -144.22 -70.76 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -64.96 165.55 10.72 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 149.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.0 -160.64 20.68 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.393 1.473 . . . . 0.0 110.08 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.5 m 74.42 178.1 0.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.031 2.132 . . . . 0.0 110.947 -169.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 m -59.74 156.01 14.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.726 1.21 . . . . 0.0 111.063 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.57 115.52 8.04 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 106.256 -2.738 . . . . 0.0 106.256 152.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.9 51.7 1.98 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.228 1.014 . . . . 0.0 109.094 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -77.74 78.17 4.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.616 1.566 . . . . 0.0 107.632 -171.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 55.37 -179.08 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.617 1.967 . . . . 0.0 111.175 -158.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -170.28 -177.24 2.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.002 1.721 . . . . 0.0 107.527 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.3 mp 16.24 79.23 0.01 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 129.157 2.983 . . . . 0.0 113.333 160.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -49.7 129.75 20.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.412 1.085 . . . . 0.0 111.522 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.1 -20.7 64.08 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.071 1.348 . . . . 0.0 110.912 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.55 160.35 36.85 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.504 1.922 . . . . 0.0 112.125 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.34 147.87 60.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.653 2.235 . . . . 0.0 109.169 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 155.41 50.23 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.13 140.97 81.08 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.43 2.086 . . . . 0.0 108.179 171.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.09 172.06 7.96 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.287 1.991 . . . . 0.0 111.037 170.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -66.29 170.57 5.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.95 0.9 . . . . 0.0 110.1 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -49.76 124.81 16.45 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-O 117.593 -1.194 . . . . 0.0 107.796 160.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.06 136.0 46.25 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 CA-C-N 120.205 1.109 . . . . 0.0 109.352 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -78.77 164.55 24.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.176 1.465 . . . . 0.0 107.095 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 t -124.4 112.45 32.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.14 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -109.45 -82.5 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -167.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.07 134.47 47.08 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.245 1.418 . . . . 0.0 108.267 171.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -140.03 135.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.812 1.187 . . . . 0.0 108.545 163.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.0 p -110.68 -74.1 0.66 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -168.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 2.1 pttp -163.93 -26.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 129.641 3.177 . . . . 0.0 110.036 163.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -140.41 9.33 2.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.839 1.256 . . . . 0.0 112.287 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -126.99 160.66 30.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.851 0.75 . . . . 0.0 110.452 162.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -151.65 133.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.624 1.57 . . . . 0.0 106.946 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -79.98 132.64 36.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.7 142.08 35.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.291 1.437 . . . . 0.0 108.16 167.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.524 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -140.19 111.46 7.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.802 1.314 . . . . 0.0 108.466 -173.235 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.483 ' CH2' HD11 ' A' ' 51' ' ' ILE . 42.8 p90 -129.22 171.35 12.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.901 0.773 . . . . 0.0 109.56 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -124.84 145.48 50.02 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -74.72 144.07 30.86 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.461 2.774 . . . . 0.0 109.573 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.31 -175.78 49.73 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m -57.67 133.39 82.57 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 123.503 0.721 . . . . 0.0 111.506 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.02 -171.67 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.627 2.885 . . . . 0.0 113.417 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.68 -125.14 0.8 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 156.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -66.8 -23.03 66.01 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 128.992 2.917 . . . . 0.0 113.242 -160.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 18.3 mt -131.75 172.08 7.98 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.971 2.108 . . . . 0.0 109.356 172.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 41.9 Cg_endo -76.38 -136.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.582 3.521 . . . . 0.0 107.774 163.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.61 120.15 5.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -35.71 78.59 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.345 1.058 . . . . 0.0 112.483 -170.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.3 -167.86 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.227 1.011 . . . . 0.0 108.707 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -123.36 169.22 11.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.404 2.282 . . . . 0.0 108.273 164.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -127.27 156.02 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 130.734 3.613 . . . . 0.0 105.721 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.483 HD11 ' CH2' ' A' ' 36' ' ' TRP . 24.3 mt -128.63 136.71 59.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 164.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.69 153.36 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 108.175 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.14 128.76 22.98 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.767 1.227 . . . . 0.0 109.461 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.64 151.3 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.787 1.635 . . . . 0.0 107.197 171.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.28 105.87 1.0 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.106 -0.372 . . . . 0.0 110.359 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.94 -31.36 72.43 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -171.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 m -105.36 49.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.081 1.352 . . . . 0.0 110.218 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG22 ' HD2' ' A' ' 80' ' ' ARG . 92.2 t -134.85 -88.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 160.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.67 3.85 7.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.387 1.875 . . . . 0.0 110.401 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.49 -71.64 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.796 2.038 . . . . 0.0 109.758 -170.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -36.74 148.89 0.02 OUTLIER 'General case' 0 C--O 1.238 0.474 0 C-N-CA 130.437 3.495 . . . . 0.0 115.418 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -65.44 134.76 54.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.329 1.452 . . . . 0.0 108.079 171.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -129.9 130.2 44.86 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.25 94.86 0.17 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.07 -13.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.358 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.86 26.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.296 0.953 . . . . 0.0 109.475 162.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.46 26.11 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.4 m170 40.98 63.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.683 1.993 . . . . 0.0 111.915 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.25 138.26 24.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 C-N-CA 128.073 2.549 . . . . 0.0 108.115 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 29.15 5.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.869 0.867 . . . . 0.0 111.695 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.74 152.95 44.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.8 p -88.28 2.97 51.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.291 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -136.32 121.62 19.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.635 2.374 . . . . 0.0 107.693 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -146.39 139.23 25.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.427 1.012 . . . . 0.0 112.271 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -81.0 99.68 8.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.827 2.051 . . . . 0.0 108.492 170.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.0 143.58 15.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -131.69 178.14 6.98 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.247 1.419 . . . . 0.0 110.374 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 23.48 68.93 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.27 -159.32 0.73 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' HD2' HG22 ' A' ' 58' ' ' VAL . 58.1 mtt-85 -134.98 140.85 36.23 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-O 117.753 -1.118 . . . . 0.0 109.437 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.17 158.91 51.08 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.935 2.423 . . . . 0.0 110.588 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.04 45.44 3.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.967 2.107 . . . . 0.0 112.294 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -136.22 128.14 29.39 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 125.845 1.658 . . . . 0.0 107.889 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mm -65.17 145.61 13.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -134.57 158.29 44.37 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.626 1.571 . . . . 0.0 108.085 159.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mt -107.26 162.22 14.08 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 154.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.47 148.54 49.27 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.9 mtm -130.86 167.97 18.05 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 158.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.34 154.4 16.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.562 ' HD3' HD22 ' A' ' 97' ' ' LEU . 9.8 mtt180 -132.26 141.47 49.02 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.03 153.78 22.51 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.19 150.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.612 1.565 . . . . 0.0 107.44 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.36 160.2 18.13 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.52 10.67 2.42 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.177 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -120.56 15.21 11.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.563 2.345 . . . . 0.0 110.23 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.99 176.47 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 124.896 1.236 . . . . 0.0 110.778 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.562 HD22 ' HD3' ' A' ' 90' ' ' ARG . 2.0 mp -81.91 165.6 20.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.1 p -72.47 167.13 21.23 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.155 0.979 . . . . 0.0 110.144 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.52 150.11 0.55 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 152.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.36 149.65 80.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.198 1.932 . . . . 0.0 109.147 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -63.16 164.19 14.78 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 163.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.34 151.13 18.47 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.169 1.246 . . . . 0.0 109.519 154.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 40.9 mtm -68.31 151.28 47.14 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.988 -0.445 . . . . 0.0 110.528 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.5 p -60.5 -7.64 2.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.427 2.291 . . . . 0.0 115.24 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.23 157.24 0.15 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.228 2.211 . . . . 0.0 111.068 -158.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.01 100.88 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.159 2.573 . . . . 0.0 110.112 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.82 129.66 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.601 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -79.45 158.16 27.36 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 p -91.13 168.85 11.32 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.452 1.12 . . . . 0.0 109.903 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -71.64 177.05 4.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.903 1.811 . . . . 0.0 111.116 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -77.27 151.75 34.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 110.53 -3.032 . . . . 0.0 108.878 166.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.519 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -94.0 11.07 31.01 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -168.159 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.24 116.99 5.43 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 118.539 -1.145 . . . . 0.0 112.645 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.16 166.74 29.16 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 CA-C-N 120.409 2.104 . . . . 0.0 110.186 159.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.1 t -150.27 -160.22 1.14 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.787 1.635 . . . . 0.0 107.822 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 p -146.32 115.96 7.2 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.682 1.193 . . . . 0.0 109.138 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -172.037 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.413 0 CA-C-O 121.631 0.573 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.62 120.62 18.48 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 160.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 m 33.83 67.44 0.2 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.925 2.49 . . . . 0.0 113.847 168.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.34 -111.81 1.92 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 124.16 0.886 . . . . 0.0 111.421 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 m -59.31 98.71 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.86 1.264 . . . . 0.0 111.69 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 m -71.02 175.98 4.74 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 152.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -136.07 16.61 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -74.19 68.33 1.44 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.662 1.185 . . . . 0.0 110.205 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -67.69 119.23 12.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 164.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 t80 67.88 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.608 2.363 . . . . 0.0 109.553 -176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.37 171.19 15.86 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.077 1.351 . . . . 0.0 109.653 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.45 -0.44 0.89 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.794 2.438 . . . . 0.0 114.912 -166.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 15' ' ' LEU . 14.2 p -33.75 118.65 0.36 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.585 2.354 . . . . 0.0 113.861 175.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -74.0 62.54 0.88 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.543 1.937 . . . . 0.0 108.169 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 13' ' ' SER . 73.8 mt -127.47 159.04 67.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.158 2.183 . . . . 0.0 107.441 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.87 158.19 34.74 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.167 2.578 . . . . 0.0 112.041 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.33 151.46 50.22 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 167.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.446 2.097 . . . . 0.0 111.528 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -63.21 168.25 11.28 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.147 1.231 . . . . 0.0 110.491 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -88.19 163.39 16.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 10.9 tmtt? -57.39 125.49 71.71 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 117.092 -1.432 . . . . 0.0 109.467 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.88 157.9 56.71 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.293 1.328 . . . . 0.0 111.842 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -135.06 118.39 16.71 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 127.396 2.279 . . . . 0.0 105.988 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -63.16 161.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 114.394 -1.276 . . . . 0.0 109.429 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -140.75 -79.91 0.27 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.442 1.097 . . . . 0.0 109.082 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -79.69 143.01 34.98 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 108.335 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.01 146.51 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 160.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.3 p -118.04 -62.47 1.54 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 pttt 172.4 -34.98 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 130.647 3.579 . . . . 0.0 108.196 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.49 5.82 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.731 1.212 . . . . 0.0 111.018 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -132.75 155.34 49.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.44 134.64 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.261 1.424 . . . . 0.0 107.859 175.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.0 m -95.89 128.52 42.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.114 0.966 . . . . 0.0 109.22 178.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.32 122.59 47.86 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.002 2.121 . . . . 0.0 107.381 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -92.42 147.83 22.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 159.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.49 ' CH2' HD11 ' A' ' 51' ' ' ILE . 44.1 p90 -139.85 172.15 13.19 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 124.821 1.248 . . . . 0.0 107.92 156.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -109.06 144.11 29.01 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.21 158.36 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.839 3.026 . . . . 0.0 112.141 -168.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.97 -176.21 39.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.915 0.769 . . . . 0.0 112.008 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.47 154.85 87.79 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.298 1.439 . . . . 0.0 111.326 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.41 -101.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 125.667 4.245 . . . . 0.0 109.631 161.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.34 -92.67 0.69 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 128.194 2.807 . . . . 0.0 108.769 161.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -55.66 28.91 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.292 2.237 . . . . 0.0 109.963 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -134.29 160.4 68.63 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.068 1.347 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -75.28 154.17 40.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.237 3.291 . . . . 0.0 108.981 172.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.2 161.82 21.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.489 1.137 . . . . 0.0 110.359 170.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.439 ' HB2' HG22 ' A' ' 92' ' ' ILE . 3.2 m -119.58 -43.87 2.57 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.76 2.424 . . . . 0.0 109.237 -175.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.07 -164.83 0.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.33 1.452 . . . . 0.0 107.725 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.92 161.03 30.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.372 2.269 . . . . 0.0 108.362 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.0 mt -126.98 156.2 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.872 2.469 . . . . 0.0 106.471 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.49 HD11 ' CH2' ' A' ' 36' ' ' TRP . 70.7 mt -122.66 136.27 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 160.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -109.73 153.05 24.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 166.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.09 155.84 48.37 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.977 1.311 . . . . 0.0 107.686 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -133.05 153.69 51.26 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.485 1.514 . . . . 0.0 107.258 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.6 t -153.37 133.47 13.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.36 -18.37 63.06 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -103.1 1.79 33.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.162 1.385 . . . . 0.0 113.127 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -94.21 -79.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.1 m -128.78 -6.14 5.1 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.133 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t30 55.46 47.55 20.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.582 1.083 . . . . 0.0 109.0 -169.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.1 m -142.61 139.37 31.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.53 2.332 . . . . 0.0 107.932 -172.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -77.47 129.61 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 162.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -126.55 152.54 46.42 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.538 1.135 . . . . 0.0 108.215 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 135.23 47.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.73 0.08 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.326 1.451 . . . . 0.0 112.317 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.565 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . . . -151.68 139.53 19.92 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 164.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -142.93 143.69 32.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.102 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 37.37 63.15 0.77 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.508 1.523 . . . . 0.0 111.36 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -86.38 133.84 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -118.5 45.95 1.92 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.061 0.945 . . . . 0.0 109.754 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 t -157.88 -174.58 4.91 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.65 1.58 . . . . 0.0 107.543 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 p -124.95 3.26 8.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.051 2.141 . . . . 0.0 111.454 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.8 131.46 53.77 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 165.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 56.4 t80 -145.96 151.06 37.2 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.563 1.145 . . . . 0.0 109.267 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.3 m -109.84 102.31 11.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.058 1.743 . . . . 0.0 107.357 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.83 141.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -133.85 -177.59 4.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.032 1.733 . . . . 0.0 108.24 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.09 78.95 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 123.157 0.408 . . . . 0.0 112.876 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.83 -171.8 3.15 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.008 0.923 . . . . 0.0 108.837 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -116.39 143.19 30.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 125.107 1.363 . . . . 0.0 109.092 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -74.56 157.75 44.36 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.248 2.632 . . . . 0.0 111.885 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.1 t30 46.64 34.27 2.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.348 1.859 . . . . 0.0 112.023 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 m -125.02 130.33 52.11 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mm -74.71 151.29 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -131.91 169.1 16.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.11 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.425 HD13 ' SD ' ' A' ' 103' ' ' MET . 14.6 mt -119.74 156.25 30.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 152.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -131.01 146.44 52.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.119 1.768 . . . . 0.0 106.742 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.73 117.92 9.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.863 1.665 . . . . 0.0 107.012 -177.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.24 112.76 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -97.85 135.56 39.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 163.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.71 166.74 15.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 165.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.6 OUTLIER -127.73 151.56 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.74 1.616 . . . . 0.0 108.168 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -145.04 178.43 1.44 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.067 1.747 . . . . 0.0 108.447 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.63 -10.04 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.865 2.377 . . . . 0.0 115.848 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -113.13 -32.79 6.21 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.411 1.46 . . . . 0.0 112.935 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.4 -156.58 17.89 Favored Glycine 0 C--O 1.238 0.397 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mp -103.93 149.51 25.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.776 1.23 . . . . 0.0 110.056 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.9 p -72.16 166.27 22.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.772 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.37 146.62 0.34 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 126.446 1.899 . . . . 0.0 112.157 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.43 104.96 0.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.63 2.22 . . . . 0.0 109.051 166.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -48.82 166.89 0.22 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.002 2.521 . . . . 0.0 113.907 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.59 135.67 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.252 1.968 . . . . 0.0 110.044 155.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.425 ' SD ' HD13 ' A' ' 86' ' ' LEU . 45.5 mtt -63.69 163.4 11.52 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.9 0.773 . . . . 0.0 110.234 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.482 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 85.6 p -65.7 -1.75 3.03 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.57 155.08 0.11 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.726 1.611 . . . . 0.0 110.925 -159.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -69.98 98.74 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.48 2.12 . . . . 0.0 111.65 -168.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 m -99.26 142.55 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.89 0.876 . . . . 0.0 110.597 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -93.11 147.99 22.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 122.96 0.504 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.7 p -79.32 152.03 30.71 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 158.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.87 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.611 1.964 . . . . 0.0 111.654 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -175.56 154.31 1.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.335 2.254 . . . . 0.0 106.396 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 t -111.64 17.37 20.0 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.507 1.123 . . . . 0.0 111.999 -172.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -63.98 -74.71 0.42 Allowed Glycine 0 CA--C 1.534 1.257 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 168.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.47 147.93 90.58 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.765 1.643 . . . . 0.0 110.328 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 m -142.48 140.56 31.93 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -174.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 t -151.87 90.55 1.55 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.419 1.009 . . . . 0.0 111.246 -168.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 N-CA-C 105.264 -3.135 . . . . 0.0 105.264 167.087 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.696 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -157.21 111.03 2.61 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.48 1.512 . . . . 0.0 107.697 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.0 p -157.5 169.98 23.47 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.976 0.91 . . . . 0.0 108.777 157.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.41 -162.87 11.02 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 125.357 1.456 . . . . 0.0 109.781 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.6 m -62.63 168.92 3.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.796 0.808 . . . . 0.0 110.049 162.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 m -57.17 166.96 0.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.042 0.937 . . . . 0.0 108.915 152.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.57 37.21 0.02 OUTLIER Glycine 0 C--N 1.33 0.231 0 CA-C-O 118.585 -1.119 . . . . 0.0 112.974 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -107.43 135.09 49.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.801 1.301 . . . . 0.0 108.353 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -141.39 -167.18 2.35 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 149.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -84.73 172.22 11.69 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.696 1.134 . . . . 0.0 108.055 154.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.12 -174.55 4.04 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 125.183 1.393 . . . . 0.0 107.533 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.49 -23.13 9.47 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.743 1.156 . . . . 0.0 113.531 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.88 145.39 29.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.588 1.155 . . . . 0.0 110.207 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -70.1 -27.13 64.34 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.757 -0.589 . . . . 0.0 111.044 172.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.01 157.02 87.52 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 129.048 2.939 . . . . 0.0 110.731 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.68 165.0 19.38 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.685 3.59 . . . . 0.0 110.829 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.92 159.38 41.75 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 170.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.2 152.86 78.94 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.061 2.508 . . . . 0.0 111.324 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.16 156.4 55.54 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.33 2.02 . . . . 0.0 110.493 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 m -79.02 176.99 9.15 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.845 -0.534 . . . . 0.0 109.724 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 28.5 tttt -55.51 120.3 30.57 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-O 117.945 -1.026 . . . . 0.0 108.679 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.48 141.42 95.41 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 CA-C-N 120.257 1.128 . . . . 0.0 109.391 167.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -79.74 171.61 14.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 161.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.656 HG21 HG11 ' A' ' 107' ' ' VAL . 46.2 t -117.84 137.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 162.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.257 68.7 p -117.18 -98.42 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -72.42 142.81 48.67 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 109.08 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.79 -177.67 3.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 pttt -74.71 -16.67 60.74 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.259 -0.901 . . . . 0.0 112.12 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -136.39 2.72 2.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.686 1.13 . . . . 0.0 111.718 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.4 p -153.33 166.83 31.39 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.43 -1.418 . . . . 0.0 110.19 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.63 145.83 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.427 1.091 . . . . 0.0 108.57 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -105.64 124.36 49.43 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.539 1.535 . . . . 0.0 107.315 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.82 132.01 53.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.725 2.01 . . . . 0.0 110.828 -171.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.8 108.68 11.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.321 1.848 . . . . 0.0 106.621 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -109.86 173.11 6.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.13 148.87 42.41 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.51 134.74 12.65 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.533 3.488 . . . . 0.0 110.915 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.47 30.87 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-O 122.756 1.198 . . . . 0.0 111.165 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -61.18 154.06 63.94 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.66 1.984 . . . . 0.0 111.148 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.73 -174.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 125.042 3.828 . . . . 0.0 114.702 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.03 -154.89 7.83 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -47.72 23.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 160.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.506 HD13 ' HG2' ' A' ' 94' ' ' PRO . 11.3 mt -103.62 144.01 27.8 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.56 0.618 . . . . 0.0 110.487 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -81.36 151.75 17.78 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.371 2.714 . . . . 0.0 110.652 -165.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.71 122.42 5.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.762 1.225 . . . . 0.0 111.526 168.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.592 ' HB2' HG22 ' A' ' 92' ' ' ILE . 33.8 m -76.94 -61.82 1.85 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.578 1.951 . . . . 0.0 108.434 162.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -158.99 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 110.115 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -132.61 168.65 17.88 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.637 1.975 . . . . 0.0 109.219 165.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.76 159.67 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 128.745 2.818 . . . . 0.0 106.907 168.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.1 mt -130.22 129.79 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.91 166.03 11.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.934 0.894 . . . . 0.0 109.181 163.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.45 147.28 34.32 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.079 1.752 . . . . 0.0 108.205 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -127.89 119.78 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 44.6 t -73.59 -72.01 0.29 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.141 1.337 . . . . 0.0 110.082 166.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 142.73 -58.88 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 131.699 4.0 . . . . 0.0 106.096 -156.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 t -121.18 39.75 3.74 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.485 1.493 . . . . 0.0 109.363 -155.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.718 HG23 ' H ' ' A' ' 59' ' ' SER 0.272 25.1 m -120.41 -84.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -167.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.718 ' H ' HG23 ' A' ' 58' ' ' VAL . 8.3 m -129.96 16.83 5.69 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.441 1.096 . . . . 0.0 112.51 168.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 47.1 51.73 12.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.952 1.701 . . . . 0.0 111.161 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -153.26 153.33 32.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.06 1.744 . . . . 0.0 108.155 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.91 137.19 58.22 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 155.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -134.42 146.62 50.01 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.72 123.42 26.66 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.32 -3.02 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.537 1.135 . . . . 0.0 111.611 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.45 140.05 19.77 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 158.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.38 129.04 30.67 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -172.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 63.41 56.33 1.67 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.033 1.733 . . . . 0.0 112.094 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 134.31 27.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.474 1.51 . . . . 0.0 107.977 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . 32.9 mtpt -122.89 51.84 1.39 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.974 2.109 . . . . 0.0 109.108 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 t -150.45 -178.69 6.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.643 1.577 . . . . 0.0 107.22 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.6 p -118.52 2.12 11.76 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.171 1.789 . . . . 0.0 111.213 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -137.55 103.66 5.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -128.52 137.29 51.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -86.13 105.2 16.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.98 140.47 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -129.13 178.5 6.37 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.259 1.424 . . . . 0.0 110.89 -173.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.24 13.62 67.64 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 124.748 1.166 . . . . 0.0 114.304 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.02 164.81 25.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.68 1.229 . . . . 0.0 110.31 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -93.29 146.03 31.14 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.219 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.66 157.48 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.95 2.433 . . . . 0.0 110.581 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 53.23 14.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.782 1.633 . . . . 0.0 113.542 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -109.29 132.12 54.42 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 120.208 1.367 . . . . 0.0 108.744 -170.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -61.96 145.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 85.3 m-85 -140.42 150.77 44.28 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.927 1.346 . . . . 0.0 108.369 163.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.8 mt -110.36 162.28 14.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 111.675 -2.511 . . . . 0.0 107.926 159.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -142.21 126.31 17.39 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.48 1.912 . . . . 0.0 108.769 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.1 mtm -104.99 154.82 19.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 163.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.97 134.72 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.871 ' HD3' HD13 ' A' ' 97' ' ' LEU . 49.0 mtt180 -118.72 147.55 43.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 167.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.9 158.84 20.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.592 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.5 OUTLIER -125.52 143.98 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' HA ' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -138.02 172.82 6.12 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 126.0 1.72 . . . . 0.0 107.288 173.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.506 ' HG2' HD13 ' A' ' 44' ' ' LEU . 44.8 Cg_endo -81.97 28.12 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.553 2.168 . . . . 0.0 112.382 -172.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -132.78 -42.45 0.91 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 127.134 2.174 . . . . 0.0 110.46 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.27 -177.36 44.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 122.336 0.965 . . . . 0.0 112.959 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.871 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.5 pp -92.42 165.47 13.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.433 1.493 . . . . 0.0 111.052 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.55 ' O ' HD12 ' A' ' 97' ' ' LEU . 18.9 p -87.18 167.16 14.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -174.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.1 150.72 1.02 Allowed Pre-proline 0 C--O 1.237 0.424 0 O-C-N 121.524 -0.735 . . . . 0.0 109.205 152.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.55 154.89 72.3 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 120.863 1.042 . . . . 0.0 110.444 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 p -53.25 151.36 9.77 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 123.463 0.705 . . . . 0.0 111.043 160.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -53.54 140.94 64.21 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.77 1.647 . . . . 0.0 109.841 154.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 mmt -57.66 129.44 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.027 0.531 . . . . 0.0 111.715 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.645 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.87 -16.41 50.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.534 1.534 . . . . 0.0 112.255 169.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t0 85.87 153.38 0.1 Allowed Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 129.457 3.103 . . . . 0.0 110.824 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.09 97.08 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.901 2.401 . . . . 0.0 112.185 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.656 HG11 HG21 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -85.73 156.3 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 124.66 1.184 . . . . 0.0 109.481 176.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -106.08 165.33 11.3 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.969 1.308 . . . . 0.0 109.038 172.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -102.03 163.76 12.07 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.283 1.433 . . . . 0.0 109.248 169.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -74.05 174.56 8.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.947 0.88 . . . . 0.0 111.669 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.37 151.64 36.3 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.102 2.161 . . . . 0.0 109.73 170.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.8 t -130.56 74.48 1.6 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.418 1.087 . . . . 0.0 108.288 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -138.33 -115.85 1.38 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.12 158.22 45.69 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.283 2.655 . . . . 0.0 111.168 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.6 p -162.13 162.64 28.6 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.653 -0.654 . . . . 0.0 110.8 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.2 m 47.72 36.12 5.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.253 1.421 . . . . 0.0 112.768 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.817 0 N-CA-C 105.478 -3.049 . . . . 0.0 105.478 176.228 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.91 0 CA-C-O 121.143 0.302 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.6 m -141.96 3.79 1.63 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.156 1.782 . . . . 0.0 111.852 162.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 t -147.07 88.47 1.73 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.48 118.49 2.52 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.6 m -157.26 43.92 0.35 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.981 1.312 . . . . 0.0 109.865 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 p -145.71 167.35 23.36 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.688 0.795 . . . . 0.0 109.669 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.67 -134.77 41.33 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -140.89 167.17 22.83 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -154.97 139.4 16.8 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.508 1.049 . . . . 0.0 109.838 165.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -68.69 -30.04 68.62 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.801 0.841 . . . . 0.0 110.984 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 47.47 -162.6 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 127.349 2.26 . . . . 0.0 110.693 -162.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.41 31.09 5.67 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.4 1.08 . . . . 0.0 108.671 166.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 t -58.21 132.68 54.29 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.942 0.897 . . . . 0.0 110.379 -170.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.63 -42.58 24.56 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt -76.68 141.64 69.14 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 124.805 1.242 . . . . 0.0 110.227 -174.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -66.93 147.11 79.82 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.345 2.03 . . . . 0.0 111.519 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.08 142.01 28.55 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.422 1.487 . . . . 0.0 110.363 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.3 148.85 85.11 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.706 2.27 . . . . 0.0 110.231 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -64.61 160.7 38.74 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.819 1.679 . . . . 0.0 110.867 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -67.16 168.32 10.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.86 0.864 . . . . 0.0 109.788 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -57.02 124.64 66.56 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.013 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.18 135.81 32.84 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.535 1.584 . . . . 0.0 110.535 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -80.36 168.61 18.81 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 125.103 1.361 . . . . 0.0 109.778 166.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.5 95.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 112.056 -2.338 . . . . 0.0 106.169 171.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.3 p -93.58 -89.33 0.21 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 126.29 28.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.566 1.146 . . . . 0.0 110.542 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.49 159.1 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.714 1.206 . . . . 0.0 108.079 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 p -137.95 -56.52 0.67 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt 170.85 -31.44 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 1 C-N-CA 132.082 4.153 . . . . 0.0 108.969 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.25 2.26 2.06 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.528 1.531 . . . . 0.0 112.12 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 p -132.4 154.56 49.69 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.093 0.86 . . . . 0.0 109.919 165.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 p -147.63 141.92 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.49 143.41 26.84 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.5 mt -112.66 138.35 49.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.352 1.461 . . . . 0.0 107.81 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.89 120.51 30.63 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -136.63 170.55 15.88 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.272 1.397 . . . . 0.0 107.63 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -115.64 149.61 43.33 Favored Pre-proline 0 C--O 1.237 0.443 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.51 153.29 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.358 2.039 . . . . 0.0 110.126 -165.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.87 176.44 54.02 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-O 122.642 1.135 . . . . 0.0 111.633 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.9 m -62.01 149.5 85.94 Favored Pre-proline 0 N--CA 1.435 -1.217 0 C-N-CA 126.355 1.862 . . . . 0.0 108.667 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -69.55 178.68 4.2 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 CA-C-O 123.77 1.488 . . . . 0.0 113.049 170.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.57 -160.79 9.24 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 130.686 3.993 . . . . 0.0 103.401 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -43.66 72.97 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.805 0.842 . . . . 0.0 111.52 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.46 154.52 37.52 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 118.793 0.724 . . . . 0.0 111.478 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.84 151.54 31.56 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.943 3.095 . . . . 0.0 110.316 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.27 104.27 9.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.426 ' H ' ' HA ' ' A' ' 93' ' ' ASN . 3.0 m -52.43 -52.8 52.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.251 2.221 . . . . 0.0 112.929 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.81 -163.81 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.509 1.924 . . . . 0.0 107.201 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -127.23 157.96 38.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.82 1.248 . . . . 0.0 110.08 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -107.1 154.12 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.661 1.984 . . . . 0.0 107.217 164.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.45 119.73 46.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -100.91 155.85 17.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.66 156.37 48.95 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 126.192 1.797 . . . . 0.0 106.306 169.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -132.83 156.14 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.03 124.41 5.29 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -21.67 65.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.776 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 t -94.65 -3.49 49.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.18 0.992 . . . . 0.0 111.697 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 t -111.28 -68.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 125.235 1.414 . . . . 0.0 108.367 -161.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 m -142.95 -5.25 0.89 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 111.611 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 t30 54.36 32.03 15.63 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -133.95 153.16 51.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.568 1.547 . . . . 0.0 108.27 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -71.29 141.74 50.5 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 159.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -135.11 132.76 38.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 175.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -71.87 94.18 1.4 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.97 -25.63 14.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.781 0.832 . . . . 0.0 110.902 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.75 46.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 163.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -133.96 143.96 48.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.452 1.501 . . . . 0.0 107.597 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.3 m80 47.26 64.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.068 1.347 . . . . 0.0 111.595 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.3 133.5 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -117.89 56.65 0.85 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.853 1.261 . . . . 0.0 108.271 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 t -161.35 176.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.4 p -110.46 0.0 17.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 111.465 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -142.99 101.57 3.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.581 1.152 . . . . 0.0 108.944 -169.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -134.18 124.29 25.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.612 0.765 . . . . 0.0 112.838 -164.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.0 m -70.82 98.37 1.55 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.764 2.426 . . . . 0.0 110.805 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.83 146.99 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 120.646 -1.284 . . . . 0.0 108.167 163.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -140.81 -178.19 5.43 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.861 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.25 49.66 60.45 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt -115.26 -160.5 0.74 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.822 1.249 . . . . 0.0 108.905 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -131.08 139.57 35.95 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.541 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.79 160.21 50.14 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.312 2.674 . . . . 0.0 111.601 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.1 m120 47.95 21.93 0.34 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.207 1.803 . . . . 0.0 113.844 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -121.03 121.44 37.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.83 1.652 . . . . 0.0 106.789 -170.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 mm -58.78 146.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -136.07 159.91 40.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 162.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.4 HD13 ' SD ' ' A' ' 103' ' ' MET . 15.0 mt -112.2 162.57 15.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 125.758 1.623 . . . . 0.0 107.782 158.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -142.57 143.42 32.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.439 1.712 . . . . 0.0 107.727 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 mtm -138.46 149.04 45.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.13 150.31 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -129.02 148.46 50.97 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 167.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.25 152.42 22.32 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 163.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.34 151.03 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.426 ' HA ' ' H ' ' A' ' 47' ' ' SER . 1.0 OUTLIER -146.61 174.99 2.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.034 0.934 . . . . 0.0 109.529 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.54 29.5 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.913 3.075 . . . . 0.0 114.114 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.56 -52.19 0.48 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.49 1.916 . . . . 0.0 109.756 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.96 -144.06 4.03 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 127.263 2.363 . . . . 0.0 108.971 -170.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 pp -142.73 167.43 22.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.865 1.266 . . . . 0.0 111.609 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.7 p -75.35 165.52 25.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.269 0.628 . . . . 0.0 110.645 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -51.83 152.19 5.5 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 157.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.9 142.28 51.35 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.665 1.577 . . . . 0.0 109.136 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 p -59.09 162.27 7.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 O-C-N 121.812 -0.555 . . . . 0.0 111.062 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -54.55 129.83 36.94 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.6 2.867 . . . . 0.0 109.835 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.4 ' SD ' HD13 ' A' ' 86' ' ' LEU . 5.4 mtm -49.75 151.68 1.7 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.322 1.419 . . . . 0.0 113.199 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.3 p -60.5 -12.22 9.12 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.79 155.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.344 1.857 . . . . 0.0 108.739 -157.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -70.74 137.42 32.56 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.229 1.953 . . . . 0.0 109.883 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.62 125.78 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.35 127.65 35.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.9 p -66.07 157.96 29.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -66.91 172.99 3.88 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.146 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.74 8.0 9.04 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.579 1.151 . . . . 0.0 113.932 -169.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 t 59.53 31.27 20.88 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.032 2.533 . . . . 0.0 113.714 -177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -136.04 73.32 0.44 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.26 177.05 6.33 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.866 2.377 . . . . 0.0 112.59 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.1 t -136.41 -177.48 4.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.719 2.008 . . . . 0.0 106.856 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.7 p -130.62 114.51 15.52 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.279 1.832 . . . . 0.0 107.128 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.786 0 CA-C-O 117.462 -1.744 . . . . 0.0 109.042 178.915 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -110.08 11.28 23.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.336 0.655 . . . . 0.0 112.605 -153.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.3 p -66.69 -179.94 0.95 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.199 0.999 . . . . 0.0 110.95 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.87 -126.66 0.73 Allowed Glycine 0 CA--C 1.528 0.845 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 149.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.9 m 75.38 126.49 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.868 2.467 . . . . 0.0 109.607 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -42.26 127.2 3.57 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.238 1.415 . . . . 0.0 110.315 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.29 -179.45 29.65 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.042 1.306 . . . . 0.0 110.459 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 mttp 60.39 168.27 0.08 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.048 2.539 . . . . 0.0 113.167 -164.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -154.0 100.7 2.36 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.601 1.96 . . . . 0.0 107.04 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -67.64 -28.91 68.12 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.503 0.721 . . . . 0.0 112.766 -174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 53.35 -159.57 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 111.932 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.6 mt -119.46 78.53 1.32 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 166.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 m -69.67 161.8 28.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.944 0.878 . . . . 0.0 110.138 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 6.4 m-20 -74.05 -36.25 64.35 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.909 -0.494 . . . . 0.0 110.666 173.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.99 155.24 64.36 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.405 1.082 . . . . 0.0 109.99 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.21 149.66 84.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.889 2.392 . . . . 0.0 112.422 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 148.48 44.78 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 169.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 156.45 53.63 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.813 2.342 . . . . 0.0 113.053 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.68 175.07 5.66 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.493 2.795 . . . . 0.0 112.837 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -61.09 171.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.922 0.868 . . . . 0.0 111.769 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -52.96 133.57 48.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.299 -0.858 . . . . 0.0 108.856 157.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.54 148.27 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.433 1.422 . . . . 0.0 110.927 167.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -119.3 117.14 27.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.612 1.565 . . . . 0.0 108.658 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.89 144.6 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 113.357 -1.747 . . . . 0.0 107.698 169.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 p -128.75 -85.72 0.56 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -73.84 149.12 41.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.704 1.602 . . . . 0.0 109.475 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.97 141.95 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 122.004 0.907 . . . . 0.0 108.687 161.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.9 p -128.54 -172.21 2.65 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 107.996 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -62.05 -36.99 83.27 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.176 -0.953 . . . . 0.0 112.706 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -139.67 23.86 2.45 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.902 1.228 . . . . 0.0 111.398 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -146.14 164.13 33.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.518 0.599 . . . . 0.0 109.501 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.05 138.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -94.44 135.18 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.36 130.63 52.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 125.886 1.674 . . . . 0.0 108.318 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 1.4 t -103.32 151.92 22.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.69 1.196 . . . . 0.0 108.127 161.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.597 ' CH2' HD11 ' A' ' 51' ' ' ILE . 24.2 p90 -140.04 171.12 14.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 156.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.32 144.82 32.46 Favored Pre-proline 0 C--O 1.239 0.516 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.94 140.73 18.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.835 2.357 . . . . 0.0 110.751 -167.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.21 -168.19 26.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 166.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.3 m -86.85 159.98 50.76 Favored Pre-proline 0 N--CA 1.441 -0.878 0 C-N-CA 128.775 2.83 . . . . 0.0 109.458 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.84 -169.06 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.813 3.676 . . . . 0.0 111.085 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.35 -148.41 6.21 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 105.872 -2.891 . . . . 0.0 105.872 164.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -53.63 -33.4 54.95 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.549 0.739 . . . . 0.0 110.144 171.095 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 95' ' ' GLN . 12.6 mt -104.36 157.72 33.47 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 118.379 0.536 . . . . 0.0 111.124 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.36 170.58 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.045 2.497 . . . . 0.0 109.303 164.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.61 162.6 13.56 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.473 1.109 . . . . 0.0 109.033 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -116.54 -47.28 2.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.86 2.064 . . . . 0.0 109.481 -171.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.51 -160.99 0.55 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -134.83 148.86 50.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.444 2.298 . . . . 0.0 108.555 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 64' ' ' THR . 2.2 mt -124.99 113.86 37.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 129.15 2.98 . . . . 0.0 105.754 172.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.597 HD11 ' CH2' ' A' ' 36' ' ' TRP . 69.7 mt -94.54 120.39 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 171.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.78 154.29 20.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.26 148.21 51.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.015 1.726 . . . . 0.0 108.08 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.23 157.46 19.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 166.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.3 144.57 21.01 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -95.53 -4.99 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.545 1.538 . . . . 0.0 112.622 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.0 m -119.56 9.98 11.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.362 1.465 . . . . 0.0 113.281 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -115.17 -77.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.14 1.776 . . . . 0.0 109.023 -168.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -141.67 5.85 1.81 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.289 0.95 . . . . 0.0 112.786 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 m120 59.58 2.93 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.431 2.692 . . . . 0.0 114.964 -175.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -106.23 161.16 14.78 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 126.632 1.973 . . . . 0.0 110.518 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.424 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 81.6 m95 -77.78 144.62 36.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 153.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -138.32 148.68 44.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 HG23 ' A' ' 50' ' ' ILE . 32.4 m -77.19 108.57 10.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -95.11 -15.47 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.215 1.006 . . . . 0.0 111.93 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.92 102.45 2.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.307 0.958 . . . . 0.0 108.835 167.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.81 157.89 15.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.196 0.998 . . . . 0.0 110.394 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 44.89 46.23 8.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.473 2.709 . . . . 0.0 112.449 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t -79.99 136.75 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 126.75 2.02 . . . . 0.0 108.056 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -123.27 61.41 1.04 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 122.093 0.949 . . . . 0.0 108.799 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 t -158.31 179.27 9.3 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 p -122.85 5.86 9.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.697 1.199 . . . . 0.0 111.441 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 7.8 tp -135.89 128.36 30.46 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 163.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -145.95 151.24 37.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -101.42 103.77 14.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.227 1.411 . . . . 0.0 107.827 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.52 137.49 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -122.48 -167.38 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.546 1.938 . . . . 0.0 107.543 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.68 21.11 64.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.112 171.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -99.95 -166.46 1.34 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.822 1.311 . . . . 0.0 110.616 -167.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -122.73 153.15 63.15 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 107.248 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.69 156.17 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.519 2.146 . . . . 0.0 110.382 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 35.58 57.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.222 1.809 . . . . 0.0 110.598 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.9 m -139.0 138.33 37.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.66 1.984 . . . . 0.0 106.19 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 mm -79.44 146.1 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.127 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -142.13 150.87 41.68 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.179 1.391 . . . . 0.0 109.411 173.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.03 166.27 10.85 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 162.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -138.34 149.22 45.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.647 1.217 . . . . 0.0 108.731 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.424 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 73.3 mtm -136.81 152.53 50.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 163.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 36' ' ' TRP . 71.0 t -119.3 109.66 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -169.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.603 ' HD3' HD13 ' A' ' 97' ' ' LEU . 73.8 mtt180 -94.84 132.28 39.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 129.25 35.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 165.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.05 149.52 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.7 176.79 2.27 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.101 1.361 . . . . 0.0 108.926 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.99 4.09 0.77 Allowed 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.581 2.854 . . . . 0.0 115.935 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.537 ' HB2' HD12 ' A' ' 44' ' ' LEU . 15.8 tp60 -140.48 -17.4 0.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.926 1.29 . . . . 0.0 112.617 -161.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.19 -156.84 29.05 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.858 1.694 . . . . 0.0 109.402 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.603 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -129.76 146.97 51.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.849 1.66 . . . . 0.0 107.765 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.3 p -72.41 167.11 21.23 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.04 153.75 0.49 Allowed Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.234 1.413 . . . . 0.0 110.919 173.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.1 136.3 68.18 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -61.3 172.02 1.08 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 165.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.98 144.77 35.33 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.012 1.142 . . . . 0.0 109.733 156.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.51 143.6 57.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.6 p -64.48 -2.48 2.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.902 1.681 . . . . 0.0 115.043 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t0 68.71 151.5 0.13 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.945 2.498 . . . . 0.0 109.751 -158.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.65 105.58 1.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.081 2.521 . . . . 0.0 110.206 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.83 167.72 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 129.04 47.38 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.201 1.4 . . . . 0.0 108.233 172.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.2 p -65.4 160.64 21.52 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.208 0.317 . . . . 0.0 110.81 171.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -83.88 -176.75 6.43 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.202 1.001 . . . . 0.0 110.458 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.95 157.52 31.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 111.991 -177.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 m -115.83 32.67 5.95 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.562 1.945 . . . . 0.0 113.345 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.86 -138.31 1.17 Allowed Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 168.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.8 163.54 18.63 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 CA-C-N 119.688 1.744 . . . . 0.0 110.441 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.36 133.1 46.49 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.722 0.809 . . . . 0.0 109.353 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.12 165.23 7.39 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 157.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.908 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 -176.013 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -125.33 67.43 1.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -145.64 80.1 1.58 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -162.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.7 -44.95 95.62 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.565 -164.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -179.57 155.03 0.64 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.294 1.438 . . . . 0.0 109.999 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -73.41 -39.46 65.02 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.807 0.443 . . . . 0.0 110.865 163.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.53 -152.4 45.04 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -168.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -131.5 129.36 41.01 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -144.51 91.03 2.14 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 171.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -75.8 162.34 28.25 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 163.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 72.86 -178.0 0.19 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.441 1.896 . . . . 0.0 109.365 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.5 mt -101.17 34.39 2.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.961 1.304 . . . . 0.0 108.263 160.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.2 m 56.66 37.33 28.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.209 1.803 . . . . 0.0 112.59 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.449 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-20 -65.97 -34.3 77.8 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.645 1.178 . . . . 0.0 111.861 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.26 151.22 96.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.159 1.784 . . . . 0.0 111.077 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.38 159.93 47.91 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.879 3.053 . . . . 0.0 111.35 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.07 152.38 48.99 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.91 138.91 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.708 1.605 . . . . 0.0 108.606 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -64.91 163.7 27.29 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 121.894 1.729 . . . . 0.0 111.168 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.3 m -74.25 160.46 31.09 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.54 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.89 121.12 21.53 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.042 1.337 . . . . 0.0 112.027 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.45 146.59 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.755 1.636 . . . . 0.0 113.577 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.11 125.25 53.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 125.602 1.561 . . . . 0.0 111.373 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 107' ' ' VAL . 1.3 m -86.08 133.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 113.615 -1.63 . . . . 0.0 108.885 -176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -121.88 -90.97 0.57 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -167.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -72.23 141.16 48.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.34 136.02 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.9 p -105.76 -52.88 2.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.362 -170.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 pttp 160.61 -26.13 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.331 1 C-N-CA 133.795 4.838 . . . . 0.0 108.373 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.18 -0.29 1.13 Allowed 'General case' 0 CA--C 1.523 -0.083 0 O-C-N 121.173 -0.954 . . . . 0.0 112.745 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -125.15 160.33 29.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.945 1.248 . . . . 0.0 110.156 160.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.51 130.96 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.127 1.371 . . . . 0.0 108.475 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.3 m -90.21 122.57 33.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.825 2.05 . . . . 0.0 108.249 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.75 126.64 54.79 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.874 2.07 . . . . 0.0 107.844 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.06 152.65 18.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 160.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.7 p90 -139.76 172.42 12.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 152.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -102.09 146.03 31.56 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.3 156.12 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.558 2.839 . . . . 0.0 109.964 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.13 177.86 50.76 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-O 123.878 1.821 . . . . 0.0 110.815 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 m -64.73 154.82 84.29 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 127.546 2.338 . . . . 0.0 109.357 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.62 -171.69 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.995 2.463 . . . . 0.0 112.828 166.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.75 6.14 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -73.7 -45.01 54.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 161.28 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 mt -97.59 150.19 36.52 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 123.365 0.666 . . . . 0.0 109.978 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.23 151.61 54.91 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.889 3.059 . . . . 0.0 109.537 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.58 159.97 26.3 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.649 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.499 ' HB2' HG22 ' A' ' 92' ' ' ILE . 21.2 m -135.71 -42.0 0.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.447 1.499 . . . . 0.0 110.514 -166.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.58 -171.07 2.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.373 1.069 . . . . 0.0 108.427 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.56 167.57 10.35 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.851 0.834 . . . . 0.0 109.686 156.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.05 158.16 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.677 2.791 . . . . 0.0 106.471 164.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 92.3 mt -127.05 139.16 52.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 166.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.83 161.98 19.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.776 1.231 . . . . 0.0 108.275 172.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -143.87 162.15 36.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.195 1.398 . . . . 0.0 108.559 172.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -136.2 149.49 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.652 1.981 . . . . 0.0 106.057 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.665 ' HB3' HG22 ' A' ' 58' ' ' VAL . 8.1 t -141.42 165.07 28.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 161.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.71 33.84 2.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.378 1.071 . . . . 0.0 111.761 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.92 34.01 0.21 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.268 -0.895 . . . . 0.0 112.42 165.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG22 ' HB3' ' A' ' 55' ' ' SER . 14.8 m -120.14 -72.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.959 1.304 . . . . 0.0 109.628 -175.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.577 ' H ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -154.01 0.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.887 1.275 . . . . 0.0 112.005 -178.48 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.14 -21.11 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.266 2.626 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 m -63.66 159.27 19.39 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.476 1.91 . . . . 0.0 110.714 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -76.37 154.49 34.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 151.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -141.92 152.97 44.02 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 134.46 49.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 53' ' ' ALA . 22.9 m -122.98 -19.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.308 -0.854 . . . . 0.0 111.473 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . -135.63 157.06 47.82 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.904 1.229 . . . . 0.0 108.338 160.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -143.02 147.75 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 52.52 49.37 20.56 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.014 0.912 . . . . 0.0 111.806 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.5 t -79.13 102.27 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -94.47 50.67 1.37 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.876 1.27 . . . . 0.0 109.076 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -157.44 -170.06 3.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.057 1.743 . . . . 0.0 107.508 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.4 p -131.98 2.91 4.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.116 2.166 . . . . 0.0 111.624 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.0 tp -129.38 120.64 25.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -145.21 151.45 38.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.051 0.94 . . . . 0.0 109.502 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.8 m -110.2 114.29 27.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.396 1.078 . . . . 0.0 108.733 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.88 145.96 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -133.43 176.98 8.05 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 112.111 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.42 27.09 57.78 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.788 1.185 . . . . 0.0 113.935 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.9 mt -79.32 -179.13 6.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.153 0.977 . . . . 0.0 110.075 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -96.8 139.23 21.47 Favored Pre-proline 0 CA--C 1.516 -0.365 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.63 159.97 47.56 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.513 2.142 . . . . 0.0 110.32 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 t30 48.53 34.79 5.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.94 1.696 . . . . 0.0 111.8 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.1 m -133.19 132.89 42.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.111 1.764 . . . . 0.0 107.581 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.31 147.87 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -131.58 159.16 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 156.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mt -107.52 157.71 17.8 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 152.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -132.72 152.12 51.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 125.828 1.955 . . . . 0.0 107.369 172.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.61 165.84 23.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 162.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.67 145.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.653 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.8 mtp180 -120.95 147.62 45.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 162.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.99 159.05 19.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.499 HG22 ' HB2' ' A' ' 47' ' ' SER . 1.5 mt -121.28 150.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 126.316 1.846 . . . . 0.0 107.535 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.62 172.2 5.49 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 127.138 2.175 . . . . 0.0 107.322 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.9 -23.93 74.37 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.65 2.233 . . . . 0.0 114.985 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -105.64 -45.99 4.28 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.576 1.55 . . . . 0.0 110.407 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.84 35.29 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 122.739 1.188 . . . . 0.0 112.214 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.653 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.3 mp -84.86 166.75 16.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -72.36 166.24 22.91 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 122.171 0.986 . . . . 0.0 109.619 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.81 159.88 1.64 Allowed Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.148 152.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.24 148.3 61.66 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.091 1.194 . . . . 0.0 111.182 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.1 p -62.38 167.51 5.25 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 159.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.97 150.34 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.427 1.418 . . . . 0.0 109.724 152.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -69.04 154.85 41.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.648 166.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.1 p -60.54 -7.53 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.578 2.351 . . . . 0.0 115.143 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.7 153.63 0.14 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 127.333 2.253 . . . . 0.0 109.169 -155.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -77.55 108.5 2.59 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.976 2.451 . . . . 0.0 108.603 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 24' ' ' VAL . 3.6 m -108.49 133.23 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 124.544 1.138 . . . . 0.0 109.156 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -92.66 135.27 34.24 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.7 p -63.68 154.32 33.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.971 0.891 . . . . 0.0 109.185 164.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.44 171.66 0.57 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 123.614 1.673 . . . . 0.0 110.02 163.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -77.27 149.72 35.39 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.925 169.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 p -58.32 15.97 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 129.16 2.984 . . . . 0.0 115.41 167.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -67.62 147.13 48.08 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 119.667 1.121 . . . . 0.0 110.823 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.33 139.59 46.06 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 N-CA-C 107.423 -1.799 . . . . 0.0 107.423 159.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.7 p -148.66 175.91 10.8 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.497 1.519 . . . . 0.0 108.916 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.41 -168.4 3.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.688 1.195 . . . . 0.0 108.455 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 171.53 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.704 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m 66.4 81.52 0.2 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 126.12 1.768 . . . . 0.0 112.325 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -145.04 152.9 40.85 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.527 0.731 . . . . 0.0 109.616 164.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.16 166.46 54.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.5 t -136.38 99.86 4.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 -175.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -153.26 14.92 0.52 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.478 1.111 . . . . 0.0 112.596 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.87 83.23 0.92 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 125.531 1.539 . . . . 0.0 110.103 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -75.94 74.85 2.85 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.236 1.017 . . . . 0.0 110.819 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.99 157.78 39.69 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.899 2.479 . . . . 0.0 104.962 166.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -68.76 157.0 37.29 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 155.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.53 157.46 34.27 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.584 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.3 mt -117.51 -132.3 0.32 Allowed 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -168.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -67.41 157.91 33.0 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.15 0.98 . . . . 0.0 111.909 -170.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -73.64 18.2 0.13 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.771 1.628 . . . . 0.0 112.505 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt -105.87 148.34 36.33 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 110.193 -171.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.52 159.45 36.29 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.078 3.852 . . . . 0.0 113.425 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.66 141.94 46.1 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.825 1.202 . . . . 0.0 111.227 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.84 147.49 80.88 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.255 1.97 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.9 164.76 15.68 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.583 2.189 . . . . 0.0 112.413 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -74.91 167.87 21.04 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.707 0.803 . . . . 0.0 110.037 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -59.4 117.83 25.55 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.854 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.03 157.33 60.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 120.619 1.257 . . . . 0.0 111.182 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -124.24 146.86 48.47 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 126.789 2.036 . . . . 0.0 109.367 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 107' ' ' VAL . 2.5 m -96.75 139.03 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 C-N-CA 124.511 1.124 . . . . 0.0 108.309 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -128.74 -79.78 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.533 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.05 130.73 42.28 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.53 137.09 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.4 p -115.47 -74.33 0.62 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -162.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 3.1 pttp -171.34 -29.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 1 C-N-CA 133.272 4.629 . . . . 0.0 108.638 161.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.8 -15.47 14.1 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.821 1.648 . . . . 0.0 109.944 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 m -142.33 159.37 42.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.604 0.638 . . . . 0.0 110.094 -167.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.428 HG12 ' CD1' ' A' ' 79' ' ' LEU . 1.8 p -153.13 128.92 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.8 m -86.13 138.72 31.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.448 1.099 . . . . 0.0 110.066 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -113.04 141.38 46.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 107.931 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -130.77 129.45 42.47 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 126.99 2.116 . . . . 0.0 108.381 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -140.34 170.59 15.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.538 0.685 . . . . 0.0 112.19 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -98.77 145.63 30.27 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 124.324 1.05 . . . . 0.0 108.749 164.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.32 139.39 14.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 124.478 3.452 . . . . 0.0 109.483 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.75 -179.06 44.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 165.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.6 m -87.04 151.01 51.13 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 128.312 2.645 . . . . 0.0 110.163 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.81 -174.87 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.664 3.576 . . . . 0.0 111.757 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.98 -126.41 0.82 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 p -57.13 -31.02 64.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.266 2.626 . . . . 0.0 114.318 -173.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 mt -130.95 164.91 38.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.35 1.46 . . . . 0.0 109.234 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.78 135.7 6.87 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.993 2.462 . . . . 0.0 109.843 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.9 149.97 43.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.328 164.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -125.06 -56.7 1.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.628 1.171 . . . . 0.0 109.014 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 92' ' ' ILE . . . -152.55 -177.38 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 91' ' ' ALA . 89.1 m-85 -122.91 173.17 7.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.755 0.822 . . . . 0.0 109.204 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.3 mt -121.49 152.86 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 126.835 2.054 . . . . 0.0 106.448 166.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -123.29 137.44 56.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 160.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.52 164.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.514 1.125 . . . . 0.0 108.56 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.18 163.7 32.16 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.44 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -159.32 124.07 4.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 108.7 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.69 ' HB3' HG22 ' A' ' 58' ' ' VAL . 12.6 t -106.17 1.63 26.31 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.381 1.072 . . . . 0.0 112.457 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 53.46 3.09 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -167.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.53 1.24 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.651 -1.28 . . . . 0.0 111.907 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 55' ' ' SER . 1.6 m -74.69 -78.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 109.327 173.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.407 ' H ' HG23 ' A' ' 58' ' ' VAL . 37.2 m -121.35 15.35 11.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.549 1.14 . . . . 0.0 110.848 164.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 53.86 27.16 6.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.298 1.439 . . . . 0.0 110.835 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.6 m -144.41 151.81 39.78 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.825 2.85 . . . . 0.0 108.503 -167.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -78.76 142.74 36.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 109.911 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -135.76 135.88 40.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.276 0.631 . . . . 0.0 109.71 -169.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.79 94.34 1.39 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -81.65 -21.75 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.053 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.39 107.34 3.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.84 168.09 16.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 169.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 36.5 58.61 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.84 2.456 . . . . 0.0 112.627 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.93 118.59 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -111.5 50.07 0.85 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.62 1.168 . . . . 0.0 108.645 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -156.14 -177.75 6.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.727 1.211 . . . . 0.0 108.064 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -118.58 0.98 11.65 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.909 2.883 . . . . 0.0 110.917 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 111.38 7.08 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.731 1.213 . . . . 0.0 109.182 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -141.19 127.77 20.13 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.737 0.815 . . . . 0.0 111.164 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.4 m -75.96 103.16 5.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.169 2.188 . . . . 0.0 109.229 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.7 t -70.15 147.34 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 166.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -135.96 174.49 10.55 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.046 1.339 . . . . 0.0 113.591 -168.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.09 6.07 82.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.117 1.817 . . . . 0.0 114.718 168.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD1' HG12 ' A' ' 32' ' ' VAL . 24.9 mt -74.48 171.96 12.83 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.17 1.788 . . . . 0.0 111.111 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.0 142.77 29.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 126.011 1.724 . . . . 0.0 108.567 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.76 156.57 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 109.461 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 40.51 48.07 2.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.089 1.756 . . . . 0.0 111.958 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.5 m -133.64 132.73 41.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.918 1.687 . . . . 0.0 106.761 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.27 146.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.96 157.15 46.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 160.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' SD ' ' A' ' 103' ' ' MET . 70.7 mt -107.35 157.13 18.19 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 127.504 2.322 . . . . 0.0 106.271 158.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -138.5 146.23 41.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 126.195 2.185 . . . . 0.0 107.862 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.1 mtm -142.53 152.51 42.7 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.13 144.04 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 125.366 1.466 . . . . 0.0 107.187 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.477 ' HD3' HD13 ' A' ' 97' ' ' LEU . 43.7 mtt180 -128.65 139.87 52.04 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 169.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 49' ' ' TYR . . . -86.89 149.14 25.02 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -123.53 145.29 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.218 1.007 . . . . 0.0 109.889 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -150.46 177.24 1.92 Allowed Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 109.109 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.69 67.24 8.48 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.072 2.514 . . . . 0.0 110.135 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -163.88 -73.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.835 2.854 . . . . 0.0 104.637 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.53 -164.34 12.09 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 126.136 1.827 . . . . 0.0 110.93 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.477 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -101.14 151.59 21.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.13 1.372 . . . . 0.0 108.381 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.4 p -72.67 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.179 1.792 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -50.66 150.29 5.13 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.368 158.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.33 161.0 45.1 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.316 1.344 . . . . 0.0 111.106 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 91.8 p -55.57 167.61 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.258 163.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.52 144.25 10.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 121.66 1.573 . . . . 0.0 110.484 151.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.474 ' SD ' HD13 ' A' ' 86' ' ' LEU . 22.4 mtm -64.65 144.86 56.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.442 0.697 . . . . 0.0 109.789 171.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -63.99 -9.55 16.46 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 127.187 2.195 . . . . 0.0 113.736 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 77.56 155.28 0.14 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 128.808 2.843 . . . . 0.0 108.792 -160.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -73.14 117.94 5.33 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.591 2.194 . . . . 0.0 108.53 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 24' ' ' VAL . 2.7 m -116.48 135.1 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.956 1.302 . . . . 0.0 110.083 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 142.37 27.77 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.5 p -73.46 159.33 33.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.428 1.585 . . . . 0.0 109.495 162.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -66.27 175.04 2.32 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.955 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -74.18 157.69 35.49 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 111.623 -2.535 . . . . 0.0 110.086 163.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 6.2 t -85.6 48.96 1.67 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.869 1.668 . . . . 0.0 109.101 169.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -115.8 159.54 13.78 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.963 2.221 . . . . 0.0 110.04 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.91 164.74 33.57 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.721 2.281 . . . . 0.0 111.377 -171.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.0 m -153.26 -54.86 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.491 1.117 . . . . 0.0 108.538 166.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.3 m 55.57 18.84 2.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.46 1.104 . . . . 0.0 113.615 -172.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.343 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 177.934 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.407 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 m -134.93 85.02 2.14 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.965 0.882 . . . . 0.0 109.26 -170.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -152.76 3.9 0.34 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.47 72.07 0.66 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.4 t -54.23 121.66 8.67 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.662 1.585 . . . . 0.0 111.439 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -61.26 -57.54 11.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.572 0.749 . . . . 0.0 111.075 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 -69.52 1.11 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.26 -1.3 . . . . 0.0 110.372 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 40.07 80.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.747 2.819 . . . . 0.0 111.646 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -141.32 179.97 6.47 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.925 1.69 . . . . 0.0 107.335 171.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -143.26 123.16 13.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.314 1.446 . . . . 0.0 109.214 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.01 155.19 34.88 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.572 1.549 . . . . 0.0 108.682 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.39 78.47 9.64 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 125.863 1.665 . . . . 0.0 107.385 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -139.83 153.08 46.97 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.797 0.839 . . . . 0.0 110.485 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -101.87 17.8 22.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.686 2.394 . . . . 0.0 109.762 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' LEU . 86.1 mt -98.78 162.69 20.8 Favored Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 119.799 -1.813 . . . . 0.0 110.556 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -61.76 164.8 15.22 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.765 2.31 . . . . 0.0 111.806 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.17 126.61 28.79 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 164.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.95 154.49 61.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.215 1.943 . . . . 0.0 111.82 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -80.06 173.16 13.0 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.457 2.771 . . . . 0.0 111.236 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -66.61 170.13 6.74 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.702 -0.624 . . . . 0.0 111.373 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -49.9 124.41 16.54 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 150.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 150.1 74.77 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 121.203 1.269 . . . . 0.0 109.178 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -111.78 124.29 52.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.65 142.46 16.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.353 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.5 p -122.01 -87.63 0.63 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.92 134.59 38.9 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 109.049 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.77 138.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 119.099 0.863 . . . . 0.0 109.697 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -126.87 -162.21 1.13 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.998 1.719 . . . . 0.0 107.861 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -77.18 -29.06 54.21 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 121.192 -0.943 . . . . 0.0 111.075 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -150.87 14.57 0.73 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.199 0.909 . . . . 0.0 111.955 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -127.27 163.08 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.782 159.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.78 146.86 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.692 1.597 . . . . 0.0 107.38 169.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.9 m -102.07 149.43 24.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.469 1.508 . . . . 0.0 109.084 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.38 148.46 51.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.261 2.624 . . . . 0.0 107.535 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -139.94 114.71 9.47 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.515 1.134 . . . . 0.0 108.998 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CH2' HD11 ' A' ' 51' ' ' ILE . 42.6 p90 -134.87 153.11 52.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.903 0.774 . . . . 0.0 111.217 -176.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -93.48 140.9 23.3 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.49 148.29 18.27 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 124.096 3.197 . . . . 0.0 108.987 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.76 -178.05 52.21 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 122.27 0.928 . . . . 0.0 111.632 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -55.12 153.95 11.44 Favored Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.957 2.103 . . . . 0.0 108.444 158.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 -114.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.143 3.229 . . . . 0.0 108.51 162.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.4 -109.81 0.42 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 164.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.8 p -60.35 -35.3 75.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.729 2.012 . . . . 0.0 111.819 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 mt -132.63 169.24 14.46 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.849 1.66 . . . . 0.0 109.07 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.48 155.74 14.16 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.507 2.805 . . . . 0.0 109.271 168.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 160.46 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.551 0.691 . . . . 0.0 109.656 171.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.429 ' HB2' HG22 ' A' ' 92' ' ' ILE . 3.5 m -117.81 -43.37 2.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.074 1.75 . . . . 0.0 109.822 -175.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.0 -172.27 1.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.468 1.107 . . . . 0.0 109.592 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.714 ' HB2' HG23 ' A' ' 69' ' ' VAL . 12.4 m-85 -116.78 165.6 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.729 1.612 . . . . 0.0 107.961 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.88 154.04 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 129.361 3.064 . . . . 0.0 104.833 168.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.455 HD11 ' CH2' ' A' ' 36' ' ' TRP . 82.2 mt -129.29 135.9 60.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 166.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.84 156.51 29.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.17 157.87 45.69 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.032 1.333 . . . . 0.0 108.193 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.96 163.11 35.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.915 1.686 . . . . 0.0 109.81 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -156.75 -38.69 0.08 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -161.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 64.09 -22.46 0.07 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.71 2.404 . . . . 0.0 116.585 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.25 -24.45 11.5 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 121.036 1.744 . . . . 0.0 112.109 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 80' ' ' ARG . 78.3 t -69.9 -77.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 120.209 1.368 . . . . 0.0 109.418 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -135.49 22.91 3.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.511 1.125 . . . . 0.0 111.535 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 t30 23.22 60.23 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 C-N-CA 129.367 3.067 . . . . 0.0 112.815 176.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.7 m -165.74 158.61 15.42 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.674 1.989 . . . . 0.0 108.952 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.462 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 67.3 m95 -72.46 123.85 23.96 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 162.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -113.24 139.17 49.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -83.41 94.36 7.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 m -82.33 -19.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.366 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.62 143.31 32.34 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.14 0.976 . . . . 0.0 108.488 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.91 157.2 47.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.338 0.655 . . . . 0.0 109.553 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m170 52.71 32.78 12.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.45 1.5 . . . . 0.0 111.922 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 49' ' ' TYR . 3.2 m -74.39 154.28 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.326 1.06 . . . . 0.0 110.229 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -134.73 54.14 1.96 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -148.6 176.41 10.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.585 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 p -117.41 -3.04 11.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.441 1.497 . . . . 0.0 111.698 169.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.23 133.55 47.58 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.068 1.347 . . . . 0.0 108.949 166.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.538 ' CD2' HG11 ' A' ' 69' ' ' VAL . 27.3 t80 -146.48 146.31 30.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -108.09 97.85 7.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.919 1.688 . . . . 0.0 108.904 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.95 134.83 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -128.16 171.82 11.57 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.285 0.634 . . . . 0.0 112.028 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.13 50.95 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.99 1.281 . . . . 0.0 112.994 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.1 mt -83.32 -166.84 1.47 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.743 1.217 . . . . 0.0 109.51 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HD2' HG22 ' A' ' 58' ' ' VAL . 12.9 mtt85 -121.45 143.72 38.42 Favored Pre-proline 0 CA--C 1.517 -0.326 0 C-N-CA 124.422 1.089 . . . . 0.0 109.502 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.95 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.481 2.787 . . . . 0.0 111.822 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 55.02 3.83 0.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.016 2.526 . . . . 0.0 116.24 -176.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.2 m -101.3 130.66 47.5 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.34 1.856 . . . . 0.0 108.746 -166.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 mm -68.71 147.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.27 165.3 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.654 1.181 . . . . 0.0 108.928 168.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -117.39 157.95 25.29 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 125.53 1.532 . . . . 0.0 108.121 162.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -143.07 131.43 22.15 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 125.298 1.624 . . . . 0.0 109.283 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.462 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 5.4 mtt -115.67 173.31 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.89 151.8 35.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.426 ' HD3' HD13 ' A' ' 97' ' ' LEU . 95.4 mtt180 -138.65 121.9 17.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . . . -86.15 118.95 25.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.8 OUTLIER -86.14 148.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 108.996 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.76 173.6 4.21 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.773 1.629 . . . . 0.0 108.632 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.99 23.58 0.4 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.119 2.546 . . . . 0.0 113.658 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -130.38 -17.45 3.35 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.839 1.656 . . . . 0.0 113.919 173.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.47 9.4 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 123.909 0.766 . . . . 0.0 112.371 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 15' ' ' LEU . 4.1 pp -129.81 144.7 51.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.229 1.812 . . . . 0.0 107.768 177.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -72.33 159.37 34.14 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 109.737 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -48.86 132.31 14.65 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.084 0.954 . . . . 0.0 110.388 -172.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -51.04 113.96 1.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.112 3.208 . . . . 0.0 111.49 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 p -52.67 159.23 1.8 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.648 0.779 . . . . 0.0 112.832 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -52.26 144.14 40.17 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.863 3.042 . . . . 0.0 111.073 163.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.5 mtp -67.28 144.43 55.91 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.506 0.722 . . . . 0.0 112.619 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.3 p -65.7 -5.19 7.84 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.818 2.447 . . . . 0.0 116.1 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.46 144.64 0.1 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.139 1.776 . . . . 0.0 111.024 -165.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.58 106.84 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.166 2.578 . . . . 0.0 110.849 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.9 m -105.0 140.61 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.383 1.473 . . . . 0.0 109.965 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -87.15 -174.4 4.87 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.524 0.73 . . . . 0.0 109.98 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.0 p -130.99 158.23 40.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.364 1.866 . . . . 0.0 107.195 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -68.38 173.29 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.825 0.821 . . . . 0.0 110.039 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -80.32 160.34 25.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.94 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 t -111.09 -8.87 14.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.31 2.644 . . . . 0.0 110.736 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -76.77 -177.7 45.26 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.715 1.15 . . . . 0.0 111.45 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.63 62.84 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.131 3.221 . . . . 0.0 108.915 165.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.2 m -50.73 113.04 0.8 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.893 2.077 . . . . 0.0 111.117 -166.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.1 p -154.3 176.06 12.76 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 125.162 1.385 . . . . 0.0 109.968 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.027 0 N-CA-C 104.723 -3.351 . . . . 0.0 104.723 -167.743 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 118.152 -0.928 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 161.14 24.23 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 111.606 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.53 141.81 30.29 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 162.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -69.48 162.42 42.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.421 2.081 . . . . 0.0 113.031 -168.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.37 168.34 9.75 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.194 2.596 . . . . 0.0 112.825 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -74.83 169.97 16.84 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 110.199 168.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -56.22 134.23 75.27 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 167.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.37 164.9 16.41 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 CA-C-O 124.04 1.6 . . . . 0.0 112.697 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -105.25 172.12 6.96 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 128.909 2.884 . . . . 0.0 106.644 162.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -123.75 137.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.119 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.9 p -124.32 -90.66 0.56 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.699 0.625 . . . . 0.0 110.646 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.94 138.71 42.52 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 125.343 1.457 . . . . 0.0 107.914 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.47 155.05 22.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.48 1.037 . . . . 0.0 110.046 163.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -137.33 -159.88 1.0 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.208 1.403 . . . . 0.0 108.039 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -65.1 -31.61 72.9 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.545 167.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -152.54 1.66 0.32 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -113.66 152.55 30.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.178 0.899 . . . . 0.0 108.919 162.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -147.87 148.44 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.4 m -110.31 133.83 52.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.16 140.03 48.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.356 1.863 . . . . 0.0 107.004 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.76 135.17 49.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 174.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -138.72 171.57 14.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 120.582 1.537 . . . . 0.0 108.628 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.71 142.77 25.66 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.609 1.164 . . . . 0.0 108.7 168.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.4 170.49 20.11 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.769 2.313 . . . . 0.0 112.707 -161.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.47 -175.6 22.93 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 164.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.53 149.19 71.09 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.84 -179.81 5.54 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.652 2.901 . . . . 0.0 113.13 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.36 -99.02 0.15 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -57.83 -51.95 67.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.452 1.901 . . . . 0.0 110.565 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.61 166.26 25.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 124.271 1.028 . . . . 0.0 110.278 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.93 167.51 25.06 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.292 3.328 . . . . 0.0 109.382 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.51 25.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.962 1.705 . . . . 0.0 109.04 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -94.54 -57.23 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.326 1.051 . . . . 0.0 109.713 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.61 -171.24 2.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.269 0.94 . . . . 0.0 108.932 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.39 164.9 16.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -118.03 159.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.85 2.06 . . . . 0.0 106.484 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -124.2 134.31 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 158.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.32 160.98 15.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 166.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.84 162.38 34.13 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.328 1.851 . . . . 0.0 107.313 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -148.07 141.0 24.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -155.79 121.36 4.93 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.71 -34.84 74.99 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.24 0.543 . . . . 0.0 111.693 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.08 17.22 3.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.11 2.564 . . . . 0.0 114.033 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.2 -73.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 t -147.7 146.54 29.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.59 -0.31 2.75 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.173 1.389 . . . . 0.0 113.681 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -102.62 155.67 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.974 2.51 . . . . 0.0 111.882 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -74.74 136.05 41.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 153.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.19 155.16 49.82 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.112 0.869 . . . . 0.0 110.528 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.97 130.65 43.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.296 1.438 . . . . 0.0 107.801 170.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.6 -6.75 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.058 1.343 . . . . 0.0 112.149 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.52 152.73 36.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 149.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -135.81 140.88 44.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.127 1.371 . . . . 0.0 108.421 -172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.45 43.77 29.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.661 1.184 . . . . 0.0 111.863 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.77 126.17 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 126.136 1.774 . . . . 0.0 107.161 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -108.2 15.2 24.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.798 0.839 . . . . 0.0 112.17 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -129.45 175.31 8.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.773 1.629 . . . . 0.0 109.306 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.5 p -112.42 -5.73 14.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.538 2.335 . . . . 0.0 111.545 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -135.73 123.18 22.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -145.9 121.14 10.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.859 0.754 . . . . 0.0 112.31 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.4 m -69.84 103.66 2.26 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.682 1.993 . . . . 0.0 110.241 164.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 76' ' ' VAL . 9.9 t -60.9 148.64 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 126.936 2.094 . . . . 0.0 107.932 158.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -140.2 175.32 9.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.055 1.342 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.47 7.68 87.08 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 123.803 0.716 . . . . 0.0 114.455 165.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.73 -171.66 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.62 1.168 . . . . 0.0 109.039 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -113.05 132.89 22.16 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -59.23 156.46 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.544 2.163 . . . . 0.0 112.28 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.1 t30 41.57 33.63 0.32 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.718 2.807 . . . . 0.0 113.78 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.8 m -120.66 135.73 55.03 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.386 1.874 . . . . 0.0 106.831 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.16 148.6 8.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.825 0.85 . . . . 0.0 109.081 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -141.36 149.49 41.21 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.733 1.213 . . . . 0.0 110.62 171.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -107.72 160.83 15.41 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.371 162.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.04 144.45 33.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 124.753 1.283 . . . . 0.0 108.521 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 62.0 mtm -130.45 153.49 48.72 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.08 148.27 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HD3' HD22 ' A' ' 97' ' ' LEU . 3.0 mtt180 -131.9 136.14 47.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.755 1.222 . . . . 0.0 108.249 176.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 152.13 22.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.82 148.15 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.005 2.122 . . . . 0.0 109.141 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -148.5 178.04 1.59 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 109.239 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.48 -2.68 2.72 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.602 2.868 . . . . 0.0 117.117 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -129.54 -17.42 3.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.393 1.451 . . . . 0.0 113.582 -167.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.33 -176.79 45.96 Favored Glycine 0 C--O 1.238 0.357 0 CA-C-N 119.527 1.058 . . . . 0.0 111.209 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.424 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.97 151.69 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 157.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 83.1 p -71.47 168.79 16.76 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.867 1.267 . . . . 0.0 110.102 168.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -42.07 149.04 0.45 Allowed Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.849 153.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.15 164.27 36.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.809 1.672 . . . . 0.0 110.952 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.2 p -67.14 167.07 15.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 159.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.57 149.89 4.36 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.257 1.971 . . . . 0.0 112.363 151.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.0 mtm -65.36 143.15 57.93 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.43 0.692 . . . . 0.0 111.405 166.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.2 t -54.01 -23.12 12.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.175 2.19 . . . . 0.0 113.621 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.54 154.14 0.13 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 127.055 2.142 . . . . 0.0 110.193 -162.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -68.89 110.05 2.28 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.384 2.723 . . . . 0.0 111.554 -159.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -75.4 162.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.64 133.52 54.98 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 163.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.4 p -62.67 169.34 3.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 166.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -81.91 -116.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t0 . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.359 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.444 -0.76 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -63.0 158.18 44.84 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.47 2.113 . . . . 0.0 110.85 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.92 143.08 48.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.2 152.93 79.96 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.877 1.718 . . . . 0.0 110.645 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -64.15 171.8 7.16 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.929 2.42 . . . . 0.0 111.646 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -74.12 174.56 8.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.623 0.769 . . . . 0.0 110.255 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -55.74 135.62 72.0 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.034 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.91 124.62 10.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.745 1.302 . . . . 0.0 109.95 160.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.64 171.46 12.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.636 161.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 107' ' ' VAL . 62.0 t -125.31 136.54 60.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 p -126.33 -66.59 0.91 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.812 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -104.69 139.48 39.46 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.937 0.895 . . . . 0.0 109.097 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.14 142.75 24.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 119.677 1.126 . . . . 0.0 110.147 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 p -130.41 -176.31 3.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.263 1.825 . . . . 0.0 109.107 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -63.86 -17.77 63.49 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 120.868 -1.145 . . . . 0.0 113.307 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.34 13.13 1.08 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 120.357 -1.464 . . . . 0.0 113.113 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.76 160.39 40.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.231 0.923 . . . . 0.0 110.421 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.18 129.09 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.512 0.725 . . . . 0.0 109.284 170.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -81.05 120.39 24.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.196 0.998 . . . . 0.0 108.345 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -90.34 157.1 17.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.961 1.305 . . . . 0.0 109.116 166.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -149.01 99.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.13 0.972 . . . . 0.0 109.071 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.564 ' CH2' HD11 ' A' ' 51' ' ' ILE . 29.4 p90 -105.44 161.63 14.16 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.777 0.831 . . . . 0.0 109.083 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -95.45 147.55 33.2 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 165.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.19 171.77 16.18 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.79 2.993 . . . . 0.0 111.94 -167.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.42 177.48 33.48 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 168.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.503 HG23 ' HD2' ' A' ' 41' ' ' PRO . 2.8 m -107.57 157.69 35.14 Favored Pre-proline 0 N--CA 1.443 -0.793 0 C-N-CA 127.75 2.42 . . . . 0.0 109.874 -174.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 40' ' ' THR . 40.1 Cg_endo -71.42 -159.96 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 125.014 3.809 . . . . 0.0 113.073 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.38 -123.05 0.8 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 170.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 p -72.35 -27.62 62.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.981 1.712 . . . . 0.0 112.415 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 mt -136.33 149.23 67.17 Favored Pre-proline 0 C--O 1.24 0.56 0 C-N-CA 123.311 0.644 . . . . 0.0 112.244 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.54 163.94 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.541 3.494 . . . . 0.0 110.891 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.75 141.5 28.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -112.77 -32.53 6.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.007 1.723 . . . . 0.0 112.198 -168.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.87 -162.03 0.67 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 159.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.12 165.09 14.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.306 1.443 . . . . 0.0 108.384 157.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -116.71 152.56 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.736 2.414 . . . . 0.0 105.288 164.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.564 HD11 ' CH2' ' A' ' 36' ' ' TRP . 83.2 mt -127.59 135.18 63.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 166.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -121.16 159.4 25.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -137.87 161.52 36.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.131 1.372 . . . . 0.0 108.246 174.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -138.87 135.89 34.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.762 ' HB3' HG22 ' A' ' 58' ' ' VAL . 5.1 t -115.98 149.29 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.581 1.082 . . . . 0.0 108.123 155.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -80.53 16.26 1.41 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.966 0.506 . . . . 0.0 111.001 162.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -132.35 10.99 4.51 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.542 -1.349 . . . . 0.0 110.417 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 55' ' ' SER 0.311 34.8 m -121.84 -91.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.596 ' H ' HG23 ' A' ' 58' ' ' VAL . 10.9 m -119.32 5.32 11.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 121.436 1.925 . . . . 0.0 113.179 -175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.28 21.19 1.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.783 1.633 . . . . 0.0 112.925 -171.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.4 m -122.17 163.98 18.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.579 3.151 . . . . 0.0 108.896 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.77 144.88 25.6 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 165.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -138.24 143.14 39.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.33 96.0 1.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.423 1.089 . . . . 0.0 108.178 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 53' ' ' ALA . 33.0 m -82.9 -16.95 11.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 121.86 -0.525 . . . . 0.0 110.969 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.95 134.53 22.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 162.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -121.01 136.67 54.93 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 52.6 69.93 0.63 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.746 2.019 . . . . 0.0 112.418 -171.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.0 129.87 39.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.579 1.552 . . . . 0.0 107.575 168.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -117.42 38.13 3.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.428 1.091 . . . . 0.0 110.573 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -151.75 -178.49 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.044 1.738 . . . . 0.0 107.515 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p -113.23 -2.52 14.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.095 2.558 . . . . 0.0 111.9 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.93 139.7 46.31 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -146.66 140.94 26.36 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.1 m -94.18 102.57 14.6 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 174.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.87 135.99 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -130.82 178.85 6.35 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.42 1.088 . . . . 0.0 110.778 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.01 6.68 74.32 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.93 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.4 mt -72.17 -176.72 1.87 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.625 1.212 . . . . 0.0 110.381 -172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.4 mtp85 -108.51 149.83 39.87 Favored Pre-proline 0 CA--C 1.513 -0.471 0 C-N-CA 125.25 1.42 . . . . 0.0 108.608 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.42 154.52 24.45 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.873 1.715 . . . . 0.0 111.638 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.62 16.99 0.34 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.894 2.078 . . . . 0.0 114.373 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.9 m -102.11 133.01 47.64 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.123 2.169 . . . . 0.0 108.354 -172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.7 mm -70.04 148.43 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.54 158.27 44.06 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.52 164.99 12.0 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.647 1.179 . . . . 0.0 108.437 160.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.56 145.67 33.83 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.722 1.889 . . . . 0.0 109.643 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.3 mtm -135.42 162.84 31.48 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.732 1.213 . . . . 0.0 107.916 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.64 143.27 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.787 2.035 . . . . 0.0 105.817 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.577 ' HD3' HD13 ' A' ' 97' ' ' LEU . 27.3 mtt85 -132.6 138.85 47.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 124.57 33.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -86.4 152.82 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.812 1.245 . . . . 0.0 108.518 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.88 168.02 11.84 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.513 1.925 . . . . 0.0 109.066 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.69 -9.87 8.19 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.391 3.394 . . . . 0.0 117.05 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -111.48 -43.26 3.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.462 1.505 . . . . 0.0 110.141 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.08 -149.65 6.21 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 119.063 0.847 . . . . 0.0 111.074 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.577 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -129.85 158.98 37.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.662 1.585 . . . . 0.0 108.7 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.1 p -71.89 167.09 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 111.308 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -47.26 151.15 1.33 Allowed Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 154.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.7 148.19 52.39 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.431 1.421 . . . . 0.0 110.338 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.4 p -50.46 151.99 3.55 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.023 163.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -47.41 122.52 6.76 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.942 1.762 . . . . 0.0 107.88 153.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.8 ttm -58.11 148.67 25.79 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 124.212 1.005 . . . . 0.0 109.871 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.5 p -60.38 162.5 6.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 123.047 1.403 . . . . 0.0 109.471 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.63 154.53 68.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.658 164.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.68 92.6 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.198 2.599 . . . . 0.0 111.846 -175.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 24' ' ' VAL . 2.2 m -84.17 163.44 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.525 1.53 . . . . 0.0 109.482 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.91 146.35 47.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 125.385 1.474 . . . . 0.0 109.006 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -61.58 161.7 9.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 159.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -75.75 178.32 6.21 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 168.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.833 0.825 . . . . 0.0 110.494 177.82 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 CA--C 1.536 0.405 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -59.27 156.12 36.88 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.678 2.252 . . . . 0.0 112.12 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.37 120.84 21.76 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 153.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.08 161.51 44.51 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.235 2.623 . . . . 0.0 111.103 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.38 158.16 57.0 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.282 1.988 . . . . 0.0 110.712 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -71.21 175.16 5.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.918 0.487 . . . . 0.0 110.835 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 103' ' ' MET . 83.8 tttt -53.54 120.83 23.71 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 104' ' ' SER . 8.4 Cg_endo -66.5 149.44 84.42 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 120.715 1.291 . . . . 0.0 109.374 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -79.21 170.94 15.89 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 161.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.0 t -122.68 121.61 63.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 129.151 2.981 . . . . 0.0 104.506 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.254 82.1 p -119.21 -84.81 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.859 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.71 150.07 37.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.106 1.321 . . . . 0.0 108.274 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.98 152.6 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.493 0.717 . . . . 0.0 109.769 163.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.4 p -141.21 -172.45 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 108.869 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -57.89 -37.08 73.33 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.141 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -136.19 17.21 3.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.866 1.666 . . . . 0.0 112.14 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -151.37 161.33 42.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.551 -1.343 . . . . 0.0 110.175 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.01 140.85 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.72 145.5 47.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.536 1.934 . . . . 0.0 107.522 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.68 114.47 9.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.446 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.492 ' CE2' ' HA ' ' A' ' 72' ' ' THR . 39.2 p90 -123.3 171.32 9.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.997 1.272 . . . . 0.0 110.208 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -97.87 144.98 28.98 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 165.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.24 133.3 24.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.192 3.261 . . . . 0.0 107.669 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.67 -178.54 43.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -62.1 152.95 76.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.069 1.348 . . . . 0.0 110.157 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.82 -148.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.911 3.741 . . . . 0.0 109.843 167.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -125.44 0.76 Allowed Glycine 0 C--N 1.333 0.4 0 O-C-N 118.941 -2.349 . . . . 0.0 109.478 163.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.3 p -49.78 -35.88 24.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.642 2.377 . . . . 0.0 110.112 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 59.9 mt -135.75 170.03 12.11 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 127.642 2.377 . . . . 0.0 109.495 -168.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 62.3 Cg_endo -78.48 170.07 18.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.896 3.064 . . . . 0.0 110.003 169.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.23 22.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 m -53.49 -49.45 67.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.28 2.632 . . . . 0.0 111.919 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.15 -162.2 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.126 0.97 . . . . 0.0 108.594 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -131.92 168.81 17.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.056 1.742 . . . . 0.0 107.752 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.0 165.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 129.266 3.027 . . . . 0.0 106.622 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.11 136.08 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 162.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -114.31 161.72 17.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.327 1.051 . . . . 0.0 108.314 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.76 150.19 36.81 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.125 1.37 . . . . 0.0 109.086 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -127.3 141.13 51.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.347 1.459 . . . . 0.0 107.533 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -144.85 136.65 25.67 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 153.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.85 -37.36 81.81 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.932 165.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -76.31 16.33 0.48 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.066 2.146 . . . . 0.0 113.966 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.51 -77.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 125.324 1.45 . . . . 0.0 107.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.15 21.19 0.97 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.898 0.479 . . . . 0.0 110.287 -176.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 36.66 51.02 0.87 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.687 2.395 . . . . 0.0 111.885 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -143.37 143.48 31.67 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -66.51 136.83 56.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 153.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.97 145.25 39.51 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.896 1.278 . . . . 0.0 107.624 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.08 125.53 24.77 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.36 -6.37 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.278 1.031 . . . . 0.0 112.243 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.93 151.33 33.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 154.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -132.92 150.45 52.16 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 44.32 64.46 1.31 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.163 1.785 . . . . 0.0 110.683 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.77 -28.45 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.319 1.848 . . . . 0.0 112.067 -161.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mttt 60.62 15.18 5.51 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.581 2.352 . . . . 0.0 114.172 163.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -137.42 -177.66 4.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.229 1.412 . . . . 0.0 108.063 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 36' ' ' TRP . 23.6 p -124.96 0.33 7.95 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.917 1.687 . . . . 0.0 111.351 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.71 112.2 10.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -145.58 151.5 38.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.059 0.845 . . . . 0.0 111.376 -175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -103.71 102.19 12.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.134 1.774 . . . . 0.0 109.06 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.41 139.73 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.559 1.544 . . . . 0.0 107.719 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -133.71 -170.25 2.46 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.814 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.6 73.49 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.668 -0.518 . . . . 0.0 112.688 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.41 -166.68 1.66 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.055 0.928 . . . . 0.0 109.346 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -116.44 155.13 48.92 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 126.706 2.002 . . . . 0.0 108.472 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.57 156.74 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.901 2.4 . . . . 0.0 111.835 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.8 t30 43.31 37.02 1.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.299 2.239 . . . . 0.0 112.712 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.3 m -121.89 131.25 53.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.992 1.717 . . . . 0.0 107.403 -174.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.2 mm -69.06 149.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.903 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -140.3 149.02 42.27 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.028 0.918 . . . . 0.0 111.289 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.92 162.58 13.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.129 156.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.85 166.71 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.707 1.88 . . . . 0.0 110.465 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 17.5 mtt -134.14 168.68 18.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 157.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.11 109.32 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.744 ' HD3' HD13 ' A' ' 97' ' ' LEU . 50.6 mtt180 -90.76 140.69 29.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.7 148.17 26.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.98 147.6 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 165.34 17.65 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -174.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.3 -20.89 71.43 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.457 1.438 . . . . 0.0 115.199 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.7 -38.66 11.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.398 1.479 . . . . 0.0 111.503 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.44 -149.7 6.28 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 118.905 0.775 . . . . 0.0 111.537 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.744 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -123.71 156.63 35.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.351 1.861 . . . . 0.0 106.424 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.4 p -76.05 167.39 21.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.621 0.768 . . . . 0.0 112.741 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.22 164.77 0.57 Allowed Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 122.055 -0.403 . . . . 0.0 111.116 161.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.12 127.43 6.02 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.709 2.273 . . . . 0.0 110.452 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.8 p -49.07 155.45 1.12 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 111.678 163.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -59.18 123.88 14.4 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.901 2.401 . . . . 0.0 108.698 164.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.423 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 4.3 mpp? -55.59 124.62 17.94 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.448 1.022 . . . . 0.0 109.933 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.441 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 73.0 p -54.68 -16.03 2.23 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.889 2.475 . . . . 0.0 115.356 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 92.04 146.5 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.421 1 C-N-CA 132.607 4.363 . . . . 0.0 109.575 168.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.29 107.81 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.394 2.729 . . . . 0.0 111.211 -153.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.47 169.52 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -126.8 148.14 49.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.71 1.604 . . . . 0.0 108.086 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.7 p -76.64 167.81 21.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.805 0.812 . . . . 0.0 110.966 166.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -77.32 178.25 7.28 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.719 -0.613 . . . . 0.0 110.119 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.372 0 C-N-CA 123.945 0.898 . . . . 0.0 110.423 172.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.76 141.02 77.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.446 1.431 . . . . 0.0 109.775 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.34 138.75 45.44 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 163.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.36 153.49 55.87 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.276 1.984 . . . . 0.0 111.918 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.71 161.74 40.43 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.488 1.459 . . . . 0.0 110.343 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -77.48 173.82 11.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.105 0.562 . . . . 0.0 109.744 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -51.99 125.31 31.33 Favored Pre-proline 0 C--O 1.239 0.518 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.487 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.54 135.82 47.44 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.699 1.6 . . . . 0.0 109.78 169.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -91.37 134.47 34.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.841 1.256 . . . . 0.0 108.197 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.49 143.61 15.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 167.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 p -127.51 -97.45 0.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.84 135.69 56.8 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 126.05 1.74 . . . . 0.0 109.152 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.71 148.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.5 1.045 . . . . 0.0 110.654 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -137.82 -169.72 2.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.622 1.569 . . . . 0.0 109.547 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -57.55 -41.17 80.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.377 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -136.58 12.63 3.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.298 0.954 . . . . 0.0 112.481 -169.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -141.82 158.43 43.81 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.472 1.033 . . . . 0.0 110.336 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.97 134.14 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.318 1.047 . . . . 0.0 108.782 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -85.6 130.32 34.6 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 108.984 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.9 mt -109.49 146.12 35.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.003 1.721 . . . . 0.0 107.835 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.657 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.82 102.34 3.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.778 1.299 . . . . 0.0 107.993 -163.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.552 ' CH2' HD11 ' A' ' 51' ' ' ILE . 36.3 p90 -119.87 158.76 25.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.062 0.846 . . . . 0.0 110.986 -175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -81.77 134.94 49.5 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 164.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.3 157.76 56.14 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.868 3.045 . . . . 0.0 109.008 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.58 -176.62 35.58 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.752 1.168 . . . . 0.0 111.653 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 150.57 68.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.073 1.349 . . . . 0.0 109.855 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.11 -167.66 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 125.237 3.958 . . . . 0.0 112.54 169.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.61 -109.39 0.25 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 169.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 p -66.63 -46.09 76.94 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.105 2.162 . . . . 0.0 111.17 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' A' ' 94' ' ' PRO . 49.1 mt -128.46 162.27 51.92 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 124.14 0.976 . . . . 0.0 109.793 -164.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.14 145.28 27.51 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 108.159 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.84 158.38 25.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 -47.99 1.98 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.101 -170.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.23 -166.26 0.88 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -128.78 162.04 28.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.155 1.782 . . . . 0.0 109.217 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.84 152.19 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 128.733 2.813 . . . . 0.0 106.718 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.552 HD11 ' CH2' ' A' ' 36' ' ' TRP . 95.2 mt -137.94 105.22 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -101.04 136.67 40.51 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.743 1.217 . . . . 0.0 108.755 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.72 165.21 12.01 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.015 1.326 . . . . 0.0 109.258 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -137.89 145.26 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.804 1.242 . . . . 0.0 107.85 170.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -154.46 119.79 5.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -66.22 -19.06 65.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.63 12.77 22.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.019 0.928 . . . . 0.0 111.37 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.22 -59.82 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -158.86 137.56 11.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.384 1.874 . . . . 0.0 108.079 171.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.03 -17.51 63.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.001 0.819 . . . . 0.0 111.617 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 m -68.3 143.28 55.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.611 -0.68 . . . . 0.0 109.548 169.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -67.15 144.83 55.82 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -125.67 118.18 25.09 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 m -74.93 93.43 2.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.25 -17.67 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 0.0 111.076 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.28 149.47 34.92 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.97 147.97 42.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.477 1.911 . . . . 0.0 106.216 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.43 ' O ' ' HE2' ' A' ' 70' ' ' LYS . 8.9 m170 57.99 51.2 9.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.04 0.936 . . . . 0.0 111.211 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.2 t -82.61 139.11 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.389 1.476 . . . . 0.0 107.335 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 68' ' ' HIS . 3.5 mtmt -119.15 25.36 10.21 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.62 1.168 . . . . 0.0 112.243 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.2 t -143.93 173.2 11.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.177 0.991 . . . . 0.0 108.828 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -103.56 2.51 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.127 2.171 . . . . 0.0 112.042 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.657 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 4.7 tp -140.04 114.83 9.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.972 1.709 . . . . 0.0 107.425 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -145.65 120.97 10.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 118.148 0.431 . . . . 0.0 111.9 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.7 m -66.8 101.4 0.81 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.485 1.914 . . . . 0.0 109.08 164.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.92 144.83 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 162.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 50.7 mtt-85 -136.91 178.58 6.97 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.23 1.412 . . . . 0.0 110.502 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.56 80.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 123.5 0.571 . . . . 0.0 112.557 170.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.08 -172.75 4.33 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.704 0.752 . . . . 0.0 110.291 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -114.25 146.62 36.17 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 125.563 1.545 . . . . 0.0 107.811 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.71 154.12 30.39 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.492 2.128 . . . . 0.0 110.374 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.62 44.95 17.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.664 1.186 . . . . 0.0 111.465 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.9 m -131.13 136.26 48.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 mm -74.15 146.65 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.189 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.87 148.65 48.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.052 0.845 . . . . 0.0 109.457 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.25 161.02 15.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.617 -1.174 . . . . 0.0 107.899 158.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -143.85 143.12 31.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 126.001 2.063 . . . . 0.0 107.814 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 13.2 mtm -136.67 125.65 24.33 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 129.209 3.004 . . . . 0.0 107.479 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.1 t -94.59 145.78 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.434 ' HD3' HD13 ' A' ' 97' ' ' LEU . 35.1 mtt180 -131.63 128.6 39.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 167.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 125.12 33.97 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.27 148.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.549 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -135.77 179.81 1.27 Allowed Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.221 1.809 . . . . 0.0 107.403 166.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HG2' HD13 ' A' ' 44' ' ' LEU . 88.2 Cg_endo -74.67 -0.1 9.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 122.4 1.893 . . . . 0.0 113.812 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -116.72 -37.91 3.57 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.981 1.312 . . . . 0.0 110.301 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.26 -141.39 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.434 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -142.9 159.52 42.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.753 2.421 . . . . 0.0 106.729 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.0 p -72.05 166.61 21.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.333 0.653 . . . . 0.0 110.244 -169.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.31 148.42 3.28 Favored Pre-proline 0 C--O 1.244 0.771 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 160.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.33 130.17 20.63 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.923 1.749 . . . . 0.0 108.631 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -54.62 161.73 2.05 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.119 0.568 . . . . 0.0 111.817 165.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.93 138.14 69.36 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.342 2.028 . . . . 0.0 110.649 159.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -58.64 150.24 23.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.913 0.779 . . . . 0.0 109.999 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 88.2 p -63.14 -4.58 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.25 149.87 0.11 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.935 1.694 . . . . 0.0 110.808 -163.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.01 99.02 1.13 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.134 1.889 . . . . 0.0 112.636 -164.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.46 155.22 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.432 0.693 . . . . 0.0 109.167 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -108.1 150.95 26.53 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.108 1.363 . . . . 0.0 109.901 166.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.4 p -77.7 167.95 20.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.789 0.804 . . . . 0.0 111.407 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -77.45 178.82 6.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.275 0.63 . . . . 0.0 109.943 169.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 109.404 170.952 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.6 mt . . . . . 0 CA--C 1.541 0.614 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.43 149.6 84.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.434 2.089 . . . . 0.0 111.26 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -51.79 134.25 35.36 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.88 154.71 72.79 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.996 1.898 . . . . 0.0 111.361 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -60.81 168.55 6.92 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.743 2.295 . . . . 0.0 111.772 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.86 171.67 12.27 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -61.22 144.47 91.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.58 129.1 19.3 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.496 1.464 . . . . 0.0 111.337 161.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -81.64 158.18 24.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.017 2.127 . . . . 0.0 109.218 158.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.99 121.19 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.337 -1.756 . . . . 0.0 107.141 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.1 p -116.2 -95.67 0.47 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.329 -167.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.27 143.28 41.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.6 1.56 . . . . 0.0 109.653 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.37 148.96 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.719 0.808 . . . . 0.0 110.685 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 p -135.8 -168.33 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.399 1.48 . . . . 0.0 108.021 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -71.11 -16.32 62.56 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.444 -1.41 . . . . 0.0 112.642 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -152.36 15.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.099 -1.626 . . . . 0.0 112.633 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -139.43 161.85 36.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.46 140.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.446 1.499 . . . . 0.0 108.111 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -92.74 126.47 37.84 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.33 1.052 . . . . 0.0 108.642 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -107.35 139.8 41.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.133 1.773 . . . . 0.0 107.363 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -134.64 138.69 44.7 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 51' ' ' ILE . 14.1 p90 -139.32 171.19 14.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.199 0.523 . . . . 0.0 111.474 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -98.87 148.83 35.1 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.24 161.49 17.67 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.546 2.831 . . . . 0.0 111.44 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.1 -173.3 49.56 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 165.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.41 171.78 11.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.158 1.383 . . . . 0.0 108.588 169.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.31 -156.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.151 3.234 . . . . 0.0 109.565 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.9 -131.75 2.75 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 167.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -55.53 -27.58 49.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.942 2.097 . . . . 0.0 112.118 164.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 51.9 mt -144.58 162.39 39.28 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 127.612 2.365 . . . . 0.0 109.543 -156.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 92.6 Cg_endo -76.37 158.34 36.84 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.091 3.194 . . . . 0.0 110.989 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.68 128.9 41.67 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.96 -27.53 10.12 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.129 0.572 . . . . 0.0 111.508 -165.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.75 -165.97 1.64 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 160.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -128.83 169.74 14.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.785 2.034 . . . . 0.0 109.354 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.75 157.1 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 127.608 2.363 . . . . 0.0 107.214 171.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.492 HD11 ' CH2' ' A' ' 36' ' ' TRP . 55.9 mt -125.43 133.08 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 165.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -113.4 158.42 20.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.78 146.68 46.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.368 1.067 . . . . 0.0 108.223 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -109.34 146.88 33.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 166.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.53 124.94 5.21 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.677 0.671 . . . . 0.0 109.346 170.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.54 -34.97 72.86 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -169.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 7.41 11.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.85 0.75 . . . . 0.0 112.276 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.5 t -121.68 -55.34 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.717 1.207 . . . . 0.0 107.944 -171.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 t -141.31 -98.3 0.14 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 p30 140.49 -17.18 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.778 2.831 . . . . 0.0 111.119 -149.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -119.02 150.98 39.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.294 1.038 . . . . 0.0 110.187 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -70.6 121.86 18.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -118.84 143.52 46.9 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.323 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.92 93.95 3.3 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.66 -15.43 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.084 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.08 152.38 30.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.103 0.961 . . . . 0.0 108.944 161.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -142.93 170.24 16.07 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.762 0.825 . . . . 0.0 111.355 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 51.97 38.19 23.08 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.915 0.864 . . . . 0.0 112.422 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.65 127.84 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 125.845 1.658 . . . . 0.0 108.449 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -113.34 29.96 7.58 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.701 0.801 . . . . 0.0 112.253 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -150.47 173.6 13.88 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 108.305 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -98.48 2.9 48.12 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.658 2.383 . . . . 0.0 112.186 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.28 117.1 10.98 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.583 1.083 . . . . 0.0 110.325 -176.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -146.1 151.41 37.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.545 0.738 . . . . 0.0 111.591 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -101.19 103.4 14.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.142 1.377 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.1 139.21 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -139.93 176.07 9.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 111.386 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.77 79.59 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.63 0.633 . . . . 0.0 112.35 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.42 -175.79 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.489 0.715 . . . . 0.0 110.403 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -98.16 145.06 29.16 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.043 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -75.61 159.38 39.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.73 2.953 . . . . 0.0 111.686 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.6 t30 45.54 38.13 3.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.645 1.978 . . . . 0.0 111.842 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.2 m -132.18 134.13 45.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.538 1.135 . . . . 0.0 108.817 -170.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.34 141.52 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.09 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -139.17 154.48 48.08 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 125.056 1.473 . . . . 0.0 108.077 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.25 165.69 11.31 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.051 1.34 . . . . 0.0 108.302 164.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -137.28 140.07 41.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.952 0.782 . . . . 0.0 109.953 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 28.2 mtm -118.86 167.71 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 161.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.94 155.82 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -133.78 141.66 47.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 165.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.54 142.81 27.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 165.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.74 147.07 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 124.492 1.117 . . . . 0.0 109.243 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.81 171.2 6.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.95 22.64 0.47 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 123.683 2.922 . . . . 0.0 114.929 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -131.55 -34.3 1.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.905 1.682 . . . . 0.0 111.201 172.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.14 -165.26 33.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.515 1.052 . . . . 0.0 111.035 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -98.5 148.55 23.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 p -73.07 166.42 23.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.1 143.76 15.8 Favored Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 126.823 2.049 . . . . 0.0 110.301 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.99 127.77 22.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.858 1.705 . . . . 0.0 113.07 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -54.37 160.68 2.4 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.669 1.988 . . . . 0.0 112.666 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.94 120.79 8.74 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.136 1.891 . . . . 0.0 109.354 156.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 ptp -77.58 151.76 34.29 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 120.194 1.361 . . . . 0.0 109.182 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.4 t -58.95 154.47 15.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.464 1.106 . . . . 0.0 109.402 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.48 150.02 57.7 Favored Pre-proline 0 N--CA 1.475 0.792 0 O-C-N 120.874 -1.141 . . . . 0.0 109.465 158.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.09 102.98 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.104 2.536 . . . . 0.0 110.905 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.03 163.29 3.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -122.07 141.66 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.986 1.314 . . . . 0.0 107.655 164.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 p -68.07 161.08 27.58 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -66.74 -175.27 0.38 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.995 1.379 . . . . 0.0 109.205 163.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.065 -174.819 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 119.421 -0.323 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.02 150.57 83.51 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.285 1.99 . . . . 0.0 108.872 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.37 147.97 41.61 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 163.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.52 147.1 63.67 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.143 1.896 . . . . 0.0 111.431 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -66.0 165.14 24.85 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.411 2.074 . . . . 0.0 110.528 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.2 p -67.71 169.39 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.787 -0.571 . . . . 0.0 110.763 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -48.62 127.65 13.54 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.538 155.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.48 142.82 45.67 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.787 1.317 . . . . 0.0 110.261 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.43 161.4 26.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.53 1.532 . . . . 0.0 109.351 163.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -124.35 105.21 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -110.65 -62.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.838 1.655 . . . . 0.0 111.124 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -111.02 136.0 50.69 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.216 1.807 . . . . 0.0 110.738 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.26 150.39 17.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 119.855 1.207 . . . . 0.0 110.588 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.5 p -139.88 -174.54 3.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.345 1.858 . . . . 0.0 107.818 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.6 -24.77 61.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.385 -1.447 . . . . 0.0 112.461 -175.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -131.81 4.65 4.2 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.167 1.349 . . . . 0.0 110.959 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 m -150.78 163.61 38.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.525 1.511 . . . . 0.0 110.356 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 p -156.74 136.76 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.145 1.378 . . . . 0.0 108.155 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -80.3 140.72 36.04 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -114.55 150.05 35.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 t -138.16 134.68 34.85 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.447 1.099 . . . . 0.0 108.515 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -138.98 170.23 16.35 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 110.387 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.32 138.08 25.8 Favored Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 164.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.66 140.45 47.08 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.99 3.127 . . . . 0.0 107.62 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 163.07 43.35 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 41' ' ' PRO . 3.0 m -73.3 143.36 82.95 Favored Pre-proline 0 N--CA 1.433 -1.308 0 C-N-CA 126.009 1.723 . . . . 0.0 110.938 -164.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.488 ' O ' HG22 ' A' ' 40' ' ' THR . 61.2 Cg_endo -71.53 -169.13 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.438 3.426 . . . . 0.0 111.758 166.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.82 -114.09 0.54 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 163.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -47.05 -40.68 15.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.763 2.825 . . . . 0.0 112.607 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 mt -134.7 163.24 52.58 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.273 1.029 . . . . 0.0 109.277 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.62 171.31 15.9 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.664 2.909 . . . . 0.0 110.809 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.03 107.14 16.91 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.253 1.021 . . . . 0.0 109.064 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' HG22 ' A' ' 92' ' ' ILE . 14.4 m -58.91 -51.4 70.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.144 2.578 . . . . 0.0 112.388 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.0 -164.88 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.973 -1.079 . . . . 0.0 108.191 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.72 164.23 24.44 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.9 2.08 . . . . 0.0 108.63 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mt -120.34 154.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 127.131 2.172 . . . . 0.0 106.563 161.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.62 124.97 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 156.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -100.78 151.92 21.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.61 151.38 51.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -123.47 151.0 43.18 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -140.53 136.17 32.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -56.85 -50.84 71.21 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.599 163.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -73.7 25.37 0.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.04 2.936 . . . . 0.0 113.469 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -135.7 -62.55 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.43 -5.38 0.66 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -165.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t30 46.63 36.52 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.372 1.469 . . . . 0.0 111.931 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.8 m -149.97 157.85 43.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 128.412 2.685 . . . . 0.0 105.187 -169.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.91 154.02 21.15 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -136.34 146.03 46.1 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.8 m -71.32 128.5 36.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.16 -12.36 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.18 74.94 0.93 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.347 1.859 . . . . 0.0 108.834 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.71 144.64 29.23 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.21 2.604 . . . . 0.0 109.185 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.403 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 57.8 m-70 38.32 60.81 1.23 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.911 2.085 . . . . 0.0 111.8 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.53 145.56 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -128.17 40.68 3.63 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.17 1.388 . . . . 0.0 110.355 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -148.0 -176.93 5.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -114.99 2.31 14.21 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.675 2.79 . . . . 0.0 110.991 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mp -135.43 143.85 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.531 0.733 . . . . 0.0 109.271 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -146.26 129.74 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 m -71.6 94.49 1.33 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.377 1.471 . . . . 0.0 107.515 161.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.97 138.02 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.99 179.82 6.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.917 1.287 . . . . 0.0 110.045 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.42 22.15 79.07 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.862 -0.41 . . . . 0.0 112.38 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt -87.0 172.36 10.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.576 1.179 . . . . 0.0 110.087 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 mtt85 -103.4 149.73 37.3 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 125.668 1.587 . . . . 0.0 107.345 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.11 160.02 40.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.779 1.653 . . . . 0.0 110.338 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 t30 46.5 33.15 1.85 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.018 1.327 . . . . 0.0 111.633 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.8 m -119.99 126.91 52.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.59 148.19 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.208 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -139.92 146.65 39.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.289 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.92 156.69 18.92 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 160.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -137.33 146.7 44.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.683 1.865 . . . . 0.0 107.816 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 45.0 mtm -134.53 137.84 44.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 160.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.95 139.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.551 ' HD3' HD22 ' A' ' 97' ' ' LEU . 73.6 mtt180 -120.43 146.53 46.12 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 168.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 163.97 16.49 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.2 OUTLIER -126.46 150.86 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 126.665 1.986 . . . . 0.0 108.806 174.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.85 169.91 9.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 0.0 110.165 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.98 19.24 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.06 2.506 . . . . 0.0 114.982 -174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -127.85 -58.71 1.22 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 126.288 1.835 . . . . 0.0 110.091 166.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.66 -173.36 17.82 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 121.836 0.686 . . . . 0.0 113.983 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.1 mp -81.69 157.08 24.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.6 p -71.64 168.43 17.71 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.875 0.87 . . . . 0.0 109.757 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -41.6 142.19 1.07 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 151.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.59 156.15 64.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.676 1.584 . . . . 0.0 109.346 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 p -68.59 166.53 25.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.891 -0.505 . . . . 0.0 110.296 164.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -54.58 146.53 53.08 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 111.17 163.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.9 mtm -60.2 144.85 49.08 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.29 0.496 . . . . 0.0 110.14 171.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.0 p -62.93 -11.39 18.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.238 1.815 . . . . 0.0 115.175 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 t0 69.62 156.46 0.15 Allowed Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.411 -153.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -76.07 101.15 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.411 2.074 . . . . 0.0 111.375 -173.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.27 165.45 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -127.34 141.05 51.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.559 2.344 . . . . 0.0 107.612 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.6 p -74.39 161.14 30.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.044 0.838 . . . . 0.0 109.527 163.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -67.22 165.66 15.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.745 0.783 . . . . 0.0 109.896 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.5 t0 . . . . . 0 N--CA 1.476 0.863 0 CA-C-O 123.608 1.67 . . . . 0.0 112.498 -172.16 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.93 164.91 30.89 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.22 2.613 . . . . 0.0 111.457 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.97 149.65 49.5 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.75 141.01 44.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.334 2.689 . . . . 0.0 110.857 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -65.74 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.689 1.593 . . . . 0.0 110.203 170.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m -79.96 171.19 15.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -57.25 122.1 51.93 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.099 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.97 156.41 62.67 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.5 1.466 . . . . 0.0 109.358 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.75 124.68 43.91 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.88 151.24 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.787 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 p -136.53 -75.65 0.43 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.541 0.736 . . . . 0.0 109.47 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.12 135.46 37.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.77 157.19 20.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 162.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -141.13 -64.97 0.44 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -168.24 -39.25 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.208 2.203 . . . . 0.0 107.414 171.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -129.22 5.04 5.26 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.916 0.886 . . . . 0.0 110.863 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -152.5 152.17 31.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.592 0.633 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -153.59 127.31 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.8 m -77.98 148.09 34.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 87' ' ' PHE . 70.2 mt -128.35 138.97 52.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 126.647 1.979 . . . . 0.0 108.256 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -134.3 94.91 3.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.789 1.306 . . . . 0.0 110.74 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -109.26 170.72 7.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.901 0.858 . . . . 0.0 111.225 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -101.53 140.09 20.95 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 166.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.01 171.19 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.521 2.814 . . . . 0.0 109.26 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.75 -130.44 2.48 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.619 -2.193 . . . . 0.0 107.619 160.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.08 165.77 20.72 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 125.177 1.391 . . . . 0.0 107.916 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.84 -147.68 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.991 1 C-N-CA 125.892 4.395 . . . . 0.0 110.201 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.16 -91.68 0.12 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -62.78 -52.97 61.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 126.136 1.774 . . . . 0.0 109.928 172.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.6 mt -133.69 163.9 47.86 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 110.818 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.52 174.27 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.968 3.112 . . . . 0.0 110.856 167.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.85 108.1 19.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -54.82 -53.06 60.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.489 2.315 . . . . 0.0 111.913 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.08 -166.36 1.69 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 0.0 107.255 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -131.03 160.27 35.08 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.622 1.969 . . . . 0.0 107.929 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mt -118.73 156.19 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.12 2.168 . . . . 0.0 107.564 167.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.8 128.51 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -148.23 139.15 23.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.648 1.179 . . . . 0.0 107.84 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.89 129.96 55.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.326 1.45 . . . . 0.0 108.149 170.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.5 112.93 8.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.14 -20.66 60.87 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 3.45 26.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.357 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.04 -80.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.252 1.821 . . . . 0.0 106.695 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -133.12 -5.41 3.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.932 0.787 . . . . 0.0 112.888 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 54.57 42.93 30.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.934 0.873 . . . . 0.0 111.497 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.8 m -140.64 152.39 45.36 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 127.161 2.184 . . . . 0.0 106.946 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.475 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 93.0 m95 -72.17 132.84 44.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 157.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -125.54 151.78 45.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.352 1.461 . . . . 0.0 107.294 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.64 127.68 33.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.1 -3.67 10.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.641 0.776 . . . . 0.0 111.23 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . . . -154.1 126.82 8.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.766 1.627 . . . . 0.0 108.454 168.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -115.06 139.89 49.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.767 0.827 . . . . 0.0 110.02 165.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 50.32 69.9 0.57 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.148 2.579 . . . . 0.0 114.637 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.7 141.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -124.2 32.67 5.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.904 0.882 . . . . 0.0 112.029 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.32 165.18 27.88 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -90.34 0.48 57.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.81 1.644 . . . . 0.0 112.595 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -132.5 133.06 43.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 108.78 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 76.2 t80 -146.72 152.17 38.38 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 127.197 2.199 . . . . 0.0 109.17 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -111.25 112.95 25.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.084 1.354 . . . . 0.0 108.626 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.7 t -66.22 143.57 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.64 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -136.25 -175.09 3.87 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.671 0.788 . . . . 0.0 110.723 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.87 17.93 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.509 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.7 mt -85.79 -163.39 0.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.676 1.238 . . . . 0.0 109.112 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -135.84 139.42 30.57 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.59 158.49 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.431 2.754 . . . . 0.0 111.121 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 48.64 31.31 2.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.235 1.814 . . . . 0.0 113.251 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.5 m -124.44 136.38 53.99 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.518 1.527 . . . . 0.0 108.396 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.6 mm -76.58 148.04 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 124.637 1.175 . . . . 0.0 109.413 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -139.54 153.93 47.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.64 2.376 . . . . 0.0 106.335 171.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 11.2 mt -112.64 157.0 21.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.359 1.463 . . . . 0.0 107.918 154.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.459 ' CD2' HD21 ' A' ' 34' ' ' LEU . 31.1 m-85 -127.03 157.99 38.14 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.692 1.997 . . . . 0.0 110.013 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.475 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 20.0 mtt -128.71 155.89 44.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.85 2.06 . . . . 0.0 106.634 164.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.9 t -122.3 141.81 41.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 162.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.841 ' HD3' HD13 ' A' ' 97' ' ' LEU . 83.2 mtt-85 -132.34 146.29 51.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.07 156.96 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.46 152.74 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 127.217 2.207 . . . . 0.0 107.226 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.3 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.297 1.039 . . . . 0.0 110.263 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -59.67 2.87 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.996 3.131 . . . . 0.0 116.463 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -127.91 -37.8 1.89 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.952 1.701 . . . . 0.0 112.018 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.28 -150.49 8.45 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -170.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.841 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.5 pp -124.71 157.33 35.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 97' ' ' LEU . 89.1 p -72.5 166.48 22.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.164 0.986 . . . . 0.0 111.598 -174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -44.61 152.97 0.49 Allowed Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 156.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.14 142.07 49.61 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.239 1.959 . . . . 0.0 110.895 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 94.0 p -60.04 165.41 4.86 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.181 0.592 . . . . 0.0 111.131 156.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.2 141.65 94.06 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 158.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.66 147.68 45.08 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.678 -1.264 . . . . 0.0 111.777 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 p -57.31 -18.16 15.58 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.598 2.759 . . . . 0.0 116.381 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 88.06 150.74 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 128.613 2.765 . . . . 0.0 107.156 -153.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.2 109.14 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.98 2.454 . . . . 0.0 108.709 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.2 127.72 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.218 1.007 . . . . 0.0 109.539 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 140.59 30.04 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.8 p -64.19 164.84 10.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -78.75 -175.99 4.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 122.302 1.049 . . . . 0.0 108.426 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.697 164.652 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 mt . . . . . 0 CA--C 1.534 0.335 0 CA-C-O 119.376 -0.345 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.96 150.45 38.35 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.774 2.316 . . . . 0.0 109.799 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 159.57 53.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.148 1.356 . . . . 0.0 112.381 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.14 124.32 12.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.145 2.563 . . . . 0.0 109.784 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.56 165.77 14.9 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.73 2.287 . . . . 0.0 112.456 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -70.42 162.13 29.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.567 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -56.38 121.91 46.01 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.687 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.88 142.76 94.38 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.59 1.527 . . . . 0.0 111.119 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -122.42 131.91 54.11 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.179 1.392 . . . . 0.0 110.102 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.588 HG11 HG11 ' A' ' 107' ' ' VAL . 2.2 m -80.27 142.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.104 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 p -135.64 -42.18 0.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.814 -166.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.28 145.33 48.33 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.794 1.238 . . . . 0.0 108.42 166.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.37 151.38 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.449 1.099 . . . . 0.0 108.099 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -125.24 -43.03 1.96 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -168.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 pttt 143.34 -27.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 1 C-N-CA 133.719 4.808 . . . . 0.0 110.071 -174.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -138.94 -4.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.101 1.76 . . . . 0.0 109.995 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.01 156.47 47.79 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.823 2.049 . . . . 0.0 106.937 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -154.37 128.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.6 m -80.42 137.05 36.46 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.1 mt -125.82 146.39 49.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 126.576 1.95 . . . . 0.0 106.925 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.6 116.96 11.28 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 125.15 1.531 . . . . 0.0 108.263 -166.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.587 ' CH2' HD11 ' A' ' 51' ' ' ILE . 49.3 p90 -139.03 156.91 46.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.453 1.024 . . . . 0.0 109.55 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.47 144.87 29.42 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.097 0.559 . . . . 0.0 109.96 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.65 117.68 3.72 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.594 2.862 . . . . 0.0 110.841 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 174.99 30.72 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 124.734 1.159 . . . . 0.0 110.391 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.3 m -61.65 153.69 69.63 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 129.091 2.956 . . . . 0.0 110.781 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.96 -173.23 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.239 2.626 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.11 -160.87 9.41 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 104.578 -3.409 . . . . 0.0 104.578 160.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.38 -50.03 63.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.141 -1.529 . . . . 0.0 109.69 166.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.32 161.58 32.35 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.689 1.131 . . . . 0.0 112.203 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.96 153.11 9.82 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 124.384 3.389 . . . . 0.0 110.23 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.91 37.8 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.896 0.855 . . . . 0.0 111.138 170.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.11 -59.93 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.406 1.482 . . . . 0.0 107.798 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.67 -170.47 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.382 1.073 . . . . 0.0 109.045 -165.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -111.9 163.17 14.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.391 1.876 . . . . 0.0 108.269 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.22 152.12 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.573 2.349 . . . . 0.0 107.099 157.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.587 HD11 ' CH2' ' A' ' 36' ' ' TRP . 85.4 mt -132.29 108.38 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -99.89 158.95 15.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.53 150.88 44.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.758 2.023 . . . . 0.0 107.742 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -128.01 150.25 50.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.69 117.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.995 0.902 . . . . 0.0 110.54 171.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -67.1 -36.45 81.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.432 -0.793 . . . . 0.0 111.465 -173.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -71.9 5.98 2.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.114 2.166 . . . . 0.0 113.685 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.56 -69.36 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.4 m -158.83 121.05 3.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.221 2.208 . . . . 0.0 105.471 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -72.18 82.42 1.0 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.593 0.633 . . . . 0.0 109.72 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -170.47 159.26 6.84 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.535 2.734 . . . . 0.0 107.524 168.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -76.69 142.35 40.57 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 161.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -130.71 139.64 50.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.278 1.431 . . . . 0.0 107.943 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -88.46 94.07 9.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.5 -15.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.691 1.196 . . . . 0.0 113.044 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . -142.48 149.73 39.58 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 156.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.88 154.07 51.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 62.32 29.11 17.25 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.8 134.43 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 120.698 -1.252 . . . . 0.0 108.193 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -106.16 -8.49 17.37 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.81 -174.44 3.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.009 1.723 . . . . 0.0 109.297 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.8 p -120.57 0.97 10.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.364 1.866 . . . . 0.0 111.929 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -130.64 137.91 49.83 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.261 -0.899 . . . . 0.0 108.72 161.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.16 145.47 30.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.765 0.711 . . . . 0.0 109.084 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.0 m -89.21 106.67 18.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.072 1.749 . . . . 0.0 108.578 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.33 151.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.334 1.054 . . . . 0.0 108.223 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -135.6 -176.16 4.19 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.494 1.518 . . . . 0.0 110.777 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.41 7.64 85.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.968 1.27 . . . . 0.0 114.004 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.56 -177.49 6.55 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 123.148 1.451 . . . . 0.0 110.238 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -118.54 151.04 49.19 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 126.49 1.916 . . . . 0.0 108.422 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.74 156.64 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.385 2.723 . . . . 0.0 109.929 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 53.58 26.14 5.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.788 1.235 . . . . 0.0 111.854 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.1 m -119.68 129.19 54.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.115 1.766 . . . . 0.0 107.758 -170.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.84 144.98 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.69 153.7 47.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 109.178 168.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.08 162.3 14.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.074 1.35 . . . . 0.0 107.506 160.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -139.69 135.18 32.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 125.099 1.499 . . . . 0.0 107.889 172.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.4 mtm -124.45 135.16 53.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.97 144.37 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.606 ' HD3' HD22 ' A' ' 97' ' ' LEU . 6.3 mtp180 -120.9 150.99 40.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 160.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 165.15 15.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.47 152.41 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 127.232 2.213 . . . . 0.0 108.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.92 178.17 1.78 Allowed Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.888 0.875 . . . . 0.0 111.329 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.67 -4.06 1.72 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.586 3.524 . . . . 0.0 117.905 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -130.45 -37.18 1.41 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.402 1.455 . . . . 0.0 111.394 -170.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.83 -170.84 34.75 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -168.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.606 HD22 ' HD3' ' A' ' 90' ' ' ARG . 2.2 mp -97.89 166.16 11.59 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.469 1.108 . . . . 0.0 109.046 166.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 91.4 p -72.08 167.73 19.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.665 0.786 . . . . 0.0 110.07 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -48.81 150.56 2.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.051 -0.405 . . . . 0.0 110.153 153.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.7 132.98 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.745 2.297 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.8 p -59.03 168.83 1.33 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.8 0.84 . . . . 0.0 112.66 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.13 136.35 37.8 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.374 2.716 . . . . 0.0 112.237 161.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 149.73 33.49 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.974 0.806 . . . . 0.0 109.583 165.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 76.5 p -60.31 -9.43 3.46 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.593 1.957 . . . . 0.0 115.89 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.6 147.0 0.11 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.073 2.149 . . . . 0.0 109.604 -155.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.21 118.83 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.677 2.251 . . . . 0.0 110.066 -168.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.588 HG11 HG11 ' A' ' 24' ' ' VAL . 1.5 m -114.45 131.58 66.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.882 1.273 . . . . 0.0 110.457 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 145.21 31.7 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 p -71.37 168.41 17.47 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.53 0.732 . . . . 0.0 110.829 162.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -65.39 -167.86 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.018 1.39 . . . . 0.0 110.1 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 t0 . . . . . 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 113.516 -163.328 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 CA--C 1.53 0.181 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -67.18 169.65 14.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.373 2.049 . . . . 0.0 110.922 167.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.38 168.06 49.69 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.38 1.467 . . . . 0.0 112.124 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.61 132.69 31.73 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.109 2.54 . . . . 0.0 108.844 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.09 165.37 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.7 1.6 . . . . 0.0 111.817 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.02 163.54 27.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.303 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 11.0 tmtt? -50.29 119.04 10.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.135 171.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -67.21 160.14 48.91 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 CA-C-N 120.082 1.065 . . . . 0.0 110.47 172.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -135.93 125.89 25.94 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.963 2.105 . . . . 0.0 107.975 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 107' ' ' VAL . 9.2 m -69.13 149.27 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.6 p -134.06 -41.45 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.427 0.691 . . . . 0.0 110.169 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -123.44 145.09 49.08 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 109.146 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.82 145.82 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 119.758 1.163 . . . . 0.0 108.552 164.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.2 p -134.11 -169.12 2.25 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.533 1.133 . . . . 0.0 108.913 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -66.51 -16.49 64.17 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 120.857 -1.152 . . . . 0.0 113.35 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -156.35 6.2 0.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -123.64 160.07 27.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.201 1.364 . . . . 0.0 111.297 165.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.59 136.85 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -96.61 142.13 29.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.1 mt -134.74 133.79 40.3 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.073 1.749 . . . . 0.0 108.255 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 6.9 t -118.96 130.23 55.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 129.371 3.068 . . . . 0.0 108.311 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -139.12 170.94 15.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -104.87 148.59 36.35 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 162.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.58 160.66 44.96 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.202 2.601 . . . . 0.0 109.703 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.02 174.15 43.75 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -57.64 155.02 22.74 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 126.466 1.906 . . . . 0.0 110.074 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.86 -175.86 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.525 2.817 . . . . 0.0 111.892 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.02 -147.45 7.94 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 105.575 -3.01 . . . . 0.0 105.575 168.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -33.84 64.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 165.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.38 157.42 33.75 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 123.181 0.593 . . . . 0.0 112.052 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.88 150.28 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.794 3.662 . . . . 0.0 110.034 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 125.58 28.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.383 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -73.45 -49.21 28.06 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.436 172.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 68' ' ' HIS . . . -161.18 -165.18 1.28 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.434 1.015 . . . . 0.0 110.184 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.89 161.55 32.76 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.831 0.852 . . . . 0.0 109.943 167.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -118.84 158.26 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 128.203 2.601 . . . . 0.0 106.806 167.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mt -126.02 129.24 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 163.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -105.89 153.86 21.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.231 1.412 . . . . 0.0 108.112 171.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.1 127.68 20.12 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.493 1.517 . . . . 0.0 110.209 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -91.74 149.35 21.65 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.233 1.413 . . . . 0.0 107.772 169.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.22 113.56 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.338 1.066 . . . . 0.0 112.477 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.35 -38.56 81.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 112.844 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 m -73.87 8.43 2.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.943 1.297 . . . . 0.0 113.382 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.49 -72.54 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 124.268 1.027 . . . . 0.0 108.895 -168.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.1 t -150.38 12.88 0.74 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.631 0.772 . . . . 0.0 110.058 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 61.02 -79.73 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.593 2.357 . . . . 0.0 111.753 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.57 162.11 0.04 OUTLIER 'General case' 0 C--O 1.234 0.26 0 C-N-CA 129.664 3.186 . . . . 0.0 114.895 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 94.9 m95 -67.79 138.28 56.05 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -124.54 142.56 51.25 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -72.73 107.21 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -95.68 -28.28 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 0.0 111.655 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 138.07 31.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 135.47 41.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.44 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 10.9 m-70 50.04 68.83 0.69 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.798 2.039 . . . . 0.0 110.923 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.4 t -84.97 -53.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.93 1.292 . . . . 0.0 113.623 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 mttt 66.21 -23.66 0.1 Allowed 'General case' 0 C--N 1.316 -0.884 1 C-N-CA 131.79 4.036 . . . . 0.0 115.578 170.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -71.42 173.09 8.35 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.388 1.449 . . . . 0.0 108.607 168.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.04 -4.71 20.17 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.958 168.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 5.4 tp -121.17 131.71 54.4 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 121.596 1.998 . . . . 0.0 110.211 160.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -134.61 152.8 52.04 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.283 1.033 . . . . 0.0 109.432 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -112.77 101.07 9.18 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.355 1.862 . . . . 0.0 107.203 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.98 143.56 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 162.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -139.01 178.93 6.8 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.36 1.864 . . . . 0.0 108.2 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 24.29 67.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.414 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.1 mt -82.1 -173.54 4.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.624 1.17 . . . . 0.0 109.772 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -112.22 141.9 25.9 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 117.694 -1.146 . . . . 0.0 109.228 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.79 157.47 61.62 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.21 1.94 . . . . 0.0 112.156 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 41.62 42.64 2.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.477 1.911 . . . . 0.0 112.339 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.4 m -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.252 1.421 . . . . 0.0 107.817 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.57 147.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.73 155.63 46.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.038 167.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.77 163.12 13.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.87 132.38 26.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.43 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 41.0 mtm -131.4 165.6 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 123.895 0.747 . . . . 0.0 109.338 161.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.5 t -132.21 140.36 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.976 1.71 . . . . 0.0 107.284 -166.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.489 ' HD3' HD22 ' A' ' 97' ' ' LEU . 13.1 mtt180 -132.1 132.03 42.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.5 118.67 26.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.34 145.7 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' A' ' 47' ' ' SER . 1.9 p-10 -141.52 173.84 4.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.712 1.205 . . . . 0.0 108.096 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -73.26 31.63 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.34 2.693 . . . . 0.0 114.075 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -134.04 -67.83 0.58 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.325 1.85 . . . . 0.0 106.657 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.55 -148.26 4.73 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.914 1.245 . . . . 0.0 112.159 -167.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.489 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.4 mt -122.7 142.21 50.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.539 3.136 . . . . 0.0 106.398 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.9 p -72.33 166.96 21.45 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.359 0.6 . . . . 0.0 112.116 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -60.35 158.0 31.39 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 124.568 1.147 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.22 122.59 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.944 1.762 . . . . 0.0 111.983 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 p -60.5 157.79 34.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.454 1.501 . . . . 0.0 111.784 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 128.66 24.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.812 3.008 . . . . 0.0 110.506 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.8 mtt -56.27 150.66 14.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.082 1.764 . . . . 0.0 111.451 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.499 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 1.5 p -69.9 -1.61 10.03 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 81.82 155.54 0.12 Allowed Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 131.119 3.768 . . . . 0.0 108.874 -167.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.61 117.6 5.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.279 2.653 . . . . 0.0 109.171 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 24' ' ' VAL . 2.7 m -116.97 144.68 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 123.599 0.76 . . . . 0.0 109.385 -171.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -104.32 138.51 40.66 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 123.38 0.672 . . . . 0.0 109.925 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -67.29 169.06 9.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.969 168.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -82.73 175.7 9.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.733 0.778 . . . . 0.0 110.007 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.749 164.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -60.0 142.63 98.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.381 2.721 . . . . 0.0 110.473 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.02 142.64 38.31 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 161.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.18 145.95 96.13 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.179 1.919 . . . . 0.0 110.187 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -64.68 157.96 52.93 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.72 1.613 . . . . 0.0 109.987 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -68.47 166.48 16.76 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.222 0.609 . . . . 0.0 110.37 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -46.03 121.83 5.98 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.21 1.004 . . . . 0.0 109.242 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -60.26 146.29 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -113.28 125.14 53.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.219 1.408 . . . . 0.0 109.007 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 107' ' ' VAL . 19.8 t -80.58 112.54 18.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -102.31 -82.7 0.48 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.6 139.37 40.61 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -137.33 145.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 p -125.88 -173.58 2.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.183 0.993 . . . . 0.0 108.613 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.11 -14.87 53.74 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -163.57 26.47 0.08 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.092 1.315 . . . . 0.0 112.939 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -146.93 161.87 39.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 107.982 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -158.26 136.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.126 0.97 . . . . 0.0 108.482 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -91.13 110.94 22.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.033 1.333 . . . . 0.0 107.942 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -93.11 140.84 29.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.805 1.242 . . . . 0.0 109.224 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.656 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.61 99.21 3.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.612 1.195 . . . . 0.0 108.887 -163.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -119.05 172.81 7.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.532 1.133 . . . . 0.0 109.674 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -118.79 145.57 38.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.99 143.9 29.63 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.671 2.914 . . . . 0.0 110.779 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.47 175.68 52.84 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 170.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -62.18 146.15 92.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.884 1.274 . . . . 0.0 109.167 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.13 -168.7 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.953 3.769 . . . . 0.0 112.42 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.31 -149.51 5.54 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -37.81 68.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.562 1.145 . . . . 0.0 110.673 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 7.1 mt -111.95 167.31 9.32 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.714 0.806 . . . . 0.0 111.913 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 61.0 Cg_endo -73.88 -130.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 124.628 3.552 . . . . 0.0 108.299 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.6 161.8 24.01 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 127.669 2.388 . . . . 0.0 106.622 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -105.84 -35.38 7.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.132 2.173 . . . . 0.0 110.502 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.74 -159.42 0.08 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.744 1.217 . . . . 0.0 109.626 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 91' ' ' ALA . 84.6 m-85 -128.82 169.24 14.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.445 2.298 . . . . 0.0 108.161 162.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.76 155.15 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.051 2.94 . . . . 0.0 106.031 167.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.5 mt -122.54 132.8 70.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -118.17 158.31 25.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.32 46.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 109.979 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -131.28 168.17 17.98 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.093 2.557 . . . . 0.0 105.833 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.6 t -144.12 -42.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.898 1.226 . . . . 0.0 113.676 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 115.95 -48.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.437 1 C-N-CA 133.234 4.614 . . . . 0.0 108.652 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -87.41 -36.68 17.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.533 0.733 . . . . 0.0 111.786 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.71 -62.17 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 123.591 0.757 . . . . 0.0 109.066 -159.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -160.26 98.81 1.3 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.5 -9.63 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.5 m -39.73 -39.6 0.8 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 129.122 2.969 . . . . 0.0 116.366 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.8 m95 61.34 140.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.16 1.384 . . . . 0.0 111.299 -138.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -134.11 152.9 52.04 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 134.21 50.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 165.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.0 -8.76 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.33 0.652 . . . . 0.0 111.616 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.94 138.46 17.71 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.158 1.783 . . . . 0.0 107.258 158.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -116.18 158.31 23.48 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m170 51.47 51.67 16.3 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.844 1.307 . . . . 0.0 112.218 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.87 110.69 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 127.112 2.165 . . . . 0.0 106.629 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -106.58 52.04 0.73 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.243 1.417 . . . . 0.0 108.203 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -158.39 -171.98 3.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.926 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.4 p -127.78 -3.75 5.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.967 1.307 . . . . 0.0 112.25 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -125.75 121.12 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.863 1.665 . . . . 0.0 107.476 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -145.35 117.51 8.37 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.445 0.64 . . . . 0.0 111.365 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -71.89 98.53 2.03 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.408 2.283 . . . . 0.0 108.802 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.6 143.69 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -136.77 172.69 12.64 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.538 1.535 . . . . 0.0 109.208 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.94 2.96 58.18 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.045 1.307 . . . . 0.0 113.055 170.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.8 mt -78.14 178.2 7.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 117.691 0.745 . . . . 0.0 109.607 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -96.67 146.74 31.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.203 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.64 158.79 46.88 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.376 2.717 . . . . 0.0 111.146 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.39 21.75 1.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.166 2.587 . . . . 0.0 112.876 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -119.28 121.37 39.48 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mm -59.27 147.44 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -138.51 152.83 48.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.582 162.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 103' ' ' MET . 36.4 mt -107.08 156.04 19.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.106 163.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -141.78 133.45 27.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.451 1.719 . . . . 0.0 107.843 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 15.5 mtt -112.34 156.09 23.04 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.526 2.331 . . . . 0.0 106.903 170.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.76 113.09 31.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 167.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.785 ' HD3' HD13 ' A' ' 97' ' ' LEU . 35.9 mtt180 -97.47 147.72 23.95 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.29 -1.506 . . . . 0.0 107.203 167.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 98' ' ' SER . . . -86.7 158.33 19.46 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.69 152.49 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 126.118 1.767 . . . . 0.0 107.323 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -139.97 172.71 5.94 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 127.186 2.195 . . . . 0.0 108.576 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 -19.15 27.72 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.807 2.338 . . . . 0.0 113.352 166.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -115.58 -11.13 11.77 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.63 -160.88 29.54 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.785 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.6 pp -113.09 162.7 15.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.892 1.277 . . . . 0.0 110.802 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 51.4 p -77.82 168.55 19.75 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.053 2.141 . . . . 0.0 112.953 -171.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.45 149.73 0.97 Allowed Pre-proline 0 C--O 1.242 0.699 0 O-C-N 121.18 -0.95 . . . . 0.0 110.029 155.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.36 129.46 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.842 2.361 . . . . 0.0 109.717 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 p -52.61 162.08 1.01 Allowed Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.53 1.532 . . . . 0.0 113.458 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -63.8 125.96 16.45 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 109.818 158.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.414 ' SD ' HD13 ' A' ' 86' ' ' LEU . 57.6 mtm -55.53 148.2 16.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.798 -0.564 . . . . 0.0 111.418 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 -8.14 47.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 3.7 t0 85.04 153.35 0.11 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 130.605 3.562 . . . . 0.0 110.107 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 105' ' ' ASP . 19.4 Cg_endo -70.01 105.46 1.53 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.228 1.952 . . . . 0.0 111.516 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 24' ' ' VAL . 1.9 m -103.06 142.74 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.366 1.067 . . . . 0.0 109.361 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.0 141.39 32.89 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 109.295 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.1 p -72.89 151.04 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.174 0.59 . . . . 0.0 110.623 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.12 -178.76 2.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 112.07 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 N--CA 1.461 0.108 0 O-C-N 121.449 -0.782 . . . . 0.0 112.868 -178.152 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt . . . . . 0 N--CA 1.463 0.221 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.08 156.71 53.29 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.195 2.597 . . . . 0.0 111.665 -168.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.61 152.09 48.24 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.64 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -67.64 141.16 54.02 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.264 1.976 . . . . 0.0 109.164 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.03 153.37 78.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.213 1.275 . . . . 0.0 109.189 162.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -74.03 177.87 5.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.678 0.791 . . . . 0.0 110.8 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -47.33 120.34 6.89 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 117.379 -1.296 . . . . 0.0 108.631 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.76 137.49 58.88 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -119.93 121.06 38.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.476 1.511 . . . . 0.0 108.822 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 149.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.202 173.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 p -129.35 -93.75 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.77 143.51 56.87 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.101 0.96 . . . . 0.0 109.615 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.91 141.8 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 p -128.21 -169.18 2.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.55 1.14 . . . . 0.0 108.541 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -61.61 -23.85 66.3 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 121.219 -0.926 . . . . 0.0 112.568 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -154.93 10.85 0.35 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.754 -1.216 . . . . 0.0 113.538 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -120.42 164.54 16.22 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.624 0.647 . . . . 0.0 110.833 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 p -153.48 134.26 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 165.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.1 m -88.53 114.45 25.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -93.72 138.49 31.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.844 1.658 . . . . 0.0 108.559 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -117.9 138.38 52.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.624 2.37 . . . . 0.0 107.189 170.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -139.8 170.92 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.734 0.414 . . . . 0.0 110.079 166.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 142.4 24.51 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.27 128.42 11.26 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.801 3.667 . . . . 0.0 109.546 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.52 167.96 54.63 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -85.49 154.95 59.67 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.769 1.228 . . . . 0.0 110.158 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.85 -158.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 125.193 3.928 . . . . 0.0 110.279 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.26 -112.7 0.46 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 44.1 p -58.74 -48.93 79.49 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.6 mt -140.82 148.09 51.12 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 125.068 1.347 . . . . 0.0 110.669 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 141.09 18.79 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.879 3.052 . . . . 0.0 110.14 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 109.34 1.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.604 1.561 . . . . 0.0 108.647 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' HG22 ' A' ' 92' ' ' ILE . 24.1 m -61.01 -62.46 1.84 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.377 2.271 . . . . 0.0 110.802 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.14 -166.72 2.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -121.73 163.77 18.52 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.201 1.4 . . . . 0.0 108.62 165.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.403 HD12 HD11 ' A' ' 92' ' ' ILE . 1.2 mt -115.9 162.73 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.391 2.276 . . . . 0.0 107.315 162.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.04 129.76 72.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 161.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.58 150.86 30.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 160.37 32.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 107.467 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -133.6 147.86 51.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.58 117.48 4.42 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -75.09 -26.63 59.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.483 -0.761 . . . . 0.0 111.983 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -81.06 17.07 1.31 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.29 1.036 . . . . 0.0 111.398 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -128.29 -71.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 m -151.53 1.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.5 50.78 16.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.378 1.444 . . . . 0.0 110.68 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -135.31 146.52 48.56 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.767 1.227 . . . . 0.0 108.38 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -72.88 108.86 6.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 161.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -100.0 134.65 42.61 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.652 1.981 . . . . 0.0 108.053 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -78.74 94.76 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.4 -15.81 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.609 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.7 150.11 30.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.017 1.28 . . . . 0.0 108.576 164.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -142.82 161.81 37.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.951 0.341 . . . . 0.0 111.208 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 47.35 55.11 8.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.754 1.222 . . . . 0.0 111.332 -171.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -91.92 129.63 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 29.83 7.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.723 0.809 . . . . 0.0 111.848 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -136.76 174.27 10.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.022 1.329 . . . . 0.0 107.505 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.5 p -120.28 0.0 10.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.871 1.668 . . . . 0.0 111.687 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.18 104.35 5.87 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.27 150.93 50.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.952 1.301 . . . . 0.0 109.718 -169.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.5 m -103.51 106.02 16.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -62.54 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -139.72 176.04 9.07 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.27 1.028 . . . . 0.0 112.269 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.95 84.43 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 124.81 1.195 . . . . 0.0 112.616 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -74.67 179.43 4.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.296 1.046 . . . . 0.0 109.768 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -104.12 138.05 19.41 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.039 -1.458 . . . . 0.0 108.241 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.19 147.17 59.49 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.523 2.149 . . . . 0.0 112.112 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.9 t30 44.94 42.02 5.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.53 2.332 . . . . 0.0 112.526 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.1 m -129.38 136.61 50.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 127.091 2.156 . . . . 0.0 106.524 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.0 mm -72.44 145.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.966 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -140.62 155.27 46.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.343 1.457 . . . . 0.0 109.388 168.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.3 mt -108.24 166.18 10.94 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 126.229 1.811 . . . . 0.0 108.912 162.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.36 136.91 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 125.092 1.495 . . . . 0.0 111.257 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.9 mtt -105.38 151.37 24.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 160.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.21 149.58 6.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 154.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.498 ' HD3' HD13 ' A' ' 97' ' ' LEU . 73.3 mtt180 -125.11 139.58 53.64 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.29 151.03 23.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 165.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 47' ' ' SER . 2.0 mt -125.07 152.12 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.87 1.668 . . . . 0.0 108.628 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -151.69 -176.84 0.62 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.608 1.563 . . . . 0.0 109.186 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.29 -14.08 27.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.227 . . . . 0.0 115.577 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -116.41 -14.04 10.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.031 1.332 . . . . 0.0 112.402 -164.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.04 -143.8 10.17 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.498 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.0 pp -140.02 160.98 38.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.33 1.852 . . . . 0.0 110.061 -175.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 97.3 p -72.21 168.06 19.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 126.908 2.083 . . . . 0.0 114.463 -166.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -32.25 145.45 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 123.56 0.744 . . . . 0.0 109.914 145.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.35 132.48 31.56 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.175 1.917 . . . . 0.0 109.095 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 p -61.4 154.58 62.97 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.554 163.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.04 142.22 91.76 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.899 2.399 . . . . 0.0 110.303 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.6 mmt -53.12 131.92 37.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -17.01 16.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.961 1.704 . . . . 0.0 112.187 170.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t0 70.44 161.68 0.15 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.733 2.013 . . . . 0.0 109.265 -158.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -74.75 121.68 6.83 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.974 2.449 . . . . 0.0 111.072 -175.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.57 158.43 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.011 0.925 . . . . 0.0 108.997 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.48 137.22 43.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.102 1.361 . . . . 0.0 108.369 163.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.9 p -66.04 164.79 14.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.781 0.8 . . . . 0.0 109.53 158.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -80.79 173.5 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.403 1.097 . . . . 0.0 109.749 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.59 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.5 169.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.3 mt . . . . . 0 CA--C 1.543 0.694 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -63.07 166.46 14.39 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.378 3.385 . . . . 0.0 113.144 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 147.08 50.41 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.793 -1.004 . . . . 0.0 110.607 165.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.3 157.63 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.918 2.412 . . . . 0.0 112.047 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.78 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.346 2.031 . . . . 0.0 110.877 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.3 m -74.58 166.75 23.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.634 0.774 . . . . 0.0 110.933 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.39 127.04 16.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 116.78 -1.581 . . . . 0.0 109.576 168.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.62 159.25 22.06 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.75 2.3 . . . . 0.0 114.306 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -107.5 129.41 54.96 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 128.778 2.831 . . . . 0.0 107.849 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.59 153.78 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 p -132.04 -90.27 0.42 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.74 120.29 25.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.318 -172.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -120.32 147.95 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 119.738 1.154 . . . . 0.0 110.789 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.4 p -141.3 -167.2 2.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.684 1.594 . . . . 0.0 107.731 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -65.04 -33.59 76.41 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -149.2 17.32 0.95 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.667 -1.27 . . . . 0.0 112.763 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -136.64 150.43 48.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.98 132.68 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.804 1.241 . . . . 0.0 109.413 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.2 m -79.4 139.61 37.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.045 0.938 . . . . 0.0 109.412 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.38 144.19 45.2 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.46 2.304 . . . . 0.0 107.227 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.64 131.94 40.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.133 2.573 . . . . 0.0 106.506 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -139.26 172.07 13.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.274 1.03 . . . . 0.0 109.315 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.18 141.94 24.52 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.74 162.66 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.334 2.689 . . . . 0.0 111.094 -168.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 169.06 36.1 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 122.468 1.038 . . . . 0.0 110.952 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -65.3 147.16 98.78 Favored Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 126.99 2.116 . . . . 0.0 111.135 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.37 174.69 9.65 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 125.206 3.937 . . . . 0.0 113.911 166.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.93 -118.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.706 1.146 . . . . 0.0 110.314 -174.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.6 p -69.15 -37.51 78.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.151 1.78 . . . . 0.0 112.752 -162.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 mt -138.38 158.27 70.96 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 123.04 0.536 . . . . 0.0 111.216 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.13 165.46 32.35 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.298 2.665 . . . . 0.0 109.915 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.18 121.1 44.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.74 -33.04 25.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.331 0.652 . . . . 0.0 111.995 -162.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' H ' HG22 ' A' ' 92' ' ' ILE . . . -166.47 -167.77 1.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.867 1.667 . . . . 0.0 106.561 167.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -118.08 166.19 12.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.42 154.56 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.013 2.525 . . . . 0.0 106.305 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 135.82 61.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -117.99 154.84 31.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.445 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -141.91 163.17 33.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.91 1.284 . . . . 0.0 109.034 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -140.16 145.54 37.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.05 1.74 . . . . 0.0 107.139 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.628 ' HB3' HG22 ' A' ' 58' ' ' VAL . 4.9 t -134.3 166.23 23.3 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 155.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -99.64 14.41 30.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.679 1.192 . . . . 0.0 111.957 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 t -139.26 21.52 2.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.302 1.841 . . . . 0.0 110.982 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.808 HG23 ' H ' ' A' ' 59' ' ' SER . 15.5 m -121.89 -85.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.764 1.226 . . . . 0.0 108.044 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.808 ' H ' HG23 ' A' ' 58' ' ' VAL . 28.7 m -139.19 8.66 2.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.795 2.038 . . . . 0.0 110.39 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 54.33 22.97 4.04 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.27 2.228 . . . . 0.0 113.683 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.7 m -116.35 159.32 22.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.943 0.897 . . . . 0.0 110.943 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -73.63 138.88 45.09 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 157.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.62 139.39 36.71 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 m -63.21 95.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.588 1.155 . . . . 0.0 108.277 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 53' ' ' ALA . 18.6 m -87.22 -17.54 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.124 -0.985 . . . . 0.0 112.016 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.81 131.79 22.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 165.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -117.67 152.83 34.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 43.8 67.83 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.608 1.563 . . . . 0.0 112.491 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -98.64 118.54 45.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.596 1.158 . . . . 0.0 108.455 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.65 50.79 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.89 175.47 13.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.458 1.903 . . . . 0.0 107.388 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -125.39 12.42 8.14 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.003 1.721 . . . . 0.0 113.12 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mp -129.43 140.95 51.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 109.564 147.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -145.2 151.65 38.76 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.58 1.152 . . . . 0.0 108.419 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -109.94 108.79 19.18 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.868 1.667 . . . . 0.0 108.767 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -60.11 140.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 165.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -130.44 -177.63 4.42 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.428 1.091 . . . . 0.0 108.874 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.15 37.76 41.82 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 mt -108.0 -178.68 3.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 110.393 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -103.58 139.32 19.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 125.491 1.516 . . . . 0.0 109.391 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.75 159.33 42.34 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.049 2.499 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 55.28 15.51 1.36 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.481 1.912 . . . . 0.0 112.903 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -119.76 139.41 52.34 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.813 1.645 . . . . 0.0 110.149 -164.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.41 148.67 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.694 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -142.09 162.24 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.921 0.888 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.548 HD13 ' SD ' ' A' ' 103' ' ' MET . 21.2 mt -124.86 162.81 23.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 125.841 1.656 . . . . 0.0 108.929 165.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -138.57 155.74 48.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 125.476 1.735 . . . . 0.0 110.968 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 6.8 mtt -129.22 167.07 18.19 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 126.525 1.93 . . . . 0.0 106.972 160.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.0 t -132.06 146.34 33.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 168.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.546 ' HD3' HD13 ' A' ' 97' ' ' LEU . 82.5 mtt180 -136.38 134.02 37.38 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.219 1.407 . . . . 0.0 107.244 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 126.21 34.72 Favored 'General case' 0 C--O 1.228 -0.076 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -86.59 152.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.773 0.829 . . . . 0.0 108.971 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.62 168.9 10.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.506 0.722 . . . . 0.0 109.83 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -72.38 19.61 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.153 2.569 . . . . 0.0 113.845 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -121.13 -65.35 1.15 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.513 1.525 . . . . 0.0 107.531 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.81 -127.44 1.89 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.397 1.475 . . . . 0.0 110.969 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.546 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -139.23 145.74 39.61 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.525 2.33 . . . . 0.0 107.443 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.0 p -72.58 165.99 23.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.277 1.031 . . . . 0.0 109.869 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -54.85 142.95 53.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.565 -0.71 . . . . 0.0 109.188 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.99 133.15 42.8 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.435 1.423 . . . . 0.0 108.992 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.4 p -54.69 156.02 6.98 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.373 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -47.63 143.79 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.1 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.548 ' SD ' HD13 ' A' ' 86' ' ' LEU . 35.2 mtm -57.9 146.93 30.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.724 0.773 . . . . 0.0 110.299 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -65.26 0.2 1.5 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.062 -1.923 . . . . 0.0 115.81 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.2 t70 68.74 153.69 0.14 Allowed Pre-proline 0 N--CA 1.476 0.834 0 CA-C-N 121.147 1.794 . . . . 0.0 108.398 -154.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -67.47 113.26 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.006 2.471 . . . . 0.0 109.648 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.36 165.09 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -124.06 142.59 51.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 166.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 p -72.98 160.69 31.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.081 0.552 . . . . 0.0 110.745 165.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -79.14 -178.44 6.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.934 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.1 t70 . . . . . 0 CA--C 1.543 0.707 0 C-N-CA 125.285 1.434 . . . . 0.0 111.394 175.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.34 147.87 60.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.653 2.235 . . . . 0.0 109.169 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 155.41 50.23 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.13 140.97 81.08 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.43 2.086 . . . . 0.0 108.179 171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.09 172.06 7.96 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.287 1.991 . . . . 0.0 111.037 170.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -66.29 170.57 5.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.95 0.9 . . . . 0.0 110.1 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -49.76 124.81 16.45 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-O 117.593 -1.194 . . . . 0.0 107.796 160.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.06 136.0 46.25 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 CA-C-N 120.205 1.109 . . . . 0.0 109.352 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -78.77 164.55 24.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.176 1.465 . . . . 0.0 107.095 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 t -124.4 112.45 32.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.14 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -109.45 -82.5 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -167.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.07 134.47 47.08 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.245 1.418 . . . . 0.0 108.267 171.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -140.03 135.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.812 1.187 . . . . 0.0 108.545 163.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.0 p -110.68 -74.1 0.66 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -168.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.1 pttp -163.93 -26.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 129.641 3.177 . . . . 0.0 110.036 163.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -140.41 9.33 2.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.839 1.256 . . . . 0.0 112.287 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -126.99 160.66 30.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.851 0.75 . . . . 0.0 110.452 162.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -151.65 133.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.624 1.57 . . . . 0.0 106.946 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -79.98 132.64 36.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.7 142.08 35.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.291 1.437 . . . . 0.0 108.16 167.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.524 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -140.19 111.46 7.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.802 1.314 . . . . 0.0 108.466 -173.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.483 ' CH2' HD11 ' A' ' 51' ' ' ILE . 42.8 p90 -129.22 171.35 12.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.901 0.773 . . . . 0.0 109.56 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -124.84 145.48 50.02 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -74.72 144.07 30.86 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.461 2.774 . . . . 0.0 109.573 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.31 -175.78 49.73 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m -57.67 133.39 82.57 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 123.503 0.721 . . . . 0.0 111.506 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.02 -171.67 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.627 2.885 . . . . 0.0 113.417 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.68 -125.14 0.8 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 156.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -66.8 -23.03 66.01 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 128.992 2.917 . . . . 0.0 113.242 -160.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.473 ' CB ' HD21 ' A' ' 93' ' ' ASN . 18.3 mt -131.75 172.08 7.98 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.971 2.108 . . . . 0.0 109.356 172.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 41.9 Cg_endo -76.38 -136.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.582 3.521 . . . . 0.0 107.774 163.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.61 120.15 5.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -35.71 78.59 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.345 1.058 . . . . 0.0 112.483 -170.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.3 -167.86 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.227 1.011 . . . . 0.0 108.707 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -123.36 169.22 11.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.404 2.282 . . . . 0.0 108.273 164.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -127.27 156.02 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 130.734 3.613 . . . . 0.0 105.721 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.483 HD11 ' CH2' ' A' ' 36' ' ' TRP . 24.3 mt -128.63 136.71 59.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 164.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.69 153.36 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 108.175 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.14 128.76 22.98 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.767 1.227 . . . . 0.0 109.461 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.64 151.3 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.787 1.635 . . . . 0.0 107.197 171.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.28 105.87 1.0 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.106 -0.372 . . . . 0.0 110.359 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.94 -31.36 72.43 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -171.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 m -105.36 49.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.081 1.352 . . . . 0.0 110.218 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG22 ' HD2' ' A' ' 80' ' ' ARG . 92.2 t -134.85 -88.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 160.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.67 3.85 7.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.387 1.875 . . . . 0.0 110.401 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.49 -71.64 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.796 2.038 . . . . 0.0 109.758 -170.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -36.74 148.89 0.02 OUTLIER 'General case' 0 C--O 1.238 0.474 0 C-N-CA 130.437 3.495 . . . . 0.0 115.418 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -65.44 134.76 54.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.329 1.452 . . . . 0.0 108.079 171.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -129.9 130.2 44.86 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.25 94.86 0.17 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.07 -13.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.358 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.86 26.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.296 0.953 . . . . 0.0 109.475 162.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.46 26.11 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.4 m170 40.98 63.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.683 1.993 . . . . 0.0 111.915 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.25 138.26 24.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 C-N-CA 128.073 2.549 . . . . 0.0 108.115 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 29.15 5.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.869 0.867 . . . . 0.0 111.695 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.74 152.95 44.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.8 p -88.28 2.97 51.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.291 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -136.32 121.62 19.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.635 2.374 . . . . 0.0 107.693 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -146.39 139.23 25.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.427 1.012 . . . . 0.0 112.271 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -81.0 99.68 8.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.827 2.051 . . . . 0.0 108.492 170.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.0 143.58 15.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -131.69 178.14 6.98 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.247 1.419 . . . . 0.0 110.374 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 23.48 68.93 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.27 -159.32 0.73 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.408 ' HD2' HG22 ' A' ' 58' ' ' VAL . 58.1 mtt-85 -134.98 140.85 36.23 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-O 117.753 -1.118 . . . . 0.0 109.437 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.17 158.91 51.08 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.935 2.423 . . . . 0.0 110.588 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.04 45.44 3.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.967 2.107 . . . . 0.0 112.294 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -136.22 128.14 29.39 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 125.845 1.658 . . . . 0.0 107.889 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mm -65.17 145.61 13.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -134.57 158.29 44.37 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.626 1.571 . . . . 0.0 108.085 159.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mt -107.26 162.22 14.08 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 154.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.47 148.54 49.27 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.9 mtm -130.86 167.97 18.05 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 158.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.34 154.4 16.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.562 ' HD3' HD22 ' A' ' 97' ' ' LEU . 9.8 mtt180 -132.26 141.47 49.02 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.03 153.78 22.51 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.19 150.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.612 1.565 . . . . 0.0 107.44 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.473 HD21 ' CB ' ' A' ' 44' ' ' LEU . 17.4 t30 -163.36 160.2 18.13 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.52 10.67 2.42 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.177 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -120.56 15.21 11.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.563 2.345 . . . . 0.0 110.23 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.99 176.47 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 124.896 1.236 . . . . 0.0 110.778 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.562 HD22 ' HD3' ' A' ' 90' ' ' ARG . 2.0 mp -81.91 165.6 20.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.1 p -72.47 167.13 21.23 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.155 0.979 . . . . 0.0 110.144 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.52 150.11 0.55 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 152.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.36 149.65 80.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.198 1.932 . . . . 0.0 109.147 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -63.16 164.19 14.78 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 163.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.34 151.13 18.47 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.169 1.246 . . . . 0.0 109.519 154.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 40.9 mtm -68.31 151.28 47.14 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.988 -0.445 . . . . 0.0 110.528 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.5 p -60.5 -7.64 2.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.427 2.291 . . . . 0.0 115.24 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.23 157.24 0.15 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.228 2.211 . . . . 0.0 111.068 -158.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.01 100.88 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.159 2.573 . . . . 0.0 110.112 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.82 129.66 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.601 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -79.45 158.16 27.36 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 p -91.13 168.85 11.32 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.452 1.12 . . . . 0.0 109.903 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -71.64 177.05 4.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.903 1.811 . . . . 0.0 111.116 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 t70 . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 110.53 -3.032 . . . . 0.0 108.878 166.915 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.8 mt . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.87 158.19 34.74 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.167 2.578 . . . . 0.0 112.041 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.33 151.46 50.22 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 167.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.446 2.097 . . . . 0.0 111.528 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -63.21 168.25 11.28 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.147 1.231 . . . . 0.0 110.491 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -88.19 163.39 16.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 10.9 tmtt? -57.39 125.49 71.71 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 117.092 -1.432 . . . . 0.0 109.467 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.88 157.9 56.71 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.293 1.328 . . . . 0.0 111.842 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -135.06 118.39 16.71 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 127.396 2.279 . . . . 0.0 105.988 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -63.16 161.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 114.394 -1.276 . . . . 0.0 109.429 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -140.75 -79.91 0.27 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.442 1.097 . . . . 0.0 109.082 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -79.69 143.01 34.98 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 108.335 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.01 146.51 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 160.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.3 p -118.04 -62.47 1.54 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 pttt 172.4 -34.98 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 130.647 3.579 . . . . 0.0 108.196 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.49 5.82 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.731 1.212 . . . . 0.0 111.018 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -132.75 155.34 49.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.44 134.64 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.261 1.424 . . . . 0.0 107.859 175.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.0 m -95.89 128.52 42.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.114 0.966 . . . . 0.0 109.22 178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.32 122.59 47.86 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.002 2.121 . . . . 0.0 107.381 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -92.42 147.83 22.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 159.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.49 ' CH2' HD11 ' A' ' 51' ' ' ILE . 44.1 p90 -139.85 172.15 13.19 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 124.821 1.248 . . . . 0.0 107.92 156.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -109.06 144.11 29.01 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.21 158.36 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.839 3.026 . . . . 0.0 112.141 -168.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.97 -176.21 39.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.915 0.769 . . . . 0.0 112.008 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.47 154.85 87.79 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.298 1.439 . . . . 0.0 111.326 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.41 -101.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 125.667 4.245 . . . . 0.0 109.631 161.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.34 -92.67 0.69 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 128.194 2.807 . . . . 0.0 108.769 161.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -55.66 28.91 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.292 2.237 . . . . 0.0 109.963 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -134.29 160.4 68.63 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.068 1.347 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -75.28 154.17 40.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.237 3.291 . . . . 0.0 108.981 172.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.2 161.82 21.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.489 1.137 . . . . 0.0 110.359 170.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.439 ' HB2' HG22 ' A' ' 92' ' ' ILE . 3.2 m -119.58 -43.87 2.57 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.76 2.424 . . . . 0.0 109.237 -175.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.07 -164.83 0.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.33 1.452 . . . . 0.0 107.725 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.92 161.03 30.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.372 2.269 . . . . 0.0 108.362 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.0 mt -126.98 156.2 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.872 2.469 . . . . 0.0 106.471 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.49 HD11 ' CH2' ' A' ' 36' ' ' TRP . 70.7 mt -122.66 136.27 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 160.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -109.73 153.05 24.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 166.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.09 155.84 48.37 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.977 1.311 . . . . 0.0 107.686 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -133.05 153.69 51.26 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.485 1.514 . . . . 0.0 107.258 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.6 t -153.37 133.47 13.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.36 -18.37 63.06 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -103.1 1.79 33.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.162 1.385 . . . . 0.0 113.127 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -94.21 -79.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.1 m -128.78 -6.14 5.1 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.133 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t30 55.46 47.55 20.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.582 1.083 . . . . 0.0 109.0 -169.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.1 m -142.61 139.37 31.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.53 2.332 . . . . 0.0 107.932 -172.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -77.47 129.61 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 162.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -126.55 152.54 46.42 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.538 1.135 . . . . 0.0 108.215 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 135.23 47.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.73 0.08 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.326 1.451 . . . . 0.0 112.317 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.565 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . . . -151.68 139.53 19.92 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 164.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -142.93 143.69 32.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.102 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 37.37 63.15 0.77 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.508 1.523 . . . . 0.0 111.36 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -86.38 133.84 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -118.5 45.95 1.92 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.061 0.945 . . . . 0.0 109.754 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 t -157.88 -174.58 4.91 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.65 1.58 . . . . 0.0 107.543 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 p -124.95 3.26 8.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.051 2.141 . . . . 0.0 111.454 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.8 131.46 53.77 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 165.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 56.4 t80 -145.96 151.06 37.2 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.563 1.145 . . . . 0.0 109.267 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.3 m -109.84 102.31 11.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.058 1.743 . . . . 0.0 107.357 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.83 141.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -133.85 -177.59 4.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.032 1.733 . . . . 0.0 108.24 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.09 78.95 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 123.157 0.408 . . . . 0.0 112.876 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.83 -171.8 3.15 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.008 0.923 . . . . 0.0 108.837 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -116.39 143.19 30.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 125.107 1.363 . . . . 0.0 109.092 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -74.56 157.75 44.36 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.248 2.632 . . . . 0.0 111.885 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.1 t30 46.64 34.27 2.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.348 1.859 . . . . 0.0 112.023 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 m -125.02 130.33 52.11 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mm -74.71 151.29 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -131.91 169.1 16.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.11 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.425 HD13 ' SD ' ' A' ' 103' ' ' MET . 14.6 mt -119.74 156.25 30.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 152.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -131.01 146.44 52.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.119 1.768 . . . . 0.0 106.742 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.73 117.92 9.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.863 1.665 . . . . 0.0 107.012 -177.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.24 112.76 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -97.85 135.56 39.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 163.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.71 166.74 15.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 165.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.6 OUTLIER -127.73 151.56 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.74 1.616 . . . . 0.0 108.168 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -145.04 178.43 1.44 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.067 1.747 . . . . 0.0 108.447 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.63 -10.04 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.865 2.377 . . . . 0.0 115.848 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -113.13 -32.79 6.21 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.411 1.46 . . . . 0.0 112.935 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.4 -156.58 17.89 Favored Glycine 0 C--O 1.238 0.397 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mp -103.93 149.51 25.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.776 1.23 . . . . 0.0 110.056 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.9 p -72.16 166.27 22.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.772 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.37 146.62 0.34 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 126.446 1.899 . . . . 0.0 112.157 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.43 104.96 0.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.63 2.22 . . . . 0.0 109.051 166.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -48.82 166.89 0.22 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.002 2.521 . . . . 0.0 113.907 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.59 135.67 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.252 1.968 . . . . 0.0 110.044 155.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.425 ' SD ' HD13 ' A' ' 86' ' ' LEU . 45.5 mtt -63.69 163.4 11.52 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.9 0.773 . . . . 0.0 110.234 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.482 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 85.6 p -65.7 -1.75 3.03 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.57 155.08 0.11 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.726 1.611 . . . . 0.0 110.925 -159.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -69.98 98.74 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.48 2.12 . . . . 0.0 111.65 -168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 m -99.26 142.55 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.89 0.876 . . . . 0.0 110.597 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -93.11 147.99 22.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 122.96 0.504 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.7 p -79.32 152.03 30.71 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 158.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.87 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.611 1.964 . . . . 0.0 111.654 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.3 t0 . . . . . 0 C--N 1.331 -0.231 0 C-N-CA 127.335 2.254 . . . . 0.0 106.396 -177.249 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 119.423 -0.322 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.68 165.0 19.38 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.685 3.59 . . . . 0.0 110.829 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.92 159.38 41.75 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 170.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.2 152.86 78.94 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.061 2.508 . . . . 0.0 111.324 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.16 156.4 55.54 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.33 2.02 . . . . 0.0 110.493 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 m -79.02 176.99 9.15 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.845 -0.534 . . . . 0.0 109.724 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 28.5 tttt -55.51 120.3 30.57 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-O 117.945 -1.026 . . . . 0.0 108.679 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.48 141.42 95.41 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 CA-C-N 120.257 1.128 . . . . 0.0 109.391 167.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -79.74 171.61 14.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 161.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.656 HG21 HG11 ' A' ' 107' ' ' VAL . 46.2 t -117.84 137.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 162.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.257 68.7 p -117.18 -98.42 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -72.42 142.81 48.67 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 109.08 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.79 -177.67 3.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 pttt -74.71 -16.67 60.74 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.259 -0.901 . . . . 0.0 112.12 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -136.39 2.72 2.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.686 1.13 . . . . 0.0 111.718 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.4 p -153.33 166.83 31.39 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.43 -1.418 . . . . 0.0 110.19 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.63 145.83 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.427 1.091 . . . . 0.0 108.57 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -105.64 124.36 49.43 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.539 1.535 . . . . 0.0 107.315 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.82 132.01 53.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.725 2.01 . . . . 0.0 110.828 -171.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.8 108.68 11.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.321 1.848 . . . . 0.0 106.621 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -109.86 173.11 6.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.13 148.87 42.41 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.51 134.74 12.65 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.533 3.488 . . . . 0.0 110.915 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.47 30.87 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-O 122.756 1.198 . . . . 0.0 111.165 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -61.18 154.06 63.94 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.66 1.984 . . . . 0.0 111.148 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.73 -174.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 125.042 3.828 . . . . 0.0 114.702 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.03 -154.89 7.83 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -47.72 23.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 160.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.506 HD13 ' HG2' ' A' ' 94' ' ' PRO . 11.3 mt -103.62 144.01 27.8 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.56 0.618 . . . . 0.0 110.487 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -81.36 151.75 17.78 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.371 2.714 . . . . 0.0 110.652 -165.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.71 122.42 5.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.762 1.225 . . . . 0.0 111.526 168.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.592 ' HB2' HG22 ' A' ' 92' ' ' ILE . 33.8 m -76.94 -61.82 1.85 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.578 1.951 . . . . 0.0 108.434 162.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -158.99 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 110.115 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -132.61 168.65 17.88 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.637 1.975 . . . . 0.0 109.219 165.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.76 159.67 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 128.745 2.818 . . . . 0.0 106.907 168.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.1 mt -130.22 129.79 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.91 166.03 11.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.934 0.894 . . . . 0.0 109.181 163.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.45 147.28 34.32 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.079 1.752 . . . . 0.0 108.205 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -127.89 119.78 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 44.6 t -73.59 -72.01 0.29 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.141 1.337 . . . . 0.0 110.082 166.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 142.73 -58.88 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 131.699 4.0 . . . . 0.0 106.096 -156.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 t -121.18 39.75 3.74 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.485 1.493 . . . . 0.0 109.363 -155.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.718 HG23 ' H ' ' A' ' 59' ' ' SER 0.272 25.1 m -120.41 -84.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -167.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.718 ' H ' HG23 ' A' ' 58' ' ' VAL . 8.3 m -129.96 16.83 5.69 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.441 1.096 . . . . 0.0 112.51 168.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 47.1 51.73 12.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.952 1.701 . . . . 0.0 111.161 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -153.26 153.33 32.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.06 1.744 . . . . 0.0 108.155 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.91 137.19 58.22 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 155.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -134.42 146.62 50.01 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.72 123.42 26.66 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.32 -3.02 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.537 1.135 . . . . 0.0 111.611 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.45 140.05 19.77 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 158.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.38 129.04 30.67 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -172.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 63.41 56.33 1.67 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.033 1.733 . . . . 0.0 112.094 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 134.31 27.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.474 1.51 . . . . 0.0 107.977 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . 32.9 mtpt -122.89 51.84 1.39 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.974 2.109 . . . . 0.0 109.108 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 t -150.45 -178.69 6.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.643 1.577 . . . . 0.0 107.22 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.6 p -118.52 2.12 11.76 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.171 1.789 . . . . 0.0 111.213 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -137.55 103.66 5.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -128.52 137.29 51.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -86.13 105.2 16.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.98 140.47 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -129.13 178.5 6.37 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.259 1.424 . . . . 0.0 110.89 -173.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.24 13.62 67.64 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 124.748 1.166 . . . . 0.0 114.304 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.02 164.81 25.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.68 1.229 . . . . 0.0 110.31 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -93.29 146.03 31.14 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.219 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.66 157.48 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.95 2.433 . . . . 0.0 110.581 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 53.23 14.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.782 1.633 . . . . 0.0 113.542 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -109.29 132.12 54.42 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 120.208 1.367 . . . . 0.0 108.744 -170.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -61.96 145.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 85.3 m-85 -140.42 150.77 44.28 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.927 1.346 . . . . 0.0 108.369 163.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.8 mt -110.36 162.28 14.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 111.675 -2.511 . . . . 0.0 107.926 159.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -142.21 126.31 17.39 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.48 1.912 . . . . 0.0 108.769 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.1 mtm -104.99 154.82 19.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 163.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.97 134.72 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.871 ' HD3' HD13 ' A' ' 97' ' ' LEU . 49.0 mtt180 -118.72 147.55 43.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 167.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.9 158.84 20.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.592 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.5 OUTLIER -125.52 143.98 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.417 ' HA ' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -138.02 172.82 6.12 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 126.0 1.72 . . . . 0.0 107.288 173.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.506 ' HG2' HD13 ' A' ' 44' ' ' LEU . 44.8 Cg_endo -81.97 28.12 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.553 2.168 . . . . 0.0 112.382 -172.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -132.78 -42.45 0.91 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 127.134 2.174 . . . . 0.0 110.46 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.27 -177.36 44.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 122.336 0.965 . . . . 0.0 112.959 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.871 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.5 pp -92.42 165.47 13.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.433 1.493 . . . . 0.0 111.052 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.55 ' O ' HD12 ' A' ' 97' ' ' LEU . 18.9 p -87.18 167.16 14.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -174.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.1 150.72 1.02 Allowed Pre-proline 0 C--O 1.237 0.424 0 O-C-N 121.524 -0.735 . . . . 0.0 109.205 152.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.55 154.89 72.3 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 120.863 1.042 . . . . 0.0 110.444 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 p -53.25 151.36 9.77 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 123.463 0.705 . . . . 0.0 111.043 160.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -53.54 140.94 64.21 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.77 1.647 . . . . 0.0 109.841 154.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 mmt -57.66 129.44 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.027 0.531 . . . . 0.0 111.715 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.645 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.87 -16.41 50.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.534 1.534 . . . . 0.0 112.255 169.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t0 85.87 153.38 0.1 Allowed Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 129.457 3.103 . . . . 0.0 110.824 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.09 97.08 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.901 2.401 . . . . 0.0 112.185 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.656 HG11 HG21 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -85.73 156.3 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 124.66 1.184 . . . . 0.0 109.481 176.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -106.08 165.33 11.3 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.969 1.308 . . . . 0.0 109.038 172.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -102.03 163.76 12.07 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.283 1.433 . . . . 0.0 109.248 169.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -74.05 174.56 8.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.947 0.88 . . . . 0.0 111.669 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.208 0 C-N-CA 127.102 2.161 . . . . 0.0 109.73 170.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -66.93 147.11 79.82 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.345 2.03 . . . . 0.0 111.519 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.08 142.01 28.55 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.422 1.487 . . . . 0.0 110.363 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.3 148.85 85.11 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.706 2.27 . . . . 0.0 110.231 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -64.61 160.7 38.74 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.819 1.679 . . . . 0.0 110.867 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -67.16 168.32 10.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.86 0.864 . . . . 0.0 109.788 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -57.02 124.64 66.56 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.013 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.18 135.81 32.84 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.535 1.584 . . . . 0.0 110.535 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -80.36 168.61 18.81 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 125.103 1.361 . . . . 0.0 109.778 166.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.5 95.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 112.056 -2.338 . . . . 0.0 106.169 171.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.3 p -93.58 -89.33 0.21 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 126.29 28.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.566 1.146 . . . . 0.0 110.542 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.49 159.1 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.714 1.206 . . . . 0.0 108.079 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 p -137.95 -56.52 0.67 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt 170.85 -31.44 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 1 C-N-CA 132.082 4.153 . . . . 0.0 108.969 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.25 2.26 2.06 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.528 1.531 . . . . 0.0 112.12 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 p -132.4 154.56 49.69 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.093 0.86 . . . . 0.0 109.919 165.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 p -147.63 141.92 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.49 143.41 26.84 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.5 mt -112.66 138.35 49.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.352 1.461 . . . . 0.0 107.81 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.89 120.51 30.63 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -136.63 170.55 15.88 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.272 1.397 . . . . 0.0 107.63 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -115.64 149.61 43.33 Favored Pre-proline 0 C--O 1.237 0.443 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.51 153.29 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.358 2.039 . . . . 0.0 110.126 -165.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.87 176.44 54.02 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-O 122.642 1.135 . . . . 0.0 111.633 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.9 m -62.01 149.5 85.94 Favored Pre-proline 0 N--CA 1.435 -1.217 0 C-N-CA 126.355 1.862 . . . . 0.0 108.667 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -69.55 178.68 4.2 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 CA-C-O 123.77 1.488 . . . . 0.0 113.049 170.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.57 -160.79 9.24 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 130.686 3.993 . . . . 0.0 103.401 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -43.66 72.97 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.805 0.842 . . . . 0.0 111.52 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.46 154.52 37.52 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 118.793 0.724 . . . . 0.0 111.478 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.84 151.54 31.56 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.943 3.095 . . . . 0.0 110.316 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.27 104.27 9.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.426 ' H ' ' HA ' ' A' ' 93' ' ' ASN . 3.0 m -52.43 -52.8 52.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.251 2.221 . . . . 0.0 112.929 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.81 -163.81 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.509 1.924 . . . . 0.0 107.201 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -127.23 157.96 38.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.82 1.248 . . . . 0.0 110.08 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -107.1 154.12 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.661 1.984 . . . . 0.0 107.217 164.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.45 119.73 46.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -100.91 155.85 17.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.66 156.37 48.95 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 126.192 1.797 . . . . 0.0 106.306 169.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -132.83 156.14 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.03 124.41 5.29 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -21.67 65.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.776 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 t -94.65 -3.49 49.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.18 0.992 . . . . 0.0 111.697 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 t -111.28 -68.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 125.235 1.414 . . . . 0.0 108.367 -161.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 m -142.95 -5.25 0.89 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 111.611 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 t30 54.36 32.03 15.63 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -133.95 153.16 51.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.568 1.547 . . . . 0.0 108.27 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -71.29 141.74 50.5 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 159.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -135.11 132.76 38.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 175.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -71.87 94.18 1.4 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.97 -25.63 14.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.781 0.832 . . . . 0.0 110.902 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.75 46.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 163.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -133.96 143.96 48.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.452 1.501 . . . . 0.0 107.597 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 47.26 64.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.068 1.347 . . . . 0.0 111.595 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.3 133.5 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -117.89 56.65 0.85 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.853 1.261 . . . . 0.0 108.271 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 t -161.35 176.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.4 p -110.46 0.0 17.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 111.465 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -142.99 101.57 3.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.581 1.152 . . . . 0.0 108.944 -169.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -134.18 124.29 25.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.612 0.765 . . . . 0.0 112.838 -164.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.0 m -70.82 98.37 1.55 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.764 2.426 . . . . 0.0 110.805 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.83 146.99 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 120.646 -1.284 . . . . 0.0 108.167 163.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -140.81 -178.19 5.43 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.861 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.25 49.66 60.45 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt -115.26 -160.5 0.74 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.822 1.249 . . . . 0.0 108.905 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -131.08 139.57 35.95 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.541 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.79 160.21 50.14 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.312 2.674 . . . . 0.0 111.601 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.1 m120 47.95 21.93 0.34 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.207 1.803 . . . . 0.0 113.844 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -121.03 121.44 37.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.83 1.652 . . . . 0.0 106.789 -170.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 mm -58.78 146.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -136.07 159.91 40.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 162.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.4 HD13 ' SD ' ' A' ' 103' ' ' MET . 15.0 mt -112.2 162.57 15.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 125.758 1.623 . . . . 0.0 107.782 158.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -142.57 143.42 32.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.439 1.712 . . . . 0.0 107.727 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 mtm -138.46 149.04 45.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.13 150.31 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -129.02 148.46 50.97 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 167.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.25 152.42 22.32 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 163.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.34 151.03 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.426 ' HA ' ' H ' ' A' ' 47' ' ' SER . 1.0 OUTLIER -146.61 174.99 2.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.034 0.934 . . . . 0.0 109.529 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.54 29.5 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.913 3.075 . . . . 0.0 114.114 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.56 -52.19 0.48 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.49 1.916 . . . . 0.0 109.756 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.96 -144.06 4.03 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 127.263 2.363 . . . . 0.0 108.971 -170.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 pp -142.73 167.43 22.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.865 1.266 . . . . 0.0 111.609 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.7 p -75.35 165.52 25.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.269 0.628 . . . . 0.0 110.645 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -51.83 152.19 5.5 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 157.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.9 142.28 51.35 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.665 1.577 . . . . 0.0 109.136 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 p -59.09 162.27 7.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 O-C-N 121.812 -0.555 . . . . 0.0 111.062 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -54.55 129.83 36.94 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.6 2.867 . . . . 0.0 109.835 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.4 ' SD ' HD13 ' A' ' 86' ' ' LEU . 5.4 mtm -49.75 151.68 1.7 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.322 1.419 . . . . 0.0 113.199 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.3 p -60.5 -12.22 9.12 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.79 155.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.344 1.857 . . . . 0.0 108.739 -157.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -70.74 137.42 32.56 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.229 1.953 . . . . 0.0 109.883 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.62 125.78 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.35 127.65 35.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.9 p -66.07 157.96 29.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -66.91 172.99 3.88 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.146 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.695 0 C-N-CA 124.579 1.151 . . . . 0.0 113.932 -169.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 CA--C 1.534 0.347 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.21 149.66 84.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.889 2.392 . . . . 0.0 112.422 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 148.48 44.78 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 169.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 156.45 53.63 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.813 2.342 . . . . 0.0 113.053 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.68 175.07 5.66 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.493 2.795 . . . . 0.0 112.837 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -61.09 171.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.922 0.868 . . . . 0.0 111.769 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -52.96 133.57 48.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.299 -0.858 . . . . 0.0 108.856 157.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.54 148.27 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.433 1.422 . . . . 0.0 110.927 167.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -119.3 117.14 27.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.612 1.565 . . . . 0.0 108.658 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.89 144.6 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 113.357 -1.747 . . . . 0.0 107.698 169.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 p -128.75 -85.72 0.56 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -73.84 149.12 41.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.704 1.602 . . . . 0.0 109.475 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.97 141.95 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 122.004 0.907 . . . . 0.0 108.687 161.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.9 p -128.54 -172.21 2.65 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 107.996 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -62.05 -36.99 83.27 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.176 -0.953 . . . . 0.0 112.706 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -139.67 23.86 2.45 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.902 1.228 . . . . 0.0 111.398 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -146.14 164.13 33.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.518 0.599 . . . . 0.0 109.501 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.05 138.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -94.44 135.18 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.36 130.63 52.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 125.886 1.674 . . . . 0.0 108.318 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 1.4 t -103.32 151.92 22.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.69 1.196 . . . . 0.0 108.127 161.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.597 ' CH2' HD11 ' A' ' 51' ' ' ILE . 24.2 p90 -140.04 171.12 14.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 156.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.32 144.82 32.46 Favored Pre-proline 0 C--O 1.239 0.516 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.94 140.73 18.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.835 2.357 . . . . 0.0 110.751 -167.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.21 -168.19 26.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 166.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.3 m -86.85 159.98 50.76 Favored Pre-proline 0 N--CA 1.441 -0.878 0 C-N-CA 128.775 2.83 . . . . 0.0 109.458 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.84 -169.06 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.813 3.676 . . . . 0.0 111.085 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.35 -148.41 6.21 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 105.872 -2.891 . . . . 0.0 105.872 164.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.63 -33.4 54.95 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.549 0.739 . . . . 0.0 110.144 171.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 95' ' ' GLN . 12.6 mt -104.36 157.72 33.47 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 118.379 0.536 . . . . 0.0 111.124 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.36 170.58 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.045 2.497 . . . . 0.0 109.303 164.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.61 162.6 13.56 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.473 1.109 . . . . 0.0 109.033 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -116.54 -47.28 2.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.86 2.064 . . . . 0.0 109.481 -171.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.51 -160.99 0.55 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -134.83 148.86 50.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.444 2.298 . . . . 0.0 108.555 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 64' ' ' THR . 2.2 mt -124.99 113.86 37.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 129.15 2.98 . . . . 0.0 105.754 172.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.597 HD11 ' CH2' ' A' ' 36' ' ' TRP . 69.7 mt -94.54 120.39 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 171.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.78 154.29 20.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.26 148.21 51.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.015 1.726 . . . . 0.0 108.08 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.23 157.46 19.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 166.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.3 144.57 21.01 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -95.53 -4.99 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.545 1.538 . . . . 0.0 112.622 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.0 m -119.56 9.98 11.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.362 1.465 . . . . 0.0 113.281 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -115.17 -77.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.14 1.776 . . . . 0.0 109.023 -168.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -141.67 5.85 1.81 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.289 0.95 . . . . 0.0 112.786 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 m120 59.58 2.93 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.431 2.692 . . . . 0.0 114.964 -175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -106.23 161.16 14.78 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 126.632 1.973 . . . . 0.0 110.518 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.424 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 81.6 m95 -77.78 144.62 36.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 153.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -138.32 148.68 44.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 HG23 ' A' ' 50' ' ' ILE . 32.4 m -77.19 108.57 10.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -95.11 -15.47 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.215 1.006 . . . . 0.0 111.93 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.92 102.45 2.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.307 0.958 . . . . 0.0 108.835 167.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.81 157.89 15.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.196 0.998 . . . . 0.0 110.394 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.8 m170 44.89 46.23 8.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.473 2.709 . . . . 0.0 112.449 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t -79.99 136.75 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 126.75 2.02 . . . . 0.0 108.056 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -123.27 61.41 1.04 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 122.093 0.949 . . . . 0.0 108.799 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 t -158.31 179.27 9.3 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 p -122.85 5.86 9.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.697 1.199 . . . . 0.0 111.441 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 7.8 tp -135.89 128.36 30.46 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 163.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -145.95 151.24 37.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -101.42 103.77 14.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.227 1.411 . . . . 0.0 107.827 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.52 137.49 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -122.48 -167.38 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.546 1.938 . . . . 0.0 107.543 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.68 21.11 64.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.112 171.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -99.95 -166.46 1.34 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.822 1.311 . . . . 0.0 110.616 -167.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -122.73 153.15 63.15 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 107.248 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.69 156.17 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.519 2.146 . . . . 0.0 110.382 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 35.58 57.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.222 1.809 . . . . 0.0 110.598 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.9 m -139.0 138.33 37.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.66 1.984 . . . . 0.0 106.19 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 mm -79.44 146.1 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.127 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -142.13 150.87 41.68 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.179 1.391 . . . . 0.0 109.411 173.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.03 166.27 10.85 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 162.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -138.34 149.22 45.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.647 1.217 . . . . 0.0 108.731 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.424 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 73.3 mtm -136.81 152.53 50.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 163.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 36' ' ' TRP . 71.0 t -119.3 109.66 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -169.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.603 ' HD3' HD13 ' A' ' 97' ' ' LEU . 73.8 mtt180 -94.84 132.28 39.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 129.25 35.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 165.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.05 149.52 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.7 176.79 2.27 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.101 1.361 . . . . 0.0 108.926 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.99 4.09 0.77 Allowed 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.581 2.854 . . . . 0.0 115.935 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.537 ' HB2' HD12 ' A' ' 44' ' ' LEU . 15.8 tp60 -140.48 -17.4 0.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.926 1.29 . . . . 0.0 112.617 -161.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.19 -156.84 29.05 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.858 1.694 . . . . 0.0 109.402 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.603 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -129.76 146.97 51.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.849 1.66 . . . . 0.0 107.765 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.3 p -72.41 167.11 21.23 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.04 153.75 0.49 Allowed Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.234 1.413 . . . . 0.0 110.919 173.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.1 136.3 68.18 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -61.3 172.02 1.08 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 165.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.98 144.77 35.33 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.012 1.142 . . . . 0.0 109.733 156.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.51 143.6 57.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.6 p -64.48 -2.48 2.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.902 1.681 . . . . 0.0 115.043 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t0 68.71 151.5 0.13 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.945 2.498 . . . . 0.0 109.751 -158.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.65 105.58 1.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.081 2.521 . . . . 0.0 110.206 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.83 167.72 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 129.04 47.38 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.201 1.4 . . . . 0.0 108.233 172.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.2 p -65.4 160.64 21.52 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.208 0.317 . . . . 0.0 110.81 171.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -83.88 -176.75 6.43 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.202 1.001 . . . . 0.0 110.458 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.538 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 111.991 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 CA--C 1.539 0.55 0 N-CA-C 111.077 0.028 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.38 159.93 47.91 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.879 3.053 . . . . 0.0 111.35 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.07 152.38 48.99 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.91 138.91 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.708 1.605 . . . . 0.0 108.606 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -64.91 163.7 27.29 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 121.894 1.729 . . . . 0.0 111.168 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.3 m -74.25 160.46 31.09 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.54 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.89 121.12 21.53 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.042 1.337 . . . . 0.0 112.027 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.45 146.59 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.755 1.636 . . . . 0.0 113.577 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.11 125.25 53.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 125.602 1.561 . . . . 0.0 111.373 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 107' ' ' VAL . 1.3 m -86.08 133.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 113.615 -1.63 . . . . 0.0 108.885 -176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -121.88 -90.97 0.57 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -167.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -72.23 141.16 48.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.34 136.02 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.9 p -105.76 -52.88 2.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.362 -170.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 pttp 160.61 -26.13 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.331 1 C-N-CA 133.795 4.838 . . . . 0.0 108.373 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.18 -0.29 1.13 Allowed 'General case' 0 CA--C 1.523 -0.083 0 O-C-N 121.173 -0.954 . . . . 0.0 112.745 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -125.15 160.33 29.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.945 1.248 . . . . 0.0 110.156 160.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.51 130.96 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.127 1.371 . . . . 0.0 108.475 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.3 m -90.21 122.57 33.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.825 2.05 . . . . 0.0 108.249 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.75 126.64 54.79 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.874 2.07 . . . . 0.0 107.844 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.06 152.65 18.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 160.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.7 p90 -139.76 172.42 12.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 152.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -102.09 146.03 31.56 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.3 156.12 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.558 2.839 . . . . 0.0 109.964 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.13 177.86 50.76 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-O 123.878 1.821 . . . . 0.0 110.815 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 m -64.73 154.82 84.29 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 127.546 2.338 . . . . 0.0 109.357 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.62 -171.69 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.995 2.463 . . . . 0.0 112.828 166.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.75 6.14 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.7 -45.01 54.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 161.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 mt -97.59 150.19 36.52 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 123.365 0.666 . . . . 0.0 109.978 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.23 151.61 54.91 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.889 3.059 . . . . 0.0 109.537 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.58 159.97 26.3 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.649 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.499 ' HB2' HG22 ' A' ' 92' ' ' ILE . 21.2 m -135.71 -42.0 0.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.447 1.499 . . . . 0.0 110.514 -166.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.58 -171.07 2.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.373 1.069 . . . . 0.0 108.427 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.56 167.57 10.35 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.851 0.834 . . . . 0.0 109.686 156.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.05 158.16 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.677 2.791 . . . . 0.0 106.471 164.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 92.3 mt -127.05 139.16 52.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 166.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.83 161.98 19.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.776 1.231 . . . . 0.0 108.275 172.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -143.87 162.15 36.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.195 1.398 . . . . 0.0 108.559 172.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -136.2 149.49 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.652 1.981 . . . . 0.0 106.057 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.665 ' HB3' HG22 ' A' ' 58' ' ' VAL . 8.1 t -141.42 165.07 28.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 161.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.71 33.84 2.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.378 1.071 . . . . 0.0 111.761 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.92 34.01 0.21 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.268 -0.895 . . . . 0.0 112.42 165.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.665 HG22 ' HB3' ' A' ' 55' ' ' SER . 14.8 m -120.14 -72.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.959 1.304 . . . . 0.0 109.628 -175.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.577 ' H ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -154.01 0.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.887 1.275 . . . . 0.0 112.005 -178.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.14 -21.11 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.266 2.626 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 m -63.66 159.27 19.39 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.476 1.91 . . . . 0.0 110.714 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -76.37 154.49 34.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 151.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -141.92 152.97 44.02 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 134.46 49.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 53' ' ' ALA . 22.9 m -122.98 -19.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.308 -0.854 . . . . 0.0 111.473 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . -135.63 157.06 47.82 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.904 1.229 . . . . 0.0 108.338 160.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -143.02 147.75 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 52.52 49.37 20.56 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.014 0.912 . . . . 0.0 111.806 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.5 t -79.13 102.27 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -94.47 50.67 1.37 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.876 1.27 . . . . 0.0 109.076 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -157.44 -170.06 3.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.057 1.743 . . . . 0.0 107.508 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.4 p -131.98 2.91 4.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.116 2.166 . . . . 0.0 111.624 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.0 tp -129.38 120.64 25.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -145.21 151.45 38.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.051 0.94 . . . . 0.0 109.502 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.8 m -110.2 114.29 27.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.396 1.078 . . . . 0.0 108.733 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.88 145.96 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -133.43 176.98 8.05 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 112.111 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.42 27.09 57.78 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.788 1.185 . . . . 0.0 113.935 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.9 mt -79.32 -179.13 6.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.153 0.977 . . . . 0.0 110.075 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -96.8 139.23 21.47 Favored Pre-proline 0 CA--C 1.516 -0.365 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.63 159.97 47.56 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.513 2.142 . . . . 0.0 110.32 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 t30 48.53 34.79 5.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.94 1.696 . . . . 0.0 111.8 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.1 m -133.19 132.89 42.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.111 1.764 . . . . 0.0 107.581 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.31 147.87 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -131.58 159.16 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 156.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mt -107.52 157.71 17.8 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 152.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -132.72 152.12 51.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 125.828 1.955 . . . . 0.0 107.369 172.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.61 165.84 23.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 162.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.67 145.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.653 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.8 mtp180 -120.95 147.62 45.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 162.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.99 159.05 19.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.499 HG22 ' HB2' ' A' ' 47' ' ' SER . 1.5 mt -121.28 150.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 126.316 1.846 . . . . 0.0 107.535 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.62 172.2 5.49 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 127.138 2.175 . . . . 0.0 107.322 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.9 -23.93 74.37 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.65 2.233 . . . . 0.0 114.985 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -105.64 -45.99 4.28 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.576 1.55 . . . . 0.0 110.407 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.84 35.29 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 122.739 1.188 . . . . 0.0 112.214 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.653 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.3 mp -84.86 166.75 16.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -72.36 166.24 22.91 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 122.171 0.986 . . . . 0.0 109.619 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.81 159.88 1.64 Allowed Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.148 152.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.24 148.3 61.66 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.091 1.194 . . . . 0.0 111.182 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.1 p -62.38 167.51 5.25 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 159.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.97 150.34 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.427 1.418 . . . . 0.0 109.724 152.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -69.04 154.85 41.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.648 166.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.1 p -60.54 -7.53 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.578 2.351 . . . . 0.0 115.143 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.7 153.63 0.14 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 127.333 2.253 . . . . 0.0 109.169 -155.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -77.55 108.5 2.59 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.976 2.451 . . . . 0.0 108.603 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 24' ' ' VAL . 3.6 m -108.49 133.23 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 124.544 1.138 . . . . 0.0 109.156 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -92.66 135.27 34.24 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.7 p -63.68 154.32 33.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.971 0.891 . . . . 0.0 109.185 164.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.44 171.66 0.57 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 123.614 1.673 . . . . 0.0 110.02 163.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.5 t0 . . . . . 0 C--N 1.314 -0.938 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.925 169.034 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 118.434 -0.794 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.52 159.45 36.29 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.078 3.852 . . . . 0.0 113.425 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.66 141.94 46.1 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.825 1.202 . . . . 0.0 111.227 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.84 147.49 80.88 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.255 1.97 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.9 164.76 15.68 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.583 2.189 . . . . 0.0 112.413 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -74.91 167.87 21.04 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.707 0.803 . . . . 0.0 110.037 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -59.4 117.83 25.55 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.854 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.03 157.33 60.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 120.619 1.257 . . . . 0.0 111.182 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -124.24 146.86 48.47 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 126.789 2.036 . . . . 0.0 109.367 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 107' ' ' VAL . 2.5 m -96.75 139.03 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 C-N-CA 124.511 1.124 . . . . 0.0 108.309 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -128.74 -79.78 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.533 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.05 130.73 42.28 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.53 137.09 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.4 p -115.47 -74.33 0.62 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -162.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 pttp -171.34 -29.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 1 C-N-CA 133.272 4.629 . . . . 0.0 108.638 161.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.8 -15.47 14.1 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.821 1.648 . . . . 0.0 109.944 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 m -142.33 159.37 42.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.604 0.638 . . . . 0.0 110.094 -167.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.428 HG12 ' CD1' ' A' ' 79' ' ' LEU . 1.8 p -153.13 128.92 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.8 m -86.13 138.72 31.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.448 1.099 . . . . 0.0 110.066 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -113.04 141.38 46.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 107.931 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -130.77 129.45 42.47 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 126.99 2.116 . . . . 0.0 108.381 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -140.34 170.59 15.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.538 0.685 . . . . 0.0 112.19 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -98.77 145.63 30.27 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 124.324 1.05 . . . . 0.0 108.749 164.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.32 139.39 14.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 124.478 3.452 . . . . 0.0 109.483 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.75 -179.06 44.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 165.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.6 m -87.04 151.01 51.13 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 128.312 2.645 . . . . 0.0 110.163 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.81 -174.87 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.664 3.576 . . . . 0.0 111.757 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.98 -126.41 0.82 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 p -57.13 -31.02 64.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.266 2.626 . . . . 0.0 114.318 -173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 mt -130.95 164.91 38.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.35 1.46 . . . . 0.0 109.234 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.78 135.7 6.87 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.993 2.462 . . . . 0.0 109.843 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.9 149.97 43.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.328 164.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -125.06 -56.7 1.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.628 1.171 . . . . 0.0 109.014 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 92' ' ' ILE . . . -152.55 -177.38 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 91' ' ' ALA . 89.1 m-85 -122.91 173.17 7.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.755 0.822 . . . . 0.0 109.204 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.3 mt -121.49 152.86 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 126.835 2.054 . . . . 0.0 106.448 166.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -123.29 137.44 56.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 160.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.52 164.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.514 1.125 . . . . 0.0 108.56 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.18 163.7 32.16 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.44 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -159.32 124.07 4.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 108.7 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.69 ' HB3' HG22 ' A' ' 58' ' ' VAL . 12.6 t -106.17 1.63 26.31 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.381 1.072 . . . . 0.0 112.457 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 53.46 3.09 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -167.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.53 1.24 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.651 -1.28 . . . . 0.0 111.907 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 55' ' ' SER . 1.6 m -74.69 -78.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 109.327 173.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.407 ' H ' HG23 ' A' ' 58' ' ' VAL . 37.2 m -121.35 15.35 11.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.549 1.14 . . . . 0.0 110.848 164.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 53.86 27.16 6.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.298 1.439 . . . . 0.0 110.835 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.6 m -144.41 151.81 39.78 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.825 2.85 . . . . 0.0 108.503 -167.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -78.76 142.74 36.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 109.911 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -135.76 135.88 40.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.276 0.631 . . . . 0.0 109.71 -169.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.79 94.34 1.39 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -81.65 -21.75 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.053 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.39 107.34 3.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.84 168.09 16.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 169.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 36.5 58.61 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.84 2.456 . . . . 0.0 112.627 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.93 118.59 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -111.5 50.07 0.85 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.62 1.168 . . . . 0.0 108.645 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -156.14 -177.75 6.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.727 1.211 . . . . 0.0 108.064 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -118.58 0.98 11.65 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.909 2.883 . . . . 0.0 110.917 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 111.38 7.08 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.731 1.213 . . . . 0.0 109.182 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -141.19 127.77 20.13 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.737 0.815 . . . . 0.0 111.164 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.4 m -75.96 103.16 5.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.169 2.188 . . . . 0.0 109.229 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.7 t -70.15 147.34 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 166.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -135.96 174.49 10.55 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.046 1.339 . . . . 0.0 113.591 -168.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.09 6.07 82.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.117 1.817 . . . . 0.0 114.718 168.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD1' HG12 ' A' ' 32' ' ' VAL . 24.9 mt -74.48 171.96 12.83 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.17 1.788 . . . . 0.0 111.111 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.0 142.77 29.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 126.011 1.724 . . . . 0.0 108.567 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.76 156.57 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 109.461 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 40.51 48.07 2.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.089 1.756 . . . . 0.0 111.958 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.5 m -133.64 132.73 41.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.918 1.687 . . . . 0.0 106.761 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.27 146.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.96 157.15 46.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 160.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' SD ' ' A' ' 103' ' ' MET . 70.7 mt -107.35 157.13 18.19 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 127.504 2.322 . . . . 0.0 106.271 158.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -138.5 146.23 41.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 126.195 2.185 . . . . 0.0 107.862 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.1 mtm -142.53 152.51 42.7 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.13 144.04 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 125.366 1.466 . . . . 0.0 107.187 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.477 ' HD3' HD13 ' A' ' 97' ' ' LEU . 43.7 mtt180 -128.65 139.87 52.04 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 169.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 49' ' ' TYR . . . -86.89 149.14 25.02 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -123.53 145.29 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.218 1.007 . . . . 0.0 109.889 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -150.46 177.24 1.92 Allowed Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 109.109 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.69 67.24 8.48 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.072 2.514 . . . . 0.0 110.135 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -163.88 -73.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.835 2.854 . . . . 0.0 104.637 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.53 -164.34 12.09 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 126.136 1.827 . . . . 0.0 110.93 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.477 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -101.14 151.59 21.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.13 1.372 . . . . 0.0 108.381 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.4 p -72.67 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.179 1.792 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -50.66 150.29 5.13 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.368 158.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.33 161.0 45.1 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.316 1.344 . . . . 0.0 111.106 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 91.8 p -55.57 167.61 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.258 163.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.52 144.25 10.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 121.66 1.573 . . . . 0.0 110.484 151.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . 0.474 ' SD ' HD13 ' A' ' 86' ' ' LEU . 22.4 mtm -64.65 144.86 56.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.442 0.697 . . . . 0.0 109.789 171.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -63.99 -9.55 16.46 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 127.187 2.195 . . . . 0.0 113.736 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 77.56 155.28 0.14 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 128.808 2.843 . . . . 0.0 108.792 -160.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -73.14 117.94 5.33 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.591 2.194 . . . . 0.0 108.53 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 24' ' ' VAL . 2.7 m -116.48 135.1 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.956 1.302 . . . . 0.0 110.083 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 142.37 27.77 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.5 p -73.46 159.33 33.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.428 1.585 . . . . 0.0 109.495 162.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -66.27 175.04 2.32 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.955 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.1 t0 . . . . . 0 N--CA 1.443 -0.805 0 CA-C-N 111.623 -2.535 . . . . 0.0 110.086 163.371 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' LEU . 86.1 mt . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 118.9 -0.571 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -61.76 164.8 15.22 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.765 2.31 . . . . 0.0 111.806 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.17 126.61 28.79 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 164.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.95 154.49 61.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.215 1.943 . . . . 0.0 111.82 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -80.06 173.16 13.0 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.457 2.771 . . . . 0.0 111.236 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -66.61 170.13 6.74 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.702 -0.624 . . . . 0.0 111.373 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -49.9 124.41 16.54 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 150.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 150.1 74.77 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 121.203 1.269 . . . . 0.0 109.178 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -111.78 124.29 52.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.65 142.46 16.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.353 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.5 p -122.01 -87.63 0.63 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.92 134.59 38.9 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 109.049 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.77 138.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 119.099 0.863 . . . . 0.0 109.697 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -126.87 -162.21 1.13 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.998 1.719 . . . . 0.0 107.861 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -77.18 -29.06 54.21 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 121.192 -0.943 . . . . 0.0 111.075 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -150.87 14.57 0.73 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.199 0.909 . . . . 0.0 111.955 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -127.27 163.08 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.782 159.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.78 146.86 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.692 1.597 . . . . 0.0 107.38 169.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.9 m -102.07 149.43 24.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.469 1.508 . . . . 0.0 109.084 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.38 148.46 51.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.261 2.624 . . . . 0.0 107.535 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -139.94 114.71 9.47 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.515 1.134 . . . . 0.0 108.998 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CH2' HD11 ' A' ' 51' ' ' ILE . 42.6 p90 -134.87 153.11 52.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.903 0.774 . . . . 0.0 111.217 -176.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -93.48 140.9 23.3 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.49 148.29 18.27 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 124.096 3.197 . . . . 0.0 108.987 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.76 -178.05 52.21 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 122.27 0.928 . . . . 0.0 111.632 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -55.12 153.95 11.44 Favored Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.957 2.103 . . . . 0.0 108.444 158.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 -114.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.143 3.229 . . . . 0.0 108.51 162.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.4 -109.81 0.42 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 164.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.8 p -60.35 -35.3 75.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.729 2.012 . . . . 0.0 111.819 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 mt -132.63 169.24 14.46 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.849 1.66 . . . . 0.0 109.07 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.48 155.74 14.16 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.507 2.805 . . . . 0.0 109.271 168.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 160.46 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.551 0.691 . . . . 0.0 109.656 171.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.429 ' HB2' HG22 ' A' ' 92' ' ' ILE . 3.5 m -117.81 -43.37 2.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.074 1.75 . . . . 0.0 109.822 -175.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.0 -172.27 1.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.468 1.107 . . . . 0.0 109.592 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.714 ' HB2' HG23 ' A' ' 69' ' ' VAL . 12.4 m-85 -116.78 165.6 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.729 1.612 . . . . 0.0 107.961 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.88 154.04 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 129.361 3.064 . . . . 0.0 104.833 168.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.455 HD11 ' CH2' ' A' ' 36' ' ' TRP . 82.2 mt -129.29 135.9 60.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 166.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.84 156.51 29.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.17 157.87 45.69 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.032 1.333 . . . . 0.0 108.193 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.96 163.11 35.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.915 1.686 . . . . 0.0 109.81 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -156.75 -38.69 0.08 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -161.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 64.09 -22.46 0.07 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.71 2.404 . . . . 0.0 116.585 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.25 -24.45 11.5 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 121.036 1.744 . . . . 0.0 112.109 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 80' ' ' ARG . 78.3 t -69.9 -77.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 120.209 1.368 . . . . 0.0 109.418 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -135.49 22.91 3.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.511 1.125 . . . . 0.0 111.535 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 t30 23.22 60.23 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 C-N-CA 129.367 3.067 . . . . 0.0 112.815 176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.7 m -165.74 158.61 15.42 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.674 1.989 . . . . 0.0 108.952 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.462 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 67.3 m95 -72.46 123.85 23.96 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 162.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -113.24 139.17 49.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -83.41 94.36 7.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 m -82.33 -19.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.366 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.62 143.31 32.34 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.14 0.976 . . . . 0.0 108.488 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.91 157.2 47.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.338 0.655 . . . . 0.0 109.553 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m170 52.71 32.78 12.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.45 1.5 . . . . 0.0 111.922 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 49' ' ' TYR . 3.2 m -74.39 154.28 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.326 1.06 . . . . 0.0 110.229 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -134.73 54.14 1.96 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -148.6 176.41 10.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.585 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 p -117.41 -3.04 11.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.441 1.497 . . . . 0.0 111.698 169.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.23 133.55 47.58 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.068 1.347 . . . . 0.0 108.949 166.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.538 ' CD2' HG11 ' A' ' 69' ' ' VAL . 27.3 t80 -146.48 146.31 30.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -108.09 97.85 7.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.919 1.688 . . . . 0.0 108.904 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.95 134.83 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -128.16 171.82 11.57 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.285 0.634 . . . . 0.0 112.028 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.13 50.95 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.99 1.281 . . . . 0.0 112.994 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.1 mt -83.32 -166.84 1.47 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.743 1.217 . . . . 0.0 109.51 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HD2' HG22 ' A' ' 58' ' ' VAL . 12.9 mtt85 -121.45 143.72 38.42 Favored Pre-proline 0 CA--C 1.517 -0.326 0 C-N-CA 124.422 1.089 . . . . 0.0 109.502 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.95 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.481 2.787 . . . . 0.0 111.822 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 55.02 3.83 0.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.016 2.526 . . . . 0.0 116.24 -176.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.2 m -101.3 130.66 47.5 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.34 1.856 . . . . 0.0 108.746 -166.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 mm -68.71 147.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.27 165.3 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.654 1.181 . . . . 0.0 108.928 168.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -117.39 157.95 25.29 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 125.53 1.532 . . . . 0.0 108.121 162.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -143.07 131.43 22.15 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 125.298 1.624 . . . . 0.0 109.283 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . 0.462 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 5.4 mtt -115.67 173.31 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.89 151.8 35.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.426 ' HD3' HD13 ' A' ' 97' ' ' LEU . 95.4 mtt180 -138.65 121.9 17.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . . . -86.15 118.95 25.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.8 OUTLIER -86.14 148.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 108.996 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.76 173.6 4.21 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.773 1.629 . . . . 0.0 108.632 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.99 23.58 0.4 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.119 2.546 . . . . 0.0 113.658 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -130.38 -17.45 3.35 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.839 1.656 . . . . 0.0 113.919 173.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.47 9.4 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 123.909 0.766 . . . . 0.0 112.371 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 15' ' ' LEU . 4.1 pp -129.81 144.7 51.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.229 1.812 . . . . 0.0 107.768 177.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -72.33 159.37 34.14 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 109.737 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -48.86 132.31 14.65 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.084 0.954 . . . . 0.0 110.388 -172.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -51.04 113.96 1.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.112 3.208 . . . . 0.0 111.49 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 p -52.67 159.23 1.8 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.648 0.779 . . . . 0.0 112.832 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -52.26 144.14 40.17 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.863 3.042 . . . . 0.0 111.073 163.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.5 mtp -67.28 144.43 55.91 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.506 0.722 . . . . 0.0 112.619 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.3 p -65.7 -5.19 7.84 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.818 2.447 . . . . 0.0 116.1 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.46 144.64 0.1 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.139 1.776 . . . . 0.0 111.024 -165.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.58 106.84 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.166 2.578 . . . . 0.0 110.849 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.9 m -105.0 140.61 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.383 1.473 . . . . 0.0 109.965 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -87.15 -174.4 4.87 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.524 0.73 . . . . 0.0 109.98 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.0 p -130.99 158.23 40.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.364 1.866 . . . . 0.0 107.195 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -68.38 173.29 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.825 0.821 . . . . 0.0 110.039 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.94 172.829 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.788 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -71.43 -0.38 10.19 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.519 1.159 . . . . 0.0 113.669 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -133.31 160.01 38.59 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 150.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.18 14.88 1.3 Allowed Glycine 0 CA--C 1.522 0.492 0 C-N-CA 126.274 1.892 . . . . 0.0 111.748 -175.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.7 155.49 44.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.742 1.271 . . . . 0.0 109.086 169.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 p -155.25 176.58 12.38 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.588 1.955 . . . . 0.0 107.266 171.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.0 -59.36 9.72 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -79.15 167.94 20.31 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 122.149 -0.618 . . . . 0.0 109.514 167.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -130.76 123.32 28.93 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 57.71 -179.98 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.66 1.984 . . . . 0.0 113.5 -174.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -153.52 164.46 38.19 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.983 1.713 . . . . 0.0 107.036 169.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 28.3 mt -86.74 65.89 9.21 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 165.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 9.7 t -142.05 145.38 34.29 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 123.329 0.652 . . . . 0.0 110.851 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -120.15 19.99 12.13 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.993 1.717 . . . . 0.0 110.437 171.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt -107.34 159.06 31.52 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 126.321 1.848 . . . . 0.0 110.439 -173.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -61.27 161.14 24.23 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.011 2.474 . . . . 0.0 111.606 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -73.53 141.81 30.29 Favored Glycine 0 CA--C 1.533 1.212 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 162.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -69.48 162.42 42.0 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.421 2.081 . . . . 0.0 113.031 -168.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.37 168.34 9.75 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.194 2.596 . . . . 0.0 112.825 168.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.1 m -74.83 169.97 16.84 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.568 0.747 . . . . 0.0 110.199 168.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttt -56.22 134.23 75.27 Favored Pre-proline 0 C--O 1.239 0.552 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 167.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.37 164.9 16.41 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 CA-C-O 124.04 1.6 . . . . 0.0 112.697 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 53.3 mm-40 -105.25 172.12 6.96 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 128.909 2.884 . . . . 0.0 106.644 162.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.5 t -123.75 137.57 56.44 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.119 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.9 p -124.32 -90.66 0.56 Allowed 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.699 0.625 . . . . 0.0 110.646 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.94 138.71 42.52 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 125.343 1.457 . . . . 0.0 107.914 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.47 155.05 22.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 119.48 1.037 . . . . 0.0 110.046 163.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 p -137.33 -159.88 1.0 Allowed 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.208 1.403 . . . . 0.0 108.039 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -65.1 -31.61 72.9 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 117.759 -1.115 . . . . 0.0 112.545 167.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 p30 -152.54 1.66 0.32 Allowed 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -171.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.5 m -113.66 152.55 30.27 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 119.178 0.899 . . . . 0.0 108.919 162.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.3 p -147.87 148.44 16.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 169.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 64.4 m -110.31 133.83 52.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.16 140.03 48.26 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.356 1.863 . . . . 0.0 107.004 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.76 135.17 49.75 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 174.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 29.2 p90 -138.72 171.57 14.15 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 120.582 1.537 . . . . 0.0 108.628 172.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -106.71 142.77 25.66 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 124.609 1.164 . . . . 0.0 108.7 168.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.4 170.49 20.11 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.769 2.313 . . . . 0.0 112.707 -161.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.47 -175.6 22.93 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 164.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.53 149.19 71.09 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 170.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.84 -179.81 5.54 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 123.652 2.901 . . . . 0.0 113.13 173.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.36 -99.02 0.15 Allowed Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 107.224 -2.351 . . . . 0.0 107.224 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 12.1 p -57.83 -51.95 67.47 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.452 1.901 . . . . 0.0 110.565 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.61 166.26 25.81 Favored Pre-proline 0 C--O 1.237 0.446 0 C-N-CA 124.271 1.028 . . . . 0.0 110.278 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.93 167.51 25.06 Favored 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 124.292 3.328 . . . . 0.0 109.382 169.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.16 144.51 25.55 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.962 1.705 . . . . 0.0 109.04 176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.6 m -94.54 -57.23 2.54 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 124.326 1.051 . . . . 0.0 109.713 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.61 -171.24 2.67 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.269 0.94 . . . . 0.0 108.932 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.39 164.9 16.36 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.572 1.149 . . . . 0.0 109.122 173.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.5 mt -118.03 159.94 18.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 126.85 2.06 . . . . 0.0 106.484 161.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 53.0 mt -124.2 134.31 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 158.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.32 160.98 15.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 166.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.84 162.38 34.13 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 126.328 1.851 . . . . 0.0 107.313 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -148.07 141.0 24.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.2 m -155.79 121.36 4.93 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.71 -34.84 74.99 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.24 0.543 . . . . 0.0 111.693 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.08 17.22 3.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 128.11 2.564 . . . . 0.0 114.033 177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.2 t -126.2 -73.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 28.6 t -147.7 146.54 29.3 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 171.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -66.59 -0.31 2.75 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.173 1.389 . . . . 0.0 113.681 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 m -102.62 155.67 18.14 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.974 2.51 . . . . 0.0 111.882 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 69.5 m95 -74.74 136.05 41.77 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 153.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -133.19 155.16 49.82 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 119.112 0.869 . . . . 0.0 110.528 175.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -68.97 130.65 43.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 125.296 1.438 . . . . 0.0 107.801 170.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.6 -6.75 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 125.058 1.343 . . . . 0.0 112.149 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.52 152.73 36.07 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 149.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -135.81 140.88 44.58 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.127 1.371 . . . . 0.0 108.421 -172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 54.45 43.77 29.86 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.661 1.184 . . . . 0.0 111.863 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.77 126.17 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 126.136 1.774 . . . . 0.0 107.161 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.4 mtmt -108.2 15.2 24.36 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.798 0.839 . . . . 0.0 112.17 -177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -129.45 175.31 8.87 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.773 1.629 . . . . 0.0 109.306 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 70.5 p -112.42 -5.73 14.07 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.538 2.335 . . . . 0.0 111.545 -175.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -135.73 123.18 22.02 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -145.9 121.14 10.19 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.859 0.754 . . . . 0.0 112.31 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.4 m -69.84 103.66 2.26 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 126.682 1.993 . . . . 0.0 110.241 164.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 76' ' ' VAL . 9.9 t -60.9 148.64 8.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 126.936 2.094 . . . . 0.0 107.932 158.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 92.9 mtt-85 -140.2 175.32 9.69 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.055 1.342 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.47 7.68 87.08 Favored Glycine 0 C--N 1.334 0.445 0 C-N-CA 123.803 0.716 . . . . 0.0 114.455 165.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.6 mt -74.73 -171.66 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.62 1.168 . . . . 0.0 109.039 -172.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -113.05 132.89 22.16 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -59.23 156.46 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.866 0 C-N-CA 122.544 2.163 . . . . 0.0 112.28 170.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.1 t30 41.57 33.63 0.32 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.718 2.807 . . . . 0.0 113.78 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 96.8 m -120.66 135.73 55.03 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.386 1.874 . . . . 0.0 106.831 -176.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.5 mm -73.16 148.6 8.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 123.825 0.85 . . . . 0.0 109.081 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -141.36 149.49 41.21 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 124.733 1.213 . . . . 0.0 110.62 171.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -107.72 160.83 15.41 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.371 162.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -142.04 144.45 33.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 124.753 1.283 . . . . 0.0 108.521 173.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 62.0 mtm -130.45 153.49 48.72 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 159.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 60.9 t -102.08 148.27 7.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 171.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.424 ' HD3' HD22 ' A' ' 97' ' ' LEU . 3.0 mtt180 -131.9 136.14 47.18 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.755 1.222 . . . . 0.0 108.249 176.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.08 152.13 22.63 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 169.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -122.82 148.15 26.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 C-N-CA 127.005 2.122 . . . . 0.0 109.141 175.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -148.5 178.04 1.59 Allowed Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 125.522 1.529 . . . . 0.0 109.239 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -61.48 -2.68 2.72 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.602 2.868 . . . . 0.0 117.117 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 80.0 mm-40 -129.54 -17.42 3.7 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 120.393 1.451 . . . . 0.0 113.582 -167.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 173.33 -176.79 45.96 Favored Glycine 0 C--O 1.238 0.357 0 CA-C-N 119.527 1.058 . . . . 0.0 111.209 -173.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.424 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.0 OUTLIER -85.97 151.69 23.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 157.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 83.1 p -71.47 168.79 16.76 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.867 1.267 . . . . 0.0 110.102 168.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -42.07 149.04 0.45 Allowed Pre-proline 0 C--O 1.241 0.65 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.849 153.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -72.15 164.27 36.16 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 121.809 1.672 . . . . 0.0 110.952 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 81.2 p -67.14 167.07 15.85 Favored Pre-proline 0 CA--C 1.537 0.467 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 159.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -47.57 149.89 4.36 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.257 1.971 . . . . 0.0 112.363 151.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 7.0 mtm -65.36 143.15 57.93 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.43 0.692 . . . . 0.0 111.405 166.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.2 t -54.01 -23.12 12.28 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.175 2.19 . . . . 0.0 113.621 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 67.54 154.14 0.13 Allowed Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 127.055 2.142 . . . . 0.0 110.193 -162.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -68.89 110.05 2.28 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.384 2.723 . . . . 0.0 111.554 -159.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.1 p -75.4 162.83 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 168.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.64 133.52 54.98 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 163.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 47.4 p -62.67 169.34 3.15 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 166.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -81.91 -116.06 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.129 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -151.47 165.95 32.59 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 173.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.0 t -85.15 20.83 1.81 Allowed 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 125.92 1.688 . . . . 0.0 111.232 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -75.83 174.79 52.57 Favored Glycine 0 CA--C 1.535 1.339 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 163.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -80.0 -21.4 8.13 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.428 2.085 . . . . 0.0 112.599 174.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.1 m 54.17 48.07 21.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.156 1.383 . . . . 0.0 112.6 -166.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.27 106.73 6.05 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 159.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 N-CA-C 104.684 -3.366 . . . . 0.0 104.684 174.095 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.753 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.2 m -68.51 -29.9 68.59 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -169.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.7 t -87.23 132.01 34.03 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -173.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.38 -153.7 16.74 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 124.15 0.881 . . . . 0.0 112.056 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 66.3 p -76.74 86.92 3.36 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.32 1.048 . . . . 0.0 110.343 -177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -71.09 -60.32 2.3 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.669 0.788 . . . . 0.0 111.457 -174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.47 -166.08 27.36 Favored Glycine 0 C--O 1.239 0.414 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -163.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -137.9 93.08 2.73 Favored 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 169.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 60.33 73.14 0.49 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 126.462 1.905 . . . . 0.0 110.477 -175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.6 m-30 -119.6 166.86 12.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.719 1.207 . . . . 0.0 108.794 169.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.64 168.28 4.96 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.951 1.3 . . . . 0.0 111.416 -175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.2 mt -121.15 -121.82 0.29 Allowed 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.438 1.495 . . . . 0.0 107.727 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.1 m -132.54 144.17 50.23 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.099 1.36 . . . . 0.0 109.249 -171.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -17.83 61.27 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 119.389 0.995 . . . . 0.0 110.891 174.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.8 mt -75.45 153.87 85.8 Favored Pre-proline 0 N--CA 1.444 -0.76 0 C-N-CA 123.455 0.702 . . . . 0.0 109.352 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -63.0 158.18 44.84 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.47 2.113 . . . . 0.0 110.85 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.92 143.08 48.38 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -66.2 152.93 79.96 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.877 1.718 . . . . 0.0 110.645 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -64.15 171.8 7.16 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.929 2.42 . . . . 0.0 111.646 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.2 m -74.12 174.56 8.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.623 0.769 . . . . 0.0 110.255 167.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -55.74 135.62 72.0 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.034 170.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -70.91 124.62 10.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.745 1.302 . . . . 0.0 109.95 160.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -84.64 171.46 12.39 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.636 161.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 107' ' ' VAL . 62.0 t -125.31 136.54 60.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -174.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 p -126.33 -66.59 0.91 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-O 118.907 -0.568 . . . . 0.0 111.812 -168.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -104.69 139.48 39.46 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.937 0.895 . . . . 0.0 109.097 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.8 p -144.14 142.75 24.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 119.677 1.126 . . . . 0.0 110.147 174.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 p -130.41 -176.31 3.92 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 126.263 1.825 . . . . 0.0 109.107 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.2 pttm -63.86 -17.77 63.49 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 120.868 -1.145 . . . . 0.0 113.307 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.34 13.13 1.08 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 120.357 -1.464 . . . . 0.0 113.113 -178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.76 160.39 40.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 119.231 0.923 . . . . 0.0 110.421 177.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -153.18 129.09 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 123.512 0.725 . . . . 0.0 109.284 170.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.1 m -81.05 120.39 24.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.196 0.998 . . . . 0.0 108.345 168.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 28.8 mt -90.34 157.1 17.8 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.961 1.305 . . . . 0.0 109.116 166.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 m -149.01 99.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.13 0.972 . . . . 0.0 109.071 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.564 ' CH2' HD11 ' A' ' 51' ' ' ILE . 29.4 p90 -105.44 161.63 14.16 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.777 0.831 . . . . 0.0 109.083 175.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -95.45 147.55 33.2 Favored Pre-proline 0 N--CA 1.446 -0.636 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 165.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.19 171.77 16.18 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.79 2.993 . . . . 0.0 111.94 -167.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.42 177.48 33.48 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 168.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.503 HG23 ' HD2' ' A' ' 41' ' ' PRO . 2.8 m -107.57 157.69 35.14 Favored Pre-proline 0 N--CA 1.443 -0.793 0 C-N-CA 127.75 2.42 . . . . 0.0 109.874 -174.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HD2' HG23 ' A' ' 40' ' ' THR . 40.1 Cg_endo -71.42 -159.96 0.07 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 125.014 3.809 . . . . 0.0 113.073 176.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.38 -123.05 0.8 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 170.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.7 p -72.35 -27.62 62.52 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.981 1.712 . . . . 0.0 112.415 176.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 52.6 mt -136.33 149.23 67.17 Favored Pre-proline 0 C--O 1.24 0.56 0 C-N-CA 123.311 0.644 . . . . 0.0 112.244 -178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -75.54 163.94 33.24 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 124.541 3.494 . . . . 0.0 110.891 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -91.75 141.5 28.61 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.5 m -112.77 -32.53 6.38 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.007 1.723 . . . . 0.0 112.198 -168.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -163.87 -162.03 0.67 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 159.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.12 165.09 14.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.306 1.443 . . . . 0.0 108.384 157.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -116.71 152.56 18.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 127.736 2.414 . . . . 0.0 105.288 164.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.564 HD11 ' CH2' ' A' ' 36' ' ' TRP . 83.2 mt -127.59 135.18 63.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 166.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -121.16 159.4 25.93 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -137.87 161.52 36.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.131 1.372 . . . . 0.0 108.246 174.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -138.87 135.89 34.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.762 ' HB3' HG22 ' A' ' 58' ' ' VAL . 5.1 t -115.98 149.29 39.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.581 1.082 . . . . 0.0 108.123 155.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -80.53 16.26 1.41 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.966 0.506 . . . . 0.0 111.001 162.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -132.35 10.99 4.51 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 120.542 -1.349 . . . . 0.0 110.417 -177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.762 HG22 ' HB3' ' A' ' 55' ' ' SER 0.311 34.8 m -121.84 -91.83 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 -178.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.596 ' H ' HG23 ' A' ' 58' ' ' VAL . 10.9 m -119.32 5.32 11.19 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 121.436 1.925 . . . . 0.0 113.179 -175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 52.28 21.19 1.58 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.783 1.633 . . . . 0.0 112.925 -171.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.4 m -122.17 163.98 18.6 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 129.579 3.151 . . . . 0.0 108.896 -172.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -89.77 144.88 25.6 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 165.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -138.24 143.14 39.98 Favored 'General case' 0 CA--C 1.513 -0.481 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.33 96.0 1.08 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 124.423 1.089 . . . . 0.0 108.178 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 53' ' ' ALA . 33.0 m -82.9 -16.95 11.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 121.86 -0.525 . . . . 0.0 110.969 177.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.95 134.53 22.12 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 162.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -121.01 136.67 54.93 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 173.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 52.6 69.93 0.63 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.746 2.019 . . . . 0.0 112.418 -171.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 92.0 t -89.0 129.87 39.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.154 0 C-N-CA 125.579 1.552 . . . . 0.0 107.575 168.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -117.42 38.13 3.67 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.428 1.091 . . . . 0.0 110.573 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.2 t -151.75 -178.49 6.75 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.044 1.738 . . . . 0.0 107.515 -176.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 p -113.23 -2.52 14.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 128.095 2.558 . . . . 0.0 111.9 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.1 mp -133.93 139.7 46.31 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 170.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -146.66 140.94 26.36 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.1 m -94.18 102.57 14.6 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 174.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.7 t -58.87 135.99 22.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 44.6 mtt85 -130.82 178.85 6.35 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.42 1.088 . . . . 0.0 110.778 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.01 6.68 74.32 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 119.252 -0.749 . . . . 0.0 113.93 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.4 mt -72.17 -176.72 1.87 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.625 1.212 . . . . 0.0 110.381 -172.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 29.4 mtp85 -108.51 149.83 39.87 Favored Pre-proline 0 CA--C 1.513 -0.471 0 C-N-CA 125.25 1.42 . . . . 0.0 108.608 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.42 154.52 24.45 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 121.873 1.715 . . . . 0.0 111.638 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 50.62 16.99 0.34 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.894 2.078 . . . . 0.0 114.373 -177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 99.9 m -102.11 133.01 47.64 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 127.123 2.169 . . . . 0.0 108.354 -172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 31.7 mm -70.04 148.43 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 171.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -141.54 158.27 44.06 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 164.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.7 mt -109.52 164.99 12.0 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.647 1.179 . . . . 0.0 108.437 160.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.56 145.67 33.83 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 125.722 1.889 . . . . 0.0 109.643 -178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 67.3 mtm -135.42 162.84 31.48 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 124.732 1.213 . . . . 0.0 107.916 167.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.4 t -130.64 143.27 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.787 2.035 . . . . 0.0 105.817 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.577 ' HD3' HD13 ' A' ' 97' ' ' LEU . 27.3 mtt85 -132.6 138.85 47.55 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.32 124.57 33.5 Favored 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -86.4 152.82 3.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 124.812 1.245 . . . . 0.0 108.518 174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -150.88 168.02 11.84 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 126.513 1.925 . . . . 0.0 109.066 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -58.69 -9.87 8.19 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.391 3.394 . . . . 0.0 117.05 -176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -111.48 -43.26 3.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.462 1.505 . . . . 0.0 110.141 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.08 -149.65 6.21 Favored Glycine 0 C--N 1.333 0.416 0 CA-C-N 119.063 0.847 . . . . 0.0 111.074 -173.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.577 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -129.85 158.98 37.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.662 1.585 . . . . 0.0 108.7 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.1 p -71.89 167.09 20.78 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.554 1.142 . . . . 0.0 111.308 -171.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -47.26 151.15 1.33 Allowed Pre-proline 0 C--O 1.243 0.724 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 154.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.7 148.19 52.39 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.431 1.421 . . . . 0.0 110.338 -174.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 77.4 p -50.46 151.99 3.55 Favored Pre-proline 0 C--O 1.239 0.538 0 CA-C-O 118.329 -0.843 . . . . 0.0 110.023 163.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -47.41 122.52 6.76 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 121.942 1.762 . . . . 0.0 107.88 153.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 8.8 ttm -58.11 148.67 25.79 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 124.212 1.005 . . . . 0.0 109.871 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.5 p -60.38 162.5 6.1 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 123.047 1.403 . . . . 0.0 109.471 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.63 154.53 68.43 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 114.088 -1.414 . . . . 0.0 108.658 164.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -66.68 92.6 0.31 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.198 2.599 . . . . 0.0 111.846 -175.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.405 HG11 HG21 ' A' ' 24' ' ' VAL . 2.2 m -84.17 163.44 2.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 125.525 1.53 . . . . 0.0 109.482 173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.3 ttt85 -121.91 146.35 47.21 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 125.385 1.474 . . . . 0.0 109.006 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -61.58 161.7 9.35 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 159.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -75.75 178.32 6.21 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 168.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.54 153.85 29.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 121.833 0.825 . . . . 0.0 110.494 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.2 -30.86 63.82 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.176 1.39 . . . . 0.0 113.437 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -89.94 163.09 30.43 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-N 119.524 1.056 . . . . 0.0 114.053 -162.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -80.28 82.24 2.53 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 124.268 3.312 . . . . 0.0 109.342 171.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.75 119.78 4.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 124.324 1.05 . . . . 0.0 109.203 175.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.0 m -73.46 99.48 3.0 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.474 0.71 . . . . 0.0 110.438 -167.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 N-CA-C 105.639 -2.984 . . . . 0.0 105.639 -173.163 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.761 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 m 15.11 83.33 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 130.3 3.44 . . . . 0.0 114.916 167.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.5 m -69.59 106.47 3.04 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.342 1.457 . . . . 0.0 109.078 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.62 -17.79 0.07 OUTLIER Glycine 0 CA--C 1.519 0.292 0 CA-C-O 118.906 -0.941 . . . . 0.0 112.7 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 m -72.04 123.9 23.79 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 m -156.82 166.73 32.54 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.036 0.935 . . . . 0.0 109.464 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -93.95 165.52 26.86 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 152.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 tttp -151.93 162.91 40.31 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 158.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -144.88 160.59 41.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 162.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.85 137.68 15.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 129.212 3.005 . . . . 0.0 106.72 -176.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 t70 67.08 173.61 0.26 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.699 1.6 . . . . 0.0 110.463 -164.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 64.8 mt 5.46 85.63 0.01 OUTLIER 'General case' 0 C--N 1.348 0.517 0 C-N-CA 130.491 3.516 . . . . 0.0 113.483 -171.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.57 106.46 4.7 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -86.56 -20.83 27.38 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 165.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.61 160.04 74.97 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.76 2.024 . . . . 0.0 112.111 -160.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -59.27 156.12 36.88 Favored 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.678 2.252 . . . . 0.0 112.12 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.37 120.84 21.76 Favored Glycine 0 CA--C 1.531 1.081 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 153.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -72.08 161.51 44.51 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.235 2.623 . . . . 0.0 111.103 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -70.38 158.16 57.0 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.282 1.988 . . . . 0.0 110.712 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 p -71.21 175.16 5.53 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.918 0.487 . . . . 0.0 110.835 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HE3' ' O ' ' A' ' 103' ' ' MET . 83.8 tttt -53.54 120.83 23.71 Favored Pre-proline 0 C--O 1.237 0.409 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 170.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HG2' ' HB3' ' A' ' 104' ' ' SER . 8.4 Cg_endo -66.5 149.44 84.42 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 120.715 1.291 . . . . 0.0 109.374 171.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -79.21 170.94 15.89 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 161.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 37.0 t -122.68 121.61 63.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 129.151 2.981 . . . . 0.0 104.506 172.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.254 82.1 p -119.21 -84.81 0.66 Allowed 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.859 -170.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.71 150.07 37.95 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 120.106 1.321 . . . . 0.0 108.274 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.4 p -143.98 152.6 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 C-N-CA 123.493 0.717 . . . . 0.0 109.769 163.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.4 p -141.21 -172.45 3.5 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 125.643 1.577 . . . . 0.0 108.869 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -57.89 -37.08 73.33 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-O 117.964 -1.017 . . . . 0.0 113.141 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -136.19 17.21 3.21 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 120.866 1.666 . . . . 0.0 112.14 -175.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -151.37 161.33 42.89 Favored 'General case' 0 C--O 1.232 0.144 0 O-C-N 120.551 -1.343 . . . . 0.0 110.175 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -158.01 140.85 6.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -94.84 139.66 30.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 172.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.6 mt -120.72 145.5 47.42 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.536 1.934 . . . . 0.0 107.522 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.68 114.47 9.42 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 118.359 -0.829 . . . . 0.0 109.446 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.492 ' CE2' ' HA ' ' A' ' 72' ' ' THR . 39.2 p90 -123.3 171.32 9.48 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 119.997 1.272 . . . . 0.0 110.208 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -97.87 144.98 28.98 Favored Pre-proline 0 C--O 1.238 0.477 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 165.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.24 133.3 24.35 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 124.192 3.261 . . . . 0.0 107.669 168.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.67 -178.54 43.6 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -62.1 152.95 76.31 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.069 1.348 . . . . 0.0 110.157 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -70.82 -148.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 124.911 3.741 . . . . 0.0 109.843 167.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.06 -125.44 0.76 Allowed Glycine 0 C--N 1.333 0.4 0 O-C-N 118.941 -2.349 . . . . 0.0 109.478 163.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.3 p -49.78 -35.88 24.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 127.642 2.377 . . . . 0.0 110.112 169.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 59.9 mt -135.75 170.03 12.11 Favored Pre-proline 0 N--CA 1.443 -0.778 0 C-N-CA 127.642 2.377 . . . . 0.0 109.495 -168.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 62.3 Cg_endo -78.48 170.07 18.94 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.896 3.064 . . . . 0.0 110.003 169.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.64 109.23 22.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 m -53.49 -49.45 67.48 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.28 2.632 . . . . 0.0 111.919 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.15 -162.2 1.18 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.126 0.97 . . . . 0.0 108.594 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -131.92 168.81 17.22 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.056 1.742 . . . . 0.0 107.752 167.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.3 mt -127.0 165.3 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 129.266 3.027 . . . . 0.0 106.622 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.3 mt -131.11 136.08 58.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 162.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -114.31 161.72 17.52 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.327 1.051 . . . . 0.0 108.314 170.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.76 150.19 36.81 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.125 1.37 . . . . 0.0 109.086 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -127.3 141.13 51.79 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.347 1.459 . . . . 0.0 107.533 173.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.3 t -144.85 136.65 25.67 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 153.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.85 -37.36 81.81 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.932 165.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.4 m -76.31 16.33 0.48 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 127.066 2.146 . . . . 0.0 113.966 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.1 t -128.51 -77.44 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.461 0.076 0 C-N-CA 125.324 1.45 . . . . 0.0 107.14 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.15 21.19 0.97 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.898 0.479 . . . . 0.0 110.287 -176.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 36.66 51.02 0.87 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.687 2.395 . . . . 0.0 111.885 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.9 m -143.37 143.48 31.67 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.127 1.371 . . . . 0.0 108.223 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -66.51 136.83 56.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 153.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -138.97 145.25 39.51 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.896 1.278 . . . . 0.0 107.624 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.08 125.53 24.77 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 167.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.36 -6.37 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 124.278 1.031 . . . . 0.0 112.243 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -149.93 151.33 33.22 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 154.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -132.92 150.45 52.16 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 44.32 64.46 1.31 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.163 1.785 . . . . 0.0 110.683 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.77 -28.45 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 C-N-CA 126.319 1.848 . . . . 0.0 112.067 -161.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.3 mttt 60.62 15.18 5.51 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 127.581 2.352 . . . . 0.0 114.172 163.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.2 t -137.42 -177.66 4.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 125.229 1.412 . . . . 0.0 108.063 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' CE2' ' A' ' 36' ' ' TRP . 23.6 p -124.96 0.33 7.95 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 125.917 1.687 . . . . 0.0 111.351 -178.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.1 tp -134.71 112.2 10.58 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 174.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -145.58 151.5 38.2 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 119.059 0.845 . . . . 0.0 111.376 -175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 97.7 m -103.71 102.19 12.03 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 126.134 1.774 . . . . 0.0 109.06 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.0 t -64.41 139.73 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 125.559 1.544 . . . . 0.0 107.719 169.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -133.71 -170.25 2.46 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 125.09 1.356 . . . . 0.0 109.814 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 67.75 28.6 73.49 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 119.668 -0.518 . . . . 0.0 112.688 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 83.4 mt -89.41 -166.68 1.66 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.055 0.928 . . . . 0.0 109.346 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 43.4 mtp85 -116.44 155.13 48.92 Favored Pre-proline 0 C--O 1.235 0.306 0 C-N-CA 126.706 2.002 . . . . 0.0 108.472 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.57 156.74 18.88 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 122.901 2.4 . . . . 0.0 111.835 176.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 48.8 t30 43.31 37.02 1.18 Allowed 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 127.299 2.239 . . . . 0.0 112.712 -175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.3 m -121.89 131.25 53.93 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.992 1.717 . . . . 0.0 107.403 -174.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 26.2 mm -69.06 149.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.903 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -140.3 149.02 42.27 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 122.028 0.918 . . . . 0.0 111.289 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -107.92 162.58 13.89 Favored 'General case' 0 CA--C 1.494 -1.18 0 CA-C-N 113.557 -1.656 . . . . 0.0 108.129 156.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -135.85 166.71 22.67 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 125.707 1.88 . . . . 0.0 110.465 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 17.5 mtt -134.14 168.68 18.4 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 157.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.9 t -132.11 109.32 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 163.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.744 ' HD3' HD13 ' A' ' 97' ' ' LEU . 50.6 mtt180 -90.76 140.69 29.55 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.7 148.17 26.0 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 166.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.98 147.6 14.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.904 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 176.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -151.77 165.34 17.65 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -174.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -63.3 -20.89 71.43 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.457 1.438 . . . . 0.0 115.199 -173.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -93.7 -38.66 11.19 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 125.398 1.479 . . . . 0.0 111.503 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.44 -149.7 6.28 Favored Glycine 0 CA--C 1.52 0.348 0 CA-C-N 118.905 0.775 . . . . 0.0 111.537 -176.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.744 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -123.71 156.63 35.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 126.351 1.861 . . . . 0.0 106.424 172.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.4 p -76.05 167.39 21.96 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.621 0.768 . . . . 0.0 112.741 -170.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.22 164.77 0.57 Allowed Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 122.055 -0.403 . . . . 0.0 111.116 161.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.12 127.43 6.02 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.709 2.273 . . . . 0.0 110.452 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.8 p -49.07 155.45 1.12 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.581 1.552 . . . . 0.0 111.678 163.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -59.18 123.88 14.4 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.901 2.401 . . . . 0.0 108.698 164.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.423 ' O ' ' HE3' ' A' ' 21' ' ' LYS . 4.3 mpp? -55.59 124.62 17.94 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.448 1.022 . . . . 0.0 109.933 174.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.441 ' HB3' ' HG2' ' A' ' 22' ' ' PRO . 73.0 p -54.68 -16.03 2.23 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.889 2.475 . . . . 0.0 115.356 -174.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 92.04 146.5 0.05 OUTLIER Pre-proline 0 CA--C 1.536 0.421 1 C-N-CA 132.607 4.363 . . . . 0.0 109.575 168.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.29 107.81 0.52 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.394 2.729 . . . . 0.0 111.211 -153.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.47 169.52 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.11 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -126.8 148.14 49.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.71 1.604 . . . . 0.0 108.086 166.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 4.7 p -76.64 167.81 21.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.805 0.812 . . . . 0.0 110.966 166.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -77.32 178.25 7.28 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.719 -0.613 . . . . 0.0 110.119 169.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.49 164.72 22.78 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.945 0.898 . . . . 0.0 110.423 172.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 89.0 p -110.31 -5.3 15.28 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -109.69 -177.13 21.2 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.664 1.126 . . . . 0.0 111.569 -174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.66 116.08 4.38 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 123.362 2.708 . . . . 0.0 109.299 175.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.1 m -161.61 38.99 0.13 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.768 2.427 . . . . 0.0 108.116 169.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.4 t -89.5 -77.95 0.37 Allowed 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 162.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.532 0 N-CA-C 104.763 -3.335 . . . . 0.0 104.763 126.726 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.949 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 74.7 m -132.47 122.02 24.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.869 1.668 . . . . 0.0 108.671 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 p -87.08 65.34 8.87 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.2 1.4 . . . . 0.0 112.911 -165.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -67.41 -167.72 3.51 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.939 0.78 . . . . 0.0 111.983 170.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 p -54.39 123.34 12.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.022 0.929 . . . . 0.0 110.64 173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.3 m -76.65 -176.88 3.98 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.088 0.555 . . . . 0.0 110.471 164.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -136.96 41.85 1.37 Allowed Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.336 1.445 . . . . 0.0 109.996 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -149.03 28.78 0.82 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.84 2.056 . . . . 0.0 110.044 -171.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -144.19 103.54 4.01 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -158.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -112.4 11.57 19.97 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.389 1.475 . . . . 0.0 110.993 -173.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -57.69 146.14 31.94 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.171 0.989 . . . . 0.0 110.382 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.9 mt -91.59 52.0 1.97 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.664 1.585 . . . . 0.0 108.735 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.4 t 46.48 79.79 0.05 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.616 2.366 . . . . 0.0 113.892 173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.81 7.97 18.93 Favored 'General case' 0 CA--C 1.547 0.86 0 O-C-N 121.22 -0.925 . . . . 0.0 111.792 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.04 167.35 13.77 Favored Pre-proline 0 CA--C 1.537 0.478 0 O-C-N 119.563 -1.96 . . . . 0.0 109.068 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -63.76 141.02 77.05 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 121.446 1.431 . . . . 0.0 109.775 172.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.34 138.75 45.44 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 163.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.36 153.49 55.87 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.276 1.984 . . . . 0.0 111.918 -168.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -66.71 161.74 40.43 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 121.488 1.459 . . . . 0.0 110.343 169.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -77.48 173.82 11.55 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.105 0.562 . . . . 0.0 109.744 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -51.99 125.31 31.33 Favored Pre-proline 0 C--O 1.239 0.518 0 CA-C-O 117.819 -1.086 . . . . 0.0 109.487 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.54 135.82 47.44 Favored 'Trans proline' 0 N--CA 1.452 -0.949 0 C-N-CA 121.699 1.6 . . . . 0.0 109.78 169.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -91.37 134.47 34.58 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.841 1.256 . . . . 0.0 108.197 168.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.49 143.61 15.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 167.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.7 p -127.51 -97.45 0.4 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 166.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.84 135.69 56.8 Favored 'General case' 0 C--N 1.333 -0.132 0 C-N-CA 126.05 1.74 . . . . 0.0 109.152 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.71 148.22 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 119.5 1.045 . . . . 0.0 110.654 168.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 16.6 p -137.82 -169.72 2.61 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.622 1.569 . . . . 0.0 109.547 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.3 pttt -57.55 -41.17 80.46 Favored 'General case' 0 C--O 1.223 -0.342 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.377 175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -136.58 12.63 3.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.298 0.954 . . . . 0.0 112.481 -169.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -141.82 158.43 43.81 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 119.472 1.033 . . . . 0.0 110.336 177.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -151.97 134.14 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 124.318 1.047 . . . . 0.0 108.782 172.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 86.1 m -85.6 130.32 34.6 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.919 0.888 . . . . 0.0 108.984 171.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 38.9 mt -109.49 146.12 35.11 Favored 'General case' 0 CA--C 1.51 -0.587 0 C-N-CA 126.003 1.721 . . . . 0.0 107.835 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.657 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.82 102.34 3.77 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 124.778 1.299 . . . . 0.0 107.993 -163.625 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.552 ' CH2' HD11 ' A' ' 51' ' ' ILE . 36.3 p90 -119.87 158.76 25.96 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.062 0.846 . . . . 0.0 110.986 -175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -81.77 134.94 49.5 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 164.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.3 157.76 56.14 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 123.868 3.045 . . . . 0.0 109.008 170.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -96.58 -176.62 35.58 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 124.752 1.168 . . . . 0.0 111.653 177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.17 150.57 68.38 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.073 1.349 . . . . 0.0 109.855 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -75.11 -167.66 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 125.237 3.958 . . . . 0.0 112.54 169.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.61 -109.39 0.25 Allowed Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 169.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.0 p -66.63 -46.09 76.94 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.105 2.162 . . . . 0.0 111.17 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 HD13 ' HG2' ' A' ' 94' ' ' PRO . 49.1 mt -128.46 162.27 51.92 Favored Pre-proline 0 C--O 1.237 0.399 0 C-N-CA 124.14 0.976 . . . . 0.0 109.793 -164.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.14 145.28 27.51 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.159 1.906 . . . . 0.0 108.159 177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.84 158.38 25.24 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 163.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 -47.99 1.98 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.101 -170.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.23 -166.26 0.88 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 172.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -128.78 162.04 28.37 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.155 1.782 . . . . 0.0 109.217 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 mt -126.84 152.19 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 128.733 2.813 . . . . 0.0 106.718 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.552 HD11 ' CH2' ' A' ' 36' ' ' TRP . 95.2 mt -137.94 105.22 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -101.04 136.67 40.51 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.743 1.217 . . . . 0.0 108.755 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -110.72 165.21 12.01 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.015 1.326 . . . . 0.0 109.258 174.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -137.89 145.26 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 124.804 1.242 . . . . 0.0 107.85 170.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.7 t -154.46 119.79 5.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 163.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -66.22 -19.06 65.71 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.63 12.77 22.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.019 0.928 . . . . 0.0 111.37 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.4 t -124.22 -59.82 1.95 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.4 m -158.86 137.56 11.04 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 126.384 1.874 . . . . 0.0 108.079 171.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -70.03 -17.51 63.26 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 119.001 0.819 . . . . 0.0 111.617 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.5 m -68.3 143.28 55.28 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 121.611 -0.68 . . . . 0.0 109.548 169.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 50.9 m95 -67.15 144.83 55.82 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 165.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -125.67 118.18 25.09 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 m -74.93 93.43 2.68 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 m -88.25 -17.67 8.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 123.764 0.826 . . . . 0.0 111.076 -172.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.28 149.47 34.92 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 157.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -138.97 147.97 42.89 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.477 1.911 . . . . 0.0 106.216 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.43 ' O ' ' HE2' ' A' ' 70' ' ' LYS . 8.9 m170 57.99 51.2 9.16 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.04 0.936 . . . . 0.0 111.211 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 66.2 t -82.61 139.11 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 125.389 1.476 . . . . 0.0 107.335 169.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 68' ' ' HIS . 3.5 mtmt -119.15 25.36 10.21 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.62 1.168 . . . . 0.0 112.243 -178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.2 t -143.93 173.2 11.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.177 0.991 . . . . 0.0 108.828 -176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 p -103.56 2.51 33.56 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 127.127 2.171 . . . . 0.0 112.042 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.657 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 4.7 tp -140.04 114.83 9.5 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.972 1.709 . . . . 0.0 107.425 -172.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -145.65 120.97 10.24 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 118.148 0.431 . . . . 0.0 111.9 -176.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 28.7 m -66.8 101.4 0.81 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.485 1.914 . . . . 0.0 109.08 164.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.4 t -64.92 144.83 14.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 162.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 50.7 mtt-85 -136.91 178.58 6.97 Favored 'General case' 0 CA--C 1.523 -0.088 0 C-N-CA 125.23 1.412 . . . . 0.0 110.502 -174.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.33 15.56 80.79 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 123.5 0.571 . . . . 0.0 112.557 170.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 66.7 mt -84.08 -172.75 4.33 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 117.704 0.752 . . . . 0.0 110.291 -169.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -114.25 146.62 36.17 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 125.563 1.545 . . . . 0.0 107.811 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -77.71 154.12 30.39 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.492 2.128 . . . . 0.0 110.374 174.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 50.4 t30 47.62 44.95 17.73 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.664 1.186 . . . . 0.0 111.465 -175.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.9 m -131.13 136.26 48.19 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 15.0 mm -74.15 146.65 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.916 -1.038 . . . . 0.0 109.189 171.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -135.87 148.65 48.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.052 0.845 . . . . 0.0 109.457 165.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.25 161.02 15.64 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.617 -1.174 . . . . 0.0 107.899 158.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -143.85 143.12 31.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 126.001 2.063 . . . . 0.0 107.814 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 13.2 mtm -136.67 125.65 24.33 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 129.209 3.004 . . . . 0.0 107.479 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 25.1 t -94.59 145.78 7.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 175.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.434 ' HD3' HD13 ' A' ' 97' ' ' LEU . 35.1 mtt180 -131.63 128.6 39.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 167.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 125.12 33.97 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 172.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -86.27 148.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 125.707 1.603 . . . . 0.0 109.549 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -135.77 179.81 1.27 Allowed Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.221 1.809 . . . . 0.0 107.403 166.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.435 ' HG2' HD13 ' A' ' 44' ' ' LEU . 88.2 Cg_endo -74.67 -0.1 9.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 CA-C-N 122.4 1.893 . . . . 0.0 113.812 -172.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.0 mm-40 -116.72 -37.91 3.57 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 124.981 1.312 . . . . 0.0 110.301 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.26 -141.39 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.434 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -142.9 159.52 42.09 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 127.753 2.421 . . . . 0.0 106.729 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.0 p -72.05 166.61 21.9 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 123.333 0.653 . . . . 0.0 110.244 -169.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.31 148.42 3.28 Favored Pre-proline 0 C--O 1.244 0.771 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 160.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.33 130.17 20.63 Favored 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 121.923 1.749 . . . . 0.0 108.631 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.3 p -54.62 161.73 2.05 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.119 0.568 . . . . 0.0 111.817 165.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.93 138.14 69.36 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.342 2.028 . . . . 0.0 110.649 159.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -58.64 150.24 23.75 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.913 0.779 . . . . 0.0 109.999 170.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 88.2 p -63.14 -4.58 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.25 149.87 0.11 Allowed Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.935 1.694 . . . . 0.0 110.808 -163.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -74.01 99.02 1.13 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.134 1.889 . . . . 0.0 112.636 -164.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 15.0 p -77.46 155.22 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 123.432 0.693 . . . . 0.0 109.167 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -108.1 150.95 26.53 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.108 1.363 . . . . 0.0 109.901 166.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.4 p -77.7 167.95 20.75 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.789 0.804 . . . . 0.0 111.407 164.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -77.45 178.82 6.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.275 0.63 . . . . 0.0 109.943 169.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -81.86 167.13 19.31 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.802 0.841 . . . . 0.0 109.404 170.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.6 t -103.81 -0.22 29.51 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.268 2.227 . . . . 0.0 111.884 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -60.26 112.29 4.37 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 117.931 -1.483 . . . . 0.0 110.103 174.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.11 79.85 3.22 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.295 2.664 . . . . 0.0 110.895 -170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.1 t -134.4 138.03 44.51 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.8 m -166.6 164.23 16.93 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 129.027 2.931 . . . . 0.0 107.689 171.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 N-CA-C 106.433 -2.667 . . . . 0.0 106.433 179.063 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.748 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -52.5 158.1 1.34 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 118.372 1.086 . . . . 0.0 112.502 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.3 p -138.59 -39.19 0.52 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -166.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.7 -142.52 16.09 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -160.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.1 m -110.17 -29.78 8.03 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.704 1.202 . . . . 0.0 112.797 173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.1 t -172.98 151.11 2.11 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 125.75 1.62 . . . . 0.0 107.505 176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.16 -126.93 2.72 Favored Glycine 0 N--CA 1.452 -0.253 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -68.5 137.11 54.14 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 170.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -140.2 152.26 45.86 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 159.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -95.25 141.54 28.72 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 166.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.26 0.18 5.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.562 1.145 . . . . 0.0 113.153 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.22 65.06 5.25 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 127.354 2.262 . . . . 0.0 110.543 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.95 156.57 30.55 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.566 2.346 . . . . 0.0 108.08 174.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.15 -28.24 67.13 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.214 -0.929 . . . . 0.0 109.871 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.6 mt -60.89 154.93 56.48 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 126.893 2.077 . . . . 0.0 111.667 -171.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.43 149.6 84.6 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.434 2.089 . . . . 0.0 111.26 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -51.79 134.25 35.36 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 172.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.88 154.71 72.79 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 CA-C-N 119.996 1.898 . . . . 0.0 111.361 -175.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -60.81 168.55 6.92 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.743 2.295 . . . . 0.0 111.772 177.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.86 171.67 12.27 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 161.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -61.22 144.47 91.38 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -67.58 129.1 19.3 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.496 1.464 . . . . 0.0 111.337 161.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -81.64 158.18 24.4 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.017 2.127 . . . . 0.0 109.218 158.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.8 t -119.99 121.19 65.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 113.337 -1.756 . . . . 0.0 107.141 -175.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.1 p -116.2 -95.67 0.47 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 118.638 -0.696 . . . . 0.0 109.329 -167.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -76.27 143.28 41.01 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.6 1.56 . . . . 0.0 109.653 175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.9 p -141.37 148.96 20.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 123.719 0.808 . . . . 0.0 110.685 170.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 35.7 p -135.8 -168.33 2.19 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 125.399 1.48 . . . . 0.0 108.021 172.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 pttt -71.11 -16.32 62.56 Favored 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.444 -1.41 . . . . 0.0 112.642 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -152.36 15.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.463 0 O-C-N 120.099 -1.626 . . . . 0.0 112.633 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -139.43 161.85 36.47 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 172.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.46 140.16 7.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 C-N-CA 125.446 1.499 . . . . 0.0 108.111 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.4 m -92.74 126.47 37.84 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.33 1.052 . . . . 0.0 108.642 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -107.35 139.8 41.27 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.133 1.773 . . . . 0.0 107.363 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.3 t -134.64 138.69 44.7 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 51' ' ' ILE . 14.1 p90 -139.32 171.19 14.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.199 0.523 . . . . 0.0 111.474 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -98.87 148.83 35.1 Favored Pre-proline 0 C--O 1.238 0.498 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 160.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -82.24 161.49 17.67 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 123.546 2.831 . . . . 0.0 111.44 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -83.1 -173.3 49.56 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 165.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -80.41 171.78 11.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 125.158 1.383 . . . . 0.0 108.588 169.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -71.31 -156.51 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.151 3.234 . . . . 0.0 109.565 167.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -140.9 -131.75 2.75 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 108.354 -1.899 . . . . 0.0 108.354 167.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 p -55.53 -27.58 49.66 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.942 2.097 . . . . 0.0 112.118 164.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 51.9 mt -144.58 162.39 39.28 Favored Pre-proline 0 N--CA 1.449 -0.498 0 C-N-CA 127.612 2.365 . . . . 0.0 109.543 -156.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 92.6 Cg_endo -76.37 158.34 36.84 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.091 3.194 . . . . 0.0 110.989 -178.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -94.68 128.9 41.67 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 170.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.96 -27.53 10.12 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 123.129 0.572 . . . . 0.0 111.508 -165.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.75 -165.97 1.64 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 160.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -128.83 169.74 14.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 126.785 2.034 . . . . 0.0 109.354 167.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -130.75 157.1 43.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 127.608 2.363 . . . . 0.0 107.214 171.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.492 HD11 ' CH2' ' A' ' 36' ' ' TRP . 55.9 mt -125.43 133.08 70.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 165.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -113.4 158.42 20.66 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 171.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -136.78 146.68 46.01 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.368 1.067 . . . . 0.0 108.223 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -109.34 146.88 33.64 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 166.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.53 124.94 5.21 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.677 0.671 . . . . 0.0 109.346 170.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -70.54 -34.97 72.86 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -169.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.27 7.41 11.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.85 0.75 . . . . 0.0 112.276 177.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.5 t -121.68 -55.34 3.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 124.717 1.207 . . . . 0.0 107.944 -171.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.9 t -141.31 -98.3 0.14 Allowed 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 p30 140.49 -17.18 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 128.778 2.831 . . . . 0.0 111.119 -149.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.2 m -119.02 150.98 39.04 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.294 1.038 . . . . 0.0 110.187 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -70.6 121.86 18.67 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -118.84 143.52 46.9 Favored 'General case' 0 CA--C 1.507 -0.698 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.323 -174.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.92 93.95 3.3 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -174.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 m -84.66 -15.43 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 O-C-N 121.56 -0.712 . . . . 0.0 111.084 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -154.08 152.38 30.39 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.103 0.961 . . . . 0.0 108.944 161.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -142.93 170.24 16.07 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.762 0.825 . . . . 0.0 111.355 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 51.97 38.19 23.08 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 121.915 0.864 . . . . 0.0 112.422 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.5 t -83.65 127.84 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 125.845 1.658 . . . . 0.0 108.449 -174.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -113.34 29.96 7.58 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.701 0.801 . . . . 0.0 112.253 -172.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -150.47 173.6 13.88 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.17 1.388 . . . . 0.0 108.305 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.2 p -98.48 2.9 48.12 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 127.658 2.383 . . . . 0.0 112.186 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.28 117.1 10.98 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 119.583 1.083 . . . . 0.0 110.325 -176.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -146.1 151.41 37.64 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.545 0.738 . . . . 0.0 111.591 -176.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.4 m -101.19 103.4 14.43 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.142 1.377 . . . . 0.0 109.21 175.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.1 139.21 21.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 168.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -139.93 176.07 9.05 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.958 1.303 . . . . 0.0 111.386 -177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 74.23 20.77 79.59 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.63 0.633 . . . . 0.0 112.35 172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.9 mt -85.42 -175.79 5.83 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.489 0.715 . . . . 0.0 110.403 -171.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 12.4 mtp180 -98.16 145.06 29.16 Favored Pre-proline 0 N--CA 1.473 0.697 0 CA-C-O 117.758 -1.115 . . . . 0.0 110.043 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -75.61 159.38 39.18 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.73 2.953 . . . . 0.0 111.686 173.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 63.6 t30 45.54 38.13 3.67 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.645 1.978 . . . . 0.0 111.842 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.2 m -132.18 134.13 45.02 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 124.538 1.135 . . . . 0.0 108.817 -170.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 24.5 mm -70.34 141.52 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.09 173.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -139.17 154.48 48.08 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 125.056 1.473 . . . . 0.0 108.077 167.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 22.8 mt -108.25 165.69 11.31 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 125.051 1.34 . . . . 0.0 108.302 164.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -137.28 140.07 41.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.952 0.782 . . . . 0.0 109.953 170.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 28.2 mtm -118.86 167.71 11.45 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 161.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 65.7 t -123.94 155.82 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.02 -1.844 . . . . 0.0 106.02 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -133.78 141.66 47.57 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 165.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.54 142.81 27.57 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 165.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -105.74 147.07 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 C-N-CA 124.492 1.117 . . . . 0.0 109.243 175.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.81 171.2 6.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 124.083 0.953 . . . . 0.0 109.312 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -75.95 22.64 0.47 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 123.683 2.922 . . . . 0.0 114.929 -177.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -131.55 -34.3 1.38 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.905 1.682 . . . . 0.0 111.201 172.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.14 -165.26 33.14 Favored Glycine 0 C--N 1.336 0.577 0 CA-C-N 119.515 1.052 . . . . 0.0 111.035 -176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.8 mp -98.5 148.55 23.63 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 163.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 p -73.07 166.42 23.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -51.1 143.76 15.8 Favored Pre-proline 0 N--CA 1.466 0.355 0 C-N-CA 126.823 2.049 . . . . 0.0 110.301 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.99 127.77 22.29 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.858 1.705 . . . . 0.0 113.07 -171.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -54.37 160.68 2.4 Favored Pre-proline 0 CA--C 1.536 0.405 0 C-N-CA 126.669 1.988 . . . . 0.0 112.666 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -54.94 120.79 8.74 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.136 1.891 . . . . 0.0 109.354 156.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.0 ptp -77.58 151.76 34.29 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 120.194 1.361 . . . . 0.0 109.182 178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 15.4 t -58.95 154.47 15.29 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.464 1.106 . . . . 0.0 109.402 171.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.48 150.02 57.7 Favored Pre-proline 0 N--CA 1.475 0.792 0 O-C-N 120.874 -1.141 . . . . 0.0 109.465 158.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -65.09 102.98 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 123.104 2.536 . . . . 0.0 110.905 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.03 163.29 3.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -122.07 141.66 51.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.986 1.314 . . . . 0.0 107.655 164.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.8 p -68.07 161.08 27.58 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 168.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -66.74 -175.27 0.38 Allowed 'General case' 0 C--O 1.235 0.33 0 CA-C-O 122.995 1.379 . . . . 0.0 109.205 163.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -104.34 153.84 20.55 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 113.325 -1.761 . . . . 0.0 111.065 -174.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.9 p -87.88 46.1 1.35 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.049 1.74 . . . . 0.0 111.939 -169.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -151.03 -140.46 3.18 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.258 1.408 . . . . 0.0 110.227 -173.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -62.27 126.17 17.98 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.437 2.091 . . . . 0.0 109.309 172.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.9 t -141.62 124.77 16.36 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.77 2.028 . . . . 0.0 106.669 -167.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 51.1 m 52.75 178.46 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.208 1.403 . . . . 0.0 111.85 -158.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 N-CA-C 103.645 -3.782 . . . . 0.0 103.645 178.043 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.091 0 N-CA-C 107.596 -2.202 . . . . 0.0 107.596 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 t 57.75 177.85 0.05 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.098 0.949 . . . . 0.0 110.354 -149.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.7 m -164.55 178.73 7.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.512 2.725 . . . . 0.0 107.672 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.62 -172.73 52.31 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -175.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.4 m -153.71 142.59 21.11 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.449 -1.03 . . . . 0.0 108.39 175.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 m -176.18 176.59 1.69 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 129.087 2.955 . . . . 0.0 106.48 176.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 140.49 -68.82 0.47 Allowed Glycine 0 C--N 1.336 0.569 0 O-C-N 121.412 -0.805 . . . . 0.0 111.271 166.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.79 167.61 11.53 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 159.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -129.86 100.68 5.56 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -91.69 26.12 2.47 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.996 1.318 . . . . 0.0 113.379 -163.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -57.38 166.36 1.23 Allowed 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.766 1.626 . . . . 0.0 112.694 -177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp -79.69 -106.03 0.02 OUTLIER 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.888 0.875 . . . . 0.0 109.431 176.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.1 149.15 52.14 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 126.441 1.897 . . . . 0.0 107.686 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -19.38 65.96 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.68 1.592 . . . . 0.0 111.043 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.1 mt -78.5 162.61 65.3 Favored Pre-proline 0 N--CA 1.446 -0.631 0 C-N-CA 127.632 2.373 . . . . 0.0 110.353 -173.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -61.02 150.57 83.51 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.285 1.99 . . . . 0.0 108.872 172.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -59.37 147.97 41.61 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 163.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -69.52 147.1 63.67 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.143 1.896 . . . . 0.0 111.431 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -66.0 165.14 24.85 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.411 2.074 . . . . 0.0 110.528 168.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.2 p -67.71 169.39 9.61 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 121.787 -0.571 . . . . 0.0 110.763 177.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -48.62 127.65 13.54 Favored Pre-proline 0 C--O 1.24 0.603 0 CA-C-O 117.319 -1.324 . . . . 0.0 107.538 155.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.48 142.82 45.67 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 CA-C-N 120.787 1.317 . . . . 0.0 110.261 170.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -79.43 161.4 26.15 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 125.53 1.532 . . . . 0.0 109.351 163.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -124.35 105.21 14.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -110.65 -62.24 1.56 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.838 1.655 . . . . 0.0 111.124 -169.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -111.02 136.0 50.69 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.216 1.807 . . . . 0.0 110.738 -177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.26 150.39 17.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 119.855 1.207 . . . . 0.0 110.588 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.5 p -139.88 -174.54 3.94 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.345 1.858 . . . . 0.0 107.818 176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.505 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 0.0 OUTLIER -72.6 -24.77 61.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 120.385 -1.447 . . . . 0.0 112.461 -175.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -131.81 4.65 4.2 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.167 1.349 . . . . 0.0 110.959 -177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.7 m -150.78 163.61 38.18 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 120.525 1.511 . . . . 0.0 110.356 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 p -156.74 136.76 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.145 1.378 . . . . 0.0 108.155 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 m -80.3 140.72 36.04 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 166.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.1 mt -114.55 150.05 35.54 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 162.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.0 t -138.16 134.68 34.85 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 124.447 1.099 . . . . 0.0 108.515 173.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -138.98 170.23 16.35 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 123.485 0.714 . . . . 0.0 110.387 176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -91.32 138.08 25.8 Favored Pre-proline 0 N--CA 1.446 -0.645 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 164.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.66 140.45 47.08 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.99 3.127 . . . . 0.0 107.62 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.93 163.07 43.35 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 41' ' ' PRO . 3.0 m -73.3 143.36 82.95 Favored Pre-proline 0 N--CA 1.433 -1.308 0 C-N-CA 126.009 1.723 . . . . 0.0 110.938 -164.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' O ' HG22 ' A' ' 40' ' ' THR . 61.2 Cg_endo -71.53 -169.13 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 124.438 3.426 . . . . 0.0 111.758 166.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.82 -114.09 0.54 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 163.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.3 p -47.05 -40.68 15.39 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.763 2.825 . . . . 0.0 112.607 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 55.9 mt -134.7 163.24 52.58 Favored Pre-proline 0 N--CA 1.449 -0.504 0 C-N-CA 124.273 1.029 . . . . 0.0 109.277 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.62 171.31 15.9 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.664 2.909 . . . . 0.0 110.809 176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.03 107.14 16.91 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.253 1.021 . . . . 0.0 109.064 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' HG22 ' A' ' 92' ' ' ILE . 14.4 m -58.91 -51.4 70.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 128.144 2.578 . . . . 0.0 112.388 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -166.0 -164.88 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 O-C-N 120.973 -1.079 . . . . 0.0 108.191 -179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -129.72 164.23 24.44 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 126.9 2.08 . . . . 0.0 108.63 168.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.4 mt -120.34 154.84 23.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 127.131 2.172 . . . . 0.0 106.563 161.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 51.9 mt -116.62 124.97 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 156.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -100.78 151.92 21.12 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.61 151.38 51.65 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -123.47 151.0 43.18 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 169.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 9.8 t -140.53 136.17 32.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -56.85 -50.84 71.21 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.599 163.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 m -73.7 25.37 0.07 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 129.04 2.936 . . . . 0.0 113.469 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 71.8 t -135.7 -62.55 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -145.43 -5.38 0.66 Allowed 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -165.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.1 t30 46.63 36.52 3.75 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 125.372 1.469 . . . . 0.0 111.931 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.8 m -149.97 157.85 43.58 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 128.412 2.685 . . . . 0.0 105.187 -169.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -86.91 154.02 21.15 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -136.34 146.03 46.1 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 167.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.8 m -71.32 128.5 36.09 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 m -125.16 -12.36 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -171.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -155.18 74.94 0.93 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.347 1.859 . . . . 0.0 108.834 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -83.71 144.64 29.23 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 128.21 2.604 . . . . 0.0 109.185 -170.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.403 ' O ' ' HE3' ' A' ' 70' ' ' LYS . 57.8 m-70 38.32 60.81 1.23 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.911 2.085 . . . . 0.0 111.8 -169.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -80.53 145.56 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.403 ' HE3' ' O ' ' A' ' 68' ' ' HIS . 0.1 OUTLIER -128.17 40.68 3.63 Favored 'General case' 0 C--N 1.332 -0.153 0 C-N-CA 125.17 1.388 . . . . 0.0 110.355 178.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.4 t -148.0 -176.93 5.47 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -114.99 2.31 14.21 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 128.675 2.79 . . . . 0.0 110.991 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.3 mp -135.43 143.85 46.16 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 123.531 0.733 . . . . 0.0 109.271 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -146.26 129.74 16.87 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 172.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.5 m -71.6 94.49 1.33 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.377 1.471 . . . . 0.0 107.515 161.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 48.7 t -63.97 138.02 23.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -134.99 179.82 6.08 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.917 1.287 . . . . 0.0 110.045 -178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.42 22.15 79.07 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 119.862 -0.41 . . . . 0.0 112.38 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 73.4 mt -87.0 172.36 10.05 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 122.576 1.179 . . . . 0.0 110.087 -178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 56.2 mtt85 -103.4 149.73 37.3 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 125.668 1.587 . . . . 0.0 107.345 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.11 160.02 40.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 121.779 1.653 . . . . 0.0 110.338 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 t30 46.5 33.15 1.85 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.018 1.327 . . . . 0.0 111.633 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 68.8 m -119.99 126.91 52.01 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -174.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.59 148.19 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.208 173.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -139.92 146.65 39.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.289 169.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 13.7 mt -107.92 156.69 18.92 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 160.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -137.33 146.7 44.9 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 125.683 1.865 . . . . 0.0 107.816 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 45.0 mtm -134.53 137.84 44.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 160.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.6 t -94.95 139.05 19.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 170.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.551 ' HD3' HD22 ' A' ' 97' ' ' LEU . 73.6 mtt180 -120.43 146.53 46.12 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 168.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 163.97 16.49 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 161.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.2 OUTLIER -126.46 150.86 32.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 126.665 1.986 . . . . 0.0 108.806 174.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -154.85 169.91 9.45 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 124.407 1.083 . . . . 0.0 110.165 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -73.98 19.24 0.42 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 123.06 2.506 . . . . 0.0 114.982 -174.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -127.85 -58.71 1.22 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 126.288 1.835 . . . . 0.0 110.091 166.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.66 -173.36 17.82 Favored Glycine 0 CA--C 1.523 0.581 0 CA-C-O 121.836 0.686 . . . . 0.0 113.983 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.1 mp -81.69 157.08 24.74 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 162.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 98.6 p -71.64 168.43 17.71 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 123.875 0.87 . . . . 0.0 109.757 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -41.6 142.19 1.07 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 151.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.59 156.15 64.57 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.676 1.584 . . . . 0.0 109.346 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.5 p -68.59 166.53 25.52 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 121.891 -0.505 . . . . 0.0 110.296 164.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -54.58 146.53 53.08 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.79 2.327 . . . . 0.0 111.17 163.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.9 mtm -60.2 144.85 49.08 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 118.29 0.496 . . . . 0.0 110.14 171.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 54.0 p -62.93 -11.39 18.23 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 126.238 1.815 . . . . 0.0 115.175 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.3 t0 69.62 156.46 0.15 Allowed Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.155 1.782 . . . . 0.0 109.411 -153.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -76.07 101.15 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.411 2.074 . . . . 0.0 111.375 -173.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.27 165.45 2.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 166.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 4.5 ttt180 -127.34 141.05 51.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.559 2.344 . . . . 0.0 107.612 169.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 12.6 p -74.39 161.14 30.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 119.044 0.838 . . . . 0.0 109.527 163.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -67.22 165.66 15.69 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.745 0.783 . . . . 0.0 109.896 174.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -89.04 39.65 0.94 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 123.608 1.67 . . . . 0.0 112.498 -172.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.505 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 22.8 t 65.57 -71.43 0.08 Allowed 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 126.964 2.106 . . . . 0.0 111.001 -173.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -154.28 76.27 0.22 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 125.408 1.48 . . . . 0.0 109.68 -173.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.34 86.64 0.52 Allowed 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.883 2.389 . . . . 0.0 107.956 169.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 22.7 m 56.47 -177.48 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.397 1.479 . . . . 0.0 112.25 -162.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -117.83 62.09 0.76 Allowed 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 N-CA-C 105.344 -3.102 . . . . 0.0 105.344 -167.731 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.877 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 t -85.24 161.31 19.62 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 118.43 1.115 . . . . 0.0 109.244 168.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 p -155.31 164.8 38.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.717 1.207 . . . . 0.0 108.903 170.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.12 -162.78 54.54 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -173.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 t 58.08 -167.2 0.14 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.007 0.923 . . . . 0.0 110.238 -166.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.6 m -76.2 38.39 0.17 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.599 1.959 . . . . 0.0 112.46 -175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.68 119.75 13.08 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 120.805 -1.184 . . . . 0.0 110.89 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.0 pttt -67.61 167.0 13.86 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.301 1.05 . . . . 0.0 108.627 159.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -137.82 110.45 7.56 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 171.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 16.2 t80 78.1 -58.89 0.45 Allowed 'General case' 0 C--O 1.232 0.177 0 C-N-CA 127.828 2.451 . . . . 0.0 112.185 167.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -146.26 168.91 19.9 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.355 1.462 . . . . 0.0 108.23 172.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -81.78 40.76 0.61 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.787 0.835 . . . . 0.0 110.945 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.7 m 60.49 67.09 0.86 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.277 2.231 . . . . 0.0 111.232 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.62 56.96 4.08 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 122.836 1.303 . . . . 0.0 110.308 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.0 mt -130.99 156.75 79.69 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 126.278 1.831 . . . . 0.0 109.062 -177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -75.93 164.91 30.89 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.22 2.613 . . . . 0.0 111.457 -176.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -68.97 149.65 49.5 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.75 141.01 44.11 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.334 2.689 . . . . 0.0 110.857 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -65.74 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.689 1.593 . . . . 0.0 110.203 170.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 m -79.96 171.19 15.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.144 0.497 . . . . 0.0 110.534 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -57.25 122.1 51.93 Favored Pre-proline 0 C--O 1.235 0.337 0 CA-C-O 118.363 -0.827 . . . . 0.0 109.099 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -64.97 156.41 62.67 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.5 1.466 . . . . 0.0 109.358 174.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -122.75 124.68 43.91 Favored 'General case' 0 CA--C 1.497 -1.083 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.8 m -62.88 151.24 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.429 0 CA-C-N 114.496 -1.229 . . . . 0.0 108.787 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 p -136.53 -75.65 0.43 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 123.541 0.736 . . . . 0.0 109.47 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.12 135.46 37.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 170.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.4 p -141.77 157.19 20.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 162.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.5 p -141.13 -64.97 0.44 Allowed 'General case' 0 C--O 1.213 -0.862 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -173.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 pttt -168.24 -39.25 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 127.208 2.203 . . . . 0.0 107.414 171.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -129.22 5.04 5.26 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.916 0.886 . . . . 0.0 110.863 -172.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.7 p -152.5 152.17 31.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 118.592 0.633 . . . . 0.0 110.988 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -153.59 127.31 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -172.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 92.8 m -77.98 148.09 34.59 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 171.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 87' ' ' PHE . 70.2 mt -128.35 138.97 52.61 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 126.647 1.979 . . . . 0.0 108.256 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -134.3 94.91 3.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 124.789 1.306 . . . . 0.0 110.74 -171.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 38.4 p90 -109.26 170.72 7.87 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.901 0.858 . . . . 0.0 111.225 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -101.53 140.09 20.95 Favored Pre-proline 0 N--CA 1.444 -0.725 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 166.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -71.01 171.19 16.33 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.521 2.814 . . . . 0.0 109.26 177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.75 -130.44 2.48 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 107.619 -2.193 . . . . 0.0 107.619 160.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -145.08 165.77 20.72 Favored Pre-proline 0 C--O 1.241 0.619 0 C-N-CA 125.177 1.391 . . . . 0.0 107.916 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.84 -147.68 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.991 1 C-N-CA 125.892 4.395 . . . . 0.0 110.201 167.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 156.16 -91.68 0.12 Allowed Glycine 0 N--CA 1.45 -0.403 0 N-CA-C 106.509 -2.636 . . . . 0.0 106.509 170.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.7 p -62.78 -52.97 61.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 126.136 1.774 . . . . 0.0 109.928 172.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 33.6 mt -133.69 163.9 47.86 Favored Pre-proline 0 C--O 1.237 0.441 0 C-N-CA 123.889 0.876 . . . . 0.0 110.818 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -71.52 174.27 11.19 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.968 3.112 . . . . 0.0 110.856 167.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.85 108.1 19.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.9 m -54.82 -53.06 60.22 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 127.489 2.315 . . . . 0.0 111.913 178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.08 -166.36 1.69 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.37 1.468 . . . . 0.0 107.255 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -131.03 160.27 35.08 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 126.622 1.969 . . . . 0.0 107.929 172.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.2 mt -118.73 156.19 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 127.12 2.168 . . . . 0.0 107.564 167.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 67.0 mt -129.8 128.51 65.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 167.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 169.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 86' ' ' LEU . . . -148.23 139.15 23.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.648 1.179 . . . . 0.0 107.84 174.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.89 129.96 55.48 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 125.326 1.45 . . . . 0.0 108.149 170.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.5 112.93 8.33 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.14 -20.66 60.87 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.87 3.45 26.08 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.492 1.117 . . . . 0.0 112.357 171.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.04 -80.65 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 C-N-CA 126.252 1.821 . . . . 0.0 106.695 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 19.6 m -133.12 -5.41 3.06 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 118.932 0.787 . . . . 0.0 112.888 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 65.2 t30 54.57 42.93 30.98 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 121.934 0.873 . . . . 0.0 111.497 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.8 m -140.64 152.39 45.36 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 127.161 2.184 . . . . 0.0 106.946 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.475 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 93.0 m95 -72.17 132.84 44.68 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 157.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -125.54 151.78 45.92 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.352 1.461 . . . . 0.0 107.294 175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.64 127.68 33.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 166.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -111.1 -3.67 10.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 C-N-CA 123.641 0.776 . . . . 0.0 111.23 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 74' ' ' TYR . . . -154.1 126.82 8.15 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.766 1.627 . . . . 0.0 108.454 168.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -115.06 139.89 49.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.767 0.827 . . . . 0.0 110.02 165.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 50.32 69.9 0.57 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 128.148 2.579 . . . . 0.0 114.637 -171.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.0 t -90.7 141.59 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 165.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -124.2 32.67 5.46 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.904 0.882 . . . . 0.0 112.029 177.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.32 165.18 27.88 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 177.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.9 p -90.34 0.48 57.23 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.81 1.644 . . . . 0.0 112.595 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 mp -132.5 133.06 43.33 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.787 1.235 . . . . 0.0 108.78 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 66' ' ' ALA . 76.2 t80 -146.72 152.17 38.38 Favored 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 127.197 2.199 . . . . 0.0 109.17 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.0 m -111.25 112.95 25.09 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.084 1.354 . . . . 0.0 108.626 174.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.7 t -66.22 143.57 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.217 1.407 . . . . 0.0 107.64 168.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -136.25 -175.09 3.87 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.671 0.788 . . . . 0.0 110.723 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 68.87 17.93 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.105 -0.83 . . . . 0.0 113.509 175.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.7 mt -85.79 -163.39 0.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 118.676 1.238 . . . . 0.0 109.112 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -135.84 139.42 30.57 Favored Pre-proline 0 C--O 1.237 0.44 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -173.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.59 158.49 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.431 2.754 . . . . 0.0 111.121 178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 48.64 31.31 2.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 126.235 1.814 . . . . 0.0 113.251 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.5 m -124.44 136.38 53.99 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 125.518 1.527 . . . . 0.0 108.396 -172.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 22.6 mm -76.58 148.04 7.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 124.637 1.175 . . . . 0.0 109.413 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -139.54 153.93 47.55 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.64 2.376 . . . . 0.0 106.335 171.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 53' ' ' ALA . 11.2 mt -112.64 157.0 21.77 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.359 1.463 . . . . 0.0 107.918 154.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.459 ' CD2' HD21 ' A' ' 34' ' ' LEU . 31.1 m-85 -127.03 157.99 38.14 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.692 1.997 . . . . 0.0 110.013 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.475 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 20.0 mtt -128.71 155.89 44.35 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.85 2.06 . . . . 0.0 106.634 164.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 83.9 t -122.3 141.81 41.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 106.303 -1.739 . . . . 0.0 106.303 162.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.841 ' HD3' HD13 ' A' ' 97' ' ' LEU . 83.2 mtt-85 -132.34 146.29 51.87 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.07 156.96 18.51 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.46 152.74 23.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 127.217 2.207 . . . . 0.0 107.226 174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -147.3 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.297 1.039 . . . . 0.0 110.263 178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -59.67 2.87 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.996 3.131 . . . . 0.0 116.463 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -127.91 -37.8 1.89 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.952 1.701 . . . . 0.0 112.018 -175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.28 -150.49 8.45 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -170.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.841 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.5 pp -124.71 157.33 35.91 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.48 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.552 ' O ' HD12 ' A' ' 97' ' ' LEU . 89.1 p -72.5 166.48 22.56 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 124.164 0.986 . . . . 0.0 111.598 -174.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -44.61 152.97 0.49 Allowed Pre-proline 0 C--O 1.243 0.76 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 156.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.14 142.07 49.61 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.239 1.959 . . . . 0.0 110.895 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 94.0 p -60.04 165.41 4.86 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 123.181 0.592 . . . . 0.0 111.131 156.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -61.2 141.65 94.06 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.138 2.558 . . . . 0.0 111.142 158.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.9 mpp? -61.66 147.68 45.08 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.678 -1.264 . . . . 0.0 111.777 166.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 22.5 p -57.31 -18.16 15.58 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 128.598 2.759 . . . . 0.0 116.381 -171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.0 t70 88.06 150.74 0.08 OUTLIER Pre-proline 0 N--CA 1.477 0.889 0 C-N-CA 128.613 2.765 . . . . 0.0 107.156 -153.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -73.2 109.14 2.77 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.98 2.454 . . . . 0.0 108.709 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -103.2 127.72 56.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.218 1.007 . . . . 0.0 109.539 -172.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.16 140.59 30.04 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 174.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 28.8 p -64.19 164.84 10.24 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 160.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -78.75 -175.99 4.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-O 122.302 1.049 . . . . 0.0 108.426 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -74.24 154.42 39.0 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.102 -1.408 . . . . 0.0 109.697 164.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.4 t -79.93 46.18 0.77 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.269 1.828 . . . . 0.0 112.953 -168.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -150.81 -79.36 0.03 OUTLIER Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.048 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -81.39 59.79 7.46 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.963 3.109 . . . . 0.0 112.203 -167.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.1 m -67.42 168.96 9.81 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.523 0.729 . . . . 0.0 110.862 168.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.5 m -125.08 178.33 5.6 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 149.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 N-CA-C 105.259 -3.136 . . . . 0.0 105.259 -150.418 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.702 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.0 p -157.52 158.86 36.47 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 125.497 1.519 . . . . 0.0 109.08 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 p -162.53 -169.99 2.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.841 1.657 . . . . 0.0 107.676 168.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.52 15.58 70.82 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.877 -0.957 . . . . 0.0 115.048 163.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.1 t -137.46 169.12 18.33 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 119.146 1.473 . . . . 0.0 108.92 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -78.46 100.05 6.69 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.68 83.5 0.11 Allowed Glycine 0 C--N 1.335 0.484 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.46 155.77 44.27 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 163.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.32 98.4 6.03 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 -172.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 t80 57.21 -168.67 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.415 0.686 . . . . 0.0 109.886 -161.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -94.17 148.86 21.78 Favored 'General case' 0 CA--C 1.517 -0.309 0 CA-C-O 122.045 0.926 . . . . 0.0 109.351 167.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -81.8 26.12 0.52 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.625 1.57 . . . . 0.0 112.946 -167.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.9 t 122.39 147.65 0.0 OUTLIER 'General case' 0 C--O 1.24 0.555 1 C-N-CA 132.686 4.395 . . . . 0.0 110.188 174.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 67.1 m-20 -76.7 -42.9 39.78 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.005 0.922 . . . . 0.0 109.121 166.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 mt -79.44 159.24 72.66 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 126.808 2.043 . . . . 0.0 111.159 -170.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -74.96 150.45 38.35 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.774 2.316 . . . . 0.0 109.799 170.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.19 159.57 53.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.148 1.356 . . . . 0.0 112.381 -174.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -67.14 124.32 12.03 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.145 2.563 . . . . 0.0 109.784 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -62.56 165.77 14.9 Favored 'Trans proline' 0 CA--C 1.535 0.546 0 C-N-CA 122.73 2.287 . . . . 0.0 112.456 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 m -70.42 162.13 29.23 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.988 0.423 . . . . 0.0 110.567 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 tttt -56.38 121.91 46.01 Favored Pre-proline 0 C--O 1.237 0.408 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.687 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -61.88 142.76 94.38 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.59 1.527 . . . . 0.0 111.119 175.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -122.42 131.91 54.11 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 125.179 1.392 . . . . 0.0 110.102 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.588 HG11 HG11 ' A' ' 107' ' ' VAL . 2.2 m -80.27 142.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.862 0 CA-C-N 114.026 -1.443 . . . . 0.0 109.104 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.3 p -135.64 -42.18 0.69 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.814 -166.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -122.28 145.33 48.33 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 124.794 1.238 . . . . 0.0 108.42 166.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -141.37 151.38 19.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 124.449 1.099 . . . . 0.0 108.099 169.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.2 p -125.24 -43.03 1.96 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.574 1.694 . . . . 0.0 115.574 -168.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 2.1 pttt 143.34 -27.69 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.305 1 C-N-CA 133.719 4.808 . . . . 0.0 110.071 -174.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -138.94 -4.89 1.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.101 1.76 . . . . 0.0 109.995 -173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.01 156.47 47.79 Favored 'General case' 0 N--CA 1.443 -0.798 0 C-N-CA 126.823 2.049 . . . . 0.0 106.937 -176.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 p -154.37 128.63 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 172.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.6 m -80.42 137.05 36.46 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 169.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.1 mt -125.82 146.39 49.82 Favored 'General case' 0 CA--C 1.51 -0.559 0 C-N-CA 126.576 1.95 . . . . 0.0 106.925 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.6 116.96 11.28 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 125.15 1.531 . . . . 0.0 108.263 -166.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.587 ' CH2' HD11 ' A' ' 51' ' ' ILE . 49.3 p90 -139.03 156.91 46.84 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 119.453 1.024 . . . . 0.0 109.55 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.47 144.87 29.42 Favored Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 123.097 0.559 . . . . 0.0 109.96 -178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.65 117.68 3.72 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 123.594 2.862 . . . . 0.0 110.841 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -68.56 174.99 30.72 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 124.734 1.159 . . . . 0.0 110.391 172.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 18.3 m -61.65 153.69 69.63 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 129.091 2.956 . . . . 0.0 110.781 -166.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -69.96 -173.23 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.239 2.626 . . . . 0.0 111.4 169.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -134.11 -160.87 9.41 Favored Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 104.578 -3.409 . . . . 0.0 104.578 160.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 14' ' ' ASP . 0.9 OUTLIER -52.38 -50.03 63.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 113.141 -1.529 . . . . 0.0 109.69 166.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.32 161.58 32.35 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 119.689 1.131 . . . . 0.0 112.203 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -85.96 153.11 9.82 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 124.384 3.389 . . . . 0.0 110.23 172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.99 156.91 37.8 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.896 0.855 . . . . 0.0 111.138 170.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.11 -59.93 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 125.406 1.482 . . . . 0.0 107.798 160.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.67 -170.47 2.92 Favored 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.382 1.073 . . . . 0.0 109.045 -165.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -111.9 163.17 14.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 126.391 1.876 . . . . 0.0 108.269 168.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -116.22 152.12 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 127.573 2.349 . . . . 0.0 107.099 157.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.587 HD11 ' CH2' ' A' ' 36' ' ' TRP . 85.4 mt -132.29 108.38 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -99.89 158.95 15.44 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 174.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.53 150.88 44.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.758 2.023 . . . . 0.0 107.742 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -128.01 150.25 50.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 170.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.69 117.96 4.13 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.995 0.902 . . . . 0.0 110.54 171.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -67.1 -36.45 81.97 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.432 -0.793 . . . . 0.0 111.465 -173.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -71.9 5.98 2.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.114 2.166 . . . . 0.0 113.685 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 37.5 t -127.56 -69.36 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.226 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -168.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.4 m -158.83 121.05 3.55 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.221 2.208 . . . . 0.0 105.471 -173.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -72.18 82.42 1.0 Allowed 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.593 0.633 . . . . 0.0 109.72 175.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m -170.47 159.26 6.84 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.535 2.734 . . . . 0.0 107.524 168.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -76.69 142.35 40.57 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 161.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -130.71 139.64 50.31 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 125.278 1.431 . . . . 0.0 107.943 -175.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.3 m -88.46 94.07 9.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.5 -15.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 124.691 1.196 . . . . 0.0 113.044 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . -142.48 149.73 39.58 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 156.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -134.88 154.07 51.8 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.481 -2.044 . . . . 0.0 105.481 176.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 62.32 29.11 17.25 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 73.8 t -75.8 134.43 29.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 O-C-N 120.698 -1.252 . . . . 0.0 108.193 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.4 mtmt -106.16 -8.49 17.37 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.81 -174.44 3.83 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.009 1.723 . . . . 0.0 109.297 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 41.8 p -120.57 0.97 10.58 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 126.364 1.866 . . . . 0.0 111.929 175.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mp -130.64 137.91 49.83 Favored 'General case' 0 CA--C 1.517 -0.317 0 O-C-N 121.261 -0.899 . . . . 0.0 108.72 161.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -146.16 145.47 30.48 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 118.765 0.711 . . . . 0.0 109.084 174.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.0 m -89.21 106.67 18.59 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.072 1.749 . . . . 0.0 108.578 172.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.33 151.47 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.334 1.054 . . . . 0.0 108.223 164.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 85.8 mtt85 -135.6 -176.16 4.19 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.494 1.518 . . . . 0.0 110.777 174.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.41 7.64 85.29 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 124.968 1.27 . . . . 0.0 114.004 171.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.4 mt -81.56 -177.49 6.55 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 123.148 1.451 . . . . 0.0 110.238 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 91.5 mtt-85 -118.54 151.04 49.19 Favored Pre-proline 0 C--N 1.324 -0.54 0 C-N-CA 126.49 1.916 . . . . 0.0 108.422 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -81.74 156.64 18.43 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.385 2.723 . . . . 0.0 109.929 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 53.58 26.14 5.45 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.788 1.235 . . . . 0.0 111.854 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.1 m -119.68 129.19 54.43 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 126.115 1.766 . . . . 0.0 107.758 -170.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.5 mm -68.84 144.98 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.035 0.934 . . . . 0.0 109.85 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -139.69 153.7 47.31 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 125.989 1.716 . . . . 0.0 109.178 168.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.5 mt -108.08 162.3 14.17 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 125.074 1.35 . . . . 0.0 107.506 160.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -139.69 135.18 32.94 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 125.099 1.499 . . . . 0.0 107.889 172.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.4 mtm -124.45 135.16 53.02 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 26.1 t -94.97 144.37 9.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 173.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.606 ' HD3' HD22 ' A' ' 97' ' ' LEU . 6.3 mtp180 -120.9 150.99 40.22 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 160.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.46 165.15 15.75 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 159.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.47 152.41 31.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 127.232 2.213 . . . . 0.0 108.628 -178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -159.92 178.17 1.78 Allowed Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.888 0.875 . . . . 0.0 111.329 -172.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -58.67 -4.06 1.72 Allowed 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.586 3.524 . . . . 0.0 117.905 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 -130.45 -37.18 1.41 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 120.402 1.455 . . . . 0.0 111.394 -170.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.83 -170.84 34.75 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -168.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.606 HD22 ' HD3' ' A' ' 90' ' ' ARG . 2.2 mp -97.89 166.16 11.59 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 124.469 1.108 . . . . 0.0 109.046 166.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 91.4 p -72.08 167.73 19.6 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.665 0.786 . . . . 0.0 110.07 172.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -48.81 150.56 2.54 Favored Pre-proline 0 CA--C 1.542 0.654 0 O-C-N 122.051 -0.405 . . . . 0.0 110.153 153.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.7 132.98 15.06 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.745 2.297 . . . . 0.0 109.796 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.8 p -59.03 168.83 1.33 Allowed Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 123.8 0.84 . . . . 0.0 112.66 170.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -50.13 136.35 37.8 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.374 2.716 . . . . 0.0 112.237 161.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.49 149.73 33.49 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.974 0.806 . . . . 0.0 109.583 165.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 76.5 p -60.31 -9.43 3.46 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 126.593 1.957 . . . . 0.0 115.89 -177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 66.6 147.0 0.11 Allowed Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 127.073 2.149 . . . . 0.0 109.604 -155.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.21 118.83 5.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.677 2.251 . . . . 0.0 110.066 -168.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.588 HG11 HG11 ' A' ' 24' ' ' VAL . 1.5 m -114.45 131.58 66.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.882 1.273 . . . . 0.0 110.457 -174.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 145.21 31.7 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 3.3 p -71.37 168.41 17.47 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 123.53 0.732 . . . . 0.0 110.829 162.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -65.39 -167.86 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 123.018 1.39 . . . . 0.0 110.1 165.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -114.52 8.51 16.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 113.516 -163.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.461 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 1.7 t 72.95 -2.88 2.57 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 129.055 2.942 . . . . 0.0 114.523 175.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -61.88 116.27 9.12 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 117.639 -1.645 . . . . 0.0 109.459 162.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.89 93.3 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.974 2.449 . . . . 0.0 108.418 175.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 13.3 t -149.44 100.12 2.97 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.99 170.01 23.14 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.221 1.008 . . . . 0.0 109.468 151.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.977 0 N-CA-C 104.995 -3.242 . . . . 0.0 104.995 -173.423 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.674 0 N-CA-C 110.131 -1.187 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -80.39 108.85 14.35 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.874 0.87 . . . . 0.0 109.022 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.1 p -156.64 167.34 30.76 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.057 0.943 . . . . 0.0 108.899 160.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.45 147.11 39.9 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 123.807 0.718 . . . . 0.0 112.144 -178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 30.0 t -160.19 -53.38 0.05 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 123.28 0.632 . . . . 0.0 109.783 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.2 m -60.16 151.83 26.03 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 122.594 0.357 . . . . 0.0 111.557 -174.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.74 81.5 0.26 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 124.813 1.197 . . . . 0.0 110.156 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.8 mttp -62.47 106.9 0.83 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -157.95 144.0 17.33 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 129.888 3.275 . . . . 0.0 104.187 -174.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.99 172.37 13.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 118.442 0.565 . . . . 0.0 110.204 -178.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -147.8 162.9 38.3 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.94 -132.57 0.31 Allowed 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.104 1.362 . . . . 0.0 107.336 -175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.9 m -149.09 61.15 1.05 Allowed 'General case' 0 C--O 1.237 0.419 0 C-N-CA 126.051 1.74 . . . . 0.0 107.02 171.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -72.54 -37.92 68.16 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.645 1.178 . . . . 0.0 109.33 166.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 mt -65.92 152.38 93.5 Favored Pre-proline 0 CA--C 1.53 0.181 0 C-N-CA 127.233 2.213 . . . . 0.0 110.483 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -67.18 169.65 14.8 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.373 2.049 . . . . 0.0 110.922 167.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -81.38 168.06 49.69 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.38 1.467 . . . . 0.0 112.124 -175.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -65.61 132.69 31.73 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.109 2.54 . . . . 0.0 108.844 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -60.09 165.37 10.67 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.7 1.6 . . . . 0.0 111.817 171.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.4 m -72.02 163.54 27.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.303 175.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 11.0 tmtt? -50.29 119.04 10.14 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.135 171.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -67.21 160.14 48.91 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 CA-C-N 120.082 1.065 . . . . 0.0 110.47 172.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -135.93 125.89 25.94 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 126.963 2.105 . . . . 0.0 107.975 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 107' ' ' VAL . 9.2 m -69.13 149.27 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.172 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 174.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.6 p -134.06 -41.45 0.82 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 123.427 0.691 . . . . 0.0 110.169 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -123.44 145.09 49.08 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 124.487 1.115 . . . . 0.0 109.146 171.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 p -138.82 145.82 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.174 0 CA-C-N 119.758 1.163 . . . . 0.0 108.552 164.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.2 p -134.11 -169.12 2.25 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.533 1.133 . . . . 0.0 108.913 176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -66.51 -16.49 64.17 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 120.857 -1.152 . . . . 0.0 113.35 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -156.35 6.2 0.18 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -123.64 160.07 27.93 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 120.201 1.364 . . . . 0.0 111.297 165.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -145.59 136.85 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 166.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.4 m -96.61 142.13 29.03 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 49.1 mt -134.74 133.79 40.3 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.073 1.749 . . . . 0.0 108.255 -169.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 6.9 t -118.96 130.23 55.59 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 129.371 3.068 . . . . 0.0 108.311 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.7 p90 -139.12 170.94 15.05 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 171.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -104.87 148.59 36.35 Favored Pre-proline 0 N--CA 1.448 -0.537 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 162.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -66.58 160.66 44.96 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 123.202 2.601 . . . . 0.0 109.703 174.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -88.02 174.15 43.75 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 163.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.4 m -57.64 155.02 22.74 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 126.466 1.906 . . . . 0.0 110.074 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -68.86 -175.86 1.07 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 123.525 2.817 . . . . 0.0 111.892 173.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -120.02 -147.45 7.94 Favored Glycine 0 N--CA 1.442 -0.93 0 N-CA-C 105.575 -3.01 . . . . 0.0 105.575 168.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.56 -33.84 64.87 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 165.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 mt -102.38 157.42 33.75 Favored Pre-proline 0 C--O 1.237 0.396 0 C-N-CA 123.181 0.593 . . . . 0.0 112.052 -173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -80.88 150.28 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 124.794 3.662 . . . . 0.0 110.034 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.36 125.58 28.17 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.383 176.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.408 ' H ' ' HA ' ' A' ' 93' ' ' ASN . 0.4 OUTLIER -73.45 -49.21 28.06 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.16 0.984 . . . . 0.0 109.436 172.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 68' ' ' HIS . . . -161.18 -165.18 1.28 Allowed 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.434 1.015 . . . . 0.0 110.184 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -131.89 161.55 32.76 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 123.831 0.852 . . . . 0.0 109.943 167.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.1 mt -118.84 158.26 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 128.203 2.601 . . . . 0.0 106.806 167.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.1 mt -126.02 129.24 72.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 163.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -105.89 153.86 21.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.231 1.412 . . . . 0.0 108.112 171.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.1 127.68 20.12 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.493 1.517 . . . . 0.0 110.209 173.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -91.74 149.35 21.65 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 125.233 1.413 . . . . 0.0 107.772 169.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.22 113.56 2.67 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 122.338 1.066 . . . . 0.0 112.477 172.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -68.35 -38.56 81.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.552 0.741 . . . . 0.0 112.844 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 m -73.87 8.43 2.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.943 1.297 . . . . 0.0 113.382 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.8 t -127.49 -72.54 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 124.268 1.027 . . . . 0.0 108.895 -168.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.1 t -150.38 12.88 0.74 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.631 0.772 . . . . 0.0 110.058 -171.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 61.02 -79.73 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.26 0 C-N-CA 127.593 2.357 . . . . 0.0 111.753 -172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.57 162.11 0.04 OUTLIER 'General case' 0 C--O 1.234 0.26 0 C-N-CA 129.664 3.186 . . . . 0.0 114.895 -170.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.43 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 94.9 m95 -67.79 138.28 56.05 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -124.54 142.56 51.25 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 171.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 m -72.73 107.21 5.06 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 174.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 m -95.68 -28.28 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 121.234 -0.916 . . . . 0.0 111.655 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.05 138.07 31.52 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 174.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.88 135.47 41.66 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -169.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.44 ' HA ' ' HB1' ' A' ' 48' ' ' ALA . 10.9 m-70 50.04 68.83 0.69 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 126.798 2.039 . . . . 0.0 110.923 -175.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.4 t -84.97 -53.3 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.93 1.292 . . . . 0.0 113.623 -169.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.7 mttt 66.21 -23.66 0.1 Allowed 'General case' 0 C--N 1.316 -0.884 1 C-N-CA 131.79 4.036 . . . . 0.0 115.578 170.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -71.42 173.09 8.35 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 120.388 1.449 . . . . 0.0 108.607 168.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.04 -4.71 20.17 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 117.364 -1.303 . . . . 0.0 112.958 168.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.505 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 5.4 tp -121.17 131.71 54.4 Favored 'General case' 0 C--N 1.35 0.602 0 CA-C-N 121.596 1.998 . . . . 0.0 110.211 160.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -134.61 152.8 52.04 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 124.283 1.033 . . . . 0.0 109.432 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -112.77 101.07 9.18 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 126.355 1.862 . . . . 0.0 107.203 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 79.3 t -60.98 143.56 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 162.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 43.3 mtt-85 -139.01 178.93 6.8 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 126.36 1.864 . . . . 0.0 108.2 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 63.2 24.29 67.1 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.468 -0.629 . . . . 0.0 113.414 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.1 mt -82.1 -173.54 4.57 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.624 1.17 . . . . 0.0 109.772 176.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -112.22 141.9 25.9 Favored Pre-proline 0 CA--C 1.515 -0.379 0 CA-C-O 117.694 -1.146 . . . . 0.0 109.228 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -67.79 157.47 61.62 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.21 1.94 . . . . 0.0 112.156 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 41.62 42.64 2.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.477 1.911 . . . . 0.0 112.339 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 93.4 m -130.81 140.06 50.24 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.252 1.421 . . . . 0.0 107.817 -175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 27.3 mm -81.57 147.75 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 175.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -140.73 155.63 46.4 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.286 -1.324 . . . . 0.0 108.038 167.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.77 163.12 13.38 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 163.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -140.87 132.38 26.97 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.43 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 41.0 mtm -131.4 165.6 23.15 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 123.895 0.747 . . . . 0.0 109.338 161.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 74.5 t -132.21 140.36 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.976 1.71 . . . . 0.0 107.284 -166.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.489 ' HD3' HD22 ' A' ' 97' ' ' LEU . 13.1 mtt180 -132.1 132.03 42.91 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.5 118.67 26.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 174.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -86.34 145.7 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 174.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.408 ' HA ' ' H ' ' A' ' 47' ' ' SER . 1.9 p-10 -141.52 173.84 4.41 Favored Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 124.712 1.205 . . . . 0.0 108.096 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -73.26 31.63 0.31 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.34 2.693 . . . . 0.0 114.075 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -134.04 -67.83 0.58 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 126.325 1.85 . . . . 0.0 106.657 169.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -146.55 -148.26 4.73 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.914 1.245 . . . . 0.0 112.159 -167.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.489 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.4 mt -122.7 142.21 50.94 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 129.539 3.136 . . . . 0.0 106.398 179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.9 p -72.33 166.96 21.45 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.359 0.6 . . . . 0.0 112.116 176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -60.35 158.0 31.39 Favored Pre-proline 0 C--O 1.237 0.405 0 C-N-CA 124.568 1.147 . . . . 0.0 110.988 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.22 122.59 9.89 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.944 1.762 . . . . 0.0 111.983 -175.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 p -60.5 157.79 34.16 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.454 1.501 . . . . 0.0 111.784 170.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.43 128.66 24.28 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 123.812 3.008 . . . . 0.0 110.506 171.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 26.8 mtt -56.27 150.66 14.07 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 121.082 1.764 . . . . 0.0 111.451 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.499 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 1.5 p -69.9 -1.61 10.03 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 177.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 81.82 155.54 0.12 Allowed Pre-proline 0 N--CA 1.484 1.271 0 C-N-CA 131.119 3.768 . . . . 0.0 108.874 -167.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -72.61 117.6 5.2 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.279 2.653 . . . . 0.0 109.171 -175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG11 HG11 ' A' ' 24' ' ' VAL . 2.7 m -116.97 144.68 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 C-N-CA 123.599 0.76 . . . . 0.0 109.385 -171.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -104.32 138.51 40.66 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 123.38 0.672 . . . . 0.0 109.925 -174.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 66.7 p -67.29 169.06 9.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.969 168.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 9.9 mm-40 -82.73 175.7 9.92 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 121.733 0.778 . . . . 0.0 110.007 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.62 158.79 17.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.749 164.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.94 -6.9 20.82 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 46.12 -162.93 0.14 Allowed Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.933 1.254 . . . . 0.0 114.028 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -81.95 13.71 2.42 Favored 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 123.882 3.055 . . . . 0.0 111.605 158.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.7 m -56.1 126.43 26.0 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.852 1.661 . . . . 0.0 112.346 -162.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.7 p -68.06 175.31 3.23 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 124.122 0.969 . . . . 0.0 111.515 176.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.45 0 N-CA-C 105.679 -2.969 . . . . 0.0 105.679 167.471 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.719 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 t -60.69 126.7 28.39 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.102 0.961 . . . . 0.0 108.961 169.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.6 p -166.97 172.81 9.86 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 127.335 2.254 . . . . 0.0 107.795 171.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -66.73 98.75 0.43 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 107.687 -2.165 . . . . 0.0 107.687 166.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 m -149.04 -60.07 0.22 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.396 1.098 . . . . 0.0 110.838 -172.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 m -85.36 130.72 34.53 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.734 0.813 . . . . 0.0 109.538 177.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.89 149.55 46.82 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 167.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tttt -74.46 164.1 26.99 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -151.52 134.11 15.51 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 168.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 51.37 172.28 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.099 2.559 . . . . 0.0 113.432 -166.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -140.29 154.15 46.72 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 126.183 1.793 . . . . 0.0 106.827 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.37 -1.44 57.03 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.767 0.827 . . . . 0.0 111.356 -178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 68.9 m -151.22 173.86 13.93 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 120.657 -1.277 . . . . 0.0 108.997 173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.61 -43.29 3.04 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.873 1.269 . . . . 0.0 111.362 -178.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.3 162.4 40.15 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 126.467 1.907 . . . . 0.0 109.025 -173.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -60.0 142.63 98.85 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.381 2.721 . . . . 0.0 110.473 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -56.02 142.64 38.31 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 108.399 -1.881 . . . . 0.0 108.399 161.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -62.18 145.95 96.13 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.179 1.919 . . . . 0.0 110.187 -174.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -64.68 157.96 52.93 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 121.72 1.613 . . . . 0.0 109.987 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 m -68.47 166.48 16.76 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.222 0.609 . . . . 0.0 110.37 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -46.03 121.83 5.98 Favored Pre-proline 0 CA--C 1.531 0.233 0 C-N-CA 124.21 1.004 . . . . 0.0 109.242 172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -60.26 146.29 96.76 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 N-CA-C 108.905 -1.229 . . . . 0.0 108.905 172.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -113.28 125.14 53.97 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.219 1.408 . . . . 0.0 109.007 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 107' ' ' VAL . 19.8 t -80.58 112.54 18.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 p -102.31 -82.7 0.48 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -76.6 139.37 40.61 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 171.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -137.33 145.81 28.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 166.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.2 p -125.88 -173.58 2.88 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 124.183 0.993 . . . . 0.0 108.613 177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 1.0 OUTLIER -63.11 -14.87 53.74 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 171.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -163.57 26.47 0.08 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-N 120.092 1.315 . . . . 0.0 112.939 -177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -146.93 161.87 39.87 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 107.982 172.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 p -158.26 136.0 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.126 0.97 . . . . 0.0 108.482 173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.5 m -91.13 110.94 22.22 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.033 1.333 . . . . 0.0 107.942 176.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 86.3 mt -93.11 140.84 29.07 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 124.805 1.242 . . . . 0.0 109.224 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.656 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -144.61 99.21 3.32 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 124.612 1.195 . . . . 0.0 108.887 -163.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.9 p90 -119.05 172.81 7.29 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.532 1.133 . . . . 0.0 109.674 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -118.79 145.57 38.04 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -74.99 143.9 29.63 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 123.671 2.914 . . . . 0.0 110.779 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.47 175.68 52.84 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.181 -0.767 . . . . 0.0 111.181 170.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.1 m -62.18 146.15 92.75 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.884 1.274 . . . . 0.0 109.167 176.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.13 -168.7 0.26 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.953 3.769 . . . . 0.0 112.42 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -159.31 -149.51 5.54 Favored Glycine 0 N--CA 1.437 -1.249 0 N-CA-C 107.298 -2.321 . . . . 0.0 107.298 174.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.46 -37.81 68.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.562 1.145 . . . . 0.0 110.673 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' HB3' ' HD2' ' A' ' 45' ' ' PRO . 7.1 mt -111.95 167.31 9.32 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 123.714 0.806 . . . . 0.0 111.913 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 61.0 Cg_endo -73.88 -130.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 124.628 3.552 . . . . 0.0 108.299 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.6 161.8 24.01 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 127.669 2.388 . . . . 0.0 106.622 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 3.1 m -105.84 -35.38 7.35 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.132 2.173 . . . . 0.0 110.502 -174.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -174.74 -159.42 0.08 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.744 1.217 . . . . 0.0 109.626 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 91' ' ' ALA . 84.6 m-85 -128.82 169.24 14.81 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.445 2.298 . . . . 0.0 108.161 162.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.0 mt -125.76 155.15 35.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 129.051 2.94 . . . . 0.0 106.031 167.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.5 mt -122.54 132.8 70.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 166.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -118.17 158.31 25.34 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 173.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.21 155.32 46.96 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.078 0.951 . . . . 0.0 109.979 176.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -131.28 168.17 17.98 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.093 2.557 . . . . 0.0 105.833 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.6 t -144.12 -42.41 0.26 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.898 1.226 . . . . 0.0 113.676 -176.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 115.95 -48.4 0.0 OUTLIER 'General case' 0 C--N 1.346 0.437 1 C-N-CA 133.234 4.614 . . . . 0.0 108.652 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -87.41 -36.68 17.61 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.533 0.733 . . . . 0.0 111.786 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.4 t -75.71 -62.17 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.17 0 C-N-CA 123.591 0.757 . . . . 0.0 109.066 -159.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m -160.26 98.81 1.3 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.5 -9.63 1.74 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 175.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 68.5 m -39.73 -39.6 0.8 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 129.122 2.969 . . . . 0.0 116.366 170.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 88.8 m95 61.34 140.84 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.16 1.384 . . . . 0.0 111.299 -138.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -134.11 152.9 52.04 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 173.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.15 134.21 50.16 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 165.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.0 m -123.0 -8.76 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 123.33 0.652 . . . . 0.0 111.616 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.94 138.46 17.71 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 126.158 1.783 . . . . 0.0 107.258 158.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -116.18 158.31 23.48 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 171.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.7 m170 51.47 51.67 16.3 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 122.844 1.307 . . . . 0.0 112.218 175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.7 t -78.87 110.69 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 127.112 2.165 . . . . 0.0 106.629 177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.6 mmmm -106.58 52.04 0.73 Allowed 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.243 1.417 . . . . 0.0 108.203 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.7 t -158.39 -171.98 3.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.149 -0.932 . . . . 0.0 108.926 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.4 p -127.78 -3.75 5.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.967 1.307 . . . . 0.0 112.25 169.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.656 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -125.75 121.12 32.48 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 125.863 1.665 . . . . 0.0 107.476 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -145.35 117.51 8.37 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-O 121.445 0.64 . . . . 0.0 111.365 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 39.6 m -71.89 98.53 2.03 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.408 2.283 . . . . 0.0 108.802 168.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 26.3 t -67.6 143.69 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 164.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -136.77 172.69 12.64 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 125.538 1.535 . . . . 0.0 109.208 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.94 2.96 58.18 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.045 1.307 . . . . 0.0 113.055 170.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 17.8 mt -78.14 178.2 7.75 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 117.691 0.745 . . . . 0.0 109.607 -164.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -96.67 146.74 31.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.203 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -73.64 158.79 46.88 Favored 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 123.376 2.717 . . . . 0.0 111.146 171.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 52.39 21.75 1.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.166 2.587 . . . . 0.0 112.876 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -119.28 121.37 39.48 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.0 mm -59.27 147.44 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 170.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -138.51 152.83 48.59 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.582 162.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.414 HD13 ' SD ' ' A' ' 103' ' ' MET . 36.4 mt -107.08 156.04 19.2 Favored 'General case' 0 CA--C 1.499 -0.99 0 CA-C-N 112.992 -1.913 . . . . 0.0 107.106 163.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -141.78 133.45 27.01 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 125.451 1.719 . . . . 0.0 107.843 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 15.5 mtt -112.34 156.09 23.04 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 127.526 2.331 . . . . 0.0 106.903 170.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 94.6 t -126.76 113.09 31.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 167.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.785 ' HD3' HD13 ' A' ' 97' ' ' LEU . 35.9 mtt180 -97.47 147.72 23.95 Favored 'General case' 0 N--CA 1.466 0.358 0 O-C-N 120.29 -1.506 . . . . 0.0 107.203 167.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 98' ' ' SER . . . -86.7 158.33 19.46 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 163.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.69 152.49 27.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 126.118 1.767 . . . . 0.0 107.323 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -139.97 172.71 5.94 Favored Pre-proline 0 C--N 1.323 -0.577 0 C-N-CA 127.186 2.195 . . . . 0.0 108.576 -176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.43 -19.15 27.72 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.807 2.338 . . . . 0.0 113.352 166.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -115.58 -11.13 11.77 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 -167.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 153.63 -160.88 29.54 Favored Glycine 0 C--O 1.23 -0.148 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 -176.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.785 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.6 pp -113.09 162.7 15.62 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.892 1.277 . . . . 0.0 110.802 176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' A' ' 91' ' ' ALA . 51.4 p -77.82 168.55 19.75 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.053 2.141 . . . . 0.0 112.953 -171.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -45.45 149.73 0.97 Allowed Pre-proline 0 C--O 1.242 0.699 0 O-C-N 121.18 -0.95 . . . . 0.0 110.029 155.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.36 129.46 12.96 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.842 2.361 . . . . 0.0 109.717 176.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.3 p -52.61 162.08 1.01 Allowed Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 125.53 1.532 . . . . 0.0 113.458 170.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -63.8 125.96 16.45 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.398 2.732 . . . . 0.0 109.818 158.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.414 ' SD ' HD13 ' A' ' 86' ' ' LEU . 57.6 mtm -55.53 148.2 16.18 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.798 -0.564 . . . . 0.0 111.418 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.21 -8.14 47.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' CG ' ' HD2' ' A' ' 106' ' ' PRO . 3.7 t0 85.04 153.35 0.11 Allowed Pre-proline 0 N--CA 1.485 1.321 0 C-N-CA 130.605 3.562 . . . . 0.0 110.107 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 105' ' ' ASP . 19.4 Cg_endo -70.01 105.46 1.53 Allowed 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.228 1.952 . . . . 0.0 111.516 -165.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.475 HG21 HG21 ' A' ' 24' ' ' VAL . 1.9 m -103.06 142.74 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 C-N-CA 124.366 1.067 . . . . 0.0 109.361 -175.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.0 141.39 32.89 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 109.295 -177.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 6.1 p -72.89 151.04 42.12 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 123.174 0.59 . . . . 0.0 110.623 166.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -71.12 -178.76 2.1 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.835 1.254 . . . . 0.0 112.07 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -76.51 147.12 37.99 Favored 'General case' 0 N--CA 1.461 0.108 0 O-C-N 121.449 -0.782 . . . . 0.0 112.868 -178.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 2.2 p -84.99 -5.84 59.35 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 126.275 1.83 . . . . 0.0 114.924 -163.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -71.21 177.16 36.42 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 118.883 0.765 . . . . 0.0 113.387 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.75 129.84 15.01 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.738 2.292 . . . . 0.0 109.21 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.0 t -156.03 154.46 31.07 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 157.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.8 m 35.39 86.85 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.459 1.904 . . . . 0.0 112.936 -169.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.846 0 N-CA-C 108.536 -1.825 . . . . 0.0 108.536 148.174 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.677 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.1 m 62.35 120.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.821 2.449 . . . . 0.0 114.556 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 84.1 p -161.03 111.5 1.74 Allowed 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 160.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 109.78 105.26 2.92 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 175.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 38.0 m -163.03 -52.88 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.892 1.677 . . . . 0.0 108.26 164.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 m -74.72 131.58 40.96 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 158.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.11 -70.56 0.93 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 124.463 1.03 . . . . 0.0 112.636 -164.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -133.73 78.18 1.76 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.638 0.719 . . . . 0.0 109.309 -169.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 31.4 m-20 41.67 82.12 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 128.257 2.623 . . . . 0.0 112.47 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -139.88 165.06 28.33 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.991 0.916 . . . . 0.0 109.386 179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -158.78 -164.5 1.45 Allowed 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 127.617 2.367 . . . . 0.0 108.814 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.4 mt -128.16 0.42 5.81 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 125.522 1.529 . . . . 0.0 113.624 -164.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -87.3 165.85 15.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 118.319 0.509 . . . . 0.0 110.874 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.423 ' HA ' HG21 ' A' ' 43' ' ' THR . 0.9 OUTLIER -66.6 -48.69 68.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -58.55 146.46 73.18 Favored Pre-proline 0 N--CA 1.463 0.221 0 C-N-CA 126.328 1.851 . . . . 0.0 111.711 -170.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -63.08 156.71 53.29 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.195 2.597 . . . . 0.0 111.665 -168.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.61 152.09 48.24 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.64 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -67.64 141.16 54.02 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.264 1.976 . . . . 0.0 109.164 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -66.03 153.37 78.39 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 121.213 1.275 . . . . 0.0 109.189 162.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.2 m -74.03 177.87 5.38 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.678 0.791 . . . . 0.0 110.8 -177.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -47.33 120.34 6.89 Favored Pre-proline 0 N--CA 1.472 0.655 0 CA-C-O 117.379 -1.296 . . . . 0.0 108.631 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -63.76 137.49 58.88 Favored 'Trans proline' 0 N--CA 1.441 -1.606 0 N-CA-C 107.942 -1.599 . . . . 0.0 107.942 168.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -119.93 121.06 38.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 C-N-CA 125.476 1.511 . . . . 0.0 108.822 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -66.32 149.04 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.202 173.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.8 p -129.35 -93.75 0.43 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 176.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -66.77 143.51 56.87 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.101 0.96 . . . . 0.0 109.615 172.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.91 141.8 28.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 167.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.2 p -128.21 -169.18 2.02 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.55 1.14 . . . . 0.0 108.541 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 pttt -61.61 -23.85 66.3 Favored 'General case' 0 C--O 1.224 -0.278 0 O-C-N 121.219 -0.926 . . . . 0.0 112.568 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -154.93 10.85 0.35 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 120.754 -1.216 . . . . 0.0 113.538 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -120.42 164.54 16.22 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 118.624 0.647 . . . . 0.0 110.833 166.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 p -153.48 134.26 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 165.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 95.1 m -88.53 114.45 25.16 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 76.6 mt -93.72 138.49 31.87 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.844 1.658 . . . . 0.0 108.559 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.2 t -117.9 138.38 52.18 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.624 2.37 . . . . 0.0 107.189 170.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -139.8 170.92 14.99 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 122.734 0.414 . . . . 0.0 110.079 166.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.33 142.4 24.51 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 166.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -75.27 128.42 11.26 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 124.801 3.667 . . . . 0.0 109.546 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -74.52 167.96 54.63 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 108.763 -1.735 . . . . 0.0 108.763 169.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.2 m -85.49 154.95 59.67 Favored Pre-proline 0 N--CA 1.443 -0.813 0 C-N-CA 124.769 1.228 . . . . 0.0 110.158 -169.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -68.85 -158.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 125.193 3.928 . . . . 0.0 110.279 170.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 171.26 -112.7 0.46 Allowed Glycine 0 C--N 1.331 0.305 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.423 HG21 ' HA ' ' A' ' 14' ' ' ASP . 44.1 p -58.74 -48.93 79.49 Favored 'General case' 0 N--CA 1.436 -1.153 0 C-N-CA 125.628 1.571 . . . . 0.0 110.219 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.6 mt -140.82 148.09 51.12 Favored Pre-proline 0 C--O 1.238 0.466 0 C-N-CA 125.068 1.347 . . . . 0.0 110.669 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.9 141.09 18.79 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 123.879 3.052 . . . . 0.0 110.14 -166.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.33 109.34 1.87 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.604 1.561 . . . . 0.0 108.647 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.538 ' HB2' HG22 ' A' ' 92' ' ' ILE . 24.1 m -61.01 -62.46 1.84 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.377 2.271 . . . . 0.0 110.802 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.14 -166.72 2.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -121.73 163.77 18.52 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 125.201 1.4 . . . . 0.0 108.62 165.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.403 HD12 HD11 ' A' ' 92' ' ' ILE . 1.2 mt -115.9 162.73 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 127.391 2.276 . . . . 0.0 107.315 162.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 63.0 mt -126.04 129.76 72.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 161.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.58 150.86 30.77 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 171.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.47 160.37 32.51 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 125.786 1.634 . . . . 0.0 107.467 175.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -133.6 147.86 51.53 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 170.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.58 117.48 4.42 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 173.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -75.09 -26.63 59.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.483 -0.761 . . . . 0.0 111.983 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -81.06 17.07 1.31 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.29 1.036 . . . . 0.0 111.398 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 93.9 t -128.29 -71.86 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 15.7 m -151.53 1.61 0.38 Allowed 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.5 50.78 16.38 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 120.378 1.444 . . . . 0.0 110.68 -176.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.6 m -135.31 146.52 48.56 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.767 1.227 . . . . 0.0 108.38 174.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -72.88 108.86 6.05 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 161.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -100.0 134.65 42.61 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 126.652 1.981 . . . . 0.0 108.053 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.4 m -78.74 94.76 5.16 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 27.4 m -85.4 -15.81 10.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 118.211 -0.899 . . . . 0.0 112.609 -175.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.7 150.11 30.66 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 120.017 1.28 . . . . 0.0 108.576 164.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -142.82 161.81 37.11 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 117.951 0.341 . . . . 0.0 111.208 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 47.35 55.11 8.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.754 1.222 . . . . 0.0 111.332 -171.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 97.6 t -91.92 129.63 42.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.32 29.83 7.58 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.723 0.809 . . . . 0.0 111.848 -178.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.1 t -136.76 174.27 10.8 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.022 1.329 . . . . 0.0 107.505 -178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.5 p -120.28 0.0 10.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.871 1.668 . . . . 0.0 111.687 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.18 104.35 5.87 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -135.27 150.93 50.14 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.952 1.301 . . . . 0.0 109.718 -169.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.5 m -103.51 106.02 16.42 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 43.6 t -62.54 142.68 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 166.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 84.9 mtt180 -139.72 176.04 9.07 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.27 1.028 . . . . 0.0 112.269 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 79.28 11.95 84.43 Favored Glycine 0 C--O 1.226 -0.38 0 C-N-CA 124.81 1.195 . . . . 0.0 112.616 175.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 mt -74.67 179.43 4.77 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 122.296 1.046 . . . . 0.0 109.768 -174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 11.9 mtp85 -104.12 138.05 19.41 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 117.039 -1.458 . . . . 0.0 108.241 175.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.19 147.17 59.49 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.523 2.149 . . . . 0.0 112.112 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.9 t30 44.94 42.02 5.84 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.53 2.332 . . . . 0.0 112.526 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.1 m -129.38 136.61 50.19 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 127.091 2.156 . . . . 0.0 106.524 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 25.0 mm -72.44 145.42 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.966 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -140.62 155.27 46.59 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.343 1.457 . . . . 0.0 109.388 168.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 51.3 mt -108.24 166.18 10.94 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 126.229 1.811 . . . . 0.0 108.912 162.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -146.36 136.91 24.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 125.092 1.495 . . . . 0.0 111.257 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 1.9 mtt -105.38 151.37 24.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 160.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.21 149.58 6.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 154.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.498 ' HD3' HD13 ' A' ' 97' ' ' LEU . 73.3 mtt180 -125.11 139.58 53.64 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 164.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.29 151.03 23.93 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 165.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.538 HG22 ' HB2' ' A' ' 47' ' ' SER . 2.0 mt -125.07 152.12 31.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 125.87 1.668 . . . . 0.0 108.628 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -151.69 -176.84 0.62 Allowed Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.608 1.563 . . . . 0.0 109.186 178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -60.29 -14.08 27.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.227 . . . . 0.0 115.577 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -116.41 -14.04 10.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.031 1.332 . . . . 0.0 112.402 -164.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 156.04 -143.8 10.17 Favored Glycine 0 C--N 1.335 0.497 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.498 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.0 pp -140.02 160.98 38.7 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.33 1.852 . . . . 0.0 110.061 -175.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 97.3 p -72.21 168.06 19.03 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 126.908 2.083 . . . . 0.0 114.463 -166.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -32.25 145.45 0.1 OUTLIER Pre-proline 0 C--O 1.241 0.642 0 C-N-CA 123.56 0.744 . . . . 0.0 109.914 145.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.35 132.48 31.56 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.175 1.917 . . . . 0.0 109.095 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.0 p -61.4 154.58 62.97 Favored Pre-proline 0 CA--C 1.539 0.557 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.554 163.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -62.04 142.22 91.76 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.899 2.399 . . . . 0.0 110.303 175.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.6 mmt -53.12 131.92 37.43 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 173.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.35 -17.01 16.88 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.961 1.704 . . . . 0.0 112.187 170.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.2 t0 70.44 161.68 0.15 Allowed Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 126.733 2.013 . . . . 0.0 109.265 -158.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -74.75 121.68 6.83 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.974 2.449 . . . . 0.0 111.072 -175.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 8.6 p -92.57 158.43 2.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 124.011 0.925 . . . . 0.0 108.997 169.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.48 137.22 43.66 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.102 1.361 . . . . 0.0 108.369 163.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.9 p -66.04 164.79 14.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.781 0.8 . . . . 0.0 109.53 158.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -80.79 173.5 12.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 122.403 1.097 . . . . 0.0 109.749 176.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.57 162.2 26.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.204 -1.362 . . . . 0.0 110.5 169.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.2 p -113.83 18.14 17.56 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.261 1.824 . . . . 0.0 112.765 -171.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -62.09 174.55 7.29 Favored Glycine 0 CA--C 1.534 1.238 0 CA-C-N 118.807 0.73 . . . . 0.0 111.807 174.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.38 66.58 7.17 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.734 2.956 . . . . 0.0 111.178 -177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 50.7 m -57.17 152.96 12.64 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.419 1.088 . . . . 0.0 110.556 173.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 61.3 p -95.29 86.32 4.51 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.79 0 N-CA-C 106.962 -2.455 . . . . 0.0 106.962 -177.294 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.023 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 p -145.08 114.78 7.27 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 117.889 0.844 . . . . 0.0 109.439 -169.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 m -152.76 155.15 36.63 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.318 1.047 . . . . 0.0 109.555 169.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.19 -140.67 10.38 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 107.51 -2.236 . . . . 0.0 107.51 157.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 81.0 p -81.72 168.53 17.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.562 1.181 . . . . 0.0 108.963 164.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -168.99 85.74 0.16 Allowed 'General case' 0 C--O 1.232 0.151 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -172.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.67 -35.38 1.19 Allowed Glycine 0 CA--C 1.527 0.81 0 O-C-N 121.009 -1.057 . . . . 0.0 112.869 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -66.95 158.84 29.82 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.672 1.236 . . . . 0.0 109.111 155.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -151.12 164.84 35.57 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.868 2.067 . . . . 0.0 106.649 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -141.17 -89.92 0.15 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 166.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.3 t0 74.49 158.62 0.21 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 128.107 2.563 . . . . 0.0 110.462 -166.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.9 mt 49.78 35.22 8.7 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 128.094 2.558 . . . . 0.0 112.695 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.4 t -83.68 88.82 7.06 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.648 1.579 . . . . 0.0 109.448 -169.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -68.2 11.96 0.14 Allowed 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.244 1.818 . . . . 0.0 113.742 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.3 mt -91.91 152.54 43.06 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 120.48 -1.388 . . . . 0.0 109.395 -176.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -63.07 166.46 14.39 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 124.378 3.385 . . . . 0.0 113.144 -176.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -62.9 147.08 50.41 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 118.793 -1.004 . . . . 0.0 110.607 165.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.3 157.63 37.26 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.918 2.412 . . . . 0.0 112.047 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -69.78 161.4 46.1 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.346 2.031 . . . . 0.0 110.877 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.3 m -74.58 166.75 23.02 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.634 0.774 . . . . 0.0 110.933 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.39 127.04 16.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 CA-C-O 116.78 -1.581 . . . . 0.0 109.576 168.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -80.62 159.25 22.06 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.75 2.3 . . . . 0.0 114.306 178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -107.5 129.41 54.96 Favored 'General case' 0 CA--C 1.499 -0.989 0 C-N-CA 128.778 2.831 . . . . 0.0 107.849 172.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.59 153.78 7.95 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.451 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 159.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 p -132.04 -90.27 0.42 Allowed 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 173.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -83.74 120.29 25.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.318 -172.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.4 p -120.32 147.95 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-N 119.738 1.154 . . . . 0.0 110.789 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 76.4 p -141.3 -167.2 2.35 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.684 1.594 . . . . 0.0 107.731 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -65.04 -33.59 76.41 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 113.77 1.026 . . . . 0.0 113.77 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -149.2 17.32 0.95 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.667 -1.27 . . . . 0.0 112.763 -176.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.8 m -136.64 150.43 48.52 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 172.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.98 132.68 12.41 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 124.804 1.241 . . . . 0.0 109.413 173.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.2 m -79.4 139.61 37.66 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.045 0.938 . . . . 0.0 109.412 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.1 mt -117.38 144.19 45.2 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 127.46 2.304 . . . . 0.0 107.227 171.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.64 131.94 40.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 128.133 2.573 . . . . 0.0 106.506 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.3 p90 -139.26 172.07 13.36 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.274 1.03 . . . . 0.0 109.315 174.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 42.2 mt-30 -109.18 141.94 24.52 Favored Pre-proline 0 CA--C 1.542 0.668 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 164.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -82.74 162.66 16.37 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.334 2.689 . . . . 0.0 111.094 -168.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -89.02 169.06 36.1 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-O 122.468 1.038 . . . . 0.0 110.952 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 17.7 m -65.3 147.16 98.78 Favored Pre-proline 0 N--CA 1.438 -1.038 0 C-N-CA 126.99 2.116 . . . . 0.0 111.135 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.37 174.69 9.65 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 125.206 3.937 . . . . 0.0 113.911 166.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -174.93 -118.69 0.53 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 124.706 1.146 . . . . 0.0 110.314 -174.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.6 p -69.15 -37.51 78.31 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.151 1.78 . . . . 0.0 112.752 -162.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.6 mt -138.38 158.27 70.96 Favored Pre-proline 0 C--O 1.237 0.418 0 C-N-CA 123.04 0.536 . . . . 0.0 111.216 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.13 165.46 32.35 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.298 2.665 . . . . 0.0 109.915 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -110.18 121.1 44.47 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.74 -33.04 25.16 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 123.331 0.652 . . . . 0.0 111.995 -162.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' H ' HG22 ' A' ' 92' ' ' ILE . . . -166.47 -167.77 1.07 Allowed 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.867 1.667 . . . . 0.0 106.561 167.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -118.08 166.19 12.85 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 169.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.42 154.56 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.013 2.525 . . . . 0.0 106.305 168.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.08 135.82 61.8 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 168.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -117.99 154.84 31.3 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -141.91 163.17 33.62 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.91 1.284 . . . . 0.0 109.034 176.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -140.16 145.54 37.64 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 126.05 1.74 . . . . 0.0 107.139 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.628 ' HB3' HG22 ' A' ' 58' ' ' VAL . 4.9 t -134.3 166.23 23.3 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 155.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -99.64 14.41 30.18 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.679 1.192 . . . . 0.0 111.957 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 t -139.26 21.52 2.58 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.302 1.841 . . . . 0.0 110.982 -175.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.808 HG23 ' H ' ' A' ' 59' ' ' SER . 15.5 m -121.89 -85.66 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.764 1.226 . . . . 0.0 108.044 -173.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.808 ' H ' HG23 ' A' ' 58' ' ' VAL . 28.7 m -139.19 8.66 2.48 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.795 2.038 . . . . 0.0 110.39 177.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 m-20 54.33 22.97 4.04 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 127.27 2.228 . . . . 0.0 113.683 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 49.7 m -116.35 159.32 22.11 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 123.943 0.897 . . . . 0.0 110.943 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -73.63 138.88 45.09 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 157.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -139.62 139.39 36.71 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 m -63.21 95.24 0.09 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.588 1.155 . . . . 0.0 108.277 171.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.445 HG11 ' HB3' ' A' ' 53' ' ' ALA . 18.6 m -87.22 -17.54 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 O-C-N 121.124 -0.985 . . . . 0.0 112.016 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.81 131.79 22.99 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 165.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -117.67 152.83 34.43 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 43.8 67.83 0.61 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.608 1.563 . . . . 0.0 112.491 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.0 t -98.64 118.54 45.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 124.596 1.158 . . . . 0.0 108.455 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -113.65 50.79 0.89 Allowed 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.89 175.47 13.73 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.458 1.903 . . . . 0.0 107.388 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.4 p -125.39 12.42 8.14 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.003 1.721 . . . . 0.0 113.12 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 mp -129.43 140.95 51.15 Favored 'General case' 0 C--N 1.349 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 109.564 147.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -145.2 151.65 38.76 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.58 1.152 . . . . 0.0 108.419 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 17.4 m -109.94 108.79 19.18 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.868 1.667 . . . . 0.0 108.767 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 t -60.11 140.52 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 165.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -130.44 -177.63 4.42 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 124.428 1.091 . . . . 0.0 108.874 166.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.15 37.76 41.82 Favored Glycine 0 CA--C 1.519 0.305 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 168.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 13.6 mt -108.0 -178.68 3.68 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.929 1.292 . . . . 0.0 110.393 -176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.6 mtp85 -103.58 139.32 19.99 Favored Pre-proline 0 N--CA 1.468 0.442 0 C-N-CA 125.491 1.516 . . . . 0.0 109.391 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.75 159.33 42.34 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 123.049 2.499 . . . . 0.0 112.109 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 55.28 15.51 1.36 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 126.481 1.912 . . . . 0.0 112.903 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -119.76 139.41 52.34 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.813 1.645 . . . . 0.0 110.149 -164.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 30.0 mm -78.41 148.67 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.694 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -142.09 162.24 35.98 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.921 0.888 . . . . 0.0 109.729 175.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.548 HD13 ' SD ' ' A' ' 103' ' ' MET . 21.2 mt -124.86 162.81 23.57 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 125.841 1.656 . . . . 0.0 108.929 165.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -138.57 155.74 48.09 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 125.476 1.735 . . . . 0.0 110.968 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 6.8 mtt -129.22 167.07 18.19 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 126.525 1.93 . . . . 0.0 106.972 160.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 92.0 t -132.06 146.34 33.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 168.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.546 ' HD3' HD13 ' A' ' 97' ' ' LEU . 82.5 mtt180 -136.38 134.02 37.38 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.219 1.407 . . . . 0.0 107.244 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.37 126.21 34.72 Favored 'General case' 0 C--O 1.228 -0.076 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.407 HG22 ' H ' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -86.59 152.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 123.773 0.829 . . . . 0.0 108.971 179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.62 168.9 10.45 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 123.506 0.722 . . . . 0.0 109.83 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -72.38 19.61 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.153 2.569 . . . . 0.0 113.845 -177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 39.8 mm-40 -121.13 -65.35 1.15 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.513 1.525 . . . . 0.0 107.531 169.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -145.81 -127.44 1.89 Allowed Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.397 1.475 . . . . 0.0 110.969 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.546 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -139.23 145.74 39.61 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.525 2.33 . . . . 0.0 107.443 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 92.0 p -72.58 165.99 23.61 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.277 1.031 . . . . 0.0 109.869 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -54.85 142.95 53.35 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 121.565 -0.71 . . . . 0.0 109.188 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -61.99 133.15 42.8 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.435 1.423 . . . . 0.0 108.992 178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.4 p -54.69 156.02 6.98 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.373 169.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -47.63 143.79 11.75 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.173 2.582 . . . . 0.0 111.1 166.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.548 ' SD ' HD13 ' A' ' 86' ' ' LEU . 35.2 mtm -57.9 146.93 30.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.724 0.773 . . . . 0.0 110.299 175.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.4 p -65.26 0.2 1.5 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 116.062 -1.923 . . . . 0.0 115.81 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.2 t70 68.74 153.69 0.14 Allowed Pre-proline 0 N--CA 1.476 0.834 0 CA-C-N 121.147 1.794 . . . . 0.0 108.398 -154.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -67.47 113.26 2.85 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 123.006 2.471 . . . . 0.0 109.648 176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.36 165.09 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 166.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -124.06 142.59 51.05 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.47 1.108 . . . . 0.0 109.742 166.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 15.0 p -72.98 160.69 31.7 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 123.081 0.552 . . . . 0.0 110.745 165.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -79.14 -178.44 6.16 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.782 0.801 . . . . 0.0 109.934 168.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -81.28 167.55 19.42 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.285 1.434 . . . . 0.0 111.394 175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.5 t -103.6 37.7 1.97 Allowed 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 127.044 2.138 . . . . 0.0 111.627 -174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.05 164.27 54.7 Favored Glycine 0 CA--C 1.535 1.29 0 O-C-N 120.522 -1.361 . . . . 0.0 111.781 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.42 147.13 28.47 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.166 2.577 . . . . 0.0 110.549 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.2 m -156.21 111.88 2.98 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.729 1.612 . . . . 0.0 108.246 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 20.8 t -170.79 178.89 3.37 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.308 2.243 . . . . 0.0 106.172 172.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.951 1 N-CA-C 103.069 -4.012 . . . . 0.0 103.069 167.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -144.22 -70.76 0.29 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 173.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -64.96 165.55 10.72 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 149.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.0 -160.64 20.68 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.393 1.473 . . . . 0.0 110.08 170.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.5 m 74.42 178.1 0.22 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.031 2.132 . . . . 0.0 110.947 -169.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.4 m -59.74 156.01 14.78 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.726 1.21 . . . . 0.0 111.063 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.57 115.52 8.04 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 106.256 -2.738 . . . . 0.0 106.256 152.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -82.9 51.7 1.98 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.228 1.014 . . . . 0.0 109.094 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -77.74 78.17 4.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 125.616 1.566 . . . . 0.0 107.632 -171.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 55.37 -179.08 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.617 1.967 . . . . 0.0 111.175 -158.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -170.28 -177.24 2.42 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.002 1.721 . . . . 0.0 107.527 174.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.3 mp 16.24 79.23 0.01 OUTLIER 'General case' 0 C--N 1.345 0.392 0 C-N-CA 129.157 2.983 . . . . 0.0 113.333 160.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -49.7 129.75 20.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.412 1.085 . . . . 0.0 111.522 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.1 -20.7 64.08 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.071 1.348 . . . . 0.0 110.912 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -91.55 160.35 36.85 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.504 1.922 . . . . 0.0 112.125 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -70.34 147.87 60.09 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.653 2.235 . . . . 0.0 109.169 165.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -65.76 155.41 50.23 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 174.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.13 140.97 81.08 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.43 2.086 . . . . 0.0 108.179 171.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.09 172.06 7.96 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.287 1.991 . . . . 0.0 111.037 170.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -66.29 170.57 5.75 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.95 0.9 . . . . 0.0 110.1 171.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -49.76 124.81 16.45 Favored Pre-proline 0 C--O 1.236 0.377 0 CA-C-O 117.593 -1.194 . . . . 0.0 107.796 160.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -65.06 136.0 46.25 Favored 'Trans proline' 0 N--CA 1.446 -1.271 0 CA-C-N 120.205 1.109 . . . . 0.0 109.352 169.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -78.77 164.55 24.45 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 123.176 1.465 . . . . 0.0 107.095 163.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.7 t -124.4 112.45 32.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.14 178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.0 p -109.45 -82.5 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -167.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -71.07 134.47 47.08 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 125.245 1.418 . . . . 0.0 108.267 171.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.1 p -140.03 135.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 119.812 1.187 . . . . 0.0 108.545 163.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 82.0 p -110.68 -74.1 0.66 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 -168.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 2.1 pttp -163.93 -26.68 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 129.641 3.177 . . . . 0.0 110.036 163.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -140.41 9.33 2.25 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 124.839 1.256 . . . . 0.0 112.287 174.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -126.99 160.66 30.41 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.851 0.75 . . . . 0.0 110.452 162.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -151.65 133.65 5.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 125.624 1.57 . . . . 0.0 106.946 173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -79.98 132.64 36.07 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 168.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.6 mt -104.7 142.08 35.33 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.291 1.437 . . . . 0.0 108.16 167.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.524 ' HB3' ' CD1' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -140.19 111.46 7.14 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.802 1.314 . . . . 0.0 108.466 -173.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.483 ' CH2' HD11 ' A' ' 51' ' ' ILE . 42.8 p90 -129.22 171.35 12.53 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.901 0.773 . . . . 0.0 109.56 -176.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -124.84 145.48 50.02 Favored Pre-proline 0 N--CA 1.448 -0.538 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -74.72 144.07 30.86 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.461 2.774 . . . . 0.0 109.573 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -86.31 -175.78 49.73 Favored Glycine 0 C--N 1.336 0.56 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 170.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m -57.67 133.39 82.57 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 123.503 0.721 . . . . 0.0 111.506 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.02 -171.67 0.18 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.627 2.885 . . . . 0.0 113.417 170.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.68 -125.14 0.8 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 107.733 -2.147 . . . . 0.0 107.733 156.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 m -66.8 -23.03 66.01 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 128.992 2.917 . . . . 0.0 113.242 -160.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.473 ' CB ' HD21 ' A' ' 93' ' ' ASN . 18.3 mt -131.75 172.08 7.98 Favored Pre-proline 0 C--O 1.237 0.44 0 C-N-CA 126.971 2.108 . . . . 0.0 109.356 172.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 44' ' ' LEU . 41.9 Cg_endo -76.38 -136.79 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 124.582 3.521 . . . . 0.0 107.774 163.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -154.61 120.15 5.11 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 175.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.59 -35.71 78.59 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.345 1.058 . . . . 0.0 112.483 -170.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -165.3 -167.86 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.227 1.011 . . . . 0.0 108.707 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -123.36 169.22 11.56 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.404 2.282 . . . . 0.0 108.273 164.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.7 mt -127.27 156.02 38.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 130.734 3.613 . . . . 0.0 105.721 168.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.483 HD11 ' CH2' ' A' ' 36' ' ' TRP . 24.3 mt -128.63 136.71 59.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 164.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -122.69 153.36 39.51 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.343 1.057 . . . . 0.0 108.175 175.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.14 128.76 22.98 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.767 1.227 . . . . 0.0 109.461 178.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -96.64 151.3 19.74 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.787 1.635 . . . . 0.0 107.197 171.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.28 105.87 1.0 Allowed 'General case' 0 C--O 1.235 0.303 0 O-C-N 122.106 -0.372 . . . . 0.0 110.359 -177.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -62.94 -31.36 72.43 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -171.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 37.2 m -105.36 49.14 0.81 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.081 1.352 . . . . 0.0 110.218 172.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG22 ' HD2' ' A' ' 80' ' ' ARG . 92.2 t -134.85 -88.62 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 160.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.67 3.85 7.5 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.387 1.875 . . . . 0.0 110.401 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 66.49 -71.64 0.09 Allowed 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 126.796 2.038 . . . . 0.0 109.758 -170.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.2 m -36.74 148.89 0.02 OUTLIER 'General case' 0 C--O 1.238 0.474 0 C-N-CA 130.437 3.495 . . . . 0.0 115.418 176.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 86.6 m95 -65.44 134.76 54.14 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.329 1.452 . . . . 0.0 108.079 171.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -129.9 130.2 44.86 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.25 94.86 0.17 Allowed 'General case' 0 C--O 1.239 0.533 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 172.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -84.07 -13.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 C-N-CA 124.166 0.986 . . . . 0.0 110.358 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.93 147.86 26.45 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 119.296 0.953 . . . . 0.0 109.475 162.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -129.71 163.46 26.11 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.4 m170 40.98 63.45 1.19 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.683 1.993 . . . . 0.0 111.915 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.25 138.26 24.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 C-N-CA 128.073 2.549 . . . . 0.0 108.115 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 29.15 5.95 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.869 0.867 . . . . 0.0 111.695 -175.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -141.74 152.95 44.27 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.746 -1.575 . . . . 0.0 106.746 178.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 74.8 p -88.28 2.97 51.24 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.291 176.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 ' CD1' ' HB3' ' A' ' 35' ' ' SER . 8.4 tp -136.32 121.62 19.23 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 127.635 2.374 . . . . 0.0 107.693 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -146.39 139.23 25.45 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 119.427 1.012 . . . . 0.0 112.271 178.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 88.5 m -81.0 99.68 8.56 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.827 2.051 . . . . 0.0 108.492 170.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.4 t -65.0 143.58 15.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 165.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -131.69 178.14 6.98 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.247 1.419 . . . . 0.0 110.374 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 23.48 68.93 Favored Glycine 0 CA--C 1.518 0.25 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 165.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.8 mt -97.27 -159.32 0.73 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.408 ' HD2' HG22 ' A' ' 58' ' ' VAL . 58.1 mtt-85 -134.98 140.85 36.23 Favored Pre-proline 0 CA--C 1.515 -0.39 0 CA-C-O 117.753 -1.118 . . . . 0.0 109.437 -172.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -72.17 158.91 51.08 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.935 2.423 . . . . 0.0 110.588 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.2 m120 42.04 45.44 3.38 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.967 2.107 . . . . 0.0 112.294 -178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 79.7 m -136.22 128.14 29.39 Favored 'General case' 0 C--N 1.335 -0.064 0 C-N-CA 125.845 1.658 . . . . 0.0 107.889 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 12.7 mm -65.17 145.61 13.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 168.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -134.57 158.29 44.37 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 125.626 1.571 . . . . 0.0 108.085 159.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mt -107.26 162.22 14.08 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 106.104 -1.814 . . . . 0.0 106.104 154.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -135.47 148.54 49.27 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 76.9 mtm -130.86 167.97 18.05 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 158.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.9 t -115.34 154.4 16.75 Favored 'Isoleucine or valine' 0 C--O 1.247 0.963 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 170.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.562 ' HD3' HD22 ' A' ' 97' ' ' LEU . 9.8 mtt180 -132.26 141.47 49.02 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 160.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.03 153.78 22.51 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 164.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -114.19 150.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 C-N-CA 125.612 1.565 . . . . 0.0 107.44 174.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.473 HD21 ' CB ' ' A' ' 44' ' ' LEU . 17.4 t30 -163.36 160.2 18.13 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.52 10.67 2.42 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 123.41 2.74 . . . . 0.0 112.177 -174.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -120.56 15.21 11.97 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.563 2.345 . . . . 0.0 110.23 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.99 176.47 17.05 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 124.896 1.236 . . . . 0.0 110.778 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.562 HD22 ' HD3' ' A' ' 90' ' ' ARG . 2.0 mp -81.91 165.6 20.63 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 173.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.1 p -72.47 167.13 21.23 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 122.155 0.979 . . . . 0.0 110.144 171.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -43.52 150.11 0.55 Allowed Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 152.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -67.36 149.65 80.83 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.198 1.932 . . . . 0.0 109.147 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 88.7 p -63.16 164.19 14.78 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 163.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.34 151.13 18.47 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 121.169 1.246 . . . . 0.0 109.519 154.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 40.9 mtm -68.31 151.28 47.14 Favored 'General case' 0 C--O 1.232 0.161 0 O-C-N 121.988 -0.445 . . . . 0.0 110.528 171.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 78.5 p -60.5 -7.64 2.25 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 127.427 2.291 . . . . 0.0 115.24 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 69.23 157.24 0.15 Allowed Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 127.228 2.211 . . . . 0.0 111.068 -158.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.01 100.88 1.33 Allowed 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.159 2.573 . . . . 0.0 110.112 -172.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.82 129.66 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 C-N-CA 124.68 1.192 . . . . 0.0 109.601 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.9 ttt85 -79.45 158.16 27.36 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 168.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 14.8 p -91.13 168.85 11.32 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 122.452 1.12 . . . . 0.0 109.903 168.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -71.64 177.05 4.33 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.903 1.811 . . . . 0.0 111.116 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -77.27 151.75 34.92 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 110.53 -3.032 . . . . 0.0 108.878 166.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.519 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -94.0 11.07 31.01 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -168.159 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -74.24 116.99 5.43 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 118.539 -1.145 . . . . 0.0 112.645 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.16 166.74 29.16 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 CA-C-N 120.409 2.104 . . . . 0.0 110.186 159.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 9.1 t -150.27 -160.22 1.14 Allowed 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.787 1.635 . . . . 0.0 107.822 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.3 p -146.32 115.96 7.2 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.682 1.193 . . . . 0.0 109.138 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.147 0 N-CA-C 107.585 -2.206 . . . . 0.0 107.585 -172.037 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.413 0 CA-C-O 121.631 0.573 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.62 120.62 18.48 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 160.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.9 m 33.83 67.44 0.2 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.925 2.49 . . . . 0.0 113.847 168.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.34 -111.81 1.92 Allowed Glycine 0 C--N 1.335 0.507 0 C-N-CA 124.16 0.886 . . . . 0.0 111.421 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.3 m -59.31 98.71 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 124.86 1.264 . . . . 0.0 111.69 -172.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.9 m -71.02 175.98 4.74 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 152.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.34 -136.07 16.61 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 172.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.5 ttpt -74.19 68.33 1.44 Allowed 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.662 1.185 . . . . 0.0 110.205 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -67.69 119.23 12.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 164.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 4.1 t80 67.88 -81.12 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 127.608 2.363 . . . . 0.0 109.553 -176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.37 171.19 15.86 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.077 1.351 . . . . 0.0 109.653 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.45 -0.44 0.89 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 127.794 2.438 . . . . 0.0 114.912 -166.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.405 ' HB2' HD12 ' A' ' 15' ' ' LEU . 14.2 p -33.75 118.65 0.36 Allowed 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 127.585 2.354 . . . . 0.0 113.861 175.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -74.0 62.54 0.88 Allowed 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.543 1.937 . . . . 0.0 108.169 169.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 13' ' ' SER . 73.8 mt -127.47 159.04 67.77 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 127.158 2.183 . . . . 0.0 107.441 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.87 158.19 34.74 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.167 2.578 . . . . 0.0 112.041 -178.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.33 151.46 50.22 Favored Glycine 0 CA--C 1.538 1.474 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 167.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -58.47 141.67 97.38 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.446 2.097 . . . . 0.0 111.528 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -63.21 168.25 11.28 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 121.147 1.231 . . . . 0.0 110.491 163.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -88.19 163.39 16.18 Favored 'General case' 0 N--CA 1.453 -0.31 0 O-C-N 121.66 -0.65 . . . . 0.0 109.381 172.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.482 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 10.9 tmtt? -57.39 125.49 71.71 Favored Pre-proline 0 C--O 1.239 0.512 0 CA-C-O 117.092 -1.432 . . . . 0.0 109.467 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -65.88 157.9 56.71 Favored 'Trans proline' 0 N--CA 1.445 -1.332 0 C-N-CA 121.293 1.328 . . . . 0.0 111.842 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -135.06 118.39 16.71 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 127.396 2.279 . . . . 0.0 105.988 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.2 m -63.16 161.71 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 114.394 -1.276 . . . . 0.0 109.429 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.4 p -140.75 -79.91 0.27 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 124.442 1.097 . . . . 0.0 109.082 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -79.69 143.01 34.98 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.539 1.536 . . . . 0.0 108.335 170.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.01 146.51 21.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 160.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.3 p -118.04 -62.47 1.54 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -169.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.9 pttt 172.4 -34.98 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 130.647 3.579 . . . . 0.0 108.196 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -138.49 5.82 2.48 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.731 1.212 . . . . 0.0 111.018 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 m -132.75 155.34 49.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 174.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.2 p -155.44 134.64 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 125.261 1.424 . . . . 0.0 107.859 175.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 98.0 m -95.89 128.52 42.85 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.114 0.966 . . . . 0.0 109.22 178.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 42.6 mt -113.32 122.59 47.86 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 127.002 2.121 . . . . 0.0 107.381 -177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.2 t -92.42 147.83 22.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 159.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.49 ' CH2' HD11 ' A' ' 51' ' ' ILE . 44.1 p90 -139.85 172.15 13.19 Favored 'General case' 0 C--N 1.318 -0.803 0 C-N-CA 124.821 1.248 . . . . 0.0 107.92 156.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -109.06 144.11 29.01 Favored Pre-proline 0 C--O 1.238 0.475 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -81.21 158.36 20.16 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.839 3.026 . . . . 0.0 112.141 -168.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -93.97 -176.21 39.49 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 123.915 0.769 . . . . 0.0 112.008 171.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.47 154.85 87.79 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.298 1.439 . . . . 0.0 111.326 -178.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.41 -101.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.538 0.695 1 C-N-CA 125.667 4.245 . . . . 0.0 109.631 161.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.34 -92.67 0.69 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 128.194 2.807 . . . . 0.0 108.769 161.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -55.66 28.91 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.292 2.237 . . . . 0.0 109.963 175.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 46.2 mt -134.29 160.4 68.63 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 125.068 1.347 . . . . 0.0 109.096 172.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -75.28 154.17 40.99 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 124.237 3.291 . . . . 0.0 108.981 172.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.2 161.82 21.23 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 122.489 1.137 . . . . 0.0 110.359 170.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.439 ' HB2' HG22 ' A' ' 92' ' ' ILE . 3.2 m -119.58 -43.87 2.57 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.76 2.424 . . . . 0.0 109.237 -175.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.07 -164.83 0.57 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.33 1.452 . . . . 0.0 107.725 169.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -128.92 161.03 30.8 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 127.372 2.269 . . . . 0.0 108.362 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.0 mt -126.98 156.2 38.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 127.872 2.469 . . . . 0.0 106.471 170.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.49 HD11 ' CH2' ' A' ' 36' ' ' TRP . 70.7 mt -122.66 136.27 60.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 160.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -109.73 153.05 24.85 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 166.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.09 155.84 48.37 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.977 1.311 . . . . 0.0 107.686 174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -133.05 153.69 51.26 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.485 1.514 . . . . 0.0 107.258 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 32.6 t -153.37 133.47 13.34 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 161.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.36 -18.37 63.06 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -103.1 1.79 33.81 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.162 1.385 . . . . 0.0 113.127 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -94.21 -79.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 168.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.1 m -128.78 -6.14 5.1 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 117.944 -1.027 . . . . 0.0 113.133 178.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.6 t30 55.46 47.55 20.85 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 119.582 1.083 . . . . 0.0 109.0 -169.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.1 m -142.61 139.37 31.27 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 127.53 2.332 . . . . 0.0 107.932 -172.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -77.47 129.61 35.95 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 162.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -126.55 152.54 46.42 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.538 1.135 . . . . 0.0 108.215 172.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.87 135.23 47.9 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 167.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.73 0.08 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 125.326 1.451 . . . . 0.0 112.317 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.565 ' HB2' ' CE2' ' A' ' 74' ' ' TYR . . . -151.68 139.53 19.92 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 164.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -142.93 143.69 32.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 118.668 0.667 . . . . 0.0 110.102 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 37.37 63.15 0.77 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.508 1.523 . . . . 0.0 111.36 -165.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.7 t -86.38 133.84 28.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 171.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -118.5 45.95 1.92 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.061 0.945 . . . . 0.0 109.754 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.0 t -157.88 -174.58 4.91 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.65 1.58 . . . . 0.0 107.543 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.3 p -124.95 3.26 8.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 127.051 2.141 . . . . 0.0 111.454 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.8 131.46 53.77 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 165.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 66' ' ' ALA . 56.4 t80 -145.96 151.06 37.2 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.563 1.145 . . . . 0.0 109.267 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.3 m -109.84 102.31 11.1 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 126.058 1.743 . . . . 0.0 107.357 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.83 141.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -133.85 -177.59 4.63 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 126.032 1.733 . . . . 0.0 108.24 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.09 78.95 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 123.157 0.408 . . . . 0.0 112.876 169.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.83 -171.8 3.15 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 124.008 0.923 . . . . 0.0 108.837 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -116.39 143.19 30.68 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 125.107 1.363 . . . . 0.0 109.092 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -74.56 157.75 44.36 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.248 2.632 . . . . 0.0 111.885 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.1 t30 46.64 34.27 2.41 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.348 1.859 . . . . 0.0 112.023 -174.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 70.3 m -125.02 130.33 52.11 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -175.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mm -74.71 151.29 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 173.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -131.91 169.1 16.75 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.11 169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.425 HD13 ' SD ' ' A' ' 103' ' ' MET . 14.6 mt -119.74 156.25 30.92 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 152.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -131.01 146.44 52.39 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.119 1.768 . . . . 0.0 106.742 173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.73 117.92 9.54 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.863 1.665 . . . . 0.0 107.012 -177.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 39.4 t -94.24 112.76 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -97.85 135.56 39.42 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 163.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.71 166.74 15.88 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 165.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.439 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.6 OUTLIER -127.73 151.56 34.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 C-N-CA 125.74 1.616 . . . . 0.0 108.168 178.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -145.04 178.43 1.44 Allowed Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 126.067 1.747 . . . . 0.0 108.447 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.63 -10.04 10.63 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.865 2.377 . . . . 0.0 115.848 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -113.13 -32.79 6.21 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 120.411 1.46 . . . . 0.0 112.935 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.4 -156.58 17.89 Favored Glycine 0 C--O 1.238 0.397 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -172.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.6 mp -103.93 149.51 25.05 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.776 1.23 . . . . 0.0 110.056 172.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 54.9 p -72.16 166.27 22.69 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.772 173.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -39.37 146.62 0.34 Allowed Pre-proline 0 C--O 1.239 0.515 0 C-N-CA 126.446 1.899 . . . . 0.0 112.157 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -64.43 104.96 0.56 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.63 2.22 . . . . 0.0 109.051 166.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.1 p -48.82 166.89 0.22 Allowed Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 128.002 2.521 . . . . 0.0 113.907 176.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -53.59 135.67 62.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.252 1.968 . . . . 0.0 110.044 155.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.425 ' SD ' HD13 ' A' ' 86' ' ' LEU . 45.5 mtt -63.69 163.4 11.52 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 118.9 0.773 . . . . 0.0 110.234 171.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.482 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 85.6 p -65.7 -1.75 3.03 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 61.57 155.08 0.11 Allowed Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.726 1.611 . . . . 0.0 110.925 -159.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -69.98 98.74 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.48 2.12 . . . . 0.0 111.65 -168.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.1 m -99.26 142.55 14.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.89 0.876 . . . . 0.0 110.597 -176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 12.9 ttt85 -93.11 147.99 22.39 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 122.96 0.504 . . . . 0.0 110.53 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 19.7 p -79.32 152.03 30.71 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 158.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -60.87 -97.9 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.611 1.964 . . . . 0.0 111.654 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -175.56 154.31 1.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 127.335 2.254 . . . . 0.0 106.396 -177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 3.8 t -111.64 17.37 20.0 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.507 1.123 . . . . 0.0 111.999 -172.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -63.98 -74.71 0.42 Allowed Glycine 0 CA--C 1.534 1.257 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 168.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.47 147.93 90.58 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.765 1.643 . . . . 0.0 110.328 -177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 15.0 m -142.48 140.56 31.93 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -174.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 t -151.87 90.55 1.55 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-N 119.419 1.009 . . . . 0.0 111.246 -168.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 N-CA-C 105.264 -3.135 . . . . 0.0 105.264 167.087 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.696 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -157.21 111.03 2.61 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 125.48 1.512 . . . . 0.0 107.697 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.0 p -157.5 169.98 23.47 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.976 0.91 . . . . 0.0 108.777 157.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.41 -162.87 11.02 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 125.357 1.456 . . . . 0.0 109.781 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.6 m -62.63 168.92 3.37 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.796 0.808 . . . . 0.0 110.049 162.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.6 m -57.17 166.96 0.97 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.042 0.937 . . . . 0.0 108.915 152.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.57 37.21 0.02 OUTLIER Glycine 0 C--N 1.33 0.231 0 CA-C-O 118.585 -1.119 . . . . 0.0 112.974 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -107.43 135.09 49.49 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 118.801 1.301 . . . . 0.0 108.353 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -141.39 -167.18 2.35 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 149.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -84.73 172.22 11.69 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.696 1.134 . . . . 0.0 108.055 154.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -141.12 -174.55 4.04 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 125.183 1.393 . . . . 0.0 107.533 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.49 -23.13 9.47 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 119.743 1.156 . . . . 0.0 113.531 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.88 145.39 29.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.588 1.155 . . . . 0.0 110.207 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -70.1 -27.13 64.34 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.757 -0.589 . . . . 0.0 111.044 172.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.01 157.02 87.52 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 129.048 2.939 . . . . 0.0 110.731 176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -63.68 165.0 19.38 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 124.685 3.59 . . . . 0.0 110.829 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -80.92 159.38 41.75 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 170.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -67.2 152.86 78.94 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.061 2.508 . . . . 0.0 111.324 -176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -63.16 156.4 55.54 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 122.33 2.02 . . . . 0.0 110.493 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.4 m -79.02 176.99 9.15 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.845 -0.534 . . . . 0.0 109.724 176.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 104' ' ' SER . 28.5 tttt -55.51 120.3 30.57 Favored Pre-proline 0 C--O 1.235 0.33 0 CA-C-O 117.945 -1.026 . . . . 0.0 108.679 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -60.48 141.42 95.41 Favored 'Trans proline' 0 N--CA 1.447 -1.235 0 CA-C-N 120.257 1.128 . . . . 0.0 109.391 167.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.7 mm-40 -79.74 171.61 14.89 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 161.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.656 HG21 HG11 ' A' ' 107' ' ' VAL . 46.2 t -117.84 137.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 162.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . 0.257 68.7 p -117.18 -98.42 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 174.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -72.42 142.81 48.67 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 125.15 1.38 . . . . 0.0 109.08 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.7 p -136.32 143.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.79 -177.67 3.81 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 177.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.9 pttt -74.71 -16.67 60.74 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 121.259 -0.901 . . . . 0.0 112.12 173.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -136.39 2.72 2.76 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.686 1.13 . . . . 0.0 111.718 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.4 p -153.33 166.83 31.39 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 120.43 -1.418 . . . . 0.0 110.19 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -151.63 145.83 15.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.427 1.091 . . . . 0.0 108.57 175.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.1 m -105.64 124.36 49.43 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.539 1.535 . . . . 0.0 107.315 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.82 132.01 53.69 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.725 2.01 . . . . 0.0 110.828 -171.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.8 108.68 11.25 Favored 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 126.321 1.848 . . . . 0.0 106.621 -175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.4 p90 -109.86 173.11 6.47 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 176.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.13 148.87 42.41 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 168.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -78.51 134.74 12.65 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.533 3.488 . . . . 0.0 110.915 -176.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.38 -179.47 30.87 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-O 122.756 1.198 . . . . 0.0 111.165 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.7 m -61.18 154.06 63.94 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.66 1.984 . . . . 0.0 111.148 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -55.73 -174.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 125.042 3.828 . . . . 0.0 114.702 169.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.03 -154.89 7.83 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 107.427 -2.269 . . . . 0.0 107.427 170.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.01 -47.72 23.76 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 160.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.506 HD13 ' HG2' ' A' ' 94' ' ' PRO . 11.3 mt -103.62 144.01 27.8 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 118.56 0.618 . . . . 0.0 110.487 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -81.36 151.75 17.78 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 C-N-CA 123.371 2.714 . . . . 0.0 110.652 -165.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -48.71 122.42 5.6 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 124.762 1.225 . . . . 0.0 111.526 168.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.592 ' HB2' HG22 ' A' ' 92' ' ' ILE . 33.8 m -76.94 -61.82 1.85 Allowed 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 126.578 1.951 . . . . 0.0 108.434 162.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.16 -158.99 0.72 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.108 0.963 . . . . 0.0 110.115 -171.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -132.61 168.65 17.88 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.637 1.975 . . . . 0.0 109.219 165.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -123.76 159.67 28.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 128.745 2.818 . . . . 0.0 106.907 168.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 85.1 mt -130.22 129.79 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 166.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 83.8 mt-10 -108.91 166.03 11.13 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.934 0.894 . . . . 0.0 109.181 163.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.45 147.28 34.32 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 126.079 1.752 . . . . 0.0 108.205 170.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -127.89 119.78 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 104.192 -2.521 . . . . 0.0 104.192 169.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 44.6 t -73.59 -72.01 0.29 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 120.141 1.337 . . . . 0.0 110.082 166.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 142.73 -58.88 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 131.699 4.0 . . . . 0.0 106.096 -156.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.2 t -121.18 39.75 3.74 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 120.485 1.493 . . . . 0.0 109.363 -155.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.718 HG23 ' H ' ' A' ' 59' ' ' SER 0.272 25.1 m -120.41 -84.13 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -167.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.718 ' H ' HG23 ' A' ' 58' ' ' VAL . 8.3 m -129.96 16.83 5.69 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.441 1.096 . . . . 0.0 112.51 168.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 47.1 51.73 12.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.952 1.701 . . . . 0.0 111.161 173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.0 m -153.26 153.33 32.46 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.06 1.744 . . . . 0.0 108.155 171.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -61.91 137.19 58.22 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 155.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -134.42 146.62 50.01 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.72 123.42 26.66 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.32 -3.02 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 124.537 1.135 . . . . 0.0 111.611 -176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -152.45 140.05 19.77 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 158.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.38 129.04 30.67 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -172.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 63.41 56.33 1.67 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.033 1.733 . . . . 0.0 112.094 -176.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.25 134.31 27.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 125.474 1.51 . . . . 0.0 107.977 177.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 70' ' ' LYS . 32.9 mtpt -122.89 51.84 1.39 Allowed 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.974 2.109 . . . . 0.0 109.108 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 t -150.45 -178.69 6.68 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.643 1.577 . . . . 0.0 107.22 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.6 p -118.52 2.12 11.76 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.171 1.789 . . . . 0.0 111.213 171.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.6 tp -137.55 103.66 5.11 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -176.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -128.52 137.29 51.69 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.7 m -86.13 105.2 16.37 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.98 140.47 19.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 168.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.3 mtt180 -129.13 178.5 6.37 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.259 1.424 . . . . 0.0 110.89 -173.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 69.24 13.62 67.64 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 124.748 1.166 . . . . 0.0 114.304 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 93.1 mt -76.02 164.81 25.78 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.68 1.229 . . . . 0.0 110.31 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -93.29 146.03 31.14 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.219 177.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -79.66 157.48 24.84 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.95 2.433 . . . . 0.0 110.581 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 53.23 14.59 0.53 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.782 1.633 . . . . 0.0 113.542 -176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -109.29 132.12 54.42 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 120.208 1.367 . . . . 0.0 108.744 -170.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 14.1 mm -61.96 145.63 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 172.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 55' ' ' SER . 85.3 m-85 -140.42 150.77 44.28 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.927 1.346 . . . . 0.0 108.369 163.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 47.8 mt -110.36 162.28 14.8 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 111.675 -2.511 . . . . 0.0 107.926 159.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -142.21 126.31 17.39 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 126.48 1.912 . . . . 0.0 108.769 -175.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 69.1 mtm -104.99 154.82 19.6 Favored 'General case' 0 CA--C 1.521 -0.164 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 163.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.97 134.72 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 103.514 -2.772 . . . . 0.0 103.514 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.871 ' HD3' HD13 ' A' ' 97' ' ' LEU . 49.0 mtt180 -118.72 147.55 43.72 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 167.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.9 158.84 20.47 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 165.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.592 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.5 OUTLIER -125.52 143.98 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 172.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.417 ' HA ' ' H ' ' A' ' 47' ' ' SER . 0.6 OUTLIER -138.02 172.82 6.12 Favored Pre-proline 0 C--N 1.325 -0.485 0 C-N-CA 126.0 1.72 . . . . 0.0 107.288 173.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.506 ' HG2' HD13 ' A' ' 44' ' ' LEU . 44.8 Cg_endo -81.97 28.12 0.57 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.553 2.168 . . . . 0.0 112.382 -172.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -132.78 -42.45 0.91 Allowed 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 127.134 2.174 . . . . 0.0 110.46 171.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -175.27 -177.36 44.28 Favored Glycine 0 CA--C 1.526 0.762 0 CA-C-O 122.336 0.965 . . . . 0.0 112.959 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.871 HD13 ' HD3' ' A' ' 90' ' ' ARG . 2.5 pp -92.42 165.47 13.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.433 1.493 . . . . 0.0 111.052 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.55 ' O ' HD12 ' A' ' 97' ' ' LEU . 18.9 p -87.18 167.16 14.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -174.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.1 150.72 1.02 Allowed Pre-proline 0 C--O 1.237 0.424 0 O-C-N 121.524 -0.735 . . . . 0.0 109.205 152.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.55 154.89 72.3 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 120.863 1.042 . . . . 0.0 110.444 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 p -53.25 151.36 9.77 Favored Pre-proline 0 C--O 1.241 0.64 0 C-N-CA 123.463 0.705 . . . . 0.0 111.043 160.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -53.54 140.94 64.21 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.77 1.647 . . . . 0.0 109.841 154.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.4 mmt -57.66 129.44 41.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.027 0.531 . . . . 0.0 111.715 178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.645 ' HA ' ' HE2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -61.87 -16.41 50.23 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.534 1.534 . . . . 0.0 112.255 169.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.5 t0 85.87 153.38 0.1 Allowed Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 129.457 3.103 . . . . 0.0 110.824 178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -73.09 97.08 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.901 2.401 . . . . 0.0 112.185 -164.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.656 HG11 HG21 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -85.73 156.3 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.305 0 C-N-CA 124.66 1.184 . . . . 0.0 109.481 176.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.4 ttt-85 -106.08 165.33 11.3 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 124.969 1.308 . . . . 0.0 109.038 172.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 7.7 p -102.03 163.76 12.07 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 125.283 1.433 . . . . 0.0 109.248 169.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -74.05 174.56 8.46 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.947 0.88 . . . . 0.0 111.669 -178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -62.37 151.64 36.3 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 127.102 2.161 . . . . 0.0 109.73 170.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.8 t -130.56 74.48 1.6 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.418 1.087 . . . . 0.0 108.288 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -138.33 -115.85 1.38 Allowed Glycine 0 CA--C 1.531 1.035 0 N-CA-C 108.248 -1.941 . . . . 0.0 108.248 175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.12 158.22 45.69 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.283 2.655 . . . . 0.0 111.168 -178.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.6 p -162.13 162.64 28.6 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 121.653 -0.654 . . . . 0.0 110.8 167.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 71.2 m 47.72 36.12 5.32 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.253 1.421 . . . . 0.0 112.768 -172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.817 0 N-CA-C 105.478 -3.049 . . . . 0.0 105.478 176.228 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.91 0 CA-C-O 121.143 0.302 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.6 m -141.96 3.79 1.63 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.156 1.782 . . . . 0.0 111.852 162.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 t -147.07 88.47 1.73 Allowed 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.48 118.49 2.52 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 108.568 -1.813 . . . . 0.0 108.568 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.6 m -157.26 43.92 0.35 Allowed 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.981 1.312 . . . . 0.0 109.865 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 p -145.71 167.35 23.36 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.688 0.795 . . . . 0.0 109.669 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 63.67 -134.77 41.33 Favored Glycine 0 CA--C 1.521 0.417 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -168.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 33.1 tttt -140.89 167.17 22.83 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 168.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -154.97 139.4 16.8 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 119.508 1.049 . . . . 0.0 109.838 165.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -68.69 -30.04 68.62 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.801 0.841 . . . . 0.0 110.984 172.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 47.47 -162.6 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 127.349 2.26 . . . . 0.0 110.693 -162.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.41 31.09 5.67 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.4 1.08 . . . . 0.0 108.671 166.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 t -58.21 132.68 54.29 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.942 0.897 . . . . 0.0 110.379 -170.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.63 -42.58 24.56 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt -76.68 141.64 69.14 Favored Pre-proline 0 CA--C 1.531 0.243 0 C-N-CA 124.805 1.242 . . . . 0.0 110.227 -174.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -66.93 147.11 79.82 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 122.345 2.03 . . . . 0.0 111.519 -174.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -53.08 142.01 28.55 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 125.422 1.487 . . . . 0.0 110.363 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.3 148.85 85.11 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.706 2.27 . . . . 0.0 110.231 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -64.61 160.7 38.74 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 121.819 1.679 . . . . 0.0 110.867 174.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.0 m -67.16 168.32 10.51 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.86 0.864 . . . . 0.0 109.788 172.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -57.02 124.64 66.56 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-O 117.23 -1.367 . . . . 0.0 109.013 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.18 135.81 32.84 Favored 'Trans proline' 0 N--CA 1.45 -1.08 0 CA-C-N 121.535 1.584 . . . . 0.0 110.535 173.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -80.36 168.61 18.81 Favored 'General case' 0 CA--C 1.508 -0.66 0 C-N-CA 125.103 1.361 . . . . 0.0 109.778 166.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.2 t -130.5 95.33 2.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 112.056 -2.338 . . . . 0.0 106.169 171.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.3 p -93.58 -89.33 0.21 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.91 126.29 28.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.566 1.146 . . . . 0.0 110.542 -177.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -138.49 159.1 31.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.714 1.206 . . . . 0.0 108.079 173.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 p -137.95 -56.52 0.67 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.872 1.804 . . . . 0.0 115.872 -171.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt 170.85 -31.44 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.548 1 C-N-CA 132.082 4.153 . . . . 0.0 108.969 174.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -139.25 2.26 2.06 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.528 1.531 . . . . 0.0 112.12 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.3 p -132.4 154.56 49.69 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 119.093 0.86 . . . . 0.0 109.919 165.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.8 p -147.63 141.92 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.75 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.49 143.41 26.84 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.5 mt -112.66 138.35 49.58 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.352 1.461 . . . . 0.0 107.81 174.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -125.89 120.51 30.63 Favored 'General case' 0 C--O 1.232 0.154 0 N-CA-C 104.66 -2.348 . . . . 0.0 104.66 177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 25.8 p90 -136.63 170.55 15.88 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 120.272 1.397 . . . . 0.0 107.63 171.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -115.64 149.61 43.33 Favored Pre-proline 0 C--O 1.237 0.443 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.51 153.29 15.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.358 2.039 . . . . 0.0 110.126 -165.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -81.87 176.44 54.02 Favored Glycine 0 N--CA 1.437 -1.26 0 CA-C-O 122.642 1.135 . . . . 0.0 111.633 -176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.9 m -62.01 149.5 85.94 Favored Pre-proline 0 N--CA 1.435 -1.217 0 C-N-CA 126.355 1.862 . . . . 0.0 108.667 177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -69.55 178.68 4.2 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 CA-C-O 123.77 1.488 . . . . 0.0 113.049 170.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -148.57 -160.79 9.24 Favored Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 130.686 3.993 . . . . 0.0 103.401 170.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -43.66 72.97 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 123.805 0.842 . . . . 0.0 111.52 -173.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.6 mt -98.46 154.52 37.52 Favored Pre-proline 0 N--CA 1.468 0.445 0 CA-C-N 118.793 0.724 . . . . 0.0 111.478 -172.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -76.84 151.54 31.56 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.943 3.095 . . . . 0.0 110.316 -176.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.27 104.27 9.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.426 ' H ' ' HA ' ' A' ' 93' ' ' ASN . 3.0 m -52.43 -52.8 52.07 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.251 2.221 . . . . 0.0 112.929 176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -169.81 -163.81 0.39 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.509 1.924 . . . . 0.0 107.201 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -127.23 157.96 38.41 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.82 1.248 . . . . 0.0 110.08 171.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 mt -107.1 154.12 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 126.661 1.984 . . . . 0.0 107.217 164.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.45 119.73 46.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 166.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -100.91 155.85 17.72 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 170.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.66 156.37 48.95 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 126.192 1.797 . . . . 0.0 106.306 169.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -132.83 156.14 47.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.182 -1.785 . . . . 0.0 106.182 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.03 124.41 5.29 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 170.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -68.01 -21.67 65.03 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.776 -175.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.0 t -94.65 -3.49 49.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.18 0.992 . . . . 0.0 111.697 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.0 t -111.28 -68.15 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 125.235 1.414 . . . . 0.0 108.367 -161.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.3 m -142.95 -5.25 0.89 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.967 1.307 . . . . 0.0 111.611 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 t30 54.36 32.03 15.63 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.763 1.225 . . . . 0.0 112.777 -177.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 m -133.95 153.16 51.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.568 1.547 . . . . 0.0 108.27 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -71.29 141.74 50.5 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 159.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -135.11 132.76 38.5 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 175.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 55.8 m -71.87 94.18 1.4 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 m -77.97 -25.63 14.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 123.781 0.832 . . . . 0.0 110.902 -176.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.03 147.75 46.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 163.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -133.96 143.96 48.49 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.452 1.501 . . . . 0.0 107.597 177.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 47.26 64.55 1.53 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.068 1.347 . . . . 0.0 111.595 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.3 133.5 29.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.7 mtmt -117.89 56.65 0.85 Allowed 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.853 1.261 . . . . 0.0 108.271 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.8 t -161.35 176.58 11.01 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 174.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 52.4 p -110.46 0.0 17.63 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.578 1.551 . . . . 0.0 111.465 173.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -142.99 101.57 3.85 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 124.581 1.152 . . . . 0.0 108.944 -169.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -134.18 124.29 25.77 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.612 0.765 . . . . 0.0 112.838 -164.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.0 m -70.82 98.37 1.55 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.764 2.426 . . . . 0.0 110.805 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.83 146.99 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 O-C-N 120.646 -1.284 . . . . 0.0 108.167 163.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 36.3 mtt180 -140.81 -178.19 5.43 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.053 -1.03 . . . . 0.0 109.861 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 65.25 49.66 60.45 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 172.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 29.6 mt -115.26 -160.5 0.74 Allowed 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.822 1.249 . . . . 0.0 108.905 -175.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 mtt85 -131.08 139.57 35.95 Favored Pre-proline 0 N--CA 1.468 0.451 0 CA-C-O 117.793 -1.099 . . . . 0.0 110.541 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.79 160.21 50.14 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.312 2.674 . . . . 0.0 111.601 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.1 m120 47.95 21.93 0.34 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 126.207 1.803 . . . . 0.0 113.844 -177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 21.4 m -121.03 121.44 37.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 125.83 1.652 . . . . 0.0 106.789 -170.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 13.3 mm -58.78 146.27 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 170.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -136.07 159.91 40.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 162.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.4 HD13 ' SD ' ' A' ' 103' ' ' MET . 15.0 mt -112.2 162.57 15.33 Favored 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 125.758 1.623 . . . . 0.0 107.782 158.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -142.57 143.42 32.45 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.439 1.712 . . . . 0.0 107.727 178.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 mtm -138.46 149.04 45.04 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.13 150.31 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -129.02 148.46 50.97 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 167.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.25 152.42 22.32 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 163.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -124.34 151.03 29.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 -179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.426 ' HA ' ' H ' ' A' ' 47' ' ' SER . 1.0 OUTLIER -146.61 174.99 2.96 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.034 0.934 . . . . 0.0 109.529 -179.093 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -76.54 29.5 0.4 Allowed 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.913 3.075 . . . . 0.0 114.114 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -140.56 -52.19 0.48 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.49 1.916 . . . . 0.0 109.756 -174.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.96 -144.06 4.03 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 127.263 2.363 . . . . 0.0 108.971 -170.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.3 pp -142.73 167.43 22.1 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.865 1.266 . . . . 0.0 111.609 178.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 44.7 p -75.35 165.52 25.03 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.269 0.628 . . . . 0.0 110.645 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -51.83 152.19 5.5 Favored Pre-proline 0 C--O 1.24 0.59 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 157.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -68.9 142.28 51.35 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.665 1.577 . . . . 0.0 109.136 175.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.8 p -59.09 162.27 7.73 Favored Pre-proline 0 CA--C 1.551 0.985 0 O-C-N 121.812 -0.555 . . . . 0.0 111.062 170.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -54.55 129.83 36.94 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.6 2.867 . . . . 0.0 109.835 167.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.4 ' SD ' HD13 ' A' ' 86' ' ' LEU . 5.4 mtm -49.75 151.68 1.7 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.322 1.419 . . . . 0.0 113.199 -176.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.3 p -60.5 -12.22 9.12 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 65.79 155.04 0.13 Allowed Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 126.344 1.857 . . . . 0.0 108.739 -157.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -70.74 137.42 32.56 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 122.229 1.953 . . . . 0.0 109.883 -175.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.3 m -130.62 125.78 59.41 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.35 127.65 35.49 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 11.9 p -66.07 157.96 29.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 173.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -66.91 172.99 3.88 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.633 0.73 . . . . 0.0 110.146 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.74 8.0 9.04 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.579 1.151 . . . . 0.0 113.932 -169.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 t 59.53 31.27 20.88 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.032 2.533 . . . . 0.0 113.714 -177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -136.04 73.32 0.44 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 171.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.26 177.05 6.33 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.866 2.377 . . . . 0.0 112.59 -178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 29.1 t -136.41 -177.48 4.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.719 2.008 . . . . 0.0 106.856 174.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.7 p -130.62 114.51 15.52 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.279 1.832 . . . . 0.0 107.128 175.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.786 0 CA-C-O 117.462 -1.744 . . . . 0.0 109.042 178.915 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.863 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 m -110.08 11.28 23.89 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.336 0.655 . . . . 0.0 112.605 -153.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.3 p -66.69 -179.94 0.95 Allowed 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.199 0.999 . . . . 0.0 110.95 175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.87 -126.66 0.73 Allowed Glycine 0 CA--C 1.528 0.845 0 N-CA-C 107.9 -2.08 . . . . 0.0 107.9 149.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.9 m 75.38 126.49 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 127.868 2.467 . . . . 0.0 109.607 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.0 m -42.26 127.2 3.57 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 125.238 1.415 . . . . 0.0 110.315 175.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.29 -179.45 29.65 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.042 1.306 . . . . 0.0 110.459 -175.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.8 mttp 60.39 168.27 0.08 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 128.048 2.539 . . . . 0.0 113.167 -164.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -154.0 100.7 2.36 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.601 1.96 . . . . 0.0 107.04 171.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.5 m-30 -67.64 -28.91 68.12 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.503 0.721 . . . . 0.0 112.766 -174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 53.35 -159.57 0.14 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.1 1.76 . . . . 0.0 111.932 176.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.6 mt -119.46 78.53 1.32 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 166.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.5 m -69.67 161.8 28.98 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.944 0.878 . . . . 0.0 110.138 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 6.4 m-20 -74.05 -36.25 64.35 Favored 'General case' 0 C--O 1.236 0.386 0 O-C-N 121.909 -0.494 . . . . 0.0 110.666 173.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.99 155.24 64.36 Favored Pre-proline 0 CA--C 1.534 0.347 0 C-N-CA 124.405 1.082 . . . . 0.0 109.99 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.21 149.66 84.04 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 122.889 2.392 . . . . 0.0 112.422 176.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.89 148.48 44.78 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 169.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.62 156.45 53.63 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.813 2.342 . . . . 0.0 113.053 -169.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -66.68 175.07 5.66 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.493 2.795 . . . . 0.0 112.837 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -61.09 171.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.922 0.868 . . . . 0.0 111.769 164.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -52.96 133.57 48.94 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-O 118.299 -0.858 . . . . 0.0 108.856 157.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.54 148.27 90.49 Favored 'Trans proline' 0 N--CA 1.45 -1.083 0 C-N-CA 121.433 1.422 . . . . 0.0 110.927 167.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -119.3 117.14 27.78 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 125.612 1.565 . . . . 0.0 108.658 175.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -66.89 144.6 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-N 113.357 -1.747 . . . . 0.0 107.698 169.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.5 p -128.75 -85.72 0.56 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -73.84 149.12 41.79 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.704 1.602 . . . . 0.0 109.475 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.97 141.95 28.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 122.004 0.907 . . . . 0.0 108.687 161.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.9 p -128.54 -172.21 2.65 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 125.675 1.59 . . . . 0.0 107.996 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -62.05 -36.99 83.27 Favored 'General case' 0 C--O 1.221 -0.44 0 O-C-N 121.176 -0.953 . . . . 0.0 112.706 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -139.67 23.86 2.45 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.902 1.228 . . . . 0.0 111.398 -177.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.0 m -146.14 164.13 33.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.518 0.599 . . . . 0.0 109.501 172.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.05 138.61 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.0 m -94.44 135.18 36.16 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.3 mt -124.36 130.63 52.84 Favored 'General case' 0 CA--C 1.512 -0.502 0 C-N-CA 125.886 1.674 . . . . 0.0 108.318 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.428 ' HB2' ' CD1' ' A' ' 73' ' ' LEU . 1.4 t -103.32 151.92 22.16 Favored 'General case' 0 CA--C 1.516 -0.348 0 C-N-CA 124.69 1.196 . . . . 0.0 108.127 161.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.597 ' CH2' HD11 ' A' ' 51' ' ' ILE . 24.2 p90 -140.04 171.12 14.63 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 156.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.32 144.82 32.46 Favored Pre-proline 0 C--O 1.239 0.516 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 171.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -77.94 140.73 18.42 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.835 2.357 . . . . 0.0 110.751 -167.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.21 -168.19 26.12 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 166.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.3 m -86.85 159.98 50.76 Favored Pre-proline 0 N--CA 1.441 -0.878 0 C-N-CA 128.775 2.83 . . . . 0.0 109.458 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.84 -169.06 0.4 Allowed 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 124.813 3.676 . . . . 0.0 111.085 166.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -131.35 -148.41 6.21 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 105.872 -2.891 . . . . 0.0 105.872 164.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -53.63 -33.4 54.95 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.549 0.739 . . . . 0.0 110.144 171.095 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 95' ' ' GLN . 12.6 mt -104.36 157.72 33.47 Favored Pre-proline 0 C--O 1.235 0.34 0 CA-C-N 118.379 0.536 . . . . 0.0 111.124 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.36 170.58 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.099 0 C-N-CA 123.045 2.497 . . . . 0.0 109.303 164.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -95.61 162.6 13.56 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.473 1.109 . . . . 0.0 109.033 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.5 m -116.54 -47.28 2.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.86 2.064 . . . . 0.0 109.481 -171.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -164.51 -160.99 0.55 Allowed 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -134.83 148.86 50.26 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.444 2.298 . . . . 0.0 108.555 175.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.405 HG23 HG23 ' A' ' 64' ' ' THR . 2.2 mt -124.99 113.86 37.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 129.15 2.98 . . . . 0.0 105.754 172.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.597 HD11 ' CH2' ' A' ' 36' ' ' TRP . 69.7 mt -94.54 120.39 43.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 171.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -104.78 154.29 20.21 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 170.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.26 148.21 51.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 126.015 1.726 . . . . 0.0 108.08 173.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -110.23 157.46 19.42 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 166.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.3 144.57 21.01 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 165.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -95.53 -4.99 43.77 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.545 1.538 . . . . 0.0 112.622 -173.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.0 m -119.56 9.98 11.66 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.362 1.465 . . . . 0.0 113.281 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.4 t -115.17 -77.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 126.14 1.776 . . . . 0.0 109.023 -168.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.5 m -141.67 5.85 1.81 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 119.289 0.95 . . . . 0.0 112.786 -175.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.3 m120 59.58 2.93 0.37 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 128.431 2.692 . . . . 0.0 114.964 -175.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 67.7 m -106.23 161.16 14.78 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 126.632 1.973 . . . . 0.0 110.518 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.424 ' CH2' ' HG3' ' A' ' 88' ' ' MET . 81.6 m95 -77.78 144.62 36.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 153.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -138.32 148.68 44.87 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 173.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.405 HG23 HG23 ' A' ' 50' ' ' ILE . 32.4 m -77.19 108.57 10.39 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 175.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.3 m -95.11 -15.47 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 124.215 1.006 . . . . 0.0 111.93 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -150.92 102.45 2.98 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 119.307 0.958 . . . . 0.0 108.835 167.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.81 157.89 15.73 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 122.196 0.998 . . . . 0.0 110.394 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.8 m170 44.89 46.23 8.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 128.473 2.709 . . . . 0.0 112.449 175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 76.4 t -79.99 136.75 22.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 126.75 2.02 . . . . 0.0 108.056 177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.5 mtmt -123.27 61.41 1.04 Allowed 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 122.093 0.949 . . . . 0.0 108.799 174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.6 t -158.31 179.27 9.3 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 174.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.9 p -122.85 5.86 9.37 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.697 1.199 . . . . 0.0 111.441 179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 35' ' ' SER . 7.8 tp -135.89 128.36 30.46 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 163.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 29.2 t80 -145.95 151.24 37.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.3 m -101.42 103.77 14.7 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 125.227 1.411 . . . . 0.0 107.827 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.52 137.49 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 59.4 mtt-85 -122.48 -167.38 1.56 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.546 1.938 . . . . 0.0 107.543 169.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.68 21.11 64.53 Favored Glycine 0 CA--C 1.524 0.647 0 CA-C-O 119.298 -0.723 . . . . 0.0 114.112 171.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.9 mt -99.95 -166.46 1.34 Allowed 'General case' 0 C--O 1.237 0.44 0 CA-C-N 118.822 1.311 . . . . 0.0 110.616 -167.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.9 mtp180 -122.73 153.15 63.15 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 127.044 2.138 . . . . 0.0 107.248 170.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -82.69 156.17 15.92 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.519 2.146 . . . . 0.0 110.382 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 35.58 57.94 0.88 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.222 1.809 . . . . 0.0 110.598 -173.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 86.9 m -139.0 138.33 37.15 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 126.66 1.984 . . . . 0.0 106.19 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.7 mm -79.44 146.1 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.127 177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -142.13 150.87 41.68 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 125.179 1.391 . . . . 0.0 109.411 173.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 24.7 mt -108.03 166.27 10.85 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 162.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -138.34 149.22 45.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.647 1.217 . . . . 0.0 108.731 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.424 ' HG3' ' CH2' ' A' ' 62' ' ' TRP . 73.3 mtm -136.81 152.53 50.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 163.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 36' ' ' TRP . 71.0 t -119.3 109.66 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -169.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.603 ' HD3' HD13 ' A' ' 97' ' ' LEU . 73.8 mtt180 -94.84 132.28 39.81 Favored 'General case' 0 CA--C 1.513 -0.454 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 170.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.18 129.25 35.03 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 165.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.05 149.52 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 170.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.7 176.79 2.27 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.101 1.361 . . . . 0.0 108.926 177.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.99 4.09 0.77 Allowed 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.581 2.854 . . . . 0.0 115.935 179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.537 ' HB2' HD12 ' A' ' 44' ' ' LEU . 15.8 tp60 -140.48 -17.4 0.89 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.926 1.29 . . . . 0.0 112.617 -161.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 165.19 -156.84 29.05 Favored Glycine 0 CA--C 1.524 0.628 0 C-N-CA 125.858 1.694 . . . . 0.0 109.402 -176.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.603 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.4 pp -129.76 146.97 51.5 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 125.849 1.66 . . . . 0.0 107.765 177.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 29.3 p -72.41 167.11 21.23 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 -175.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.04 153.75 0.49 Allowed Pre-proline 0 N--CA 1.469 0.501 0 C-N-CA 125.234 1.413 . . . . 0.0 110.919 173.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -60.1 136.3 68.18 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 N-CA-C 108.468 -1.397 . . . . 0.0 108.468 170.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 86.6 p -61.3 172.02 1.08 Allowed Pre-proline 0 CA--C 1.539 0.539 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 165.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.98 144.77 35.33 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 121.012 1.142 . . . . 0.0 109.733 156.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 2.2 mtp -65.51 143.6 57.55 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 168.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 89.6 p -64.48 -2.48 2.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.902 1.681 . . . . 0.0 115.043 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t0 68.71 151.5 0.13 Allowed Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 127.945 2.498 . . . . 0.0 109.751 -158.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -70.65 105.58 1.66 Allowed 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 123.081 2.521 . . . . 0.0 110.206 -176.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.0 p -77.83 167.72 2.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 170.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.95 129.04 47.38 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 125.201 1.4 . . . . 0.0 108.233 172.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 13.2 p -65.4 160.64 21.52 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 123.208 0.317 . . . . 0.0 110.81 171.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -83.88 -176.75 6.43 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.202 1.001 . . . . 0.0 110.458 178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.95 157.52 31.25 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.021 1.728 . . . . 0.0 111.991 -177.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.3 m -115.83 32.67 5.95 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 126.562 1.945 . . . . 0.0 113.345 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -77.86 -138.31 1.17 Allowed Glycine 0 CA--C 1.532 1.152 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 168.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -61.8 163.54 18.63 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 CA-C-N 119.688 1.744 . . . . 0.0 110.441 174.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -101.36 133.1 46.49 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.722 0.809 . . . . 0.0 109.353 -177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.12 165.23 7.39 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 157.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.908 0 N-CA-C 107.138 -2.385 . . . . 0.0 107.138 -176.013 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.043 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 m -125.33 67.43 1.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 172.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.2 p -145.64 80.1 1.58 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -162.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.7 -44.95 95.62 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.565 -164.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -179.57 155.03 0.64 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.294 1.438 . . . . 0.0 109.999 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.3 m -73.41 -39.46 65.02 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 122.807 0.443 . . . . 0.0 110.865 163.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.53 -152.4 45.04 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -168.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -131.5 129.36 41.01 Favored 'General case' 0 CA--C 1.513 -0.475 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -144.51 91.03 2.14 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 171.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -75.8 162.34 28.25 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 163.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.0 t70 72.86 -178.0 0.19 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.441 1.896 . . . . 0.0 109.365 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.5 mt -101.17 34.39 2.55 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.961 1.304 . . . . 0.0 108.263 160.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 55.2 m 56.66 37.33 28.73 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 126.209 1.803 . . . . 0.0 112.59 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.449 ' HA ' ' HB ' ' A' ' 43' ' ' THR . 94.2 m-20 -65.97 -34.3 77.8 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.645 1.178 . . . . 0.0 111.861 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.26 151.22 96.11 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.159 1.784 . . . . 0.0 111.077 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -66.38 159.93 47.91 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.879 3.053 . . . . 0.0 111.35 177.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -64.07 152.38 48.99 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 109.991 -1.244 . . . . 0.0 109.991 175.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.91 138.91 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.182 0 C-N-CA 121.708 1.605 . . . . 0.0 108.606 167.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -64.91 163.7 27.29 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 121.894 1.729 . . . . 0.0 111.168 175.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 62.3 m -74.25 160.46 31.09 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.54 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.89 121.12 21.53 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.042 1.337 . . . . 0.0 112.027 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -69.45 146.59 62.61 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.755 1.636 . . . . 0.0 113.577 -177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -114.11 125.25 53.75 Favored 'General case' 0 CA--C 1.498 -1.054 0 C-N-CA 125.602 1.561 . . . . 0.0 111.373 -179.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 107' ' ' VAL . 1.3 m -86.08 133.25 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.099 0 CA-C-N 113.615 -1.63 . . . . 0.0 108.885 -176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.1 p -121.88 -90.97 0.57 Allowed 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -167.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -72.23 141.16 48.98 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 167.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.34 136.02 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 162.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.9 p -105.76 -52.88 2.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.362 -170.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 pttp 160.61 -26.13 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.331 1 C-N-CA 133.795 4.838 . . . . 0.0 108.373 -178.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -143.18 -0.29 1.13 Allowed 'General case' 0 CA--C 1.523 -0.083 0 O-C-N 121.173 -0.954 . . . . 0.0 112.745 178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -125.15 160.33 29.38 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.945 1.248 . . . . 0.0 110.156 160.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -152.51 130.96 2.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.127 1.371 . . . . 0.0 108.475 175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 90.3 m -90.21 122.57 33.26 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 126.825 2.05 . . . . 0.0 108.249 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.75 126.64 54.79 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 126.874 2.07 . . . . 0.0 107.844 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.06 152.65 18.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 160.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.7 p90 -139.76 172.42 12.81 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 152.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -102.09 146.03 31.56 Favored Pre-proline 0 C--O 1.239 0.528 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 160.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.3 156.12 62.65 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 123.558 2.839 . . . . 0.0 109.964 -174.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -85.13 177.86 50.76 Favored Glycine 0 N--CA 1.439 -1.15 0 CA-C-O 123.878 1.821 . . . . 0.0 110.815 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.9 m -64.73 154.82 84.29 Favored Pre-proline 0 N--CA 1.436 -1.151 0 C-N-CA 127.546 2.338 . . . . 0.0 109.357 176.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -65.62 -171.69 0.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.995 2.463 . . . . 0.0 112.828 166.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -133.62 -149.75 6.14 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 107.174 -2.37 . . . . 0.0 107.174 171.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 14' ' ' ASP . 0.3 OUTLIER -73.7 -45.01 54.92 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 161.28 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 mt -97.59 150.19 36.52 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 123.365 0.666 . . . . 0.0 109.978 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.23 151.61 54.91 Favored 'Trans proline' 0 N--CA 1.447 -1.258 0 C-N-CA 123.889 3.059 . . . . 0.0 109.537 -175.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.58 159.97 26.3 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.649 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.499 ' HB2' HG22 ' A' ' 92' ' ' ILE . 21.2 m -135.71 -42.0 0.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.447 1.499 . . . . 0.0 110.514 -166.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.58 -171.07 2.99 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.373 1.069 . . . . 0.0 108.427 165.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -112.56 167.57 10.35 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.851 0.834 . . . . 0.0 109.686 156.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.05 158.16 23.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.677 2.791 . . . . 0.0 106.471 164.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 66' ' ' ALA . 92.3 mt -127.05 139.16 52.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 166.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -118.83 161.98 19.24 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.776 1.231 . . . . 0.0 108.275 172.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' HB3' HG11 ' A' ' 65' ' ' VAL . . . -143.87 162.15 36.84 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.195 1.398 . . . . 0.0 108.559 172.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -136.2 149.49 48.6 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 126.652 1.981 . . . . 0.0 106.057 173.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.665 ' HB3' HG22 ' A' ' 58' ' ' VAL . 8.1 t -141.42 165.07 28.53 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 161.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -98.71 33.84 2.2 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.378 1.071 . . . . 0.0 111.761 171.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.92 34.01 0.21 Allowed 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.268 -0.895 . . . . 0.0 112.42 165.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG22 ' HB3' ' A' ' 55' ' ' SER . 14.8 m -120.14 -72.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.959 1.304 . . . . 0.0 109.628 -175.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.577 ' H ' HG23 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -154.01 0.66 0.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.887 1.275 . . . . 0.0 112.005 -178.48 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 63.14 -21.11 0.05 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.266 2.626 . . . . 0.0 115.36 -178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 28.9 m -63.66 159.27 19.39 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.476 1.91 . . . . 0.0 110.714 164.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 68.5 m95 -76.37 154.49 34.88 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 151.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -141.92 152.97 44.02 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 134.46 49.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 165.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 53' ' ' ALA . 22.9 m -122.98 -19.1 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 118.308 -0.854 . . . . 0.0 111.473 176.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . -135.63 157.06 47.82 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 119.904 1.229 . . . . 0.0 108.338 160.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -143.02 147.75 35.62 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.471 -0.936 . . . . 0.0 108.471 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 52.52 49.37 20.56 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 122.014 0.912 . . . . 0.0 111.806 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 71.5 t -79.13 102.27 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 33.8 mtmt -94.47 50.67 1.37 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 124.876 1.27 . . . . 0.0 109.076 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -157.44 -170.06 3.1 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.057 1.743 . . . . 0.0 107.508 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 38.4 p -131.98 2.91 4.03 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.116 2.166 . . . . 0.0 111.624 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.0 tp -129.38 120.64 25.9 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 169.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -145.21 151.45 38.43 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.051 0.94 . . . . 0.0 109.502 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 51.8 m -110.2 114.29 27.66 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 124.396 1.078 . . . . 0.0 108.733 -175.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.1 t -64.88 145.96 13.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 168.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -133.43 176.98 8.05 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 112.111 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.42 27.09 57.78 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.788 1.185 . . . . 0.0 113.935 169.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.9 mt -79.32 -179.13 6.59 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 118.153 0.977 . . . . 0.0 110.075 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -96.8 139.23 21.47 Favored Pre-proline 0 CA--C 1.516 -0.365 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 174.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.63 159.97 47.56 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.513 2.142 . . . . 0.0 110.32 173.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.8 t30 48.53 34.79 5.2 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.94 1.696 . . . . 0.0 111.8 177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.1 m -133.19 132.89 42.07 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 126.111 1.764 . . . . 0.0 107.581 -171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.31 147.87 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 170.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -131.58 159.16 39.03 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 156.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.2 mt -107.52 157.71 17.8 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 152.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -132.72 152.12 51.81 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 125.828 1.955 . . . . 0.0 107.369 172.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 66.8 mtm -133.61 165.84 23.97 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 107.742 -1.206 . . . . 0.0 107.742 162.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.67 145.7 25.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 170.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.653 ' HD3' HD22 ' A' ' 97' ' ' LEU . 7.8 mtp180 -120.95 147.62 45.21 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 162.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.99 159.05 19.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 163.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.499 HG22 ' HB2' ' A' ' 47' ' ' SER . 1.5 mt -121.28 150.7 24.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 C-N-CA 126.316 1.846 . . . . 0.0 107.535 175.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -149.62 172.2 5.49 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 127.138 2.175 . . . . 0.0 107.322 -178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -59.9 -23.93 74.37 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.65 2.233 . . . . 0.0 114.985 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -105.64 -45.99 4.28 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.576 1.55 . . . . 0.0 110.407 -170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -157.98 174.84 35.29 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 122.739 1.188 . . . . 0.0 112.214 -170.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.653 HD22 ' HD3' ' A' ' 90' ' ' ARG . 1.3 mp -84.86 166.75 16.61 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 172.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -72.36 166.24 22.91 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 122.171 0.986 . . . . 0.0 109.619 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -52.81 159.88 1.64 Allowed Pre-proline 0 C--O 1.242 0.677 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.148 152.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.24 148.3 61.66 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 121.091 1.194 . . . . 0.0 111.182 -172.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.1 p -62.38 167.51 5.25 Favored Pre-proline 0 CA--C 1.537 0.469 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 159.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -52.97 150.34 23.78 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 121.427 1.418 . . . . 0.0 109.724 152.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -69.04 154.85 41.36 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.648 166.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.1 p -60.54 -7.53 2.21 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.578 2.351 . . . . 0.0 115.143 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t70 75.7 153.63 0.14 Allowed Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 127.333 2.253 . . . . 0.0 109.169 -155.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -77.55 108.5 2.59 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.976 2.451 . . . . 0.0 108.603 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.542 HG11 HG11 ' A' ' 24' ' ' VAL . 3.6 m -108.49 133.23 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.493 0 C-N-CA 124.544 1.138 . . . . 0.0 109.156 -171.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.1 ttt85 -92.66 135.27 34.24 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 17.7 p -63.68 154.32 33.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.971 0.891 . . . . 0.0 109.185 164.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -58.44 171.66 0.57 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 123.614 1.673 . . . . 0.0 110.02 163.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -77.27 149.72 35.39 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.925 169.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.8 p -58.32 15.97 0.0 OUTLIER 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 129.16 2.984 . . . . 0.0 115.41 167.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -67.62 147.13 48.08 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-N 119.667 1.121 . . . . 0.0 110.823 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.33 139.59 46.06 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 N-CA-C 107.423 -1.799 . . . . 0.0 107.423 159.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 8.7 p -148.66 175.91 10.8 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 125.497 1.519 . . . . 0.0 108.916 -175.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -147.41 -168.4 3.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.688 1.195 . . . . 0.0 108.455 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 N-CA-C 106.728 -2.549 . . . . 0.0 106.728 171.53 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.704 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m 66.4 81.52 0.2 Allowed 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 126.12 1.768 . . . . 0.0 112.325 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 m -145.04 152.9 40.85 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.527 0.731 . . . . 0.0 109.616 164.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.16 166.46 54.82 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 174.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.5 t -136.38 99.86 4.21 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 -175.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.1 m -153.26 14.92 0.52 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.478 1.111 . . . . 0.0 112.596 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.87 83.23 0.92 Allowed Glycine 0 C--N 1.334 0.47 0 C-N-CA 125.531 1.539 . . . . 0.0 110.103 -178.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -75.94 74.85 2.85 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 122.236 1.017 . . . . 0.0 110.819 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -127.99 157.78 39.69 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.899 2.479 . . . . 0.0 104.962 166.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -68.76 157.0 37.29 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 155.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -67.53 157.46 34.27 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.584 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.3 mt -117.51 -132.3 0.32 Allowed 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -168.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.6 m -67.41 157.91 33.0 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 124.15 0.98 . . . . 0.0 111.909 -170.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -73.64 18.2 0.13 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.771 1.628 . . . . 0.0 112.505 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.1 mt -105.87 148.34 36.33 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 125.561 1.544 . . . . 0.0 110.193 -171.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -62.52 159.45 36.29 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 125.078 3.852 . . . . 0.0 113.425 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -58.66 141.94 46.1 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.825 1.202 . . . . 0.0 111.227 173.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -66.84 147.49 80.88 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.255 1.97 . . . . 0.0 110.841 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.9 164.76 15.68 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.583 2.189 . . . . 0.0 112.413 174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -74.91 167.87 21.04 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.707 0.803 . . . . 0.0 110.037 176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -59.4 117.83 25.55 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-O 117.093 -1.432 . . . . 0.0 108.854 174.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.03 157.33 60.02 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 CA-C-N 120.619 1.257 . . . . 0.0 111.182 172.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -124.24 146.86 48.47 Favored 'General case' 0 CA--C 1.5 -0.969 0 C-N-CA 126.789 2.036 . . . . 0.0 109.367 176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 107' ' ' VAL . 2.5 m -96.75 139.03 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 C-N-CA 124.511 1.124 . . . . 0.0 108.309 -176.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.0 p -128.74 -79.78 0.57 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 118.686 -0.673 . . . . 0.0 110.533 -179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.05 130.73 42.28 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 172.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 p -139.53 137.09 40.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 164.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.4 p -115.47 -74.33 0.62 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 -162.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 112' ' ' SER . 3.1 pttp -171.34 -29.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.395 1 C-N-CA 133.272 4.629 . . . . 0.0 108.638 161.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -109.8 -15.47 14.1 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 125.821 1.648 . . . . 0.0 109.944 -177.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.7 m -142.33 159.37 42.36 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 118.604 0.638 . . . . 0.0 110.094 -167.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.428 HG12 ' CD1' ' A' ' 79' ' ' LEU . 1.8 p -153.13 128.92 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.8 m -86.13 138.72 31.7 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.448 1.099 . . . . 0.0 110.066 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.9 mt -113.04 141.38 46.94 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.363 2.265 . . . . 0.0 107.931 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.5 t -130.77 129.45 42.47 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 126.99 2.116 . . . . 0.0 108.381 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -140.34 170.59 15.52 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.538 0.685 . . . . 0.0 112.19 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -98.77 145.63 30.27 Favored Pre-proline 0 C--O 1.239 0.535 0 C-N-CA 124.324 1.05 . . . . 0.0 108.749 164.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.32 139.39 14.68 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 124.478 3.452 . . . . 0.0 109.483 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.75 -179.06 44.71 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 165.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.6 m -87.04 151.01 51.13 Favored Pre-proline 0 N--CA 1.435 -1.188 0 C-N-CA 128.312 2.645 . . . . 0.0 110.163 -172.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.81 -174.87 2.05 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.664 3.576 . . . . 0.0 111.757 163.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -160.98 -126.41 0.82 Allowed Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.5 p -57.13 -31.02 64.9 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 128.266 2.626 . . . . 0.0 114.318 -173.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 47.4 mt -130.95 164.91 38.77 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 125.35 1.46 . . . . 0.0 109.234 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.78 135.7 6.87 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.993 2.462 . . . . 0.0 109.843 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.9 149.97 43.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.753 -1.112 . . . . 0.0 108.328 164.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.1 t -125.06 -56.7 1.54 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.628 1.171 . . . . 0.0 109.014 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 92' ' ' ILE . . . -152.55 -177.38 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.4 ' CD1' ' HA ' ' A' ' 91' ' ' ALA . 89.1 m-85 -122.91 173.17 7.96 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 123.755 0.822 . . . . 0.0 109.204 174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.3 mt -121.49 152.86 25.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 126.835 2.054 . . . . 0.0 106.448 166.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 93.7 mt -123.29 137.44 56.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 160.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.52 164.51 15.7 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 124.514 1.125 . . . . 0.0 108.56 170.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.18 163.7 32.16 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.275 1.43 . . . . 0.0 108.44 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -159.32 124.07 4.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 108.7 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.69 ' HB3' HG22 ' A' ' 58' ' ' VAL . 12.6 t -106.17 1.63 26.31 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.381 1.072 . . . . 0.0 112.457 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 53.46 3.09 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -167.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.53 1.24 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 O-C-N 120.651 -1.28 . . . . 0.0 111.907 -173.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.69 HG22 ' HB3' ' A' ' 55' ' ' SER . 1.6 m -74.69 -78.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 109.327 173.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.407 ' H ' HG23 ' A' ' 58' ' ' VAL . 37.2 m -121.35 15.35 11.32 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.549 1.14 . . . . 0.0 110.848 164.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.1 m120 53.86 27.16 6.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.298 1.439 . . . . 0.0 110.835 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.6 m -144.41 151.81 39.78 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 128.825 2.85 . . . . 0.0 108.503 -167.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -78.76 142.74 36.77 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.16 0.584 . . . . 0.0 109.911 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.2 mt-30 -135.76 135.88 40.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.276 0.631 . . . . 0.0 109.71 -169.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.79 94.34 1.39 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.7 m -81.65 -21.75 10.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 118.732 -0.651 . . . . 0.0 111.053 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -153.39 107.34 3.05 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 173.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -83.84 168.09 16.44 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 169.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 36.5 58.61 1.04 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 127.84 2.456 . . . . 0.0 112.627 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.4 t -76.93 118.59 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 173.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -111.5 50.07 0.85 Allowed 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.62 1.168 . . . . 0.0 108.645 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -156.14 -177.75 6.81 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.727 1.211 . . . . 0.0 108.064 179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.3 p -118.58 0.98 11.65 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 128.909 2.883 . . . . 0.0 110.917 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.19 111.38 7.08 Favored 'General case' 0 C--N 1.344 0.343 0 C-N-CA 124.731 1.213 . . . . 0.0 109.182 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -141.19 127.77 20.13 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.737 0.815 . . . . 0.0 111.164 -171.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.4 m -75.96 103.16 5.9 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 127.169 2.188 . . . . 0.0 109.229 170.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 45.7 t -70.15 147.34 11.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 166.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -135.96 174.49 10.55 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.046 1.339 . . . . 0.0 113.591 -168.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.09 6.07 82.04 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 126.117 1.817 . . . . 0.0 114.718 168.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' CD1' HG12 ' A' ' 32' ' ' VAL . 24.9 mt -74.48 171.96 12.83 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 126.17 1.788 . . . . 0.0 111.111 -168.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -90.0 142.77 29.1 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 126.011 1.724 . . . . 0.0 108.567 177.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -77.76 156.57 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.265 2.644 . . . . 0.0 109.461 174.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 40.51 48.07 2.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.089 1.756 . . . . 0.0 111.958 -176.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 83.5 m -133.64 132.73 41.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.918 1.687 . . . . 0.0 106.761 -178.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.27 146.8 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -138.96 157.15 46.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 160.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.474 HD13 ' SD ' ' A' ' 103' ' ' MET . 70.7 mt -107.35 157.13 18.19 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 127.504 2.322 . . . . 0.0 106.271 158.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -138.5 146.23 41.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 126.195 2.185 . . . . 0.0 107.862 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.1 mtm -142.53 152.51 42.7 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 166.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.1 t -105.13 144.04 15.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 C-N-CA 125.366 1.466 . . . . 0.0 107.187 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.477 ' HD3' HD13 ' A' ' 97' ' ' LEU . 43.7 mtt180 -128.65 139.87 52.04 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 169.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HA ' ' CD1' ' A' ' 49' ' ' TYR . . . -86.89 149.14 25.02 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -123.53 145.29 30.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 124.218 1.007 . . . . 0.0 109.889 -177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -150.46 177.24 1.92 Allowed Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 125.026 1.33 . . . . 0.0 109.109 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.69 67.24 8.48 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.072 2.514 . . . . 0.0 110.135 177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -163.88 -73.31 0.04 OUTLIER 'General case' 0 C--O 1.235 0.329 0 C-N-CA 128.835 2.854 . . . . 0.0 104.637 166.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -151.53 -164.34 12.09 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 126.136 1.827 . . . . 0.0 110.93 -168.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.477 HD13 ' HD3' ' A' ' 90' ' ' ARG . 4.6 pp -101.14 151.59 21.65 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.13 1.372 . . . . 0.0 108.381 172.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 53.4 p -72.67 167.63 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.179 1.792 . . . . 0.0 110.466 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -50.66 150.29 5.13 Favored Pre-proline 0 C--O 1.244 0.771 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.368 158.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.33 161.0 45.1 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 121.316 1.344 . . . . 0.0 111.106 176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 91.8 p -55.57 167.61 0.74 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.258 163.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -47.52 144.25 10.6 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 121.66 1.573 . . . . 0.0 110.484 151.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.474 ' SD ' HD13 ' A' ' 86' ' ' LEU . 22.4 mtm -64.65 144.86 56.93 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.442 0.697 . . . . 0.0 109.789 171.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 83.7 p -63.99 -9.55 16.46 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 127.187 2.195 . . . . 0.0 113.736 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 77.56 155.28 0.14 Allowed Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 128.808 2.843 . . . . 0.0 108.792 -160.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -73.14 117.94 5.33 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.591 2.194 . . . . 0.0 108.53 -179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 24' ' ' VAL . 2.7 m -116.48 135.1 57.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.312 0 C-N-CA 124.956 1.302 . . . . 0.0 110.083 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.51 142.37 27.77 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.5 p -73.46 159.33 33.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 123.428 1.585 . . . . 0.0 109.495 162.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -66.27 175.04 2.32 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 112.417 -2.174 . . . . 0.0 110.955 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -74.18 157.69 35.49 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 111.623 -2.535 . . . . 0.0 110.086 163.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.457 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 6.2 t -85.6 48.96 1.67 Allowed 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 125.869 1.668 . . . . 0.0 109.101 169.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -115.8 159.54 13.78 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 126.963 2.221 . . . . 0.0 110.04 172.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.91 164.74 33.57 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.721 2.281 . . . . 0.0 111.377 -171.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 59.0 m -153.26 -54.86 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.491 1.117 . . . . 0.0 108.538 166.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.3 m 55.57 18.84 2.93 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.46 1.104 . . . . 0.0 113.615 -172.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.343 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 177.934 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.407 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 m -134.93 85.02 2.14 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 117.965 0.882 . . . . 0.0 109.26 -170.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -152.76 3.9 0.34 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -175.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.47 72.07 0.66 Allowed Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -168.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.4 t -54.23 121.66 8.67 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 125.662 1.585 . . . . 0.0 111.439 -174.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.2 m -61.26 -57.54 11.97 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.572 0.749 . . . . 0.0 111.075 -178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.32 -69.52 1.11 Allowed Glycine 0 CA--C 1.529 0.94 0 CA-C-O 118.26 -1.3 . . . . 0.0 110.372 -169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 98.3 mttt 40.07 80.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 128.747 2.819 . . . . 0.0 111.646 177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -141.32 179.97 6.47 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.925 1.69 . . . . 0.0 107.335 171.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -143.26 123.16 13.49 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.314 1.446 . . . . 0.0 109.214 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.01 155.19 34.88 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.572 1.549 . . . . 0.0 108.682 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.39 78.47 9.64 Favored 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 125.863 1.665 . . . . 0.0 107.385 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -139.83 153.08 46.97 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 123.797 0.839 . . . . 0.0 110.485 174.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -101.87 17.8 22.16 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.686 2.394 . . . . 0.0 109.762 174.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 97' ' ' LEU . 86.1 mt -98.78 162.69 20.8 Favored Pre-proline 0 CA--C 1.536 0.412 0 O-C-N 119.799 -1.813 . . . . 0.0 110.556 -174.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -61.76 164.8 15.22 Favored 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.765 2.31 . . . . 0.0 111.806 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.17 126.61 28.79 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 164.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -61.95 154.49 61.35 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.215 1.943 . . . . 0.0 111.82 -177.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -80.06 173.16 13.0 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.457 2.771 . . . . 0.0 111.236 -177.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.0 p -66.61 170.13 6.74 Favored 'General case' 0 C--O 1.236 0.349 0 O-C-N 121.702 -0.624 . . . . 0.0 111.373 175.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -49.9 124.41 16.54 Favored Pre-proline 0 C--O 1.237 0.417 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 150.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.55 150.1 74.77 Favored 'Trans proline' 0 N--CA 1.448 -1.173 0 C-N-CA 121.203 1.269 . . . . 0.0 109.178 170.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -111.78 124.29 52.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 172.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.65 142.46 16.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.353 173.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.5 p -122.01 -87.63 0.63 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -76.92 134.59 38.9 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 124.258 1.023 . . . . 0.0 109.049 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.77 138.65 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 119.099 0.863 . . . . 0.0 109.697 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.3 p -126.87 -162.21 1.13 Allowed 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.998 1.719 . . . . 0.0 107.861 -177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.6 pttt -77.18 -29.06 54.21 Favored 'General case' 0 C--O 1.222 -0.369 0 O-C-N 121.192 -0.943 . . . . 0.0 111.075 -175.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -150.87 14.57 0.73 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 119.199 0.909 . . . . 0.0 111.955 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m -127.27 163.08 24.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.046 0.451 . . . . 0.0 111.782 159.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -150.78 146.86 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 C-N-CA 125.692 1.597 . . . . 0.0 107.38 169.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.9 m -102.07 149.43 24.27 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.469 1.508 . . . . 0.0 109.084 172.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 71.3 mt -129.38 148.46 51.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 128.261 2.624 . . . . 0.0 107.535 -173.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.2 m -139.94 114.71 9.47 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 124.515 1.134 . . . . 0.0 108.998 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.455 ' CH2' HD11 ' A' ' 51' ' ' ILE . 42.6 p90 -134.87 153.11 52.18 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 118.903 0.774 . . . . 0.0 111.217 -176.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.9 mm-40 -93.48 140.9 23.3 Favored Pre-proline 0 N--CA 1.449 -0.495 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.49 148.29 18.27 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 124.096 3.197 . . . . 0.0 108.987 179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -82.76 -178.05 52.21 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-O 122.27 0.928 . . . . 0.0 111.632 164.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.3 m -55.12 153.95 11.44 Favored Pre-proline 0 N--CA 1.442 -0.834 0 C-N-CA 126.957 2.103 . . . . 0.0 108.444 158.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.56 -114.17 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 124.143 3.229 . . . . 0.0 108.51 162.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.4 -109.81 0.42 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.244 -1.543 . . . . 0.0 109.244 164.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.8 p -60.35 -35.3 75.35 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.729 2.012 . . . . 0.0 111.819 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 38.9 mt -132.63 169.24 14.46 Favored Pre-proline 0 N--CA 1.452 -0.333 0 C-N-CA 125.849 1.66 . . . . 0.0 109.07 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -83.48 155.74 14.16 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.507 2.805 . . . . 0.0 109.271 168.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.94 160.46 32.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.551 0.691 . . . . 0.0 109.656 171.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.429 ' HB2' HG22 ' A' ' 92' ' ' ILE . 3.5 m -117.81 -43.37 2.78 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.074 1.75 . . . . 0.0 109.822 -175.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.0 -172.27 1.11 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.468 1.107 . . . . 0.0 109.592 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.714 ' HB2' HG23 ' A' ' 69' ' ' VAL . 12.4 m-85 -116.78 165.6 13.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.729 1.612 . . . . 0.0 107.961 167.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.88 154.04 37.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 129.361 3.064 . . . . 0.0 104.833 168.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.455 HD11 ' CH2' ' A' ' 36' ' ' TRP . 82.2 mt -129.29 135.9 60.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 166.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -118.84 156.51 29.32 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 175.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -137.17 157.87 45.69 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.032 1.333 . . . . 0.0 108.193 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -144.96 163.11 35.18 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 125.915 1.686 . . . . 0.0 109.81 -178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -156.75 -38.69 0.08 Allowed 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -161.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 64.09 -22.46 0.07 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 127.71 2.404 . . . . 0.0 116.585 -172.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -108.25 -24.45 11.5 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 121.036 1.744 . . . . 0.0 112.109 175.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.438 HG22 ' HD2' ' A' ' 80' ' ' ARG . 78.3 t -69.9 -77.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 120.209 1.368 . . . . 0.0 109.418 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.6 m -135.49 22.91 3.42 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.511 1.125 . . . . 0.0 111.535 -173.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.7 t30 23.22 60.23 0.03 OUTLIER 'General case' 0 C--O 1.233 0.213 0 C-N-CA 129.367 3.067 . . . . 0.0 112.815 176.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.7 m -165.74 158.61 15.42 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.674 1.989 . . . . 0.0 108.952 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.462 ' CZ3' ' HG3' ' A' ' 88' ' ' MET . 67.3 m95 -72.46 123.85 23.96 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 162.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -113.24 139.17 49.03 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -83.41 94.36 7.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.3 m -82.33 -19.17 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 123.856 0.862 . . . . 0.0 112.366 -171.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.62 143.31 32.34 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.14 0.976 . . . . 0.0 108.488 169.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -136.91 157.2 47.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.338 0.655 . . . . 0.0 109.553 175.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.6 m170 52.71 32.78 12.6 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.45 1.5 . . . . 0.0 111.922 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.714 HG23 ' HB2' ' A' ' 49' ' ' TYR . 3.2 m -74.39 154.28 6.67 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-O 122.326 1.06 . . . . 0.0 110.229 177.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -134.73 54.14 1.96 Allowed 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -175.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -148.6 176.41 10.36 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.585 178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.7 p -117.41 -3.04 11.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.441 1.497 . . . . 0.0 111.698 169.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mp -129.23 133.55 47.58 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.068 1.347 . . . . 0.0 108.949 166.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.538 ' CD2' HG11 ' A' ' 69' ' ' VAL . 27.3 t80 -146.48 146.31 30.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 84.9 m -108.09 97.85 7.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.919 1.688 . . . . 0.0 108.904 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -64.95 134.83 29.09 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 O-C-N 121.218 -0.926 . . . . 0.0 108.99 174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -128.16 171.82 11.57 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 123.285 0.634 . . . . 0.0 112.028 169.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 92.36 16.13 50.95 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.99 1.281 . . . . 0.0 112.994 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.1 mt -83.32 -166.84 1.47 Allowed 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.743 1.217 . . . . 0.0 109.51 -175.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.438 ' HD2' HG22 ' A' ' 58' ' ' VAL . 12.9 mtt85 -121.45 143.72 38.42 Favored Pre-proline 0 CA--C 1.517 -0.326 0 C-N-CA 124.422 1.089 . . . . 0.0 109.502 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -67.95 157.26 62.56 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 123.481 2.787 . . . . 0.0 111.822 170.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 55.02 3.83 0.07 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 128.016 2.526 . . . . 0.0 116.24 -176.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.2 m -101.3 130.66 47.5 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 126.34 1.856 . . . . 0.0 108.746 -166.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 10.2 mm -68.71 147.07 12.42 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 170.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -142.27 165.3 27.8 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 124.654 1.181 . . . . 0.0 108.928 168.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 27.8 mt -117.39 157.95 25.29 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 125.53 1.532 . . . . 0.0 108.121 162.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -143.07 131.43 22.15 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 125.298 1.624 . . . . 0.0 109.283 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.462 ' HG3' ' CZ3' ' A' ' 62' ' ' TRP . 5.4 mtt -115.67 173.31 6.61 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.89 151.8 35.17 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.426 ' HD3' HD13 ' A' ' 97' ' ' LEU . 95.4 mtt180 -138.65 121.9 17.0 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.4 ' HB2' ' CE1' ' A' ' 49' ' ' TYR . . . -86.15 118.95 25.94 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 176.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.429 HG22 ' HB2' ' A' ' 47' ' ' SER . 0.8 OUTLIER -86.14 148.24 4.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 108.996 -179.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -150.76 173.6 4.21 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.773 1.629 . . . . 0.0 108.632 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -74.99 23.58 0.4 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.119 2.546 . . . . 0.0 113.658 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -130.38 -17.45 3.35 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.839 1.656 . . . . 0.0 113.919 173.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 158.3 -143.47 9.4 Favored Glycine 0 C--N 1.32 -0.311 0 C-N-CA 123.909 0.766 . . . . 0.0 112.371 -176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.517 ' O ' HD13 ' A' ' 15' ' ' LEU . 4.1 pp -129.81 144.7 51.43 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.229 1.812 . . . . 0.0 107.768 177.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.7 p -72.33 159.37 34.14 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.67 0.788 . . . . 0.0 109.737 -176.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -48.86 132.31 14.65 Favored Pre-proline 0 C--O 1.234 0.262 0 C-N-CA 124.084 0.954 . . . . 0.0 110.388 -172.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -51.04 113.96 1.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 124.112 3.208 . . . . 0.0 111.49 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 55.0 p -52.67 159.23 1.8 Allowed Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 123.648 0.779 . . . . 0.0 112.832 -174.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -52.26 144.14 40.17 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.863 3.042 . . . . 0.0 111.073 163.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.5 mtp -67.28 144.43 55.91 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.506 0.722 . . . . 0.0 112.619 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.3 p -65.7 -5.19 7.84 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 127.818 2.447 . . . . 0.0 116.1 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 70.46 144.64 0.1 Allowed Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.139 1.776 . . . . 0.0 111.024 -165.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -71.58 106.84 2.04 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.166 2.578 . . . . 0.0 110.849 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.9 m -105.0 140.61 22.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 C-N-CA 125.383 1.473 . . . . 0.0 109.965 -176.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 20.1 ttt180 -87.15 -174.4 4.87 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 123.524 0.73 . . . . 0.0 109.98 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 26.0 p -130.99 158.23 40.84 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.364 1.866 . . . . 0.0 107.195 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -68.38 173.29 5.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.825 0.821 . . . . 0.0 110.039 178.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -80.32 160.34 25.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.816 -1.084 . . . . 0.0 109.94 172.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.2 t -111.09 -8.87 14.4 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 128.31 2.644 . . . . 0.0 110.736 -176.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -76.77 -177.7 45.26 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 124.715 1.15 . . . . 0.0 111.45 177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.63 62.84 7.25 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 124.131 3.221 . . . . 0.0 108.915 165.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.2 m -50.73 113.04 0.8 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.893 2.077 . . . . 0.0 111.117 -166.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 7.1 p -154.3 176.06 12.76 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 125.162 1.385 . . . . 0.0 109.968 -174.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.027 0 N-CA-C 104.723 -3.351 . . . . 0.0 104.723 -167.743 . . . . . . . . 0 0 . 1 stop_ save_